data_1emw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1emw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.307 0.575 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.03 133.23 29.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.498 HD12 ' CD1' ' A' ' 36' ' ' ILE . 79.8 mt -99.74 133.99 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.31 -0.869 . . . . 0.0 109.054 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.28 -171.57 3.97 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.957 -1.089 . . . . 0.0 110.586 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.462 HD21 ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -88.7 126.75 35.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 110.255 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.05 104.28 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.374 -0.829 . . . . 0.0 110.613 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.306 -0.872 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 10.7 m-85 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.6 mtm-85 -107.99 159.35 16.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.742 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -98.78 79.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.261 0.4 OUTLIER -98.04 166.48 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.758 -174.053 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.16 109.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.768 -0.583 . . . . 0.0 110.121 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.222 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CD2' HG22 ' A' ' 20' ' ' VAL . 9.2 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.426 0.631 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.3 -23.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.638 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.62 164.35 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 116.04 31.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.516 HG22 ' CD1' ' A' ' 59' ' ' TRP . 22.9 pt -107.01 -37.43 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 0.0 111.351 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -121.63 171.04 14.96 Favored Glycine 0 C--N 1.294 -1.758 0 C-N-CA 119.006 -1.569 . . . . 0.0 111.597 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' N ' HG13 ' A' ' 19' ' ' ILE . 64.7 t80 -139.57 141.96 37.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.489 ' CD2' HD12 ' A' ' 73' ' ' LEU . 29.3 t80 -135.34 142.6 45.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.718 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 178.764 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD12 ' CD2' ' A' ' 73' ' ' LEU . 4.8 tt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.419 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 100.9 5.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.295 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.82 153.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.976 -1.078 . . . . 0.0 111.336 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.4 t0 -100.04 70.84 1.6 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -34.93 -30.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 122.312 -0.242 . . . . 0.0 111.57 -177.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 tt0 -60.81 -54.8 40.7 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.713 -1.242 . . . . 0.0 108.804 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -70.93 -39.51 72.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.364 -0.835 . . . . 0.0 108.83 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.76 -17.68 64.79 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 13.4 ttt180 -87.51 -25.15 23.82 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 4.7 t80 -60.26 -44.67 95.09 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.246 1.498 . . . . 0.0 107.966 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.543 ' CD1' HG23 ' A' ' 21' ' ' VAL . 84.7 m95 -69.73 -55.87 8.74 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.149 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.1 mt -53.33 -22.56 7.48 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.447 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 15.3 t -82.35 -22.75 35.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.455 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 59' ' ' TRP . 3.7 m -99.14 32.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 120.839 -1.163 . . . . 0.0 109.572 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.47 29.04 72.91 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.65 127.32 32.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.086 -1.244 . . . . 0.0 109.763 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -97.6 110.72 56.25 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.7 Cg_endo -85.61 129.33 3.59 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 3.2 t -55.17 168.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.762 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -55.44 -37.7 68.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.739 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -70.41 -58.56 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.729 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 5' ' ' ARG . . . -63.76 -23.33 67.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.39 -0.819 . . . . 0.0 109.117 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 67' ' ' THR . 4.1 ttt180 -69.71 -42.73 73.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -73.41 -10.04 59.32 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.49 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 39' ' ' TYR . 18.1 mt -98.22 -24.89 15.08 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 108.623 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 17.9 mt -71.11 -30.43 66.51 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HG2' ' HA ' ' A' ' 72' ' ' ARG . 10.3 ptm180 -77.78 -28.8 50.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.444 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 9.2 tp-100 -76.42 -37.22 57.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.055 0.931 . . . . 0.0 109.581 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.439 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -75.15 -1.28 22.42 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.059 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 50.33 11.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.437 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 40.2 t . . . . . 0 C--N 1.307 -1.272 0 O-C-N 121.301 -1.117 . . . . 0.0 111.721 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.403 ' CG1' HG11 ' A' ' 21' ' ' VAL . 47.9 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.215 0.531 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -140.5 133.1 28.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.489 HD11 ' CD1' ' A' ' 36' ' ' ILE . 68.8 mt -100.26 134.89 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.013 -1.054 . . . . 0.0 109.409 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.7 ptm180 -151.19 -172.72 4.29 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.1 -1.0 . . . . 0.0 110.928 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.37 125.87 35.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.21 112.87 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.364 -0.835 . . . . 0.0 110.562 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.582 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.116 . . . . 0.0 112.892 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 9.3 m-30 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.0 mtt85 -101.35 162.18 13.08 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.26 176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.93 80.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -97.46 164.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.907 -173.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.36 112.64 40.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 120.974 -1.079 . . . . 0.0 110.598 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 10.4 p90 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.631 0.729 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.25 -50.2 12.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -157.69 179.19 9.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -106.86 107.23 18.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.292 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.489 ' CD1' HD11 ' A' ' 4' ' ' ILE . 20.7 pt -100.55 -39.08 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.146 -0.971 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -118.2 166.35 12.81 Favored Glycine 0 C--N 1.296 -1.683 0 C-N-CA 118.967 -1.587 . . . . 0.0 112.122 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.431 ' N ' HG12 ' A' ' 19' ' ' ILE . 11.4 t80 -140.73 128.79 22.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.514 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 38.1 t80 -128.27 142.48 51.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.709 -1.245 . . . . 0.0 109.906 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.6 t0 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.222 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.447 HD13 ' CD2' ' A' ' 73' ' ' LEU . 9.1 tt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.228 0.537 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.18 90.38 3.28 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.682 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.51 130.93 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.005 . . . . 0.0 111.178 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.0 t0 -78.03 71.01 4.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -35.73 -30.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 122.258 -0.276 . . . . 0.0 111.624 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.8 mt-10 -59.76 -51.03 71.49 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.706 -1.247 . . . . 0.0 108.967 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 27.1 mmm180 -75.52 -38.14 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.263 -0.898 . . . . 0.0 108.713 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.82 -19.39 65.83 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.2 ttp180 -89.16 -23.81 22.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.481 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -63.31 -48.71 76.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 123.116 1.436 . . . . 0.0 107.456 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CD1' HG21 ' A' ' 21' ' ' VAL . 82.1 m95 -65.29 -56.19 14.1 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.951 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.55 -21.59 10.69 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.558 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.91 -20.45 38.73 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.427 -0.795 . . . . 0.0 110.389 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 59' ' ' TRP . 3.8 m -98.7 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.871 -1.143 . . . . 0.0 109.322 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.53 26.61 74.33 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -77.28 115.32 16.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.089 -1.242 . . . . 0.0 109.855 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 126.15 59.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 53.3 Cg_endo -85.47 162.56 11.04 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.494 1.26 . . . . 0.0 109.483 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 p -83.94 -171.69 3.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.051 -1.031 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.401 ' O ' ' OG1' ' A' ' 69' ' ' THR . 0.1 OUTLIER -83.82 48.27 1.42 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 68' ' ' ASP . 25.2 m -166.03 -56.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.62 65.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.4 ttp180 -66.59 -42.25 87.23 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -66.14 -45.81 79.71 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.786 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' ' 39' ' ' TYR . 51.7 mt -60.29 -31.99 70.77 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.412 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 20.3 mt -69.15 -26.81 65.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -28.81 30.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.811 0.815 . . . . 0.0 108.82 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -81.84 -36.15 28.6 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.904 0.859 . . . . 0.0 110.062 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.96 -9.21 43.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.751 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 53' ' ' VAL . . . 82.52 48.5 5.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.433 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 41.4 t . . . . . 0 N--CA 1.487 1.379 0 O-C-N 121.12 -1.224 . . . . 0.0 111.605 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -140.53 133.19 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.496 HD11 ' CD1' ' A' ' 36' ' ' ILE . 79.7 mt -108.34 131.2 59.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.992 -1.068 . . . . 0.0 109.883 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.0 ptm180 -151.08 -169.62 3.44 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.287 -0.883 . . . . 0.0 110.297 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 84.4 mt -89.17 127.69 35.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.519 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.25 102.34 13.95 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.713 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 112.565 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.4 m-85 . . . . . 0 C--O 1.213 -0.838 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.86 159.08 15.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -98.07 81.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.488 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -98.47 162.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.024 -174.07 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.544 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.29 109.42 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.757 -0.589 . . . . 0.0 110.529 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.983 . . . . 0.0 110.29 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.488 ' CD2' HG22 ' A' ' 20' ' ' VAL . 23.4 p90 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.547 0.689 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 ' CH2' ' A' ' 59' ' ' TRP . 8.1 mt -70.94 -51.7 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -154.65 165.45 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -0.774 . . . . 0.0 109.58 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -99.43 116.73 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 109.956 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 59' ' ' TRP . 44.9 pt -107.18 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 111.152 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.501 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -124.82 167.94 17.05 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.029 -1.557 . . . . 0.0 112.228 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 19' ' ' ILE . 37.0 t80 -140.67 129.26 22.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.5 t80 -129.71 134.07 47.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.731 -1.23 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.919 -1.113 . . . . 0.0 110.884 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.409 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 8.5 tp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.629 0.728 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.05 94.64 3.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 109.217 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.476 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.04 149.87 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -94.81 70.51 3.44 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -32.72 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -60.29 -56.02 26.56 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.802 -1.186 . . . . 0.0 109.159 178.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 4.4 mmp_? -69.92 -42.02 73.87 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 108.872 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -63.15 -18.36 63.37 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.9 ttp180 -87.87 -25.26 23.36 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.9 t80 -60.38 -45.83 92.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.359 1.552 . . . . 0.0 107.789 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' CD1' HG23 ' A' ' 21' ' ' VAL . 79.4 m95 -66.11 -54.48 25.03 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.94 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.4 ' CD1' HG11 ' A' ' 79' ' ' VAL . 18.9 mt -54.97 -21.47 11.89 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.495 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 t -81.46 -23.16 37.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 110.694 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' A' ' 59' ' ' TRP . 5.5 m -98.96 32.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.797 -1.189 . . . . 0.0 109.568 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.93 29.47 72.48 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -67.78 135.45 52.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.076 -1.25 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 109.06 61.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 110.389 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -79.13 128.3 8.14 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.619 1.326 . . . . 0.0 109.871 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 t -54.22 171.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.11 -0.994 . . . . 0.0 110.204 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.47 54.98 0.78 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -167.25 -56.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -24.22 66.36 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -67.4 -40.92 85.62 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -42.99 80.33 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.776 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 15.2 mt -67.08 -27.08 67.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 ' HA ' HG22 ' A' ' 79' ' ' VAL . 13.7 mt -69.82 -28.47 65.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -30.54 45.71 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -80.39 -31.84 37.67 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.944 0.878 . . . . 0.0 109.993 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.471 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -75.4 -2.13 27.14 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.402 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.5 51.64 9.43 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.479 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 52.6 t . . . . . 0 C--N 1.307 -1.253 0 O-C-N 121.271 -1.134 . . . . 0.0 111.872 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.458 0.647 . . . . 0.0 110.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -140.2 132.83 28.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.425 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.491 HD13 ' CB ' ' A' ' 59' ' ' TRP . 65.8 mt -107.62 133.52 52.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.044 -1.035 . . . . 0.0 110.05 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptm180 -151.07 -173.15 4.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.278 -0.889 . . . . 0.0 110.437 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mp -89.38 125.49 35.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.447 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.46 107.42 19.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.473 -0.767 . . . . 0.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 36.7 ttp85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 112.936 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 9.8 m-85 . . . . . 0 C--O 1.209 -1.06 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mtp85 -121.83 156.02 34.13 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 79.56 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.469 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.255 0.4 OUTLIER -97.95 159.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.5 -173.912 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -107.92 106.03 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.334 0.587 . . . . 0.0 110.387 -177.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 2.1 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CD2' HG21 ' A' ' 20' ' ' VAL . 32.1 p90 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.471 0.653 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 mt -56.15 -51.93 56.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.565 -0.71 . . . . 0.0 109.204 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.92 149.46 26.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -89.66 119.29 29.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 56' ' ' ALA . 27.7 pt -105.88 -34.14 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.489 -0.757 . . . . 0.0 111.738 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -120.64 169.33 14.12 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 119.118 -1.515 . . . . 0.0 112.26 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 19' ' ' ILE . 86.8 t80 -140.46 127.33 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 44.7 t80 -121.28 142.29 50.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.815 -1.178 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 178.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.6 tt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.336 0.588 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -131.47 94.66 3.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.293 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.8 148.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 111.043 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -92.38 70.65 5.15 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -36.47 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 122.224 -0.297 . . . . 0.0 111.481 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 7.2 mm-40 -61.1 -53.25 59.44 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.693 -1.254 . . . . 0.0 108.522 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -71.29 -40.59 70.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.65 -16.56 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.1 ttt-85 -88.64 -26.3 21.96 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 13.2 t80 -59.43 -42.63 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 123.212 1.482 . . . . 0.0 107.382 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.569 ' CD1' HG21 ' A' ' 21' ' ' VAL . 81.3 m95 -69.63 -54.24 14.91 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.13 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD1' HG11 ' A' ' 79' ' ' VAL . 7.4 mt -56.56 -20.9 23.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.468 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -80.72 -24.56 38.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.426 -0.796 . . . . 0.0 110.517 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 59' ' ' TRP . 27.3 m -99.01 32.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.879 -1.138 . . . . 0.0 109.606 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.02 31.48 79.57 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -60.99 146.99 45.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.242 . . . . 0.0 110.017 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 2.0 mm-40 -108.88 93.82 13.25 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.43 -0.794 . . . . 0.0 110.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 54.9 Cg_endo -80.34 124.79 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.48 1.253 . . . . 0.0 109.923 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 2.7 t -57.82 163.58 2.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.944 -1.097 . . . . 0.0 109.702 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -57.88 -22.87 50.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -84.55 -53.71 5.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.862 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -70.8 -29.45 65.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -66.9 -37.35 84.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -26.85 67.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 49' ' ' LEU . 21.0 mt -86.37 -30.39 22.2 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.541 -0.724 . . . . 0.0 109.247 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 80.7 mt -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -78.24 -30.43 48.71 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.1 tp-100 -79.11 -33.58 44.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.942 0.877 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.17 -9.43 52.87 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.704 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 53' ' ' VAL . . . 87.48 52.34 3.05 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 60' ' ' LEU . 40.2 t . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.058 -1.26 . . . . 0.0 111.519 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.449 HG11 ' CZ3' ' A' ' 59' ' ' TRP . 50.2 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.148 0.499 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -140.16 138.73 35.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.554 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.496 HD12 ' CD1' ' A' ' 36' ' ' ILE . 86.0 mt -103.25 130.92 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.29 -0.881 . . . . 0.0 109.343 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.75 -172.0 4.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 110.65 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 5.0 mp -88.97 125.56 35.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.425 -0.797 . . . . 0.0 110.469 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.55 112.51 24.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.56 -0.712 . . . . 0.0 109.797 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 112.675 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.426 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.5 ttm180 -104.55 153.52 21.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.148 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -98.53 78.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.483 HG12 ' CD2' ' A' ' 32' ' ' TYR 0.272 0.4 OUTLIER -97.98 166.17 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.527 -173.684 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -109.36 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.755 -0.59 . . . . 0.0 110.51 -177.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 110.179 179.326 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' CD2' HG12 ' A' ' 20' ' ' VAL . 17.0 p90 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.462 0.649 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.403 HG23 ' CZ2' ' A' ' 59' ' ' TRP . 2.8 mp -58.87 -53.35 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -149.75 173.74 13.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -109.93 119.7 40.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.951 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.496 ' CD1' HD12 ' A' ' 4' ' ' ILE . 21.7 pt -110.7 -38.81 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.049 -1.032 . . . . 0.0 111.656 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -121.1 167.83 14.11 Favored Glycine 0 C--N 1.295 -1.72 0 C-N-CA 118.897 -1.621 . . . . 0.0 111.45 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.45 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.7 t80 -137.23 141.17 42.06 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.425 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 25.5 t80 -138.5 139.27 38.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.75 -1.218 . . . . 0.0 110.718 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 178.869 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 10.1 tt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.229 0.537 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 3.7 mmmt -126.88 103.76 7.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' CG2' ' CD1' ' A' ' 19' ' ' ILE . 1.3 t -127.32 149.0 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.877 -1.139 . . . . 0.0 111.4 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.8 t0 -97.56 70.45 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -33.77 -32.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 120.562 0.22 . . . . 0.0 111.435 -177.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.4 tt0 -60.99 -53.98 50.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.822 -1.173 . . . . 0.0 108.865 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 48.0 mmm-85 -73.72 -38.37 64.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.27 -21.35 66.56 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -89.2 -24.11 22.22 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.104 -0.997 . . . . 0.0 109.932 178.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -59.01 -49.6 77.26 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 123.269 1.509 . . . . 0.0 107.197 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.541 ' CD1' HG22 ' A' ' 21' ' ' VAL . 84.6 m95 -62.56 -52.29 64.0 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.265 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 4.0 mt -54.24 -22.41 11.58 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.338 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -80.81 -22.08 40.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 110.743 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 59' ' ' TRP . 4.5 m -98.93 33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 120.823 -1.173 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.28 28.17 72.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 60' ' ' LEU . . . -68.21 134.01 49.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -1.228 . . . . 0.0 110.081 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.19 109.09 59.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HB3' HD13 ' A' ' 74' ' ' LEU . 51.4 Cg_endo -84.59 126.86 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.616 1.324 . . . . 0.0 110.352 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 3.3 t -60.51 173.41 0.71 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 109.89 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -58.21 -27.83 64.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 111.103 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.447 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 1.8 m -83.13 -52.08 6.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.762 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 5' ' ' ARG . . . -68.67 -26.47 65.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 67' ' ' THR . 2.4 ttt-85 -68.2 -38.65 82.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -45.22 80.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.6 mt -65.88 -25.76 67.33 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 66' ' ' PRO . 17.2 mt -74.4 -26.06 59.85 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -29.38 26.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -84.29 -36.08 22.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.823 0.82 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.14 41.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.06 57.14 2.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 21.7 t . . . . . 0 N--CA 1.486 1.337 0 O-C-N 121.176 -1.191 . . . . 0.0 111.092 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.494 HG12 ' CZ3' ' A' ' 59' ' ' TRP . 66.3 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.309 0.576 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -134.04 128.75 34.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.303 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' A' ' 4' ' ' ILE . 1.3 mm -103.74 133.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 16.5 ptm180 -151.0 177.65 9.95 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.889 -1.132 . . . . 0.0 110.858 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 pp -89.55 132.17 35.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.892 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -99.05 157.81 16.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.56 -0.712 . . . . 0.0 109.232 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.496 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 8.8 tmm_? . . . . . 0 C--N 1.303 -1.418 0 O-C-N 120.889 -1.132 . . . . 0.0 111.315 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 14.0 m-85 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -137.24 150.83 48.11 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.01 -1.056 . . . . 0.0 108.301 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -97.06 85.95 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 178.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.496 HG22 ' CG ' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -98.49 168.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.634 -173.158 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG1' ' CD2' ' A' ' 59' ' ' TRP . 1.7 t -113.81 102.78 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.694 -0.629 . . . . 0.0 110.776 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.349 -0.844 . . . . 0.0 110.391 179.833 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CG ' HG22 ' A' ' 20' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.311 0.576 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.3 -58.63 6.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -145.08 173.91 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.012 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 115.34 29.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.202 -0.936 . . . . 0.0 109.572 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 59' ' ' TRP . 18.1 pt -108.98 -40.01 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.108 -0.995 . . . . 0.0 111.243 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -111.76 167.05 12.31 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.112 -1.518 . . . . 0.0 112.225 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.432 ' N ' HG12 ' A' ' 19' ' ' ILE . 87.5 t80 -140.8 126.18 18.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.523 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 13.9 t80 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.726 -1.234 . . . . 0.0 110.046 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t0 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.071 -1.018 . . . . 0.0 109.848 179.298 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.429 ' CD1' HD22 ' A' ' 73' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.449 0.642 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -133.36 101.6 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.517 -0.74 . . . . 0.0 109.264 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -129.22 135.25 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 111.412 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.1 t0 -77.62 70.06 3.95 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -35.91 -30.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 122.276 -0.265 . . . . 0.0 111.286 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.2 -53.44 57.63 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.834 -1.166 . . . . 0.0 108.723 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.501 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmm180 -74.0 -38.17 64.18 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.23 -17.57 63.7 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.0 ttt180 -89.19 -25.58 21.71 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.282 -0.886 . . . . 0.0 109.324 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.501 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -59.59 -44.68 93.29 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 123.575 1.655 . . . . 0.0 106.953 178.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 80.5 m95 -67.23 -59.5 3.38 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.003 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mt -54.04 -21.88 9.38 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.826 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 30.6 t -81.27 -19.07 43.83 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.427 -0.796 . . . . 0.0 110.262 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.62 32.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.843 -1.161 . . . . 0.0 109.214 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.33 25.49 75.42 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB3' ' CG1' ' A' ' 4' ' ' ILE . . . -70.68 126.57 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.178 -1.19 . . . . 0.0 110.026 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.31 111.35 53.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 51.9 Cg_endo -80.86 131.23 7.95 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.48 1.253 . . . . 0.0 110.332 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.9 p -56.92 159.17 4.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.61 -34.23 50.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.991 . . . . 0.0 111.581 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.405 HG22 ' CD2' ' A' ' 6' ' ' LEU . 5.3 m -83.68 -49.9 8.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 111.191 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -71.26 -22.98 61.9 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.253 -0.904 . . . . 0.0 109.264 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -70.97 -36.14 72.41 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -33.4 74.74 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.439 HD12 ' CD2' ' A' ' 39' ' ' TYR . 21.3 mt -75.17 -30.24 60.65 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.573 -0.704 . . . . 0.0 109.172 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 16.1 mt -68.03 -29.43 68.41 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -77.68 -31.03 52.23 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -77.49 -28.54 52.24 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.986 0.898 . . . . 0.0 109.391 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.07 -8.79 48.44 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.225 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.99 31.43 11.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 47.4 t . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.218 -1.166 . . . . 0.0 110.651 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 17.1 m . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.449 0.642 . . . . 0.0 110.588 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 22' ' ' THR . 17.2 ptmt -140.73 138.99 34.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.045 -1.034 . . . . 0.0 110.42 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.466 ' CG2' HD12 ' A' ' 36' ' ' ILE . 4.5 mt -103.84 135.32 42.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.048 -1.032 . . . . 0.0 108.681 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -150.64 -170.42 3.65 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.861 -1.149 . . . . 0.0 110.777 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.0 mp -89.03 129.22 35.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -102.85 108.47 19.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 111.453 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 8.6 ttp180 . . . . . 0 N--CA 1.487 1.42 0 O-C-N 120.99 -1.069 . . . . 0.0 111.009 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 6.5 m-30 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -102.85 166.89 10.21 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.058 176.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.11 85.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.45 ' CG2' ' HD2' ' A' ' 18' ' ' ARG 0.26 0.4 OUTLIER -99.21 164.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.283 -175.011 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.542 HG22 ' CD1' ' A' ' 59' ' ' TRP . 1.3 t -107.9 110.87 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 109.961 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 110.505 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 7.8 p90 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.629 0.728 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.82 -41.93 13.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.573 -0.704 . . . . 0.0 109.303 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -151.17 150.35 30.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.117 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -96.46 118.88 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.975 . . . . 0.0 109.91 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.482 ' HB ' ' CA ' ' A' ' 56' ' ' ALA . 43.3 pt -99.84 -27.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 111.756 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -150.64 -174.41 21.66 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.001 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 36.7 t80 -140.83 147.45 39.03 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.872 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.2 t80 -140.21 132.89 28.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.588 -1.32 . . . . 0.0 109.664 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 27.4 t0 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.896 -1.127 . . . . 0.0 110.401 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.444 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 11.5 tp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.558 0.694 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -140.1 72.95 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.48 -0.762 . . . . 0.0 110.199 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.56 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -94.69 129.44 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.274 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.6 t0 -73.88 70.12 1.44 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -36.36 -29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.149 -0.344 . . . . 0.0 111.606 -177.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -62.99 -55.89 21.81 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.619 -1.301 . . . . 0.0 109.082 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -0.872 . . . . 0.0 108.994 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . . . -73.38 -22.93 60.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.947 -1.096 . . . . 0.0 108.082 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttt85 -86.0 -21.35 27.86 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.142 -0.974 . . . . 0.0 108.912 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 81.4 m95 -61.55 -53.33 57.75 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.316 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -52.67 -22.71 5.44 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -22.32 42.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.546 -0.721 . . . . 0.0 110.434 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 59' ' ' TRP . 4.4 m -98.85 32.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.74 -1.225 . . . . 0.0 109.52 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.19 27.26 73.11 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -67.95 134.31 50.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.152 -1.205 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -105.94 105.65 54.1 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.3 Cg_endo -79.07 129.51 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.607 1.319 . . . . 0.0 110.051 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' A' ' 70' ' ' ALA . 4.0 t -58.45 165.8 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.47 -27.89 58.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.164 -0.96 . . . . 0.0 111.515 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -82.24 -52.7 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.934 -1.104 . . . . 0.0 110.806 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -69.49 -26.49 64.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.326 -0.859 . . . . 0.0 108.721 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -66.52 -38.45 87.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -41.16 90.38 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.954 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 14.7 mt -71.13 -27.2 63.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 12.9 mt -70.52 -27.83 64.48 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -32.83 51.64 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -79.94 -29.34 39.69 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.981 0.896 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -74.27 -4.47 36.29 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.866 -0.521 . . . . 0.0 110.257 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.53 39.46 30.07 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.456 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 48.2 t . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.282 -1.128 . . . . 0.0 111.459 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' CE3' ' A' ' 59' ' ' TRP . 60.8 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.198 0.523 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 2.1 mtpt -140.49 129.72 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.784 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.461 HD11 ' CD1' ' A' ' 36' ' ' ILE . 52.1 mt -101.22 132.09 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.06 -1.025 . . . . 0.0 109.132 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.12 -169.47 3.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 110.95 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.7 mp -88.8 125.89 35.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.0 108.51 20.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.756 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.584 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.4 ttt-85 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.023 -1.048 . . . . 0.0 111.592 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 11.7 m-30 . . . . . 0 C--O 1.211 -0.925 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -101.46 160.38 14.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.86 -1.536 . . . . 0.0 108.021 177.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.7 OUTLIER -98.83 79.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.253 0.4 OUTLIER -97.82 160.63 3.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.886 -174.236 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -102.73 121.08 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 32' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.943 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CD2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.46 0.648 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.421 HG22 ' CZ2' ' A' ' 59' ' ' TRP . 5.8 mt -92.17 -37.43 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.538 -0.727 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.6 153.94 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 109.824 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HA ' ' CG2' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -94.43 116.0 28.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.007 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.5 pt -103.02 -32.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -124.41 169.03 16.44 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 119.218 -1.467 . . . . 0.0 111.341 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.467 ' N ' HG13 ' A' ' 19' ' ' ILE . 48.0 t80 -140.15 134.64 31.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.0 t80 -133.6 131.24 39.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 110.121 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.581 -1.325 . . . . 0.0 110.758 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 8.3 tt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.301 0.572 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.85 96.59 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.484 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.496 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -120.86 151.04 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 111.499 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.4 t70 -96.88 67.87 2.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -33.62 -31.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.038 -177.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 27.4 tt0 -62.34 -56.84 14.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.729 -1.232 . . . . 0.0 109.012 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 13.5 mmm180 -72.77 -35.54 67.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.508 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.46 -20.78 66.39 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 34.8 ttt85 -88.25 -25.05 23.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.577 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -59.94 -46.72 88.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.152 1.453 . . . . 0.0 107.301 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.577 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 87.5 m95 -65.4 -55.52 17.61 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.814 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.452 ' CD1' HD11 ' A' ' 74' ' ' LEU . 6.4 mt -53.42 -22.6 8.0 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.529 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 t -82.81 -19.62 37.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.394 -0.816 . . . . 0.0 110.568 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 59' ' ' TRP . 3.3 m -98.98 32.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 120.798 -1.189 . . . . 0.0 109.272 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.87 72.93 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' A' ' 60' ' ' LEU . . . -71.42 134.91 46.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.439 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 7.1 mt-30 -101.79 108.12 54.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.8 Cg_endo -81.27 140.74 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.536 1.282 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -73.24 169.27 17.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 109.744 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.01 -18.47 34.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.775 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.422 ' HB ' HD12 ' A' ' 6' ' ' LEU . 3.5 m -95.07 -49.68 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.021 . . . . 0.0 110.515 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.68 -25.48 62.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.343 -0.848 . . . . 0.0 108.768 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -69.12 -35.4 76.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -67.19 -34.47 77.58 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.42 ' CD2' HD13 ' A' ' 49' ' ' LEU . 31.6 mt -73.84 -28.0 61.38 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.587 -0.696 . . . . 0.0 109.514 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 54.0 mt -71.96 -27.25 62.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -30.5 33.26 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -82.51 -38.33 23.99 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.788 0.804 . . . . 0.0 110.015 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -64.23 -12.15 38.15 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.817 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.93 36.41 8.44 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 21.9 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.273 . . . . 0.0 111.324 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.236 0.541 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 9.3 mtpt -140.32 136.66 33.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.868 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' CG1' ' CD1' ' A' ' 36' ' ' ILE . 1.1 mp -99.62 119.13 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.4 ptt85 -150.33 -179.79 7.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.987 -1.07 . . . . 0.0 110.906 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 6.0 mp -88.91 124.73 34.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.279 -0.888 . . . . 0.0 111.024 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.7 100.84 11.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.414 -0.804 . . . . 0.0 111.687 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.469 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 47.3 ttt180 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 111.533 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 3.5 m-85 . . . . . 0 C--O 1.214 -0.812 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.1 mmt180 -100.05 156.22 17.29 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.677 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.5 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 mt -98.55 77.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.256 0.3 OUTLIER -97.06 176.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.273 -172.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.559 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -120.44 115.77 48.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.367 0.603 . . . . 0.0 109.947 -177.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 16.8 p90 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 121.884 0.85 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mt -95.9 -44.43 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.686 -0.634 . . . . 0.0 110.055 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 166.31 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -101.25 106.79 18.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 110.131 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.507 HG23 ' CD1' ' A' ' 59' ' ' TRP . 16.1 pt -100.12 -34.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -127.63 165.41 20.72 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.486 ' N ' HG13 ' A' ' 19' ' ' ILE . 26.9 t80 -139.19 143.45 38.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.925 . . . . 0.0 109.687 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' C ' ' CD1' ' A' ' 39' ' ' TYR . 13.2 t80 -131.74 132.4 43.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.943 -1.098 . . . . 0.0 109.47 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 t0 . . . . . 0 N--CA 1.494 1.773 0 O-C-N 120.764 -1.21 . . . . 0.0 110.907 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 HD11 ' N ' ' A' ' 50' ' ' LYS . 2.3 tm? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.526 0.679 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.437 ' N ' HD11 ' A' ' 49' ' ' LEU . 3.7 mtpp -130.81 111.0 11.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.071 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.475 HG23 ' CA ' ' A' ' 37' ' ' GLY . 1.3 t -132.02 144.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.533 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -93.29 70.75 4.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.04 -31.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -177.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.16 -54.41 46.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.731 -1.23 . . . . 0.0 109.114 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 5.5 mtm-85 -74.53 -35.86 63.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.092 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -66.71 -20.98 66.09 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.8 ttp85 -89.16 -23.34 22.46 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -60.63 -49.06 79.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 123.394 1.568 . . . . 0.0 107.091 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.559 ' CD1' HG22 ' A' ' 21' ' ' VAL . 85.0 m95 -63.6 -50.99 67.23 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.3 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 6.5 mt -56.07 -21.03 19.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 176.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.6 t -81.23 -21.68 39.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.368 -0.833 . . . . 0.0 110.436 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.9 m -98.86 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.874 -1.141 . . . . 0.0 109.791 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.97 30.8 76.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . . . -64.76 143.84 57.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -1.209 . . . . 0.0 109.624 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -106.7 99.37 24.87 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.333 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.1 Cg_endo -79.64 125.0 5.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.697 1.367 . . . . 0.0 110.279 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.6 t -58.86 170.14 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.826 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.88 -20.01 47.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.149 -0.969 . . . . 0.0 110.892 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.99 -53.42 4.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.181 -0.949 . . . . 0.0 110.386 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.06 65.06 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 75' ' ' ARG . 9.1 ttp85 -68.95 -39.26 79.62 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.453 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.86 -40.84 87.99 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.782 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 77' ' ' ALA . 16.0 mt -70.81 -25.13 62.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.465 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 12.4 mt -70.51 -29.36 65.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.453 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 3.6 mtm180 -78.47 -34.4 47.68 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -26.42 37.93 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.739 0.781 . . . . 0.0 110.667 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' LEU . . . -76.19 -1.97 28.95 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.743 -0.598 . . . . 0.0 110.161 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.14 38.03 30.9 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.461 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 32.0 t . . . . . 0 C--N 1.308 -1.212 0 O-C-N 121.249 -1.148 . . . . 0.0 111.129 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.122 0.487 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.12 135.84 32.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.215 -0.928 . . . . 0.0 110.75 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.497 HD13 ' CB ' ' A' ' 59' ' ' TRP . 63.1 mt -101.98 135.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 109.232 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 8.7 ptm180 -150.93 178.31 9.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.005 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.5 pp -89.61 131.74 35.46 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.326 -0.949 . . . . 0.0 109.48 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -98.9 164.02 12.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.525 -0.734 . . . . 0.0 109.056 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.483 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.346 0 O-C-N 120.913 -1.117 . . . . 0.0 111.562 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.485 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 13.0 m-85 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 29.3 mtt-85 -135.13 151.22 50.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.881 -1.137 . . . . 0.0 108.986 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -97.01 82.9 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.281 0.4 OUTLIER -98.38 163.2 2.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.353 -173.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.94 113.47 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.71 . . . . 0.0 110.322 -178.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.395 -0.815 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 2.0 p90 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 121.617 0.722 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.68 -47.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.553 -0.717 . . . . 0.0 109.923 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.88 159.51 41.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.419 -0.801 . . . . 0.0 109.741 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -95.7 109.57 21.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' CD1' ' A' ' 59' ' ' TRP . 36.2 pt -100.19 -35.19 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.071 -1.018 . . . . 0.0 110.541 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.485 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -121.14 167.35 14.08 Favored Glycine 0 C--N 1.294 -1.799 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.264 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.401 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.4 t80 -141.06 117.52 10.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.524 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 7.8 t80 -109.02 142.47 39.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.277 . . . . 0.0 109.497 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 39.9 t0 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.941 -1.099 . . . . 0.0 110.111 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 77' ' ' ALA . 3.9 tt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.435 0.636 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.19 89.33 2.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.399 -0.813 . . . . 0.0 109.144 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.485 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 137.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.108 -0.995 . . . . 0.0 111.07 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.8 t0 -82.44 70.48 9.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.447 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -37.18 -30.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.259 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' ASP . 12.7 mt-10 -63.18 -49.69 73.3 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.812 -1.18 . . . . 0.0 108.786 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.77 -33.51 52.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 108.819 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -69.43 -22.0 63.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.6 ttt-85 -87.49 -23.48 24.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.353 -0.842 . . . . 0.0 109.466 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -58.87 -50.15 75.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.426 1.584 . . . . 0.0 107.042 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 85.3 m95 -62.62 -55.19 29.33 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.7 mt -52.83 -23.33 6.76 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -78.68 -19.47 52.42 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.503 -0.748 . . . . 0.0 110.12 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 59' ' ' TRP . 3.6 m -98.41 31.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.996 -1.065 . . . . 0.0 109.311 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.45 78.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.54 128.37 35.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -1.181 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -100.39 119.92 57.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.177 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.8 Cg_endo -83.39 146.46 12.32 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.505 1.266 . . . . 0.0 110.407 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.433 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -71.29 158.44 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.0 109.987 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -55.53 -26.3 42.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 111.219 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 6' ' ' LEU . 11.6 m -90.7 -48.39 7.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.697 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -71.13 -26.93 63.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.811 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 67' ' ' THR . 31.9 ttp180 -68.02 -36.79 80.52 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -35.66 76.17 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 29.1 mt -73.29 -38.44 65.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 66.9 mt -63.25 -28.44 70.03 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -77.13 -32.41 56.38 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.436 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -76.6 -32.19 57.94 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.15 0.976 . . . . 0.0 109.523 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -70.25 -7.99 46.62 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.78 42.31 7.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.434 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 39.7 t . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.176 -1.19 . . . . 0.0 111.157 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.434 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 92.3 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -140.67 133.0 28.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.127 -0.983 . . . . 0.0 110.534 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 33.1 mt -103.64 130.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.092 -1.005 . . . . 0.0 109.328 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.1 ptt85 -151.09 -167.46 2.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.652 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.476 HD23 ' CD2' ' A' ' 39' ' ' TYR . 13.1 mt -89.32 126.11 35.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.223 -0.923 . . . . 0.0 111.081 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.0 104.06 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.175 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 8.1 tmm_? . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 0.0 112.241 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 10.7 m-85 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HG2' ' HA ' ' A' ' 38' ' ' TYR . 1.4 ttm-85 -100.55 154.08 18.86 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.565 ' O ' HD13 ' A' ' 36' ' ' ILE . 1.1 mt -97.63 84.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.467 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.26 0.4 OUTLIER -98.51 172.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.988 -173.068 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.514 HG11 ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.73 105.28 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.597 -0.689 . . . . 0.0 111.037 -177.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.2 -0.938 . . . . 0.0 109.959 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' CD2' HG23 ' A' ' 20' ' ' VAL . 10.6 p90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.455 0.645 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 mt -86.02 -49.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.27 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.66 172.57 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -0.807 . . . . 0.0 109.778 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HB3' ' CD ' ' A' ' 18' ' ' ARG . 1.8 mtmt -111.82 126.3 54.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.04 -1.037 . . . . 0.0 110.0 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.566 HG13 ' HA ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.86 -13.71 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.008 -1.057 . . . . 0.0 111.819 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -133.89 154.83 21.51 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 119.286 -1.435 . . . . 0.0 109.6 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.444 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 24.2 t80 -128.92 151.81 49.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.268 -1.136 . . . . 0.0 109.13 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' CD2' HD23 ' A' ' 6' ' ' LEU . 38.8 t80 -149.93 116.5 5.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.721 -1.237 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.684 -1.26 . . . . 0.0 110.575 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.476 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.6 tt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.383 0.611 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -140.33 85.9 2.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 109.288 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.542 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.3 t -115.85 143.54 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.922 -1.111 . . . . 0.0 111.412 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.8 t0 -94.58 69.8 3.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -32.9 -32.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.809 -177.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.28 -50.23 74.46 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.695 -1.253 . . . . 0.0 108.562 178.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.0 mmm180 -74.44 -36.17 63.38 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HA ' HG13 ' A' ' 36' ' ' ILE . . . -68.85 -16.57 63.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.944 -1.097 . . . . 0.0 108.129 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -90.38 -21.72 21.83 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 121.362 -0.836 . . . . 0.0 108.908 177.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.493 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -66.83 -48.22 69.57 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 123.032 1.396 . . . . 0.0 107.658 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 75.3 m95 -66.94 -54.36 22.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.424 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 74' ' ' LEU . 3.3 mt -56.6 -21.31 26.05 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.537 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 2.8 m -82.34 -20.91 36.37 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.397 -0.814 . . . . 0.0 110.446 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 59' ' ' TRP . 3.8 m -99.07 31.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.915 -1.116 . . . . 0.0 109.536 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 26.41 73.75 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -67.14 137.44 56.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.331 . . . . 0.0 109.644 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -103.03 108.26 58.02 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 0.0 110.609 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 55.0 Cg_endo -79.69 126.62 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.65 1.342 . . . . 0.0 109.736 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 t -62.21 -175.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.55 51.94 1.77 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 m -164.33 -56.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.33 -25.59 64.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 6.8 tmm_? -66.76 -39.62 87.93 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -40.86 96.57 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' ' 49' ' ' LEU . 21.4 mt -69.3 -29.29 67.12 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.515 -0.741 . . . . 0.0 109.348 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.428 ' CD1' HD13 ' A' ' 60' ' ' LEU . 45.7 mt -69.65 -28.09 65.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -27.05 29.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -83.55 -36.7 23.79 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.597 0.713 . . . . 0.0 110.533 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -70.19 -6.86 37.45 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.815 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.31 56.37 2.86 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.425 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 24.3 t . . . . . 0 N--CA 1.484 1.264 0 O-C-N 121.122 -1.223 . . . . 0.0 111.052 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.464 HG13 ' CE3' ' A' ' 59' ' ' TRP . 66.1 t . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.289 0.566 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 65' ' ' GLN . 3.6 tptm -140.49 128.44 22.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.436 HD11 ' CB ' ' A' ' 59' ' ' TRP . 71.6 mt -99.97 128.91 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.041 -1.037 . . . . 0.0 109.901 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 6.6 ptm180 -151.23 -173.89 4.64 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 6.6 mp -88.96 126.07 35.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.518 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.34 103.57 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.355 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.482 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 111.179 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.563 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.6 m-85 . . . . . 0 C--O 1.214 -0.779 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 6.5 mmt180 -100.68 158.68 15.77 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.759 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 38' ' ' TYR . 1.1 mt -99.04 78.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 0.4 OUTLIER -97.26 163.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.733 -173.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 112.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.286 0.565 . . . . 0.0 110.308 -177.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.4 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 22.2 p90 . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.55 0.691 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 mp -84.34 -28.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 109.939 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.91 164.75 1.52 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.975 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.32 113.77 26.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.982 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.474 HG22 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -108.24 -34.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.115 -0.99 . . . . 0.0 110.664 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.489 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -122.27 164.34 15.36 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.342 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.486 ' N ' HG13 ' A' ' 19' ' ' ILE . 11.6 t80 -139.48 142.95 37.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.46 ' CD2' HD13 ' A' ' 73' ' ' LEU . 19.9 t80 -135.64 132.98 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.723 -1.235 . . . . 0.0 110.208 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 120.787 -1.195 . . . . 0.0 110.34 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.3 tm? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.347 0.594 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 104.24 9.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.102 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.489 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 2.1 t -129.52 139.15 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.099 . . . . 0.0 111.357 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.8 t0 -84.94 70.83 10.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -31.91 -34.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -59.96 -51.01 71.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.774 -1.204 . . . . 0.0 108.837 178.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 47.1 mmm-85 -71.11 -45.52 63.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -59.87 -22.38 62.24 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.2 ttt180 -87.78 -26.42 22.88 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.317 -0.864 . . . . 0.0 109.864 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.1 t80 -59.29 -46.67 87.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.32 1.534 . . . . 0.0 107.237 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.564 ' CD1' HG23 ' A' ' 21' ' ' VAL . 75.4 m95 -62.85 -54.68 35.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.512 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.428 ' CD1' HG11 ' A' ' 79' ' ' VAL . 7.3 mt -56.05 -20.58 17.48 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.583 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -79.02 -24.24 43.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.776 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 59' ' ' TRP . 14.4 m -98.92 33.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.939 -1.101 . . . . 0.0 109.568 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.28 27.15 73.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -68.26 130.93 44.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.004 -1.292 . . . . 0.0 109.964 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' O ' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -98.13 111.25 58.99 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 110.454 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.464 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . 53.4 Cg_endo -87.53 125.43 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.616 1.324 . . . . 0.0 109.951 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -53.98 166.31 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.016 -1.053 . . . . 0.0 109.767 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -33.8 36.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.041 -1.037 . . . . 0.0 110.919 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 m -76.04 -54.82 6.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.975 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -67.1 -23.36 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.475 -0.766 . . . . 0.0 109.222 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 2.0 ttt-85 -69.77 -43.19 72.68 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.676 -0.809 . . . . 0.0 108.977 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 39' ' ' TYR . 77.5 mt -65.15 -22.89 66.98 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.571 -0.706 . . . . 0.0 109.443 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.464 ' CD1' ' CB ' ' A' ' 66' ' ' PRO . 14.0 mt -70.73 -30.41 66.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.441 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 2.8 mtm180 -72.66 -34.67 67.41 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -77.52 -28.81 52.14 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.91 0.862 . . . . 0.0 110.077 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -73.34 -4.64 34.62 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.199 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.65 20.32 51.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 60' ' ' LEU . 21.1 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.091 -1.241 . . . . 0.0 110.569 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.255 0.55 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 2.7 tttt -140.2 133.44 29.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.245 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.477 HD12 ' CD1' ' A' ' 36' ' ' ILE . 98.0 mt -102.03 133.26 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.07 -1.019 . . . . 0.0 109.924 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -172.54 4.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 110.893 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.73 126.0 35.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.404 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.62 104.45 16.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 111.191 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 2.6 tmm_? . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.555 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 7.4 m-85 . . . . . 0 C--O 1.208 -1.131 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.41 159.59 16.55 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.66 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 81.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 177.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.478 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.264 0.4 OUTLIER -97.81 164.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.572 -174.0 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.511 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -111.86 106.1 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 110.471 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.413 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.102 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CD2' HG23 ' A' ' 20' ' ' VAL . 45.5 p90 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.603 0.716 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.466 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.6 mt -72.56 -46.31 55.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.662 -0.649 . . . . 0.0 110.036 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -152.41 166.24 32.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.6 pttt -104.33 115.77 30.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.175 -0.953 . . . . 0.0 109.998 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.522 HG22 ' CD1' ' A' ' 59' ' ' TRP . 38.7 pt -108.32 -33.71 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.939 -1.1 . . . . 0.0 111.56 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -125.69 166.91 18.24 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.859 -1.638 . . . . 0.0 112.76 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -140.94 121.4 14.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 20.8 t80 -114.94 139.95 49.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.777 -1.202 . . . . 0.0 109.778 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 109.864 178.884 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 7.9 tt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.222 0.534 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -120.78 93.58 4.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.408 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.495 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.79 133.01 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.044 -1.035 . . . . 0.0 111.2 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.0 t0 -78.37 69.13 4.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -34.06 -32.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.542 -177.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tt0 -62.42 -52.15 64.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.916 -1.115 . . . . 0.0 109.105 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.1 mtm-85 -75.49 -34.7 60.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.078 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -67.15 -23.48 65.8 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 40.8 ttt180 -86.15 -20.55 28.46 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.328 -0.857 . . . . 0.0 109.952 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -62.31 -48.56 79.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 123.078 1.418 . . . . 0.0 107.235 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.522 ' CD1' HG22 ' A' ' 36' ' ' ILE . 89.0 m95 -63.02 -55.92 21.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.714 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.69 -21.85 7.84 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.5 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.96 -20.09 39.28 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.456 -0.778 . . . . 0.0 110.64 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 59' ' ' TRP . 4.3 m -99.07 32.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.811 -1.181 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.88 27.1 72.82 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.95 117.64 22.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.136 -1.214 . . . . 0.0 109.992 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -91.36 127.75 49.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -83.7 165.42 13.84 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.352 1.185 . . . . 0.0 109.744 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -85.19 -174.94 5.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.226 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.68 46.68 1.19 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -165.7 -55.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.83 -26.07 65.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 67.1 ttt180 -64.83 -40.53 95.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -39.35 89.64 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.875 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 39' ' ' TYR . 41.7 mt -70.71 -28.28 64.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 40.9 mt -70.95 -29.46 65.48 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -28.26 38.44 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -83.86 -32.37 25.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.725 0.774 . . . . 0.0 110.097 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -66.41 -11.39 51.43 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.722 -0.611 . . . . 0.0 109.811 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.16 15.72 29.75 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.867 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.46 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 17.9 t . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.724 -1.456 . . . . 0.0 110.138 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.056 0.455 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.14 142.18 36.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 110.688 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.494 HD11 ' CD1' ' A' ' 36' ' ' ILE . 84.7 mt -104.06 135.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.142 -0.974 . . . . 0.0 109.409 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -151.22 -168.81 3.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 5.1 mp -89.3 127.3 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.846 . . . . 0.0 110.367 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.86 104.27 15.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.088 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.905 . . . . 0.0 112.539 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 14.1 m-85 . . . . . 0 C--O 1.211 -0.931 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.2 mtt85 -100.29 159.36 15.19 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.83 177.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.485 ' N ' ' CD1' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -98.71 81.43 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 177.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 0.4 OUTLIER -97.69 171.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.934 -173.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -116.16 108.77 25.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.167 0.508 . . . . 0.0 110.048 -177.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 110.233 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 20.4 p90 . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.555 0.693 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 mt -82.64 -51.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 109.876 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -152.79 152.72 31.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.959 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -89.57 108.17 19.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.018 . . . . 0.0 110.125 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.51 HG22 ' CD1' ' A' ' 59' ' ' TRP . 28.5 pt -100.07 -36.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 111.371 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -120.78 168.03 13.98 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.021 -1.562 . . . . 0.0 112.392 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 19' ' ' ILE . 10.2 t80 -141.07 124.78 16.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.479 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 22.6 t80 -125.85 124.71 41.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.811 -1.18 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 120.731 -1.231 . . . . 0.0 110.69 -179.83 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.463 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 8.2 tt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.291 0.567 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.91 94.91 3.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.0 138.56 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.952 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -84.74 72.38 10.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -35.98 -30.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 122.309 -0.245 . . . . 0.0 111.492 -177.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 35.1 mt-10 -60.47 -53.75 53.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.77 -1.206 . . . . 0.0 108.771 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.3 mmp_? -71.31 -39.66 71.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.432 -0.792 . . . . 0.0 108.891 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.74 -17.82 64.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 38.8 ttp180 -89.65 -22.68 22.17 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.19 -0.944 . . . . 0.0 109.594 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 4.4 t80 -61.4 -44.86 96.42 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 123.167 1.461 . . . . 0.0 107.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.525 ' CD1' HG22 ' A' ' 21' ' ' VAL . 84.6 m95 -69.84 -56.49 6.95 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.921 -1.491 . . . . 0.0 109.982 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.9 mt -53.98 -22.7 11.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.421 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -80.9 -22.3 39.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.474 -0.766 . . . . 0.0 110.56 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.0 m -98.69 32.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.764 -1.21 . . . . 0.0 109.478 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 30.03 74.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 128.96 35.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.065 -1.256 . . . . 0.0 110.141 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -94.76 110.24 48.27 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' CB ' HD13 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -82.31 131.09 6.5 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.552 1.29 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 41.2 p -52.54 160.41 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.88 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.27 -16.3 20.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.909 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.427 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 5.4 m -92.34 -52.93 4.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.417 ' O ' ' HG ' ' A' ' 74' ' ' LEU . . . -70.93 -28.48 64.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.4 ttt180 -65.53 -39.89 92.29 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -64.09 -27.6 69.2 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.075 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 49' ' ' LEU . 15.9 mt -85.5 -31.13 22.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.581 -0.699 . . . . 0.0 109.444 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.425 HD13 ' CB ' ' A' ' 66' ' ' PRO . 83.4 mt -69.01 -28.43 66.59 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -29.31 36.47 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.8 tp-100 -77.95 -35.08 50.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.899 0.857 . . . . 0.0 109.316 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.63 -9.36 49.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.77 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 53' ' ' VAL . . . 88.11 54.54 2.42 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.436 ' CG2' ' HB ' ' A' ' 53' ' ' VAL . 36.6 t . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.165 -1.197 . . . . 0.0 111.381 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.249 0.547 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -140.5 131.51 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.55 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.477 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 40.3 mt -99.76 129.31 50.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.074 -1.016 . . . . 0.0 109.012 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 18.5 ptt85 -150.24 174.04 13.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 17' ' ' TYR . 4.5 pp -88.21 127.03 35.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.96 111.68 23.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 112.427 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.485 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 7.4 ttt-85 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.144 -0.973 . . . . 0.0 110.793 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.211 -0.927 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 12.4 ttm180 -99.93 146.24 26.89 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.398 -1.321 . . . . 0.0 108.107 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.519 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -96.33 80.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 102.164 -3.273 . . . . 0.0 102.164 178.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.486 HG23 ' CD1' ' A' ' 32' ' ' TYR 0.289 0.4 OUTLIER -97.22 168.45 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.103 -173.197 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.544 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -114.12 109.76 29.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.49 -0.756 . . . . 0.0 110.507 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.342 179.758 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.486 ' CD1' HG23 ' A' ' 20' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.443 0.64 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.455 HG22 ' CH2' ' A' ' 59' ' ' TRP . 8.2 mt -61.3 -39.19 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.831 . . . . 0.0 109.918 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.36 170.93 11.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.912 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.57 121.02 44.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.005 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.481 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -115.78 -23.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.025 -1.047 . . . . 0.0 110.828 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.519 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -122.98 162.2 16.89 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 118.803 -1.665 . . . . 0.0 111.072 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.445 ' N ' HG12 ' A' ' 19' ' ' ILE . 63.9 t80 -140.22 133.64 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 2.6 t80 -126.93 121.81 32.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 109.906 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.0 110.064 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' CD1' HD22 ' A' ' 73' ' ' LEU . 1.7 tt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.368 0.604 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -133.48 86.81 2.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.31 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.492 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -115.67 130.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.119 -0.988 . . . . 0.0 111.327 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.6 t70 -74.35 70.82 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -35.86 -30.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 122.233 -0.292 . . . . 0.0 111.471 -177.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.8 tp10 -62.83 -50.12 72.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.797 -1.19 . . . . 0.0 108.623 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -76.72 -33.74 58.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 108.988 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' CB ' HD12 ' A' ' 36' ' ' ILE . . . -70.21 -21.5 63.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' VAL . 23.4 tpt180 -86.28 -22.27 26.9 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 55' ' ' ARG 0.25 0.5 OUTLIER -62.22 -48.08 81.59 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.258 1.504 . . . . 0.0 107.367 178.38 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' CD1' HG22 ' A' ' 21' ' ' VAL . 77.9 m95 -64.98 -56.08 15.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.788 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' HG12 ' A' ' 79' ' ' VAL . 47.2 mt -53.09 -22.47 6.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.561 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.71 -22.07 40.66 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.408 -0.808 . . . . 0.0 110.826 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 59' ' ' TRP . 7.2 m -98.89 32.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.813 -1.18 . . . . 0.0 109.543 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.61 70.83 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -73.17 110.75 7.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.073 -1.251 . . . . 0.0 110.136 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 115.61 56.08 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.8 Cg_endo -82.66 144.59 12.58 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.539 1.284 . . . . 0.0 109.992 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -65.93 165.51 13.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.59 -16.03 59.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 110.9 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -104.28 -46.79 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.175 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -67.83 -25.95 65.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -65.9 -38.68 89.38 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' NH1' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -62.01 -32.84 73.36 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.919 178.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.44 HD22 ' CD1' ' A' ' 49' ' ' LEU . 19.4 mt -76.89 -35.67 57.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 76.7 mt -63.89 -28.77 70.07 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -78.4 -29.79 47.44 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.439 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.1 tp-100 -73.16 -34.04 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.056 0.931 . . . . 0.0 108.928 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.44 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.57 -7.99 43.4 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.983 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.81 39.13 10.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 60' ' ' LEU . 45.5 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.176 -1.191 . . . . 0.0 111.893 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.436 HG13 ' CG2' ' A' ' 62' ' ' VAL . 61.1 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.199 0.524 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 65' ' ' GLN . 3.7 mtmt -140.18 139.5 35.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 110.793 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.464 HD12 ' CG1' ' A' ' 21' ' ' VAL . 1.5 mp -99.96 130.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.85 -176.71 5.63 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.1 -1.0 . . . . 0.0 110.845 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.413 HD23 ' HB2' ' A' ' 17' ' ' TYR . 16.1 mt -89.7 127.14 35.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.847 . . . . 0.0 110.8 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.72 107.08 19.07 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.769 -1.207 . . . . 0.0 112.805 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 11.0 m-85 . . . . . 0 C--O 1.21 -0.995 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 24.2 ttt180 -112.41 152.65 28.41 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.483 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 1.2 mt -98.73 78.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.451 HG12 ' CD2' ' A' ' 32' ' ' TYR 0.271 0.4 OUTLIER -98.07 165.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.179 -173.134 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.44 106.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.854 -0.529 . . . . 0.0 110.612 -177.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.7 t . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.151 -0.968 . . . . 0.0 110.258 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.451 ' CD2' HG12 ' A' ' 20' ' ' VAL . 10.6 p90 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.475 0.655 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 mt -90.45 -34.39 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.988 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.71 -175.54 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -119.18 112.75 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.507 HG23 ' CD1' ' A' ' 59' ' ' TRP . 21.4 pt -108.96 -38.0 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.924 -1.11 . . . . 0.0 111.208 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -125.79 163.73 19.63 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.81 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.449 ' N ' HG13 ' A' ' 19' ' ' ILE . 25.0 t80 -133.69 152.54 51.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 17' ' ' TYR . 16.4 t80 -143.54 137.86 28.75 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.974 -1.079 . . . . 0.0 109.738 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 t0 . . . . . 0 N--CA 1.496 1.835 0 O-C-N 120.759 -1.213 . . . . 0.0 110.479 179.831 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 7.2 tt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.48 0.657 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 94.01 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 108.715 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.5 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -120.58 154.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.255 1.026 . . . . 0.0 111.712 -178.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 9.1 t0 -103.95 68.07 0.9 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -29.95 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.9 tt0 -60.28 -52.46 65.2 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.771 -1.206 . . . . 0.0 109.197 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 28.0 mmm180 -72.3 -41.01 67.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -63.37 -20.37 65.47 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 23.2 ttp85 -89.79 -21.95 22.37 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -63.36 -47.23 82.97 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 123.176 1.465 . . . . 0.0 107.311 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CD1' HG21 ' A' ' 21' ' ' VAL . 90.4 m95 -66.81 -55.29 15.54 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.915 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -54.62 -22.82 14.66 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.317 177.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -81.67 -19.2 42.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.46 -0.775 . . . . 0.0 110.41 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 2' ' ' VAL . 3.4 m -99.0 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.799 -1.188 . . . . 0.0 109.31 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.88 28.05 73.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . . . -71.15 146.12 49.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.072 -1.252 . . . . 0.0 110.301 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 3' ' ' LYS . 1.9 mm100 -113.1 109.59 51.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.2 Cg_endo -86.64 128.38 2.9 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.59 1.311 . . . . 0.0 110.619 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.409 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 2.3 t -54.81 165.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.09 -17.52 27.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.154 -0.966 . . . . 0.0 111.202 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.1 m -90.24 -52.88 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.0 110.487 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB2' ' CG2' ' A' ' 19' ' ' ILE . . . -68.99 -28.82 66.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -68.34 -39.16 81.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -39.57 88.75 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -73.63 -27.3 61.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.41 -0.806 . . . . 0.0 109.267 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.466 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 21.3 mt -69.64 -27.83 65.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -25.83 37.84 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.3 tp-100 -83.85 -36.55 23.35 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.792 0.806 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.447 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.01 -6.63 29.1 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.281 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.35 43.88 7.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 23.8 t . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.156 -1.202 . . . . 0.0 111.2 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.464 HG11 ' CE3' ' A' ' 59' ' ' TRP . 41.0 t . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.267 0.555 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HG3' ' HB2' ' A' ' 65' ' ' GLN . 7.3 mttt -140.33 140.37 35.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 36' ' ' ILE . 95.2 mt -108.18 134.88 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.745 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -150.96 -163.65 1.82 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.312 -0.868 . . . . 0.0 110.112 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 36.4 mt -89.3 136.03 33.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.071 -1.018 . . . . 0.0 110.986 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -106.47 105.22 15.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.59 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.505 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.9 ttp85 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 111.177 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 4.7 m-30 . . . . . 0 C--O 1.212 -0.905 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -104.14 164.77 11.49 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.743 -1.583 . . . . 0.0 106.997 176.151 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -98.39 86.39 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.42 ' CG2' ' HD3' ' A' ' 18' ' ' ARG 0.264 0.4 OUTLIER -98.12 168.72 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.285 -174.782 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.533 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -113.75 106.19 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.673 -177.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.952 . . . . 0.0 109.418 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.58 0.705 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 mt -92.07 -50.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 110.04 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -150.15 164.59 35.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.01 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -103.07 116.71 33.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.142 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.52 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.9 pt -110.5 -33.8 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.985 -1.072 . . . . 0.0 111.991 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -128.38 174.46 18.86 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.187 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' N ' HG13 ' A' ' 19' ' ' ILE . 85.1 t80 -140.49 142.9 35.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 7.8 t80 -140.16 132.91 29.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.722 -1.236 . . . . 0.0 110.036 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.8 t0 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 120.835 -1.165 . . . . 0.0 110.236 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.5 tt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.238 0.542 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.39 96.06 4.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.388 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.494 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -120.74 149.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 111.476 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t0 -95.75 68.89 2.88 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.21 -35.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mt-10 -59.68 -52.98 63.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.746 -1.221 . . . . 0.0 109.202 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -70.79 -40.86 72.31 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.4 -0.812 . . . . 0.0 109.049 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -66.09 -18.69 65.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 108.548 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.26 -22.96 23.65 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.242 -0.911 . . . . 0.0 109.524 178.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 3.7 t80 -61.05 -43.28 99.12 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.139 1.447 . . . . 0.0 107.305 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.533 ' NE1' HG23 ' A' ' 21' ' ' VAL . 78.7 m95 -68.6 -53.31 23.52 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.893 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.39 -21.02 33.37 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.574 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -81.58 -23.89 36.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.453 -0.779 . . . . 0.0 110.651 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 59' ' ' TRP . 25.5 m -99.15 32.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 120.817 -1.177 . . . . 0.0 109.649 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.42 31.25 76.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.54 141.68 51.86 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.006 -1.291 . . . . 0.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -105.91 103.04 42.42 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 110.128 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.4 Cg_endo -81.26 125.14 5.07 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.698 1.367 . . . . 0.0 110.226 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.404 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 4.5 t -54.9 176.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.0 -1.062 . . . . 0.0 109.695 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.79 -19.68 62.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.182 -0.949 . . . . 0.0 111.026 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.402 ' CG2' HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -90.5 -51.17 5.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.686 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.4 -27.59 64.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -69.21 -37.98 78.35 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -69.47 -47.34 64.25 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.545 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.423 ' CB ' HD11 ' A' ' 19' ' ' ILE . 15.4 mt -60.48 -25.13 65.81 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 23.1 mt -76.19 -25.94 55.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -31.49 30.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.5 tp-100 -87.18 -36.46 18.01 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.724 0.773 . . . . 0.0 110.7 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -64.86 -10.78 31.01 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.705 -0.622 . . . . 0.0 110.01 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.64 48.78 5.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.447 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 49.5 t . . . . . 0 N--CA 1.487 1.377 0 O-C-N 121.065 -1.256 . . . . 0.0 111.44 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.41 HG13 ' CG2' ' A' ' 62' ' ' VAL . 49.9 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.299 0.571 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt -138.6 133.41 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 36' ' ' ILE . 84.9 mt -106.05 133.37 50.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.162 -0.961 . . . . 0.0 109.649 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.473 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.2 174.33 13.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.956 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.476 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 1.2 pp -89.26 129.43 35.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.1 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -98.65 165.5 11.77 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.473 -0.767 . . . . 0.0 109.334 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 120.974 -1.079 . . . . 0.0 111.483 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 14.5 m-85 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' CD ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -127.69 147.16 50.38 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.006 -1.059 . . . . 0.0 108.384 178.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -97.31 81.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 178.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.445 HG23 ' CD ' ' A' ' 18' ' ' ARG 0.29 0.4 OUTLIER -98.2 160.49 3.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.78 -173.347 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -104.16 107.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.686 -0.634 . . . . 0.0 109.862 -178.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 110.425 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.6 p90 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.539 0.685 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.92 -29.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.488 -0.758 . . . . 0.0 109.643 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.37 179.94 4.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 31.9 pttt -120.81 121.82 38.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.509 ' CD1' HD11 ' A' ' 4' ' ' ILE . 23.9 pt -116.92 -38.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.135 -0.978 . . . . 0.0 111.607 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -119.0 165.64 13.05 Favored Glycine 0 C--N 1.296 -1.686 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.531 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.412 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.6 t80 -139.07 126.68 21.86 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -119.27 136.59 54.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.959 -1.088 . . . . 0.0 110.548 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.633 179.416 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.426 HD11 ' CD2' ' A' ' 73' ' ' LEU . 1.4 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.43 0.633 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.16 94.79 4.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.43 -0.793 . . . . 0.0 108.884 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.51 141.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 111.557 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -85.3 67.19 10.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -35.82 -29.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -61.13 -47.32 86.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.78 -1.2 . . . . 0.0 108.567 178.138 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 30.8 mmm180 -76.88 -38.53 53.46 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.463 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.68 -21.75 66.81 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.3 -21.16 24.58 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.442 -0.786 . . . . 0.0 109.536 178.252 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.588 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -65.81 -49.39 68.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.242 1.496 . . . . 0.0 107.451 178.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.588 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 86.7 m95 -63.6 -56.08 18.72 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.748 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.4 mt -52.95 -22.79 6.04 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.421 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -19.06 41.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.544 -0.722 . . . . 0.0 110.337 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 59' ' ' TRP . 3.2 m -98.74 31.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.849 -1.157 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.25 72.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.23 143.57 52.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -1.209 . . . . 0.0 110.109 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -106.54 105.65 55.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 0.0 110.532 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.3 Cg_endo -80.85 140.48 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.616 1.324 . . . . 0.0 110.335 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 70.5 p -72.24 163.52 27.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.993 -1.067 . . . . 0.0 110.166 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.63 -22.48 61.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.725 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.476 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 12.5 m -92.78 -48.23 6.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.173 -0.954 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -69.78 -30.21 67.71 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 67' ' ' THR . 12.2 ttt-85 -66.12 -37.5 85.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -28.9 70.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 14.8 mt -83.94 -33.4 24.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 80.5 mt -63.99 -30.53 71.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -25.72 41.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.401 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.3 tp-100 -74.32 -35.01 63.62 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.12 0.962 . . . . 0.0 109.26 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.473 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -72.24 -5.8 38.48 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.23 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 53' ' ' VAL . . . 82.45 48.31 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 111.501 -179.282 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.6 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.304 0.573 . . . . 0.0 110.337 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -140.22 129.16 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 36' ' ' ILE . 74.9 mt -99.8 131.9 46.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.023 -1.048 . . . . 0.0 109.373 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.0 ptm180 -150.42 -167.06 2.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.038 -1.039 . . . . 0.0 110.361 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 6.6 mp -89.31 131.22 35.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.356 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -103.08 105.06 15.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 111.206 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 O-C-N 121.192 -0.943 . . . . 0.0 111.525 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 3.9 m-30 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -104.03 165.91 10.74 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.24 176.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -98.46 83.74 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.405 HG22 ' HD2' ' A' ' 18' ' ' ARG 0.252 0.3 OUTLIER -97.6 169.73 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.146 -174.943 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -113.47 104.83 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.56 -0.712 . . . . 0.0 110.496 -177.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.248 -0.907 . . . . 0.0 110.166 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.513 0.673 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 mt -82.77 -43.62 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.482 -0.761 . . . . 0.0 109.37 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 161.72 30.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.486 -0.758 . . . . 0.0 109.624 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -98.13 116.74 30.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.101 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.5 pt -104.66 -36.08 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.975 -1.078 . . . . 0.0 111.472 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -129.08 177.04 18.14 Favored Glycine 0 C--N 1.294 -1.753 0 C-N-CA 118.917 -1.611 . . . . 0.0 112.291 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG13 ' A' ' 19' ' ' ILE . 17.2 t80 -140.58 145.63 36.97 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 4.2 t80 -142.92 129.64 20.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.609 -1.307 . . . . 0.0 110.5 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 t0 . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.818 -1.176 . . . . 0.0 110.25 179.834 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.422 HD22 ' HB3' ' A' ' 76' ' ' GLN . 11.8 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.579 0.704 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -128.25 110.45 12.41 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.503 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.24 160.96 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.419 1.104 . . . . 0.0 111.72 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.4 t70 -104.91 67.58 0.8 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -33.05 -32.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.593 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -63.58 -52.06 62.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.9 -1.125 . . . . 0.0 109.232 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.8 mtm-85 -75.69 -33.3 60.35 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.241 -0.912 . . . . 0.0 109.428 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -68.99 -23.8 64.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.5 ttt-85 -86.3 -21.89 27.06 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.24 -0.912 . . . . 0.0 109.726 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -61.02 -50.57 72.8 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.252 1.501 . . . . 0.0 107.039 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.573 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 84.5 m95 -60.27 -53.02 62.65 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.576 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mt -54.42 -22.04 11.43 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -77.97 -22.75 48.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.542 -0.724 . . . . 0.0 110.408 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 59' ' ' TRP . 8.9 m -99.05 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.784 -1.197 . . . . 0.0 109.736 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.58 25.58 74.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -66.84 129.69 40.7 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.237 -1.155 . . . . 0.0 109.763 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.35 116.43 63.75 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.2 Cg_endo -82.77 128.4 5.21 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.526 1.277 . . . . 0.0 109.921 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.413 HG21 ' CB ' ' A' ' 5' ' ' ARG . 4.9 t -55.49 176.42 0.06 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.852 -1.155 . . . . 0.0 110.194 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 55.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 m -166.67 -59.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.15 -23.16 66.43 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 18.0 ttp85 -65.62 -42.71 91.25 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.433 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 3.1 ttm180 -67.46 -42.16 83.47 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.424 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.1 mt -68.19 -26.16 65.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 13.7 mt -67.61 -30.17 69.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.433 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 9.0 mtm180 -75.98 -34.52 59.78 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.422 ' HB3' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -76.39 -28.26 56.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.925 0.869 . . . . 0.0 109.9 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -69.65 -7.55 39.89 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.306 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.95 19.51 33.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 12.2 t . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.256 . . . . 0.0 110.763 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 39.7 t . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.242 0.544 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -140.92 134.72 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.993 . . . . 0.0 110.323 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 37.9 mt -99.73 133.99 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 108.917 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.464 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.8 ptt180 -150.35 172.99 14.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.006 -1.059 . . . . 0.0 109.941 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 2.9 pp -89.28 130.84 35.61 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 109.518 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -99.15 162.21 13.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.571 -0.706 . . . . 0.0 109.212 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.482 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 70.6 ttt180 . . . . . 0 N--CA 1.486 1.366 0 O-C-N 120.931 -1.106 . . . . 0.0 111.4 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 12.5 m-85 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' HG3' ' HA ' ' A' ' 38' ' ' TYR . 2.2 ttp180 -132.05 147.19 52.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.017 -1.052 . . . . 0.0 108.18 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.459 ' CD1' HG21 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -97.22 83.24 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 178.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.291 0.4 OUTLIER -97.56 167.0 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.338 -173.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.85 105.65 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.488 -0.758 . . . . 0.0 110.986 -177.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.0 110.004 179.467 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' OH ' ' NH2' ' A' ' 18' ' ' ARG . 31.8 p90 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.419 0.628 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.455 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.7 mp -62.61 -46.12 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.81 171.66 19.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.613 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.63 125.15 53.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.652 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.511 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -120.76 -28.05 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.044 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -119.26 158.77 14.86 Favored Glycine 0 C--N 1.297 -1.607 0 C-N-CA 118.945 -1.598 . . . . 0.0 111.078 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 69.2 t80 -132.61 133.2 43.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.401 ' HB3' ' HB2' ' A' ' 17' ' ' TYR . 6.0 t80 -124.39 136.1 53.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.301 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.013 -1.055 . . . . 0.0 110.007 179.562 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 3.9 tt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.322 0.582 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -135.33 91.93 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.453 -0.78 . . . . 0.0 109.373 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -117.86 137.8 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 111.132 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.3 t70 -82.18 70.2 9.06 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.435 ' CB ' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.69 -31.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.556 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.5 tt0 -62.87 -52.05 64.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.869 -1.144 . . . . 0.0 108.902 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.68 -34.78 60.46 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.024 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.431 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -66.67 -18.07 65.18 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 28.9 ttp180 -88.39 -25.19 22.82 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.376 -0.827 . . . . 0.0 109.361 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -59.06 -44.84 91.88 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.356 1.55 . . . . 0.0 107.096 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.52 ' CD1' HG21 ' A' ' 21' ' ' VAL . 81.1 m95 -68.38 -57.88 5.21 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.836 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mt -52.74 -23.31 6.53 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.314 -0.954 . . . . 0.0 108.612 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 t -80.78 -21.41 41.01 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 110.38 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 59' ' ' TRP . 3.5 m -98.63 32.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.773 -1.204 . . . . 0.0 109.293 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.05 74.17 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.98 109.33 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 110.312 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.08 114.5 42.66 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 110.413 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.0 Cg_endo -82.08 148.76 15.29 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.496 1.261 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.8 p -74.81 161.79 29.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.014 -1.053 . . . . 0.0 109.83 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.41 -25.6 59.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.043 -1.036 . . . . 0.0 110.985 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.474 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 38.4 m -93.28 -47.58 6.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 0.0 110.6 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -69.51 -27.63 65.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.8 ttt-85 -65.65 -38.85 90.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -34.77 76.75 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.524 -0.87 . . . . 0.0 108.879 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -76.74 -33.42 58.13 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 74.3 mt -65.38 -28.27 69.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' CG ' ' O ' ' A' ' 71' ' ' ARG . 3.7 mmm180 -79.01 -32.15 45.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.1 tp-100 -72.06 -34.44 68.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.153 0.978 . . . . 0.0 108.998 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -67.67 -9.74 46.14 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.148 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 44.36 7.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.435 HG23 ' CB ' ' A' ' 53' ' ' VAL . 47.2 t . . . . . 0 N--CA 1.486 1.346 0 O-C-N 121.193 -1.181 . . . . 0.0 111.394 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.483 HG13 ' CZ3' ' A' ' 59' ' ' TRP . 26.9 t . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.23 0.538 . . . . 0.0 109.855 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.653 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.482 HD11 ' CD1' ' A' ' 36' ' ' ILE . 54.8 mt -109.53 133.41 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.146 -0.971 . . . . 0.0 109.48 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 5.2 ptp180 -151.52 -166.79 2.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.781 -1.199 . . . . 0.0 110.69 -178.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.432 HD13 ' CG2' ' A' ' 69' ' ' THR . 41.9 mt -88.67 127.68 35.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.85 107.33 18.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.3 -0.875 . . . . 0.0 110.905 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ttt180 . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.973 . . . . 0.0 109.97 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.5 m-30 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.88 156.27 17.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -98.23 75.77 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 176.427 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.449 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.257 0.3 OUTLIER -97.27 165.46 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.859 -173.261 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.7 113.25 42.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.463 0.649 . . . . 0.0 111.407 -176.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.665 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CD2' HG23 ' A' ' 20' ' ' VAL . 6.3 p90 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.3 mt -89.11 -41.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.59 -0.694 . . . . 0.0 109.882 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.58 162.22 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.9 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -101.44 113.89 27.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 0.0 109.734 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.498 HG22 ' CD1' ' A' ' 59' ' ' TRP . 39.4 pt -107.37 -34.77 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.198 -0.938 . . . . 0.0 111.24 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.479 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -124.49 165.77 17.37 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.099 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.472 ' N ' HG13 ' A' ' 19' ' ' ILE . 12.7 t80 -137.49 142.46 41.5 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -138.11 133.21 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.767 -1.208 . . . . 0.0 110.404 -179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 120.946 -1.096 . . . . 0.0 109.767 179.54 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.415 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.7 tt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.249 0.547 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -118.17 104.3 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.975 . . . . 0.0 109.508 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.478 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.2 t -128.15 149.31 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.347 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 21.8 t0 -94.23 67.99 3.61 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -32.96 -34.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.632 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -61.72 -54.17 46.12 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.894 -1.122 . . . . 0.0 108.57 178.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -74.32 -33.06 63.06 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.437 -0.79 . . . . 0.0 109.331 178.973 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -69.02 -23.56 64.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -87.02 -19.78 28.17 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.552 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -62.47 -48.49 79.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.277 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.574 ' CD1' HG22 ' A' ' 21' ' ' VAL . 89.5 m95 -63.08 -55.42 25.62 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.257 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mt -52.4 -22.91 5.16 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.558 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.93 -21.9 43.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.433 -0.792 . . . . 0.0 110.797 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 59' ' ' TRP . 6.4 m -98.79 33.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.843 -1.161 . . . . 0.0 109.227 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.55 27.48 73.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 59' ' ' TRP . . . -72.71 142.54 48.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.192 -1.181 . . . . 0.0 109.833 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.38 114.6 38.28 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 110.523 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 49.5 Cg_endo -79.77 128.95 7.92 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.497 1.261 . . . . 0.0 110.308 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.99 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.516 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.77 53.56 1.14 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.432 ' CG2' HD13 ' A' ' 6' ' ' LEU . 3.1 m -166.77 -59.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 74' ' ' LEU . . . -66.52 -22.94 66.17 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.435 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 2.5 ttt85 -69.01 -43.24 75.21 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 ttm-85 -66.38 -38.44 87.56 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.731 178.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.37 -26.37 60.08 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 13.7 mt -72.0 -29.84 64.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -28.98 38.31 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.415 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.68 -34.58 30.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.814 0.816 . . . . 0.0 109.932 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . -62.19 -14.26 35.95 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.793 -0.567 . . . . 0.0 109.877 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 25.58 8.56 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 17.5 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 120.846 -1.385 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.123 0.487 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -140.11 143.28 36.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.121 -0.987 . . . . 0.0 110.874 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.511 ' N ' ' CD1' ' A' ' 4' ' ' ILE . 1.7 mp -100.23 139.09 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 108.901 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.3 -166.12 2.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 31.1 mt -89.5 135.7 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.86 . . . . 0.0 109.904 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -105.42 103.44 12.96 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.802 . . . . 0.0 111.029 -179.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.515 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.381 0 O-C-N 121.53 -0.731 . . . . 0.0 110.942 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 3.9 m-30 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 3.9 ptm180 -103.55 167.61 9.69 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 117.453 -1.699 . . . . 0.0 107.571 176.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.58 86.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 178.907 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.256 0.3 OUTLIER -98.95 170.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.224 -174.856 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.5 HG22 ' CD1' ' A' ' 59' ' ' TRP . 1.8 t -111.95 113.78 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.595 -0.69 . . . . 0.0 110.209 -178.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 8.6 p90 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.459 0.647 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' VAL . 4.7 mt -64.63 -63.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.944 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 21' ' ' VAL . 44.1 mt-10 -139.27 161.48 37.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.918 . . . . 0.0 110.255 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 118.92 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -0.948 . . . . 0.0 109.976 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 59' ' ' TRP . 49.5 pt -99.95 -27.96 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -150.6 -174.1 21.35 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 117.908 -2.091 . . . . 0.0 112.769 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 31.4 t80 -141.25 151.12 43.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.262 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.517 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 2.6 t80 -144.02 124.68 14.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.689 -1.257 . . . . 0.0 109.701 177.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 63.0 t0 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.588 -1.32 . . . . 0.0 110.335 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 73' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.47 0.653 . . . . 0.0 110.549 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -136.69 75.94 1.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.569 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -97.26 134.47 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 110.968 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -80.43 69.07 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 175.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.462 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -34.47 -31.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.514 -177.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.09 -55.98 26.21 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.899 -1.125 . . . . 0.0 108.778 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 5.1 mmp_? -69.28 -41.2 77.16 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . . . -64.54 -16.7 63.03 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.947 -1.095 . . . . 0.0 108.071 178.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.65 -25.73 22.25 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 177.849 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -59.71 -46.62 88.56 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.23 1.49 . . . . 0.0 107.406 178.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.513 ' CD1' HG23 ' A' ' 36' ' ' ILE . 94.6 m95 -67.0 -56.57 9.54 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.259 -178.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.45 -23.22 5.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.391 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.5 -21.0 42.37 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.647 -0.658 . . . . 0.0 110.272 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.3 m -98.67 32.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.468 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.27 29.36 74.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.66 129.1 35.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.269 -1.136 . . . . 0.0 109.924 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -97.67 108.52 46.03 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.438 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.8 Cg_endo -77.13 135.38 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.613 1.323 . . . . 0.0 110.368 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 2.3 p -54.69 161.08 1.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.892 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.74 -22.62 58.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.009 . . . . 0.0 110.107 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.0 m -89.19 -52.38 5.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' ' CG2' ' A' ' 19' ' ' ILE . . . -67.13 -23.88 65.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -70.06 -38.58 75.81 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.336 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -64.92 -34.24 77.94 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.87 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 69' ' ' THR . 47.8 mt -74.08 -32.58 63.32 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 56.3 mt -68.29 -28.88 67.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -30.4 52.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -29.21 37.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.891 0.853 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -76.98 -1.67 29.91 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.198 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.09 50.08 8.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.459 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 58.3 t . . . . . 0 N--CA 1.484 1.272 0 O-C-N 121.291 -1.123 . . . . 0.0 111.336 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.462 HG11 ' CZ3' ' A' ' 59' ' ' TRP . 84.1 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.283 0.564 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.78 137.06 34.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.387 -0.82 . . . . 0.0 109.999 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 59' ' ' TRP . 1.8 mp -99.63 135.89 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 5.3 ptp180 -151.18 175.39 12.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.707 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -88.17 126.16 34.99 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.935 178.882 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.19 109.84 22.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.56 -0.713 . . . . 0.0 111.917 -177.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.495 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 52.6 ttp180 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 111.152 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.8 m-85 . . . . . 0 C--O 1.21 -1.0 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 2.6 ttt85 -104.64 150.28 24.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.629 178.195 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.526 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 mm -97.35 80.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.459 HG23 ' CG ' ' A' ' 32' ' ' TYR 0.288 0.4 OUTLIER -97.35 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.734 -173.821 . . . . . . . . 4 4 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 59' ' ' TRP . 1.4 t -115.65 107.73 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.516 -176.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.268 -0.895 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CG ' HG23 ' A' ' 20' ' ' VAL . 20.0 p90 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.349 0.595 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.414 HG22 ' CZ2' ' A' ' 59' ' ' TRP . 10.4 mt -107.69 -36.43 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 110.329 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.84 176.04 9.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.68 109.45 19.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.694 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 59' ' ' TRP . 31.7 pt -106.11 -33.1 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.14 -0.975 . . . . 0.0 111.124 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.526 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -127.37 166.08 20.25 Favored Glycine 0 C--N 1.295 -1.723 0 C-N-CA 118.603 -1.76 . . . . 0.0 111.039 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.457 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.1 t80 -138.45 142.29 39.47 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.52 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.1 t80 -134.47 130.76 37.19 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.056 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.1 t0 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 110.195 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 76' ' ' GLN . 9.4 tp . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.589 0.709 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -132.7 97.35 4.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.758 . . . . 0.0 109.148 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.484 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 151.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 110.925 -179.133 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.6 t0 -96.65 67.95 2.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.99 -30.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 122.252 -0.28 . . . . 0.0 111.509 -177.281 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.7 tp10 -60.45 -54.62 43.33 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.761 -1.212 . . . . 0.0 108.581 178.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 47.3 mmm-85 -72.97 -37.06 67.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.825 . . . . 0.0 109.005 178.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.54 -20.59 66.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.8 ttt180 -88.35 -24.37 23.14 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.277 -0.889 . . . . 0.0 109.519 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -60.06 -46.59 89.04 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 123.5 1.619 . . . . 0.0 106.928 178.288 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CD1' HG23 ' A' ' 36' ' ' ILE . 79.1 m95 -63.72 -55.92 19.59 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.952 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -52.8 -22.36 5.26 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.549 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.37 -20.89 43.08 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.0 110.691 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 59' ' ' TRP . 4.3 m -99.0 32.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.875 -1.14 . . . . 0.0 109.952 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.85 71.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -77.0 138.51 39.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -1.112 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -116.78 118.29 36.76 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.391 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 54.2 Cg_endo -79.67 140.46 14.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.397 1.209 . . . . 0.0 109.856 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 t -62.56 176.22 0.68 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.96 -1.088 . . . . 0.0 110.468 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -81.58 49.77 1.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.154 -0.966 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.14 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -66.58 -23.91 66.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 25.6 ttt85 -63.81 -40.39 96.51 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -35.83 74.23 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.439 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 46.6 mt -72.46 -38.58 68.22 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 24.8 mt -61.04 -28.15 68.85 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -31.0 52.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.8 tp-100 -75.81 -35.16 60.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.039 0.923 . . . . 0.0 109.866 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.47 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.13 -7.02 32.33 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.472 178.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.2 8.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.457 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 57.4 t . . . . . 0 C--N 1.307 -1.275 0 O-C-N 121.356 -1.085 . . . . 0.0 111.572 -179.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 78.0 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.173 0.511 . . . . 0.0 109.904 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 59.7 mtpt -140.32 132.39 27.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.428 HD13 ' CB ' ' A' ' 59' ' ' TRP . 61.9 mt -100.17 127.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 121.076 -1.015 . . . . 0.0 109.153 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 1.2 ptm180 -150.74 -170.4 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.017 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.0 mp -88.49 126.32 35.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 105.8 17.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 111.085 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 36.8 ttp180 . . . . . 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 109.817 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 13.9 m-85 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HG2' ' CD1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -104.13 158.9 16.12 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.379 -1.329 . . . . 0.0 108.089 177.166 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -98.3 77.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 32' ' ' TYR 0.255 0.3 OUTLIER -97.25 164.69 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.855 -173.398 . . . . . . . . 4 4 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.44 105.48 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 109.967 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.429 HG23 ' HB3' ' A' ' 32' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.649 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.4 HG23 ' CH2' ' A' ' 59' ' ' TRP . 4.9 mt -59.88 -50.01 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.764 . . . . 0.0 109.926 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -178.31 5.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 109.904 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -117.8 125.39 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.943 . . . . 0.0 110.343 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.532 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.48 -33.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.176 -0.953 . . . . 0.0 111.242 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -119.5 161.37 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 C-N-CA 118.919 -1.61 . . . . 0.0 110.967 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' HG2' ' A' ' 18' ' ' ARG . 72.3 t80 -133.62 145.08 49.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 17.6 t80 -139.74 134.37 31.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.686 -1.259 . . . . 0.0 109.918 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 0.0 110.61 -179.788 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.483 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.0 tt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.332 0.587 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.76 97.96 3.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.156 -0.965 . . . . 0.0 109.636 178.95 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 2.1 t -128.66 130.34 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.864 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 17.2 t0 -80.16 72.29 6.96 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -34.6 -31.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 122.342 -0.224 . . . . 0.0 111.523 -177.108 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -59.93 -51.49 69.46 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.818 -1.176 . . . . 0.0 108.666 177.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 14.4 mmm180 -73.57 -41.12 63.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.464 ' CB ' ' CD1' ' A' ' 36' ' ' ILE . . . -62.62 -18.43 62.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 52.0 ttp85 -88.34 -26.15 22.37 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.512 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 1.1 t80 -62.01 -44.72 96.11 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 123.289 1.519 . . . . 0.0 107.462 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.545 ' CD1' HG21 ' A' ' 21' ' ' VAL . 71.9 m95 -68.03 -57.08 6.72 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.038 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 mt -56.67 -21.43 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.524 177.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -79.25 -23.22 43.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 110.718 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 59' ' ' TRP . 13.9 m -98.9 31.95 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 120.854 -1.154 . . . . 0.0 109.458 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.38 26.73 74.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -63.13 136.27 57.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.314 . . . . 0.0 109.896 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.429 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.52 108.1 48.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 110.551 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 53.0 Cg_endo -81.72 141.18 12.07 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.626 1.329 . . . . 0.0 109.19 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 t -73.77 178.74 4.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.991 -1.068 . . . . 0.0 110.801 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.01 53.67 2.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.1 m -165.73 -59.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB2' ' CG2' ' A' ' 19' ' ' ILE . . . -67.08 -26.85 66.93 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 22.1 ttp85 -62.58 -42.0 99.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -64.99 -29.15 70.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.403 HD22 HD11 ' A' ' 49' ' ' LEU . 18.3 mt -85.1 -28.41 25.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.376 -0.828 . . . . 0.0 109.234 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 21.8 mt -69.05 -27.25 65.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.089 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.43 ' CG ' ' O ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -82.62 -31.26 28.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.116 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.6 tp-100 -76.24 -35.34 59.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.103 0.954 . . . . 0.0 109.452 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.437 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.93 -12.48 50.0 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.747 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 91.86 48.6 3.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.425 HG22 ' HB ' ' A' ' 53' ' ' VAL . 34.1 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.918 -1.342 . . . . 0.0 111.496 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.371 0.605 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -140.12 128.86 23.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.482 HD12 ' CD1' ' A' ' 36' ' ' ILE . 31.6 mt -100.81 133.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.909 -1.119 . . . . 0.0 109.564 179.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.0 ptt180 -151.55 -172.55 4.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.072 -1.018 . . . . 0.0 110.342 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.487 HD21 ' CD2' ' A' ' 39' ' ' TYR . 6.0 mp -88.7 126.66 35.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -98.98 104.72 16.79 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 7.2 tmm_? . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 111.66 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 7.0 m-85 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 0.4 OUTLIER -99.7 156.59 17.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.991 177.521 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -98.52 79.37 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 178.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.408 HG11 ' CB ' ' A' ' 32' ' ' TYR 0.274 0.4 OUTLIER -97.98 156.66 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.228 -174.206 . . . . . . . . 4 4 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.546 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -105.05 114.76 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.341 0.591 . . . . 0.0 111.066 -177.89 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.412 -0.805 . . . . 0.0 110.049 179.362 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 28.1 p90 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.522 0.677 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.402 HG23 ' CZ2' ' A' ' 59' ' ' TRP . 2.7 mp -57.57 -61.07 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.11 155.68 42.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.815 . . . . 0.0 110.141 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.4 pttp -89.87 118.57 29.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 0.0 109.77 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.9 pt -107.9 -32.46 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.138 -0.976 . . . . 0.0 111.524 -179.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -126.74 167.32 19.21 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 118.813 -1.661 . . . . 0.0 111.388 -178.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 40' ' ' ASP . 12.5 t80 -138.57 139.41 38.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.496 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 40.3 t80 -136.67 124.02 21.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.71 -1.244 . . . . 0.0 109.699 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.473 ' HB2' ' CE1' ' A' ' 38' ' ' TYR . 54.9 t0 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 120.753 -1.217 . . . . 0.0 110.762 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.456 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.4 tt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.442 0.639 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.89 99.68 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.143 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t -128.32 142.56 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.035 . . . . 0.0 111.763 -178.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t0 -88.23 69.97 9.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.071 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -34.44 -31.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.808 -177.423 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.0 mt-10 -63.81 -56.18 17.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.82 -1.175 . . . . 0.0 108.953 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -72.26 -36.1 68.95 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.27 -0.894 . . . . 0.0 109.112 178.928 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.86 -20.19 66.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.04 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.3 ttt180 -86.95 -22.33 25.68 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.246 -0.909 . . . . 0.0 109.795 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.9 OUTLIER -62.17 -46.62 88.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.276 1.513 . . . . 0.0 107.523 178.753 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.546 ' CD1' HG23 ' A' ' 21' ' ' VAL . 86.2 m95 -65.64 -58.35 5.94 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.863 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 48.5 mt -53.78 -22.55 9.67 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.488 177.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 1.1 m -79.2 -20.49 48.21 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.475 -0.766 . . . . 0.0 110.014 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.4 m -98.81 32.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.967 -1.083 . . . . 0.0 109.061 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.31 23.79 71.83 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . . . -61.33 136.77 58.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -1.194 . . . . 0.0 109.759 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.98 108.62 55.2 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 110.163 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 55.2 Cg_endo -83.62 123.69 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.51 1.268 . . . . 0.0 109.745 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -50.17 168.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' A' ' 69' ' ' THR . 4.7 t0 -73.1 56.26 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.098 -1.001 . . . . 0.0 110.42 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 68' ' ' ASP . 19.2 m -166.49 -60.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . . . -64.23 -24.86 67.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 9.3 ttt-85 -67.06 -44.42 80.17 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -69.25 -11.86 61.17 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.137 179.163 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.19 -27.32 13.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.422 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 13.4 mt -72.8 -29.32 63.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.43 ' HG2' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.4 -30.93 48.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.942 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -78.2 -31.73 49.61 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.846 0.831 . . . . 0.0 109.344 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.427 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -66.58 -10.57 46.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.876 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.36 14.72 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.646 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.442 HG22 ' CB ' ' A' ' 53' ' ' VAL . 21.2 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.9 -1.353 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.151 0.5 . . . . 0.0 109.671 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -140.26 133.33 29.46 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.526 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.479 HD12 ' CD1' ' A' ' 36' ' ' ILE . 79.0 mt -99.81 137.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.067 -1.021 . . . . 0.0 109.251 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.5 ptm180 -150.82 178.4 9.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.014 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 4.4 pp -89.5 130.92 35.76 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.592 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -99.37 171.97 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.507 -0.746 . . . . 0.0 109.199 -179.164 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 1.7 tmt_? . . . . . 0 N--CA 1.488 1.444 0 O-C-N 120.935 -1.103 . . . . 0.0 112.065 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 8' ' ' ARG 0.255 12.1 m-30 . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 43.2 mtt180 -134.83 153.07 52.19 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.279 177.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -96.83 82.65 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 178.174 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.28 0.4 OUTLIER -97.95 158.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.162 -174.224 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.588 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.19 111.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.584 -0.698 . . . . 0.0 111.096 -177.524 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.7 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 26.9 p90 . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.607 0.718 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.446 HG21 ' CZ2' ' A' ' 59' ' ' TRP . 7.2 mt -72.38 -53.32 19.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.625 -0.672 . . . . 0.0 110.262 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -151.87 158.58 43.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 110.119 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.2 pttm -92.47 112.56 24.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.497 HG23 ' CD1' ' A' ' 59' ' ' TRP . 30.0 pt -104.75 -37.28 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.038 -1.039 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.493 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -116.24 166.34 12.33 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 119.02 -1.562 . . . . 0.0 112.232 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -140.95 117.19 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.528 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 14.3 t80 -109.12 147.14 32.92 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.58 -1.325 . . . . 0.0 110.472 -179.302 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.164 -0.96 . . . . 0.0 109.06 178.83 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 1.5 tt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.587 0.708 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 86.91 2.37 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.493 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -115.11 136.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 111.206 -178.963 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -81.23 69.05 7.77 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -36.53 -29.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 122.226 -0.296 . . . . 0.0 111.268 -177.423 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 15.5 tt0 -61.2 -50.5 72.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.714 -1.241 . . . . 0.0 108.416 177.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 22.6 mmm180 -76.23 -37.17 58.05 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.297 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.83 -19.3 65.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.207 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.6 ttm-85 -89.56 -22.47 22.36 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.289 -0.882 . . . . 0.0 109.552 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -62.7 -48.33 79.72 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.251 1.5 . . . . 0.0 107.182 178.366 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.588 ' CD1' HG22 ' A' ' 21' ' ' VAL . 84.3 m95 -65.07 -56.31 13.75 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.793 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 20.5 mt -53.86 -22.07 9.05 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.141 -0.975 . . . . 0.0 108.434 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.55 -19.48 38.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.351 -0.843 . . . . 0.0 110.391 179.129 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG23 ' HA ' ' A' ' 59' ' ' TRP . 3.5 m -98.91 32.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 120.87 -1.144 . . . . 0.0 109.403 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.75 25.56 74.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . . . -72.79 122.31 21.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.001 -1.293 . . . . 0.0 110.274 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.55 116.05 65.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.223 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.6 Cg_endo -80.01 153.88 22.34 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.425 1.224 . . . . 0.0 110.188 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -76.57 167.06 22.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.078 -1.014 . . . . 0.0 109.96 179.608 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -28.8 64.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -0.954 . . . . 0.0 110.953 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.0 m -96.25 -44.98 7.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -65.48 -28.46 69.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 67' ' ' THR . 1.7 ttm-85 -68.22 -40.35 82.13 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.64 -15.14 63.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.003 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.2 mt -99.31 -29.46 12.78 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.242 -0.911 . . . . 0.0 108.943 178.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 33.4 mt -72.82 -27.74 62.14 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.96 -29.61 44.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.268 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -79.2 -35.83 41.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.129 0.966 . . . . 0.0 109.24 179.201 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -57.51 -17.8 15.63 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.627 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.97 16.85 12.64 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 21.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 120.911 -1.347 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.4 HG12 ' CE3' ' A' ' 59' ' ' TRP . 97.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.176 0.512 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -140.62 128.51 21.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 0.0 111.072 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.502 HD13 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -100.04 131.55 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.198 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 9.5 ptm180 -151.78 -165.24 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 110.654 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 79.4 mt -89.04 128.43 35.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.79 103.29 14.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.699 -0.626 . . . . 0.0 109.588 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.464 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 49.4 ttt-85 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 112.405 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 7.3 m-85 . . . . . 0 C--O 1.216 -0.7 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.424 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.6 ttt180 -99.33 159.87 14.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -98.22 83.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.711 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.07 169.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.977 -173.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -114.82 114.13 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.271 0.558 . . . . 0.0 110.285 -177.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 2.4 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 20.6 p90 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.685 0.755 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.0 -43.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' OE1' ' CD ' ' A' ' 55' ' ' ARG . 5.4 tt0 -160.98 169.33 22.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.956 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -103.7 111.76 24.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.528 HG23 ' CD1' ' A' ' 59' ' ' TRP . 30.2 pt -101.67 -34.69 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.313 -0.867 . . . . 0.0 110.974 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -126.97 165.83 20.02 Favored Glycine 0 C--N 1.294 -1.774 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.547 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG13 ' A' ' 19' ' ' ILE . 34.4 t80 -134.51 142.3 46.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.127 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -140.42 134.13 30.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.812 -1.18 . . . . 0.0 109.974 -179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t0 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.771 -1.206 . . . . 0.0 110.512 179.671 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 9.2 tt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.312 0.577 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -136.1 87.32 2.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 109.318 178.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -112.53 157.82 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.374 1.083 . . . . 0.0 111.567 -179.054 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -106.02 64.91 0.68 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.064 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.9 -33.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.771 -177.365 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.1 mt-10 -60.77 -52.49 64.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.837 -1.164 . . . . 0.0 108.923 178.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.48 -35.56 60.81 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 108.957 178.665 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -66.05 -21.45 66.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -86.59 -22.2 26.38 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.336 -0.852 . . . . 0.0 109.836 178.507 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -61.31 -48.6 80.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.223 1.487 . . . . 0.0 107.2 178.521 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.579 ' CD1' HG22 ' A' ' 21' ' ' VAL . 90.5 m95 -63.54 -53.47 51.31 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.527 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 5.8 mt -52.86 -23.59 7.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -22.78 45.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.694 -0.629 . . . . 0.0 110.25 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.8 m -98.81 32.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.841 -1.162 . . . . 0.0 109.666 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.11 73.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 60' ' ' LEU . . . -66.37 135.11 53.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.076 -1.249 . . . . 0.0 110.119 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.23 111.01 64.39 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.947 . . . . 0.0 110.5 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.99 127.0 6.69 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.452 1.238 . . . . 0.0 109.894 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -58.6 -177.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.038 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -76.6 52.05 0.78 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.264 -0.898 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.78 -57.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.75 -23.46 66.74 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -68.73 -40.75 79.74 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -40.87 88.96 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.639 178.833 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.52 -31.18 72.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.8 mt -72.38 -25.38 61.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.5 -28.82 28.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.461 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.9 tp-100 -86.52 -37.28 18.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.674 0.75 . . . . 0.0 110.543 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -10.54 42.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.762 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.01 54.75 3.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 49.4 t . . . . . 0 N--CA 1.488 1.426 0 O-C-N 121.172 -1.193 . . . . 0.0 111.678 -179.3 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.148 0.499 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -140.32 139.17 35.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.379 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 36' ' ' ILE . 46.6 mt -100.04 139.06 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.007 -1.058 . . . . 0.0 109.427 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -150.85 -168.38 3.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.839 -1.163 . . . . 0.0 110.873 -179.101 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 6' ' ' LEU . 6.6 mp -89.15 129.21 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -101.31 102.86 13.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.235 -0.916 . . . . 0.0 110.704 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 111.575 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 8.6 m-85 . . . . . 0 C--O 1.213 -0.846 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -99.98 163.55 12.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.083 -1.447 . . . . 0.0 108.085 177.229 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -98.4 81.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 103.047 -2.945 . . . . 0.0 103.047 177.359 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.468 HG21 ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.71 165.61 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.787 0.803 . . . . 0.0 111.984 -173.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -109.07 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.251 0.548 . . . . 0.0 110.782 -177.462 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.246 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD2' HG21 ' A' ' 20' ' ' VAL . 10.7 p90 . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.483 0.658 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.3 mt -99.01 -27.25 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.925 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -174.54 165.16 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 109.864 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.1 pttt -102.94 111.89 24.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.498 HG23 ' CD1' ' A' ' 59' ' ' TRP . 36.7 pt -106.06 -30.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.976 -1.077 . . . . 0.0 110.883 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -126.9 167.38 19.36 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.07 -1.538 . . . . 0.0 112.304 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.427 ' N ' HG12 ' A' ' 19' ' ' ILE . 5.7 t80 -141.24 124.72 16.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.021 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.525 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.7 t80 -124.97 131.6 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.671 -1.268 . . . . 0.0 109.533 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.7 t0 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 110.58 179.857 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.421 HD13 ' CD2' ' A' ' 73' ' ' LEU . 5.8 tt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.329 0.585 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -126.9 92.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.06 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.471 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.51 137.41 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.118 -178.906 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.7 t0 -78.43 69.56 4.64 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -35.2 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.601 -177.773 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.3 mt-10 -65.08 -49.42 70.12 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.96 -1.088 . . . . 0.0 109.276 178.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.74 -32.73 52.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 178.75 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.496 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -70.04 -23.38 63.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.151 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -85.0 -21.52 29.44 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 178.093 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -60.77 -48.53 81.38 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.158 1.456 . . . . 0.0 107.147 178.464 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CD1' HG23 ' A' ' 21' ' ' VAL . 87.3 m95 -62.88 -55.44 26.09 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.627 -179.481 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -54.24 -21.81 10.03 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.234 -0.986 . . . . 0.0 108.467 177.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.49 -20.47 43.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.81 . . . . 0.0 110.589 179.345 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 59' ' ' TRP . 4.7 m -98.92 32.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 120.865 -1.147 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.36 74.43 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -77.89 141.18 39.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.122 -1.222 . . . . 0.0 110.035 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 123.79 29.1 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.6 Cg_endo -85.12 145.45 9.78 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.454 1.239 . . . . 0.0 109.938 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -64.65 -178.8 0.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.078 -1.014 . . . . 0.0 110.577 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.04 52.47 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.2 m -165.97 -61.39 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . . . -64.73 -26.41 68.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 2.8 ttt180 -66.39 -44.75 82.19 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -67.34 -12.58 60.52 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.106 179.234 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 10.7 mt -99.89 -29.86 12.35 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.446 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 26.5 mt -71.62 -28.46 63.81 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.28 -29.87 42.7 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.961 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -78.36 -31.35 48.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.955 0.883 . . . . 0.0 109.363 178.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.64 -12.44 45.89 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.978 178.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.0 16.59 20.95 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 74' ' ' LEU . 17.1 t . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.362 . . . . 0.0 110.152 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.486 HG12 ' CE3' ' A' ' 59' ' ' TRP . 47.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.16 0.505 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 130.94 25.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 0.0 110.539 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.487 HD12 ' CD1' ' A' ' 36' ' ' ILE . 82.9 mt -102.47 135.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 121.126 -0.984 . . . . 0.0 109.783 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.445 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.49 177.87 9.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.941 179.94 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 4.3 pp -89.13 130.52 35.55 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.035 178.664 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -98.78 165.82 11.6 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.392 -0.817 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 O-C-N 120.967 -1.083 . . . . 0.0 111.673 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 17.6 m-30 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 0.0 OUTLIER -127.81 149.09 50.42 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.962 -1.086 . . . . 0.0 108.76 177.899 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -96.94 81.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 178.112 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.471 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.291 0.4 OUTLIER -98.3 161.66 2.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.783 -173.526 . . . . . . . . 4 4 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.12 106.94 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.569 -178.102 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.471 ' CD2' HG22 ' A' ' 20' ' ' VAL . 22.8 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.428 0.632 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.3 mt -78.36 -37.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.412 -0.805 . . . . 0.0 109.919 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 168.07 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -103.7 113.47 27.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.87 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 35.3 pt -104.76 -34.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -122.9 166.92 15.21 Favored Glycine 0 C--N 1.295 -1.698 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.895 -178.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.418 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 16.3 t80 -140.6 122.34 15.34 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.61 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.511 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 7.1 t80 -114.46 141.01 48.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.733 -1.229 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.408 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t70 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.813 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 73' ' ' LEU . 3.8 tt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.438 0.637 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -133.04 88.07 2.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 0.0 108.95 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -114.11 139.55 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.115 -0.991 . . . . 0.0 111.09 -179.067 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.3 t0 -84.65 70.2 10.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -34.63 -32.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 122.268 -0.27 . . . . 0.0 111.461 -177.467 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tm-20 -61.54 -54.64 40.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.863 -1.148 . . . . 0.0 108.728 178.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -69.33 -39.93 77.89 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.717 0.77 . . . . 0.0 109.065 178.685 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.478 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.57 -21.18 66.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.475 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -87.14 -20.5 26.95 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 178.642 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.1 t80 -61.37 -48.94 78.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.362 1.553 . . . . 0.0 107.142 178.365 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CD1' HG23 ' A' ' 21' ' ' VAL . 81.9 m95 -63.18 -54.27 40.19 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.768 -178.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mt -53.86 -21.99 8.86 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.28 177.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -22.78 38.56 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.471 -0.768 . . . . 0.0 110.679 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 59' ' ' TRP . 5.2 m -99.24 31.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.832 -1.168 . . . . 0.0 109.908 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.82 26.22 71.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 142.81 56.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.873 -1.369 . . . . 0.0 110.324 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 105.99 57.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.2 Cg_endo -83.2 124.99 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.582 1.306 . . . . 0.0 110.763 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 6.3 t -58.73 156.3 11.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.067 -1.02 . . . . 0.0 109.06 179.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -48.66 47.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.054 -1.029 . . . . 0.0 111.556 -179.052 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.411 HG21 ' CD2' ' A' ' 6' ' ' LEU . 1.5 m -62.22 -56.42 18.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.1 -1.0 . . . . 0.0 111.825 -178.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -68.45 -25.68 65.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 109.093 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 67' ' ' THR . 25.7 ttt180 -69.8 -38.39 76.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -61.53 -30.41 70.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.419 178.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.442 ' CD2' HD12 ' A' ' 49' ' ' LEU . 24.7 mt -78.31 -37.6 44.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 68.6 mt -62.42 -30.66 71.38 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.788 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -28.48 44.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 9.7 tp-100 -75.49 -35.76 60.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.069 0.938 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -70.2 -8.0 46.45 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.057 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.93 53.02 3.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.413 HG23 ' HA ' ' A' ' 53' ' ' VAL . 61.9 t . . . . . 0 N--CA 1.487 1.389 0 O-C-N 121.206 -1.173 . . . . 0.0 111.46 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.487 HG11 ' CZ3' ' A' ' 59' ' ' TRP . 95.2 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 16.3 mtpt -140.02 139.25 35.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.433 ' CG2' HD11 ' A' ' 36' ' ' ILE . 41.4 mt -103.51 130.33 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.142 -0.974 . . . . 0.0 109.264 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.52 -165.28 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 110.331 -179.118 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.434 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 44.7 mt -89.09 133.81 34.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.99 -1.069 . . . . 0.0 110.695 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -104.95 105.84 16.06 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.518 -0.738 . . . . 0.0 110.996 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.505 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 15.6 ttp180 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.894 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 5.2 m-30 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 1.1 ptp180 -105.59 165.73 10.95 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.325 176.081 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -98.11 85.32 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.219 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.489 HG21 ' CG ' ' A' ' 32' ' ' TYR 0.261 0.3 OUTLIER -98.05 166.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.152 -175.031 . . . . . . . . 4 4 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.42 107.41 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 110.159 -178.459 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CG ' HG21 ' A' ' 20' ' ' VAL . 15.8 p90 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.482 0.658 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 mp -98.11 -25.22 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.608 -0.683 . . . . 0.0 109.632 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.26 162.85 6.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 0.0 109.865 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 4.0 ptpt -105.07 115.55 30.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.114 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 59' ' ' TRP . 42.3 pt -105.09 -31.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -136.29 177.88 19.24 Favored Glycine 0 C--N 1.295 -1.705 0 C-N-CA 118.215 -1.945 . . . . 0.0 112.583 -178.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.486 ' N ' HG13 ' A' ' 19' ' ' ILE . 71.8 t80 -139.96 147.89 41.14 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 26.1 t80 -143.01 131.17 21.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.337 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.2 t0 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 120.652 -1.28 . . . . 0.0 110.505 179.695 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.478 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 4.7 tt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.26 86.98 2.57 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 108.971 178.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -116.48 149.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.472 1.13 . . . . 0.0 112.294 -178.528 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.9 t70 -99.16 64.91 1.4 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -33.97 -32.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.539 -177.289 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.07 -53.24 59.55 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.816 -1.177 . . . . 0.0 108.756 178.231 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -76.37 -34.03 58.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.434 -0.791 . . . . 0.0 108.869 178.636 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -67.52 -21.22 65.49 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.068 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 50.1 ttp85 -87.98 -21.21 24.97 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.231 -0.918 . . . . 0.0 109.721 178.089 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -60.75 -49.51 77.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CD1' HG21 ' A' ' 21' ' ' VAL . 88.6 m95 -61.72 -53.18 59.57 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.315 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.2 mt -53.94 -22.26 9.82 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.5 -22.89 40.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.561 -0.712 . . . . 0.0 110.973 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 59' ' ' TRP . 10.5 m -98.99 32.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.758 -1.214 . . . . 0.0 109.606 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.81 71.53 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -69.37 128.47 36.69 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.269 . . . . 0.0 110.015 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.466 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -97.17 109.52 49.92 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.174 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.41 136.91 10.15 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.519 1.273 . . . . 0.0 110.29 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -62.02 179.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.968 . . . . 0.0 109.525 179.476 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 19.4 p-10 -69.98 -18.98 63.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.075 -1.015 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -50.37 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.256 -0.902 . . . . 0.0 110.503 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.01 -25.06 64.31 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.351 -0.843 . . . . 0.0 108.913 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 67' ' ' THR . 7.9 ttt-85 -68.53 -38.31 80.75 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.05 -39.36 90.08 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.511 -0.875 . . . . 0.0 108.76 178.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.93 -26.26 60.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.575 -0.703 . . . . 0.0 109.261 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 16.4 mt -72.74 -25.94 61.39 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -32.0 31.19 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.181 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 7.9 tp-100 -80.1 -37.21 34.17 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.998 0.904 . . . . 0.0 109.964 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.47 -12.48 22.31 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.887 178.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.78 38.18 8.91 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.449 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 39.4 t . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.196 -1.179 . . . . 0.0 111.351 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.432 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 14.6 mtpt -140.73 143.02 34.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.637 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.426 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 46.7 mt -101.27 135.42 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.104 -0.997 . . . . 0.0 108.941 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -177.76 6.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.107 . . . . 0.0 110.956 -179.04 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mp -88.96 125.12 34.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.819 . . . . 0.0 109.887 179.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.14 111.62 23.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.461 -0.775 . . . . 0.0 110.901 -179.034 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.963 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.0 m-30 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' NE ' ' HG2' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -104.65 152.99 21.81 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.551 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 1.3 mm -98.42 80.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 178.299 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.28 0.4 OUTLIER -97.36 164.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.937 -173.759 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.499 HG12 ' CG ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -109.94 113.6 44.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.599 -0.688 . . . . 0.0 110.594 -176.92 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.2 t . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.287 -0.883 . . . . 0.0 110.413 179.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 8.5 p90 . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.485 0.66 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG23 ' CZ2' ' A' ' 59' ' ' TRP . 2.7 mp -72.97 -59.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.504 -0.748 . . . . 0.0 109.604 179.519 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.98 149.78 35.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HG2' ' NE ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -89.82 126.6 35.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.962 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.521 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.86 -24.78 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.448 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -128.37 161.44 22.14 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.662 -1.732 . . . . 0.0 110.649 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.474 ' N ' HG12 ' A' ' 19' ' ' ILE . 88.0 t80 -138.41 144.6 40.27 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.894 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 16.0 t80 -137.47 133.26 34.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.45 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t0 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 120.809 -1.182 . . . . 0.0 110.514 179.843 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 73' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.319 0.58 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 88.91 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.828 . . . . 0.0 109.095 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.486 HG23 ' HA3' ' A' ' 37' ' ' GLY . 1.5 t -118.16 129.78 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.051 -1.031 . . . . 0.0 111.369 -178.833 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t70 -75.09 72.15 2.19 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -33.7 -32.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.549 -177.509 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 16.5 tt0 -61.56 -53.15 60.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.855 -1.153 . . . . 0.0 108.857 178.045 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.45 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.89 -37.47 73.0 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.276 178.933 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.464 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -68.82 -20.77 64.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.319 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 29.2 ttt-85 -85.11 -25.16 27.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.672 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.444 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 11.1 t80 -60.2 -43.96 95.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 123.211 1.482 . . . . 0.0 107.564 178.307 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.521 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 68.9 m95 -68.72 -57.01 6.26 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.934 -179.07 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -55.11 -21.01 11.38 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.333 -0.947 . . . . 0.0 108.873 177.497 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.2 t -81.43 -23.44 37.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.279 -0.888 . . . . 0.0 110.76 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 59' ' ' TRP . 36.0 m -99.09 32.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 120.944 -1.098 . . . . 0.0 109.404 179.571 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.04 30.54 74.08 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -76.32 120.77 22.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.967 -1.314 . . . . 0.0 109.769 179.736 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.432 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -92.07 115.83 65.37 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.458 -179.69 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HB2' ' CA ' ' A' ' 71' ' ' ARG . 52.5 Cg_endo -82.87 133.25 6.7 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.435 1.229 . . . . 0.0 109.687 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 t -53.0 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.008 -1.058 . . . . 0.0 110.594 -179.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.96 52.65 1.28 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.3 -0.875 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -167.26 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.92 -22.96 66.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.538 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.435 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 5.4 ttt180 -66.99 -42.67 84.63 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.407 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -30.65 71.47 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.451 HD12 ' CD2' ' A' ' 39' ' ' TYR . 23.6 mt -77.59 -31.53 53.09 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 47.4 mt -67.42 -30.12 69.79 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.575 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -30.56 42.24 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -77.46 -33.21 54.76 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.996 0.903 . . . . 0.0 109.56 179.473 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.455 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.53 -12.8 35.23 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.06 178.608 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.38 27.92 10.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 30.5 t . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.11 -1.23 . . . . 0.0 110.495 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 70.9 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.147 0.498 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -140.82 137.12 33.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.027 -1.046 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.4 mt -100.68 134.04 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.125 -0.984 . . . . 0.0 108.494 178.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 53.9 ptt85 -150.8 -172.44 4.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.835 -1.165 . . . . 0.0 111.159 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 6.8 mp -88.58 127.43 35.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.239 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -101.22 108.98 20.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.466 -0.771 . . . . 0.0 111.455 -178.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.8 ttt-85 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 111.2 179.832 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 5.7 m-30 . . . . . 0 C--O 1.212 -0.88 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' HD3' ' CG2' ' A' ' 20' ' ' VAL . 3.2 ptm180 -104.0 161.74 13.73 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.522 -1.671 . . . . 0.0 107.755 177.142 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.6 OUTLIER -98.09 85.37 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 179.397 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.445 ' CG2' ' HD3' ' A' ' 18' ' ' ARG 0.27 0.3 OUTLIER -97.62 170.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.105 -174.324 . . . . . . . . 4 4 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -116.69 103.43 15.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.84 . . . . 0.0 110.658 -177.292 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.715 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.432 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 14.7 p90 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.356 0.598 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.25 -29.04 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.528 -0.733 . . . . 0.0 109.7 179.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -174.37 169.75 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.441 -0.787 . . . . 0.0 109.918 179.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -110.14 121.99 46.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.782 179.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.534 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -119.35 -30.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.145 -0.972 . . . . 0.0 111.179 -179.533 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.497 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -121.69 164.28 14.88 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.078 -179.838 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.466 ' N ' HG13 ' A' ' 19' ' ' ILE . 75.2 t80 -137.64 140.43 40.87 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.489 ' CE1' HD23 ' A' ' 73' ' ' LEU . 54.7 t80 -139.42 113.17 8.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.569 -1.332 . . . . 0.0 109.957 -179.023 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.437 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.5 t0 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 120.613 -1.304 . . . . 0.0 110.709 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.479 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 3.7 tt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.6 0.714 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 11.2 mtpt -140.45 94.5 2.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.222 178.833 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 2.2 t -129.94 134.9 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 112.069 -179.025 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 t0 -82.96 71.01 10.08 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -33.43 -31.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.04 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 31.8 mt-10 -60.87 -49.57 76.94 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.956 178.224 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.6 mmm180 -75.01 -39.73 61.02 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.248 -0.908 . . . . 0.0 109.084 178.51 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.455 ' CB ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.1 -22.87 67.11 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.356 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 7.5 ttt180 -86.35 -23.57 26.15 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.41 -0.806 . . . . 0.0 109.62 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.52 -49.01 75.2 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 123.205 1.478 . . . . 0.0 107.484 178.477 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.534 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 71.8 m95 -61.76 -52.57 63.68 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.275 -179.321 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mt -57.01 -21.2 28.91 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.46 -26.17 55.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.333 -0.854 . . . . 0.0 110.311 179.502 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 59' ' ' TRP . 34.4 m -99.08 32.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.048 -1.032 . . . . 0.0 109.581 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.4 76.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -64.69 96.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.353 . . . . 0.0 109.689 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.03 114.7 29.39 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.4 Cg_endo -85.67 130.44 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.528 1.278 . . . . 0.0 109.641 179.391 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -53.18 178.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.085 -1.009 . . . . 0.0 110.651 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.22 54.28 1.94 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.32 -0.862 . . . . 0.0 110.073 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -164.72 -60.29 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 5' ' ' ARG . . . -67.58 -26.34 66.24 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 33.6 ttp180 -65.41 -43.15 91.49 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.098 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.03 -42.66 99.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.862 178.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.489 HD23 ' CE1' ' A' ' 39' ' ' TYR . 27.6 mt -70.08 -28.87 65.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 28.7 mt -69.26 -29.14 66.98 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.841 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.53 -34.23 35.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.157 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -78.06 -26.02 48.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.866 0.841 . . . . 0.0 109.659 179.165 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.459 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -68.79 -9.82 53.19 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.211 0.529 . . . . 0.0 110.078 179.01 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.26 21.0 23.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 14.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.284 . . . . 0.0 110.538 179.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.4 HG12 ' CG2' ' A' ' 62' ' ' VAL . 59.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.295 0.569 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 6.5 mttt -140.64 124.67 17.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.701 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.435 HD11 ' CB ' ' A' ' 59' ' ' TRP . 49.7 mt -99.88 129.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 120.991 -1.068 . . . . 0.0 109.211 178.843 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -151.07 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.928 . . . . 0.0 110.64 -179.187 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.438 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 55.4 mt -88.59 127.96 35.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.706 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.88 100.52 11.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.54 -0.725 . . . . 0.0 110.382 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 41.1 ttt180 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 111.299 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 7.6 m-85 . . . . . 0 C--O 1.213 -0.864 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' NH1' ' HG2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -99.81 160.29 14.41 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.231 -1.788 . . . . 0.0 106.751 176.535 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.496 HG13 ' N ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -97.62 85.44 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 103.487 -2.782 . . . . 0.0 103.487 179.125 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.271 0.3 OUTLIER -97.44 169.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.945 -174.159 . . . . . . . . 4 4 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.91 110.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.434 -0.792 . . . . 0.0 110.634 -177.405 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.0 t . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.443 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 21.4 p90 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.758 0.79 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 mt -81.66 -32.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.407 0.623 . . . . 0.0 109.78 179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.79 176.75 3.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -113.32 123.86 51.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.983 . . . . 0.0 110.354 -179.822 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.542 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.8 -26.9 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.862 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -125.85 166.05 18.76 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 118.765 -1.684 . . . . 0.0 111.325 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.496 ' N ' HG13 ' A' ' 19' ' ' ILE . 40.5 t80 -138.33 140.76 39.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.103 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 15.1 t80 -138.17 127.84 25.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.909 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 t0 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.619 -1.3 . . . . 0.0 110.499 -179.862 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.7 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.221 0.534 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -136.97 95.84 3.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.527 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 2.2 t -127.75 128.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.975 -179.48 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.6 t0 -79.1 70.36 5.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.645 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.448 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -31.53 -34.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.158 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 mm-40 -60.63 -51.15 70.62 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.809 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 2.6 mmm180 -71.85 -41.85 67.61 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.386 -0.821 . . . . 0.0 108.836 178.398 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.94 -16.95 62.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.017 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -88.53 -29.03 20.39 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 178.394 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP 0.251 1.7 t80 -57.66 -43.47 84.99 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.331 1.539 . . . . 0.0 107.338 178.399 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 69.7 m95 -69.03 -52.99 22.93 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.282 -179.285 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.65 -20.37 33.02 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.83 177.148 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.4 t -83.22 -22.77 33.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 59' ' ' TRP . 35.4 m -99.07 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.979 -1.075 . . . . 0.0 109.5 179.602 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.9 72.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -67.76 128.37 36.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.383 . . . . 0.0 109.838 179.621 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.42 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 2.4 mm-40 -92.75 109.99 42.53 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.9 Cg_endo -81.17 150.86 17.85 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.468 1.246 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -81.82 170.01 16.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.684 179.564 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -17.88 30.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -99.54 -47.97 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.14 -0.975 . . . . 0.0 110.322 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.94 -25.75 64.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -38.32 83.38 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.186 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -39.82 94.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.958 178.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.407 ' HB3' HD11 ' A' ' 19' ' ' ILE . 19.4 mt -70.43 -29.5 66.1 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 179.554 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 32.1 mt -72.25 -25.91 61.8 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.638 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -27.0 27.16 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.385 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 5.9 tp-100 -85.21 -36.83 20.73 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.736 0.779 . . . . 0.0 110.212 -179.775 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.13 -10.61 32.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 178.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.44 44.83 6.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.448 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 25.5 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.113 -1.228 . . . . 0.0 111.179 -179.51 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.5 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.208 0.528 . . . . 0.0 110.031 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.32 136.45 33.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 110.304 -179.923 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' A' ' 36' ' ' ILE . 60.8 mt -99.94 138.48 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.293 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.6 ptt180 -150.6 -170.88 3.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.992 -1.068 . . . . 0.0 110.745 -179.175 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' CD2' HG23 ' A' ' 69' ' ' THR . 6.5 mp -89.41 128.78 35.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.341 -0.85 . . . . 0.0 110.991 -179.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.71 157.26 16.6 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.657 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 3.9 ttp85 . . . . . 0 N--CA 1.488 1.461 0 O-C-N 120.869 -1.145 . . . . 0.0 111.752 -178.744 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ALA 0.258 17.8 m-30 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.331 0.586 . . . . 0.0 109.678 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.422 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 31.0 mtt180 -137.1 156.84 47.87 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.069 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.01 83.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 102.896 -3.002 . . . . 0.0 102.896 177.736 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.266 0.4 OUTLIER -97.8 165.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.582 -173.76 . . . . . . . . 4 4 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -109.13 104.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 110.716 -177.33 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 179.139 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.3 p90 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 mt -75.92 -39.3 37.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.649 -0.657 . . . . 0.0 110.339 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.65 170.28 21.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 110.353 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -107.29 112.69 25.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 110.024 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.504 HG22 ' CD1' ' A' ' 59' ' ' TRP . 22.6 pt -107.27 -36.35 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 111.338 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -119.72 168.2 13.57 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.087 -1.53 . . . . 0.0 112.245 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 49.8 t80 -141.36 125.5 17.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.351 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.556 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 9.9 t80 -115.72 146.89 41.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.596 -1.315 . . . . 0.0 109.533 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 33.6 t70 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.977 -1.077 . . . . 0.0 109.715 179.077 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.438 ' CD2' HD22 ' A' ' 73' ' ' LEU . 14.6 tp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -133.15 102.51 5.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.765 . . . . 0.0 109.256 179.409 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.472 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.47 140.14 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.898 -1.126 . . . . 0.0 111.044 -179.234 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -82.33 69.23 9.03 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.948 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.448 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 1.4 p -34.25 -31.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.858 -177.773 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.1 tp10 -62.95 -53.06 59.86 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.854 -1.154 . . . . 0.0 109.01 178.315 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 2.7 mtm-85 -73.27 -37.36 66.31 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.416 -0.803 . . . . 0.0 108.981 178.734 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.99 -18.98 65.75 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.754 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -88.95 -23.31 22.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.347 -0.846 . . . . 0.0 109.736 178.446 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -60.15 -45.83 91.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 123.247 1.499 . . . . 0.0 107.094 178.439 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CD1' HG22 ' A' ' 21' ' ' VAL . 85.0 m95 -66.98 -58.48 4.87 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.791 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mt -52.89 -23.19 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.622 177.46 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t -81.13 -20.03 42.24 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.58 -0.7 . . . . 0.0 110.49 179.405 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 59' ' ' TRP . 3.9 m -98.74 31.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.767 -1.208 . . . . 0.0 109.382 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.05 75.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -72.01 143.55 49.13 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.105 -1.232 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.409 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 18.0 mt-30 -117.34 118.19 35.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HB2' ' CA ' ' A' ' 71' ' ' ARG . 55.2 Cg_endo -81.29 146.73 15.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.499 1.263 . . . . 0.0 109.881 179.603 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -70.27 -171.7 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.053 . . . . 0.0 109.94 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 50.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.146 -0.971 . . . . 0.0 110.101 179.553 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 28.4 m -165.3 -60.22 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -23.83 67.03 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.113 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.431 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 6.8 ttt-85 -68.76 -46.22 69.37 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.465 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -71.71 -8.02 51.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.417 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 69' ' ' THR . 25.8 mt -102.7 -26.2 13.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 108.604 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.431 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 41.7 mt -72.01 -30.02 64.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -77.15 -28.57 54.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.966 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -76.93 -33.23 57.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.108 0.956 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.451 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -67.4 -9.38 40.99 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.912 178.885 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.69 17.78 32.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.448 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.897 -1.355 . . . . 0.0 110.107 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.13 0.49 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.76 137.23 33.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.462 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.485 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 57.0 mt -99.56 140.16 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.098 -1.001 . . . . 0.0 109.081 179.07 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 2.2 ptt180 -150.64 171.22 17.48 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.965 -1.084 . . . . 0.0 110.266 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.442 ' CD2' HG21 ' A' ' 69' ' ' THR . 1.9 pp -89.62 128.35 36.04 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.568 179.484 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -99.02 175.99 5.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.728 . . . . 0.0 109.07 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.496 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 4.5 ttt-85 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.927 -1.108 . . . . 0.0 111.357 -179.368 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 7' ' ' ALA 0.267 9.2 m-85 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 . . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -136.71 147.08 46.56 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.825 -1.172 . . . . 0.0 109.257 177.592 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -96.2 82.56 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 177.259 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.284 0.4 OUTLIER -97.8 161.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.204 -173.389 . . . . . . . . 4 4 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.547 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.46 111.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.61 -0.682 . . . . 0.0 110.599 -177.43 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.94 179.639 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' CD2' HG23 ' A' ' 20' ' ' VAL . 12.6 p90 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.462 0.649 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 mt -50.24 -31.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -176.81 171.31 2.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.12 119.48 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.498 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -113.1 -30.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.424 -0.798 . . . . 0.0 110.286 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.51 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -116.28 163.01 12.45 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.267 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 40' ' ' ASP . 85.3 t80 -140.81 117.16 10.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 1.7 t80 -107.44 122.57 46.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.797 -1.189 . . . . 0.0 109.537 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.456 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 21.8 t0 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 120.724 -1.235 . . . . 0.0 110.163 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.3 tm? . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.618 0.723 . . . . 0.0 110.702 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -125.87 94.55 4.14 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.51 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.2 t -116.38 132.52 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.034 -1.041 . . . . 0.0 111.202 -178.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -74.2 70.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 1.1 p -35.61 -30.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 122.269 -0.269 . . . . 0.0 111.654 -177.377 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -60.63 -54.14 48.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.776 -1.202 . . . . 0.0 108.435 177.949 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmp_? -69.65 -41.77 75.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.333 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.92 -17.29 63.08 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.341 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 15.1 tpt180 -88.35 -26.01 22.43 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 109.423 178.594 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 3.0 t80 -59.49 -43.31 93.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.378 1.561 . . . . 0.0 107.302 178.241 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.547 ' CD1' HG21 ' A' ' 21' ' ' VAL . 75.8 m95 -69.23 -57.18 5.69 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.987 -178.904 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.71 -22.08 12.82 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.076 -1.015 . . . . 0.0 108.532 177.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -80.93 -22.61 39.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 110.763 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 59' ' ' TRP . 6.0 m -98.88 32.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.828 -1.17 . . . . 0.0 109.585 179.871 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.6 26.49 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -75.11 124.44 27.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.98 -1.306 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 65' ' ' GLN . 7.0 pt20 -98.84 121.01 57.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.785 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.8 Cg_endo -80.8 168.05 17.94 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.401 1.211 . . . . 0.0 110.561 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -88.8 167.92 12.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.76 179.504 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.78 -29.53 40.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 111.28 -179.247 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.442 HG21 ' CD2' ' A' ' 6' ' ' LEU . 24.2 m -97.51 -44.74 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.009 . . . . 0.0 110.855 -179.332 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -69.97 -24.61 63.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.405 -0.809 . . . . 0.0 109.038 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 67' ' ' THR . 25.1 ttt-85 -70.24 -36.54 74.57 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.577 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -30.59 71.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.002 179.133 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.1 mt -75.45 -32.04 60.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.565 179.454 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 24.6 mt -66.56 -30.0 70.2 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -79.81 -30.67 40.58 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.176 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -27.91 51.26 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.895 0.855 . . . . 0.0 109.703 179.191 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -73.16 -6.34 45.13 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.068 178.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 20.35 40.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 180.0 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 21.6 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.933 -1.333 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.434 HG12 ' CE3' ' A' ' 59' ' ' TRP . 99.1 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.311 0.577 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -140.19 138.12 34.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.068 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.463 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -104.58 133.47 48.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.112 -0.992 . . . . 0.0 109.92 -179.996 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.77 -170.65 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 -179.238 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 16.8 mt -88.6 126.64 35.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.069 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.91 103.09 14.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.93 -179.748 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.1 ttt180 . . . . . 0 N--CA 1.487 1.418 0 O-C-N 121.405 -0.809 . . . . 0.0 110.586 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 1.9 m-85 . . . . . 0 C--O 1.213 -0.844 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -107.98 160.51 15.72 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.002 176.971 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -97.91 79.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 102.604 -3.11 . . . . 0.0 102.604 177.503 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.3 OUTLIER -97.44 163.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.299 -173.843 . . . . . . . . 4 4 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -110.46 114.04 45.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.359 0.599 . . . . 0.0 110.84 -176.921 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 179.602 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 mt -77.74 -30.26 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.408 -0.807 . . . . 0.0 109.787 179.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.32 177.24 3.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 110.108 179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -115.84 123.12 47.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 110.273 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.526 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.49 -27.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.0 110.98 179.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -127.87 165.85 20.74 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.925 -1.607 . . . . 0.0 112.305 -178.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.461 ' N ' HG12 ' A' ' 19' ' ' ILE . 25.3 t80 -140.71 138.28 34.11 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.525 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 6.5 t80 -133.32 135.18 44.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.547 -1.345 . . . . 0.0 110.304 179.75 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.7 t0 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 120.974 -1.079 . . . . 0.0 110.337 179.269 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 3.0 tt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.641 0.734 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -137.43 85.67 2.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.485 -0.759 . . . . 0.0 109.07 179.466 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.475 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -117.5 134.72 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 111.227 -178.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -80.81 71.32 7.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.376 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -31.6 -35.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.505 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.6 mm-40 -59.73 -53.88 52.85 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.621 -1.299 . . . . 0.0 108.967 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmp_? -69.45 -41.42 76.28 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.785 . . . . 0.0 109.212 178.737 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -65.39 -20.69 66.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.044 -1.035 . . . . 0.0 108.406 178.936 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -87.74 -23.48 24.11 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 178.703 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.7 t80 -60.0 -45.13 93.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 123.253 1.502 . . . . 0.0 107.085 178.148 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.554 ' CD1' HG22 ' A' ' 21' ' ' VAL . 78.4 m95 -65.23 -53.76 39.62 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.441 -179.103 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' HG13 ' A' ' 79' ' ' VAL . 11.4 mt -56.76 -20.93 24.78 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.566 176.844 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.62 -23.73 39.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 59' ' ' TRP . 34.1 m -99.27 33.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.882 -1.136 . . . . 0.0 109.565 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.32 30.62 73.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.03 -1.277 . . . . 0.0 110.079 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.46 106.35 58.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HB3' HD13 ' A' ' 74' ' ' LEU . 55.6 Cg_endo -78.66 129.76 9.38 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.487 1.256 . . . . 0.0 110.238 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.15 174.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 109.9 179.646 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.59 -15.63 63.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.1 m -106.12 -45.36 4.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 179.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . . . -63.14 -24.76 68.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -70.0 -40.34 75.32 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -40.81 94.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.931 178.697 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 13.8 mt -65.99 -33.03 74.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.742 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 66' ' ' PRO . 31.9 mt -68.49 -26.68 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.336 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -28.73 47.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.907 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -80.74 -37.41 30.52 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.955 0.883 . . . . 0.0 109.897 179.938 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.438 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.64 -7.84 36.7 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.071 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 47.68 9.09 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.443 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 75.4 t . . . . . 0 N--CA 1.487 1.381 0 O-C-N 121.305 -1.115 . . . . 0.0 111.698 -179.092 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.476 HG13 ' CE3' ' A' ' 59' ' ' TRP . 33.6 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.221 0.534 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -140.75 137.85 33.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.99 -1.069 . . . . 0.0 110.758 -179.87 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.44 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 44.5 mt -103.41 132.7 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.126 -0.984 . . . . 0.0 108.964 178.754 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 10.4 ptt180 -150.85 -169.89 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.102 -0.999 . . . . 0.0 110.391 -179.285 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.47 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 52.0 mt -89.7 130.39 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -0.978 . . . . 0.0 111.452 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 104.99 16.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.705 -0.622 . . . . 0.0 110.23 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.012 -1.055 . . . . 0.0 111.253 -179.618 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.9 m-30 . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.5 mtt180 -99.19 160.03 14.56 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.131 176.017 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.47 ' CD1' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -99.21 81.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 176.969 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 0.3 OUTLIER -97.26 165.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.397 -173.511 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.486 HG12 ' CE3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -110.02 119.9 60.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.735 -0.603 . . . . 0.0 110.724 -176.941 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.035 -1.041 . . . . 0.0 110.25 179.112 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 4.4 p90 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 121.563 0.697 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 ' CZ2' ' A' ' 59' ' ' TRP . 19.7 mm -83.99 -61.66 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.415 -0.803 . . . . 0.0 109.266 179.771 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -151.16 160.48 43.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.751 -0.593 . . . . 0.0 109.593 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 110.72 21.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.525 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.7 pp -104.75 -32.41 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.082 -1.011 . . . . 0.0 111.104 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -122.04 162.54 15.78 Favored Glycine 0 C--N 1.295 -1.745 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.956 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.44 ' N ' HG13 ' A' ' 19' ' ' ILE . 45.9 t80 -134.35 141.49 46.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.217 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -142.27 130.9 22.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.087 -1.445 . . . . 0.0 111.365 -179.1 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 t0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.25 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.426 HD21 HD23 ' A' ' 73' ' ' LEU . 12.0 tp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.519 0.676 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -133.41 94.96 3.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.6 t -118.41 139.45 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 111.34 -179.037 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -85.01 72.99 10.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 175.776 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -35.53 -30.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.06 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -62.46 -48.4 79.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.589 -1.319 . . . . 0.0 108.771 178.257 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 1.1 mmp_? -76.22 -36.55 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 178.673 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -69.54 -20.39 63.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.598 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttp180 -86.78 -23.19 25.5 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.296 -0.877 . . . . 0.0 109.112 178.52 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 4.7 t80 -61.93 -45.37 94.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 123.099 1.428 . . . . 0.0 107.502 178.427 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.525 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 67.8 m95 -68.07 -57.44 6.1 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.943 -179.166 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.05 -20.82 18.45 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.329 -0.949 . . . . 0.0 108.707 177.335 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 t -79.98 -23.18 41.77 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.363 -0.836 . . . . 0.0 110.623 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 59' ' ' TRP . 18.8 m -98.89 31.93 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.964 -1.085 . . . . 0.0 109.627 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.77 75.17 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -66.56 134.88 53.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.951 -1.323 . . . . 0.0 110.164 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -99.88 107.83 48.49 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 179.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.7 Cg_endo -82.4 134.55 7.81 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.46 1.242 . . . . 0.0 110.229 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.49 163.19 0.93 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 110.032 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.07 -16.91 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.245 -0.909 . . . . 0.0 110.717 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.7 m -99.61 -47.8 4.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 110.53 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.55 -28.8 66.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.856 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -66.27 -38.6 88.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.318 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -26.74 68.3 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.287 178.939 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 49' ' ' LEU . 13.1 mt -88.11 -29.03 20.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 34.0 mt -68.74 -28.24 66.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.733 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -28.86 30.8 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.558 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -72.96 -33.76 66.07 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.142 0.972 . . . . 0.0 108.918 179.218 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.34 -9.59 54.03 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 178.523 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.91 52.9 3.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.721 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' A' ' 53' ' ' VAL . 43.0 t . . . . . 0 N--CA 1.486 1.358 0 O-C-N 121.12 -1.223 . . . . 0.0 111.716 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.257 0.551 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -140.52 134.9 31.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.888 . . . . 0.0 110.603 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.469 HD11 ' CD1' ' A' ' 36' ' ' ILE . 73.4 mt -102.27 134.79 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.026 . . . . 0.0 109.226 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.449 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.2 ptm180 -150.91 -167.86 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.009 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 4.8 mp -89.18 131.62 35.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -0.779 . . . . 0.0 110.518 -179.866 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -107.27 111.23 23.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 19.6 ttt-85 . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 112.313 -178.767 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 15.2 m-30 . . . . . 0 C--O 1.208 -1.101 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -134.32 158.17 44.48 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.193 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -97.51 86.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 178.003 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.268 0.4 OUTLIER -97.94 164.02 2.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.583 -173.945 . . . . . . . . 4 4 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -106.87 108.2 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.738 -0.601 . . . . 0.0 110.188 -178.278 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.715 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.7 p90 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.753 0.787 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.3 mp -91.27 -44.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.649 -0.657 . . . . 0.0 109.994 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 176.52 11.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -109.14 115.01 29.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 179.847 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' CD1' ' A' ' 59' ' ' TRP . 28.9 pt -113.06 -31.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 110.825 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -121.42 167.08 14.24 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.785 -178.813 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.432 ' N ' HG12 ' A' ' 19' ' ' ILE . 11.5 t80 -140.61 133.03 28.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.061 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 17.5 t80 -126.07 144.66 50.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.772 178.718 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.46 ' CD2' HD21 ' A' ' 73' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.567 0.698 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -134.49 93.29 3.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.545 -0.722 . . . . 0.0 109.102 178.951 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -113.48 135.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.032 -1.042 . . . . 0.0 111.04 -179.274 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.7 t70 -77.0 70.04 3.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.412 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -36.13 -30.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 122.265 -0.272 . . . . 0.0 111.42 -177.797 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -61.99 -55.6 27.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.898 -1.126 . . . . 0.0 109.009 178.577 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 28.8 mmm180 -71.56 -39.92 70.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.185 -0.947 . . . . 0.0 108.797 178.571 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -62.59 -18.66 62.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.279 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 25.0 ttm180 -88.58 -24.79 22.76 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 178.218 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -61.43 -47.2 86.84 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.268 1.509 . . . . 0.0 107.47 178.576 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CD1' HG22 ' A' ' 36' ' ' ILE . 83.7 m95 -64.66 -56.61 12.68 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.766 -179.016 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 38.4 mt -53.35 -22.68 7.77 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.534 177.238 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -21.13 41.1 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.47 -0.769 . . . . 0.0 110.456 179.177 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 59' ' ' TRP . 4.3 m -99.04 32.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.85 -1.156 . . . . 0.0 109.426 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.18 25.12 76.2 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . . . -69.44 128.51 36.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.016 -1.285 . . . . 0.0 109.792 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.37 113.24 65.85 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 0.0 110.669 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -79.68 132.08 9.63 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.526 1.277 . . . . 0.0 109.766 179.467 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 t -62.93 -178.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.53 52.43 1.4 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 0.0 110.239 179.735 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 6.3 m -166.05 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -66.55 -23.47 66.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.249 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 26.7 ttp180 -64.79 -41.11 96.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.105 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -63.82 -37.66 88.22 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.284 179.199 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 49' ' ' LEU . 40.3 mt -67.37 -35.79 80.06 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 55.0 mt -65.08 -26.85 68.4 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.587 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -28.09 38.24 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.027 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -35.97 42.95 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.958 0.885 . . . . 0.0 109.967 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.48 ' CB ' ' CG1' ' A' ' 51' ' ' VAL . . . -74.62 -2.9 28.13 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.042 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.01 20.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.473 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 57.9 t . . . . . 0 C--N 1.306 -1.299 0 O-C-N 121.142 -1.211 . . . . 0.0 111.479 -179.112 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.3 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.087 0.47 . . . . 0.0 109.87 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.6 ptmt -140.14 137.15 34.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.99 . . . . 0.0 111.044 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.499 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 93.6 mt -99.93 133.38 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.183 -0.948 . . . . 0.0 109.013 178.993 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.476 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -150.69 173.83 13.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.383 -179.2 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.473 HD11 ' CD2' ' A' ' 17' ' ' TYR . 4.0 pp -87.73 124.68 33.84 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.096 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.4 111.93 24.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.73 . . . . 0.0 112.462 -176.807 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.487 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.4 ttp180 . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.139 -0.976 . . . . 0.0 111.35 179.452 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 5.5 m-85 . . . . . 0 C--O 1.213 -0.84 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 14.8 ttm180 -103.12 148.13 26.14 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.422 178.2 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.503 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -96.89 79.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 178.278 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.406 HG23 ' CB ' ' A' ' 35' ' ' LYS 0.282 0.4 OUTLIER -97.61 163.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.229 -173.569 . . . . . . . . 4 4 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -110.63 110.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.497 -0.752 . . . . 0.0 110.464 -177.529 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.222 -0.924 . . . . 0.0 110.366 179.602 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.4 p90 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.375 0.607 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 HG23 ' CH2' ' A' ' 59' ' ' TRP . 1.1 mt -58.91 -36.63 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.592 179.561 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -170.57 138.71 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.899 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' CB ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -89.71 134.58 34.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.597 179.802 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.507 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -124.15 -22.75 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.054 -1.028 . . . . 0.0 111.35 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -124.86 162.96 19.0 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.766 -1.683 . . . . 0.0 110.959 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' N ' HG13 ' A' ' 19' ' ' ILE . 65.2 t80 -136.93 137.72 39.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.357 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.421 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 5.2 t80 -131.15 128.36 39.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.934 -1.103 . . . . 0.0 109.869 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 110.866 -179.675 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.454 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.5 tt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.287 0.565 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -130.9 90.36 2.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.881 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -115.76 139.95 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.033 -1.042 . . . . 0.0 111.025 -179.656 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.5 t70 -85.25 71.79 10.81 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.899 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -34.93 -31.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 122.312 -0.242 . . . . 0.0 111.526 -177.31 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.5 tt0 -62.74 -49.81 73.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.788 -1.195 . . . . 0.0 108.928 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.447 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -75.42 -36.17 60.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 108.877 178.63 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' CB ' HD12 ' A' ' 36' ' ' ILE . . . -69.3 -20.35 63.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.393 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.2 tpt180 -85.6 -25.0 26.93 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.239 -0.913 . . . . 0.0 109.216 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 4.8 t80 -60.12 -44.72 94.69 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 123.169 1.461 . . . . 0.0 107.503 178.563 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.507 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 69.2 m95 -68.32 -53.64 22.83 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.254 -179.089 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.28 -19.44 34.54 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.493 177.437 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 m -82.78 -22.75 34.17 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.334 -0.854 . . . . 0.0 110.724 179.798 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 59' ' ' TRP . 28.0 m -98.92 33.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.835 -1.165 . . . . 0.0 109.376 179.407 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.88 35.04 91.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.865 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.37 140.82 52.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.078 -1.248 . . . . 0.0 110.156 179.883 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.59 106.57 40.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.31 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -81.67 142.66 12.97 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.404 1.213 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -64.15 -176.44 0.21 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.042 . . . . 0.0 110.36 -179.762 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.53 -21.57 48.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.491 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -101.76 -44.44 5.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -66.39 -29.03 69.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 67' ' ' THR . 46.5 ttt180 -64.41 -38.32 90.63 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.365 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.35 -29.86 70.76 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.675 178.776 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.415 HD23 ' CD1' ' A' ' 49' ' ' LEU . 49.7 mt -81.86 -33.57 30.53 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.857 -0.527 . . . . 0.0 110.0 179.609 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 97.0 mt -67.04 -27.47 67.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.001 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -82.19 -30.93 30.63 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.621 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 3.1 tp-100 -78.3 -33.44 49.35 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.898 0.856 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.45 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.32 -12.83 45.87 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.93 178.414 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.74 43.5 4.8 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.438 HG23 ' CB ' ' A' ' 53' ' ' VAL . 29.3 t . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.112 -1.228 . . . . 0.0 111.321 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.403 ' CG1' HG11 ' A' ' 21' ' ' VAL . 63.9 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.257 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.433 ' CD ' ' HB3' ' A' ' 65' ' ' GLN . 5.3 mmmm -140.48 130.62 24.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 4' ' ' ILE . 31.6 mt -99.81 129.45 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.899 -1.126 . . . . 0.0 109.102 178.941 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.7 ptt180 -150.94 -174.96 4.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 110.812 -178.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.481 HD23 ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -88.98 125.36 34.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 110.969 -179.715 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.53 111.23 23.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.511 -0.743 . . . . 0.0 110.104 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 112.044 -178.807 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 8.7 m-85 . . . . . 0 C--O 1.212 -0.906 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 14.2 ttm180 -114.08 151.53 32.39 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.351 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.458 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -97.94 80.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 102.513 -3.144 . . . . 0.0 102.513 178.171 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.27 0.4 OUTLIER -97.57 166.32 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.41 -173.459 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.549 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -111.49 113.42 44.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.595 -0.691 . . . . 0.0 110.627 -177.251 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.259 179.683 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 p90 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.36 0.6 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.467 HG23 ' CH2' ' A' ' 59' ' ' TRP . 2.3 mp -55.08 -33.3 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.12 175.11 2.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 126.05 54.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.034 179.895 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.538 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -120.3 -31.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.158 -0.964 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.507 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -118.43 156.35 15.69 Favored Glycine 0 C--N 1.298 -1.543 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.72 143.5 51.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.481 ' CG ' HD23 ' A' ' 6' ' ' LEU . 33.9 t80 -138.6 136.86 36.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.671 -1.268 . . . . 0.0 110.752 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.064 -1.022 . . . . 0.0 110.047 179.336 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.456 HD13 ' CD2' ' A' ' 73' ' ' LEU . 3.1 tt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.354 0.597 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -131.96 98.31 4.41 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.32 179.269 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -122.81 138.1 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 111.324 -179.039 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t70 -83.35 72.12 10.23 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -35.15 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 CA-C-O 120.631 0.253 . . . . 0.0 111.348 -177.409 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 52' ' ' ASP . 17.4 mt-10 -60.5 -52.76 63.84 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.878 -1.138 . . . . 0.0 108.626 178.148 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 53.5 mmm-85 -72.82 -41.05 65.29 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.357 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -62.25 -18.36 60.98 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.088 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.3 ttp180 -88.85 -27.99 20.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.259 -0.901 . . . . 0.0 109.368 178.566 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 2.5 t80 -59.82 -44.33 94.09 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.294 1.521 . . . . 0.0 107.545 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' CD1' HG23 ' A' ' 21' ' ' VAL . 74.7 m95 -68.4 -56.68 7.66 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.889 -178.91 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.61 -21.67 11.14 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.006 -1.059 . . . . 0.0 108.647 177.429 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 24.4 t -80.92 -23.42 38.93 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.399 -0.813 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 59' ' ' TRP . 6.0 m -98.95 32.19 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.805 -1.184 . . . . 0.0 109.568 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.0 24.47 75.89 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.68 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -72.02 101.47 2.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.918 -1.343 . . . . 0.0 109.83 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.433 ' HB3' ' CD ' ' A' ' 3' ' ' LYS . 1.7 tt0 -69.84 114.78 27.47 Favored Pre-proline 0 C--N 1.297 -1.701 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.355 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.2 Cg_endo -82.2 124.94 4.45 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.599 1.315 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.63 164.98 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.15 -0.969 . . . . 0.0 110.212 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.1 -18.04 31.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.4 m -95.89 -50.14 5.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 74' ' ' LEU . . . -68.06 -28.5 67.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.389 -0.819 . . . . 0.0 109.206 -179.555 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -66.86 -38.08 85.66 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.735 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -23.94 65.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.069 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' CD2' HD13 ' A' ' 49' ' ' LEU . 17.9 mt -90.96 -26.39 19.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.459 -0.776 . . . . 0.0 109.621 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 25.6 mt -69.76 -30.12 67.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.85 -29.16 44.41 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.141 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.401 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 5.8 tp-100 -73.34 -34.2 65.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.139 0.971 . . . . 0.0 108.516 178.902 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.453 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -72.12 -7.33 48.42 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.692 177.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.65 50.07 4.6 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.589 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 40.6 t . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.197 -1.178 . . . . 0.0 111.442 -179.27 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -140.24 130.62 25.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.511 -179.904 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.456 HD12 ' CD1' ' A' ' 36' ' ' ILE . 77.9 mt -102.37 133.11 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.135 -0.978 . . . . 0.0 109.925 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptt85 -150.8 -165.48 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.63 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.43 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 50.5 mt -89.26 132.65 34.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.008 -1.058 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -104.26 100.88 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 179.708 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 111.169 -179.645 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.8 m-85 . . . . . 0 C--O 1.213 -0.832 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 1.8 mmt180 -99.81 165.25 11.67 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.147 -1.421 . . . . 0.0 107.999 176.736 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -98.48 81.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 177.244 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -97.4 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.681 -173.947 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -111.84 108.65 26.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.748 -0.595 . . . . 0.0 110.947 -176.951 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 3.1 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.004 179.452 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.508 0.671 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mt -82.88 -45.2 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.745 . . . . 0.0 109.667 179.76 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 165.91 32.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.447 -0.783 . . . . 0.0 110.01 179.787 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HD3' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -99.0 108.47 21.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 179.861 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.521 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 30.9 pt -101.51 -36.22 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.095 -1.003 . . . . 0.0 111.581 -179.566 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -125.95 172.04 17.78 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.758 -1.687 . . . . 0.0 112.868 -177.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 77.9 t80 -141.11 133.26 27.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.237 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.544 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 6.1 t80 -132.12 133.46 44.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.567 -1.333 . . . . 0.0 110.394 178.853 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.948 . . . . 0.0 109.724 179.138 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.9 tp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.57 0.7 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -128.4 92.64 3.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.134 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.84 149.07 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 111.29 -179.025 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t0 -93.31 67.04 4.06 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.765 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -32.05 -33.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.667 -177.334 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.34 -53.33 58.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.995 178.537 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 25.7 mmm180 -71.7 -41.87 68.08 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 108.66 178.525 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -61.99 -18.68 61.26 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.222 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.2 ttt-85 -88.27 -27.2 21.89 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.326 -0.859 . . . . 0.0 109.508 178.167 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -59.49 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.234 1.493 . . . . 0.0 107.564 178.637 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.524 ' CD1' HG23 ' A' ' 21' ' ' VAL . 81.5 m95 -66.38 -54.82 19.96 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.511 -178.923 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.405 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 9.1 mt -55.6 -21.49 17.73 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.533 177.081 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.8 t -82.57 -20.74 35.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.423 -0.798 . . . . 0.0 110.622 179.687 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 59' ' ' TRP . 4.5 m -99.12 32.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.48 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.36 72.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -68.07 142.52 55.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.036 -1.273 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.62 109.4 57.97 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 110.645 -179.699 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -80.21 125.41 5.81 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.586 1.308 . . . . 0.0 109.815 179.339 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 t -56.91 178.87 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 0.0 110.539 -179.819 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.74 54.22 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 0.0 109.781 179.172 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -165.64 -58.3 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.761 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.48 -23.7 66.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.026 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 3.4 ttm180 -69.17 -41.79 76.75 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.157 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -65.78 -41.47 91.97 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.652 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.97 -28.16 65.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.493 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 12.8 mt -68.82 -29.05 67.31 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.514 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -30.77 39.11 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.421 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -31.34 34.93 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.847 0.832 . . . . 0.0 109.877 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . -70.52 -6.83 39.1 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.051 178.863 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.45 48.6 6.24 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.449 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 48.4 t . . . . . 0 N--CA 1.485 1.282 0 O-C-N 121.206 -1.173 . . . . 0.0 111.461 -179.385 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.314 0.578 . . . . 0.0 110.146 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.19 135.33 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.491 HD13 ' CD1' ' A' ' 36' ' ' ILE . 86.2 mt -102.86 135.34 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.038 -1.039 . . . . 0.0 109.737 179.433 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.38 -168.78 3.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.373 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.0 mp -89.45 127.25 35.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 179.916 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -102.21 108.92 20.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.573 -0.705 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 2.8 ttt180 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 111.688 -179.468 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 5.0 m-85 . . . . . 0 C--O 1.211 -0.942 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 70.7 mtt180 -131.99 157.15 44.83 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.686 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -98.07 81.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 177.622 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.445 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -97.72 168.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.639 -173.785 . . . . . . . . 4 4 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.534 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -113.37 108.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.69 -0.631 . . . . 0.0 110.658 -177.087 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 179.387 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.445 ' CD2' HG22 ' A' ' 20' ' ' VAL . 5.3 p90 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.373 0.606 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.58 -36.31 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.503 -0.748 . . . . 0.0 110.002 -179.876 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.12 167.82 15.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.904 -179.958 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 4.2 pttp -102.05 111.7 24.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 179.902 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.503 HG21 ' CD1' ' A' ' 59' ' ' TRP . 32.2 pt -107.41 -35.21 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.912 -1.117 . . . . 0.0 111.244 -179.648 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.481 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -122.78 168.05 15.1 Favored Glycine 0 C--N 1.296 -1.648 0 C-N-CA 118.959 -1.591 . . . . 0.0 112.254 -177.887 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.429 ' N ' HG12 ' A' ' 19' ' ' ILE . 90.8 t80 -141.36 125.9 17.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.571 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 10.9 t80 -120.66 130.12 53.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.813 -1.179 . . . . 0.0 109.43 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 N--CA 1.5 2.05 0 O-C-N 120.293 -1.504 . . . . 0.0 111.633 179.851 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.3 tt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.204 0.526 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.93 95.66 3.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 109.5 179.393 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.57 143.53 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 111.411 -179.102 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 t70 -87.95 70.16 9.44 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.389 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.11 -32.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.486 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.47 -57.18 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.7 -1.25 . . . . 0.0 108.818 178.526 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -67.64 -41.3 84.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 108.998 178.538 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.5 -19.35 65.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.615 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.9 ttt180 -89.17 -22.26 22.89 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 178.501 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 5.3 t80 -59.95 -44.64 94.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.25 1.5 . . . . 0.0 107.14 178.282 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.534 ' CD1' HG22 ' A' ' 21' ' ' VAL . 81.0 m95 -68.43 -58.22 4.67 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.909 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.409 HD23 ' HG3' ' A' ' 66' ' ' PRO . 30.6 mt -53.13 -23.57 8.44 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.586 177.474 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -80.87 -21.33 40.77 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.484 -0.76 . . . . 0.0 110.348 179.287 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 58' ' ' TYR . 3.5 m -99.12 31.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.872 -1.143 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.91 24.9 75.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.972 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 138.59 55.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.916 -1.343 . . . . 0.0 110.264 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.449 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -105.47 107.87 60.16 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.912 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HB3' HD12 ' A' ' 74' ' ' LEU . 56.2 Cg_endo -82.38 132.01 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.474 1.25 . . . . 0.0 110.484 179.982 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.1 p -58.97 166.27 2.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 179.417 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.17 -26.31 64.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.913 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.409 ' CG2' HD23 ' A' ' 6' ' ' LEU . 8.4 m -84.87 -51.8 6.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 110.482 -179.879 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.15 -25.42 63.45 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.441 -0.787 . . . . 0.0 108.942 179.981 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 67' ' ' THR . 8.1 ttm180 -69.39 -36.09 76.44 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.131 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -40.98 92.49 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.557 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 49' ' ' LEU . 16.2 mt -69.29 -28.08 65.98 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.267 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 66' ' ' PRO . 25.0 mt -73.18 -27.03 61.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.468 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -29.93 29.84 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.117 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -84.37 -31.07 24.94 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.859 0.837 . . . . 0.0 110.045 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.449 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . -70.6 -7.9 47.62 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.772 -0.58 . . . . 0.0 109.829 178.667 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.09 50.3 4.64 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.691 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.119 -1.224 . . . . 0.0 111.206 -179.696 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 46.8 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.213 0.53 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -140.81 141.19 34.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.521 -179.775 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.497 HD13 ' CD1' ' A' ' 36' ' ' ILE . 91.0 mt -108.57 131.11 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.055 -1.028 . . . . 0.0 109.462 178.97 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.2 -175.68 5.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 110.69 -179.138 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 3.9 mp -88.72 122.41 32.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.95 107.15 19.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 112.055 -178.561 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.489 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.653 179.036 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 10.2 m-85 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -99.5 153.52 18.96 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.645 177.303 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 1.2 mm -97.67 73.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 176.336 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.258 0.4 OUTLIER -97.59 162.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.093 -173.053 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.15 114.32 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.439 0.638 . . . . 0.0 111.441 -176.883 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.2 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.603 178.888 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 35' ' ' LYS . 11.9 p90 . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.576 0.703 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.487 HD13 ' CH2' ' A' ' 59' ' ' TRP . 14.8 mt -88.45 -31.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.514 -0.741 . . . . 0.0 109.878 179.858 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.48 157.14 2.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.487 -0.758 . . . . 0.0 109.877 -179.88 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 36.3 mtmt -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.497 ' CD1' HD13 ' A' ' 4' ' ' ILE . 29.0 pt -100.0 -35.62 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 110.859 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.477 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -126.13 166.38 18.92 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.017 -178.453 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.447 ' N ' HG12 ' A' ' 19' ' ' ILE . 84.8 t80 -141.01 137.07 32.71 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.808 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.496 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 16.3 t80 -127.08 131.02 50.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 109.296 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t0 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 120.741 -1.224 . . . . 0.0 111.31 179.917 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.6 tm? . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.6 tttm -125.7 97.6 5.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.571 -0.706 . . . . 0.0 109.111 179.175 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 1.1 t -124.06 144.22 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.031 -1.043 . . . . 0.0 111.396 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.3 t0 -87.66 70.27 9.7 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.794 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.441 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -35.33 -30.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.471 -177.655 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.6 mt-10 -62.18 -54.74 36.7 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.909 -1.119 . . . . 0.0 108.967 178.092 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 3.4 mtm-85 -74.15 -33.57 63.57 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 178.951 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -68.24 -24.69 64.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.212 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -84.35 -22.94 30.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 178.285 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -61.65 -51.76 67.13 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.192 1.472 . . . . 0.0 107.722 178.909 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.607 ' CD1' HG21 ' A' ' 21' ' ' VAL . 82.9 m95 -59.81 -53.75 54.33 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.899 -179.183 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.2 -20.06 9.66 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.559 177.094 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.1 t -81.56 -21.29 38.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 110.682 179.279 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 59' ' ' TRP . 10.2 m -98.88 32.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.816 -1.177 . . . . 0.0 109.813 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.04 72.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -73.39 122.62 22.36 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.183 -1.187 . . . . 0.0 110.109 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 112.49 48.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.8 Cg_endo -82.12 127.31 5.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.518 1.273 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 167.39 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.082 -1.011 . . . . 0.0 109.789 179.677 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.33 -17.35 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.735 -179.626 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -99.06 -49.57 4.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.346 -179.868 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -66.7 -23.08 66.07 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.335 -0.853 . . . . 0.0 109.026 -179.961 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 7.5 tmm_? -71.75 -41.35 68.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.28 83.6 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.291 -0.963 . . . . 0.0 108.962 178.847 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 39' ' ' TYR . 28.5 mt -72.62 -27.05 61.91 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.742 . . . . 0.0 109.15 179.192 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 15.0 mt -72.37 -29.57 63.9 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 177.763 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -79.59 -31.88 41.85 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.548 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.31 -26.81 47.07 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.016 0.913 . . . . 0.0 109.218 178.69 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -70.67 -7.74 46.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.78 16.51 45.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.99 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 22.2 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.308 . . . . 0.0 109.826 179.728 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 92.8 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -140.77 142.49 34.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.436 HD13 ' CB ' ' A' ' 59' ' ' TRP . 73.8 mt -109.92 134.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.041 . . . . 0.0 109.825 179.382 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.27 -171.21 3.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.948 -1.095 . . . . 0.0 110.766 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.1 mp -89.01 126.4 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.92 106.31 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 110.767 -179.634 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.525 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.822 -1.174 . . . . 0.0 111.43 -179.714 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.21 -0.991 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.7 mtt-85 -108.75 160.47 15.94 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.256 -1.378 . . . . 0.0 107.988 176.678 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.62 81.53 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 177.643 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.32 164.38 2.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.611 -173.856 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -110.09 109.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.76 -0.587 . . . . 0.0 110.181 -177.483 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 5.7 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.818 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD2' HG21 ' A' ' 20' ' ' VAL . 6.3 p90 . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.62 0.724 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.459 HG23 ' CZ2' ' A' ' 59' ' ' TRP . 2.6 mp -83.7 -33.06 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.616 -0.678 . . . . 0.0 109.367 179.383 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.21 156.06 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.559 -0.713 . . . . 0.0 109.688 179.472 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 111.34 22.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.388 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.523 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.8 pp -102.42 -26.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.203 -0.935 . . . . 0.0 110.59 179.482 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -123.39 165.96 15.97 Favored Glycine 0 C--N 1.297 -1.637 0 C-N-CA 119.173 -1.489 . . . . 0.0 111.925 -179.468 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' N ' HG12 ' A' ' 19' ' ' ILE . 6.5 t80 -140.86 132.9 27.82 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.901 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.524 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 15.0 t80 -130.7 140.61 50.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.754 -1.216 . . . . 0.0 109.877 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 N--CA 1.496 1.855 0 O-C-N 120.869 -1.145 . . . . 0.0 109.863 179.051 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.449 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.3 tt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.291 0.567 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.46 88.99 2.46 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.513 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t -115.53 130.41 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 111.197 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t70 -75.32 71.42 2.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.016 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.456 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -34.18 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.681 -177.45 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 39.9 tt0 -62.12 -51.94 65.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.667 -1.271 . . . . 0.0 108.851 178.136 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -71.41 -39.18 71.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 178.701 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 36' ' ' ILE . . . -66.99 -19.53 65.73 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.335 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.1 ttp85 -87.18 -25.73 23.91 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.402 -0.811 . . . . 0.0 109.377 178.755 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 7.9 t80 -59.32 -45.9 90.07 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.231 1.491 . . . . 0.0 107.519 178.539 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.523 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 70.9 m95 -66.89 -56.95 8.04 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.415 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -53.67 -22.83 9.71 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.572 177.327 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.59 -23.28 49.95 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.465 -0.772 . . . . 0.0 110.234 179.28 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 59' ' ' TRP . 5.4 m -98.88 32.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.898 -1.126 . . . . 0.0 109.509 179.873 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.43 22.33 77.69 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.901 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -63.53 134.59 55.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.979 -1.306 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -105.83 110.0 63.71 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 110.401 -179.797 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HB2' ' CA ' ' A' ' 71' ' ' ARG . 54.1 Cg_endo -83.62 130.71 5.25 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.455 1.24 . . . . 0.0 109.814 179.516 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 4.8 t -54.76 -177.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -0.942 . . . . 0.0 110.091 -179.853 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.68 0.67 16.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.969 -1.082 . . . . 0.0 111.707 -179.163 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.6 m -110.86 -50.9 2.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.862 -1.149 . . . . 0.0 110.035 179.794 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 67' ' ' THR . . . -72.04 -26.82 62.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.635 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.6 ttt180 -67.26 -38.12 84.6 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.383 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -66.63 -36.95 83.8 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 108.724 179.061 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.429 HD21 ' CD1' ' A' ' 49' ' ' LEU . 12.2 mt -72.79 -28.32 62.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.878 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.427 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 30.9 mt -71.55 -28.69 64.03 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.443 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -30.62 46.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.327 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.2 tp-100 -84.07 -32.2 24.93 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.881 0.848 . . . . 0.0 110.265 -179.843 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.453 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.88 -13.36 44.52 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.766 -0.583 . . . . 0.0 109.999 178.963 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.26 25.03 10.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.443 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 30.1 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.801 -1.411 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.317 0.58 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.25 132.26 27.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.184 179.667 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.486 HD11 ' CD1' ' A' ' 36' ' ' ILE . 76.3 mt -103.08 132.09 50.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.095 -1.003 . . . . 0.0 109.551 179.351 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.35 -169.07 3.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.2 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 36.4 mt -88.81 129.41 35.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 179.752 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.39 101.11 12.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.155 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.456 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 1.2 tmm_? . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.722 -0.611 . . . . 0.0 111.538 -179.252 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.1 m-85 . . . . . 0 C--O 1.213 -0.852 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 2.1 mtt180 -106.6 159.56 16.1 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.13 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.497 HG13 ' N ' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -98.09 78.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 177.628 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.65 167.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.543 -173.845 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.99 105.58 19.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.285 0.564 . . . . 0.0 110.354 -177.662 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 6.5 t . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.294 179.79 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 6.1 p90 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.611 0.72 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.59 -27.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.645 -0.66 . . . . 0.0 109.33 179.751 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.34 166.26 14.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 109.798 179.817 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 117.63 34.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.506 HG22 ' CD1' ' A' ' 59' ' ' TRP . 41.4 pt -112.24 -33.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.091 -1.005 . . . . 0.0 111.153 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -130.07 170.38 20.78 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.924 -178.362 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.497 ' N ' HG13 ' A' ' 19' ' ' ILE . 68.2 t80 -139.17 143.66 38.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.651 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 11.8 t80 -140.04 123.72 17.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.857 -1.152 . . . . 0.0 109.995 -179.85 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.474 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 19.7 t0 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.613 -1.304 . . . . 0.0 110.915 -179.865 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.448 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 7.1 tt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.4 0.619 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -139.46 100.2 3.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.177 179.23 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.3 t -129.68 140.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.047 -179.054 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t0 -90.06 70.23 7.36 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.08 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -32.07 -33.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.741 -177.458 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mm-40 -60.43 -55.87 28.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.75 -1.219 . . . . 0.0 109.095 178.432 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -68.94 -40.81 78.74 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.135 178.836 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.81 -20.62 66.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.705 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.7 tpt180 -87.32 -22.52 25.07 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 178.511 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.2 t80 -60.08 -49.21 78.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.317 1.532 . . . . 0.0 107.096 178.553 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.543 ' NE1' HG23 ' A' ' 21' ' ' VAL . 87.7 m95 -61.69 -51.22 69.31 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.292 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -54.33 -22.35 11.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 176.669 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -25.09 42.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.494 -0.754 . . . . 0.0 110.777 179.529 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 59' ' ' TRP . 7.6 m -99.13 33.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.907 -1.121 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.32 78.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -63.16 138.5 58.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -1.22 . . . . 0.0 110.172 179.985 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -104.06 103.39 37.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.134 179.94 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -82.2 130.06 6.23 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.499 1.263 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 t -64.65 168.44 6.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.983 -1.073 . . . . 0.0 109.739 179.757 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.62 -26.96 24.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 111.582 -178.914 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.26 -50.25 6.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.044 -1.035 . . . . 0.0 110.894 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 5' ' ' ARG . . . -66.61 -24.91 66.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.858 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -70.75 -39.81 73.05 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.429 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -65.93 -40.66 91.61 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.603 178.539 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.425 ' CD2' HD12 ' A' ' 49' ' ' LEU . 14.7 mt -69.7 -29.07 66.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.576 -0.703 . . . . 0.0 109.125 179.017 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 20.8 mt -71.98 -27.58 62.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.565 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -26.77 32.98 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.455 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.1 tp-100 -85.39 -37.68 19.57 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.642 0.734 . . . . 0.0 110.406 -179.58 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -65.43 -10.98 38.41 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.681 178.638 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.4 50.26 3.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.409 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 43.6 t . . . . . 0 N--CA 1.487 1.39 0 O-C-N 121.087 -1.243 . . . . 0.0 111.12 -179.679 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.41 0.624 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 30.0 mtpt -140.37 134.6 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 179.759 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.499 HD12 ' CD1' ' A' ' 36' ' ' ILE . 74.3 mt -99.99 133.82 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.0 -1.063 . . . . 0.0 109.656 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -151.4 -172.27 4.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -178.968 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.487 HD23 ' CG ' ' A' ' 39' ' ' TYR . 2.8 mp -89.1 125.86 35.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.81 102.62 14.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.5 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.501 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.9 ttm180 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 111.577 179.917 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.0 m-85 . . . . . 0 C--O 1.212 -0.875 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 3.4 mmt180 -100.14 157.07 16.84 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.669 176.614 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -98.19 77.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 102.469 -3.159 . . . . 0.0 102.469 176.824 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.258 0.4 OUTLIER -97.46 171.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.51 -173.715 . . . . . . . . 4 4 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.531 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -115.98 112.81 41.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.769 -0.582 . . . . 0.0 110.633 -177.184 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.9 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 110.492 179.591 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.48 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 23.5 p90 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.615 0.721 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 HG22 ' CZ2' ' A' ' 59' ' ' TRP . 4.4 mt -82.48 -50.3 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.576 -0.703 . . . . 0.0 109.869 179.658 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -156.13 158.98 38.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.85 179.784 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -93.37 110.22 21.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 110.384 -179.864 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.522 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 26.4 pt -99.75 -36.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.22 -0.925 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.482 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -123.23 168.14 15.45 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.361 -178.403 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.458 ' N ' HG13 ' A' ' 19' ' ' ILE . 93.0 t80 -140.13 135.78 32.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' CG ' HD23 ' A' ' 6' ' ' LEU . 12.7 t80 -128.03 133.01 49.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.986 -1.071 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t0 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.901 -1.125 . . . . 0.0 110.327 179.768 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 7.9 tt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -121.99 97.22 5.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.099 179.175 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.482 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -120.3 159.73 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.334 1.064 . . . . 0.0 111.654 -178.854 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.9 t0 -107.21 65.84 0.66 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.98 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.443 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.0 -30.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -177.542 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -59.93 -54.17 49.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.747 -1.221 . . . . 0.0 108.495 178.149 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -75.74 -35.26 60.26 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.413 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.02 -21.02 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.969 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' VAL . 51.1 ttt-85 -86.61 -25.41 24.95 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.363 -0.836 . . . . 0.0 109.854 178.566 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.518 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -58.04 -46.29 85.58 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 123.179 1.466 . . . . 0.0 107.547 178.773 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' CD1' HG23 ' A' ' 21' ' ' VAL . 81.9 m95 -66.14 -52.31 49.62 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.621 -179.259 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mt -55.04 -22.19 14.87 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.441 177.119 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -80.96 -23.54 38.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.482 -0.761 . . . . 0.0 110.612 179.604 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 59' ' ' TRP . 5.1 m -98.9 32.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.925 -1.109 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.3 29.44 73.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.48 126.1 28.67 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.043 -1.269 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . 0.43 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -93.68 111.19 51.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.9 Cg_endo -82.29 130.71 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.492 1.259 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.36 168.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -53.75 -30.35 43.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -84.54 -50.4 7.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.433 -0.792 . . . . 0.0 110.384 -179.959 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.27 -22.88 66.91 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.227 -0.92 . . . . 0.0 108.781 179.972 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -40.26 67.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.51 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 -38.86 83.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.921 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.418 ' CD2' HD12 ' A' ' 49' ' ' LEU . 19.4 mt -69.05 -28.15 66.29 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.654 -0.654 . . . . 0.0 109.357 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.483 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 13.3 mt -73.07 -26.19 61.17 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.465 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.79 -28.68 30.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.271 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.8 tp-100 -83.01 -39.81 20.78 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.764 0.792 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.436 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -65.04 -11.28 37.49 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.872 178.433 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.79 51.64 3.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.855 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.443 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 53.6 t . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.076 -1.25 . . . . 0.0 111.221 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.8 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.172 0.51 . . . . 0.0 110.016 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -137.8 131.01 30.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 36' ' ' ILE . 93.3 mt -102.69 129.46 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.089 -1.007 . . . . 0.0 109.534 179.251 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 28.1 ptt180 -151.67 -166.63 2.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.0 mp -89.05 127.41 35.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.26 105.52 17.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 14.9 ttt180 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 111.302 -179.711 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 5.0 m-85 . . . . . 0 C--O 1.212 -0.908 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.5 mtt-85 -101.12 161.99 13.21 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.064 -1.455 . . . . 0.0 108.457 177.178 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -99.1 80.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 177.649 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 0.4 OUTLIER -97.61 165.25 2.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.155 -173.75 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 115.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.896 -0.503 . . . . 0.0 110.596 -177.659 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.013 . . . . 0.0 110.7 179.116 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.9 p90 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.438 0.637 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 mm -96.53 -41.35 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.576 -179.796 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.15 167.07 10.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.468 -0.77 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.24 107.65 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.988 . . . . 0.0 110.307 -179.89 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' A' ' 59' ' ' TRP . 28.1 pt -99.91 -36.51 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.157 -0.965 . . . . 0.0 110.571 179.936 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -122.78 165.89 15.35 Favored Glycine 0 C--N 1.295 -1.716 0 C-N-CA 119.027 -1.559 . . . . 0.0 111.989 -178.521 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.43 ' N ' HG12 ' A' ' 19' ' ' ILE . 9.3 t80 -140.49 130.53 24.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.066 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.515 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.9 t80 -131.58 133.14 44.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.636 -1.29 . . . . 0.0 110.378 -179.738 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 120.918 -1.113 . . . . 0.0 109.997 179.495 . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 10.2 tt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.561 0.696 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 93.83 3.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 179.328 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.03 135.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.607 -179.071 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -84.3 69.83 10.52 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 175.838 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -36.6 -29.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 122.135 -0.353 . . . . 0.0 111.496 -177.405 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -59.64 -51.69 68.74 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.7 -1.25 . . . . 0.0 108.745 178.605 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.7 mmm180 -75.9 -38.35 57.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.509 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -63.44 -21.23 66.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.282 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 15.2 ttt180 -88.31 -21.86 24.18 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.315 -0.865 . . . . 0.0 109.732 178.447 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.483 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -65.34 -48.26 73.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 123.194 1.474 . . . . 0.0 107.668 178.704 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.551 ' CD1' HG21 ' A' ' 21' ' ' VAL . 81.4 m95 -63.82 -54.03 41.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.834 -179.04 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 ' CD1' HG11 ' A' ' 79' ' ' VAL . 83.4 mt -55.33 -21.04 13.4 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.33 177.256 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.43 -23.91 39.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.4 -0.812 . . . . 0.0 110.773 179.504 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 59' ' ' TRP . 10.1 m -99.16 34.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.849 -1.157 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.32 26.06 74.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.588 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -73.67 112.07 9.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 179.69 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 116.52 64.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.664 -179.521 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 51.2 Cg_endo -83.61 124.47 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.471 1.248 . . . . 0.0 109.567 179.13 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 5' ' ' ARG . 5.2 t -55.08 175.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 110.468 -179.47 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.52 56.61 1.13 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 179.993 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 m -165.9 -60.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.745 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.85 -25.2 67.09 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.819 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.8 ttp180 -65.76 -41.56 91.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.065 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.03 -41.51 98.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.682 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.3 mt -70.03 -32.81 71.13 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.983 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 46.9 mt -68.58 -26.83 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.805 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -28.78 32.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.395 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.52 -36.86 25.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.43 -179.677 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.37 -8.96 36.8 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.986 178.663 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.22 50.75 4.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.451 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 39.8 t . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.032 -1.275 . . . . 0.0 111.36 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mtp . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.28 0.562 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.7 m -126.45 119.36 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.03 133.23 29.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.498 HD12 ' CD1' ' A' ' 36' ' ' ILE . 79.8 mt -99.74 133.99 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.31 -0.869 . . . . 0.0 109.054 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.28 -171.57 3.97 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.957 -1.089 . . . . 0.0 110.586 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.462 HD21 ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -88.7 126.75 35.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 110.255 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.529 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.05 104.28 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.374 -0.829 . . . . 0.0 110.613 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -72.3 118.49 15.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.306 -0.872 . . . . 0.0 111.15 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.529 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 19.1 m-85 -113.51 -61.5 1.73 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.133 -0.98 . . . . 0.0 110.147 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.59 131.63 11.89 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 27.6 p -101.59 -56.3 2.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -1.1 . . . . 0.0 109.72 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.455 ' N ' ' OG ' ' A' ' 11' ' ' SER . 3.7 mtpp -143.27 40.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.436 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 1.9 m-70 -135.44 -64.65 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.665 -178.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 41.8 t30 -138.29 114.43 8.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.59 -0.694 . . . . 0.0 109.472 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.1 102.13 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.464 1.244 . . . . 0.0 111.14 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.0 p80 -149.41 136.89 20.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.522 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 10.7 m-85 -118.94 155.07 31.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.461 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 10.6 mtm-85 -107.99 159.35 16.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.742 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.484 HG13 ' N ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -98.78 79.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.261 0.4 OUTLIER -98.04 166.48 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.758 -174.053 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.16 109.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.768 -0.583 . . . . 0.0 110.121 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.9 t -139.3 -166.5 2.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.222 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.6 m-20 -71.69 -161.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.548 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.03 71.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.708 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.68 144.94 12.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.213 -0.929 . . . . 0.0 110.435 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.96 169.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 109.95 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -127.65 -55.02 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.073 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.51 -47.44 2.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.16 -30.08 3.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 110.35 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 108.95 2.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -139.06 148.66 43.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.498 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.485 ' CD2' HG22 ' A' ' 20' ' ' VAL . 9.2 p90 -119.85 165.07 15.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 mp -77.3 -23.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.638 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.62 164.35 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 116.04 31.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.516 HG22 ' CD1' ' A' ' 59' ' ' TRP . 22.9 pt -107.01 -37.43 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 0.0 111.351 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -121.63 171.04 14.96 Favored Glycine 0 C--N 1.294 -1.758 0 C-N-CA 119.006 -1.569 . . . . 0.0 111.597 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' N ' HG13 ' A' ' 19' ' ' ILE . 64.7 t80 -139.57 141.96 37.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.598 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 29.3 t80 -135.34 142.6 45.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.718 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 5.3 t0 -140.66 105.39 6.38 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 43.3 Cg_endo -71.7 70.77 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.01 1.005 . . . . 0.0 110.707 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.38 130.67 46.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.112 -0.992 . . . . 0.0 110.162 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -96.97 42.21 1.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 110.433 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -112.41 -66.83 1.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.07 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.9 p -127.45 153.83 77.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.31 73.36 4.52 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.712 1.375 . . . . 0.0 110.385 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -165.02 58.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.598 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 19.1 p-90 -119.41 -14.63 9.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.116 -0.99 . . . . 0.0 110.8 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 4.8 tt -83.81 116.84 22.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.029 -1.044 . . . . 0.0 110.419 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 100.9 5.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.295 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.82 153.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.976 -1.078 . . . . 0.0 111.336 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.4 t0 -100.04 70.84 1.6 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -34.93 -30.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 122.312 -0.242 . . . . 0.0 111.57 -177.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 tt0 -60.81 -54.8 40.7 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.713 -1.242 . . . . 0.0 108.804 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.443 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -70.93 -39.51 72.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.364 -0.835 . . . . 0.0 108.83 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.76 -17.68 64.79 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 13.4 ttt180 -87.51 -25.15 23.82 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 4.7 t80 -60.26 -44.67 95.09 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.246 1.498 . . . . 0.0 107.966 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.543 ' CD1' HG23 ' A' ' 21' ' ' VAL . 84.7 m95 -69.73 -55.87 8.74 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.149 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.1 mt -53.33 -22.56 7.48 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.447 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 15.3 t -82.35 -22.75 35.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.455 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 59' ' ' TRP . 3.7 m -99.14 32.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 120.839 -1.163 . . . . 0.0 109.572 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.47 29.04 72.91 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.65 127.32 32.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.086 -1.244 . . . . 0.0 109.763 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -97.6 110.72 56.25 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.7 Cg_endo -85.61 129.33 3.59 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.416 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 3.2 t -55.17 168.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.762 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -55.44 -37.7 68.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.739 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -70.41 -58.56 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.729 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.421 ' HB3' ' HA ' ' A' ' 5' ' ' ARG . . . -63.76 -23.33 67.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.39 -0.819 . . . . 0.0 109.117 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' A' ' 67' ' ' THR . 4.1 ttt180 -69.71 -42.73 73.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -73.41 -10.04 59.32 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.49 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 39' ' ' TYR . 18.1 mt -98.22 -24.89 15.08 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 108.623 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.44 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 17.9 mt -71.11 -30.43 66.51 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.566 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 10.3 ptm180 -77.78 -28.8 50.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.444 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 9.2 tp-100 -76.42 -37.22 57.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.055 0.931 . . . . 0.0 109.581 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.439 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -75.15 -1.28 22.42 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.059 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 50.33 11.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.437 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 40.2 t -99.33 -49.94 11.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.301 -1.117 . . . . 0.0 111.721 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.566 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 5.4 m-30 -57.86 -32.71 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.118 -0.989 . . . . 0.0 110.421 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 154.68 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -70.25 160.3 32.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -132.21 153.03 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.21 178.97 8.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.14 -0.975 . . . . 0.0 110.565 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -111.02 61.79 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.319 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -52.17 169.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.37 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.49 83.14 0.18 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.187 -1.184 . . . . 0.0 110.203 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptm . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.302 0.572 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.403 ' CG1' HG11 ' A' ' 21' ' ' VAL . 47.9 t -95.16 147.55 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.084 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -140.5 133.1 28.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.489 HD11 ' CD1' ' A' ' 36' ' ' ILE . 68.8 mt -100.26 134.89 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.013 -1.054 . . . . 0.0 109.409 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.7 ptm180 -151.19 -172.72 4.29 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.1 -1.0 . . . . 0.0 110.928 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -89.37 125.87 35.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.379 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.525 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.21 112.87 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.364 -0.835 . . . . 0.0 110.562 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.582 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -81.48 122.26 27.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.116 . . . . 0.0 112.892 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.515 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 2.0 m-85 -119.08 -152.97 0.52 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.668 -0.645 . . . . 0.0 109.324 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 102.46 0.01 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -55.49 -42.23 74.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -1.135 . . . . 0.0 109.368 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -176.64 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 109.41 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -123.74 -51.41 1.82 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -0.864 . . . . 0.0 109.741 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.49 138.56 13.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.15 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.46 122.85 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.611 1.321 . . . . 0.0 110.855 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.488 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 34.0 p80 -174.94 124.89 0.26 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 9.3 m-30 -113.78 153.33 29.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.746 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 2.0 mtt85 -101.35 162.18 13.08 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.26 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.93 80.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.405 HG22 ' HA ' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -97.46 164.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.907 -173.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.36 112.64 40.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.8 t -140.54 -171.17 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.974 -1.079 . . . . 0.0 110.598 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.1 p-10 -78.6 -159.81 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.335 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.83 46.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -173.88 61.35 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.198 -0.939 . . . . 0.0 110.554 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.22 148.3 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.141 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -134.25 57.94 1.79 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.364 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 -60.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -92.73 39.71 1.04 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.65 139.87 41.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.16 95.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -1.138 . . . . 0.0 110.059 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 10.4 p90 -55.56 178.72 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.697 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.25 -50.2 12.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -157.69 179.19 9.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HA ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -106.86 107.23 18.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.292 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.489 ' CD1' HD11 ' A' ' 4' ' ' ILE . 20.7 pt -100.55 -39.08 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.146 -0.971 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -118.2 166.35 12.81 Favored Glycine 0 C--N 1.296 -1.683 0 C-N-CA 118.967 -1.587 . . . . 0.0 112.122 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.431 ' N ' HG12 ' A' ' 19' ' ' ILE . 11.4 t80 -140.73 128.79 22.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.568 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 38.1 t80 -128.27 142.48 51.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.709 -1.245 . . . . 0.0 109.906 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 20.6 t0 -140.45 103.89 6.53 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.484 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 48.5 Cg_endo -76.73 56.71 5.34 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.993 0.996 . . . . 0.0 110.855 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 172.33 8.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.982 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.78 23.79 7.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 t -119.76 -8.5 9.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.963 . . . . 0.0 110.633 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -140.36 128.33 12.71 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.892 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.88 -6.98 19.43 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.437 1.23 . . . . 0.0 110.752 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.02 80.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.568 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 10.8 p-90 -112.43 -1.74 14.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.15 -0.969 . . . . 0.0 110.748 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 9.1 tt -97.35 107.08 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.034 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.18 90.38 3.28 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.682 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.487 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.51 130.93 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.005 . . . . 0.0 111.178 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.0 t0 -78.03 71.01 4.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -35.73 -30.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 122.258 -0.276 . . . . 0.0 111.624 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.8 mt-10 -59.76 -51.03 71.49 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.706 -1.247 . . . . 0.0 108.967 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 27.1 mmm180 -75.52 -38.14 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.263 -0.898 . . . . 0.0 108.713 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.82 -19.39 65.83 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.2 ttp180 -89.16 -23.81 22.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.481 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -63.31 -48.71 76.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 123.116 1.436 . . . . 0.0 107.456 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CD1' HG21 ' A' ' 21' ' ' VAL . 82.1 m95 -65.29 -56.19 14.1 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.951 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.55 -21.59 10.69 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.558 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.91 -20.45 38.73 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.427 -0.795 . . . . 0.0 110.389 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.419 HG23 ' HA ' ' A' ' 59' ' ' TRP . 3.8 m -98.7 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.871 -1.143 . . . . 0.0 109.322 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.53 26.61 74.33 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -77.28 115.32 16.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.089 -1.242 . . . . 0.0 109.855 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 126.15 59.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 53.3 Cg_endo -85.47 162.56 11.04 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.494 1.26 . . . . 0.0 109.483 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 p -83.94 -171.69 3.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.051 -1.031 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.401 ' O ' ' OG1' ' A' ' 69' ' ' THR . 0.1 OUTLIER -83.82 48.27 1.42 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' A' ' 68' ' ' ASP . 25.2 m -166.03 -56.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.35 -25.62 65.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.4 ttp180 -66.59 -42.25 87.23 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -66.14 -45.81 79.71 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.786 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.469 HD11 ' CD2' ' A' ' 39' ' ' TYR . 51.7 mt -60.29 -31.99 70.77 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.412 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 20.3 mt -69.15 -26.81 65.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.513 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.5 -28.81 30.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.811 0.815 . . . . 0.0 108.82 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -81.84 -36.15 28.6 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.904 0.859 . . . . 0.0 110.062 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.96 -9.21 43.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.751 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' HG22 ' A' ' 53' ' ' VAL . . . 82.52 48.5 5.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.433 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 41.4 t -95.3 -66.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.12 -1.224 . . . . 0.0 111.605 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.513 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 35.7 m-85 -52.42 -47.97 66.03 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.26 -175.94 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.596 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.12 130.81 51.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.177 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.4 144.15 10.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.412 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.95 -178.96 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -89.61 76.03 7.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.232 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -60.28 2.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.193 -0.942 . . . . 0.0 110.307 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.21 45.44 0.1 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.19 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.325 0.583 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.2 m -57.93 113.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.839 . . . . 0.0 110.34 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' HD3' ' CB ' ' A' ' 24' ' ' ALA . 3.5 mtpt -140.53 133.19 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.216 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.496 HD11 ' CD1' ' A' ' 36' ' ' ILE . 79.7 mt -108.34 131.2 59.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.992 -1.068 . . . . 0.0 109.883 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.0 ptm180 -151.08 -169.62 3.44 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.287 -0.883 . . . . 0.0 110.297 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 84.4 mt -89.17 127.69 35.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.519 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.25 102.34 13.95 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.713 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -71.07 121.76 18.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 112.565 -178.368 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.527 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 4.8 m-85 -122.89 -151.95 0.5 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.464 -0.773 . . . . 0.0 109.379 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 105.5 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.451 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 1.6 p -56.24 -41.7 76.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 0.0 109.061 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.35 47.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.451 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 16.4 m-70 -124.4 -64.86 1.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.283 -0.886 . . . . 0.0 110.1 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -131.33 135.6 27.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -83.54 88.71 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.489 1.258 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.493 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 31.6 p80 -130.93 129.7 42.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 110.108 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 12.4 m-85 -111.5 147.89 34.36 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 108.429 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.527 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -99.86 159.08 15.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.487 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -98.07 81.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.488 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -98.47 162.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.024 -174.07 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.544 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.29 109.42 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.757 -0.589 . . . . 0.0 110.529 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.5 t -135.7 -169.22 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.983 . . . . 0.0 110.29 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' N ' ' OG1' ' A' ' 22' ' ' THR . 1.1 t0 -83.8 -176.15 6.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.412 ' CB ' ' HD3' ' A' ' 3' ' ' LYS . . . -153.14 43.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.026 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.53 52.74 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -141.0 168.89 18.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 110.359 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -59.79 4.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.938 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -175.28 104.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 110.37 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.83 -36.93 4.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 110.192 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.81 25.8 66.21 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -121.68 140.6 52.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.488 ' CD2' HG22 ' A' ' 20' ' ' VAL . 23.4 p90 -120.03 168.06 11.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.416 -0.803 . . . . 0.0 110.402 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.416 HG21 ' CH2' ' A' ' 59' ' ' TRP . 8.1 mt -70.94 -51.7 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -154.65 165.45 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -0.774 . . . . 0.0 109.58 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -99.43 116.73 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 109.956 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 HG22 ' CD1' ' A' ' 59' ' ' TRP . 44.9 pt -107.18 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 111.152 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -124.82 167.94 17.05 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.029 -1.557 . . . . 0.0 112.228 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.439 ' N ' HG12 ' A' ' 19' ' ' ILE . 37.0 t80 -140.67 129.26 22.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.5 t80 -129.71 134.07 47.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.731 -1.23 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -140.19 92.61 9.46 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.919 -1.113 . . . . 0.0 110.884 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.11 85.7 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.575 1.303 . . . . 0.0 110.361 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -96.44 -165.37 1.27 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.209 -0.932 . . . . 0.0 110.442 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -132.77 52.97 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.965 . . . . 0.0 110.197 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.8 t -145.14 -41.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.9 . . . . 0.0 110.565 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.14 155.28 81.02 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.624 -179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 50.6 Cg_endo -78.59 -44.28 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.737 1.388 . . . . 0.0 110.259 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.2 92.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.091 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -122.43 19.89 10.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.255 -0.903 . . . . 0.0 110.566 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.409 ' CD2' ' HB3' ' A' ' 73' ' ' LEU . 8.5 tp -116.48 125.89 52.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.066 . . . . 0.0 110.926 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.05 94.64 3.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 109.217 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.476 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.04 149.87 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -94.81 70.51 3.44 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.479 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -32.72 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -60.29 -56.02 26.56 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.802 -1.186 . . . . 0.0 109.159 178.749 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 4.4 mmp_? -69.92 -42.02 73.87 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 108.872 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -63.15 -18.36 63.37 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.9 ttp180 -87.87 -25.26 23.36 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.9 t80 -60.38 -45.83 92.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.359 1.552 . . . . 0.0 107.789 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' CD1' HG23 ' A' ' 21' ' ' VAL . 79.4 m95 -66.11 -54.48 25.03 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.94 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.4 ' CD1' HG11 ' A' ' 79' ' ' VAL . 18.9 mt -54.97 -21.47 11.89 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.495 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.5 t -81.46 -23.16 37.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 110.694 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' A' ' 59' ' ' TRP . 5.5 m -98.96 32.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.797 -1.189 . . . . 0.0 109.568 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.93 29.47 72.48 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -67.78 135.45 52.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.076 -1.25 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 109.06 61.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 110.389 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -79.13 128.3 8.14 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.619 1.326 . . . . 0.0 109.871 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.9 t -54.22 171.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.11 -0.994 . . . . 0.0 110.204 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.47 54.98 0.78 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -167.25 -56.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.5 -24.22 66.36 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.2 ttt85 -67.4 -40.92 85.62 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -42.99 80.33 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.776 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 15.2 mt -67.08 -27.08 67.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 ' HA ' HG22 ' A' ' 79' ' ' VAL . 13.7 mt -69.82 -28.47 65.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -78.77 -30.54 45.71 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -80.39 -31.84 37.67 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.944 0.878 . . . . 0.0 109.993 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -75.4 -2.13 27.14 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.402 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.5 51.64 9.43 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.479 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 52.6 t -98.95 -60.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.271 -1.134 . . . . 0.0 111.872 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.499 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 43.5 m-85 -53.04 155.06 2.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.148 -0.97 . . . . 0.0 110.291 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -149.71 71.63 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.373 -0.83 . . . . 0.0 110.172 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.75 147.07 23.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.881 . . . . 0.0 110.212 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -162.28 150.5 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.88 -174.03 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -121.18 119.26 31.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -169.33 69.56 0.07 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.58 25.8 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.11 . . . . 0.0 110.347 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.342 0.592 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.9 m -53.82 105.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 110.442 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -140.2 132.83 28.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.425 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.491 HD13 ' CB ' ' A' ' 59' ' ' TRP . 65.8 mt -107.62 133.52 52.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.044 -1.035 . . . . 0.0 110.05 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptm180 -151.07 -173.15 4.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.278 -0.889 . . . . 0.0 110.437 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.7 mp -89.38 125.49 35.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.447 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.55 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.46 107.42 19.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.473 -0.767 . . . . 0.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 36.7 ttp85 -76.02 115.75 16.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 112.936 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.55 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 1.2 m-85 -120.38 -152.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.252 -0.905 . . . . 0.0 108.917 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 116.99 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -63.97 -81.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 109.88 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.5 46.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.463 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 3.9 m-70 -134.81 -65.84 0.61 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.792 . . . . 0.0 109.924 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -120.16 105.31 42.45 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -77.43 116.46 4.11 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.479 1.252 . . . . 0.0 111.041 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 28.1 p80 -152.16 138.73 18.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.373 -0.829 . . . . 0.0 109.339 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 9.8 m-85 -112.73 165.03 12.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.231 -0.918 . . . . 0.0 108.688 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 mtp85 -121.83 156.02 34.13 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.518 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 79.56 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.469 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.255 0.4 OUTLIER -97.95 159.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.5 -173.912 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.569 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -107.92 106.03 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.334 0.587 . . . . 0.0 110.387 -177.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 2.1 t -131.59 -167.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.893 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' N ' ' OG1' ' A' ' 22' ' ' THR . 46.2 p-10 -119.07 176.0 5.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.54 -52.64 4.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 119.53 9.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 110.521 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 113.24 7.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -63.59 -76.13 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.907 . . . . 0.0 110.482 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -119.48 -20.14 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.95 147.87 52.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.66 69.42 0.53 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.44 121.34 30.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -1.121 . . . . 0.0 110.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CD2' HG21 ' A' ' 20' ' ' VAL . 32.1 p90 -58.53 150.08 23.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 110.68 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.3 mt -56.15 -51.93 56.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.565 -0.71 . . . . 0.0 109.204 179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.92 149.46 26.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -89.66 119.29 29.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 56' ' ' ALA . 27.7 pt -105.88 -34.14 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.489 -0.757 . . . . 0.0 111.738 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -120.64 169.33 14.12 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 119.118 -1.515 . . . . 0.0 112.26 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.441 ' N ' HG12 ' A' ' 19' ' ' ILE . 86.8 t80 -140.46 127.33 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.584 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 44.7 t80 -121.28 142.29 50.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.815 -1.178 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 6.2 t0 -140.79 104.38 6.31 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 45.9 Cg_endo -74.98 75.84 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.319 1.168 . . . . 0.0 110.759 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.87 124.18 34.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.156 -0.965 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 43.87 1.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.3 p -133.36 -53.47 0.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.6 p -124.84 146.98 54.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.029 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.82 57.76 5.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.53 1.279 . . . . 0.0 110.631 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -150.31 120.69 7.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.88 . . . . 0.0 109.871 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.584 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 22.1 p-90 -175.22 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.211 -0.93 . . . . 0.0 110.609 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.528 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 5.6 tt -62.95 109.7 1.55 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 110.597 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -131.47 94.66 3.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.293 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.8 148.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 111.043 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -92.38 70.65 5.15 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.46 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -36.47 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 122.224 -0.297 . . . . 0.0 111.481 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 7.2 mm-40 -61.1 -53.25 59.44 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.693 -1.254 . . . . 0.0 108.522 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.433 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -71.29 -40.59 70.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.65 -16.56 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.1 ttt-85 -88.64 -26.3 21.96 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 13.2 t80 -59.43 -42.63 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 123.212 1.482 . . . . 0.0 107.382 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.569 ' CD1' HG21 ' A' ' 21' ' ' VAL . 81.3 m95 -69.63 -54.24 14.91 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.13 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' CD1' HG11 ' A' ' 79' ' ' VAL . 7.4 mt -56.56 -20.9 23.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.468 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -80.72 -24.56 38.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.426 -0.796 . . . . 0.0 110.517 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.522 HG22 ' HA ' ' A' ' 59' ' ' TRP . 27.3 m -99.01 32.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.879 -1.138 . . . . 0.0 109.606 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.02 31.48 79.57 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -60.99 146.99 45.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.242 . . . . 0.0 110.017 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 2.0 mm-40 -108.88 93.82 13.25 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.43 -0.794 . . . . 0.0 110.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 54.9 Cg_endo -80.34 124.79 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.48 1.253 . . . . 0.0 109.923 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 2.7 t -57.82 163.58 2.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.944 -1.097 . . . . 0.0 109.702 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -57.88 -22.87 50.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -84.55 -53.71 5.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.862 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -70.8 -29.45 65.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -66.9 -37.35 84.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -26.85 67.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 49' ' ' LEU . 21.0 mt -86.37 -30.39 22.2 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.541 -0.724 . . . . 0.0 109.247 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 70' ' ' ALA . 80.7 mt -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 mtp85 -78.24 -30.43 48.71 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.1 tp-100 -79.11 -33.58 44.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.942 0.877 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.17 -9.43 52.87 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.704 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.41 ' O ' HG23 ' A' ' 53' ' ' VAL . . . 87.48 52.34 3.05 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.405 HG11 ' CD1' ' A' ' 60' ' ' LEU . 40.2 t -115.53 -0.79 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.058 -1.26 . . . . 0.0 111.519 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 11.5 m-85 -115.63 87.66 2.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.843 -1.161 . . . . 0.0 110.38 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -135.22 119.71 18.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -119.89 64.45 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.912 . . . . 0.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -159.22 89.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.22 128.29 6.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.335 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 77.66 8.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.31 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -70.28 -71.49 0.24 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 110.424 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.19 -63.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.131 . . . . 0.0 110.255 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.449 HG11 ' CZ3' ' A' ' 59' ' ' TRP . 50.2 t -78.12 128.65 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.982 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -140.16 138.73 35.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.554 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.496 HD12 ' CD1' ' A' ' 36' ' ' ILE . 86.0 mt -103.25 130.92 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.29 -0.881 . . . . 0.0 109.343 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.75 -172.0 4.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 110.65 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 5.0 mp -88.97 125.56 35.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.425 -0.797 . . . . 0.0 110.469 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.55 112.51 24.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.56 -0.712 . . . . 0.0 109.797 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.3 124.42 28.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 112.675 -178.313 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.518 ' CE2' ' HB2' ' A' ' 18' ' ' ARG . 1.3 m-85 -126.08 -154.43 0.62 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.01 138.55 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.45 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -75.54 -80.52 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.591 -0.947 . . . . 0.0 109.389 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 8.8 mtmt -149.44 57.04 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 5.3 m-70 -143.37 -56.1 0.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.298 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.05 112.25 28.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.412 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.76 112.38 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.538 1.283 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.466 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.6 p80 -151.95 132.08 13.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 8.5 m-85 -114.07 153.04 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.518 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 1.5 ttm180 -104.55 153.52 21.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.148 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.479 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -98.53 78.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.483 HG12 ' CD2' ' A' ' 32' ' ' TYR 0.272 0.4 OUTLIER -97.98 166.17 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.527 -173.684 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -109.36 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.755 -0.59 . . . . 0.0 110.51 -177.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.408 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.0 t -137.45 -166.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.408 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.4 m-20 -118.29 167.93 11.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.369 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.78 -33.17 6.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -52.3 -27.23 14.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.44 135.49 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.128 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -125.67 -6.81 6.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -93.87 0.22 56.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.871 -1.143 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 126.15 4.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.02 -1.05 . . . . 0.0 110.187 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.84 29.55 9.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -73.1 144.11 47.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -1.181 . . . . 0.0 110.252 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' CD2' HG12 ' A' ' 20' ' ' VAL . 17.0 p90 -110.46 155.5 22.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.953 . . . . 0.0 110.418 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.403 HG23 ' CZ2' ' A' ' 59' ' ' TRP . 2.8 mp -58.87 -53.35 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -149.75 173.74 13.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -109.93 119.7 40.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.951 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.496 ' CD1' HD12 ' A' ' 4' ' ' ILE . 21.7 pt -110.7 -38.81 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.049 -1.032 . . . . 0.0 111.656 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.482 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -121.1 167.83 14.11 Favored Glycine 0 C--N 1.295 -1.72 0 C-N-CA 118.897 -1.621 . . . . 0.0 111.45 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.45 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.7 t80 -137.23 141.17 42.06 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.59 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 25.5 t80 -138.5 139.27 38.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.75 -1.218 . . . . 0.0 110.718 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.8 t0 -139.62 104.69 6.98 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 43.8 Cg_endo -72.82 70.3 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 122.985 0.992 . . . . 0.0 110.375 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.81 138.65 31.3 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -98.98 33.54 2.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.8 t -132.65 -40.07 0.98 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.315 -0.866 . . . . 0.0 110.139 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 22.3 p -135.87 135.5 21.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.17 -9.56 23.46 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.678 1.357 . . . . 0.0 110.926 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.42 64.82 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.636 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.59 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 26.4 p-90 -124.72 -10.07 7.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.994 -1.066 . . . . 0.0 111.132 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 10.1 tt -91.94 109.6 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.12 . . . . 0.0 110.557 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 3.7 mmmt -126.88 103.76 7.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' CG2' ' CD1' ' A' ' 19' ' ' ILE . 1.3 t -127.32 149.0 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.877 -1.139 . . . . 0.0 111.4 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.8 t0 -97.56 70.45 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -33.77 -32.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 120.562 0.22 . . . . 0.0 111.435 -177.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.4 tt0 -60.99 -53.98 50.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.822 -1.173 . . . . 0.0 108.865 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 48.0 mmm-85 -73.72 -38.37 64.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.27 -21.35 66.56 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -89.2 -24.11 22.22 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.104 -0.997 . . . . 0.0 109.932 178.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -59.01 -49.6 77.26 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 123.269 1.509 . . . . 0.0 107.197 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.541 ' CD1' HG22 ' A' ' 21' ' ' VAL . 84.6 m95 -62.56 -52.29 64.0 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.265 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 4.0 mt -54.24 -22.41 11.58 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.338 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -80.81 -22.08 40.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 110.743 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 59' ' ' TRP . 4.5 m -98.93 33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 120.823 -1.173 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.28 28.17 72.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.412 ' HB1' ' HA ' ' A' ' 60' ' ' LEU . . . -68.21 134.01 49.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -1.228 . . . . 0.0 110.081 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.19 109.09 59.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HB3' HD13 ' A' ' 74' ' ' LEU . 51.4 Cg_endo -84.59 126.86 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.616 1.324 . . . . 0.0 110.352 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.418 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 3.3 t -60.51 173.41 0.71 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 109.89 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -58.21 -27.83 64.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 111.103 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.447 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 1.8 m -83.13 -52.08 6.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.762 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 5' ' ' ARG . . . -68.67 -26.47 65.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 67' ' ' THR . 2.4 ttt-85 -68.2 -38.65 82.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -45.22 80.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 59.6 mt -65.88 -25.76 67.33 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 66' ' ' PRO . 17.2 mt -74.4 -26.06 59.85 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.544 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -84.24 -29.38 26.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.174 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -84.29 -36.08 22.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.823 0.82 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.14 41.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.06 57.14 2.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.411 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 21.7 t -109.77 -59.31 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.176 -1.191 . . . . 0.0 111.092 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.7 m-30 -51.49 -24.48 5.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.112 -0.993 . . . . 0.0 110.499 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -111.86 105.07 13.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.642 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.81 117.54 30.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.788 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 -153.1 0.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.375 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.76 172.66 6.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 26.65 2.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.135 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -57.56 12.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.69 43.9 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.235 -1.156 . . . . 0.0 110.205 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.167 0.508 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.494 HG12 ' CZ3' ' A' ' 59' ' ' TRP . 66.3 t -77.23 133.38 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -134.04 128.75 34.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.303 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.478 ' N ' ' CD1' ' A' ' 4' ' ' ILE . 1.3 mm -103.74 133.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.486 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 16.5 ptm180 -151.0 177.65 9.95 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.889 -1.132 . . . . 0.0 110.858 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 pp -89.55 132.17 35.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.892 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.543 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.05 157.81 16.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.56 -0.712 . . . . 0.0 109.232 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.496 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 8.8 tmm_? -124.29 109.31 13.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.889 -1.132 . . . . 0.0 111.315 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.543 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -119.63 -151.44 0.48 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.897 . . . . 0.0 109.247 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.93 56.64 2.42 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 37.8 p -54.37 -56.74 15.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -1.219 . . . . 0.0 109.714 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . 22.3 mttp -146.14 54.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.3 m-70 -141.55 -63.43 0.45 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.347 -0.846 . . . . 0.0 109.817 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.417 ' ND2' ' HD2' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -165.26 142.15 4.76 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 0.0 109.81 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' ND2' ' A' ' 14' ' ' ASN . 46.3 Cg_endo -73.09 107.58 2.4 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.64 1.337 . . . . 0.0 111.34 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.507 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 27.5 p80 -150.45 147.35 27.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.288 -0.882 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 14.0 m-85 -121.74 173.06 7.7 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -137.24 150.83 48.11 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.01 -1.056 . . . . 0.0 108.301 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.523 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -97.06 85.95 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 178.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.496 HG22 ' CG ' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -98.49 168.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.634 -173.158 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.532 ' CG1' ' CD2' ' A' ' 59' ' ' TRP . 1.7 t -113.81 102.78 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.694 -0.629 . . . . 0.0 110.776 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.6 t -132.45 -173.87 3.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.349 -0.844 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.4 p30 -83.01 -160.33 0.4 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 110.381 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.14 -36.92 12.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.1 131.25 30.24 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.29 -0.881 . . . . 0.0 110.334 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 175.49 10.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 110.146 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -63.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 110.28 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -90.83 -37.45 13.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.999 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.3 140.25 22.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.49 51.97 1.56 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -112.1 115.49 28.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -1.146 . . . . 0.0 110.445 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CG ' HG22 ' A' ' 20' ' ' VAL . 12.8 p90 -62.95 166.0 6.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.887 . . . . 0.0 110.289 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.3 -58.63 6.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -145.08 173.91 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.012 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.42 115.34 29.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.202 -0.936 . . . . 0.0 109.572 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 59' ' ' TRP . 18.1 pt -108.98 -40.01 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.108 -0.995 . . . . 0.0 111.243 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -111.76 167.05 12.31 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.112 -1.518 . . . . 0.0 112.225 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.432 ' N ' HG12 ' A' ' 19' ' ' ILE . 87.5 t80 -140.8 126.18 18.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.586 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 13.9 t80 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.726 -1.234 . . . . 0.0 110.046 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 3.2 t0 -140.41 104.94 6.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.071 -1.018 . . . . 0.0 109.848 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 49.8 Cg_endo -77.62 80.1 3.03 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.213 1.112 . . . . 0.0 110.765 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -92.15 158.25 16.28 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.043 -1.036 . . . . 0.0 110.294 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 40.02 2.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.418 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -115.31 -73.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 110.053 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.4 p -127.82 156.26 76.1 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.019 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.06 63.49 4.15 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.658 1.346 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -154.56 80.79 1.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 9.5 p-90 -134.41 -29.24 1.23 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.936 . . . . 0.0 111.38 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.533 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 0.9 OUTLIER -57.24 123.41 15.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -133.36 101.6 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.517 -0.74 . . . . 0.0 109.264 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -129.22 135.25 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 111.412 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.1 t0 -77.62 70.06 3.95 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -35.91 -30.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 122.276 -0.265 . . . . 0.0 111.286 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.2 -53.44 57.63 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.834 -1.166 . . . . 0.0 108.723 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.501 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmm180 -74.0 -38.17 64.18 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.23 -17.57 63.7 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.0 ttt180 -89.19 -25.58 21.71 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.282 -0.886 . . . . 0.0 109.324 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.501 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -59.59 -44.68 93.29 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 123.575 1.655 . . . . 0.0 106.953 178.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CD2' ' CG1' ' A' ' 21' ' ' VAL . 80.5 m95 -67.23 -59.5 3.38 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.003 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mt -54.04 -21.88 9.38 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.826 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 30.6 t -81.27 -19.07 43.83 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.427 -0.796 . . . . 0.0 110.262 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.62 32.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.843 -1.161 . . . . 0.0 109.214 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.33 25.49 75.42 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' HB3' ' CG1' ' A' ' 4' ' ' ILE . . . -70.68 126.57 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.178 -1.19 . . . . 0.0 110.026 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.31 111.35 53.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 51.9 Cg_endo -80.86 131.23 7.95 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.48 1.253 . . . . 0.0 110.332 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.9 p -56.92 159.17 4.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.61 -34.23 50.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.991 . . . . 0.0 111.581 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.405 HG22 ' CD2' ' A' ' 6' ' ' LEU . 5.3 m -83.68 -49.9 8.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 111.191 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.486 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -71.26 -22.98 61.9 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.253 -0.904 . . . . 0.0 109.264 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -70.97 -36.14 72.41 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -33.4 74.74 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.439 HD12 ' CD2' ' A' ' 39' ' ' TYR . 21.3 mt -75.17 -30.24 60.65 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.573 -0.704 . . . . 0.0 109.172 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 16.1 mt -68.03 -29.43 68.41 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.436 ' HG2' ' CD1' ' A' ' 80' ' ' PHE . 2.7 tmm_? -77.68 -31.03 52.23 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -77.49 -28.54 52.24 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.986 0.898 . . . . 0.0 109.391 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.07 -8.79 48.44 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.225 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.99 31.43 11.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 47.4 t -92.14 -64.98 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -1.166 . . . . 0.0 110.651 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 75' ' ' ARG . 18.8 p90 -133.87 -172.45 2.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.69 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -117.25 169.28 9.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -70.5 107.65 3.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -130.31 125.35 34.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.128 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.58 101.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 0.0 110.415 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -92.12 68.85 5.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 109.879 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.07 128.22 23.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.5 174.36 2.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.264 -1.139 . . . . 0.0 110.256 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.225 0.536 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 17.1 m -74.48 115.9 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 110.588 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 22' ' ' THR . 17.2 ptmt -140.73 138.99 34.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.045 -1.034 . . . . 0.0 110.42 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.466 ' CG2' HD12 ' A' ' 36' ' ' ILE . 4.5 mt -103.84 135.32 42.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.048 -1.032 . . . . 0.0 108.681 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -150.64 -170.42 3.65 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.861 -1.149 . . . . 0.0 110.777 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.0 mp -89.03 129.22 35.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HB1' ' CE1' ' A' ' 9' ' ' PHE . . . -102.85 108.47 19.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 111.453 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 8.6 ttp180 -77.94 122.77 25.95 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.99 -1.069 . . . . 0.0 111.009 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.503 ' CE1' ' HB1' ' A' ' 7' ' ' ALA . 12.6 m-85 -109.2 -64.66 1.22 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.481 -0.762 . . . . 0.0 110.889 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.93 124.59 10.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.449 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 6.6 p -66.84 -38.35 86.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -1.104 . . . . 0.0 109.544 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' O ' ' CD ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -178.11 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.449 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 13.5 m-70 -123.44 -49.98 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 109.561 -179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -141.57 126.92 10.81 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.538 -0.726 . . . . 0.0 109.568 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.34 106.19 2.19 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.318 1.167 . . . . 0.0 111.017 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.499 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 35.3 p80 -161.25 122.96 2.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.851 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 6.5 m-30 -116.99 152.87 33.69 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 108.511 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -102.85 166.89 10.21 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.058 176.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.11 85.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.45 ' CG2' ' HD2' ' A' ' 18' ' ' ARG 0.26 0.4 OUTLIER -99.21 164.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.283 -175.011 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.542 HG22 ' CD1' ' A' ' 59' ' ' TRP . 1.3 t -107.9 110.87 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 109.961 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.42 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t -137.1 -170.7 2.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 110.505 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.8 p30 -143.01 148.12 36.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.81 11.16 39.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.8 50.32 0.97 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.087 -1.008 . . . . 0.0 110.45 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -165.66 76.72 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.38 67.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.287 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -135.91 -42.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -139.78 -59.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 39.03 4.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -103.67 121.55 43.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -1.131 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 7.8 p90 -55.52 170.24 0.26 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 110.47 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.82 -41.93 13.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.573 -0.704 . . . . 0.0 109.303 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -151.17 150.35 30.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.117 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp -96.46 118.88 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.975 . . . . 0.0 109.91 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.482 ' HB ' ' CA ' ' A' ' 56' ' ' ALA . 43.3 pt -99.84 -27.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 111.756 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.56 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -150.64 -174.41 21.66 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.001 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 36.7 t80 -140.83 147.45 39.03 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.872 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.2 t80 -140.21 132.89 28.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.588 -1.32 . . . . 0.0 109.664 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 27.4 t0 -139.13 97.75 8.58 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.896 -1.127 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.48 72.04 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.657 1.346 . . . . 0.0 110.831 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.51 171.68 8.22 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.205 -0.935 . . . . 0.0 110.069 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 39.92 2.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 p -110.46 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.063 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.7 p -128.12 157.64 73.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.31 -42.32 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.657 1.346 . . . . 0.0 110.016 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.47 99.49 5.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 109.958 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.45 ' CE3' ' HB2' ' A' ' 49' ' ' LEU . 1.7 p-90 -122.41 17.14 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.917 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.45 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 11.5 tp -118.9 138.53 52.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.988 -1.07 . . . . 0.0 110.789 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -140.1 72.95 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.48 -0.762 . . . . 0.0 110.199 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.56 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -94.69 129.44 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.274 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.6 t0 -73.88 70.12 1.44 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -36.36 -29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.149 -0.344 . . . . 0.0 111.606 -177.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -62.99 -55.89 21.81 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.619 -1.301 . . . . 0.0 109.082 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -0.872 . . . . 0.0 108.994 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . . . -73.38 -22.93 60.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.947 -1.096 . . . . 0.0 108.082 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttt85 -86.0 -21.35 27.86 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.142 -0.974 . . . . 0.0 108.912 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 81.4 m95 -61.55 -53.33 57.75 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.316 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -52.67 -22.71 5.44 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -22.32 42.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.546 -0.721 . . . . 0.0 110.434 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' A' ' 59' ' ' TRP . 4.4 m -98.85 32.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.74 -1.225 . . . . 0.0 109.52 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.19 27.26 73.11 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -67.95 134.31 50.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.152 -1.205 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -105.94 105.65 54.1 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.3 Cg_endo -79.07 129.51 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.607 1.319 . . . . 0.0 110.051 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.435 ' CG2' ' HB2' ' A' ' 70' ' ' ALA . 4.0 t -58.45 165.8 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.47 -27.89 58.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.164 -0.96 . . . . 0.0 111.515 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -82.24 -52.7 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.934 -1.104 . . . . 0.0 110.806 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.443 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -69.49 -26.49 64.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.326 -0.859 . . . . 0.0 108.721 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -66.52 -38.45 87.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -41.16 90.38 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.954 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.444 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 14.7 mt -71.13 -27.2 63.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 12.9 mt -70.52 -27.83 64.48 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.96 -32.83 51.64 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -79.94 -29.34 39.69 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.981 0.896 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -74.27 -4.47 36.29 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.866 -0.521 . . . . 0.0 110.257 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.53 39.46 30.07 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.456 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 48.2 t -92.39 -35.46 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.282 -1.128 . . . . 0.0 111.459 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.53 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 7.0 m-30 -80.07 103.64 10.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.559 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -89.97 97.46 11.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.871 . . . . 0.0 110.013 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.05 119.73 3.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.378 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.52 92.31 4.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 110.116 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.1 117.42 32.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.387 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.13 121.33 41.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.3 29.25 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.09 -63.85 0.46 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.399 -1.059 . . . . 0.0 110.072 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.301 0.572 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.426 HG12 ' CE3' ' A' ' 59' ' ' TRP . 60.8 t -84.75 120.57 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.296 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 2.1 mtpt -140.49 129.72 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.784 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.461 HD11 ' CD1' ' A' ' 36' ' ' ILE . 52.1 mt -101.22 132.09 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.06 -1.025 . . . . 0.0 109.132 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.12 -169.47 3.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 110.95 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.7 mp -88.8 125.89 35.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.0 108.51 20.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.756 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.584 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.4 ttt-85 -77.82 121.39 24.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.023 -1.048 . . . . 0.0 111.592 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.493 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 13.7 m-85 -113.84 -64.23 1.34 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.606 0.717 . . . . 0.0 110.301 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.69 132.16 39.93 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 34.7 p -87.24 -57.49 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -1.138 . . . . 0.0 109.868 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' N ' ' OG ' ' A' ' 11' ' ' SER . 5.6 mtmt -146.15 42.54 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -0.763 . . . . 0.0 109.092 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 4.0 m-70 -128.53 -50.53 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.483 -0.761 . . . . 0.0 109.48 -178.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -147.79 114.3 4.02 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.642 -0.661 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.79 86.23 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.493 1.259 . . . . 0.0 111.104 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.525 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 35.3 p80 -134.06 125.31 27.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.094 -1.004 . . . . 0.0 110.573 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 11.7 m-30 -114.48 151.24 33.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.44 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 5.5 mtp180 -101.46 160.38 14.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.86 -1.536 . . . . 0.0 108.021 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.7 OUTLIER -98.83 79.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.482 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.253 0.4 OUTLIER -97.82 160.63 3.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.886 -174.236 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -102.73 121.08 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 32' ' ' TYR . 7.1 p -119.51 -177.81 3.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.943 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -96.61 -169.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.246 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.2 -47.05 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 110.327 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.51 75.72 5.02 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.098 -1.001 . . . . 0.0 110.481 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -168.93 -158.95 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.287 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -157.32 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.6 84.19 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.326 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.4 -60.36 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.901 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.23 -46.26 1.7 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' A' ' 32' ' ' TYR . 31.2 pttt -67.14 -166.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -1.209 . . . . 0.0 110.346 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.482 ' CD2' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -148.54 -170.78 3.69 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.421 HG22 ' CZ2' ' A' ' 59' ' ' TRP . 5.8 mt -92.17 -37.43 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.538 -0.727 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.6 153.94 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 109.824 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HA ' ' CG2' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -94.43 116.0 28.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.007 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.5 pt -103.02 -32.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -124.41 169.03 16.44 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 119.218 -1.467 . . . . 0.0 111.341 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.467 ' N ' HG13 ' A' ' 19' ' ' ILE . 48.0 t80 -140.15 134.64 31.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.441 ' CD1' ' CE3' ' A' ' 48' ' ' TRP . 6.0 t80 -133.6 131.24 39.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 110.121 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 44.0 t0 -140.29 86.09 13.05 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.581 -1.325 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.05 66.98 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.533 1.28 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 150.49 22.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.892 . . . . 0.0 109.83 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 38.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 110.272 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.42 HG23 ' N ' ' A' ' 45' ' ' THR . 6.9 t -138.09 -41.2 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.42 ' N ' HG23 ' A' ' 44' ' ' THR . 7.4 p -108.54 131.62 21.65 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.998 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.26 -44.51 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.505 1.266 . . . . 0.0 110.493 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.76 90.83 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.404 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.5 p-90 -115.16 -4.26 12.48 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 8.3 tt -93.37 106.94 18.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.922 -1.111 . . . . 0.0 110.403 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.85 96.59 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.484 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.496 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -120.86 151.04 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 111.499 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.4 t70 -96.88 67.87 2.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -33.62 -31.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.038 -177.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 27.4 tt0 -62.34 -56.84 14.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.729 -1.232 . . . . 0.0 109.012 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.466 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 13.5 mmm180 -72.77 -35.54 67.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.46 -20.78 66.39 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 34.8 ttt85 -88.25 -25.05 23.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.577 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -59.94 -46.72 88.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.152 1.453 . . . . 0.0 107.301 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.577 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 87.5 m95 -65.4 -55.52 17.61 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.814 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.452 ' CD1' HD11 ' A' ' 74' ' ' LEU . 6.4 mt -53.42 -22.6 8.0 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.529 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 t -82.81 -19.62 37.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.394 -0.816 . . . . 0.0 110.568 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 59' ' ' TRP . 3.3 m -98.98 32.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 120.798 -1.189 . . . . 0.0 109.272 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.87 72.93 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' A' ' 60' ' ' LEU . . . -71.42 134.91 46.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.439 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 7.1 mt-30 -101.79 108.12 54.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.8 Cg_endo -81.27 140.74 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.536 1.282 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -73.24 169.27 17.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 109.744 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.01 -18.47 34.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.775 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.422 ' HB ' HD12 ' A' ' 6' ' ' LEU . 3.5 m -95.07 -49.68 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.021 . . . . 0.0 110.515 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.68 -25.48 62.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.343 -0.848 . . . . 0.0 108.768 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' THR . 1.0 OUTLIER -69.12 -35.4 76.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -67.19 -34.47 77.58 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.42 ' CD2' HD13 ' A' ' 49' ' ' LEU . 31.6 mt -73.84 -28.0 61.38 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.587 -0.696 . . . . 0.0 109.514 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 54.0 mt -71.96 -27.25 62.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -81.49 -30.5 33.26 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -82.51 -38.33 23.99 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.788 0.804 . . . . 0.0 110.015 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.414 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -64.23 -12.15 38.15 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.817 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.93 36.41 8.44 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.442 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 21.9 t -87.02 -59.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.273 . . . . 0.0 111.324 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.541 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.2 m-30 -53.44 122.08 8.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 110.225 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -48.44 9.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -140.83 143.92 35.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -127.44 161.77 27.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.387 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.05 93.01 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.529 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -117.35 50.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.843 . . . . 0.0 109.954 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -160.26 -62.95 0.07 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.94 -121.39 6.91 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.352 -1.087 . . . . 0.0 110.116 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.259 0.552 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.1 m -149.08 116.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.246 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 9.3 mtpt -140.32 136.66 33.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.868 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' CG1' ' CD1' ' A' ' 36' ' ' ILE . 1.1 mp -99.62 119.13 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.4 ptt85 -150.33 -179.79 7.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.987 -1.07 . . . . 0.0 110.906 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 6.0 mp -88.91 124.73 34.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.279 -0.888 . . . . 0.0 111.024 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.7 100.84 11.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.414 -0.804 . . . . 0.0 111.687 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.469 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 47.3 ttt180 -67.92 120.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.503 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 36.3 m-85 -108.72 -60.9 1.68 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.06 130.05 6.8 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 28.7 p -81.52 -59.39 2.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -1.03 . . . . 0.0 110.045 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -142.73 40.01 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.4 -0.813 . . . . 0.0 109.128 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.2 m-70 -127.9 -65.14 0.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 109.609 -178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 33.3 m120 -136.81 110.42 9.38 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.544 -0.723 . . . . 0.0 109.354 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -70.88 59.1 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.548 1.289 . . . . 0.0 111.396 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 31.5 p80 -95.36 135.31 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 109.524 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 3.5 m-85 -117.84 155.99 29.16 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.751 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 10.1 mmt180 -100.05 156.22 17.29 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.677 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.5 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 mt -98.55 77.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.256 0.3 OUTLIER -97.06 176.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.273 -172.869 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.559 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -120.44 115.77 48.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.367 0.603 . . . . 0.0 109.947 -177.384 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.414 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -139.35 -177.12 4.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OG1' ' A' ' 22' ' ' THR . 8.2 p-10 -116.96 154.75 30.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.778 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.33 19.25 18.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -75.48 -23.07 56.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -122.65 137.72 54.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.436 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 46.36 2.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -113.48 -62.23 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 110.319 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -106.25 -35.37 7.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.42 94.75 0.18 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 154.21 42.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -1.159 . . . . 0.0 110.062 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 16.8 p90 -114.96 179.54 3.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.0 111.193 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 4.6 mt -95.9 -44.43 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.686 -0.634 . . . . 0.0 110.055 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 166.31 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -101.25 106.79 18.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 110.131 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.507 HG23 ' CD1' ' A' ' 59' ' ' TRP . 16.1 pt -100.12 -34.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -127.63 165.41 20.72 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.486 ' N ' HG13 ' A' ' 19' ' ' ILE . 26.9 t80 -139.19 143.45 38.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.925 . . . . 0.0 109.687 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.606 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 13.2 t80 -131.74 132.4 43.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.943 -1.098 . . . . 0.0 109.47 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -140.35 105.54 6.56 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.764 -1.21 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -87.88 41.75 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.554 1.291 . . . . 0.0 110.823 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -89.54 -144.73 0.16 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.955 -1.091 . . . . 0.0 109.727 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.8 62.6 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 42' ' ' ARG . 52.9 p -150.86 97.92 2.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.534 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 19.2 m -88.69 -40.71 0.46 Allowed Pre-proline 0 C--N 1.295 -1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 111.861 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 45' ' ' THR . 52.7 Cg_endo -89.58 -49.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 122.91 0.953 . . . . 0.0 110.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -106.17 92.08 3.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.251 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.606 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 35.7 p-90 -133.61 6.96 3.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.489 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 tm? -122.3 126.94 49.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.976 -1.078 . . . . 0.0 110.29 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.437 ' N ' HD11 ' A' ' 49' ' ' LEU . 3.7 mtpp -130.81 111.0 11.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.071 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.475 HG23 ' CA ' ' A' ' 37' ' ' GLY . 1.3 t -132.02 144.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.533 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -93.29 70.75 4.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.461 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.04 -31.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -177.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.16 -54.41 46.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.731 -1.23 . . . . 0.0 109.114 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 5.5 mtm-85 -74.53 -35.86 63.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.092 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -66.71 -20.98 66.09 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.8 ttp85 -89.16 -23.34 22.46 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -60.63 -49.06 79.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 123.394 1.568 . . . . 0.0 107.091 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.559 ' CD1' HG22 ' A' ' 21' ' ' VAL . 85.0 m95 -63.6 -50.99 67.23 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.3 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 6.5 mt -56.07 -21.03 19.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 176.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.6 t -81.23 -21.68 39.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.368 -0.833 . . . . 0.0 110.436 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.9 m -98.86 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.874 -1.141 . . . . 0.0 109.791 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.97 30.8 76.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.408 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . . . -64.76 143.84 57.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -1.209 . . . . 0.0 109.624 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -106.7 99.37 24.87 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.333 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.1 Cg_endo -79.64 125.0 5.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.697 1.367 . . . . 0.0 110.279 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.6 t -58.86 170.14 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.826 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.88 -20.01 47.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.149 -0.969 . . . . 0.0 110.892 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.99 -53.42 4.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.181 -0.949 . . . . 0.0 110.386 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.31 -27.06 65.06 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.426 ' O ' ' CG ' ' A' ' 75' ' ' ARG . 9.1 ttp85 -68.95 -39.26 79.62 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.453 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.86 -40.84 87.99 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.782 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 77' ' ' ALA . 16.0 mt -70.81 -25.13 62.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.495 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 12.4 mt -70.51 -29.36 65.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.539 ' HG2' ' CE2' ' A' ' 80' ' ' PHE . 3.6 mtm180 -78.47 -34.4 47.68 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -26.42 37.93 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.739 0.781 . . . . 0.0 110.667 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' N ' ' O ' ' A' ' 73' ' ' LEU . . . -76.19 -1.97 28.95 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.743 -0.598 . . . . 0.0 110.161 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.14 38.03 30.9 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.461 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 32.0 t -98.35 -32.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 O-C-N 121.249 -1.148 . . . . 0.0 111.129 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.539 ' CE2' ' HG2' ' A' ' 75' ' ' ARG . 6.5 m-30 -87.12 -53.26 4.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.67 147.73 22.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.913 . . . . 0.0 110.732 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -173.17 -163.86 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 109.81 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -164.55 137.8 4.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.52 32.49 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.9 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -100.98 -43.59 6.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 110.299 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.06 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.153 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.03 101.44 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.214 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.162 0.506 . . . . 0.0 110.224 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.24 114.03 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.12 135.84 32.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.215 -0.928 . . . . 0.0 110.75 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.497 HD13 ' CB ' ' A' ' 59' ' ' TRP . 63.1 mt -101.98 135.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 109.232 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.467 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 8.7 ptm180 -150.93 178.31 9.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.005 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.5 pp -89.61 131.74 35.46 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.326 -0.949 . . . . 0.0 109.48 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.9 164.02 12.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.525 -0.734 . . . . 0.0 109.056 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.483 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -128.38 113.15 15.21 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.913 -1.117 . . . . 0.0 111.562 -179.061 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.522 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.99 -152.2 0.51 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.349 -0.845 . . . . 0.0 109.59 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.28 67.12 1.12 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 1.1 p -54.24 -50.68 66.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.171 -1.193 . . . . 0.0 109.834 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -167.12 37.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.481 -0.762 . . . . 0.0 109.527 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 6.8 m-70 -120.38 -57.25 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.52 -0.737 . . . . 0.0 109.293 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.3 135.89 5.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.693 -0.629 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.89 116.82 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.562 1.296 . . . . 0.0 110.863 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.497 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 23.1 p80 -158.25 149.31 20.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 110.596 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.485 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 13.0 m-85 -118.32 172.24 7.59 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 29.3 mtt-85 -135.13 151.22 50.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.881 -1.137 . . . . 0.0 108.986 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -97.01 82.9 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.281 0.4 OUTLIER -98.38 163.2 2.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.353 -173.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.94 113.47 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.71 . . . . 0.0 110.322 -178.034 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.426 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -140.03 -167.18 2.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.395 -0.815 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' N ' ' OG1' ' A' ' 22' ' ' THR . 75.0 m-20 -95.18 165.35 12.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -0.829 . . . . 0.0 109.989 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -105.11 -50.93 3.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.061 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 59.78 5.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.236 -0.915 . . . . 0.0 110.558 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.8 111.34 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -125.25 21.24 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -87.93 -22.3 24.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.16 -45.96 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.52 70.48 1.25 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 157.99 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -1.16 . . . . 0.0 110.051 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 2.0 p90 -109.32 -175.06 2.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.186 -0.946 . . . . 0.0 110.617 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.68 -47.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.553 -0.717 . . . . 0.0 109.923 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.88 159.51 41.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.419 -0.801 . . . . 0.0 109.741 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -95.7 109.57 21.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' CD1' ' A' ' 59' ' ' TRP . 36.2 pt -100.19 -35.19 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.071 -1.018 . . . . 0.0 110.541 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.485 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -121.14 167.35 14.08 Favored Glycine 0 C--N 1.294 -1.799 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.264 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.401 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.4 t80 -141.06 117.52 10.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.524 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 7.8 t80 -109.02 142.47 39.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.277 . . . . 0.0 109.497 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 39.9 t0 -134.82 83.08 42.11 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.941 -1.099 . . . . 0.0 110.111 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 42.4 Cg_endo -68.74 61.83 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.573 1.302 . . . . 0.0 110.539 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -95.16 125.03 39.53 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.224 -0.922 . . . . 0.0 110.337 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -71.14 72.08 0.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 109.824 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 p -150.03 -82.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 110.785 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -98.94 161.57 24.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.134 -0.979 . . . . 0.0 110.589 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 51.8 Cg_endo -77.01 -37.34 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.833 1.439 . . . . 0.0 110.602 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 110.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.508 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 6.5 p-90 -133.91 4.29 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 110.714 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.9 tt -102.58 126.27 49.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 110.877 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.19 89.33 2.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.399 -0.813 . . . . 0.0 109.144 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.485 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 137.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.108 -0.995 . . . . 0.0 111.07 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.8 t0 -82.44 70.48 9.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.447 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.6 OUTLIER -37.18 -30.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.259 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' ASP . 12.7 mt-10 -63.18 -49.69 73.3 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.812 -1.18 . . . . 0.0 108.786 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.77 -33.51 52.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 108.819 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -69.43 -22.0 63.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.6 ttt-85 -87.49 -23.48 24.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.353 -0.842 . . . . 0.0 109.466 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -58.87 -50.15 75.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.426 1.584 . . . . 0.0 107.042 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.58 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 85.3 m95 -62.62 -55.19 29.33 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 43.7 mt -52.83 -23.33 6.76 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -78.68 -19.47 52.42 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.503 -0.748 . . . . 0.0 110.12 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 59' ' ' TRP . 3.6 m -98.41 31.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.996 -1.065 . . . . 0.0 109.311 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.45 78.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.54 128.37 35.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -1.181 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.6 mm-40 -100.39 119.92 57.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.177 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.8 Cg_endo -83.39 146.46 12.32 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.505 1.266 . . . . 0.0 110.407 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.433 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -71.29 158.44 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.0 109.987 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -55.53 -26.3 42.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 111.219 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.428 HG23 ' CD2' ' A' ' 6' ' ' LEU . 11.6 m -90.7 -48.39 7.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.697 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.467 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -71.13 -26.93 63.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.811 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.433 ' CB ' ' O ' ' A' ' 67' ' ' THR . 31.9 ttp180 -68.02 -36.79 80.52 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -35.66 76.17 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 29.1 mt -73.29 -38.44 65.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 66.9 mt -63.25 -28.44 70.03 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 3.6 mtt180 -77.13 -32.41 56.38 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.436 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -76.6 -32.19 57.94 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.15 0.976 . . . . 0.0 109.523 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -70.25 -7.99 46.62 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.78 42.31 7.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.434 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 39.7 t -100.78 -6.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.176 -1.19 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 10.1 m-85 -115.13 142.72 46.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.302 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -108.12 138.75 43.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -141.89 152.64 43.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.76 85.94 3.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.046 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.7 -167.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -72.46 -68.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -49.9 164.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.57 103.75 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 110.256 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.225 0.536 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.434 ' CG1' ' CG1' ' A' ' 21' ' ' VAL . 92.3 t -88.75 154.81 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.161 -0.962 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -140.67 133.0 28.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.127 -0.983 . . . . 0.0 110.534 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 33.1 mt -103.64 130.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.092 -1.005 . . . . 0.0 109.328 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.1 ptt85 -151.09 -167.46 2.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.652 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.476 HD23 ' CD2' ' A' ' 39' ' ' TYR . 13.1 mt -89.32 126.11 35.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.223 -0.923 . . . . 0.0 111.081 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -100.0 104.06 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.175 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 8.1 tmm_? -75.66 125.62 29.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 0.0 112.241 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.523 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 2.0 m-85 -125.35 -153.38 0.56 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.458 -0.776 . . . . 0.0 109.331 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 105.57 0.01 OUTLIER Glycine 0 N--CA 1.483 1.825 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.6 p -59.05 -39.75 82.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -1.118 . . . . 0.0 109.033 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.59 57.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.8 -0.563 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -127.26 -64.85 0.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.229 -0.919 . . . . 0.0 110.18 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.69 143.27 31.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 0.0 109.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.92 93.55 1.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.641 1.337 . . . . 0.0 111.243 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.47 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 35.7 p80 -137.54 125.66 22.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.974 -1.078 . . . . 0.0 110.385 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 10.7 m-85 -113.23 149.15 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.4 ttm-85 -100.55 154.08 18.86 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.565 ' O ' HD13 ' A' ' 36' ' ' ILE . 1.1 mt -97.63 84.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.467 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.26 0.4 OUTLIER -98.51 172.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.988 -173.068 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.514 HG11 ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.73 105.28 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.597 -0.689 . . . . 0.0 111.037 -177.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.1 t -129.18 -177.01 4.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.2 -0.938 . . . . 0.0 109.959 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -104.23 -173.36 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.59 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.89 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 0.0 110.119 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -49.23 124.09 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.0 110.572 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -49.92 16.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -151.97 -80.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 110.004 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -120.77 34.85 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 109.738 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 93.08 9.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 61.28 2.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -120.65 70.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -1.138 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' CD2' HG23 ' A' ' 20' ' ' VAL . 10.6 p90 -64.0 176.79 0.89 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.013 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 mt -86.02 -49.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.27 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -153.66 172.57 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -0.807 . . . . 0.0 109.778 179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HB3' ' CD ' ' A' ' 18' ' ' ARG . 1.8 mtmt -111.82 126.3 54.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.04 -1.037 . . . . 0.0 110.0 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.566 HG13 ' HA ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -129.86 -13.71 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.008 -1.057 . . . . 0.0 111.819 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -133.89 154.83 21.51 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 119.286 -1.435 . . . . 0.0 109.6 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.444 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 24.2 t80 -128.92 151.81 49.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.268 -1.136 . . . . 0.0 109.13 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' CD2' HD23 ' A' ' 6' ' ' LEU . 38.8 t80 -149.93 116.5 5.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.721 -1.237 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 39.1 t0 -130.54 82.07 66.05 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.684 -1.26 . . . . 0.0 110.575 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.412 ' HG3' ' CE2' ' A' ' 39' ' ' TYR . 41.6 Cg_endo -68.48 78.63 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.681 1.358 . . . . 0.0 110.892 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -164.48 1.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.367 -0.833 . . . . 0.0 110.0 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -132.56 24.41 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 0.0 110.502 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 t -121.56 -22.54 5.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.526 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.6 p -140.56 140.54 22.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.057 . . . . 0.0 110.485 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.09 -13.64 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.657 1.346 . . . . 0.0 110.706 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.16 93.68 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.68 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 6.0 p-90 -120.39 -13.14 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.382 -0.824 . . . . 0.0 110.587 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.6 tt -77.96 129.04 34.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 111.108 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.441 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -140.33 85.9 2.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 109.288 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.542 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.3 t -115.85 143.54 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.922 -1.111 . . . . 0.0 111.412 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.8 t0 -94.58 69.8 3.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -32.9 -32.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.809 -177.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.28 -50.23 74.46 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.695 -1.253 . . . . 0.0 108.562 178.208 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.0 mmm180 -74.44 -36.17 63.38 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HA ' HG13 ' A' ' 36' ' ' ILE . . . -68.85 -16.57 63.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.944 -1.097 . . . . 0.0 108.129 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -90.38 -21.72 21.83 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 121.362 -0.836 . . . . 0.0 108.908 177.163 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.493 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -66.83 -48.22 69.57 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 123.032 1.396 . . . . 0.0 107.658 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 75.3 m95 -66.94 -54.36 22.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.424 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.428 HD13 ' CD1' ' A' ' 74' ' ' LEU . 3.3 mt -56.6 -21.31 26.05 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.537 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 2.8 m -82.34 -20.91 36.37 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.397 -0.814 . . . . 0.0 110.446 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 59' ' ' TRP . 3.8 m -99.07 31.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.915 -1.116 . . . . 0.0 109.536 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 26.41 73.75 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -67.14 137.44 56.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.331 . . . . 0.0 109.644 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -103.03 108.26 58.02 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 0.0 110.609 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.408 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 55.0 Cg_endo -79.69 126.62 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.65 1.342 . . . . 0.0 109.736 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.6 t -62.21 -175.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.55 51.94 1.77 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 m -164.33 -56.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.33 -25.59 64.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 6.8 tmm_? -66.76 -39.62 87.93 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -40.86 96.57 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.436 HD21 ' CD1' ' A' ' 49' ' ' LEU . 21.4 mt -69.3 -29.29 67.12 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.515 -0.741 . . . . 0.0 109.348 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.428 ' CD1' HD13 ' A' ' 60' ' ' LEU . 45.7 mt -69.65 -28.09 65.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.55 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.39 -27.05 29.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.476 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -83.55 -36.7 23.79 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.597 0.713 . . . . 0.0 110.533 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -70.19 -6.86 37.45 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.815 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.31 56.37 2.86 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.425 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 24.3 t -107.02 -57.0 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.122 -1.223 . . . . 0.0 111.052 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 7.0 m-30 -52.35 -57.36 10.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 110.389 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -115.4 -179.19 3.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 110.316 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -122.94 156.63 34.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -160.21 65.71 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.012 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.35 -40.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -101.73 88.84 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.72 -167.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.56 -161.0 29.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 110.183 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.168 0.509 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.464 HG13 ' CE3' ' A' ' 59' ' ' TRP . 66.1 t -83.38 137.08 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.05 -1.031 . . . . 0.0 110.443 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 65' ' ' GLN . 3.6 tptm -140.49 128.44 22.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.436 HD11 ' CB ' ' A' ' 59' ' ' TRP . 71.6 mt -99.97 128.91 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.041 -1.037 . . . . 0.0 109.901 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 6.6 ptm180 -151.23 -173.89 4.64 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 6.6 mp -88.96 126.07 35.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.518 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.34 103.57 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.355 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -71.29 119.55 15.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 111.179 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.489 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 27.1 m-85 -108.61 -63.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.61 101.79 0.04 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 25.5 p -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.165 . . . . 0.0 109.891 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.483 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -176.78 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.761 . . . . 0.0 109.42 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.483 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 7.6 m-70 -126.66 -54.13 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.757 0.789 . . . . 0.0 108.89 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 64.9 t-20 -146.69 124.96 6.19 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.9 122.26 8.33 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.364 1.192 . . . . 0.0 111.144 -179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.467 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 32.0 p80 -176.31 131.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.507 -0.745 . . . . 0.0 109.87 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.563 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.6 m-85 -122.5 155.68 35.69 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.489 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 6.5 mmt180 -100.68 158.68 15.77 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.759 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 38' ' ' TYR . 1.1 mt -99.04 78.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.25 0.4 OUTLIER -97.26 163.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.733 -173.474 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 112.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.286 0.565 . . . . 0.0 110.308 -177.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.4 t -139.17 -178.06 5.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.124 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.29 -179.56 3.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.914 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.98 -54.61 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -58.6 -20.31 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 110.378 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -94.93 143.06 26.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 0.0 110.099 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.36 23.51 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -21.47 29.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.132 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -131.44 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.76 61.84 0.47 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 142.85 42.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -1.181 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 22.2 p90 -110.38 168.79 9.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.15 -0.968 . . . . 0.0 110.633 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.1 mp -84.34 -28.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 109.939 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.91 164.75 1.52 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.975 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.32 113.77 26.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.982 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.474 HG22 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -108.24 -34.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.115 -0.99 . . . . 0.0 110.664 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.489 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -122.27 164.34 15.36 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.342 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.486 ' N ' HG13 ' A' ' 19' ' ' ILE . 11.6 t80 -139.48 142.95 37.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 19.9 t80 -135.64 132.98 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.723 -1.235 . . . . 0.0 110.208 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 9.9 t0 -140.55 103.55 6.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.787 -1.195 . . . . 0.0 110.34 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 47.9 Cg_endo -73.15 -4.67 15.83 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.498 1.262 . . . . 0.0 111.42 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.73 -18.3 26.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.865 -1.147 . . . . 0.0 110.284 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.99 123.95 11.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 28.24 1.76 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.86 163.27 43.78 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.804 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.88 64.05 2.45 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.626 1.329 . . . . 0.0 110.287 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -167.47 37.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.567 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 40.8 p-90 -79.03 1.46 23.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.743 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.506 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 2.3 tm? -119.59 112.52 19.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.955 -1.09 . . . . 0.0 110.523 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 104.24 9.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.102 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.489 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 2.1 t -129.52 139.15 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.099 . . . . 0.0 111.357 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.8 t0 -84.94 70.83 10.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -31.91 -34.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -59.96 -51.01 71.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.774 -1.204 . . . . 0.0 108.837 178.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 47.1 mmm-85 -71.11 -45.52 63.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -59.87 -22.38 62.24 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.2 ttt180 -87.78 -26.42 22.88 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.317 -0.864 . . . . 0.0 109.864 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.1 t80 -59.29 -46.67 87.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.32 1.534 . . . . 0.0 107.237 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.564 ' CD1' HG23 ' A' ' 21' ' ' VAL . 75.4 m95 -62.85 -54.68 35.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.512 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.428 ' CD1' HG11 ' A' ' 79' ' ' VAL . 7.3 mt -56.05 -20.58 17.48 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.583 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -79.02 -24.24 43.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.776 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.435 HG23 ' HA ' ' A' ' 59' ' ' TRP . 14.4 m -98.92 33.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.939 -1.101 . . . . 0.0 109.568 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.28 27.15 73.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -68.26 130.93 44.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.004 -1.292 . . . . 0.0 109.964 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' O ' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -98.13 111.25 58.99 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 110.454 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' CB ' ' CD1' ' A' ' 74' ' ' LEU . 53.4 Cg_endo -87.53 125.43 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.616 1.324 . . . . 0.0 109.951 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 t -53.98 166.31 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.016 -1.053 . . . . 0.0 109.767 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -33.8 36.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.041 -1.037 . . . . 0.0 110.919 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.7 m -76.04 -54.82 6.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.975 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.412 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -67.1 -23.36 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.475 -0.766 . . . . 0.0 109.222 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.441 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 2.0 ttt-85 -69.77 -43.19 72.68 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.676 -0.809 . . . . 0.0 108.977 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' A' ' 39' ' ' TYR . 77.5 mt -65.15 -22.89 66.98 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.571 -0.706 . . . . 0.0 109.443 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.51 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 14.0 mt -70.73 -30.41 66.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HG2' ' CE1' ' A' ' 80' ' ' PHE . 2.8 mtm180 -72.66 -34.67 67.41 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -77.52 -28.81 52.14 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.91 0.862 . . . . 0.0 110.077 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -73.34 -4.64 34.62 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.199 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.65 20.32 51.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.428 HG11 ' CD1' ' A' ' 60' ' ' LEU . 21.1 t -82.76 -60.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.091 -1.241 . . . . 0.0 110.569 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.51 ' CE2' ' HB3' ' A' ' 74' ' ' LEU . 34.2 p90 -149.73 140.87 23.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.972 -1.08 . . . . 0.0 110.865 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -109.1 29.14 7.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 110.013 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -173.5 -166.19 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.348 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.33 177.48 4.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.339 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.66 -26.72 24.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -71.92 100.05 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 110.295 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -176.35 128.5 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.203 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.54 42.86 0.21 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.225 -1.162 . . . . 0.0 110.202 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.296 0.57 . . . . 0.0 110.302 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t -146.88 108.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.968 . . . . 0.0 110.173 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 2.7 tttt -140.2 133.44 29.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.245 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.477 HD12 ' CD1' ' A' ' 36' ' ' ILE . 98.0 mt -102.03 133.26 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.07 -1.019 . . . . 0.0 109.924 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -172.54 4.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 110.893 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.73 126.0 35.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.404 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.62 104.45 16.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 111.191 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 2.6 tmm_? -71.88 118.08 14.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.522 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 20.4 m-85 -112.13 -63.41 1.43 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.152 -0.968 . . . . 0.0 110.368 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.88 103.75 0.15 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 26.9 p -70.6 -59.75 2.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -1.176 . . . . 0.0 109.496 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.0 mttp -141.9 51.81 1.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.445 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 2.3 m-70 -140.93 -59.78 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 -178.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 66.0 t30 -140.2 114.58 7.62 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.07 114.07 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.475 1.25 . . . . 0.0 111.258 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 32.0 p80 -169.52 135.66 1.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.458 -0.776 . . . . 0.0 110.264 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.555 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 7.4 m-85 -120.02 156.12 31.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.444 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -108.41 159.59 16.55 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.66 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 81.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 177.65 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.478 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.264 0.4 OUTLIER -97.81 164.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.572 -174.0 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.511 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -111.86 106.1 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 110.471 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.414 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.0 t -134.99 -169.86 2.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.102 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.414 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.8 p-10 -89.35 158.94 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.067 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -66.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.442 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -64.82 122.86 17.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.9 . . . . 0.0 110.625 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.1 ptt85 -166.33 151.53 8.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.7 -47.04 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.61 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.51 18.34 10.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.111 -0.993 . . . . 0.0 110.525 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 12.5 p-10 -138.38 98.89 3.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.147 -0.97 . . . . 0.0 109.935 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.67 72.59 0.2 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.06 157.33 39.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CD2' HG23 ' A' ' 20' ' ' VAL . 45.5 p90 -116.45 162.95 16.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.934 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.466 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.6 mt -72.56 -46.31 55.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.662 -0.649 . . . . 0.0 110.036 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -152.41 166.24 32.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.6 pttt -104.33 115.77 30.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.175 -0.953 . . . . 0.0 109.998 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.522 HG22 ' CD1' ' A' ' 59' ' ' TRP . 38.7 pt -108.32 -33.71 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.939 -1.1 . . . . 0.0 111.56 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -125.69 166.91 18.24 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.859 -1.638 . . . . 0.0 112.76 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -140.94 121.4 14.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.584 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 20.8 t80 -114.94 139.95 49.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.777 -1.202 . . . . 0.0 109.778 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 64.4 t0 -140.56 106.32 6.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 109.864 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.463 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 45.5 Cg_endo -76.47 71.08 6.05 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.051 1.027 . . . . 0.0 110.196 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -179.44 5.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.236 -0.915 . . . . 0.0 110.835 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -136.57 18.13 3.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.359 -0.838 . . . . 0.0 110.096 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 p -115.41 -20.12 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.283 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 137.57 27.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.69 -16.9 18.47 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.533 1.28 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.15 82.58 1.86 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 110.836 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.584 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 9.8 p-90 -109.93 -10.55 14.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.271 -0.893 . . . . 0.0 110.142 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.9 tt -82.53 112.22 19.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.05 . . . . 0.0 109.923 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -120.78 93.58 4.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.408 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.495 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.79 133.01 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.044 -1.035 . . . . 0.0 111.2 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.0 t0 -78.37 69.13 4.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.46 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 1.0 OUTLIER -34.06 -32.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.542 -177.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tt0 -62.42 -52.15 64.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.916 -1.115 . . . . 0.0 109.105 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.1 mtm-85 -75.49 -34.7 60.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.078 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -67.15 -23.48 65.8 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 40.8 ttt180 -86.15 -20.55 28.46 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.328 -0.857 . . . . 0.0 109.952 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -62.31 -48.56 79.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 123.078 1.418 . . . . 0.0 107.235 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.522 ' CD1' HG22 ' A' ' 36' ' ' ILE . 89.0 m95 -63.02 -55.92 21.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.714 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.2 mt -53.69 -21.85 7.84 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.5 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.96 -20.09 39.28 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.456 -0.778 . . . . 0.0 110.64 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 59' ' ' TRP . 4.3 m -99.07 32.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.811 -1.181 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.88 27.1 72.82 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.95 117.64 22.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.136 -1.214 . . . . 0.0 109.992 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -91.36 127.75 49.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -83.7 165.42 13.84 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.352 1.185 . . . . 0.0 109.744 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -85.19 -174.94 5.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.226 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.68 46.68 1.19 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -165.7 -55.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.83 -26.07 65.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 67.1 ttt180 -64.83 -40.53 95.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -39.35 89.64 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.875 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.425 HD11 ' CD2' ' A' ' 39' ' ' TYR . 41.7 mt -70.71 -28.28 64.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 40.9 mt -70.95 -29.46 65.48 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.483 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.27 -28.26 38.44 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.249 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.451 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -83.86 -32.37 25.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.725 0.774 . . . . 0.0 110.097 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -66.41 -11.39 51.43 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.722 -0.611 . . . . 0.0 109.811 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.16 15.72 29.75 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.867 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.46 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 17.9 t -76.12 -54.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.724 -1.456 . . . . 0.0 110.138 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 75' ' ' ARG . 21.1 p90 -146.07 -176.48 5.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -140.97 -59.3 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -163.22 77.53 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.453 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.06 177.39 7.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -172.17 42.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.233 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -146.37 45.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.17 158.29 5.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.159 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.32 -77.17 0.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.174 -1.192 . . . . 0.0 110.274 -179.884 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 mtp . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.284 0.564 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.97 118.98 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.14 142.18 36.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 110.688 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.494 HD11 ' CD1' ' A' ' 36' ' ' ILE . 84.7 mt -104.06 135.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.142 -0.974 . . . . 0.0 109.409 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -151.22 -168.81 3.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 5.1 mp -89.3 127.3 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.846 . . . . 0.0 110.367 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.534 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.86 104.27 15.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.088 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -71.28 122.68 20.68 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.905 . . . . 0.0 112.539 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.534 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 6.1 m-85 -124.7 -152.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.16 100.83 0.01 OUTLIER Glycine 0 N--CA 1.483 1.803 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.416 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 5.9 p -52.17 -42.96 63.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -1.168 . . . . 0.0 109.988 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.41 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.54 -0.725 . . . . 0.0 109.695 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.416 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 11.7 m-70 -110.91 -60.6 1.81 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.465 -0.772 . . . . 0.0 109.644 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.26 122.62 16.16 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.56 91.77 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.408 1.215 . . . . 0.0 111.102 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.496 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.9 p80 -137.59 131.37 31.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.323 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 14.1 m-85 -114.6 148.81 37.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 mtt85 -100.29 159.36 15.19 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.83 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.485 ' N ' ' CD1' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -98.71 81.43 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 177.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.251 0.4 OUTLIER -97.69 171.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.934 -173.745 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -116.16 108.77 25.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.167 0.508 . . . . 0.0 110.048 -177.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 3.8 t -140.16 -162.46 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 110.233 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 17.9 p-10 -93.25 -155.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.929 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.03 -40.14 12.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -175.0 176.71 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -151.22 -70.14 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.075 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.19 -64.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.15 -55.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.913 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 177.39 3.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.735 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.1 116.54 1.13 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -116.38 143.53 45.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -1.118 . . . . 0.0 109.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.421 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 20.4 p90 -118.23 176.52 5.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 110.854 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 mt -82.64 -51.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 109.876 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -152.79 152.72 31.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.959 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -89.57 108.17 19.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.018 . . . . 0.0 110.125 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.51 HG22 ' CD1' ' A' ' 59' ' ' TRP . 28.5 pt -100.07 -36.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 111.371 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -120.78 168.03 13.98 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.021 -1.562 . . . . 0.0 112.392 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.444 ' N ' HG12 ' A' ' 19' ' ' ILE . 10.2 t80 -141.07 124.78 16.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.479 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 22.6 t80 -125.85 124.71 41.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.811 -1.18 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 60.0 t0 -140.18 84.85 14.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.731 -1.231 . . . . 0.0 110.69 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 45.2 Cg_endo -72.16 77.69 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.646 1.34 . . . . 0.0 110.179 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.02 167.76 11.03 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.34 -0.85 . . . . 0.0 110.528 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 46.36 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.252 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.9 p -118.8 -66.95 1.02 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.468 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.17 161.83 59.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.02 -18.95 20.94 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.841 1.443 . . . . 0.0 110.65 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -84.59 87.07 7.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.395 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.502 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -121.72 -0.83 9.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 110.904 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.502 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 8.2 tt -96.69 114.71 26.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.916 -1.115 . . . . 0.0 110.618 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.91 94.91 3.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.0 138.56 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.952 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -84.74 72.38 10.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.293 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -35.98 -30.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 122.309 -0.245 . . . . 0.0 111.492 -177.498 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 35.1 mt-10 -60.47 -53.75 53.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.77 -1.206 . . . . 0.0 108.771 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.3 mmp_? -71.31 -39.66 71.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.432 -0.792 . . . . 0.0 108.891 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.74 -17.82 64.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 38.8 ttp180 -89.65 -22.68 22.17 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.19 -0.944 . . . . 0.0 109.594 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 4.4 t80 -61.4 -44.86 96.42 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 123.167 1.461 . . . . 0.0 107.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.525 ' CD1' HG22 ' A' ' 21' ' ' VAL . 84.6 m95 -69.84 -56.49 6.95 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.921 -1.491 . . . . 0.0 109.982 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 20.9 mt -53.98 -22.7 11.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.421 177.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -80.9 -22.3 39.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.474 -0.766 . . . . 0.0 110.56 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.0 m -98.69 32.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.764 -1.21 . . . . 0.0 109.478 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 30.03 74.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.95 128.96 35.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.065 -1.256 . . . . 0.0 110.141 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -94.76 110.24 48.27 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' CB ' HD13 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -82.31 131.09 6.5 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.552 1.29 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 41.2 p -52.54 160.41 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.88 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.27 -16.3 20.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.909 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.427 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 5.4 m -92.34 -52.93 4.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.417 ' O ' ' HG ' ' A' ' 74' ' ' LEU . . . -70.93 -28.48 64.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.4 ttt180 -65.53 -39.89 92.29 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -64.09 -27.6 69.2 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.075 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.432 HD22 ' CD1' ' A' ' 49' ' ' LEU . 15.9 mt -85.5 -31.13 22.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.581 -0.699 . . . . 0.0 109.444 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.425 HD13 ' CB ' ' A' ' 66' ' ' PRO . 83.4 mt -69.01 -28.43 66.59 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.524 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.7 -29.31 36.47 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.8 tp-100 -77.95 -35.08 50.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.899 0.857 . . . . 0.0 109.316 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.63 -9.36 49.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.77 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 53' ' ' VAL . . . 88.11 54.54 2.42 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.436 ' CG2' ' HB ' ' A' ' 53' ' ' VAL . 36.6 t -116.37 -5.21 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -1.197 . . . . 0.0 111.381 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 7.3 m-85 -112.52 -19.5 12.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.879 -1.138 . . . . 0.0 110.086 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -103.9 152.52 21.86 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.24 -0.912 . . . . 0.0 109.361 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.78 112.02 6.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.077 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -123.07 -83.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.249 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -171.71 79.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.54 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -50.75 62.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.789 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.98 -177.63 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 109.999 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.61 0.1 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.19 -1.182 . . . . 0.0 110.128 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.301 0.572 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.77 134.8 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.839 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -140.5 131.51 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.55 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.477 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 40.3 mt -99.76 129.31 50.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.074 -1.016 . . . . 0.0 109.012 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 18.5 ptt85 -150.24 174.04 13.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.475 HD11 ' CD2' ' A' ' 17' ' ' TYR . 4.5 pp -88.21 127.03 35.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.503 ' HB1' ' CE1' ' A' ' 9' ' ' PHE . . . -100.96 111.68 23.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 112.427 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.485 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 7.4 ttt-85 -73.91 123.2 23.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.144 -0.973 . . . . 0.0 110.793 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 23.3 m-85 -113.92 -60.09 1.93 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.098 -1.001 . . . . 0.0 110.6 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.55 108.6 0.13 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.417 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 1.8 p -57.66 -42.81 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -1.117 . . . . 0.0 109.443 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -175.92 48.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.403 0.621 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.483 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 10.4 m-70 -128.31 -64.21 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.59 128.42 23.95 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.704 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.61 111.58 3.35 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.422 1.222 . . . . 0.0 110.947 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.458 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 32.1 p80 -165.11 132.93 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 0.0 110.716 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.4 m-85 -123.64 152.08 42.36 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 12.4 ttm180 -99.93 146.24 26.89 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.398 -1.321 . . . . 0.0 108.107 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.519 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -96.33 80.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 102.164 -3.273 . . . . 0.0 102.164 178.325 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.486 HG23 ' CD1' ' A' ' 32' ' ' TYR 0.289 0.4 OUTLIER -97.22 168.45 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.103 -173.197 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.544 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -114.12 109.76 29.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.49 -0.756 . . . . 0.0 110.507 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.41 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.5 t -130.66 -174.26 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.342 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.7 OUTLIER -106.52 -163.24 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.258 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.12 -42.42 1.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.537 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -60.14 3.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.84 94.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 109.847 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 21.92 11.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -0.883 . . . . 0.0 110.645 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -91.82 -26.18 18.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.983 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -148.76 142.39 25.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.036 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 52.27 4.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -88.2 148.89 24.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 110.245 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' CD1' HG23 ' A' ' 20' ' ' VAL . 12.8 p90 -119.81 154.09 34.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 110.612 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.455 HG22 ' CH2' ' A' ' 59' ' ' TRP . 8.2 mt -61.3 -39.19 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.831 . . . . 0.0 109.918 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -167.36 170.93 11.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.912 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -110.57 121.02 44.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.005 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.481 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -115.78 -23.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.025 -1.047 . . . . 0.0 110.828 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.519 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -122.98 162.2 16.89 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 118.803 -1.665 . . . . 0.0 111.072 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.445 ' N ' HG12 ' A' ' 19' ' ' ILE . 63.9 t80 -140.22 133.64 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.519 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 2.6 t80 -126.93 121.81 32.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 109.906 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 8.7 t0 -134.86 82.36 43.85 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.0 110.064 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 40.9 Cg_endo -67.21 79.81 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.738 1.388 . . . . 0.0 110.922 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -92.82 154.95 17.95 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.425 -0.797 . . . . 0.0 109.988 179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -94.19 64.8 3.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.097 -1.002 . . . . 0.0 110.184 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 t -149.0 -41.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.288 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -137.24 149.47 65.99 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.191 -0.943 . . . . 0.0 110.197 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.02 -28.03 13.41 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.28 87.95 6.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.519 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 9.5 p-90 -117.15 -16.37 10.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.152 -0.968 . . . . 0.0 110.684 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 1.7 tt -77.96 127.18 31.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 109.974 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -133.48 86.81 2.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.31 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.492 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -115.67 130.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.119 -0.988 . . . . 0.0 111.327 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.6 t70 -74.35 70.82 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -35.86 -30.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 122.233 -0.292 . . . . 0.0 111.471 -177.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.8 tp10 -62.83 -50.12 72.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.797 -1.19 . . . . 0.0 108.623 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -76.72 -33.74 58.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 108.988 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' CB ' HD12 ' A' ' 36' ' ' ILE . . . -70.21 -21.5 63.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' VAL . 23.4 tpt180 -86.28 -22.27 26.9 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 55' ' ' ARG 0.25 0.5 OUTLIER -62.22 -48.08 81.59 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.258 1.504 . . . . 0.0 107.367 178.38 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' CD1' HG22 ' A' ' 21' ' ' VAL . 77.9 m95 -64.98 -56.08 15.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.788 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' CD1' HG12 ' A' ' 79' ' ' VAL . 47.2 mt -53.09 -22.47 6.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.561 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.71 -22.07 40.66 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.408 -0.808 . . . . 0.0 110.826 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 59' ' ' TRP . 7.2 m -98.89 32.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.813 -1.18 . . . . 0.0 109.543 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.61 70.83 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -73.17 110.75 7.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.073 -1.251 . . . . 0.0 110.136 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 115.61 56.08 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.462 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.8 Cg_endo -82.66 144.59 12.58 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.539 1.284 . . . . 0.0 109.992 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.43 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -65.93 165.51 13.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.59 -16.03 59.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 110.9 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -104.28 -46.79 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.175 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -67.83 -25.95 65.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -65.9 -38.68 89.38 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.251 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' NH1' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -62.01 -32.84 73.36 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.919 178.829 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.44 HD22 ' CD1' ' A' ' 49' ' ' LEU . 19.4 mt -76.89 -35.67 57.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 76.7 mt -63.89 -28.77 70.07 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.505 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 1.5 mtt180 -78.4 -29.79 47.44 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.439 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.1 tp-100 -73.16 -34.04 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.056 0.931 . . . . 0.0 108.928 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.44 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.57 -7.99 43.4 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.983 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.81 39.13 10.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.431 HG12 ' CD1' ' A' ' 60' ' ' LEU . 45.5 t -97.43 -6.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.176 -1.191 . . . . 0.0 111.893 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 10.9 m-85 -107.81 -169.26 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.871 -1.143 . . . . 0.0 110.304 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -63.48 92.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.334 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.25 135.22 33.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.115 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.86 177.12 5.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.967 . . . . 0.0 110.368 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.83 -50.22 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.298 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -161.37 -67.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -171.46 -40.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.947 . . . . 0.0 110.134 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.05 41.02 2.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.179 . . . . 0.0 110.15 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.315 0.578 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.436 HG13 ' CG2' ' A' ' 62' ' ' VAL . 61.1 t -56.67 102.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.825 . . . . 0.0 110.576 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.405 ' HD2' ' HB3' ' A' ' 65' ' ' GLN . 3.7 mtmt -140.18 139.5 35.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 110.793 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.464 HD12 ' CG1' ' A' ' 21' ' ' VAL . 1.5 mp -99.96 130.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.85 -176.71 5.63 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.1 -1.0 . . . . 0.0 110.845 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.413 HD23 ' HB2' ' A' ' 17' ' ' TYR . 16.1 mt -89.7 127.14 35.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.847 . . . . 0.0 110.8 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.521 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.72 107.08 19.07 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.89 120.04 22.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.769 -1.207 . . . . 0.0 112.805 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.521 ' CE2' ' O ' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -120.48 -157.13 0.7 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 177.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.47 128.79 0.01 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.478 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -61.65 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.178 -1.19 . . . . 0.0 109.78 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -146.41 53.77 1.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.478 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 4.2 m-70 -140.76 -53.45 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.666 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -118.19 96.88 50.3 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.855 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.14 101.99 1.54 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.754 1.397 . . . . 0.0 111.256 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.439 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 29.5 p80 -145.91 135.02 22.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.0 109.707 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 11.0 m-85 -113.35 162.36 16.16 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 109.295 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 24.2 ttt180 -112.41 152.65 28.41 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.483 ' CD1' ' CG2' ' A' ' 51' ' ' VAL . 1.2 mt -98.73 78.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.451 HG12 ' CD2' ' A' ' 32' ' ' TYR 0.271 0.4 OUTLIER -98.07 165.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.179 -173.134 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.44 106.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.854 -0.529 . . . . 0.0 110.612 -177.896 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.7 t -132.69 -173.44 3.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.151 -0.968 . . . . 0.0 110.258 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 22' ' ' THR . 51.5 p-10 -75.41 -167.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.51 -51.21 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.867 . . . . 0.0 110.143 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -177.57 116.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 110.174 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -62.08 1.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 109.852 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -169.9 -55.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.797 . . . . 0.0 109.933 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.98 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.875 . . . . 0.0 110.103 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -138.52 -166.59 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.73 94.32 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.61 59.71 1.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.44 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.451 ' CD2' HG12 ' A' ' 20' ' ' VAL . 10.6 p90 -54.47 -179.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.955 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 mt -90.45 -34.39 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.988 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.71 -175.54 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -119.18 112.75 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.507 HG23 ' CD1' ' A' ' 59' ' ' TRP . 21.4 pt -108.96 -38.0 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.924 -1.11 . . . . 0.0 111.208 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -125.79 163.73 19.63 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.81 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.449 ' N ' HG13 ' A' ' 19' ' ' ILE . 25.0 t80 -133.69 152.54 51.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.456 ' CD2' ' HD3' ' A' ' 41' ' ' PRO . 16.4 t80 -143.54 137.86 28.75 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.974 -1.079 . . . . 0.0 109.738 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 36.0 t0 -139.97 80.8 19.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.759 -1.213 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 40.1 Cg_endo -67.26 62.68 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.494 1.26 . . . . 0.0 110.886 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -99.99 148.62 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.53 67.49 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -126.19 -81.91 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.438 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -137.48 167.24 21.41 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.155 -0.966 . . . . 0.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.32 59.83 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.737 1.388 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -151.5 53.47 0.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.908 . . . . 0.0 109.699 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 16.0 p-90 -108.52 -12.87 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.748 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.2 tt -86.61 121.88 29.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 110.791 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 94.01 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 108.715 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.5 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -120.58 154.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.255 1.026 . . . . 0.0 111.712 -178.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 9.1 t0 -103.95 68.07 0.9 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -29.95 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.511 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.9 tt0 -60.28 -52.46 65.2 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.771 -1.206 . . . . 0.0 109.197 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 28.0 mmm180 -72.3 -41.01 67.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -63.37 -20.37 65.47 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 23.2 ttp85 -89.79 -21.95 22.37 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -63.36 -47.23 82.97 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 123.176 1.465 . . . . 0.0 107.311 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CD1' HG21 ' A' ' 21' ' ' VAL . 90.4 m95 -66.81 -55.29 15.54 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.915 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' CD1' ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -54.62 -22.82 14.66 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.317 177.014 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -81.67 -19.2 42.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.46 -0.775 . . . . 0.0 110.41 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.436 ' CG2' HG13 ' A' ' 2' ' ' VAL . 3.4 m -99.0 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.799 -1.188 . . . . 0.0 109.31 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.88 28.05 73.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HB2' ' CD1' ' A' ' 4' ' ' ILE . . . -71.15 146.12 49.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.072 -1.252 . . . . 0.0 110.301 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.405 ' HB3' ' HD2' ' A' ' 3' ' ' LYS . 1.9 mm100 -113.1 109.59 51.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.2 Cg_endo -86.64 128.38 2.9 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.59 1.311 . . . . 0.0 110.619 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.409 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 2.3 t -54.81 165.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.09 -17.52 27.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.154 -0.966 . . . . 0.0 111.202 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.1 m -90.24 -52.88 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.0 110.487 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB2' ' CG2' ' A' ' 19' ' ' ILE . . . -68.99 -28.82 66.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -68.34 -39.16 81.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -39.57 88.75 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -73.63 -27.3 61.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.41 -0.806 . . . . 0.0 109.267 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.466 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 21.3 mt -69.64 -27.83 65.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.543 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.72 -25.83 37.84 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.3 tp-100 -83.85 -36.55 23.35 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.792 0.806 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.447 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.01 -6.63 29.1 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.281 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.35 43.88 7.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 23.8 t -94.68 -56.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.156 -1.202 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.543 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.7 m-30 -56.21 120.89 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 110.264 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -96.43 69.12 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.961 . . . . 0.0 109.978 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -173.55 60.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.274 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -70.23 137.89 51.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.98 53.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.36 -41.91 4.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.62 -179.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.138 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.31 95.5 0.45 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 110.283 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 mtt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.217 0.532 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.464 HG11 ' CE3' ' A' ' 59' ' ' TRP . 41.0 t -91.78 135.89 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.249 -0.907 . . . . 0.0 110.43 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' HG3' ' HB2' ' A' ' 65' ' ' GLN . 7.3 mttt -140.33 140.37 35.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 36' ' ' ILE . 95.2 mt -108.18 134.88 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.745 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -150.96 -163.65 1.82 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.312 -0.868 . . . . 0.0 110.112 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 36.4 mt -89.3 136.03 33.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.071 -1.018 . . . . 0.0 110.986 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -106.47 105.22 15.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.59 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.505 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.9 ttp85 -75.57 120.91 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 111.177 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CZ ' ' HB3' ' A' ' 18' ' ' ARG . 16.2 m-85 -108.78 -64.2 1.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.411 -0.806 . . . . 0.0 110.544 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.28 128.82 23.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.434 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 3.1 p -63.71 -50.56 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.361 -1.082 . . . . 0.0 109.565 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' O ' ' CD ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -167.03 31.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.633 0.73 . . . . 0.0 109.095 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.434 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 14.1 m-70 -101.83 -53.79 2.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.602 0.715 . . . . 0.0 109.455 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -138.55 123.13 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.57 -0.706 . . . . 0.0 109.414 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.03 90.98 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.426 1.224 . . . . 0.0 111.016 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 35.4 p80 -141.97 124.75 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.557 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 4.7 m-30 -116.34 154.74 29.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 108.456 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.496 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -104.14 164.77 11.49 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.743 -1.583 . . . . 0.0 106.997 176.151 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -98.39 86.39 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.42 ' CG2' ' HD3' ' A' ' 18' ' ' ARG 0.264 0.4 OUTLIER -98.12 168.72 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.285 -174.782 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.533 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -113.75 106.19 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.673 -177.484 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -119.78 141.53 49.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.952 . . . . 0.0 109.418 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 110.006 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.34 44.23 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.117 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -69.37 -82.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.814 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.36 -176.18 3.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.552 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -120.48 21.31 11.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 110.29 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.71 59.31 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.53 -50.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.031 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.75 40.63 17.26 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.85 132.27 55.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -1.165 . . . . 0.0 110.432 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 2.8 p90 -120.02 -177.24 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.3 mt -92.07 -50.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 110.04 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -150.15 164.59 35.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.01 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -103.07 116.71 33.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.142 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.52 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.9 pt -110.5 -33.8 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.985 -1.072 . . . . 0.0 111.991 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -128.38 174.46 18.86 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.187 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' N ' HG13 ' A' ' 19' ' ' ILE . 85.1 t80 -140.49 142.9 35.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.522 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 7.8 t80 -140.16 132.91 29.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.722 -1.236 . . . . 0.0 110.036 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 10.8 t0 -140.34 89.46 10.73 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.835 -1.165 . . . . 0.0 110.236 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.8 82.88 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.466 1.245 . . . . 0.0 110.646 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.7 -166.26 1.55 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.306 -0.871 . . . . 0.0 110.279 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.38 59.87 1.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -142.52 -81.56 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.35 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.2 p -132.54 161.6 62.3 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.174 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 66.72 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.611 1.322 . . . . 0.0 110.433 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -140.49 50.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.5 p-90 -121.54 -11.46 8.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.76 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 5.5 tt -81.34 111.08 17.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.012 -1.055 . . . . 0.0 110.718 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.39 96.06 4.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.388 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.494 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -120.74 149.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 111.476 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t0 -95.75 68.89 2.88 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.21 -35.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mt-10 -59.68 -52.98 63.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.746 -1.221 . . . . 0.0 109.202 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -70.79 -40.86 72.31 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.4 -0.812 . . . . 0.0 109.049 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -66.09 -18.69 65.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 108.548 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.26 -22.96 23.65 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.242 -0.911 . . . . 0.0 109.524 178.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 3.7 t80 -61.05 -43.28 99.12 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.139 1.447 . . . . 0.0 107.305 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.533 ' NE1' HG23 ' A' ' 21' ' ' VAL . 78.7 m95 -68.6 -53.31 23.52 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.893 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.39 -21.02 33.37 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.574 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -81.58 -23.89 36.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.453 -0.779 . . . . 0.0 110.651 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 59' ' ' TRP . 25.5 m -99.15 32.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 120.817 -1.177 . . . . 0.0 109.649 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.42 31.25 76.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.54 141.68 51.86 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.006 -1.291 . . . . 0.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.408 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -105.91 103.04 42.42 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 110.128 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.4 Cg_endo -81.26 125.14 5.07 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.698 1.367 . . . . 0.0 110.226 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.404 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 4.5 t -54.9 176.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.0 -1.062 . . . . 0.0 109.695 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.79 -19.68 62.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.182 -0.949 . . . . 0.0 111.026 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.402 ' CG2' HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -90.5 -51.17 5.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.686 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.4 -27.59 64.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.2 OUTLIER -69.21 -37.98 78.35 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -69.47 -47.34 64.25 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.545 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' CB ' HD11 ' A' ' 19' ' ' ILE . 15.4 mt -60.48 -25.13 65.81 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.447 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 23.1 mt -76.19 -25.94 55.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.48 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.08 -31.49 30.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.5 tp-100 -87.18 -36.46 18.01 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.724 0.773 . . . . 0.0 110.7 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -64.86 -10.78 31.01 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.705 -0.622 . . . . 0.0 110.01 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.64 48.78 5.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.447 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 49.5 t -100.39 -62.82 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.065 -1.256 . . . . 0.0 111.44 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 19.8 m-85 -52.9 142.52 19.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.918 -1.114 . . . . 0.0 109.651 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -110.68 72.71 0.79 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.42 102.79 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -98.98 167.35 10.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.169 -0.957 . . . . 0.0 109.882 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.17 -161.9 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.044 . . . . 0.0 110.626 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -112.48 65.13 0.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -53.4 175.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.2 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.24 33.63 76.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 0.0 110.253 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.537 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.41 HG13 ' CG2' ' A' ' 62' ' ' VAL . 49.9 t -66.41 98.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt -138.6 133.41 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.509 HD11 ' CD1' ' A' ' 36' ' ' ILE . 84.9 mt -106.05 133.37 50.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.162 -0.961 . . . . 0.0 109.649 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.473 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.2 174.33 13.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.956 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.476 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 1.2 pp -89.26 129.43 35.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.1 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -98.65 165.5 11.77 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.473 -0.767 . . . . 0.0 109.334 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -128.7 117.46 21.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.974 -1.079 . . . . 0.0 111.483 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -129.22 -152.76 0.53 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.32 -0.862 . . . . 0.0 109.564 179.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.1 94.82 1.37 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.481 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 1.0 OUTLIER -62.29 -52.77 62.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 109.743 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.406 ' HG2' ' OG ' ' A' ' 11' ' ' SER . 1.9 pttm -173.5 39.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 110.063 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.481 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 13.7 m-70 -119.37 -40.45 2.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -172.61 133.23 0.7 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.633 -0.667 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.44 123.54 8.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.48 1.253 . . . . 0.0 111.141 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 30.1 p80 -153.75 143.99 22.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.102 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 14.5 m-85 -117.96 166.61 12.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.429 -0.795 . . . . 0.0 109.083 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.547 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.69 147.16 50.38 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.006 -1.059 . . . . 0.0 108.384 178.118 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -97.31 81.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 178.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.445 HG23 ' CD ' ' A' ' 18' ' ' ARG 0.29 0.4 OUTLIER -98.2 160.49 3.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.78 -173.347 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.508 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -104.16 107.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.686 -0.634 . . . . 0.0 109.862 -178.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t -139.32 -168.6 2.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 110.425 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.9 m-20 -90.47 -167.87 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 26' ' ' ARG . . . -104.85 -22.76 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -60.54 83.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -107.88 53.47 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 110.278 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -27.04 47.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -173.82 38.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.883 . . . . 0.0 110.164 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.64 172.34 14.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.048 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.52 48.57 0.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -83.66 134.32 34.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -1.222 . . . . 0.0 110.082 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.6 p90 -113.97 155.18 26.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 110.62 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 mt -68.92 -29.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.488 -0.758 . . . . 0.0 109.643 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.37 179.94 4.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 31.9 pttt -120.81 121.82 38.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.509 ' CD1' HD11 ' A' ' 4' ' ' ILE . 23.9 pt -116.92 -38.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.135 -0.978 . . . . 0.0 111.607 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -119.0 165.64 13.05 Favored Glycine 0 C--N 1.296 -1.686 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.531 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.412 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.6 t80 -139.07 126.68 21.86 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.578 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 5.8 t80 -119.27 136.59 54.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.959 -1.088 . . . . 0.0 110.548 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 32.4 t70 -131.63 87.57 45.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.633 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.5 82.82 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.554 1.292 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -99.66 168.98 9.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -0.774 . . . . 0.0 110.372 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -120.04 16.25 12.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.445 HG21 ' N ' ' A' ' 45' ' ' THR . 3.5 t -120.94 -27.53 4.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.987 . . . . 0.0 110.649 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.445 ' N ' HG21 ' A' ' 44' ' ' THR . 7.1 p -126.53 138.98 33.53 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.093 -1.005 . . . . 0.0 110.439 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.21 -41.7 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.697 1.367 . . . . 0.0 110.718 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.37 98.44 6.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.765 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.578 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.2 p-90 -132.27 -3.28 3.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 111.3 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 1.4 tt -89.97 118.74 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.781 -1.199 . . . . 0.0 110.93 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.16 94.79 4.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.43 -0.793 . . . . 0.0 108.884 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.51 141.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 111.557 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -85.3 67.19 10.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -35.82 -29.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -61.13 -47.32 86.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.78 -1.2 . . . . 0.0 108.567 178.138 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 30.8 mmm180 -76.88 -38.53 53.46 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.463 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.68 -21.75 66.81 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.3 -21.16 24.58 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.442 -0.786 . . . . 0.0 109.536 178.252 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.588 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -65.81 -49.39 68.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.242 1.496 . . . . 0.0 107.451 178.617 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.588 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 86.7 m95 -63.6 -56.08 18.72 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.748 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.4 mt -52.95 -22.79 6.04 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.421 177.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -19.06 41.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.544 -0.722 . . . . 0.0 110.337 179.003 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 59' ' ' TRP . 3.2 m -98.74 31.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.849 -1.157 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.25 72.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.23 143.57 52.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -1.209 . . . . 0.0 110.109 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -106.54 105.65 55.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 0.0 110.532 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.3 Cg_endo -80.85 140.48 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.616 1.324 . . . . 0.0 110.335 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 70.5 p -72.24 163.52 27.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.993 -1.067 . . . . 0.0 110.166 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.63 -22.48 61.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.725 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.476 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 12.5 m -92.78 -48.23 6.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.173 -0.954 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.473 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -69.78 -30.21 67.71 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 67' ' ' THR . 12.2 ttt-85 -66.12 -37.5 85.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -28.9 70.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 14.8 mt -83.94 -33.4 24.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 80.5 mt -63.99 -30.53 71.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -79.59 -25.72 41.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.401 ' HB3' HD12 ' A' ' 49' ' ' LEU . 10.3 tp-100 -74.32 -35.01 63.62 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.12 0.962 . . . . 0.0 109.26 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.473 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -72.24 -5.8 38.48 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.23 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.402 ' O ' HG22 ' A' ' 53' ' ' VAL . . . 82.45 48.31 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 44.0 t -106.01 -3.49 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 111.501 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.496 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 13.1 m-85 -109.82 -14.96 14.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.839 -1.163 . . . . 0.0 110.478 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -171.32 168.63 6.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -173.29 126.8 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.193 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.52 -47.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -176.87 163.79 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 110.067 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -111.09 15.55 21.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -72.95 132.04 42.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 110.238 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.95 -115.3 3.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.217 -1.167 . . . . 0.0 110.254 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.6 m -58.35 116.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.074 -1.016 . . . . 0.0 110.337 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -140.22 129.16 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.478 ' CD1' ' CD1' ' A' ' 36' ' ' ILE . 74.9 mt -99.8 131.9 46.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.023 -1.048 . . . . 0.0 109.373 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.0 ptm180 -150.42 -167.06 2.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.038 -1.039 . . . . 0.0 110.361 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.492 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 6.6 mp -89.31 131.22 35.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.356 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -103.08 105.06 15.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 111.206 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.2 119.49 18.49 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.192 -0.943 . . . . 0.0 111.525 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CE2' ' O ' ' A' ' 7' ' ' ALA . 11.3 m-85 -108.13 -63.43 1.32 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.516 -0.74 . . . . 0.0 109.793 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.58 104.36 0.42 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 53.1 p -66.92 -55.8 13.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 110.286 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.445 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.9 mmtt -141.1 48.99 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 2.7 m-70 -139.07 -63.01 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.937 -177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 53.0 t-20 -135.38 125.52 16.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.59 111.31 3.12 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.494 1.26 . . . . 0.0 110.895 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.519 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 33.6 p80 -169.63 119.18 0.65 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.26 -0.9 . . . . 0.0 110.393 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 3.9 m-30 -110.28 154.01 24.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.85 -1.156 . . . . 0.0 108.437 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -104.03 165.91 10.74 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.24 176.55 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 38' ' ' TYR . 0.2 OUTLIER -98.46 83.74 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.405 HG22 ' HD2' ' A' ' 18' ' ' ARG 0.252 0.3 OUTLIER -97.6 169.73 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.146 -174.943 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.53 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -113.47 104.83 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.56 -0.712 . . . . 0.0 110.496 -177.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.425 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.4 t -130.6 -173.01 2.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.248 -0.907 . . . . 0.0 110.166 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' ARG . 6.8 p-10 -147.01 -147.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.974 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.07 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' ASP . 23.4 mtm-85 -50.52 146.48 5.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.306 -0.871 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -71.3 -168.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 110.422 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.59 15.66 28.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 110.431 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -140.05 -61.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.175 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -135.38 78.95 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.5 135.08 52.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 -177.48 4.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 110.138 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 -116.88 175.64 5.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 110.285 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.9 mt -82.77 -43.62 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.482 -0.761 . . . . 0.0 109.37 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.3 161.72 30.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.486 -0.758 . . . . 0.0 109.624 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -98.13 116.74 30.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.101 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.513 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.5 pt -104.66 -36.08 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.975 -1.078 . . . . 0.0 111.472 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -129.08 177.04 18.14 Favored Glycine 0 C--N 1.294 -1.753 0 C-N-CA 118.917 -1.611 . . . . 0.0 112.291 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG13 ' A' ' 19' ' ' ILE . 17.2 t80 -140.58 145.63 36.97 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.446 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 4.2 t80 -142.92 129.64 20.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.609 -1.307 . . . . 0.0 110.5 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 9.3 t0 -137.41 92.04 13.8 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.818 -1.176 . . . . 0.0 110.25 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.91 69.46 3.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.629 1.331 . . . . 0.0 110.791 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.08 160.99 16.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.83 65.79 1.34 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.518 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -136.3 -58.61 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.1 p -127.23 163.26 43.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.6 -31.3 11.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.706 1.372 . . . . 0.0 110.566 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 119.07 25.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.327 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' CE3' ' HB2' ' A' ' 49' ' ' LEU . 1.0 OUTLIER -149.09 15.68 0.93 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.12 -0.988 . . . . 0.0 110.945 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.474 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 11.8 tp -114.23 129.09 56.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.039 -1.038 . . . . 0.0 111.213 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -128.25 110.45 12.41 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.503 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.24 160.96 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.419 1.104 . . . . 0.0 111.72 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.4 t70 -104.91 67.58 0.8 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.45 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -33.05 -32.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.593 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -63.58 -52.06 62.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.9 -1.125 . . . . 0.0 109.232 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.8 mtm-85 -75.69 -33.3 60.35 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.241 -0.912 . . . . 0.0 109.428 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -68.99 -23.8 64.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.5 ttt-85 -86.3 -21.89 27.06 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.24 -0.912 . . . . 0.0 109.726 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -61.02 -50.57 72.8 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.252 1.501 . . . . 0.0 107.039 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.573 ' CE2' ' CE2' ' A' ' 58' ' ' TYR . 84.5 m95 -60.27 -53.02 62.65 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.576 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 mt -54.42 -22.04 11.43 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -77.97 -22.75 48.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.542 -0.724 . . . . 0.0 110.408 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.448 HG23 ' HA ' ' A' ' 59' ' ' TRP . 8.9 m -99.05 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.784 -1.197 . . . . 0.0 109.736 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.58 25.58 74.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -66.84 129.69 40.7 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.237 -1.155 . . . . 0.0 109.763 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.35 116.43 63.75 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.2 Cg_endo -82.77 128.4 5.21 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.526 1.277 . . . . 0.0 109.921 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.413 HG21 ' CB ' ' A' ' 5' ' ' ARG . 4.9 t -55.49 176.42 0.06 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.852 -1.155 . . . . 0.0 110.194 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 55.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 m -166.67 -59.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.15 -23.16 66.43 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 18.0 ttp85 -65.62 -42.71 91.25 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.433 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 3.1 ttm180 -67.46 -42.16 83.47 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.424 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.1 mt -68.19 -26.16 65.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.462 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 13.7 mt -67.61 -30.17 69.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.496 ' HG2' ' CE1' ' A' ' 80' ' ' PHE . 9.0 mtm180 -75.98 -34.52 59.78 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.422 ' HB3' HD22 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -76.39 -28.26 56.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.925 0.869 . . . . 0.0 109.9 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.44 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -69.65 -7.55 39.89 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.306 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.95 19.51 33.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 12.2 t -86.74 -64.46 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.256 . . . . 0.0 110.763 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.496 ' CE1' ' HG2' ' A' ' 75' ' ' ARG . 43.4 p90 -149.11 143.93 26.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.986 -1.071 . . . . 0.0 111.098 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.02 -177.57 3.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.975 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -135.46 65.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.283 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 128.1 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.264 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -118.77 -25.89 6.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.437 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.34 -61.07 2.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -52.48 134.42 34.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.905 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.42 -141.24 16.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.197 -1.178 . . . . 0.0 110.135 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 39.7 t -54.55 116.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 110.254 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -140.92 134.72 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.993 . . . . 0.0 110.323 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.48 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 37.9 mt -99.73 133.99 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 108.917 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.464 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.8 ptt180 -150.35 172.99 14.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.006 -1.059 . . . . 0.0 109.941 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 2.9 pp -89.28 130.84 35.61 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 109.518 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.15 162.21 13.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.571 -0.706 . . . . 0.0 109.212 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 70.6 ttt180 -127.92 114.45 17.18 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.931 -1.106 . . . . 0.0 111.4 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.524 ' CE1' ' HB2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -127.18 -152.51 0.52 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.301 -0.875 . . . . 0.0 109.119 178.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.81 98.82 0.99 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -56.71 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.273 -1.133 . . . . 0.0 110.043 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.6 54.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 108.761 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.475 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 4.3 m-70 -142.51 -47.58 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.601 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -151.06 110.07 3.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.42 122.31 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.51 1.269 . . . . 0.0 110.91 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.494 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 27.1 p80 -148.57 152.33 36.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 109.845 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 12.5 m-85 -123.14 168.37 12.49 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 2.2 ttp180 -132.05 147.19 52.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.017 -1.052 . . . . 0.0 108.18 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.459 ' CD1' HG21 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -97.22 83.24 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 178.086 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.291 0.4 OUTLIER -97.56 167.0 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.338 -173.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.85 105.65 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.488 -0.758 . . . . 0.0 110.986 -177.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.9 t -134.7 -170.23 2.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.0 110.004 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 22' ' ' THR . 75.9 m-20 -102.5 -169.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.14 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.77 27.73 4.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -60.8 -166.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -69.41 -166.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.487 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.4 11.63 10.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -90.95 14.5 13.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.006 -1.059 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.64 -55.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.33 70.71 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -138.47 130.27 28.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -1.17 . . . . 0.0 110.47 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' OH ' ' NH2' ' A' ' 18' ' ' ARG . 31.8 p90 -118.72 159.55 23.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.279 -0.888 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.455 HG21 ' CH2' ' A' ' 59' ' ' TRP . 2.7 mp -62.61 -46.12 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.81 171.66 19.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.613 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.63 125.15 53.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.652 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.511 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -120.76 -28.05 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.044 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -119.26 158.77 14.86 Favored Glycine 0 C--N 1.297 -1.607 0 C-N-CA 118.945 -1.598 . . . . 0.0 111.078 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 69.2 t80 -132.61 133.2 43.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.577 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 t80 -124.39 136.1 53.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.301 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.7 t70 -132.73 83.85 51.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.013 -1.055 . . . . 0.0 110.007 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 43.5 Cg_endo -69.6 61.24 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.519 1.273 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 149.5 21.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 110.347 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -95.5 44.07 1.09 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.999 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.3 p -125.7 -43.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 0.0 110.635 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 p -132.14 152.29 79.91 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 51.0 Cg_endo -78.39 -36.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.808 1.425 . . . . 0.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.19 90.7 4.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.305 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.577 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 6.9 p-90 -125.69 -8.75 6.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 111.172 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.9 tt -83.73 126.93 33.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.834 -1.166 . . . . 0.0 110.429 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -135.33 91.93 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.453 -0.78 . . . . 0.0 109.373 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -117.86 137.8 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 111.132 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.3 t70 -82.18 70.2 9.06 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.435 ' CB ' HG23 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.69 -31.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.556 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.5 tt0 -62.87 -52.05 64.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.869 -1.144 . . . . 0.0 108.902 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.479 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.68 -34.78 60.46 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.024 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.431 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -66.67 -18.07 65.18 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 28.9 ttp180 -88.39 -25.19 22.82 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.376 -0.827 . . . . 0.0 109.361 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -59.06 -44.84 91.88 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.356 1.55 . . . . 0.0 107.096 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.52 ' CD1' HG21 ' A' ' 21' ' ' VAL . 81.1 m95 -68.38 -57.88 5.21 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.836 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.4 mt -52.74 -23.31 6.53 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.314 -0.954 . . . . 0.0 108.612 177.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 t -80.78 -21.41 41.01 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 110.38 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 59' ' ' TRP . 3.5 m -98.63 32.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.773 -1.204 . . . . 0.0 109.293 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.05 74.17 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.98 109.33 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 110.312 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.08 114.5 42.66 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 110.413 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.452 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.0 Cg_endo -82.08 148.76 15.29 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.496 1.261 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.8 p -74.81 161.79 29.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.014 -1.053 . . . . 0.0 109.83 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.41 -25.6 59.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.043 -1.036 . . . . 0.0 110.985 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.474 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 38.4 m -93.28 -47.58 6.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 0.0 110.6 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -69.51 -27.63 65.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.8 ttt-85 -65.65 -38.85 90.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -34.77 76.75 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.524 -0.87 . . . . 0.0 108.879 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -76.74 -33.42 58.13 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 74.3 mt -65.38 -28.27 69.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.481 ' HG2' ' CE1' ' A' ' 80' ' ' PHE . 3.7 mmm180 -79.01 -32.15 45.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.1 tp-100 -72.06 -34.44 68.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.153 0.978 . . . . 0.0 108.998 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -67.67 -9.74 46.14 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.148 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 44.36 7.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.435 HG23 ' CB ' ' A' ' 53' ' ' VAL . 47.2 t -103.17 -12.34 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.193 -1.181 . . . . 0.0 111.394 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 11.6 m-85 -104.5 152.34 22.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.08 . . . . 0.0 110.257 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -65.07 79.24 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.079 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 80' ' ' PHE . 6.8 mm-40 -152.82 73.28 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 110.057 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.05 -60.36 1.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 110.205 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.86 161.87 28.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.853 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -137.97 -43.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -176.59 -171.34 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.63 162.58 11.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.144 . . . . 0.0 110.119 179.987 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.255 0.55 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.483 HG13 ' CZ3' ' A' ' 59' ' ' TRP . 26.9 t -119.84 134.01 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 109.855 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.653 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.482 HD11 ' CD1' ' A' ' 36' ' ' ILE . 54.8 mt -109.53 133.41 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.146 -0.971 . . . . 0.0 109.48 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.506 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 5.2 ptp180 -151.52 -166.79 2.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.781 -1.199 . . . . 0.0 110.69 -178.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.432 HD13 ' CG2' ' A' ' 69' ' ' THR . 41.9 mt -88.67 127.68 35.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.85 107.33 18.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.3 -0.875 . . . . 0.0 110.905 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ttt180 -62.99 123.97 19.9 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.973 . . . . 0.0 109.97 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.546 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 46.8 m-85 -99.11 -75.05 0.57 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.841 0.829 . . . . 0.0 110.6 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.09 129.12 17.55 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 54.1 p -63.58 -55.55 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -1.145 . . . . 0.0 109.887 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 9.5 mtmm -147.97 48.15 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -0.807 . . . . 0.0 109.135 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -124.13 -65.09 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.461 -0.774 . . . . 0.0 109.601 -178.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 50.3 t30 -126.08 124.28 24.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.429 -0.795 . . . . 0.0 109.348 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.81 106.32 2.24 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.342 1.18 . . . . 0.0 111.403 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.538 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.8 p80 -171.75 127.09 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 0.0 110.608 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.5 m-30 -113.87 159.89 19.35 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 108.854 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.88 156.27 17.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.504 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -98.23 75.77 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 176.427 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.257 0.3 OUTLIER -97.27 165.46 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.859 -173.261 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.574 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.7 113.25 42.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.463 0.649 . . . . 0.0 111.407 -176.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.411 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.0 t -137.23 -169.85 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.665 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 22' ' ' THR . 18.1 p30 -138.22 170.24 16.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.32 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.22 28.88 3.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 0.0 110.185 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -46.7 73.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.79 -175.34 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.68 166.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -55.53 123.57 14.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.358 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.49 -174.74 5.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.046 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.27 43.09 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -103.55 103.31 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' CD2' HG23 ' A' ' 20' ' ' VAL . 6.3 p90 -116.09 175.07 5.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.236 -0.915 . . . . 0.0 110.511 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.3 mt -89.11 -41.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.59 -0.694 . . . . 0.0 109.882 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.58 162.22 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.9 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -101.44 113.89 27.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 0.0 109.734 179.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.498 HG22 ' CD1' ' A' ' 59' ' ' TRP . 39.4 pt -107.37 -34.77 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.198 -0.938 . . . . 0.0 111.24 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.479 ' N ' HG13 ' A' ' 36' ' ' ILE . . . -124.49 165.77 17.37 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.099 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.472 ' N ' HG13 ' A' ' 19' ' ' ILE . 12.7 t80 -137.49 142.46 41.5 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.603 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 39.4 t80 -138.11 133.21 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.767 -1.208 . . . . 0.0 110.404 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 7.6 t0 -140.24 101.11 6.91 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.946 -1.096 . . . . 0.0 109.767 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.508 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 51.9 Cg_endo -78.07 70.9 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.126 1.066 . . . . 0.0 110.568 -179.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -91.93 149.24 21.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.024 -1.048 . . . . 0.0 110.661 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.35 39.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.8 t -145.04 -41.19 0.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -102.6 125.39 36.04 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 110.375 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.25 -4.46 14.79 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.475 1.25 . . . . 0.0 110.76 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -117.71 89.45 3.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.603 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 16.6 p-90 -120.24 -20.07 7.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.24 -0.912 . . . . 0.0 110.756 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.543 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 6.7 tt -75.81 101.03 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.102 -0.999 . . . . 0.0 110.309 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -118.17 104.3 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.975 . . . . 0.0 109.508 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.478 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.2 t -128.15 149.31 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.347 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 21.8 t0 -94.23 67.99 3.61 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.16 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.453 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -32.96 -34.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.632 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -61.72 -54.17 46.12 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.894 -1.122 . . . . 0.0 108.57 178.333 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -74.32 -33.06 63.06 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.437 -0.79 . . . . 0.0 109.331 178.973 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -69.02 -23.56 64.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -87.02 -19.78 28.17 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.552 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -62.47 -48.49 79.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.277 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.574 ' CD1' HG22 ' A' ' 21' ' ' VAL . 89.5 m95 -63.08 -55.42 25.62 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.257 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mt -52.4 -22.91 5.16 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.558 176.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -79.93 -21.9 43.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.433 -0.792 . . . . 0.0 110.797 179.229 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 59' ' ' TRP . 6.4 m -98.79 33.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.843 -1.161 . . . . 0.0 109.227 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.55 27.48 73.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 59' ' ' TRP . . . -72.71 142.54 48.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.192 -1.181 . . . . 0.0 109.833 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.38 114.6 38.28 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 110.523 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 49.5 Cg_endo -79.77 128.95 7.92 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.497 1.261 . . . . 0.0 110.308 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.99 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.516 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.77 53.56 1.14 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.432 ' CG2' HD13 ' A' ' 6' ' ' LEU . 3.1 m -166.77 -59.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 74' ' ' LEU . . . -66.52 -22.94 66.17 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.435 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 2.5 ttt85 -69.01 -43.24 75.21 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 ttm-85 -66.38 -38.44 87.56 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.731 178.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -74.37 -26.37 60.08 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.406 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.442 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 13.7 mt -72.0 -29.84 64.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.451 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.26 -28.98 38.31 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.126 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.415 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.68 -34.58 30.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.814 0.816 . . . . 0.0 109.932 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.442 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . -62.19 -14.26 35.95 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.793 -0.567 . . . . 0.0 109.877 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 25.58 8.56 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.453 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 17.5 t -86.78 -68.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.846 -1.385 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.451 ' CE1' ' CG ' ' A' ' 75' ' ' ARG . 15.5 p90 -126.55 -167.64 1.75 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 122.52 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.004 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.75 53.66 0.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.422 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.77 168.18 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.027 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.85 -176.91 6.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -151.57 126.56 9.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -51.94 157.21 1.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 110.241 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.42 -91.07 1.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 179.872 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpp? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.26 0.552 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -140.11 143.28 36.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.121 -0.987 . . . . 0.0 110.874 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.511 ' N ' ' CD1' ' A' ' 4' ' ' ILE . 1.7 mp -100.23 139.09 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 108.901 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.3 -166.12 2.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 31.1 mt -89.5 135.7 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.86 . . . . 0.0 109.904 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.501 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . . . -105.42 103.44 12.96 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.802 . . . . 0.0 111.029 -179.454 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.515 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.55 119.36 17.67 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.53 -0.731 . . . . 0.0 110.942 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 7' ' ' ALA . 20.0 m-85 -106.07 -63.05 1.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.512 -0.742 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.88 161.09 3.91 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.485 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -85.71 -79.24 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -1.009 . . . . 0.0 109.928 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -143.89 40.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 108.851 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.485 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 5.1 m-70 -126.62 -64.65 1.01 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 0.0 109.268 -178.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 22.9 t-20 -105.56 102.05 35.6 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.365 -0.834 . . . . 0.0 109.284 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.63 109.15 2.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.612 1.322 . . . . 0.0 111.163 -179.087 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.5 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 34.1 p80 -164.74 126.89 2.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.247 -0.908 . . . . 0.0 110.575 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 3.9 m-30 -118.76 155.16 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 3.9 ptm180 -103.55 167.61 9.69 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 117.453 -1.699 . . . . 0.0 107.571 176.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.58 86.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 178.907 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.256 0.3 OUTLIER -98.95 170.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.224 -174.856 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.5 HG22 ' CD1' ' A' ' 59' ' ' TRP . 1.8 t -111.95 113.78 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.595 -0.69 . . . . 0.0 110.209 -178.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -140.49 -168.08 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.438 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.56 174.16 6.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.392 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.48 59.73 2.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.121 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.283 -0.886 . . . . 0.0 110.408 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -127.56 -166.8 1.66 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -100.74 -20.51 15.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.69 52.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.6 -171.27 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.69 57.83 0.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.19 108.99 11.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -1.158 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 8.6 p90 -113.03 151.42 30.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.177 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' VAL . 4.7 mt -64.63 -63.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.944 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 21' ' ' VAL . 44.1 mt-10 -139.27 161.48 37.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.918 . . . . 0.0 110.255 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 118.92 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -0.948 . . . . 0.0 109.976 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 59' ' ' TRP . 49.5 pt -99.95 -27.96 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -150.6 -174.1 21.35 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 117.908 -2.091 . . . . 0.0 112.769 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 31.4 t80 -141.25 151.12 43.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.262 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.558 ' CE1' ' CE3' ' A' ' 48' ' ' TRP . 2.6 t80 -144.02 124.68 14.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.689 -1.257 . . . . 0.0 109.701 177.64 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 63.0 t0 -138.53 94.36 10.63 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.588 -1.32 . . . . 0.0 110.335 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.84 83.15 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.772 1.406 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -89.86 -156.75 0.43 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -141.72 43.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.29 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -121.59 -48.16 2.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.89 166.6 19.64 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.027 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 -16.18 27.19 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.661 1.348 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -80.62 96.01 6.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.309 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.558 ' CE3' ' CE1' ' A' ' 39' ' ' TYR . 9.1 p-90 -134.57 10.39 3.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.224 -0.922 . . . . 0.0 110.56 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 1.0 OUTLIER -118.21 131.98 56.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.016 -1.052 . . . . 0.0 110.549 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -136.69 75.94 1.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.569 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -97.26 134.47 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 110.968 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -80.43 69.07 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 175.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.462 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -34.47 -31.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.514 -177.326 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.09 -55.98 26.21 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.899 -1.125 . . . . 0.0 108.778 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 5.1 mmp_? -69.28 -41.2 77.16 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' CA ' ' HB ' ' A' ' 36' ' ' ILE . . . -64.54 -16.7 63.03 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.947 -1.095 . . . . 0.0 108.071 178.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.65 -25.73 22.25 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 177.849 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.49 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.8 OUTLIER -59.71 -46.62 88.56 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.23 1.49 . . . . 0.0 107.406 178.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.513 ' CD1' HG23 ' A' ' 36' ' ' ILE . 94.6 m95 -67.0 -56.57 9.54 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.259 -178.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 mt -52.45 -23.22 5.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.391 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.5 -21.0 42.37 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.647 -0.658 . . . . 0.0 110.272 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.3 m -98.67 32.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.468 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.27 29.36 74.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -77.66 129.1 35.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.269 -1.136 . . . . 0.0 109.924 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -97.67 108.52 46.03 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.438 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.8 Cg_endo -77.13 135.38 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.613 1.323 . . . . 0.0 110.368 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 2.3 p -54.69 161.08 1.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.892 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.74 -22.62 58.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.009 . . . . 0.0 110.107 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.403 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.0 m -89.19 -52.38 5.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' ' CG2' ' A' ' 19' ' ' ILE . . . -67.13 -23.88 65.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -70.06 -38.58 75.81 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.336 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -64.92 -34.24 77.94 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.87 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 69' ' ' THR . 47.8 mt -74.08 -32.58 63.32 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 56.3 mt -68.29 -28.88 67.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.5 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.56 -30.4 52.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.957 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -29.21 37.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.891 0.853 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -76.98 -1.67 29.91 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.198 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.09 50.08 8.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.459 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 58.3 t -98.4 -57.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.291 -1.123 . . . . 0.0 111.336 -179.225 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 4.3 m-30 -61.06 -61.92 2.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.214 -0.929 . . . . 0.0 110.596 -179.09 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.27 174.54 10.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.583 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.48 150.77 23.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.923 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -100.25 132.88 45.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.318 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.98 -168.69 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.084 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -116.84 103.89 10.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -54.5 147.69 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.04 -4.5 88.79 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.328 . . . . 0.0 110.326 -179.905 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.252 0.549 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.462 HG11 ' CZ3' ' A' ' 59' ' ' TRP . 84.1 t -102.07 141.36 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.301 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.78 137.06 34.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.387 -0.82 . . . . 0.0 109.999 179.761 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.522 HD11 ' HB3' ' A' ' 59' ' ' TRP . 1.8 mp -99.63 135.89 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 5.3 ptp180 -151.18 175.39 12.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.707 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -88.17 126.16 34.99 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.935 178.882 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.525 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.19 109.84 22.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.56 -0.713 . . . . 0.0 111.917 -177.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.495 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 52.6 ttp180 -72.87 120.9 19.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 111.152 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.525 ' CE2' ' O ' ' A' ' 7' ' ' ALA . 10.5 m-85 -114.25 -63.44 1.45 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.109 -0.994 . . . . 0.0 109.972 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.14 128.94 23.18 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 27.6 p -93.17 -55.67 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -1.111 . . . . 0.0 109.827 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' N ' ' OG ' ' A' ' 11' ' ' SER . 14.8 mttt -143.92 45.61 1.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.431 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 2.0 m-70 -137.58 -64.65 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.305 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 56.0 t30 -135.44 114.78 11.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.612 -0.68 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.61 99.55 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.336 1.177 . . . . 0.0 110.947 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.459 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 32.1 p80 -149.97 134.32 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.191 -0.943 . . . . 0.0 110.403 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.52 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.8 m-85 -117.43 151.78 36.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.269 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.515 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 2.6 ttt85 -104.64 150.28 24.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.629 178.195 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.526 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 1.6 mm -97.35 80.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.459 HG23 ' CG ' ' A' ' 32' ' ' TYR 0.288 0.4 OUTLIER -97.35 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.734 -173.821 . . . . . . . . 4 4 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 59' ' ' TRP . 1.4 t -115.65 107.73 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.516 -176.743 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.06 179.56 5.17 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.268 -0.895 . . . . 0.0 110.027 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 178.38 5.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.336 -0.852 . . . . 0.0 110.305 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.33 -45.99 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -52.7 -47.7 67.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.212 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -84.1 141.26 31.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.196 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -139.4 41.03 2.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -35.51 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.366 -0.834 . . . . 0.0 110.209 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -113.05 -66.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.377 -0.827 . . . . 0.0 110.159 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.45 -8.54 28.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 170.38 6.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.0 -1.294 . . . . 0.0 110.567 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' CG ' HG23 ' A' ' 20' ' ' VAL . 20.0 p90 -109.66 -166.34 1.09 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.382 -0.824 . . . . 0.0 109.933 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.414 HG22 ' CZ2' ' A' ' 59' ' ' TRP . 10.4 mt -107.69 -36.43 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 110.329 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.84 176.04 9.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.68 109.45 19.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.694 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 59' ' ' TRP . 31.7 pt -106.11 -33.1 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.14 -0.975 . . . . 0.0 111.124 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.526 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -127.37 166.08 20.25 Favored Glycine 0 C--N 1.295 -1.723 0 C-N-CA 118.603 -1.76 . . . . 0.0 111.039 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.457 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.1 t80 -138.45 142.29 39.47 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.52 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.1 t80 -134.47 130.76 37.19 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.056 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 65.1 t0 -137.5 90.35 14.98 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 110.195 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 41.3 Cg_endo -67.35 79.1 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.715 1.376 . . . . 0.0 110.797 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -174.88 4.49 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.424 -0.798 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -130.96 69.49 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.0 t -148.29 -42.12 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.38 -0.825 . . . . 0.0 109.905 179.835 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.8 163.03 38.3 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.52 -22.24 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.6 1.316 . . . . 0.0 110.515 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 4.3 m-20 -83.03 103.51 12.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 110.078 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 49' ' ' LEU . 1.5 p-90 -137.95 20.84 2.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.21 -0.931 . . . . 0.0 110.768 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.499 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 9.4 tp -126.0 134.17 51.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.96 -1.087 . . . . 0.0 111.044 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -132.7 97.35 4.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.758 . . . . 0.0 109.148 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.484 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 151.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 110.925 -179.133 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.6 t0 -96.65 67.95 2.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.457 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.99 -30.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 122.252 -0.28 . . . . 0.0 111.509 -177.281 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.7 tp10 -60.45 -54.62 43.33 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.761 -1.212 . . . . 0.0 108.581 178.026 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 47.3 mmm-85 -72.97 -37.06 67.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.825 . . . . 0.0 109.005 178.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.439 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.54 -20.59 66.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.382 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.8 ttt180 -88.35 -24.37 23.14 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.277 -0.889 . . . . 0.0 109.519 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -60.06 -46.59 89.04 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 123.5 1.619 . . . . 0.0 106.928 178.288 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CD1' HG23 ' A' ' 36' ' ' ILE . 79.1 m95 -63.72 -55.92 19.59 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.952 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -52.8 -22.36 5.26 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.549 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.37 -20.89 43.08 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.0 110.691 179.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 59' ' ' TRP . 4.3 m -99.0 32.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.875 -1.14 . . . . 0.0 109.952 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.85 71.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -77.0 138.51 39.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -1.112 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -116.78 118.29 36.76 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.391 -179.615 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 54.2 Cg_endo -79.67 140.46 14.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.397 1.209 . . . . 0.0 109.856 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.2 t -62.56 176.22 0.68 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.96 -1.088 . . . . 0.0 110.468 -179.811 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -81.58 49.77 1.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.154 -0.966 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.14 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -66.58 -23.91 66.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.101 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 25.6 ttt85 -63.81 -40.39 96.51 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.105 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -35.83 74.23 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.439 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 46.6 mt -72.46 -38.58 68.22 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.41 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 24.8 mt -61.04 -28.15 68.85 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.161 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.547 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -77.69 -31.0 52.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.8 tp-100 -75.81 -35.16 60.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.039 0.923 . . . . 0.0 109.866 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.47 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.13 -7.02 32.33 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.472 178.953 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.2 8.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.457 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 57.4 t -96.93 -52.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.356 -1.085 . . . . 0.0 111.572 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.5 m-30 -60.03 174.64 0.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 110.32 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 132.29 35.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.03 109.04 4.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.26 141.94 57.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.893 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.54 -43.93 3.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -79.4 86.82 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.94 -64.87 0.81 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.07 -154.53 3.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.244 . . . . 0.0 110.221 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.226 0.536 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 78.0 t -99.75 139.93 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.294 -0.879 . . . . 0.0 109.904 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 59.7 mtpt -140.32 132.39 27.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.428 HD13 ' CB ' ' A' ' 59' ' ' TRP . 61.9 mt -100.17 127.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 121.076 -1.015 . . . . 0.0 109.153 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 1.2 ptm180 -150.74 -170.4 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.017 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.0 mp -88.49 126.32 35.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 105.8 17.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 111.085 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 36.8 ttp180 -63.97 125.84 25.74 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 109.817 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 16' ' ' HIS . 59.3 m-85 -102.62 -75.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 111.205 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 136.22 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.434 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 14.9 p -62.84 -47.04 85.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.374 -1.074 . . . . 0.0 109.357 179.06 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -168.37 53.06 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.484 0.659 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.434 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 14.5 m-70 -124.44 -54.45 1.67 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.088 -179.263 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 64.6 t30 -131.05 124.79 20.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.92 100.86 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.373 1.197 . . . . 0.0 111.479 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.565 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 34.6 p80 -164.38 127.39 2.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.963 . . . . 0.0 111.061 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 13.9 m-85 -117.45 160.44 21.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.3 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -104.13 158.9 16.12 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.379 -1.329 . . . . 0.0 108.089 177.166 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.515 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -98.3 77.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.468 HG11 ' CD2' ' A' ' 32' ' ' TYR 0.255 0.3 OUTLIER -97.25 164.69 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.855 -173.398 . . . . . . . . 4 4 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.545 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.44 105.48 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 109.967 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.429 HG23 ' HB3' ' A' ' 32' ' ' TYR . 3.0 p -99.99 152.22 20.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.649 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.2 -153.33 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -152.02 25.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -57.47 -18.88 20.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 110.568 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.37 179.18 7.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.565 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.13 80.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.206 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.1 119.03 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -20.41 13.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.344 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 -5.13 84.36 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.51 -166.79 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.957 -1.319 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD2' HG11 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -151.13 168.26 25.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.335 -0.853 . . . . 0.0 110.135 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.4 HG23 ' CH2' ' A' ' 59' ' ' TRP . 4.9 mt -59.88 -50.01 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.764 . . . . 0.0 109.926 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -178.31 5.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 109.904 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -117.8 125.39 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.943 . . . . 0.0 110.343 -179.799 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.532 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.48 -33.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.176 -0.953 . . . . 0.0 111.242 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -119.5 161.37 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 C-N-CA 118.919 -1.61 . . . . 0.0 110.967 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' CD1' ' HG2' ' A' ' 18' ' ' ARG . 72.3 t80 -133.62 145.08 49.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.466 ' CD2' ' HD3' ' A' ' 41' ' ' PRO . 17.6 t80 -139.74 134.37 31.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.686 -1.259 . . . . 0.0 109.918 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 3.2 t70 -140.31 77.3 24.64 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 0.0 110.61 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 40.2 Cg_endo -67.94 74.01 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.59 1.311 . . . . 0.0 110.521 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -95.2 -171.05 2.31 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.271 -0.893 . . . . 0.0 110.395 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.31 39.25 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.03 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.3 p -130.33 -49.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 110.253 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -133.64 142.97 45.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.46 -18.64 20.01 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.664 1.35 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.07 70.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.5 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 8.9 p-90 -116.01 -12.51 11.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.245 -0.909 . . . . 0.0 110.392 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 5.0 tt -84.45 120.25 26.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.922 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.76 97.96 3.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.156 -0.965 . . . . 0.0 109.636 178.95 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 2.1 t -128.66 130.34 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.864 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 17.2 t0 -80.16 72.29 6.96 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.258 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.446 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -34.6 -31.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 122.342 -0.224 . . . . 0.0 111.523 -177.108 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -59.93 -51.49 69.46 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.818 -1.176 . . . . 0.0 108.666 177.857 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 14.4 mmm180 -73.57 -41.12 63.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.464 ' CB ' ' CD1' ' A' ' 36' ' ' ILE . . . -62.62 -18.43 62.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 52.0 ttp85 -88.34 -26.15 22.37 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.512 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 1.1 t80 -62.01 -44.72 96.11 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 123.289 1.519 . . . . 0.0 107.462 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.545 ' CD1' HG21 ' A' ' 21' ' ' VAL . 71.9 m95 -68.03 -57.08 6.72 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.038 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 7.9 mt -56.67 -21.43 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.524 177.147 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.6 t -79.25 -23.22 43.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 110.718 179.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 59' ' ' TRP . 13.9 m -98.9 31.95 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 120.854 -1.154 . . . . 0.0 109.458 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.38 26.73 74.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.433 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -63.13 136.27 57.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.314 . . . . 0.0 109.896 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.52 108.1 48.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 110.551 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 53.0 Cg_endo -81.72 141.18 12.07 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.626 1.329 . . . . 0.0 109.19 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 t -73.77 178.74 4.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.991 -1.068 . . . . 0.0 110.801 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.01 53.67 2.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.1 m -165.73 -59.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB2' ' CG2' ' A' ' 19' ' ' ILE . . . -67.08 -26.85 66.93 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 22.1 ttp85 -62.58 -42.0 99.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -64.99 -29.15 70.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 HD23 ' CZ3' ' A' ' 48' ' ' TRP . 18.3 mt -85.1 -28.41 25.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.376 -0.828 . . . . 0.0 109.234 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 ' HB3' ' HE1' ' A' ' 80' ' ' PHE . 21.8 mt -69.05 -27.25 65.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.089 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -82.62 -31.26 28.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.116 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.6 tp-100 -76.24 -35.34 59.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.103 0.954 . . . . 0.0 109.452 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.437 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.93 -12.48 50.0 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.747 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 91.86 48.6 3.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.425 HG22 ' HB ' ' A' ' 53' ' ' VAL . 34.1 t -114.45 -8.85 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.918 -1.342 . . . . 0.0 111.496 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 6.8 m-85 -112.1 107.43 16.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.95 -1.094 . . . . 0.0 110.063 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -81.5 137.08 35.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.968 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -53.65 155.11 3.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -0.86 . . . . 0.0 110.652 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -118.4 88.96 3.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.919 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.77 170.7 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.454 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 131.78 35.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.76 134.19 56.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 110.362 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.63 29.35 10.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 110.217 179.949 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.201 0.524 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.1 m -151.22 106.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.216 -0.928 . . . . 0.0 110.492 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -140.12 128.86 23.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.482 HD12 ' CD1' ' A' ' 36' ' ' ILE . 31.6 mt -100.81 133.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.909 -1.119 . . . . 0.0 109.564 179.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.0 ptt180 -151.55 -172.55 4.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.072 -1.018 . . . . 0.0 110.342 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.487 HD21 ' CD2' ' A' ' 39' ' ' TYR . 6.0 mp -88.7 126.66 35.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.527 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -98.98 104.72 16.79 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 7.2 tmm_? -71.41 121.27 18.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 111.66 -179.025 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 13.5 m-85 -117.61 -61.41 1.7 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.102 -0.998 . . . . 0.0 110.061 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.8 139.69 4.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.448 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -91.61 -79.14 0.38 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.949 . . . . 0.0 109.43 179.393 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -136.31 35.97 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.448 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 1.9 m-70 -132.28 -50.4 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 -177.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 12.8 t-20 -133.58 102.29 12.72 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 110.0 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.02 106.98 2.38 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.57 1.3 . . . . 0.0 111.088 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.447 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 32.9 p80 -158.83 135.7 9.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.455 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 7.0 m-85 -119.15 148.93 42.54 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.542 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -99.7 156.59 17.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.991 177.521 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -98.52 79.37 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 178.49 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.408 HG11 ' CB ' ' A' ' 32' ' ' TYR 0.274 0.4 OUTLIER -97.98 156.66 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.228 -174.206 . . . . . . . . 4 4 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.546 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -105.05 114.76 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.341 0.591 . . . . 0.0 111.066 -177.89 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.402 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.4 t -134.66 -174.82 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.412 -0.805 . . . . 0.0 110.049 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.8 p30 -114.04 -177.17 3.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.52 -14.94 14.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -55.26 -48.19 74.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 110.393 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -53.15 159.67 1.22 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.02 -1.05 . . . . 0.0 109.679 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -39.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 110.823 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.74 -34.88 5.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.0 -67.45 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.98 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.89 50.86 6.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 155.56 17.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 109.975 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 28.1 p90 -116.73 150.97 37.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.198 -0.939 . . . . 0.0 110.578 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.402 HG23 ' CZ2' ' A' ' 59' ' ' TRP . 2.7 mp -57.57 -61.07 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.11 155.68 42.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.815 . . . . 0.0 110.141 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.4 pttp -89.87 118.57 29.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 0.0 109.77 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.522 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.9 pt -107.9 -32.46 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.138 -0.976 . . . . 0.0 111.524 -179.16 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -126.74 167.32 19.21 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 118.813 -1.661 . . . . 0.0 111.388 -178.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 40' ' ' ASP . 12.5 t80 -138.57 139.41 38.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.496 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 40.3 t80 -136.67 124.02 21.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.71 -1.244 . . . . 0.0 109.699 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.473 ' HB2' ' CE1' ' A' ' 38' ' ' TYR . 54.9 t0 -140.18 84.71 14.44 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.753 -1.217 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.488 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 44.1 Cg_endo -71.71 78.32 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.557 1.293 . . . . 0.0 110.436 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -89.82 155.34 19.23 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -87.64 50.57 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.044 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -140.58 -42.13 0.41 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.5 p -142.84 143.68 26.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.39 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.433 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 48.4 Cg_endo -74.04 -19.62 20.17 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.678 1.357 . . . . 0.0 110.35 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.24 82.4 3.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.5 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.4 p-90 -122.94 -12.38 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.245 -0.909 . . . . 0.0 111.003 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.4 tt -81.48 118.35 22.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.0 110.548 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.89 99.68 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.143 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t -128.32 142.56 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.035 . . . . 0.0 111.763 -178.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t0 -88.23 69.97 9.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.071 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -34.44 -31.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.808 -177.423 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.0 mt-10 -63.81 -56.18 17.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.82 -1.175 . . . . 0.0 108.953 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -72.26 -36.1 68.95 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.27 -0.894 . . . . 0.0 109.112 178.928 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.86 -20.19 66.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.04 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.3 ttt180 -86.95 -22.33 25.68 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.246 -0.909 . . . . 0.0 109.795 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.471 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.9 OUTLIER -62.17 -46.62 88.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.276 1.513 . . . . 0.0 107.523 178.753 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.546 ' CD1' HG23 ' A' ' 21' ' ' VAL . 86.2 m95 -65.64 -58.35 5.94 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.863 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 48.5 mt -53.78 -22.55 9.67 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.488 177.366 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 1.1 m -79.2 -20.49 48.21 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.475 -0.766 . . . . 0.0 110.014 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.428 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.4 m -98.81 32.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.967 -1.083 . . . . 0.0 109.061 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.31 23.79 71.83 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . . . -61.33 136.77 58.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -1.194 . . . . 0.0 109.759 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.98 108.62 55.2 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 110.163 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 55.2 Cg_endo -83.62 123.69 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.51 1.268 . . . . 0.0 109.745 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -50.17 168.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' A' ' 69' ' ' THR . 4.7 t0 -73.1 56.26 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.098 -1.001 . . . . 0.0 110.42 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 68' ' ' ASP . 19.2 m -166.49 -60.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.431 ' HB3' ' CG2' ' A' ' 19' ' ' ILE . . . -64.23 -24.86 67.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.47 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 9.3 ttt-85 -67.06 -44.42 80.17 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.43 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -69.25 -11.86 61.17 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.137 179.163 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.6 mt -101.19 -27.32 13.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.422 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 13.4 mt -72.8 -29.32 63.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.355 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.492 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.4 -30.93 48.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.942 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -78.2 -31.73 49.61 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.846 0.831 . . . . 0.0 109.344 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.427 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -66.58 -10.57 46.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.876 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.36 14.72 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.646 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.442 HG22 ' CB ' ' A' ' 53' ' ' VAL . 21.2 t -86.06 -69.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.9 -1.353 . . . . 0.0 110.645 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 75' ' ' ARG . 48.5 p90 -132.75 165.62 24.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.46 55.85 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.13 136.36 38.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.674 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.24 -17.77 20.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.746 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -168.14 100.6 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 110.473 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.48 -37.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 0.0 110.103 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 90.17 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.19 136.02 5.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.139 -1.212 . . . . 0.0 110.209 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.234 0.54 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.5 t -102.39 122.34 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -140.26 133.33 29.46 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.526 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.479 HD12 ' CD1' ' A' ' 36' ' ' ILE . 79.0 mt -99.81 137.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.067 -1.021 . . . . 0.0 109.251 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.458 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.5 ptm180 -150.82 178.4 9.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.014 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 4.4 pp -89.5 130.92 35.76 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.592 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.37 171.97 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.507 -0.746 . . . . 0.0 109.199 -179.164 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 1.7 tmt_? -133.8 116.88 16.22 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.935 -1.103 . . . . 0.0 112.065 -179.262 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.522 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -132.1 -150.65 0.43 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.507 -0.745 . . . . 0.0 109.487 178.737 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.42 55.24 1.27 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.296 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 15.2 p -55.28 -61.69 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -1.2 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' N ' ' OG ' ' A' ' 11' ' ' SER . 23.2 mttm -145.99 50.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.462 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.3 m-70 -138.9 -56.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.314 -0.866 . . . . 0.0 109.479 -178.833 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -173.3 142.29 0.98 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.655 -0.653 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 48.7 Cg_endo -72.98 108.32 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.532 1.28 . . . . 0.0 110.357 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.506 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 24.9 p80 -147.98 147.39 29.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.025 . . . . 0.0 110.539 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 8' ' ' ARG 0.255 12.1 m-30 -112.58 170.67 8.02 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.935 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.522 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 43.2 mtt180 -134.83 153.07 52.19 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.279 177.558 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -96.83 82.65 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 178.174 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.28 0.4 OUTLIER -97.95 158.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.162 -174.224 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.588 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.19 111.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.584 -0.698 . . . . 0.0 111.096 -177.524 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.7 t -136.88 -167.68 2.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.9 p30 -108.42 -163.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.868 . . . . 0.0 110.002 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 85.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -58.43 123.21 15.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.65 -179.751 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -169.85 1.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -95.14 28.6 2.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.228 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.82 -44.34 1.49 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.877 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.36 -168.72 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 110.09 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.68 97.57 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.15 132.85 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -1.176 . . . . 0.0 109.936 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 26.9 p90 -101.91 163.82 12.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.278 -0.889 . . . . 0.0 110.637 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.446 HG21 ' CZ2' ' A' ' 59' ' ' TRP . 7.2 mt -72.38 -53.32 19.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.625 -0.672 . . . . 0.0 110.262 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -151.87 158.58 43.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 110.119 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.2 pttm -92.47 112.56 24.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.497 HG23 ' CD1' ' A' ' 59' ' ' TRP . 30.0 pt -104.75 -37.28 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.038 -1.039 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.493 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -116.24 166.34 12.33 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 119.02 -1.562 . . . . 0.0 112.232 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -140.95 117.19 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.528 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 14.3 t80 -109.12 147.14 32.92 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.58 -1.325 . . . . 0.0 110.472 -179.302 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 7.0 t70 -139.99 84.93 14.59 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.164 -0.96 . . . . 0.0 109.06 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 43.0 Cg_endo -68.21 -23.9 38.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.6 1.316 . . . . 0.0 112.002 -178.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.405 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 18.6 mmt180 -93.04 16.85 11.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.143 . . . . 0.0 111.053 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.81 137.12 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.933 -1.104 . . . . 0.0 109.773 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.1 p -91.61 45.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.533 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.85 162.89 26.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.297 -0.877 . . . . 0.0 110.002 179.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.34 -12.95 30.38 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.673 1.354 . . . . 0.0 110.614 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.82 89.23 2.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.942 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.49 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 9.2 p-90 -116.44 6.19 13.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.973 . . . . 0.0 111.154 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 1.5 tt -112.82 129.04 56.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.819 -1.176 . . . . 0.0 111.007 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.26 86.91 2.37 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.493 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -115.11 136.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 111.206 -178.963 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -81.23 69.05 7.77 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -36.53 -29.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 122.226 -0.296 . . . . 0.0 111.268 -177.423 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 15.5 tt0 -61.2 -50.5 72.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.714 -1.241 . . . . 0.0 108.416 177.862 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 22.6 mmm180 -76.23 -37.17 58.05 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.297 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.83 -19.3 65.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.207 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.6 ttm-85 -89.56 -22.47 22.36 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.289 -0.882 . . . . 0.0 109.552 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.6 OUTLIER -62.7 -48.33 79.72 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.251 1.5 . . . . 0.0 107.182 178.366 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.588 ' CD1' HG22 ' A' ' 21' ' ' VAL . 84.3 m95 -65.07 -56.31 13.75 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.793 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' HA ' ' HB3' ' A' ' 64' ' ' ALA . 20.5 mt -53.86 -22.07 9.05 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.141 -0.975 . . . . 0.0 108.434 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.55 -19.48 38.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.351 -0.843 . . . . 0.0 110.391 179.129 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG23 ' HA ' ' A' ' 59' ' ' TRP . 3.5 m -98.91 32.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 120.87 -1.144 . . . . 0.0 109.403 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.75 25.56 74.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 60' ' ' LEU . . . -72.79 122.31 21.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.001 -1.293 . . . . 0.0 110.274 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.55 116.05 65.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.223 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.6 Cg_endo -80.01 153.88 22.34 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.425 1.224 . . . . 0.0 110.188 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -76.57 167.06 22.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.078 -1.014 . . . . 0.0 109.96 179.608 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -28.8 64.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -0.954 . . . . 0.0 110.953 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.0 m -96.25 -44.98 7.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.458 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -65.48 -28.46 69.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 67' ' ' THR . 1.7 ttm-85 -68.22 -40.35 82.13 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.115 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.64 -15.14 63.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.003 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.444 HD21 ' CH2' ' A' ' 48' ' ' TRP . 18.2 mt -99.31 -29.46 12.78 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.242 -0.911 . . . . 0.0 108.943 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 33.4 mt -72.82 -27.74 62.14 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.571 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.96 -29.61 44.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.268 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -79.2 -35.83 41.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.129 0.966 . . . . 0.0 109.24 179.201 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -57.51 -17.8 15.63 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.627 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.97 16.85 12.64 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.421 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 21.7 t -81.9 -63.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.911 -1.347 . . . . 0.0 110.495 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.51 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 45.9 p90 -137.54 125.11 22.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.107 -0.996 . . . . 0.0 110.893 -179.864 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.87 -9.63 7.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.97 168.1 28.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -72.95 105.96 4.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.956 . . . . 0.0 110.451 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.28 110.98 3.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.971 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.14 -62.01 1.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 -178.99 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 110.451 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.05 126.69 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.31 -1.112 . . . . 0.0 110.255 -179.923 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.231 0.539 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.4 HG12 ' CE3' ' A' ' 59' ' ' TRP . 97.4 t -80.3 148.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.121 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -140.62 128.51 21.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 0.0 111.072 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.502 HD13 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -100.04 131.55 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.198 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 9.5 ptm180 -151.78 -165.24 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 110.654 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 79.4 mt -89.04 128.43 35.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.519 ' HB1' ' CE1' ' A' ' 9' ' ' PHE . . . -99.79 103.29 14.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.699 -0.626 . . . . 0.0 109.588 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.464 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 49.4 ttt-85 -71.91 122.63 21.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 112.405 -178.469 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.543 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 8.0 m-85 -120.67 -149.84 0.44 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.384 -0.823 . . . . 0.0 109.036 177.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.51 97.22 0.01 OUTLIER Glycine 0 N--CA 1.484 1.879 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.45 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 53.1 p -49.95 -36.02 26.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -1.196 . . . . 0.0 109.557 179.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.471 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 9.8 ptpt 179.81 65.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.682 -0.636 . . . . 0.0 109.843 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.471 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 15.1 m-70 -141.38 -63.21 0.46 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.133 -0.979 . . . . 0.0 109.847 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -128.25 129.84 23.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 110.037 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.39 97.14 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.431 1.227 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.462 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 33.3 p80 -149.65 131.45 15.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 110.586 179.578 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 7.3 m-85 -115.9 150.33 37.26 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.543 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.6 ttt180 -99.33 159.87 14.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.427 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.484 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -98.22 83.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.711 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -98.07 169.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.977 -173.908 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -114.82 114.13 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.271 0.558 . . . . 0.0 110.285 -177.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.4 t -140.17 -164.14 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.025 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.1 m-20 -121.0 165.28 15.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.72 33.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 110.065 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -63.13 134.78 56.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 62.67 1.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.287 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.98 -53.13 5.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.249 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -151.09 21.69 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.72 -71.55 0.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.35 21.25 56.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -176.63 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 20.6 p90 -114.55 177.86 4.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.125 -0.984 . . . . 0.0 110.715 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.3 mt -89.0 -43.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.603 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' OE1' ' CD ' ' A' ' 55' ' ' ARG . 5.4 tt0 -160.98 169.33 22.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.956 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -103.7 111.76 24.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.528 HG23 ' CD1' ' A' ' 59' ' ' TRP . 30.2 pt -101.67 -34.69 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.313 -0.867 . . . . 0.0 110.974 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -126.97 165.83 20.02 Favored Glycine 0 C--N 1.294 -1.774 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.547 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG13 ' A' ' 19' ' ' ILE . 34.4 t80 -134.51 142.3 46.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.127 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 11.3 t80 -140.42 134.13 30.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.812 -1.18 . . . . 0.0 109.974 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 20.9 t0 -140.2 84.74 14.37 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.771 -1.206 . . . . 0.0 110.512 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 41.2 Cg_endo -68.77 67.44 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.536 1.282 . . . . 0.0 110.65 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 163.09 15.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.237 -0.914 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.2 30.56 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -102.01 -75.5 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.74 160.66 61.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.123 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -9.99 23.86 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.697 1.367 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.17 73.98 9.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.041 -1.037 . . . . 0.0 110.309 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.541 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -122.36 -4.77 8.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.211 -0.93 . . . . 0.0 111.027 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.541 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 9.2 tt -91.49 121.52 33.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.895 -1.128 . . . . 0.0 111.03 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -136.1 87.32 2.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 109.318 178.787 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.505 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -112.53 157.82 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.374 1.083 . . . . 0.0 111.567 -179.054 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -106.02 64.91 0.68 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.064 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.466 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.9 -33.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.771 -177.365 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.1 mt-10 -60.77 -52.49 64.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.837 -1.164 . . . . 0.0 108.923 178.408 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.48 -35.56 60.81 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 108.957 178.665 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.495 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -66.05 -21.45 66.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -86.59 -22.2 26.38 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.336 -0.852 . . . . 0.0 109.836 178.507 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -61.31 -48.6 80.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.223 1.487 . . . . 0.0 107.2 178.521 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.579 ' CD1' HG22 ' A' ' 21' ' ' VAL . 90.5 m95 -63.54 -53.47 51.31 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.527 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.416 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 5.8 mt -52.86 -23.59 7.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -22.78 45.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.694 -0.629 . . . . 0.0 110.25 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.8 m -98.81 32.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.841 -1.162 . . . . 0.0 109.666 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.11 73.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HB1' ' HA ' ' A' ' 60' ' ' LEU . . . -66.37 135.11 53.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.076 -1.249 . . . . 0.0 110.119 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.23 111.01 64.39 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.947 . . . . 0.0 110.5 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -79.99 127.0 6.69 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.452 1.238 . . . . 0.0 109.894 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -58.6 -177.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.038 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -76.6 52.05 0.78 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.264 -0.898 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.78 -57.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.75 -23.46 66.74 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.676 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -68.73 -40.75 79.74 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -40.87 88.96 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.639 178.833 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 mt -65.52 -31.18 72.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 13.8 mt -72.38 -25.38 61.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.73 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -83.5 -28.82 28.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.439 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.461 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.9 tp-100 -86.52 -37.28 18.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.674 0.75 . . . . 0.0 110.543 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -10.54 42.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.762 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.01 54.75 3.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.466 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 49.4 t -103.54 -61.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.172 -1.193 . . . . 0.0 111.678 -179.3 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 36.6 m-85 -49.54 171.86 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.999 -1.063 . . . . 0.0 110.465 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.11 114.86 4.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.208 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -86.0 102.23 13.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -0.908 . . . . 0.0 110.301 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.7 53.99 2.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.72 151.26 22.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 110.285 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -95.78 -69.96 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.67 -172.36 0.62 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.46 -94.6 0.09 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.319 -1.106 . . . . 0.0 110.13 179.974 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.255 0.55 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.2 t -65.33 107.45 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -140.32 139.17 35.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.379 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.47 HD13 ' CD1' ' A' ' 36' ' ' ILE . 46.6 mt -100.04 139.06 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.007 -1.058 . . . . 0.0 109.427 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -150.85 -168.38 3.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.839 -1.163 . . . . 0.0 110.873 -179.101 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' N ' HD13 ' A' ' 6' ' ' LEU . 6.6 mp -89.15 129.21 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -101.31 102.86 13.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.235 -0.916 . . . . 0.0 110.704 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -71.32 119.29 15.24 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 111.575 -179.54 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.5 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 15.7 m-85 -114.12 -61.31 1.76 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 178.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.19 107.07 0.16 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 45.1 p -75.13 -56.37 4.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -1.102 . . . . 0.0 109.347 179.126 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.2 mtmm -144.83 48.14 1.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.3 m-70 -136.15 -65.73 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.375 -0.828 . . . . 0.0 109.848 -178.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -138.12 133.84 17.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.79 100.64 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.586 1.308 . . . . 0.0 110.845 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.478 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 35.3 p80 -153.58 129.8 10.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 0.0 110.552 179.412 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.546 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 8.6 m-85 -119.28 151.03 39.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.5 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.98 163.55 12.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.083 -1.447 . . . . 0.0 108.085 177.229 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -98.4 81.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 103.047 -2.945 . . . . 0.0 103.047 177.359 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.468 HG21 ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.71 165.61 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.787 0.803 . . . . 0.0 111.984 -173.96 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -109.07 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.251 0.548 . . . . 0.0 110.782 -177.462 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.8 t -137.31 -174.29 3.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.246 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -178.75 3.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.21 -57.2 2.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.847 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 96.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.381 -0.824 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.84 166.15 27.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -175.26 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -79.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.38 77.17 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.54 146.11 27.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -1.182 . . . . 0.0 110.459 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD2' HG21 ' A' ' 20' ' ' VAL . 10.7 p90 -118.26 -172.01 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.418 -0.801 . . . . 0.0 110.417 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.3 mt -99.01 -27.25 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.925 179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -174.54 165.16 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 109.864 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.1 pttt -102.94 111.89 24.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.498 HG23 ' CD1' ' A' ' 59' ' ' TRP . 36.7 pt -106.06 -30.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.976 -1.077 . . . . 0.0 110.883 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -126.9 167.38 19.36 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.07 -1.538 . . . . 0.0 112.304 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.427 ' N ' HG12 ' A' ' 19' ' ' ILE . 5.7 t80 -141.24 124.72 16.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.021 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.531 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 4.7 t80 -124.97 131.6 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.671 -1.268 . . . . 0.0 109.533 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -140.32 93.34 9.01 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 110.58 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.59 85.36 0.92 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.56 1.295 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -89.71 -148.95 0.19 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 109.969 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -151.11 25.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.1 t -125.12 -32.6 2.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.5 t -132.92 149.59 73.31 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.024 . . . . 0.0 110.681 179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.55 -17.01 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.789 1.415 . . . . 0.0 110.617 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -93.52 88.29 5.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.128 -0.983 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.531 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.9 p-90 -121.62 -8.69 9.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 110.691 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 5.8 tt -85.17 114.08 22.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.969 -1.082 . . . . 0.0 110.489 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -126.9 92.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.06 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.471 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.51 137.41 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.118 -178.906 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.7 t0 -78.43 69.56 4.64 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.294 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.9 OUTLIER -35.2 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.601 -177.773 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.3 mt-10 -65.08 -49.42 70.12 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.96 -1.088 . . . . 0.0 109.276 178.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.74 -32.73 52.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 178.75 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.496 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -70.04 -23.38 63.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.151 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -85.0 -21.52 29.44 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 178.093 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -60.77 -48.53 81.38 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.158 1.456 . . . . 0.0 107.147 178.464 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CD1' HG23 ' A' ' 21' ' ' VAL . 87.3 m95 -62.88 -55.44 26.09 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.627 -179.481 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -54.24 -21.81 10.03 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.234 -0.986 . . . . 0.0 108.467 177.052 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.49 -20.47 43.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.81 . . . . 0.0 110.589 179.345 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 59' ' ' TRP . 4.7 m -98.92 32.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 120.865 -1.147 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.36 74.43 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -77.89 141.18 39.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.122 -1.222 . . . . 0.0 110.035 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 123.79 29.1 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.6 Cg_endo -85.12 145.45 9.78 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.454 1.239 . . . . 0.0 109.938 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -64.65 -178.8 0.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.078 -1.014 . . . . 0.0 110.577 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.04 52.47 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.2 m -165.97 -61.39 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . . . -64.73 -26.41 68.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 2.8 ttt180 -66.39 -44.75 82.19 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -67.34 -12.58 60.52 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.106 179.234 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 10.7 mt -99.89 -29.86 12.35 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.446 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 26.5 mt -71.62 -28.46 63.81 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -79.28 -29.87 42.7 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.961 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -78.36 -31.35 48.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.955 0.883 . . . . 0.0 109.363 178.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.64 -12.44 45.89 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.978 178.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.0 16.59 20.95 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG2' ' O ' ' A' ' 74' ' ' LEU . 17.1 t -81.25 -59.02 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.362 . . . . 0.0 110.152 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.495 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 28.8 p90 -143.03 133.6 25.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 0.0 110.423 179.497 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.404 ' NH1' ' HG3' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -71.76 -168.2 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 110.412 -179.934 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -97.68 167.76 10.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -150.46 75.6 1.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.22 93.99 7.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 110.065 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -81.58 -30.61 32.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.69 -61.32 2.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.89 -158.8 29.8 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.318 -1.107 . . . . 0.0 110.259 179.95 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.486 HG12 ' CE3' ' A' ' 59' ' ' TRP . 47.7 t -88.23 144.05 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.195 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 130.94 25.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 0.0 110.539 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.487 HD12 ' CD1' ' A' ' 36' ' ' ILE . 82.9 mt -102.47 135.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 121.126 -0.984 . . . . 0.0 109.783 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.445 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.49 177.87 9.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.941 179.94 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.428 ' CD1' ' O ' ' A' ' 6' ' ' LEU . 4.3 pp -89.13 130.52 35.55 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.035 178.664 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.504 ' HB1' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.78 165.82 11.6 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.392 -0.817 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -128.36 117.19 20.98 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.967 -1.083 . . . . 0.0 111.673 -178.929 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.552 ' CE1' ' HB2' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -128.22 -154.18 0.62 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.222 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 90.01 0.95 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -55.72 -48.28 75.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.102 179.162 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.35 35.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.548 0.69 . . . . 0.0 109.224 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 15.6 m-70 -111.18 -44.51 3.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 109.563 -179.056 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.58 132.29 2.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.502 -0.749 . . . . 0.0 109.744 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.72 106.04 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.458 1.241 . . . . 0.0 110.398 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.458 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 28.4 p80 -143.49 140.65 30.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.429 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 17.6 m-30 -114.64 167.82 10.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.552 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.81 149.09 50.42 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.962 -1.086 . . . . 0.0 108.76 177.899 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.511 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -96.94 81.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 178.112 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.471 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.291 0.4 OUTLIER -98.3 161.66 2.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.783 -173.526 . . . . . . . . 4 4 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.12 106.94 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.569 -178.102 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.8 t -133.31 -169.91 2.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.0 m-20 -99.63 174.47 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.357 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.88 -53.97 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 110.271 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.99 118.99 0.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.301 -0.874 . . . . 0.0 110.493 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -106.32 -76.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -0.856 . . . . 0.0 109.983 179.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -123.97 -74.08 0.62 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -164.09 32.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.737 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -89.58 -157.16 0.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.3 88.25 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.87 173.62 6.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -1.203 . . . . 0.0 110.595 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.471 ' CD2' HG22 ' A' ' 20' ' ' VAL . 22.8 p90 -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.463 -0.773 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.3 mt -78.36 -37.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.412 -0.805 . . . . 0.0 109.919 179.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 168.07 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -103.7 113.47 27.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.87 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 35.3 pt -104.76 -34.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -122.9 166.92 15.21 Favored Glycine 0 C--N 1.295 -1.698 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.895 -178.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.418 ' HA ' ' HG2' ' A' ' 18' ' ' ARG . 16.3 t80 -140.6 122.34 15.34 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.61 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.538 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 7.1 t80 -114.46 141.01 48.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.733 -1.229 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.9 t70 -139.21 87.21 13.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.813 179.476 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.38 79.22 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.48 1.253 . . . . 0.0 110.6 -179.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.77 178.02 5.11 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.454 -0.779 . . . . 0.0 110.311 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.35 19.61 6.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -121.37 -15.62 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.745 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 p -134.6 139.67 33.24 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 0.0 110.333 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.89 -35.11 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.579 1.305 . . . . 0.0 110.102 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.06 99.92 12.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.6 p-90 -124.21 -5.62 7.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.251 -0.906 . . . . 0.0 111.004 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.503 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.8 tt -86.62 127.58 34.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -133.04 88.07 2.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 0.0 108.95 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.492 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -114.11 139.55 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.115 -0.991 . . . . 0.0 111.09 -179.067 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.3 t0 -84.65 70.2 10.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.449 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -34.63 -32.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 122.268 -0.27 . . . . 0.0 111.461 -177.467 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tm-20 -61.54 -54.64 40.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.863 -1.148 . . . . 0.0 108.728 178.341 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.464 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -69.33 -39.93 77.89 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.717 0.77 . . . . 0.0 109.065 178.685 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.478 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.57 -21.18 66.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.475 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -87.14 -20.5 26.95 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 178.642 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.1 t80 -61.37 -48.94 78.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.362 1.553 . . . . 0.0 107.142 178.365 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CD1' HG23 ' A' ' 21' ' ' VAL . 81.9 m95 -63.18 -54.27 40.19 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.768 -178.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.7 mt -53.86 -21.99 8.86 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.28 177.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -22.78 38.56 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.471 -0.768 . . . . 0.0 110.679 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 59' ' ' TRP . 5.2 m -99.24 31.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.832 -1.168 . . . . 0.0 109.908 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.82 26.22 71.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 142.81 56.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.873 -1.369 . . . . 0.0 110.324 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 105.99 57.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.432 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.2 Cg_endo -83.2 124.99 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.582 1.306 . . . . 0.0 110.763 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 6.3 t -58.73 156.3 11.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.067 -1.02 . . . . 0.0 109.06 179.231 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -48.66 47.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.054 -1.029 . . . . 0.0 111.556 -179.052 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.411 HG21 ' CD2' ' A' ' 6' ' ' LEU . 1.5 m -62.22 -56.42 18.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.1 -1.0 . . . . 0.0 111.825 -178.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.445 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -68.45 -25.68 65.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 109.093 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 67' ' ' THR . 25.7 ttt180 -69.8 -38.39 76.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -61.53 -30.41 70.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.419 178.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.442 ' CD2' HD12 ' A' ' 49' ' ' LEU . 24.7 mt -78.31 -37.6 44.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.432 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 68.6 mt -62.42 -30.66 71.38 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.788 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.459 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.73 -28.48 44.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.061 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 9.7 tp-100 -75.49 -35.76 60.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.069 0.938 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -70.2 -8.0 46.45 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.057 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.93 53.02 3.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.413 HG23 ' HA ' ' A' ' 53' ' ' VAL . 61.9 t -109.44 -4.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.206 -1.173 . . . . 0.0 111.46 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 13.2 m-85 -112.41 39.93 2.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.891 -1.131 . . . . 0.0 110.064 -179.4 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.89 164.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.22 145.87 36.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 110.056 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -50.97 150.58 2.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.443 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.47 -69.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -69.21 -28.11 66.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.311 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -57.2 147.37 25.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.462 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.41 47.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.304 -1.115 . . . . 0.0 110.156 179.969 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.587 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG11 ' CZ3' ' A' ' 59' ' ' TRP . 95.2 t -80.89 132.41 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 0.0 110.021 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.466 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 16.3 mtpt -140.02 139.25 35.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.433 ' CG2' HD11 ' A' ' 36' ' ' ILE . 41.4 mt -103.51 130.33 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.142 -0.974 . . . . 0.0 109.264 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.52 -165.28 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 110.331 -179.118 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.434 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 44.7 mt -89.09 133.81 34.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.99 -1.069 . . . . 0.0 110.695 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -104.95 105.84 16.06 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.518 -0.738 . . . . 0.0 110.996 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.505 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 15.6 ttp180 -74.43 120.15 19.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.894 . . . . 0.0 111.1 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.52 ' CZ ' ' NE ' ' A' ' 18' ' ' ARG . 18.0 m-85 -108.03 -64.99 1.15 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.326 -0.859 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.65 127.85 27.77 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -178.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 4.5 p -62.59 -45.66 91.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -1.09 . . . . 0.0 109.505 179.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.58 34.47 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.677 0.751 . . . . 0.0 109.296 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.436 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 20.9 m-70 -101.93 -51.52 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.802 0.81 . . . . 0.0 108.901 -179.405 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.46 129.7 12.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.079 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.13 113.6 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.345 1.182 . . . . 0.0 111.343 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.497 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 34.1 p80 -167.65 124.63 1.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 5.2 m-30 -118.57 156.34 29.33 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.037 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' NE ' ' CZ ' ' A' ' 9' ' ' PHE . 1.1 ptp180 -105.59 165.73 10.95 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.325 176.081 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.486 HG13 ' N ' ' A' ' 38' ' ' TYR . 0.3 OUTLIER -98.11 85.32 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.219 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG21 ' CG ' ' A' ' 32' ' ' TYR 0.261 0.3 OUTLIER -98.05 166.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.152 -175.031 . . . . . . . . 4 4 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.42 107.41 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 110.159 -178.459 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 2.2 t -139.94 -170.31 2.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.382 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 22' ' ' THR . 6.7 t0 -104.1 166.21 10.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 109.98 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.66 29.04 4.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.331 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -53.73 41.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -156.16 162.36 40.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 110.121 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 41.08 1.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.23 32.18 1.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.048 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.77 -44.06 2.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.299 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.09 62.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -109.83 130.11 55.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 110.194 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' CG ' HG21 ' A' ' 20' ' ' VAL . 15.8 p90 -126.09 -176.44 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.338 -0.851 . . . . 0.0 110.796 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 mp -98.11 -25.22 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.608 -0.683 . . . . 0.0 109.632 179.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.26 162.85 6.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 0.0 109.865 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 4.0 ptpt -105.07 115.55 30.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.114 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 59' ' ' TRP . 42.3 pt -105.09 -31.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -136.29 177.88 19.24 Favored Glycine 0 C--N 1.295 -1.705 0 C-N-CA 118.215 -1.945 . . . . 0.0 112.583 -178.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.486 ' N ' HG13 ' A' ' 19' ' ' ILE . 71.8 t80 -139.96 147.89 41.14 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.919 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.454 ' CE2' ' HD3' ' A' ' 41' ' ' PRO . 26.1 t80 -143.01 131.17 21.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.337 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 42.2 t0 -140.37 84.84 13.95 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.652 -1.28 . . . . 0.0 110.505 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 41.4 Cg_endo -68.86 73.3 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.511 1.269 . . . . 0.0 110.498 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -100.13 137.69 38.22 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.354 -0.841 . . . . 0.0 110.484 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 60.01 2.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.062 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -143.95 -60.07 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.0 110.692 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -123.31 146.52 49.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.685 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.16 -8.94 20.32 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.747 1.393 . . . . 0.0 110.726 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.69 75.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 110.543 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.516 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 13.8 p-90 -116.72 -13.91 10.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.613 179.549 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.516 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 4.7 tt -86.17 115.55 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.26 86.98 2.57 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 108.971 178.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.569 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -116.48 149.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.472 1.13 . . . . 0.0 112.294 -178.528 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.9 t70 -99.16 64.91 1.4 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.449 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -33.97 -32.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.539 -177.289 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.07 -53.24 59.55 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.816 -1.177 . . . . 0.0 108.756 178.231 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -76.37 -34.03 58.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.434 -0.791 . . . . 0.0 108.869 178.636 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -67.52 -21.22 65.49 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.068 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 50.1 ttp85 -87.98 -21.21 24.97 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.231 -0.918 . . . . 0.0 109.721 178.089 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -60.75 -49.51 77.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CD1' HG21 ' A' ' 21' ' ' VAL . 88.6 m95 -61.72 -53.18 59.57 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.315 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 25.2 mt -53.94 -22.26 9.82 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.762 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.5 -22.89 40.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.561 -0.712 . . . . 0.0 110.973 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 59' ' ' TRP . 10.5 m -98.99 32.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.758 -1.214 . . . . 0.0 109.606 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.81 71.53 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -69.37 128.47 36.69 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.269 . . . . 0.0 110.015 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.466 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -97.17 109.52 49.92 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.174 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.41 136.91 10.15 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.519 1.273 . . . . 0.0 110.29 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -62.02 179.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.968 . . . . 0.0 109.525 179.476 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 19.4 p-10 -69.98 -18.98 63.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.075 -1.015 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -50.37 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.256 -0.902 . . . . 0.0 110.503 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.01 -25.06 64.31 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.351 -0.843 . . . . 0.0 108.913 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 67' ' ' THR . 7.9 ttt-85 -68.53 -38.31 80.75 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.05 -39.36 90.08 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.511 -0.875 . . . . 0.0 108.76 178.716 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.437 ' CD2' ' CZ3' ' A' ' 48' ' ' TRP . 40.7 mt -73.93 -26.26 60.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.575 -0.703 . . . . 0.0 109.261 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 16.4 mt -72.74 -25.94 61.39 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.581 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.544 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -81.89 -32.0 31.19 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.181 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 7.9 tp-100 -80.1 -37.21 34.17 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.998 0.904 . . . . 0.0 109.964 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.47 -12.48 22.31 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.887 178.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.78 38.18 8.91 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.449 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 39.4 t -91.39 -54.15 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.196 -1.179 . . . . 0.0 111.351 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.5 m-30 -54.32 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -126.78 150.38 49.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.175 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -169.97 67.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.184 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.51 130.87 2.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.97 . . . . 0.0 110.447 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.98 141.75 28.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.855 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 75.07 10.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -176.32 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.12 -77.37 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.319 0.581 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t -85.52 133.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.293 179.964 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.432 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 14.6 mtpt -140.73 143.02 34.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.637 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.426 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 46.7 mt -101.27 135.42 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.104 -0.997 . . . . 0.0 108.941 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -177.76 6.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.107 . . . . 0.0 110.956 -179.04 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.6 mp -88.96 125.12 34.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.819 . . . . 0.0 109.887 179.835 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.515 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.14 111.62 23.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.461 -0.775 . . . . 0.0 110.901 -179.034 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -78.16 119.43 21.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.963 . . . . 0.0 111.628 -179.382 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.524 ' CE2' ' HB2' ' A' ' 18' ' ' ARG . 8.0 m-85 -112.77 -63.88 1.38 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.376 179.482 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.53 134.06 20.35 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.513 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -77.24 -154.48 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -1.067 . . . . 0.0 109.456 179.548 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -45.54 -31.54 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.634 0.731 . . . . 0.0 110.305 178.538 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 3.8 m-70 -53.99 -68.35 0.19 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -178.239 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -127.2 103.02 23.33 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.917 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.35 122.85 6.77 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.597 1.314 . . . . 0.0 111.3 -179.416 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.501 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 34.5 p80 -172.7 125.55 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.926 178.84 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.0 m-30 -114.28 155.16 26.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.408 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -104.65 152.99 21.81 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.551 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.53 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 1.3 mm -98.42 80.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 178.299 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.28 0.4 OUTLIER -97.36 164.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.937 -173.759 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.499 HG12 ' CG ' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -109.94 113.6 44.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.599 -0.688 . . . . 0.0 110.594 -176.92 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.2 t -139.96 -166.35 2.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.287 -0.883 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.3 m-20 -128.2 -165.24 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.007 179.817 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.91 25.76 3.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.963 . . . . 0.0 110.347 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.72 -39.13 87.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 110.229 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -128.38 126.34 40.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.101 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.91 -7.81 51.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 110.679 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.35 -69.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.001 . . . . 0.0 110.339 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.21 160.17 16.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.411 -179.81 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.75 125.28 4.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 78.75 1.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -1.23 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 8.5 p90 -54.62 159.53 2.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.066 -1.021 . . . . 0.0 110.681 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG23 ' CZ2' ' A' ' 59' ' ' TRP . 2.7 mp -72.97 -59.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.504 -0.748 . . . . 0.0 109.604 179.519 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.98 149.78 35.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 179.869 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HG2' ' NE ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -89.82 126.6 35.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.962 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.521 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.86 -24.78 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.448 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -128.37 161.44 22.14 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.662 -1.732 . . . . 0.0 110.649 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.474 ' N ' HG12 ' A' ' 19' ' ' ILE . 88.0 t80 -138.41 144.6 40.27 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.894 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 16.0 t80 -137.47 133.26 34.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.45 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 34.1 t0 -140.55 106.43 6.49 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.809 -1.182 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 48.0 Cg_endo -76.36 1.19 8.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.48 1.253 . . . . 0.0 110.848 179.844 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 -30.17 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.016 -1.052 . . . . 0.0 109.421 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -51.53 116.5 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.029 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.8 p -89.34 49.83 1.82 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 -178.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 159.23 35.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.692 -0.63 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.32 60.19 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.611 1.322 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.25 30.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.981 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.579 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 32.5 p-90 -68.0 -8.65 39.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.423 -0.798 . . . . 0.0 111.34 -179.623 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.52 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.3 tt -98.81 130.12 45.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.264 179.867 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 88.91 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.828 . . . . 0.0 109.095 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.486 HG23 ' HA3' ' A' ' 37' ' ' GLY . 1.5 t -118.16 129.78 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.051 -1.031 . . . . 0.0 111.369 -178.833 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t70 -75.09 72.15 2.19 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.437 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -33.7 -32.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.549 -177.509 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 16.5 tt0 -61.56 -53.15 60.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.855 -1.153 . . . . 0.0 108.857 178.045 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.45 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.89 -37.47 73.0 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.276 178.933 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.464 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -68.82 -20.77 64.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.319 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 29.2 ttt-85 -85.11 -25.16 27.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.672 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.444 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 11.1 t80 -60.2 -43.96 95.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 123.211 1.482 . . . . 0.0 107.564 178.307 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.521 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 68.9 m95 -68.72 -57.01 6.26 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.934 -179.07 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' CD1' ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -55.11 -21.01 11.38 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.333 -0.947 . . . . 0.0 108.873 177.497 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.2 t -81.43 -23.44 37.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.279 -0.888 . . . . 0.0 110.76 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 59' ' ' TRP . 36.0 m -99.09 32.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 120.944 -1.098 . . . . 0.0 109.404 179.571 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.04 30.54 74.08 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -76.32 120.77 22.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.967 -1.314 . . . . 0.0 109.769 179.736 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.432 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -92.07 115.83 65.37 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.458 -179.69 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HB2' ' CA ' ' A' ' 71' ' ' ARG . 52.5 Cg_endo -82.87 133.25 6.7 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.435 1.229 . . . . 0.0 109.687 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.4 t -53.0 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.008 -1.058 . . . . 0.0 110.594 -179.53 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.96 52.65 1.28 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.3 -0.875 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -167.26 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.92 -22.96 66.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.538 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.435 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 5.4 ttt180 -66.99 -42.67 84.63 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.407 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -30.65 71.47 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.451 HD12 ' CD2' ' A' ' 39' ' ' TYR . 23.6 mt -77.59 -31.53 53.09 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 47.4 mt -67.42 -30.12 69.79 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.575 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.493 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -79.45 -30.56 42.24 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -77.46 -33.21 54.76 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.996 0.903 . . . . 0.0 109.56 179.473 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.455 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.53 -12.8 35.23 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.06 178.608 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.38 27.92 10.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.429 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 30.5 t -87.72 -62.29 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -1.23 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.493 ' CE1' ' HG3' ' A' ' 75' ' ' ARG . 18.1 p90 -135.67 -177.05 4.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.347 -179.848 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -135.41 -50.58 0.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.323 -0.861 . . . . 0.0 109.88 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.51 170.63 20.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.892 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 41.21 3.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.139 -0.976 . . . . 0.0 110.308 -179.726 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.48 104.28 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.254 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -60.16 -31.16 69.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.866 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.66 100.17 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.832 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.99 120.66 6.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 110.245 179.956 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.257 0.551 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 70.9 t -68.03 127.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.09 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -140.82 137.12 33.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.027 -1.046 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.4 mt -100.68 134.04 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.125 -0.984 . . . . 0.0 108.494 178.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 53.9 ptt85 -150.8 -172.44 4.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.835 -1.165 . . . . 0.0 111.159 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 6.8 mp -88.58 127.43 35.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.239 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.495 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -101.22 108.98 20.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.466 -0.771 . . . . 0.0 111.455 -178.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.537 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.8 ttt-85 -74.78 121.15 21.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 111.2 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.513 ' CZ ' ' HB3' ' A' ' 18' ' ' ARG . 15.1 m-85 -110.26 -63.16 1.42 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 0.0 110.891 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -45.78 147.48 2.27 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -178.395 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.474 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -60.2 -73.08 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.914 . . . . 0.0 109.632 178.991 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -165.88 52.22 0.1 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.567 -0.708 . . . . 0.0 109.809 -179.815 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.476 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 17.2 m-70 -130.44 -52.43 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.446 -0.784 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.26 109.68 42.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.142 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.61 91.35 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.527 1.277 . . . . 0.0 111.64 -178.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.51 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 33.7 p80 -135.25 118.56 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.288 178.723 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 5.7 m-30 -115.67 154.68 29.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.623 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.513 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 3.2 ptm180 -104.0 161.74 13.73 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.522 -1.671 . . . . 0.0 107.755 177.142 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 0.6 OUTLIER -98.09 85.37 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 179.397 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.445 ' CG2' ' HD3' ' A' ' 18' ' ' ARG 0.27 0.3 OUTLIER -97.62 170.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.105 -174.324 . . . . . . . . 4 4 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -116.69 103.43 15.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.84 . . . . 0.0 110.658 -177.292 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.432 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t -128.53 -168.54 1.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.715 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OG1' ' A' ' 22' ' ' THR . 1.1 m-20 -121.57 160.09 25.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.213 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.85 -69.68 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -60.26 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.402 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -166.84 -65.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.71 -166.79 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -90.86 7.24 40.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.751 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -62.49 -178.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 0.0 110.259 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.48 26.04 1.22 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.92 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 148.17 22.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -1.105 . . . . 0.0 110.117 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.432 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 14.7 p90 -110.29 170.16 8.26 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 110.54 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.5 mt -80.25 -29.04 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.528 -0.733 . . . . 0.0 109.7 179.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -174.37 169.75 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.441 -0.787 . . . . 0.0 109.918 179.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -110.14 121.99 46.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.782 179.816 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.534 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -119.35 -30.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.145 -0.972 . . . . 0.0 111.179 -179.533 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.497 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -121.69 164.28 14.88 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.078 -179.838 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.466 ' N ' HG13 ' A' ' 19' ' ' ILE . 75.2 t80 -137.64 140.43 40.87 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.981 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE2' ' HD3' ' A' ' 41' ' ' PRO . 54.7 t80 -139.42 113.17 8.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.569 -1.332 . . . . 0.0 109.957 -179.023 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.5 t0 -126.24 83.62 63.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.613 -1.304 . . . . 0.0 110.709 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.494 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 40.8 Cg_endo -66.72 78.04 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.708 1.373 . . . . 0.0 111.1 -179.681 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.88 124.42 40.85 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.275 -0.891 . . . . 0.0 109.939 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.56 74.88 0.4 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.952 . . . . 0.0 110.431 -179.753 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 p -150.03 -55.16 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 p -140.32 150.99 63.15 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.89 59.31 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.713 1.375 . . . . 0.0 110.642 179.92 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -153.39 75.29 1.05 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.281 -0.887 . . . . 0.0 109.738 179.808 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.504 ' CE3' ' N ' ' A' ' 49' ' ' LEU . 12.7 p-90 -124.2 -15.13 6.85 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.272 -0.893 . . . . 0.0 111.321 -179.104 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.504 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 3.7 tt -79.42 127.59 32.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.941 -1.099 . . . . 0.0 111.027 -178.877 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 11.2 mtpt -140.45 94.5 2.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.222 178.833 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 2.2 t -129.94 134.9 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 112.069 -179.025 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 t0 -82.96 71.01 10.08 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.26 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.455 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -33.43 -31.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.04 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 31.8 mt-10 -60.87 -49.57 76.94 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.956 178.224 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.482 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.6 mmm180 -75.01 -39.73 61.02 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.248 -0.908 . . . . 0.0 109.084 178.51 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.455 ' CB ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.1 -22.87 67.11 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.356 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 7.5 ttt180 -86.35 -23.57 26.15 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.41 -0.806 . . . . 0.0 109.62 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.52 -49.01 75.2 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 123.205 1.478 . . . . 0.0 107.484 178.477 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.534 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 71.8 m95 -61.76 -52.57 63.68 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.275 -179.321 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 HD11 ' CE2' ' A' ' 80' ' ' PHE . 7.4 mt -57.01 -21.2 28.91 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.899 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.46 -26.17 55.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.333 -0.854 . . . . 0.0 110.311 179.502 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 59' ' ' TRP . 34.4 m -99.08 32.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.048 -1.032 . . . . 0.0 109.581 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.4 76.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -64.69 96.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.353 . . . . 0.0 109.689 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.03 114.7 29.39 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.443 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.4 Cg_endo -85.67 130.44 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.528 1.278 . . . . 0.0 109.641 179.391 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -53.18 178.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.085 -1.009 . . . . 0.0 110.651 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.22 54.28 1.94 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.32 -0.862 . . . . 0.0 110.073 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -164.72 -60.29 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 5' ' ' ARG . . . -67.58 -26.34 66.24 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.93 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.402 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 33.6 ttp180 -65.41 -43.15 91.49 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.098 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.03 -42.66 99.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.862 178.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.489 HD23 ' CE1' ' A' ' 39' ' ' TYR . 27.6 mt -70.08 -28.87 65.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.443 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 28.7 mt -69.26 -29.14 66.98 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.841 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HG2' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.53 -34.23 35.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.157 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -78.06 -26.02 48.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.866 0.841 . . . . 0.0 109.659 179.165 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.459 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -68.79 -9.82 53.19 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.211 0.529 . . . . 0.0 110.078 179.01 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.26 21.0 23.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.455 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 14.0 t -85.8 -68.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.284 . . . . 0.0 110.538 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 75' ' ' ARG . 21.1 p90 -129.02 -167.61 1.81 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.082 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.426 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -163.35 178.06 8.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 110.293 -179.825 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -146.87 46.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -0.894 . . . . 0.0 110.12 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' O ' ' CG ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -143.49 106.9 4.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.64 39.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.085 -1.009 . . . . 0.0 110.417 -179.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -8.44 53.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.37 -65.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 0.0 110.358 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.25 168.47 37.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.246 -1.15 . . . . 0.0 110.282 -179.93 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 mmm . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.4 HG12 ' CG2' ' A' ' 62' ' ' VAL . 59.6 t -55.28 119.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.42 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 6.5 mttt -140.64 124.67 17.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.701 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.435 HD11 ' CB ' ' A' ' 59' ' ' TRP . 49.7 mt -99.88 129.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 120.991 -1.068 . . . . 0.0 109.211 178.843 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -151.07 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.928 . . . . 0.0 110.64 -179.187 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.438 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 55.4 mt -88.59 127.96 35.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.706 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . . . -99.88 100.52 11.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.54 -0.725 . . . . 0.0 110.382 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 41.1 ttt180 -69.07 122.62 19.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 111.299 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.51 ' CZ ' ' HB3' ' A' ' 18' ' ' ARG . 15.5 m-85 -114.46 -63.49 1.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.22 -0.925 . . . . 0.0 110.168 179.164 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.63 115.04 2.29 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 24.6 p -63.69 -59.5 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -1.161 . . . . 0.0 109.839 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' N ' ' OG ' ' A' ' 11' ' ' SER . 7.8 mttp -147.68 59.8 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.462 -0.773 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.451 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 4.4 m-70 -143.5 -65.96 0.37 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 109.965 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -125.76 118.41 24.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.385 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.7 79.56 1.88 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.432 1.227 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 35.5 p80 -129.78 128.02 41.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.973 . . . . 0.0 110.543 179.391 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 7.6 m-85 -117.21 150.87 38.03 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.51 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -99.81 160.29 14.41 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.231 -1.788 . . . . 0.0 106.751 176.535 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.496 HG13 ' N ' ' A' ' 38' ' ' TYR . 1.0 OUTLIER -97.62 85.44 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 103.487 -2.782 . . . . 0.0 103.487 179.125 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.271 0.3 OUTLIER -97.44 169.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.945 -174.159 . . . . . . . . 4 4 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.91 110.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.434 -0.792 . . . . 0.0 110.634 -177.405 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.0 t -139.84 -167.47 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.4 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.6 p-10 -113.98 -169.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.496 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.48 37.17 2.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.998 -1.064 . . . . 0.0 110.361 179.999 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -51.0 65.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.083 -1.011 . . . . 0.0 110.418 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -135.93 177.51 7.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -122.54 67.76 0.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.53 -53.7 0.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 179.841 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -122.4 98.0 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 179.811 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.63 85.32 0.07 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -94.76 101.32 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -1.145 . . . . 0.0 109.919 179.581 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.443 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 21.4 p90 -87.86 165.61 15.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 111.09 -179.529 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.2 mt -81.66 -32.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.407 0.623 . . . . 0.0 109.78 179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.79 176.75 3.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -113.32 123.86 51.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.983 . . . . 0.0 110.354 -179.822 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.542 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.8 -26.9 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.862 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -125.85 166.05 18.76 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 118.765 -1.684 . . . . 0.0 111.325 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.496 ' N ' HG13 ' A' ' 19' ' ' ILE . 40.5 t80 -138.33 140.76 39.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.103 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.434 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 15.1 t80 -138.17 127.84 25.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.909 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 32.1 t0 -137.63 83.62 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.619 -1.3 . . . . 0.0 110.499 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 41.1 Cg_endo -68.48 80.38 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.517 1.272 . . . . 0.0 111.106 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.49 158.64 15.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.247 -0.908 . . . . 0.0 109.849 179.392 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.62 37.67 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -126.83 -56.57 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.062 179.867 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -131.74 140.22 37.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 48' ' ' TRP . 47.8 Cg_endo -73.88 -15.57 23.66 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.529 1.278 . . . . 0.0 110.348 179.835 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -69.85 64.11 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.116 -0.99 . . . . 0.0 110.299 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.511 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 5.4 p-90 -116.59 -13.16 10.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.16 -0.962 . . . . 0.0 110.86 179.854 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 5.7 tt -79.28 121.62 25.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 110.43 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -136.97 95.84 3.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 179.721 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.527 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 2.2 t -127.75 128.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.975 -179.48 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.6 t0 -79.1 70.36 5.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.645 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.448 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -31.53 -34.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.158 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 mm-40 -60.63 -51.15 70.62 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.809 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 2.6 mmm180 -71.85 -41.85 67.61 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.386 -0.821 . . . . 0.0 108.836 178.398 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.94 -16.95 62.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.017 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -88.53 -29.03 20.39 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 178.394 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP 0.251 1.7 t80 -57.66 -43.47 84.99 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.331 1.539 . . . . 0.0 107.338 178.399 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 69.7 m95 -69.03 -52.99 22.93 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.282 -179.285 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.2 mt -57.65 -20.37 33.02 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.83 177.148 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.4 t -83.22 -22.77 33.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.493 HG21 ' HA ' ' A' ' 59' ' ' TRP . 35.4 m -99.07 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.979 -1.075 . . . . 0.0 109.5 179.602 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.9 72.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -67.76 128.37 36.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.383 . . . . 0.0 109.838 179.621 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.42 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 2.4 mm-40 -92.75 109.99 42.53 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.9 Cg_endo -81.17 150.86 17.85 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.468 1.246 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -81.82 170.01 16.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.684 179.564 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -17.88 30.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -99.54 -47.97 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.14 -0.975 . . . . 0.0 110.322 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.94 -25.75 64.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -38.32 83.38 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.186 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -39.82 94.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.958 178.821 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.407 ' HB3' HD11 ' A' ' 19' ' ' ILE . 19.4 mt -70.43 -29.5 66.1 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 179.554 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 32.1 mt -72.25 -25.91 61.8 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.638 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.55 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -84.79 -27.0 27.16 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.385 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 5.9 tp-100 -85.21 -36.83 20.73 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.736 0.779 . . . . 0.0 110.212 -179.775 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.13 -10.61 32.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 178.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.44 44.83 6.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.448 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 25.5 t -97.73 -51.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.113 -1.228 . . . . 0.0 111.179 -179.51 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.4 m-30 -59.26 99.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.468 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.412 ' NE ' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -103.32 29.47 5.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.949 . . . . 0.0 109.936 179.516 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.03 -175.68 2.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 135.54 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.149 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.73 -72.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -157.29 -139.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.38 -0.825 . . . . 0.0 109.888 -179.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.24 -72.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.878 -1.139 . . . . 0.0 110.449 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.15 46.72 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.207 -1.172 . . . . 0.0 110.237 179.825 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.235 0.54 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.5 t -69.06 134.36 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.878 . . . . 0.0 110.031 179.931 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.32 136.45 33.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 110.304 -179.923 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.473 HD12 ' CD1' ' A' ' 36' ' ' ILE . 60.8 mt -99.94 138.48 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.293 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.6 ptt180 -150.6 -170.88 3.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.992 -1.068 . . . . 0.0 110.745 -179.175 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' CD2' HG23 ' A' ' 69' ' ' THR . 6.5 mp -89.41 128.78 35.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.341 -0.85 . . . . 0.0 110.991 -179.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.52 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.71 157.26 16.6 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.657 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 3.9 ttp85 -126.35 109.35 12.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.869 -1.145 . . . . 0.0 111.752 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.52 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -118.85 -151.0 0.47 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.251 -0.906 . . . . 0.0 109.566 179.008 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.38 100.28 0.78 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.448 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.8 OUTLIER -65.27 -55.22 19.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 109.918 -179.937 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 5.1 ptpt -169.65 43.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 110.004 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.448 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 7.3 m-70 -123.81 -57.14 1.64 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.935 . . . . 0.0 109.186 -179.486 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -152.62 126.23 4.3 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.402 ' O ' ' HD2' ' A' ' 41' ' ' PRO . 47.2 Cg_endo -72.89 114.49 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.309 1.163 . . . . 0.0 111.122 -179.127 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.509 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 25.3 p80 -141.72 144.77 34.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.193 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 7' ' ' ALA 0.258 17.8 m-30 -115.32 178.06 4.43 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 31.0 mtt180 -137.1 156.84 47.87 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.069 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.556 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.01 83.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 102.896 -3.002 . . . . 0.0 102.896 177.736 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.266 0.4 OUTLIER -97.8 165.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.582 -173.76 . . . . . . . . 4 4 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -109.13 104.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 110.716 -177.33 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t -131.11 -165.76 1.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 179.139 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.2 m-20 -124.42 158.96 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.027 -1.046 . . . . 0.0 110.618 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.77 -51.77 7.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.664 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 124.0 19.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.886 . . . . 0.0 110.117 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -174.26 123.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.218 -179.817 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -68.75 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.22 -51.69 3.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.16 144.74 54.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.93 81.62 0.17 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.49 140.41 23.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.137 -1.213 . . . . 0.0 110.347 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.3 p90 -71.48 163.45 27.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.213 -0.929 . . . . 0.0 110.479 -179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.0 mt -75.92 -39.3 37.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.649 -0.657 . . . . 0.0 110.339 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.65 170.28 21.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 110.353 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -107.29 112.69 25.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 110.024 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.504 HG22 ' CD1' ' A' ' 59' ' ' TRP . 22.6 pt -107.27 -36.35 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 111.338 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -119.72 168.2 13.57 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.087 -1.53 . . . . 0.0 112.245 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 49.8 t80 -141.36 125.5 17.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.351 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.556 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 9.9 t80 -115.72 146.89 41.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.596 -1.315 . . . . 0.0 109.533 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 33.6 t70 -136.68 102.18 9.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.977 -1.077 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 15' ' ' PRO . 49.8 Cg_endo -88.43 28.01 0.51 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.686 1.361 . . . . 0.0 111.32 -179.346 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -89.66 -156.64 0.42 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.838 -1.164 . . . . 0.0 110.326 -179.682 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 7.7 ttpt -68.66 70.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 179.804 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.411 ' N ' ' O ' ' A' ' 42' ' ' ARG . 61.3 p -150.54 97.48 2.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.538 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 39.1 m -88.89 -40.54 0.45 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 111.78 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.3 Cg_endo -87.22 -45.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 122.745 0.866 . . . . 0.0 111.239 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 44' ' ' THR . 2.5 m-20 -111.04 92.48 4.06 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.216 -0.927 . . . . 0.0 110.512 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 49' ' ' LEU . 55.2 p-90 -140.75 11.16 2.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.88 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.499 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 14.6 tp -135.23 121.05 19.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 110.987 -179.697 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -133.15 102.51 5.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.765 . . . . 0.0 109.256 179.409 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.472 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.47 140.14 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.898 -1.126 . . . . 0.0 111.044 -179.234 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -82.33 69.23 9.03 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.948 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.448 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 1.4 p -34.25 -31.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.858 -177.773 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.1 tp10 -62.95 -53.06 59.86 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.854 -1.154 . . . . 0.0 109.01 178.315 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 2.7 mtm-85 -73.27 -37.36 66.31 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.416 -0.803 . . . . 0.0 108.981 178.734 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.488 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.99 -18.98 65.75 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.754 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -88.95 -23.31 22.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.347 -0.846 . . . . 0.0 109.736 178.446 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.3 OUTLIER -60.15 -45.83 91.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 123.247 1.499 . . . . 0.0 107.094 178.439 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CD1' HG22 ' A' ' 21' ' ' VAL . 85.0 m95 -66.98 -58.48 4.87 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.791 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mt -52.89 -23.19 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.622 177.46 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t -81.13 -20.03 42.24 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.58 -0.7 . . . . 0.0 110.49 179.405 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.423 HG21 ' HA ' ' A' ' 59' ' ' TRP . 3.9 m -98.74 31.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.767 -1.208 . . . . 0.0 109.382 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.05 75.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -72.01 143.55 49.13 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.105 -1.232 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.409 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 18.0 mt-30 -117.34 118.19 35.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HB2' ' CA ' ' A' ' 71' ' ' ARG . 55.2 Cg_endo -81.29 146.73 15.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.499 1.263 . . . . 0.0 109.881 179.603 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -70.27 -171.7 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.053 . . . . 0.0 109.94 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 50.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.146 -0.971 . . . . 0.0 110.101 179.553 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.442 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 28.4 m -165.3 -60.22 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.44 -23.83 67.03 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.113 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.431 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 6.8 ttt-85 -68.76 -46.22 69.37 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.465 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -71.71 -8.02 51.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.417 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 69' ' ' THR . 25.8 mt -102.7 -26.2 13.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 108.604 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.431 ' O ' ' CG2' ' A' ' 79' ' ' VAL . 41.7 mt -72.01 -30.02 64.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.781 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.522 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.15 -28.57 54.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.966 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -76.93 -33.23 57.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.108 0.956 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.451 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -67.4 -9.38 40.99 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.912 178.885 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.69 17.78 32.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.448 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 22.8 t -78.5 -67.0 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.897 -1.355 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' CE1' ' HB3' ' A' ' 75' ' ' ARG . 40.1 p90 -135.59 -169.94 2.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.22 140.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.203 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.69 135.29 29.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.372 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -106.26 58.01 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.51 176.28 8.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -53.13 -26.46 16.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -54.68 151.99 7.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.286 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.75 -157.63 22.69 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 110.26 -179.954 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.241 0.543 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t -73.93 125.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.76 137.23 33.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.462 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.485 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 57.0 mt -99.56 140.16 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.098 -1.001 . . . . 0.0 109.081 179.07 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.442 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 2.2 ptt180 -150.64 171.22 17.48 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.965 -1.084 . . . . 0.0 110.266 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.442 ' CD2' HG21 ' A' ' 69' ' ' THR . 1.9 pp -89.62 128.35 36.04 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.568 179.484 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.522 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.02 175.99 5.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.728 . . . . 0.0 109.07 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.496 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 4.5 ttt-85 -140.76 116.48 10.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.927 -1.108 . . . . 0.0 111.357 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -134.2 -153.54 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 109.806 179.302 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.62 120.27 4.74 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.494 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -65.88 -87.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.227 -1.161 . . . . 0.0 110.289 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -148.83 30.01 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.092 -179.695 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.494 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 4.2 m-70 -120.24 -38.71 2.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.475 -0.766 . . . . 0.0 109.482 -178.5 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.68 104.29 0.94 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.54 114.26 3.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.464 -179.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 24.9 p80 -122.54 159.93 26.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 110.237 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 7' ' ' ALA 0.267 9.2 m-85 -120.26 169.26 10.43 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.685 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -136.71 147.08 46.56 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.825 -1.172 . . . . 0.0 109.257 177.592 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.498 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -96.2 82.56 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 177.259 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.284 0.4 OUTLIER -97.8 161.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.204 -173.389 . . . . . . . . 4 4 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.547 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.46 111.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.61 -0.682 . . . . 0.0 110.599 -177.43 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.403 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.4 t -140.02 -164.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.94 179.639 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 22' ' ' THR . 28.2 t70 -104.91 138.31 41.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 110.142 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -80.1 -33.4 38.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.065 179.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -26.75 68.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 110.188 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 64.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.9 72.75 10.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.875 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.11 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.173 -0.955 . . . . 0.0 110.269 -179.911 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.05 -48.73 64.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.18 47.35 5.26 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.56 124.4 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' CD2' HG23 ' A' ' 20' ' ' VAL . 12.6 p90 -108.33 141.75 39.68 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 mt -50.24 -31.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 179.874 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -176.81 171.31 2.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.12 119.48 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.498 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -113.1 -30.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.424 -0.798 . . . . 0.0 110.286 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.51 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -116.28 163.01 12.45 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.267 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 40' ' ' ASP . 85.3 t80 -140.81 117.16 10.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.563 ' CE1' ' CE3' ' A' ' 48' ' ' TRP . 1.7 t80 -107.44 122.57 46.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.797 -1.189 . . . . 0.0 109.537 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 21.8 t0 -140.29 91.2 9.97 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.724 -1.235 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 43.7 Cg_endo -69.28 79.03 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.78 1.41 . . . . 0.0 110.934 -179.64 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.4 OUTLIER -89.92 120.58 31.26 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 110.12 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.14 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' ARG . 41.0 p -146.79 -63.71 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.416 ' HB ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -150.0 170.45 7.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 109.747 -179.973 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 45' ' ' THR . 43.6 Cg_endo -69.5 62.76 1.63 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.536 1.282 . . . . 0.0 110.457 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -161.88 83.38 0.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.438 -0.788 . . . . 0.0 109.634 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.563 ' CE3' ' CE1' ' A' ' 39' ' ' TYR . 17.4 p-90 -124.8 -11.85 7.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 111.139 -179.262 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 1.3 tm? -94.48 119.79 33.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.945 -1.097 . . . . 0.0 110.702 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.5 ttpt -125.87 94.55 4.14 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.694 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.51 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.2 t -116.38 132.52 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.034 -1.041 . . . . 0.0 111.202 -178.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -74.2 70.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.44 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 1.1 p -35.61 -30.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 122.269 -0.269 . . . . 0.0 111.654 -177.377 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -60.63 -54.14 48.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.776 -1.202 . . . . 0.0 108.435 177.949 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmp_? -69.65 -41.77 75.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.333 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.92 -17.29 63.08 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.341 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 15.1 tpt180 -88.35 -26.01 22.43 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 109.423 178.594 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 3.0 t80 -59.49 -43.31 93.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.378 1.561 . . . . 0.0 107.302 178.241 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.547 ' CD1' HG21 ' A' ' 21' ' ' VAL . 75.8 m95 -69.23 -57.18 5.69 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.987 -178.904 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 33.1 mt -54.71 -22.08 12.82 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.076 -1.015 . . . . 0.0 108.532 177.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -80.93 -22.61 39.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 110.763 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 59' ' ' TRP . 6.0 m -98.88 32.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.828 -1.17 . . . . 0.0 109.585 179.871 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.6 26.49 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -75.11 124.44 27.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.98 -1.306 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 65' ' ' GLN . 7.0 pt20 -98.84 121.01 57.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.785 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.8 Cg_endo -80.8 168.05 17.94 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.401 1.211 . . . . 0.0 110.561 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.454 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -88.8 167.92 12.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.76 179.504 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.78 -29.53 40.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 111.28 -179.247 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.442 HG21 ' CD2' ' A' ' 6' ' ' LEU . 24.2 m -97.51 -44.74 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.009 . . . . 0.0 110.855 -179.332 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -69.97 -24.61 63.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.405 -0.809 . . . . 0.0 109.038 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 67' ' ' THR . 25.1 ttt-85 -70.24 -36.54 74.57 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.577 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -30.59 71.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.002 179.133 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 75.1 mt -75.45 -32.04 60.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.565 179.454 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 24.6 mt -66.56 -30.0 70.2 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 4.7 tmm_? -79.81 -30.67 40.58 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.176 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -27.91 51.26 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.895 0.855 . . . . 0.0 109.703 179.191 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -73.16 -6.34 45.13 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.068 178.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 20.35 40.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 180.0 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 21.6 t -78.52 -63.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.933 -1.333 . . . . 0.0 110.289 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' CE1' ' CG ' ' A' ' 75' ' ' ARG . 14.3 p90 -133.72 -166.24 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 110.632 179.932 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -121.19 -77.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.249 -179.858 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -169.51 150.44 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.905 . . . . 0.0 110.114 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.73 165.41 14.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 146.49 46.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.46 111.52 2.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.374 -0.829 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 4.4 pt-20 -60.19 -19.3 53.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.422 ' N ' ' HG3' ' A' ' 86' ' ' GLU . . . -53.5 -78.91 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.852 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.262 -1.14 . . . . 0.0 110.133 -179.886 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.308 0.575 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.434 HG12 ' CE3' ' A' ' 59' ' ' TRP . 99.1 t -53.94 111.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.49 -179.868 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -140.19 138.12 34.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.068 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.463 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -104.58 133.47 48.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.112 -0.992 . . . . 0.0 109.92 -179.996 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.77 -170.65 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 -179.238 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 16.8 mt -88.6 126.64 35.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.069 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.91 103.09 14.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.93 -179.748 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.1 ttt180 -72.38 113.47 9.44 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.405 -0.809 . . . . 0.0 110.586 -179.921 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 66.1 m-85 -91.79 -63.91 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 109.995 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.59 134.59 42.57 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -178.828 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.408 ' OG ' ' HG2' ' A' ' 12' ' ' LYS . 1.6 p -62.23 -50.45 71.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -1.18 . . . . 0.0 109.65 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.408 ' HG2' ' OG ' ' A' ' 11' ' ' SER . 9.5 ptpp? -171.21 41.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -119.4 -63.5 1.38 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 109.509 -179.311 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -107.74 120.95 45.63 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.485 -0.759 . . . . 0.0 109.592 179.577 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.78 112.81 3.52 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.421 1.221 . . . . 0.0 111.297 -179.197 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.474 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 34.6 p80 -175.57 125.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 0.0 110.581 178.979 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 1.9 m-85 -121.23 165.17 15.82 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.884 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -107.98 160.51 15.72 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.002 176.971 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -97.91 79.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 102.604 -3.11 . . . . 0.0 102.604 177.503 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.3 OUTLIER -97.44 163.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.299 -173.843 . . . . . . . . 4 4 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -110.46 114.04 45.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.359 0.599 . . . . 0.0 110.84 -176.921 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t -137.43 -177.76 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.58 -174.55 4.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.865 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.74 65.91 5.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.358 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -53.33 -179.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.09 -83.8 0.56 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 110.482 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -168.52 33.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -138.79 -53.49 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.12 -167.14 1.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.97 111.98 0.34 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -154.07 136.04 14.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 109.788 179.733 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -116.0 163.0 16.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.236 -0.915 . . . . 0.0 110.79 -179.642 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 mt -77.74 -30.26 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.408 -0.807 . . . . 0.0 109.787 179.878 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.32 177.24 3.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 110.108 179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -115.84 123.12 47.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 110.273 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.526 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.49 -27.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.0 110.98 179.815 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.475 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -127.87 165.85 20.74 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.925 -1.607 . . . . 0.0 112.305 -178.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.461 ' N ' HG12 ' A' ' 19' ' ' ILE . 25.3 t80 -140.71 138.28 34.11 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.865 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.525 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 6.5 t80 -133.32 135.18 44.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.547 -1.345 . . . . 0.0 110.304 179.75 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 26.7 t0 -140.93 95.0 7.77 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.974 -1.079 . . . . 0.0 110.337 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 46.4 Cg_endo -73.34 67.68 4.35 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.568 1.299 . . . . 0.0 110.596 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -174.14 4.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 110.298 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.14 57.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 110.452 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 p -125.01 -43.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.194 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -145.05 163.73 31.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.919 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.6 -17.82 33.49 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.604 1.318 . . . . 0.0 110.47 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.29 105.74 18.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.195 -0.94 . . . . 0.0 110.143 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 4.8 p-90 -133.6 11.64 4.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.261 -0.899 . . . . 0.0 110.856 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.0 tt -112.66 134.59 54.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 0.0 110.617 -179.436 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -137.43 85.67 2.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.485 -0.759 . . . . 0.0 109.07 179.466 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.475 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -117.5 134.72 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 111.227 -178.974 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -80.81 71.32 7.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.376 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.446 ' O ' ' N ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -31.6 -35.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.505 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.6 mm-40 -59.73 -53.88 52.85 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.621 -1.299 . . . . 0.0 108.967 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmp_? -69.45 -41.42 76.28 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.785 . . . . 0.0 109.212 178.737 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -65.39 -20.69 66.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.044 -1.035 . . . . 0.0 108.406 178.936 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -87.74 -23.48 24.11 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 178.703 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.7 t80 -60.0 -45.13 93.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 123.253 1.502 . . . . 0.0 107.085 178.148 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.554 ' CD1' HG22 ' A' ' 21' ' ' VAL . 78.4 m95 -65.23 -53.76 39.62 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.441 -179.103 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' HG13 ' A' ' 79' ' ' VAL . 11.4 mt -56.76 -20.93 24.78 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.566 176.844 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.62 -23.73 39.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.475 HG21 ' HA ' ' A' ' 59' ' ' TRP . 34.1 m -99.27 33.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.882 -1.136 . . . . 0.0 109.565 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.32 30.62 73.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.03 -1.277 . . . . 0.0 110.079 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.46 106.35 58.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' HB3' HD13 ' A' ' 74' ' ' LEU . 55.6 Cg_endo -78.66 129.76 9.38 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.487 1.256 . . . . 0.0 110.238 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.15 174.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 109.9 179.646 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.59 -15.63 63.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 81.1 m -106.12 -45.36 4.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 179.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 73' ' ' LEU . . . -63.14 -24.76 68.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -70.0 -40.34 75.32 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -40.81 94.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.931 178.697 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 13.8 mt -65.99 -33.03 74.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.742 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.418 HD13 ' HB3' ' A' ' 66' ' ' PRO . 31.9 mt -68.49 -26.68 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.336 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.484 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.33 -28.73 47.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.907 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.437 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -80.74 -37.41 30.52 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.955 0.883 . . . . 0.0 109.897 179.938 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -68.64 -7.84 36.7 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.071 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 47.68 9.09 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.443 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 75.4 t -92.97 -57.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.305 -1.115 . . . . 0.0 111.698 -179.092 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.484 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 44.7 m-85 -53.02 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.107 -0.996 . . . . 0.0 110.486 -179.275 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.7 175.46 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 163.04 38.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 110.094 179.926 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -103.01 91.01 3.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.043 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.35 -173.55 2.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 110.114 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.11 64.28 1.28 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 110.366 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -54.29 147.57 13.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.9 24.86 22.4 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 110.136 179.935 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.2 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.269 0.557 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.476 HG13 ' CE3' ' A' ' 59' ' ' TRP . 33.6 t -86.11 140.94 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.922 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -140.75 137.85 33.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.99 -1.069 . . . . 0.0 110.758 -179.87 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.44 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 44.5 mt -103.41 132.7 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.126 -0.984 . . . . 0.0 108.964 178.754 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 10.4 ptt180 -150.85 -169.89 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.102 -0.999 . . . . 0.0 110.391 -179.285 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.47 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 52.0 mt -89.7 130.39 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -0.978 . . . . 0.0 111.452 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.509 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -100.74 104.99 16.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.705 -0.622 . . . . 0.0 110.23 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -75.74 120.48 21.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.012 -1.055 . . . . 0.0 111.253 -179.618 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 15.8 m-85 -110.24 -64.8 1.22 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.506 -0.746 . . . . 0.0 110.797 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.11 134.14 27.97 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -178.431 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.446 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 66.9 p -89.12 -59.17 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 0.0 109.291 179.191 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 11' ' ' SER . 11.4 mtpt -141.82 61.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.446 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 5.0 m-70 -142.14 -64.66 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.403 -0.81 . . . . 0.0 109.467 -178.597 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.71 130.15 10.27 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 179.655 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.62 102.24 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.427 1.225 . . . . 0.0 111.097 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 34.7 p80 -149.41 125.41 10.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.697 179.086 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.9 m-30 -117.92 154.18 32.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.047 -1.033 . . . . 0.0 108.554 178.408 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 9.5 mtt180 -99.19 160.03 14.56 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.131 176.017 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.47 ' CD1' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -99.21 81.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 176.969 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.257 0.3 OUTLIER -97.26 165.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.397 -173.511 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.486 HG12 ' CE3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -110.02 119.9 60.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.735 -0.603 . . . . 0.0 110.724 -176.941 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.0 OUTLIER -140.21 -176.34 4.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.035 -1.041 . . . . 0.0 110.25 179.112 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 22' ' ' THR . 5.7 m-20 -102.23 158.33 16.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 110.513 -179.554 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.55 -60.1 2.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.883 . . . . 0.0 109.939 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -52.1 132.63 33.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.203 -0.935 . . . . 0.0 110.087 179.78 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -155.03 140.68 17.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 0.0 110.598 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.62 -34.91 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 0.0 109.948 179.687 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.72 -42.0 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.971 179.725 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -72.0 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 110.012 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.07 77.33 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 113.11 11.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -1.16 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 4.4 p90 -50.36 172.58 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.439 HG22 ' CZ2' ' A' ' 59' ' ' TRP . 19.7 mm -83.99 -61.66 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.415 -0.803 . . . . 0.0 109.266 179.771 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -151.16 160.48 43.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.751 -0.593 . . . . 0.0 109.593 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.83 110.72 21.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.985 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.525 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.7 pp -104.75 -32.41 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.082 -1.011 . . . . 0.0 111.104 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -122.04 162.54 15.78 Favored Glycine 0 C--N 1.295 -1.745 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.956 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.44 ' N ' HG13 ' A' ' 19' ' ' ILE . 45.9 t80 -134.35 141.49 46.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.217 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -142.27 130.9 22.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.087 -1.445 . . . . 0.0 111.365 -179.1 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 46.3 t0 -131.64 94.97 24.32 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.25 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.32 78.46 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.569 1.3 . . . . 0.0 110.972 -179.357 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.13 165.77 12.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -117.15 54.43 0.87 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.41 HG22 ' N ' ' A' ' 45' ' ' THR . 4.3 t -139.21 -41.75 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.311 -0.868 . . . . 0.0 110.06 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.41 ' N ' HG22 ' A' ' 44' ' ' THR . 72.1 p -133.18 146.36 60.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.45 -14.25 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.675 1.355 . . . . 0.0 110.78 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -97.37 103.42 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.926 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.483 ' CE3' ' HB2' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -142.31 13.79 2.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 -179.823 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.483 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 12.0 tp -111.14 132.58 54.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.114 . . . . 0.0 111.34 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -133.41 94.96 3.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.6 t -118.41 139.45 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 111.34 -179.037 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -85.01 72.99 10.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 175.776 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -35.53 -30.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.06 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -62.46 -48.4 79.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.589 -1.319 . . . . 0.0 108.771 178.257 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 1.1 mmp_? -76.22 -36.55 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 178.673 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -69.54 -20.39 63.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.598 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttp180 -86.78 -23.19 25.5 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.296 -0.877 . . . . 0.0 109.112 178.52 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.429 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 4.7 t80 -61.93 -45.37 94.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 123.099 1.428 . . . . 0.0 107.502 178.427 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.525 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 67.8 m95 -68.07 -57.44 6.1 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.943 -179.166 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.9 mt -56.05 -20.82 18.45 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.329 -0.949 . . . . 0.0 108.707 177.335 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 t -79.98 -23.18 41.77 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.363 -0.836 . . . . 0.0 110.623 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 59' ' ' TRP . 18.8 m -98.89 31.93 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.964 -1.085 . . . . 0.0 109.627 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.77 75.17 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -66.56 134.88 53.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.951 -1.323 . . . . 0.0 110.164 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -99.88 107.83 48.49 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 179.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.7 Cg_endo -82.4 134.55 7.81 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.46 1.242 . . . . 0.0 110.229 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.49 163.19 0.93 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 110.032 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.07 -16.91 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.245 -0.909 . . . . 0.0 110.717 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.7 m -99.61 -47.8 4.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 110.53 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.55 -28.8 66.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.856 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -66.27 -38.6 88.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.318 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -26.74 68.3 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.287 178.939 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.426 HD23 HD21 ' A' ' 49' ' ' LEU . 13.1 mt -88.11 -29.03 20.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 34.0 mt -68.74 -28.24 66.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.733 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.517 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.52 -28.86 30.8 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.558 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -72.96 -33.76 66.07 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.142 0.972 . . . . 0.0 108.918 179.218 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.34 -9.59 54.03 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 178.523 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.91 52.9 3.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.721 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.434 HG23 ' HA ' ' A' ' 53' ' ' VAL . 43.0 t -114.91 -6.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.12 -1.223 . . . . 0.0 111.716 -179.272 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 10.3 m-85 -104.08 -27.2 12.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 0.0 110.663 -178.733 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -130.52 98.44 4.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -58.96 123.07 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.08 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -99.92 -167.24 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.29 -161.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.195 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.16 102.82 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -176.67 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 110.113 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -55.9 -40.68 82.19 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.903 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.193 -1.181 . . . . 0.0 110.158 -179.972 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 mtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.197 0.522 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 41.6 t -60.12 121.52 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 110.087 179.968 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -140.52 134.9 31.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.888 . . . . 0.0 110.603 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.469 HD11 ' CD1' ' A' ' 36' ' ' ILE . 73.4 mt -102.27 134.79 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.026 . . . . 0.0 109.226 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.449 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.2 ptm180 -150.91 -167.86 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.009 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.423 ' CD1' ' HB ' ' A' ' 69' ' ' THR . 4.8 mp -89.18 131.62 35.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -0.779 . . . . 0.0 110.518 -179.866 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' CB ' ' CZ ' ' A' ' 9' ' ' PHE . . . -107.27 111.23 23.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 19.6 ttt-85 -86.17 115.01 23.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 112.313 -178.767 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.538 ' CZ ' ' CB ' ' A' ' 7' ' ' ALA . 1.1 m-85 -114.07 -149.69 0.45 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.489 -0.757 . . . . 0.0 109.196 178.117 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.2 102.45 0.01 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 178.552 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -53.99 -50.42 66.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 0.0 109.698 179.575 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.488 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -176.77 55.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.749 -179.886 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.488 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 13.7 m-70 -133.76 -64.71 0.7 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.189 -179.658 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -123.8 120.1 26.75 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.323 179.447 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.6 120.51 6.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.46 1.242 . . . . 0.0 111.296 -179.217 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.495 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.0 p80 -164.48 131.54 3.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.405 178.836 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 15.2 m-30 -114.43 175.12 5.62 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.353 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.531 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.6 OUTLIER -134.32 158.17 44.48 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.193 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -97.51 86.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 178.003 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.268 0.4 OUTLIER -97.94 164.02 2.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.583 -173.945 . . . . . . . . 4 4 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.516 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -106.87 108.2 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.738 -0.601 . . . . 0.0 110.188 -178.278 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t -133.93 -172.71 3.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.715 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 1.1 m-20 -117.25 162.7 17.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.593 -0.692 . . . . 0.0 109.715 179.665 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.52 14.45 14.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.763 -179.778 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -58.13 -30.0 65.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.993 -1.067 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.3 167.95 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.27 1.4 4.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.582 -179.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -95.99 -71.05 0.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.238 179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.09 145.3 26.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 0.0 110.095 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.2 108.8 1.5 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.86 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -133.56 141.24 47.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -1.155 . . . . 0.0 109.849 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.7 p90 -106.34 177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.157 -0.965 . . . . 0.0 111.037 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.3 mp -91.27 -44.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.649 -0.657 . . . . 0.0 109.994 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 176.52 11.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -109.14 115.01 29.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 179.847 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG22 ' CD1' ' A' ' 59' ' ' TRP . 28.9 pt -113.06 -31.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 110.825 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -121.42 167.08 14.24 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.785 -178.813 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.432 ' N ' HG12 ' A' ' 19' ' ' ILE . 11.5 t80 -140.61 133.03 28.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.061 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.599 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 17.5 t80 -126.07 144.66 50.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.2 t0 -140.91 107.44 6.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.772 178.718 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -73.57 69.77 4.25 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.163 1.086 . . . . 0.0 110.828 -179.389 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 125.74 43.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.059 -1.026 . . . . 0.0 110.206 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -93.62 27.48 2.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.318 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 t -121.28 -14.28 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 0.0 110.68 -179.964 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 71.4 p -136.83 149.83 68.01 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.515 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.416 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 47.1 Cg_endo -73.73 -51.88 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.772 1.406 . . . . 0.0 110.62 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -76.88 107.93 9.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 0.0 110.274 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.599 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 19.0 p-90 -132.15 2.89 3.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.886 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.544 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.4 tm? -109.26 129.0 55.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.972 -1.08 . . . . 0.0 110.935 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -134.49 93.29 3.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.545 -0.722 . . . . 0.0 109.102 178.951 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -113.48 135.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.032 -1.042 . . . . 0.0 111.04 -179.274 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.7 t70 -77.0 70.04 3.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.412 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.473 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -36.13 -30.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 122.265 -0.272 . . . . 0.0 111.42 -177.797 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -61.99 -55.6 27.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.898 -1.126 . . . . 0.0 109.009 178.577 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.475 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 28.8 mmm180 -71.56 -39.92 70.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.185 -0.947 . . . . 0.0 108.797 178.571 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.481 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -62.59 -18.66 62.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.279 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 25.0 ttm180 -88.58 -24.79 22.76 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 178.218 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -61.43 -47.2 86.84 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.268 1.509 . . . . 0.0 107.47 178.576 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CD1' HG22 ' A' ' 36' ' ' ILE . 83.7 m95 -64.66 -56.61 12.68 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.766 -179.016 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 64' ' ' ALA . 38.4 mt -53.35 -22.68 7.77 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.534 177.238 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -21.13 41.1 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.47 -0.769 . . . . 0.0 110.456 179.177 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 59' ' ' TRP . 4.3 m -99.04 32.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.85 -1.156 . . . . 0.0 109.426 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.18 25.12 76.2 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.403 ' HB2' ' HA ' ' A' ' 60' ' ' LEU . . . -69.44 128.51 36.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.016 -1.285 . . . . 0.0 109.792 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.37 113.24 65.85 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 0.0 110.669 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -79.68 132.08 9.63 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.526 1.277 . . . . 0.0 109.766 179.467 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 t -62.93 -178.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.53 52.43 1.4 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 0.0 110.239 179.735 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.423 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 6.3 m -166.05 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -66.55 -23.47 66.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.249 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 26.7 ttp180 -64.79 -41.11 96.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.105 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -63.82 -37.66 88.22 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.284 179.199 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD21 ' CD2' ' A' ' 49' ' ' LEU . 40.3 mt -67.37 -35.79 80.06 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.445 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 55.0 mt -65.08 -26.85 68.4 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.587 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.531 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.32 -28.09 38.24 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.027 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -35.97 42.95 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.958 0.885 . . . . 0.0 109.967 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.48 ' CB ' ' CG1' ' A' ' 51' ' ' VAL . . . -74.62 -2.9 28.13 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.042 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.01 20.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.473 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 57.9 t -91.44 -60.17 2.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.142 -1.211 . . . . 0.0 111.479 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.531 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 46.9 m-85 -50.41 165.73 0.09 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 -179.249 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.62 113.25 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -109.11 150.29 28.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.44 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 83' ' ' GLU . 1.2 pm0 -109.35 66.81 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.21 37.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.621 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 27.72 7.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 110.024 179.847 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.81 129.71 23.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.31 -0.869 . . . . 0.0 110.408 -179.759 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.35 60.27 0.68 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.282 -1.128 . . . . 0.0 110.228 -179.903 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.179 0.514 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.56 109.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 179.876 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.6 ptmt -140.14 137.15 34.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.99 . . . . 0.0 111.044 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.499 ' CD1' ' CB ' ' A' ' 59' ' ' TRP . 93.6 mt -99.93 133.38 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.183 -0.948 . . . . 0.0 109.013 178.993 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.476 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -150.69 173.83 13.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.383 -179.2 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.473 HD11 ' CD2' ' A' ' 17' ' ' TYR . 4.0 pp -87.73 124.68 33.84 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.096 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.4 111.93 24.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.73 . . . . 0.0 112.462 -176.807 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.487 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.4 ttp180 -72.81 122.41 21.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.139 -0.976 . . . . 0.0 111.35 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.511 ' CE2' ' HB2' ' A' ' 18' ' ' ARG . 18.6 m-85 -114.03 -62.66 1.56 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.119 -0.988 . . . . 0.0 110.028 178.961 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 107.99 1.37 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.837 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.435 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 34.7 p -70.52 -53.42 16.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -1.197 . . . . 0.0 109.764 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' N ' ' OG ' ' A' ' 11' ' ' SER . 28.2 mttp -148.07 51.78 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.435 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 2.7 m-70 -141.1 -51.45 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 -178.442 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -145.23 116.4 5.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.603 -0.686 . . . . 0.0 109.36 179.614 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.41 115.33 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.404 1.212 . . . . 0.0 111.033 -179.074 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 32.2 p80 -176.68 136.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 179.139 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 5.5 m-85 -122.33 154.5 37.56 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.727 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.511 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 14.8 ttm180 -103.12 148.13 26.14 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.422 178.2 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.503 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -96.89 79.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 178.278 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.406 HG23 ' CB ' ' A' ' 35' ' ' LYS 0.282 0.4 OUTLIER -97.61 163.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.229 -173.569 . . . . . . . . 4 4 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -110.63 110.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.497 -0.752 . . . . 0.0 110.464 -177.529 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.6 t -139.94 -174.56 3.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.222 -0.924 . . . . 0.0 110.366 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 22' ' ' THR . 56.7 m-20 -111.46 160.19 17.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 110.106 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.94 25.95 6.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -60.36 2.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 110.531 -179.805 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -131.35 155.39 47.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.694 -179.504 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -125.19 34.52 4.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.457 -0.777 . . . . 0.0 109.966 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 -18.33 13.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.648 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -108.69 -43.32 4.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.334 -179.873 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.87 90.99 0.12 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.43 128.7 9.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 110.178 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.4 p90 -110.21 145.94 36.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.438 179.856 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 HG23 ' CH2' ' A' ' 59' ' ' TRP . 1.1 mt -58.91 -36.63 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.592 179.561 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -170.57 138.71 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.899 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.406 ' CB ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -89.71 134.58 34.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.597 179.802 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.507 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -124.15 -22.75 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.054 -1.028 . . . . 0.0 111.35 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 19' ' ' ILE . . . -124.86 162.96 19.0 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.766 -1.683 . . . . 0.0 110.959 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' N ' HG13 ' A' ' 19' ' ' ILE . 65.2 t80 -136.93 137.72 39.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.357 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 5.2 t80 -131.15 128.36 39.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.934 -1.103 . . . . 0.0 109.869 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 8.4 t0 -140.07 76.14 28.02 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 110.866 -179.675 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 42.3 Cg_endo -69.89 76.91 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.544 1.287 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -94.8 162.82 13.61 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -89.79 69.75 7.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 179.87 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 p -137.94 -67.32 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 110.348 -179.899 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -146.37 158.31 47.53 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.56 62.37 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.736 1.388 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -156.98 68.43 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.92 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.576 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.7 p-90 -122.54 -14.72 7.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.322 -0.861 . . . . 0.0 111.092 -179.415 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.544 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 5.5 tt -74.13 115.1 13.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.968 -1.082 . . . . 0.0 110.321 -179.295 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -130.9 90.36 2.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.881 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -115.76 139.95 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.033 -1.042 . . . . 0.0 111.025 -179.656 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.5 t70 -85.25 71.79 10.81 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.899 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.455 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -34.93 -31.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 122.312 -0.242 . . . . 0.0 111.526 -177.31 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.5 tt0 -62.74 -49.81 73.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.788 -1.195 . . . . 0.0 108.928 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.447 ' HB3' ' CG2' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -75.42 -36.17 60.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 108.877 178.63 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' CB ' HD12 ' A' ' 36' ' ' ILE . . . -69.3 -20.35 63.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.393 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.2 tpt180 -85.6 -25.0 26.93 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.239 -0.913 . . . . 0.0 109.216 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 4.8 t80 -60.12 -44.72 94.69 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 123.169 1.461 . . . . 0.0 107.503 178.563 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.507 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 69.2 m95 -68.32 -53.64 22.83 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.254 -179.089 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 23.4 mt -58.28 -19.44 34.54 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.493 177.437 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 m -82.78 -22.75 34.17 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.334 -0.854 . . . . 0.0 110.724 179.798 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 59' ' ' TRP . 28.0 m -98.92 33.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.835 -1.165 . . . . 0.0 109.376 179.407 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.88 35.04 91.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.865 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.37 140.82 52.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.078 -1.248 . . . . 0.0 110.156 179.883 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.59 106.57 40.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.31 179.965 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.439 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -81.67 142.66 12.97 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.404 1.213 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -64.15 -176.44 0.21 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.042 . . . . 0.0 110.36 -179.762 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.53 -21.57 48.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.491 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -101.76 -44.44 5.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -66.39 -29.03 69.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 67' ' ' THR . 46.5 ttt180 -64.41 -38.32 90.63 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.365 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.35 -29.86 70.76 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.675 178.776 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.415 HD23 ' CD1' ' A' ' 49' ' ' LEU . 49.7 mt -81.86 -33.57 30.53 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.857 -0.527 . . . . 0.0 110.0 179.609 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 97.0 mt -67.04 -27.47 67.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.001 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.551 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 7.3 mtp180 -82.19 -30.93 30.63 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.621 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.454 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 3.1 tp-100 -78.3 -33.44 49.35 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.898 0.856 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.45 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.32 -12.83 45.87 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.93 178.414 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.74 43.5 4.8 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.438 HG23 ' CB ' ' A' ' 53' ' ' VAL . 29.3 t -107.61 -16.58 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -1.228 . . . . 0.0 111.321 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.551 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 6.9 m-85 -96.95 81.6 3.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.261 -178.733 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -93.22 21.81 5.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 110.025 179.688 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -139.19 109.97 6.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.851 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.69 128.58 20.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -119.67 164.03 16.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -140.76 -48.9 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.88 120.21 7.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.27 65.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.163 179.935 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.288 0.566 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.403 ' CG1' HG11 ' A' ' 21' ' ' VAL . 63.9 t -81.13 148.17 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' CD ' ' HB3' ' A' ' 65' ' ' GLN . 5.3 mmmm -140.48 130.62 24.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.442 HD11 HG22 ' A' ' 4' ' ' ILE . 31.6 mt -99.81 129.45 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.899 -1.126 . . . . 0.0 109.102 178.941 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.7 ptt180 -150.94 -174.96 4.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 110.812 -178.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.481 HD23 ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -88.98 125.36 34.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 110.969 -179.715 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.53 111.23 23.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.511 -0.743 . . . . 0.0 110.104 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -80.04 120.33 24.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 112.044 -178.807 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.506 ' CE2' ' HB2' ' A' ' 18' ' ' ARG . 1.8 m-85 -118.68 -155.01 0.59 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 178.345 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.68 113.84 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.281 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.441 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 2.1 p -56.7 -47.73 79.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.203 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.04 48.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.688 -0.632 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.441 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 23.9 m-70 -116.75 -60.72 1.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.388 -0.82 . . . . 0.0 109.689 -179.198 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -133.13 130.19 21.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 0.0 109.769 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.09 114.45 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.467 1.246 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.484 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 34.4 p80 -160.35 126.81 4.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 110.245 178.98 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 8.7 m-85 -114.06 161.44 17.71 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.089 -1.007 . . . . 0.0 108.534 178.931 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 14.2 ttm180 -114.08 151.53 32.39 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.351 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.458 ' HB ' ' HA3' ' A' ' 37' ' ' GLY . 0.8 OUTLIER -97.94 80.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 102.513 -3.144 . . . . 0.0 102.513 178.171 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.27 0.4 OUTLIER -97.57 166.32 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.41 -173.459 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.549 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -111.49 113.42 44.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.595 -0.691 . . . . 0.0 110.627 -177.251 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.3 t -136.03 -176.23 4.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.259 179.683 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER -91.58 -165.76 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.02 179.814 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.16 28.52 3.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -79.73 0.38 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.329 -0.857 . . . . 0.0 110.833 -179.539 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 123.43 18.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 0.0 110.625 -179.521 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.94 45.21 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.036 179.817 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -136.97 -50.52 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.296 -179.792 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.53 173.95 7.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.5 40.91 1.99 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.96 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.47 121.52 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -1.131 . . . . 0.0 110.594 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 p90 -120.35 143.69 48.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.499 179.896 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.467 HG23 ' CH2' ' A' ' 59' ' ' TRP . 2.3 mp -55.08 -33.3 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.12 175.11 2.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 126.05 54.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.034 179.895 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.538 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -120.3 -31.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.158 -0.964 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.507 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -118.43 156.35 15.69 Favored Glycine 0 C--N 1.298 -1.543 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.72 143.5 51.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.607 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 33.9 t80 -138.6 136.86 36.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.671 -1.268 . . . . 0.0 110.752 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.6 t0 -140.39 102.83 6.61 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.064 -1.022 . . . . 0.0 110.047 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 48.0 Cg_endo -78.9 82.09 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.073 1.038 . . . . 0.0 110.574 -179.253 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -91.7 170.3 10.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.044 -1.035 . . . . 0.0 110.451 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 46.62 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -143.81 -63.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -126.01 144.12 47.72 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.41 ' HA ' ' CD1' ' A' ' 48' ' ' TRP . 46.4 Cg_endo -73.51 -8.72 22.06 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.67 1.353 . . . . 0.0 110.806 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.11 61.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.983 -1.073 . . . . 0.0 110.384 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.607 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 13.9 p-90 -121.88 -13.31 8.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.191 -0.943 . . . . 0.0 110.802 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.1 tt -81.01 117.91 22.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 110.293 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -131.96 98.31 4.41 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.32 179.269 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.507 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -122.81 138.1 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 111.324 -179.039 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t70 -83.35 72.12 10.23 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.438 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -35.15 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 CA-C-O 120.631 0.253 . . . . 0.0 111.348 -177.409 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 52' ' ' ASP . 17.4 mt-10 -60.5 -52.76 63.84 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.878 -1.138 . . . . 0.0 108.626 178.148 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 53.5 mmm-85 -72.82 -41.05 65.29 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.357 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' CB ' HD11 ' A' ' 36' ' ' ILE . . . -62.25 -18.36 60.98 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.088 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.3 ttp180 -88.85 -27.99 20.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.259 -0.901 . . . . 0.0 109.368 178.566 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 2.5 t80 -59.82 -44.33 94.09 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.294 1.521 . . . . 0.0 107.545 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' CD1' HG23 ' A' ' 21' ' ' VAL . 74.7 m95 -68.4 -56.68 7.66 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.889 -178.91 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.61 -21.67 11.14 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.006 -1.059 . . . . 0.0 108.647 177.429 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 24.4 t -80.92 -23.42 38.93 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.399 -0.813 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.445 HG23 ' HA ' ' A' ' 59' ' ' TRP . 6.0 m -98.95 32.19 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.805 -1.184 . . . . 0.0 109.568 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.0 24.47 75.89 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.68 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -72.02 101.47 2.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.918 -1.343 . . . . 0.0 109.83 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.433 ' HB3' ' CD ' ' A' ' 3' ' ' LYS . 1.7 tt0 -69.84 114.78 27.47 Favored Pre-proline 0 C--N 1.297 -1.701 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.355 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.2 Cg_endo -82.2 124.94 4.45 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.599 1.315 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.63 164.98 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.15 -0.969 . . . . 0.0 110.212 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.1 -18.04 31.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.4 m -95.89 -50.14 5.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 74' ' ' LEU . . . -68.06 -28.5 67.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.389 -0.819 . . . . 0.0 109.206 -179.555 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.2 ttp180 -66.86 -38.08 85.66 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.735 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -23.94 65.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.069 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' CD2' HD13 ' A' ' 49' ' ' LEU . 17.9 mt -90.96 -26.39 19.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.459 -0.776 . . . . 0.0 109.621 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.438 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 25.6 mt -69.76 -30.12 67.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.85 -29.16 44.41 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.141 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.401 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 5.8 tp-100 -73.34 -34.2 65.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.139 0.971 . . . . 0.0 108.516 178.902 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -72.12 -7.33 48.42 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.692 177.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.65 50.07 4.6 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.589 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 40.6 t -112.45 10.67 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -1.178 . . . . 0.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 12.1 m-85 -121.67 15.28 11.05 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.908 -1.12 . . . . 0.0 110.441 -179.785 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -80.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.78 -179.526 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -96.93 158.5 15.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.51 -179.434 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -148.48 178.55 8.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.17 54.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.285 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -131.24 -43.55 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.57 49.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.984 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 49.49 0.91 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 110.181 179.993 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.204 0.526 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.4 t -89.75 140.6 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.939 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -140.24 130.62 25.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.511 -179.904 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.456 HD12 ' CD1' ' A' ' 36' ' ' ILE . 77.9 mt -102.37 133.11 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.135 -0.978 . . . . 0.0 109.925 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptt85 -150.8 -165.48 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.63 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.43 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 50.5 mt -89.26 132.65 34.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.008 -1.058 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -104.26 100.88 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 179.708 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -71.32 119.61 15.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 111.169 -179.645 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.52 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 33.6 m-85 -105.26 -63.94 1.18 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 179.217 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.26 130.3 28.95 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.547 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.454 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 1.5 p -68.87 -42.78 76.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -1.065 . . . . 0.0 109.504 179.389 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.62 36.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.662 0.744 . . . . 0.0 109.353 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.454 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 10.8 m-70 -115.46 -59.68 1.97 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.35 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 10.9 t-20 -123.81 113.82 28.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.061 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.09 109.28 2.79 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.387 1.204 . . . . 0.0 111.255 -179.006 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.471 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 33.5 p80 -164.88 131.8 3.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.351 179.164 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.565 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.8 m-85 -122.55 155.01 37.13 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.549 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 1.8 mmt180 -99.81 165.25 11.67 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.147 -1.421 . . . . 0.0 107.999 176.736 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.544 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -98.48 81.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 177.244 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -97.4 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.681 -173.947 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.524 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -111.84 108.65 26.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.748 -0.595 . . . . 0.0 110.947 -176.951 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 3.1 t -138.93 -164.99 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.004 179.452 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OG1' ' A' ' 22' ' ' THR . 5.0 t70 -96.63 177.1 5.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 110.206 -179.942 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.07 -51.53 2.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.165 179.934 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -34.8 37.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 110.293 179.965 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -89.96 98.16 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.892 . . . . 0.0 110.038 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 -13.86 19.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.713 -179.737 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -83.69 -21.79 32.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.078 -1.014 . . . . 0.0 110.364 -179.836 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -76.83 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 179.884 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.04 16.59 40.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -112.36 144.99 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.061 -1.258 . . . . 0.0 110.277 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 -113.61 178.32 4.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.199 -0.938 . . . . 0.0 110.495 179.951 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.0 mt -82.88 -45.2 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.745 . . . . 0.0 109.667 179.76 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 165.91 32.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.447 -0.783 . . . . 0.0 110.01 179.787 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HD3' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -99.0 108.47 21.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 179.861 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.521 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 30.9 pt -101.51 -36.22 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.095 -1.003 . . . . 0.0 111.581 -179.566 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -125.95 172.04 17.78 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.758 -1.687 . . . . 0.0 112.868 -177.934 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 77.9 t80 -141.11 133.26 27.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.237 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.544 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 6.1 t80 -132.12 133.46 44.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.567 -1.333 . . . . 0.0 110.394 178.853 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 5.9 t0 -140.26 100.96 6.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.948 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.69 82.78 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.569 1.3 . . . . 0.0 111.026 -179.315 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 19.5 mtp180 -89.94 155.24 19.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.381 -0.824 . . . . 0.0 109.851 179.509 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 49.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.9 t -149.86 -41.6 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.028 -1.045 . . . . 0.0 110.795 -179.881 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 t -110.25 152.74 43.38 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.571 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.96 -49.03 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.751 1.395 . . . . 0.0 110.19 179.701 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.89 105.29 8.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CE3' ' HB2' ' A' ' 49' ' ' LEU . 1.6 p-90 -126.58 17.11 7.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.867 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.499 ' HB2' ' CE3' ' A' ' 48' ' ' TRP . 10.9 tp -120.78 130.71 54.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.932 -1.105 . . . . 0.0 111.028 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -128.4 92.64 3.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.134 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.84 149.07 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 111.29 -179.025 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t0 -93.31 67.04 4.06 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.765 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -32.05 -33.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.667 -177.334 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.34 -53.33 58.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.995 178.537 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 25.7 mmm180 -71.7 -41.87 68.08 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 108.66 178.525 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -61.99 -18.68 61.26 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.222 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.2 ttt-85 -88.27 -27.2 21.89 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.326 -0.859 . . . . 0.0 109.508 178.167 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.7 OUTLIER -59.49 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.234 1.493 . . . . 0.0 107.564 178.637 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.524 ' CD1' HG23 ' A' ' 21' ' ' VAL . 81.5 m95 -66.38 -54.82 19.96 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.511 -178.923 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.405 ' HA ' ' HB1' ' A' ' 64' ' ' ALA . 9.1 mt -55.6 -21.49 17.73 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.533 177.081 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.8 t -82.57 -20.74 35.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.423 -0.798 . . . . 0.0 110.622 179.687 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 59' ' ' TRP . 4.5 m -99.12 32.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.48 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.36 72.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -68.07 142.52 55.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.036 -1.273 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -110.62 109.4 57.97 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 110.645 -179.699 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.437 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -80.21 125.41 5.81 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.586 1.308 . . . . 0.0 109.815 179.339 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 t -56.91 178.87 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 0.0 110.539 -179.819 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.74 54.22 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 0.0 109.781 179.172 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -165.64 -58.3 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.761 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.48 -23.7 66.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.026 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 3.4 ttm180 -69.17 -41.79 76.75 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.157 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -65.78 -41.47 91.97 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.652 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 13.9 mt -69.97 -28.16 65.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.493 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 12.8 mt -68.82 -29.05 67.31 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.514 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.532 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.12 -30.77 39.11 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.421 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -31.34 34.93 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.847 0.832 . . . . 0.0 109.877 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.448 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . -70.52 -6.83 39.1 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.051 178.863 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.45 48.6 6.24 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.449 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 48.4 t -100.64 -62.18 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.206 -1.173 . . . . 0.0 111.461 -179.385 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.532 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.6 m-30 -52.74 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.077 -1.015 . . . . 0.0 110.225 -179.234 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' VAL . 58.6 mtt180 -153.78 -165.56 2.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 -179.998 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -126.22 64.26 1.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -100.44 73.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.252 -179.97 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.63 -159.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.438 -179.937 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.57 -14.29 49.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.469 -179.84 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.64 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.208 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.84 -92.69 0.56 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.155 -1.203 . . . . 0.0 110.183 -179.97 . . . . . . . . 0 0 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.308 0.575 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 70.3 t -58.67 132.51 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 110.146 -179.965 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.19 135.33 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.491 HD13 ' CD1' ' A' ' 36' ' ' ILE . 86.2 mt -102.86 135.34 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.038 -1.039 . . . . 0.0 109.737 179.433 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.38 -168.78 3.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.373 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.467 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.0 mp -89.45 127.25 35.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 179.916 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' ' CE1' ' A' ' 9' ' ' PHE . . . -102.21 108.92 20.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.573 -0.705 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.497 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 2.8 ttt180 -82.02 113.57 20.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 111.688 -179.468 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.484 ' HB2' ' CE1' ' A' ' 16' ' ' HIS . 11.3 m-85 -100.38 -62.96 1.17 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 178.43 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 124.93 33.33 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.495 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 5.8 p -52.31 -40.23 61.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.851 179.405 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 -35.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.191 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.4 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 7.4 m-70 -44.37 -64.61 0.65 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.601 0.715 . . . . 0.0 109.489 -179.634 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -106.68 96.0 13.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.586 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.05 96.17 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.788 1.415 . . . . 0.0 111.271 -178.636 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.484 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 29.9 p80 -150.75 134.87 16.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.284 178.994 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 5.0 m-85 -121.32 -179.27 4.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.247 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 70.7 mtt180 -131.99 157.15 44.83 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.686 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.516 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -98.07 81.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 177.622 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.445 HG22 ' CD2' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -97.72 168.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.639 -173.785 . . . . . . . . 4 4 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.534 HG22 ' CD1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -113.37 108.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.69 -0.631 . . . . 0.0 110.658 -177.087 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.1 t -140.19 -165.85 1.99 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.416 ' N ' ' OG1' ' A' ' 22' ' ' THR . 25.4 t0 -109.05 117.91 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.84 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.57 -47.37 82.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -29.92 21.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.494 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 85.25 6.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 179.805 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.9 78.27 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -169.9 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.249 179.8 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.98 -23.79 65.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.02 47.99 76.53 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.887 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.14 137.05 55.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -1.171 . . . . 0.0 110.179 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.445 ' CD2' HG22 ' A' ' 20' ' ' VAL . 5.3 p90 -110.17 -173.82 2.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 56.3 mt -93.58 -36.31 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.503 -0.748 . . . . 0.0 110.002 -179.876 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.12 167.82 15.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.904 -179.958 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 4.2 pttp -102.05 111.7 24.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 179.902 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.503 HG21 ' CD1' ' A' ' 59' ' ' TRP . 32.2 pt -107.41 -35.21 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.912 -1.117 . . . . 0.0 111.244 -179.648 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.481 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -122.78 168.05 15.1 Favored Glycine 0 C--N 1.296 -1.648 0 C-N-CA 118.959 -1.591 . . . . 0.0 112.254 -177.887 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.429 ' N ' HG12 ' A' ' 19' ' ' ILE . 90.8 t80 -141.36 125.9 17.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.571 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.516 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 10.9 t80 -120.66 130.12 53.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.813 -1.179 . . . . 0.0 109.43 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 14.8 t0 -140.68 82.14 16.12 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.293 -1.504 . . . . 0.0 111.633 179.851 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.24 76.65 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.343 1.181 . . . . 0.0 110.647 179.439 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -178.91 4.96 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.2 -0.938 . . . . 0.0 110.307 -179.968 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -111.73 50.77 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.036 -179.972 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -134.81 -49.79 0.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.496 -179.743 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -144.98 152.4 51.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.911 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.83 -11.32 21.8 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.75 1.395 . . . . 0.0 110.694 -179.885 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.43 74.89 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.817 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 10.9 p-90 -117.69 -21.17 8.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.18 -0.95 . . . . 0.0 110.509 179.841 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.3 tt -75.01 112.62 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.438 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.93 95.66 3.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 109.5 179.393 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.481 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.57 143.53 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 111.411 -179.102 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 t70 -87.95 70.16 9.44 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.389 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.462 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.11 -32.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.486 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.47 -57.18 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.7 -1.25 . . . . 0.0 108.818 178.526 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.435 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -67.64 -41.3 84.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 108.998 178.538 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.5 -19.35 65.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.615 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.9 ttt180 -89.17 -22.26 22.89 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 178.501 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.435 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 5.3 t80 -59.95 -44.64 94.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.25 1.5 . . . . 0.0 107.14 178.282 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.534 ' CD1' HG22 ' A' ' 21' ' ' VAL . 81.0 m95 -68.43 -58.22 4.67 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.909 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.409 HD23 ' HG3' ' A' ' 66' ' ' PRO . 30.6 mt -53.13 -23.57 8.44 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.586 177.474 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.5 m -80.87 -21.33 40.77 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.484 -0.76 . . . . 0.0 110.348 179.287 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.432 ' CG1' ' O ' ' A' ' 58' ' ' TYR . 3.5 m -99.12 31.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.872 -1.143 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.91 24.9 75.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.972 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 138.59 55.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.916 -1.343 . . . . 0.0 110.264 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.449 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -105.47 107.87 60.16 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.912 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.42 ' HB3' HD12 ' A' ' 74' ' ' LEU . 56.2 Cg_endo -82.38 132.01 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.474 1.25 . . . . 0.0 110.484 179.982 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.1 p -58.97 166.27 2.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 179.417 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.17 -26.31 64.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.913 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.409 ' CG2' HD23 ' A' ' 6' ' ' LEU . 8.4 m -84.87 -51.8 6.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 110.482 -179.879 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.15 -25.42 63.45 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.441 -0.787 . . . . 0.0 108.942 179.981 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 67' ' ' THR . 8.1 ttm180 -69.39 -36.09 76.44 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.131 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -40.98 92.49 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.557 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 49' ' ' LEU . 16.2 mt -69.29 -28.08 65.98 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.267 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.42 HD12 ' HB3' ' A' ' 66' ' ' PRO . 25.0 mt -73.18 -27.03 61.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.468 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.6 -29.93 29.84 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.117 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.435 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -84.37 -31.07 24.94 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.859 0.837 . . . . 0.0 110.045 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.449 ' HB2' ' CG1' ' A' ' 51' ' ' VAL . . . -70.6 -7.9 47.62 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.772 -0.58 . . . . 0.0 109.829 178.667 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.09 50.3 4.64 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.691 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.462 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 21.8 t -102.74 -59.87 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.119 -1.224 . . . . 0.0 111.206 -179.696 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 2.9 m-30 -56.41 -33.27 65.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.05 . . . . 0.0 109.603 -179.6 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -80.21 -168.65 1.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 110.216 -179.602 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -111.94 -174.18 2.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.892 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.82 147.72 6.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.157 179.836 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.74 111.29 5.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.268 -179.951 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.96 42.45 0.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 110.322 -179.93 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.87 77.57 1.59 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 179.987 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -116.89 -168.79 14.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.202 -1.176 . . . . 0.0 110.227 -179.905 . . . . . . . . 0 0 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.304 0.573 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 46.8 t -62.43 116.31 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.177 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -140.81 141.19 34.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.521 -179.775 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.497 HD13 ' CD1' ' A' ' 36' ' ' ILE . 91.0 mt -108.57 131.11 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.055 -1.028 . . . . 0.0 109.462 178.97 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.488 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.2 -175.68 5.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 110.69 -179.138 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 3.9 mp -88.72 122.41 32.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.95 107.15 19.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 112.055 -178.561 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.489 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -57.21 127.79 33.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.653 179.036 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.55 ' HB2' ' CE1' ' A' ' 16' ' ' HIS . 27.6 m-85 -101.65 -79.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.451 -0.781 . . . . 0.0 111.834 -178.588 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.04 168.14 0.73 Allowed Glycine 0 N--CA 1.482 1.756 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -177.901 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.464 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 8.2 p -85.56 -42.7 14.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.559 -0.965 . . . . 0.0 109.755 179.682 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.07 47.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.619 -0.676 . . . . 0.0 109.981 -179.562 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.464 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 11.4 m-70 -125.83 -64.36 1.06 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.435 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 20.0 m-20 -118.3 106.56 44.71 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.606 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' PRO . 43.8 Cg_endo -70.15 66.45 2.0 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.503 1.265 . . . . 0.0 112.667 -177.893 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.55 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 23.3 p80 -109.95 134.83 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.93 -1.106 . . . . 0.0 109.441 177.987 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 10.2 m-85 -117.82 157.84 25.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.069 179.74 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.542 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.5 153.52 18.96 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.645 177.303 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 1.2 mm -97.67 73.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 176.336 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.258 0.4 OUTLIER -97.59 162.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.093 -173.053 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.607 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.15 114.32 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.439 0.638 . . . . 0.0 111.441 -176.883 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.2 t -140.03 -173.03 3.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.603 178.888 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 15.6 p30 -104.66 176.25 5.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.178 -0.951 . . . . 0.0 110.323 -179.841 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.16 22.51 15.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.528 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -77.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 110.248 179.943 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.61 130.94 54.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.169 179.966 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -101.45 44.84 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.34 -60.4 1.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 179.885 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.68 -71.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.895 . . . . 0.0 110.211 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.74 28.87 3.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.976 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 136.54 54.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 -179.885 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.429 ' CE2' ' HG3' ' A' ' 35' ' ' LYS . 11.9 p90 -122.5 177.66 5.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.367 -0.833 . . . . 0.0 110.549 -179.851 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.487 HD13 ' CH2' ' A' ' 59' ' ' TRP . 14.8 mt -88.45 -31.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.514 -0.741 . . . . 0.0 109.878 179.858 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.48 157.14 2.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.487 -0.758 . . . . 0.0 109.877 -179.88 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 36.3 mtmt -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.497 ' CD1' HD13 ' A' ' 4' ' ' ILE . 29.0 pt -100.0 -35.62 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 110.859 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.477 ' HA3' ' CG2' ' A' ' 51' ' ' VAL . . . -126.13 166.38 18.92 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.017 -178.453 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.447 ' N ' HG12 ' A' ' 19' ' ' ILE . 84.8 t80 -141.01 137.07 32.71 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.808 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.575 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 16.3 t80 -127.08 131.02 50.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 109.296 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -140.67 107.13 6.45 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.741 -1.224 . . . . 0.0 111.31 179.917 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' CD ' ' O ' ' A' ' 15' ' ' PRO . 54.4 Cg_endo -86.75 39.15 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.521 1.274 . . . . 0.0 110.69 179.089 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -89.69 -135.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -70.99 62.04 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.736 -1.227 . . . . 0.0 109.246 179.378 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.403 ' O ' ' HB3' ' A' ' 48' ' ' TRP . 56.5 p -150.94 96.4 2.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.431 -0.793 . . . . 0.0 109.387 -179.602 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.551 ' HB ' ' HD3' ' A' ' 46' ' ' PRO . 8.9 m -88.67 -43.23 0.46 Allowed Pre-proline 0 C--N 1.295 -1.776 0 O-C-N 121.191 -0.943 . . . . 0.0 110.544 -179.824 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 45' ' ' THR . 51.3 Cg_endo -91.45 -55.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.046 1.024 . . . . 0.0 110.654 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -101.62 90.47 4.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.355 -0.841 . . . . 0.0 110.352 -179.429 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.575 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 27.3 p-90 -129.3 5.54 5.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.792 . . . . 0.0 110.831 -179.793 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 1.6 tm? -118.23 123.47 45.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.89 -1.131 . . . . 0.0 110.508 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 11.6 tttm -125.7 97.6 5.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.571 -0.706 . . . . 0.0 109.111 179.175 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.477 ' CG2' ' HA3' ' A' ' 37' ' ' GLY . 1.1 t -124.06 144.22 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.031 -1.043 . . . . 0.0 111.396 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.3 t0 -87.66 70.27 9.7 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.794 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.441 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.7 OUTLIER -35.33 -30.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.471 -177.655 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.6 mt-10 -62.18 -54.74 36.7 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.909 -1.119 . . . . 0.0 108.967 178.092 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.484 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 3.4 mtm-85 -74.15 -33.57 63.57 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 178.951 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -68.24 -24.69 64.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.212 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -84.35 -22.94 30.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 178.285 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -61.65 -51.76 67.13 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.192 1.472 . . . . 0.0 107.722 178.909 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.607 ' CD1' HG21 ' A' ' 21' ' ' VAL . 82.9 m95 -59.81 -53.75 54.33 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.899 -179.183 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.2 -20.06 9.66 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.559 177.094 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.1 t -81.56 -21.29 38.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 110.682 179.279 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.419 HG22 ' HA ' ' A' ' 59' ' ' TRP . 10.2 m -98.88 32.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.816 -1.177 . . . . 0.0 109.813 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.04 72.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -73.39 122.62 22.36 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.183 -1.187 . . . . 0.0 110.109 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 112.49 48.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.8 Cg_endo -82.12 127.31 5.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.518 1.273 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 167.39 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.082 -1.011 . . . . 0.0 109.789 179.677 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.33 -17.35 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.735 -179.626 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.404 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.0 OUTLIER -99.06 -49.57 4.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.346 -179.868 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.419 ' CB ' ' HA ' ' A' ' 5' ' ' ARG . . . -66.7 -23.08 66.07 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.335 -0.853 . . . . 0.0 109.026 -179.961 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 7.5 tmm_? -71.75 -41.35 68.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.28 83.6 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.291 -0.963 . . . . 0.0 108.962 178.847 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.414 HD22 ' CE2' ' A' ' 39' ' ' TYR . 28.5 mt -72.62 -27.05 61.91 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.742 . . . . 0.0 109.15 179.192 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 15.0 mt -72.37 -29.57 63.9 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 177.763 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 1.4 tmm_? -79.59 -31.88 41.85 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.548 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.31 -26.81 47.07 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.016 0.913 . . . . 0.0 109.218 178.69 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -70.67 -7.74 46.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.78 16.51 45.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.99 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 74' ' ' LEU . 22.2 t -77.12 -66.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.308 . . . . 0.0 109.826 179.728 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 75' ' ' ARG . 15.9 p90 -129.37 60.74 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.349 -0.844 . . . . 0.0 110.431 179.331 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.67 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.507 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -149.39 122.85 9.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.021 -1.049 . . . . 0.0 110.429 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -129.74 104.42 7.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.974 179.784 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.16 157.41 16.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.298 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.43 70.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 179.941 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -178.63 60.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 179.959 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.13 69.48 3.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.867 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.339 -1.095 . . . . 0.0 110.315 179.896 . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.249 0.547 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 92.8 t -80.0 131.56 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.24 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -140.77 142.49 34.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.436 HD13 ' CB ' ' A' ' 59' ' ' TRP . 73.8 mt -109.92 134.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.041 . . . . 0.0 109.825 179.382 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.27 -171.21 3.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.948 -1.095 . . . . 0.0 110.766 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.1 mp -89.01 126.4 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.529 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.92 106.31 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 110.767 -179.634 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.525 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -75.77 119.0 19.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.822 -1.174 . . . . 0.0 111.43 -179.714 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' A' ' 7' ' ' ALA . 9.0 m-85 -113.68 -63.5 1.44 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.139 -0.975 . . . . 0.0 110.463 178.935 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.2 115.25 2.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.449 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 36.2 p -81.18 -60.86 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 11' ' ' SER . 12.9 mtmt -141.91 41.26 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.508 -0.745 . . . . 0.0 109.035 -179.876 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.461 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.6 m-70 -128.23 -44.68 1.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.796 0.808 . . . . 0.0 109.137 -178.672 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -162.88 117.29 1.15 Allowed Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.718 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.49 107.39 2.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.304 1.16 . . . . 0.0 111.359 -178.93 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 33.6 p80 -153.14 131.39 11.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.124 178.945 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.4 m-85 -117.54 155.49 29.7 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.864 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HD2' ' CE2' ' A' ' 9' ' ' PHE . 16.7 mtt-85 -108.75 160.47 15.94 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.256 -1.378 . . . . 0.0 107.988 176.678 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.524 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.62 81.53 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 177.643 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.32 164.38 2.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.611 -173.856 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.514 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -110.09 109.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.76 -0.587 . . . . 0.0 110.181 -177.483 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 5.7 t -140.06 -158.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.818 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.3 OUTLIER -96.72 162.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 109.939 179.658 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.49 74.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.547 -179.706 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.14 123.54 1.98 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.223 -0.923 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.13 156.18 44.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.968 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.82 -1.04 33.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -97.54 -43.5 7.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -172.77 167.61 5.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.294 -0.879 . . . . 0.0 110.147 -179.971 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.0 58.92 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.954 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 105.18 16.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 110.157 179.925 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD2' HG21 ' A' ' 20' ' ' VAL . 6.3 p90 -51.86 172.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.699 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.459 HG23 ' CZ2' ' A' ' 59' ' ' TRP . 2.6 mp -83.7 -33.06 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.616 -0.678 . . . . 0.0 109.367 179.383 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.21 156.06 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.559 -0.713 . . . . 0.0 109.688 179.472 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.87 111.34 22.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.388 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.523 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 2.8 pp -102.42 -26.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.203 -0.935 . . . . 0.0 110.59 179.482 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -123.39 165.96 15.97 Favored Glycine 0 C--N 1.297 -1.637 0 C-N-CA 119.173 -1.489 . . . . 0.0 111.925 -179.468 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' N ' HG12 ' A' ' 19' ' ' ILE . 6.5 t80 -140.86 132.9 27.82 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.901 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.524 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 15.0 t80 -130.7 140.61 50.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.754 -1.216 . . . . 0.0 109.877 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 29.8 t0 -140.34 93.24 9.01 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.869 -1.145 . . . . 0.0 109.863 179.051 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 40.9 Cg_endo -67.17 82.27 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.285 1.15 . . . . 0.0 111.014 -179.184 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -104.54 156.6 17.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.338 -0.851 . . . . 0.0 110.246 179.73 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -106.94 60.71 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.394 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -140.16 -81.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.141 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -118.14 149.37 45.51 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.872 . . . . 0.0 110.025 179.899 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.44 61.26 3.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.675 1.355 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.1 60.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.48 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -123.39 -11.37 7.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.152 -0.968 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.3 tt -84.58 116.25 23.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 110.229 179.903 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.46 88.99 2.46 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.513 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.4 t -115.53 130.41 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 111.197 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t70 -75.32 71.42 2.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.016 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.456 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -34.18 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.681 -177.45 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 39.9 tt0 -62.12 -51.94 65.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.667 -1.271 . . . . 0.0 108.851 178.136 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.422 ' NE ' ' HA ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -71.41 -39.18 71.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 178.701 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' CB ' ' CD1' ' A' ' 36' ' ' ILE . . . -66.99 -19.53 65.73 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.335 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.1 ttp85 -87.18 -25.73 23.91 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.402 -0.811 . . . . 0.0 109.377 178.755 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.417 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 7.9 t80 -59.32 -45.9 90.07 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.231 1.491 . . . . 0.0 107.519 178.539 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.523 ' CD1' ' CG2' ' A' ' 36' ' ' ILE . 70.9 m95 -66.89 -56.95 8.04 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.415 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 12.7 mt -53.67 -22.83 9.71 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.572 177.327 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.59 -23.28 49.95 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.465 -0.772 . . . . 0.0 110.234 179.28 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 59' ' ' TRP . 5.4 m -98.88 32.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.898 -1.126 . . . . 0.0 109.509 179.873 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.43 22.33 77.69 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.901 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.416 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -63.53 134.59 55.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.979 -1.306 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -105.83 110.0 63.71 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 110.401 -179.797 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HB2' ' CA ' ' A' ' 71' ' ' ARG . 54.1 Cg_endo -83.62 130.71 5.25 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.455 1.24 . . . . 0.0 109.814 179.516 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.443 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 4.8 t -54.76 -177.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -0.942 . . . . 0.0 110.091 -179.853 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.68 0.67 16.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.969 -1.082 . . . . 0.0 111.707 -179.163 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.6 m -110.86 -50.9 2.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.862 -1.149 . . . . 0.0 110.035 179.794 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.403 ' HB1' HG23 ' A' ' 67' ' ' THR . . . -72.04 -26.82 62.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.635 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.6 ttt180 -67.26 -38.12 84.6 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.383 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -66.63 -36.95 83.8 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 108.724 179.061 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.429 HD21 ' CD1' ' A' ' 49' ' ' LEU . 12.2 mt -72.79 -28.32 62.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.878 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.427 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 30.9 mt -71.55 -28.69 64.03 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.443 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.402 ' HG2' ' O ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.71 -30.62 46.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.327 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.2 tp-100 -84.07 -32.2 24.93 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.881 0.848 . . . . 0.0 110.265 -179.843 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.88 -13.36 44.52 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.766 -0.583 . . . . 0.0 109.999 178.963 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.26 25.03 10.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.443 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 30.1 t -85.43 -68.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.801 -1.411 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 80' ' ' PHE . 17.8 p90 -126.83 149.91 49.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.153 -179.98 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 4.0 mtt180 -158.48 -79.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.411 -0.806 . . . . 0.0 109.904 179.932 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -164.72 1.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.044 179.727 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -96.39 76.84 2.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.862 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.77 123.62 26.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 179.693 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -107.68 132.87 52.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -62.44 -48.75 78.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.375 -0.828 . . . . 0.0 110.059 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.74 -90.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.959 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.264 -1.139 . . . . 0.0 110.323 179.972 . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.229 0.538 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.1 m -119.0 116.49 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.333 -0.854 . . . . 0.0 110.596 -179.692 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -140.25 132.26 27.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.184 179.667 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.486 HD11 ' CD1' ' A' ' 36' ' ' ILE . 76.3 mt -103.08 132.09 50.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.095 -1.003 . . . . 0.0 109.551 179.351 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.35 -169.07 3.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.2 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' HB3' ' CB ' ' A' ' 17' ' ' TYR . 36.4 mt -88.81 129.41 35.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 179.752 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.39 101.11 12.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.155 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 1.2 tmm_? -71.18 115.14 9.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.722 -0.611 . . . . 0.0 111.538 -179.252 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.507 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 27.6 m-85 -102.77 -62.33 1.29 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 178.698 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.86 140.15 38.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.679 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.44 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 55.2 p -92.75 -56.64 2.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.0 109.595 179.403 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 1.1 mtmt -144.49 55.95 1.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.936 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.44 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.8 m-70 -140.46 -64.28 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -178.615 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -135.38 116.69 12.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.629 -0.67 . . . . 0.0 109.33 179.481 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.97 83.6 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.362 1.191 . . . . 0.0 111.1 -179.18 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.468 ' O ' ' ND1' ' A' ' 16' ' ' HIS . 34.6 p80 -131.69 129.81 41.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 110.285 179.128 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.54 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 6.1 m-85 -121.4 162.17 20.87 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.224 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 2.1 mtt180 -106.6 159.56 16.1 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.13 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.497 HG13 ' N ' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -98.09 78.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 177.628 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG22 ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.65 167.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.543 -173.845 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.99 105.58 19.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.285 0.564 . . . . 0.0 110.354 -177.662 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.453 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 6.5 t -138.77 -165.85 1.9 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' ARG . 7.9 p-10 -140.57 -159.82 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.783 . . . . 0.0 109.955 179.936 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.68 85.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -48.64 147.31 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.888 . . . . 0.0 110.49 -179.515 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.14 -63.16 1.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.595 -179.475 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -101.85 -162.52 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.421 -179.761 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -80.52 79.77 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.807 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.84 135.45 13.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.957 -179.948 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 64.06 3.75 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.831 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.93 -171.51 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -1.195 . . . . 0.0 109.852 179.776 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 6.1 p90 179.45 178.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 110.777 -179.941 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.59 -27.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.645 -0.66 . . . . 0.0 109.33 179.751 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.34 166.26 14.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 109.798 179.817 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 117.63 34.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.506 HG22 ' CD1' ' A' ' 59' ' ' TRP . 41.4 pt -112.24 -33.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.091 -1.005 . . . . 0.0 111.153 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -130.07 170.38 20.78 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.924 -178.362 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.497 ' N ' HG13 ' A' ' 19' ' ' ILE . 68.2 t80 -139.17 143.66 38.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.651 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.479 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 11.8 t80 -140.04 123.72 17.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.857 -1.152 . . . . 0.0 109.995 -179.85 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.474 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 19.7 t0 -140.3 79.82 20.59 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.613 -1.304 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.476 ' HG3' ' CZ ' ' A' ' 39' ' ' TYR . 48.1 Cg_endo -72.7 65.41 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.55 1.289 . . . . 0.0 110.654 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -89.65 -164.6 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.205 -0.934 . . . . 0.0 110.339 -179.828 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.3 pttm -121.51 38.42 4.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.884 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.8 t -117.37 -32.32 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 110.141 179.99 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -145.79 146.17 28.03 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 110.011 179.846 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.81 -29.57 15.34 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.651 1.343 . . . . 0.0 110.445 179.771 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.13 101.3 13.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.108 179.97 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.508 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 6.2 p-90 -121.81 -11.2 8.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.823 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.1 tt -79.75 127.83 32.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.05 -1.031 . . . . 0.0 110.743 -179.481 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -139.46 100.2 3.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.177 179.23 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.534 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 1.3 t -129.68 140.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.047 -179.054 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t0 -90.06 70.23 7.36 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.08 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -32.07 -33.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.741 -177.458 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mm-40 -60.43 -55.87 28.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.75 -1.219 . . . . 0.0 109.095 178.432 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.465 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -68.94 -40.81 78.74 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.135 178.836 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -64.81 -20.62 66.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.705 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.7 tpt180 -87.32 -22.52 25.07 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 178.511 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.2 t80 -60.08 -49.21 78.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.317 1.532 . . . . 0.0 107.096 178.553 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.543 ' NE1' HG23 ' A' ' 21' ' ' VAL . 87.7 m95 -61.69 -51.22 69.31 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.292 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.5 mt -54.33 -22.35 11.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 176.669 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -25.09 42.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.494 -0.754 . . . . 0.0 110.777 179.529 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG23 ' HA ' ' A' ' 59' ' ' TRP . 7.6 m -99.13 33.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.907 -1.121 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.32 78.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -63.16 138.5 58.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -1.22 . . . . 0.0 110.172 179.985 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -104.06 103.39 37.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.134 179.94 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -82.2 130.06 6.23 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.499 1.263 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.8 t -64.65 168.44 6.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.983 -1.073 . . . . 0.0 109.739 179.757 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.62 -26.96 24.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 111.582 -178.914 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.26 -50.25 6.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.044 -1.035 . . . . 0.0 110.894 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB3' ' HA ' ' A' ' 5' ' ' ARG . . . -66.61 -24.91 66.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.858 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.6 ttp180 -70.75 -39.81 73.05 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.429 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -65.93 -40.66 91.61 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.603 178.539 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.425 ' CD2' HD12 ' A' ' 49' ' ' LEU . 14.7 mt -69.7 -29.07 66.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.576 -0.703 . . . . 0.0 109.125 179.017 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 20.8 mt -71.98 -27.58 62.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.565 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.22 -26.77 32.98 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.455 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.448 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.1 tp-100 -85.39 -37.68 19.57 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.642 0.734 . . . . 0.0 110.406 -179.58 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.42 ' HB3' ' CG1' ' A' ' 51' ' ' VAL . . . -65.43 -10.98 38.41 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.681 178.638 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.4 50.26 3.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.409 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 43.6 t -101.96 -56.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.087 -1.243 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.2 m-30 -54.66 -175.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 109.948 -179.379 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 42.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.46 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -88.71 48.24 1.61 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 179.837 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -97.11 76.21 2.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.319 -179.792 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.98 177.84 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.171 179.935 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.58 0.98 16.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.703 -179.928 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -52.27 152.86 3.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 0.0 110.334 -179.958 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.14 89.87 0.2 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.953 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.325 -1.103 . . . . 0.0 110.155 -179.956 . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mmm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.112 0.482 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 57.9 t -149.71 134.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.557 -179.933 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 30.0 mtpt -140.37 134.6 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 179.759 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.499 HD12 ' CD1' ' A' ' 36' ' ' ILE . 74.3 mt -99.99 133.82 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.0 -1.063 . . . . 0.0 109.656 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -151.4 -172.27 4.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -178.968 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.487 HD23 ' CG ' ' A' ' 39' ' ' TYR . 2.8 mp -89.1 125.86 35.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.81 102.62 14.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.5 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.501 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.9 ttm180 -68.97 119.12 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 111.577 179.917 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.502 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 25.7 m-85 -109.93 -62.86 1.45 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.156 -0.965 . . . . 0.0 110.13 178.569 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.35 20.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.679 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.474 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 36.9 p -84.66 -60.64 2.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -1.1 . . . . 0.0 109.84 179.714 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.2 mttt -144.19 25.94 1.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 109.271 -179.79 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.474 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 4.8 m-70 -109.97 -48.46 3.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.749 0.785 . . . . 0.0 109.21 -178.863 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 10.5 m120 -150.64 103.51 3.06 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.475 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' CG ' ' A' ' 41' ' ' PRO . 43.3 Cg_endo -69.22 64.84 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.595 1.313 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 31.4 p80 -104.63 136.12 44.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 178.895 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.0 m-85 -119.3 154.94 32.73 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.144 -0.972 . . . . 0.0 108.465 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 3.4 mmt180 -100.14 157.07 16.84 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.669 176.614 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 5' ' ' ARG . 1.0 OUTLIER -98.19 77.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 102.469 -3.159 . . . . 0.0 102.469 176.824 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 ' CD2' ' A' ' 32' ' ' TYR 0.258 0.4 OUTLIER -97.46 171.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.51 -173.715 . . . . . . . . 4 4 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.531 HG23 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -115.98 112.81 41.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.769 -0.582 . . . . 0.0 110.633 -177.184 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.48 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.9 t -136.81 -177.18 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 110.492 179.591 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -134.49 -170.63 2.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.518 -0.739 . . . . 0.0 110.189 -179.839 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.59 25.34 6.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -62.64 -67.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 -179.907 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -73.91 -171.73 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 0.0 110.217 179.968 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -65.37 150.7 47.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.927 . . . . 0.0 110.328 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -71.82 110.1 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.891 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -123.17 -51.8 1.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.97 83.04 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.942 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' O ' ' HB ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -156.86 -163.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -1.162 . . . . 0.0 110.222 -179.878 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.48 ' HA ' ' HB ' ' A' ' 22' ' ' THR . 23.5 p90 179.74 176.57 0.67 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.356 -0.84 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 HG22 ' CZ2' ' A' ' 59' ' ' TRP . 4.4 mt -82.48 -50.3 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.576 -0.703 . . . . 0.0 109.869 179.658 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -156.13 158.98 38.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.85 179.784 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -93.37 110.22 21.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 110.384 -179.864 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.522 ' CG2' ' CD1' ' A' ' 59' ' ' TRP . 26.4 pt -99.75 -36.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.22 -0.925 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.482 ' CA ' ' CG2' ' A' ' 51' ' ' VAL . . . -123.23 168.14 15.45 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.361 -178.403 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.458 ' N ' HG13 ' A' ' 19' ' ' ILE . 93.0 t80 -140.13 135.78 32.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.604 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 12.7 t80 -128.03 133.01 49.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.986 -1.071 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 31.1 t0 -140.31 105.62 6.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.901 -1.125 . . . . 0.0 110.327 179.768 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 49.1 Cg_endo -77.42 1.81 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.571 1.301 . . . . 0.0 111.083 -179.818 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -89.45 -21.06 23.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.922 -1.111 . . . . 0.0 110.091 -179.956 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.47 129.81 22.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.848 179.647 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -90.7 22.42 3.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.576 -179.503 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 171.64 7.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.602 179.445 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.75 -14.07 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.587 1.309 . . . . 0.0 110.764 -179.945 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -106.79 90.32 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.604 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 13.1 p-90 -113.64 3.5 15.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.249 -0.907 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 7.9 tt -104.4 120.06 40.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 110.195 -179.859 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -121.99 97.22 5.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.099 179.175 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.482 ' CG2' ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -120.3 159.73 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.334 1.064 . . . . 0.0 111.654 -178.854 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.9 t0 -107.21 65.84 0.66 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.98 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.443 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.0 -30.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -177.542 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -59.93 -54.17 49.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.747 -1.221 . . . . 0.0 108.495 178.149 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -75.74 -35.26 60.26 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.413 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.493 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -65.02 -21.02 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.969 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' VAL . 51.1 ttt-85 -86.61 -25.41 24.95 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.363 -0.836 . . . . 0.0 109.854 178.566 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.518 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -58.04 -46.29 85.58 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 123.179 1.466 . . . . 0.0 107.547 178.773 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' CD1' HG23 ' A' ' 21' ' ' VAL . 81.9 m95 -66.14 -52.31 49.62 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.621 -179.259 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.4 mt -55.04 -22.19 14.87 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.441 177.119 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -80.96 -23.54 38.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.482 -0.761 . . . . 0.0 110.612 179.604 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 59' ' ' TRP . 5.1 m -98.9 32.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.925 -1.109 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.3 29.44 73.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.48 126.1 28.67 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.043 -1.269 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . 0.43 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -93.68 111.19 51.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.9 Cg_endo -82.29 130.71 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.492 1.259 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.36 168.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -53.75 -30.35 43.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.418 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -84.54 -50.4 7.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.433 -0.792 . . . . 0.0 110.384 -179.959 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.27 -22.88 66.91 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.227 -0.92 . . . . 0.0 108.781 179.972 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -40.26 67.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.51 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 -38.86 83.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.921 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.418 ' CD2' HD12 ' A' ' 49' ' ' LEU . 19.4 mt -69.05 -28.15 66.29 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.654 -0.654 . . . . 0.0 109.357 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.489 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 13.3 mt -73.07 -26.19 61.17 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.465 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.538 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.79 -28.68 30.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.271 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.443 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.8 tp-100 -83.01 -39.81 20.78 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.764 0.792 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.436 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -65.04 -11.28 37.49 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.872 178.433 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.79 51.64 3.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.855 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.443 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 53.6 t -102.48 -55.84 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.076 -1.25 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.3 m-30 -52.94 -25.15 10.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.136 -0.978 . . . . 0.0 110.423 -179.267 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.81 -39.66 39.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.874 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -90.13 115.07 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 179.845 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.02 179.8 3.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.126 -0.984 . . . . 0.0 110.494 -179.806 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -155.43 -79.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.59 -69.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.477 -179.917 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -169.66 -175.13 2.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 110.208 -179.961 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.31 -141.53 3.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.382 -1.069 . . . . 0.0 110.227 179.898 . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.244 0.545 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.8 t -110.57 141.19 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.016 179.937 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -137.8 131.01 30.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.499 HD11 ' CD1' ' A' ' 36' ' ' ILE . 93.3 mt -102.69 129.46 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.089 -1.007 . . . . 0.0 109.534 179.251 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.492 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 28.1 ptt180 -151.67 -166.63 2.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 7.0 mp -89.05 127.41 35.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -100.26 105.52 17.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.476 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 14.9 ttt180 -75.08 121.93 22.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 111.302 -179.711 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.496 ' CE2' ' O ' ' A' ' 7' ' ' ALA . 16.5 m-85 -114.09 -61.61 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.29 -0.881 . . . . 0.0 110.6 179.313 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.78 134.44 5.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.269 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 24.1 p -96.4 -56.43 2.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.444 -1.033 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' N ' ' OG ' ' A' ' 11' ' ' SER . 39.2 mttt -145.3 49.17 1.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.719 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.443 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.0 m-70 -138.33 -58.74 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -177.963 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -148.29 127.06 6.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.806 179.823 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.19 90.67 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.471 1.248 . . . . 0.0 111.361 -179.423 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 35.3 p80 -132.31 129.22 39.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 110.053 178.847 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 5.0 m-85 -119.25 149.29 42.01 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.406 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.474 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 13.5 mtt-85 -101.12 161.99 13.21 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.064 -1.455 . . . . 0.0 108.457 177.178 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.515 ' CD1' ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -99.1 80.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 177.649 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.252 0.4 OUTLIER -97.61 165.25 2.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.155 -173.75 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 115.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.896 -0.503 . . . . 0.0 110.596 -177.659 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.1 t -140.66 -177.64 5.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.013 . . . . 0.0 110.7 179.116 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.6 164.41 12.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 110.526 -179.696 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.02 31.26 6.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 110.047 179.913 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.93 -59.96 3.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 110.589 -179.878 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.35 136.95 16.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -64.26 94.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 110.04 179.619 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.23 -38.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 -179.862 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -101.9 177.06 5.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.063 179.783 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.86 55.09 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.59 122.62 44.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -1.079 . . . . 0.0 110.383 -179.698 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.9 p90 -111.74 179.63 3.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.0 mm -96.53 -41.35 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.576 -179.796 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.15 167.07 10.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.468 -0.77 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.24 107.65 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.988 . . . . 0.0 110.307 -179.89 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' A' ' 59' ' ' TRP . 28.1 pt -99.91 -36.51 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.157 -0.965 . . . . 0.0 110.571 179.936 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.524 ' HA2' ' HA ' ' A' ' 51' ' ' VAL . . . -122.78 165.89 15.35 Favored Glycine 0 C--N 1.295 -1.716 0 C-N-CA 119.027 -1.559 . . . . 0.0 111.989 -178.521 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.43 ' N ' HG12 ' A' ' 19' ' ' ILE . 9.3 t80 -140.49 130.53 24.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.066 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.515 ' HB2' ' CD1' ' A' ' 19' ' ' ILE . 4.9 t80 -131.58 133.14 44.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.636 -1.29 . . . . 0.0 110.378 -179.738 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.2 t0 -133.01 89.21 34.67 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.918 -1.113 . . . . 0.0 109.997 179.495 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 41.7 Cg_endo -68.98 74.37 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.54 1.284 . . . . 0.0 110.921 -179.686 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 177.25 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.3 -0.875 . . . . 0.0 109.976 179.683 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -119.56 45.86 2.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.958 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 45' ' ' THR . 64.4 p -131.48 -69.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.036 179.888 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.406 ' N ' ' OG1' ' A' ' 44' ' ' THR . 45.8 p -112.56 144.82 31.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.118 179.848 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.01 -20.84 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.654 1.344 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 77.3 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.19 -0.944 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.501 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 8.2 p-90 -123.25 4.28 9.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -0.859 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 10.2 tt -100.51 123.61 44.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.809 -1.182 . . . . 0.0 111.071 -179.033 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.93 93.83 3.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 179.328 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.524 ' HA ' ' HA2' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.03 135.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.607 -179.071 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -84.3 69.83 10.52 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 175.838 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.451 ' CG2' ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -36.6 -29.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 122.135 -0.353 . . . . 0.0 111.496 -177.405 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -59.64 -51.69 68.74 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.7 -1.25 . . . . 0.0 108.745 178.605 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.7 mmm180 -75.9 -38.35 57.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.509 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 36' ' ' ILE . . . -63.44 -21.23 66.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.282 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 15.2 ttt180 -88.31 -21.86 24.18 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.315 -0.865 . . . . 0.0 109.732 178.447 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.483 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -65.34 -48.26 73.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 123.194 1.474 . . . . 0.0 107.668 178.704 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.551 ' CD1' HG21 ' A' ' 21' ' ' VAL . 81.4 m95 -63.82 -54.03 41.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.834 -179.04 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 ' CD1' HG11 ' A' ' 79' ' ' VAL . 83.4 mt -55.33 -21.04 13.4 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.33 177.256 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.43 -23.91 39.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.4 -0.812 . . . . 0.0 110.773 179.504 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 59' ' ' TRP . 10.1 m -99.16 34.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.849 -1.157 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.32 26.06 74.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.588 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -73.67 112.07 9.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 179.69 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 116.52 64.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.664 -179.521 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.415 ' HB2' ' HB2' ' A' ' 71' ' ' ARG . 51.2 Cg_endo -83.61 124.47 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.471 1.248 . . . . 0.0 109.567 179.13 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.426 HG22 ' HA ' ' A' ' 5' ' ' ARG . 5.2 t -55.08 175.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 110.468 -179.47 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.52 56.61 1.13 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 179.993 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 m -165.9 -60.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.745 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.85 -25.2 67.09 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.819 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.8 ttp180 -65.76 -41.56 91.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.065 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.03 -41.51 98.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.682 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.3 mt -70.03 -32.81 71.13 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.983 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 ' O ' ' HB ' ' A' ' 79' ' ' VAL . 46.9 mt -68.58 -26.83 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.805 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.534 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -82.13 -28.78 32.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.395 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.52 -36.86 25.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.43 -179.677 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.37 -8.96 36.8 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.986 178.663 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.22 50.75 4.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.451 ' HA ' ' CG2' ' A' ' 53' ' ' VAL . 39.8 t -101.11 -55.5 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.032 -1.275 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.0 m-30 -54.56 140.14 35.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 110.149 -179.44 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -68.69 161.37 28.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -68.45 158.01 34.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 110.682 -179.624 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -95.74 113.53 25.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 179.584 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.84 -26.41 44.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 110.362 -179.764 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -54.99 -63.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.01 -64.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.76 113.95 3.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.861 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.313 -1.11 . . . . 0.0 110.194 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 64' ' ' ALA . 6.7 m . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.307 0.575 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.03 133.23 29.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.936 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.8 mt -99.74 133.99 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.31 -0.869 . . . . 0.0 109.054 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.28 -171.57 3.97 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.957 -1.089 . . . . 0.0 110.586 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.927 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -88.7 126.75 35.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 110.255 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.05 104.28 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.374 -0.829 . . . . 0.0 110.613 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.306 -0.872 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.927 ' HB2' HD23 ' A' ' 6' ' ' LEU . 10.7 m-85 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 10.6 mtm-85 -107.99 159.35 16.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.742 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.953 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.78 79.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.261 0.4 OUTLIER -98.04 166.48 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.758 -174.053 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.905 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -109.16 109.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.768 -0.583 . . . . 0.0 110.121 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.222 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 20' ' ' VAL . 9.2 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.426 0.631 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -77.3 -23.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.638 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.62 164.35 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 116.04 31.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.956 HG21 ' CD1' ' A' ' 59' ' ' TRP . 22.9 pt -107.01 -37.43 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 0.0 111.351 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.792 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.63 171.04 14.96 Favored Glycine 0 C--N 1.294 -1.758 0 C-N-CA 119.006 -1.569 . . . . 0.0 111.597 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.491 ' N ' HG13 ' A' ' 19' ' ' ILE . 64.7 t80 -139.57 141.96 37.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CG ' HD21 ' A' ' 6' ' ' LEU . 29.3 t80 -135.34 142.6 45.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.718 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 178.764 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 77' ' ' ALA . 4.8 tt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.419 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 100.9 5.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.295 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -122.82 153.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.976 -1.078 . . . . 0.0 111.336 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.4 t0 -100.04 70.84 1.6 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.638 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -34.93 -30.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 122.312 -0.242 . . . . 0.0 111.57 -177.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 tt0 -60.81 -54.8 40.7 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.713 -1.242 . . . . 0.0 108.804 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.553 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.93 -39.51 72.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.364 -0.835 . . . . 0.0 108.83 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.88 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.76 -17.68 64.79 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 13.4 ttt180 -87.51 -25.15 23.82 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.854 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.7 t80 -60.26 -44.67 95.09 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.246 1.498 . . . . 0.0 107.966 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.956 ' CD1' HG21 ' A' ' 36' ' ' ILE . 84.7 m95 -69.73 -55.87 8.74 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.149 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.521 HD21 ' HG3' ' A' ' 66' ' ' PRO . 13.1 mt -53.33 -22.56 7.48 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.447 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 15.3 t -82.35 -22.75 35.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.455 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.7 m -99.14 32.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 120.839 -1.163 . . . . 0.0 109.572 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.47 29.04 72.91 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -71.65 127.32 32.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.086 -1.244 . . . . 0.0 109.763 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -97.6 110.72 56.25 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.7 Cg_endo -85.61 129.33 3.59 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.752 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.2 t -55.17 168.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.762 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -55.44 -37.7 68.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.739 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -70.41 -58.56 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.729 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.752 ' H ' HG23 ' A' ' 67' ' ' THR . . . -63.76 -23.33 67.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.39 -0.819 . . . . 0.0 109.117 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.531 ' HA ' HD12 ' A' ' 74' ' ' LEU . 4.1 ttt180 -69.71 -42.73 73.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -73.41 -10.04 59.32 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.49 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.1 mt -98.22 -24.89 15.08 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 108.623 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 71' ' ' ARG . 17.9 mt -71.11 -30.43 66.51 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 72' ' ' ARG . 10.3 ptm180 -77.78 -28.8 50.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 9.2 tp-100 -76.42 -37.22 57.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.055 0.931 . . . . 0.0 109.581 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -75.15 -1.28 22.42 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.059 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 50.33 11.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 53' ' ' VAL . 40.2 t . . . . . 0 C--N 1.307 -1.272 0 O-C-N 121.301 -1.117 . . . . 0.0 111.721 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.684 HG11 ' CE3' ' A' ' 59' ' ' TRP . 47.9 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.215 0.531 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -140.5 133.1 28.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.85 HD11 ' CB ' ' A' ' 59' ' ' TRP . 68.8 mt -100.26 134.89 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.013 -1.054 . . . . 0.0 109.409 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.7 ptm180 -151.19 -172.72 4.29 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.1 -1.0 . . . . 0.0 110.928 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 70' ' ' ALA . 4.5 mp -89.37 125.87 35.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.379 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.21 112.87 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.364 -0.835 . . . . 0.0 110.562 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.116 . . . . 0.0 112.892 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 9.3 m-30 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' C ' HD13 ' A' ' 19' ' ' ILE . 2.0 mtt85 -101.35 162.18 13.08 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.26 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.03 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.93 80.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -97.46 164.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.907 -173.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.932 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.36 112.64 40.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 120.974 -1.079 . . . . 0.0 110.598 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.4 p90 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.631 0.729 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.736 HG21 ' HH2' ' A' ' 59' ' ' TRP . 13.3 mm -92.25 -50.2 12.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -157.69 179.19 9.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -106.86 107.23 18.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.292 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 56' ' ' ALA . 20.7 pt -100.55 -39.08 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.146 -0.971 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.819 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -118.2 166.35 12.81 Favored Glycine 0 C--N 1.296 -1.683 0 C-N-CA 118.967 -1.587 . . . . 0.0 112.122 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' N ' HG12 ' A' ' 19' ' ' ILE . 11.4 t80 -140.73 128.79 22.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.03 ' HB2' HD11 ' A' ' 19' ' ' ILE . 38.1 t80 -128.27 142.48 51.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.709 -1.245 . . . . 0.0 109.906 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.6 t0 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.222 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.599 HD12 ' CD2' ' A' ' 73' ' ' LEU . 9.1 tt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.228 0.537 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.18 90.38 3.28 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.682 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.819 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.51 130.93 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.005 . . . . 0.0 111.178 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.0 t0 -78.03 71.01 4.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -35.73 -30.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 122.258 -0.276 . . . . 0.0 111.624 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.8 mt-10 -59.76 -51.03 71.49 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.706 -1.247 . . . . 0.0 108.967 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 27.1 mmm180 -75.52 -38.14 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.263 -0.898 . . . . 0.0 108.713 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.96 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.82 -19.39 65.83 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.2 ttp180 -89.16 -23.81 22.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.808 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.31 -48.71 76.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 123.116 1.436 . . . . 0.0 107.456 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.932 ' CD2' HG11 ' A' ' 21' ' ' VAL . 82.1 m95 -65.29 -56.19 14.1 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.951 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.973 HD11 HD13 ' A' ' 74' ' ' LEU . 35.0 mt -54.55 -21.59 10.69 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.558 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -81.91 -20.45 38.73 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.427 -0.795 . . . . 0.0 110.389 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.8 m -98.7 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.871 -1.143 . . . . 0.0 109.322 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.53 26.61 74.33 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -77.28 115.32 16.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.089 -1.242 . . . . 0.0 109.855 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 126.15 59.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HB3' HD12 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -85.47 162.56 11.04 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.494 1.26 . . . . 0.0 109.483 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 p -83.94 -171.69 3.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.051 -1.031 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.82 48.27 1.42 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.2 m -166.03 -56.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -68.35 -25.62 65.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.4 ttp180 -66.59 -42.25 87.23 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -66.14 -45.81 79.71 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.786 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.599 ' CD2' HD12 ' A' ' 49' ' ' LEU . 51.7 mt -60.29 -31.99 70.77 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.973 HD13 HD11 ' A' ' 60' ' ' LEU . 20.3 mt -69.15 -26.81 65.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -28.81 30.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.811 0.815 . . . . 0.0 108.82 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -81.84 -36.15 28.6 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.904 0.859 . . . . 0.0 110.062 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.96 -9.21 43.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.751 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.52 48.5 5.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 60' ' ' LEU . 41.4 t . . . . . 0 N--CA 1.487 1.379 0 O-C-N 121.12 -1.224 . . . . 0.0 111.605 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.604 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.2 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -140.53 133.19 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.915 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.7 mt -108.34 131.2 59.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.992 -1.068 . . . . 0.0 109.883 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.0 ptm180 -151.08 -169.62 3.44 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.287 -0.883 . . . . 0.0 110.297 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.476 HD22 ' HD2' ' A' ' 39' ' ' TYR . 84.4 mt -89.17 127.69 35.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.519 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.25 102.34 13.95 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.713 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 112.565 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 12.4 m-85 . . . . . 0 C--O 1.213 -0.838 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -99.86 159.08 15.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.312 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.048 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -98.07 81.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -98.47 162.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.024 -174.07 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.866 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -109.29 109.42 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.757 -0.589 . . . . 0.0 110.529 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.983 . . . . 0.0 110.29 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' HG13 ' A' ' 20' ' ' VAL . 23.4 p90 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.547 0.689 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.616 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.1 mt -70.94 -51.7 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.65 165.45 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -0.774 . . . . 0.0 109.58 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -99.43 116.73 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 109.956 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.005 HG21 ' CD1' ' A' ' 59' ' ' TRP . 44.9 pt -107.18 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 111.152 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.806 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.82 167.94 17.05 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.029 -1.557 . . . . 0.0 112.228 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG12 ' A' ' 19' ' ' ILE . 37.0 t80 -140.67 129.26 22.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.048 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.5 t80 -129.71 134.07 47.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.731 -1.23 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.919 -1.113 . . . . 0.0 110.884 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 73' ' ' LEU . 8.5 tp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.629 0.728 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.05 94.64 3.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 109.217 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.806 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.04 149.87 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -94.81 70.51 3.44 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -32.72 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -60.29 -56.02 26.56 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.802 -1.186 . . . . 0.0 109.159 178.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.743 ' HB3' HG22 ' A' ' 36' ' ' ILE . 4.4 mmp_? -69.92 -42.02 73.87 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 108.872 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.743 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -63.15 -18.36 63.37 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.9 ttp180 -87.87 -25.26 23.36 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.642 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.9 t80 -60.38 -45.83 92.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.359 1.552 . . . . 0.0 107.789 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.005 ' CD1' HG21 ' A' ' 36' ' ' ILE . 79.4 m95 -66.11 -54.48 25.03 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.94 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 60' ' ' LEU . 18.9 mt -54.97 -21.47 11.89 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.495 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 6.5 t -81.46 -23.16 37.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 110.694 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 58' ' ' TYR . 5.5 m -98.96 32.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.797 -1.189 . . . . 0.0 109.568 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.93 29.47 72.48 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.604 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -67.78 135.45 52.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.076 -1.25 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 109.06 61.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 110.389 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 71' ' ' ARG . 53.8 Cg_endo -79.13 128.3 8.14 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.619 1.326 . . . . 0.0 109.871 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 70' ' ' ALA . 7.9 t -54.22 171.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.11 -0.994 . . . . 0.0 110.204 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.47 54.98 0.78 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -167.25 -56.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.5 -24.22 66.36 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HA ' HD12 ' A' ' 74' ' ' LEU . 20.2 ttt85 -67.4 -40.92 85.62 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -42.99 80.33 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.776 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.697 ' HB3' HD21 ' A' ' 49' ' ' LEU . 15.2 mt -67.08 -27.08 67.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.675 HD23 HG21 ' A' ' 79' ' ' VAL . 13.7 mt -69.82 -28.47 65.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -30.54 45.71 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -80.39 -31.84 37.67 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.944 0.878 . . . . 0.0 109.993 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -75.4 -2.13 27.14 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.402 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.5 51.64 9.43 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.675 HG21 HD23 ' A' ' 74' ' ' LEU . 52.6 t . . . . . 0 C--N 1.307 -1.253 0 O-C-N 121.271 -1.134 . . . . 0.0 111.872 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 2' ' ' VAL . 15.9 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.458 0.647 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -140.2 132.83 28.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.425 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.955 HD11 ' CB ' ' A' ' 59' ' ' TRP . 65.8 mt -107.62 133.52 52.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.044 -1.035 . . . . 0.0 110.05 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptm180 -151.07 -173.15 4.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.278 -0.889 . . . . 0.0 110.437 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 70' ' ' ALA . 3.7 mp -89.38 125.49 35.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.447 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.46 107.42 19.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.473 -0.767 . . . . 0.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 36.7 ttp85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 112.936 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 9.8 m-85 . . . . . 0 C--O 1.209 -1.06 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.2 mtp85 -121.83 156.02 34.13 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.964 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 79.56 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.255 0.4 OUTLIER -97.95 159.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.5 -173.912 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.867 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -107.92 106.03 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.334 0.587 . . . . 0.0 110.387 -177.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.533 ' HB3' HG13 ' A' ' 20' ' ' VAL . 32.1 p90 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.471 0.653 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.595 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.3 mt -56.15 -51.93 56.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.565 -0.71 . . . . 0.0 109.204 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.92 149.46 26.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -89.66 119.29 29.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.977 HG21 ' CD1' ' A' ' 59' ' ' TRP . 27.7 pt -105.88 -34.14 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.489 -0.757 . . . . 0.0 111.738 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.821 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -120.64 169.33 14.12 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 119.118 -1.515 . . . . 0.0 112.26 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG12 ' A' ' 19' ' ' ILE . 86.8 t80 -140.46 127.33 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.964 ' HB2' HD11 ' A' ' 19' ' ' ILE . 44.7 t80 -121.28 142.29 50.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.815 -1.178 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 178.699 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.6 tt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.336 0.588 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -131.47 94.66 3.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.293 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.821 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.8 148.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 111.043 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -92.38 70.65 5.15 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.684 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -36.47 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 122.224 -0.297 . . . . 0.0 111.481 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 7.2 mm-40 -61.1 -53.25 59.44 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.693 -1.254 . . . . 0.0 108.522 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -71.29 -40.59 70.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.7 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.65 -16.56 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.1 ttt-85 -88.64 -26.3 21.96 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 62' ' ' VAL . 13.2 t80 -59.43 -42.63 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 123.212 1.482 . . . . 0.0 107.382 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.977 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.3 m95 -69.63 -54.24 14.91 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.13 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 79' ' ' VAL . 7.4 mt -56.56 -20.9 23.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.468 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -80.72 -24.56 38.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.426 -0.796 . . . . 0.0 110.517 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 59' ' ' TRP . 27.3 m -99.01 32.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.879 -1.138 . . . . 0.0 109.606 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.02 31.48 79.57 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -60.99 146.99 45.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.242 . . . . 0.0 110.017 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 2.0 mm-40 -108.88 93.82 13.25 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.43 -0.794 . . . . 0.0 110.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 54.9 Cg_endo -80.34 124.79 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.48 1.253 . . . . 0.0 109.923 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.8 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.7 t -57.82 163.58 2.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.944 -1.097 . . . . 0.0 109.702 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -57.88 -22.87 50.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.3 m -84.55 -53.71 5.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.862 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.8 ' H ' HG23 ' A' ' 67' ' ' THR . . . -70.8 -29.45 65.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -66.9 -37.35 84.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -26.85 67.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.0 mt -86.37 -30.39 22.2 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.541 -0.724 . . . . 0.0 109.247 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 56' ' ' ALA . 80.7 mt -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -78.24 -30.43 48.71 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.1 tp-100 -79.11 -33.58 44.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.942 0.877 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.17 -9.43 52.87 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.704 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 87.48 52.34 3.05 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.684 HG22 ' CB ' ' A' ' 53' ' ' VAL . 40.2 t . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.058 -1.26 . . . . 0.0 111.519 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.602 HG11 ' CE3' ' A' ' 59' ' ' TRP . 50.2 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.148 0.499 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -140.16 138.73 35.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.554 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.945 ' CG1' HG13 ' A' ' 21' ' ' VAL . 86.0 mt -103.25 130.92 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.29 -0.881 . . . . 0.0 109.343 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.75 -172.0 4.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 110.65 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 69' ' ' THR . 5.0 mp -88.97 125.56 35.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.425 -0.797 . . . . 0.0 110.469 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.55 112.51 24.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.56 -0.712 . . . . 0.0 109.797 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 112.675 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.5 ttm180 -104.55 153.52 21.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.148 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.957 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -98.53 78.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.272 0.4 OUTLIER -97.98 166.17 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.527 -173.684 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.945 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.36 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.755 -0.59 . . . . 0.0 110.51 -177.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 110.179 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CD2' HG21 ' A' ' 20' ' ' VAL . 17.0 p90 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.462 0.649 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.71 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.8 mp -58.87 -53.35 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -149.75 173.74 13.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -109.93 119.7 40.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.951 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 56' ' ' ALA . 21.7 pt -110.7 -38.81 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.049 -1.032 . . . . 0.0 111.656 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.807 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.1 167.83 14.11 Favored Glycine 0 C--N 1.295 -1.72 0 C-N-CA 118.897 -1.621 . . . . 0.0 111.45 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.7 t80 -137.23 141.17 42.06 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 25.5 t80 -138.5 139.27 38.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.75 -1.218 . . . . 0.0 110.718 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 178.869 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 49' ' ' LEU . 10.1 tt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.229 0.537 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 3.7 mmmt -126.88 103.76 7.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.957 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -127.32 149.0 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.877 -1.139 . . . . 0.0 111.4 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.8 t0 -97.56 70.45 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.627 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -33.77 -32.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 120.562 0.22 . . . . 0.0 111.435 -177.73 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.4 tt0 -60.99 -53.98 50.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.822 -1.173 . . . . 0.0 108.865 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 48.0 mmm-85 -73.72 -38.37 64.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.27 -21.35 66.56 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -89.2 -24.11 22.22 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.104 -0.997 . . . . 0.0 109.932 178.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.546 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -59.01 -49.6 77.26 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 123.269 1.509 . . . . 0.0 107.197 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.885 ' CD2' HG11 ' A' ' 21' ' ' VAL . 84.6 m95 -62.56 -52.29 64.0 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.265 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.885 HD11 HD13 ' A' ' 74' ' ' LEU . 4.0 mt -54.24 -22.41 11.58 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.338 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -80.81 -22.08 40.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 110.743 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.5 m -98.93 33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 120.823 -1.173 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.28 28.17 72.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -68.21 134.01 49.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -1.228 . . . . 0.0 110.081 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.19 109.09 59.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HG3' HD21 ' A' ' 60' ' ' LEU . 51.4 Cg_endo -84.59 126.86 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.616 1.324 . . . . 0.0 110.352 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.753 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.3 t -60.51 173.41 0.71 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 109.89 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -58.21 -27.83 64.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 111.103 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' HD13 ' A' ' 6' ' ' LEU . 1.8 m -83.13 -52.08 6.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.762 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.753 ' H ' HG23 ' A' ' 67' ' ' THR . . . -68.67 -26.47 65.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 67' ' ' THR . 2.4 ttt-85 -68.2 -38.65 82.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -45.22 80.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' CD2' HD12 ' A' ' 49' ' ' LEU . 59.6 mt -65.88 -25.76 67.33 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.885 HD13 HD11 ' A' ' 60' ' ' LEU . 17.2 mt -74.4 -26.06 59.85 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -29.38 26.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -84.29 -36.08 22.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.823 0.82 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.14 41.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.06 57.14 2.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.635 HG21 HD23 ' A' ' 74' ' ' LEU . 21.7 t . . . . . 0 N--CA 1.486 1.337 0 O-C-N 121.176 -1.191 . . . . 0.0 111.092 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.538 HG11 ' CE3' ' A' ' 59' ' ' TRP . 66.3 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.309 0.576 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.72 ' C ' HD13 ' A' ' 4' ' ' ILE . 12.9 mtpt -134.04 128.75 34.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.303 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.999 HD12 HG13 ' A' ' 21' ' ' VAL . 1.3 mm -103.74 133.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.551 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 16.5 ptm180 -151.0 177.65 9.95 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.889 -1.132 . . . . 0.0 110.858 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 pp -89.55 132.17 35.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.892 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -99.05 157.81 16.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.56 -0.712 . . . . 0.0 109.232 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 tmm_? . . . . . 0 C--N 1.303 -1.418 0 O-C-N 120.889 -1.132 . . . . 0.0 111.315 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 8' ' ' ARG . 14.0 m-85 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -137.24 150.83 48.11 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.01 -1.056 . . . . 0.0 108.301 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -97.06 85.95 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 178.008 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.646 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -98.49 168.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.634 -173.158 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.032 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.7 t -113.81 102.78 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.694 -0.629 . . . . 0.0 110.776 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.6 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.349 -0.844 . . . . 0.0 110.391 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.646 ' CD2' HG21 ' A' ' 20' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.311 0.576 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.3 -58.63 6.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -145.08 173.91 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.012 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -110.42 115.34 29.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.202 -0.936 . . . . 0.0 109.572 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.973 HD12 ' HA ' ' A' ' 56' ' ' ALA . 18.1 pt -108.98 -40.01 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.108 -0.995 . . . . 0.0 111.243 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.89 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -111.76 167.05 12.31 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.112 -1.518 . . . . 0.0 112.225 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 19' ' ' ILE . 87.5 t80 -140.8 126.18 18.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.804 ' HB2' HD11 ' A' ' 19' ' ' ILE . 13.9 t80 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.726 -1.234 . . . . 0.0 110.046 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t0 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.071 -1.018 . . . . 0.0 109.848 179.298 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 73' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.449 0.642 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -133.36 101.6 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.517 -0.74 . . . . 0.0 109.264 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.89 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -129.22 135.25 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 111.412 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.1 t0 -77.62 70.06 3.95 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.699 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -35.91 -30.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 122.276 -0.265 . . . . 0.0 111.286 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.2 -53.44 57.63 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.834 -1.166 . . . . 0.0 108.723 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmm180 -74.0 -38.17 64.18 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.973 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.23 -17.57 63.7 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.0 ttt180 -89.19 -25.58 21.71 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.282 -0.886 . . . . 0.0 109.324 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.952 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.59 -44.68 93.29 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 123.575 1.655 . . . . 0.0 106.953 178.145 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.032 ' CD2' HG11 ' A' ' 21' ' ' VAL . 80.5 m95 -67.23 -59.5 3.38 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.003 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 74' ' ' LEU . 3.9 mt -54.04 -21.88 9.38 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.826 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 30.6 t -81.27 -19.07 43.83 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.427 -0.796 . . . . 0.0 110.262 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.62 32.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.843 -1.161 . . . . 0.0 109.214 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.33 25.49 75.42 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HB1' ' CG1' ' A' ' 4' ' ' ILE . . . -70.68 126.57 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.178 -1.19 . . . . 0.0 110.026 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.31 111.35 53.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.699 ' HG3' HD21 ' A' ' 60' ' ' LEU . 51.9 Cg_endo -80.86 131.23 7.95 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.48 1.253 . . . . 0.0 110.332 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.9 p -56.92 159.17 4.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.61 -34.23 50.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.991 . . . . 0.0 111.581 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.402 ' HB ' HD23 ' A' ' 6' ' ' LEU . 5.3 m -83.68 -49.9 8.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 111.191 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.26 -22.98 61.9 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.253 -0.904 . . . . 0.0 109.264 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -70.97 -36.14 72.41 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -33.4 74.74 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.3 mt -75.17 -30.24 60.65 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.573 -0.704 . . . . 0.0 109.172 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.864 HD13 HD11 ' A' ' 60' ' ' LEU . 16.1 mt -68.03 -29.43 68.41 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -77.68 -31.03 52.23 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.54 ' HB3' HD13 ' A' ' 49' ' ' LEU . 3.5 tp-100 -77.49 -28.54 52.24 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.986 0.898 . . . . 0.0 109.391 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.07 -8.79 48.44 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.225 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.99 31.43 11.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 53' ' ' VAL . 47.4 t . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.218 -1.166 . . . . 0.0 110.651 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 64' ' ' ALA . 17.1 m . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.449 0.642 . . . . 0.0 110.588 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.2 ptmt -140.73 138.99 34.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.045 -1.034 . . . . 0.0 110.42 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.939 HG13 HG13 ' A' ' 21' ' ' VAL . 4.5 mt -103.84 135.32 42.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.048 -1.032 . . . . 0.0 108.681 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -150.64 -170.42 3.65 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.861 -1.149 . . . . 0.0 110.777 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -89.03 129.22 35.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -102.85 108.47 19.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 111.453 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 8.6 ttp180 . . . . . 0 N--CA 1.487 1.42 0 O-C-N 120.99 -1.069 . . . . 0.0 111.009 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 6.5 m-30 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.626 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -102.85 166.89 10.21 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.058 176.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.925 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.11 85.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.527 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.26 0.4 OUTLIER -99.21 164.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.283 -175.011 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.972 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.3 t -107.9 110.87 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 109.961 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 110.505 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.509 ' CD2' HG21 ' A' ' 20' ' ' VAL . 7.8 p90 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.629 0.728 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.82 -41.93 13.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.573 -0.704 . . . . 0.0 109.303 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.9 tt0 -151.17 150.35 30.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.117 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HG2' ' HD2' ' A' ' 18' ' ' ARG . 3.7 mtpp -96.46 118.88 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.975 . . . . 0.0 109.91 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.672 HD12 ' CB ' ' A' ' 56' ' ' ALA . 43.3 pt -99.84 -27.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 111.756 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -150.64 -174.41 21.66 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.001 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 36.7 t80 -140.83 147.45 39.03 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.872 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.925 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.2 t80 -140.21 132.89 28.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.588 -1.32 . . . . 0.0 109.664 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 27.4 t0 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.896 -1.127 . . . . 0.0 110.401 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.807 HD21 ' HB3' ' A' ' 73' ' ' LEU . 11.5 tp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.558 0.694 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -140.1 72.95 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.48 -0.762 . . . . 0.0 110.199 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.772 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -94.69 129.44 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.274 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.6 t0 -73.88 70.12 1.44 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.631 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.36 -29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.149 -0.344 . . . . 0.0 111.606 -177.552 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -62.99 -55.89 21.81 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.619 -1.301 . . . . 0.0 109.082 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -0.872 . . . . 0.0 108.994 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.672 ' CB ' HD12 ' A' ' 36' ' ' ILE . . . -73.38 -22.93 60.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.947 -1.096 . . . . 0.0 108.082 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttt85 -86.0 -21.35 27.86 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.142 -0.974 . . . . 0.0 108.912 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.972 ' CD2' HG11 ' A' ' 21' ' ' VAL . 81.4 m95 -61.55 -53.33 57.75 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.316 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -52.67 -22.71 5.44 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -22.32 42.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.546 -0.721 . . . . 0.0 110.434 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.4 m -98.85 32.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.74 -1.225 . . . . 0.0 109.52 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.19 27.26 73.11 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -67.95 134.31 50.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.152 -1.205 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -105.94 105.65 54.1 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.3 Cg_endo -79.07 129.51 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.607 1.319 . . . . 0.0 110.051 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.756 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.0 t -58.45 165.8 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.47 -27.89 58.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.164 -0.96 . . . . 0.0 111.515 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -82.24 -52.7 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.934 -1.104 . . . . 0.0 110.806 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 67' ' ' THR . . . -69.49 -26.49 64.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.326 -0.859 . . . . 0.0 108.721 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -66.52 -38.45 87.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -41.16 90.38 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.954 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.807 ' HB3' HD21 ' A' ' 49' ' ' LEU . 14.7 mt -71.13 -27.2 63.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.783 HD23 HG21 ' A' ' 79' ' ' VAL . 12.9 mt -70.52 -27.83 64.48 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -32.83 51.64 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -79.94 -29.34 39.69 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.981 0.896 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 79' ' ' VAL . . . -74.27 -4.47 36.29 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.866 -0.521 . . . . 0.0 110.257 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.53 39.46 30.07 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.783 HG21 HD23 ' A' ' 74' ' ' LEU . 48.2 t . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.282 -1.128 . . . . 0.0 111.459 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.452 HG11 ' HE3' ' A' ' 59' ' ' TRP . 60.8 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.198 0.523 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 2.1 mtpt -140.49 129.72 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.784 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.983 ' CG1' HG13 ' A' ' 21' ' ' VAL . 52.1 mt -101.22 132.09 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.06 -1.025 . . . . 0.0 109.132 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.12 -169.47 3.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 110.95 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.7 mp -88.8 125.89 35.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.0 108.51 20.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.756 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.559 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.4 ttt-85 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.023 -1.048 . . . . 0.0 111.592 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 11.7 m-30 . . . . . 0 C--O 1.211 -0.925 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 5.5 mtp180 -101.46 160.38 14.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.86 -1.536 . . . . 0.0 108.021 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.893 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -98.83 79.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.253 0.4 OUTLIER -97.82 160.63 3.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.886 -174.236 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.983 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -102.73 121.08 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.872 HG22 ' HB3' ' A' ' 32' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.943 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.872 ' HB3' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.46 0.648 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.668 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.8 mt -92.17 -37.43 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.538 -0.727 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -174.6 153.94 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 109.824 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -94.43 116.0 28.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.007 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.869 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.5 pt -103.02 -32.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.811 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.41 169.03 16.44 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 119.218 -1.467 . . . . 0.0 111.341 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' ILE . 48.0 t80 -140.15 134.64 31.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.0 t80 -133.6 131.24 39.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 110.121 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.581 -1.325 . . . . 0.0 110.758 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 73' ' ' LEU . 8.3 tt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.301 0.572 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -122.85 96.59 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.484 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.893 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -120.86 151.04 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 111.499 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.4 t70 -96.88 67.87 2.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.62 -31.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.038 -177.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 27.4 tt0 -62.34 -56.84 14.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.729 -1.232 . . . . 0.0 109.012 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 13.5 mmm180 -72.77 -35.54 67.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.46 -20.78 66.39 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 34.8 ttt85 -88.25 -25.05 23.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.94 -46.72 88.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.152 1.453 . . . . 0.0 107.301 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.959 ' HB3' HD11 ' A' ' 4' ' ' ILE . 87.5 m95 -65.4 -55.52 17.61 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.814 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.8 HD11 HD13 ' A' ' 74' ' ' LEU . 6.4 mt -53.42 -22.6 8.0 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.529 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 8.0 t -82.81 -19.62 37.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.394 -0.816 . . . . 0.0 110.568 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.3 m -98.98 32.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 120.798 -1.189 . . . . 0.0 109.272 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.87 72.93 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -71.42 134.91 46.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.462 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 7.1 mt-30 -101.79 108.12 54.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.8 Cg_endo -81.27 140.74 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.536 1.282 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -73.24 169.27 17.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 109.744 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.01 -18.47 34.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.775 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.435 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 3.5 m -95.07 -49.68 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.021 . . . . 0.0 110.515 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.68 -25.48 62.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.343 -0.848 . . . . 0.0 108.768 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -69.12 -35.4 76.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -67.19 -34.47 77.58 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 70' ' ' ALA . 31.6 mt -73.84 -28.0 61.38 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.587 -0.696 . . . . 0.0 109.514 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 60' ' ' LEU . 54.0 mt -71.96 -27.25 62.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -30.5 33.26 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -82.51 -38.33 23.99 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.788 0.804 . . . . 0.0 110.015 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -64.23 -12.15 38.15 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.817 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.93 36.41 8.44 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.581 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.9 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.273 . . . . 0.0 111.324 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.1 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.236 0.541 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 9.3 mtpt -140.32 136.66 33.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.868 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.918 ' CG1' HD11 ' A' ' 36' ' ' ILE . 1.1 mp -99.62 119.13 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.4 ptt85 -150.33 -179.79 7.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.987 -1.07 . . . . 0.0 110.906 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.0 mp -88.91 124.73 34.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.279 -0.888 . . . . 0.0 111.024 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.7 100.84 11.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.414 -0.804 . . . . 0.0 111.687 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 47.3 ttt180 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 111.533 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 3.5 m-85 . . . . . 0 C--O 1.214 -0.812 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.1 mmt180 -100.05 156.22 17.29 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.677 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.957 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.4 mt -98.55 77.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.256 0.3 OUTLIER -97.06 176.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.273 -172.869 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.981 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -120.44 115.77 48.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.367 0.603 . . . . 0.0 109.947 -177.384 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.8 p90 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 121.884 0.85 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.4 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.6 mt -95.9 -44.43 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.686 -0.634 . . . . 0.0 110.055 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 166.31 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -101.25 106.79 18.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 110.131 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.947 HG21 ' CD1' ' A' ' 59' ' ' TRP . 16.1 pt -100.12 -34.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.845 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.63 165.41 20.72 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.49 ' N ' HG13 ' A' ' 19' ' ' ILE . 26.9 t80 -139.19 143.45 38.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.925 . . . . 0.0 109.687 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 13.2 t80 -131.74 132.4 43.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.943 -1.098 . . . . 0.0 109.47 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 t0 . . . . . 0 N--CA 1.494 1.773 0 O-C-N 120.764 -1.21 . . . . 0.0 110.907 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 50' ' ' LYS . 2.3 tm? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.526 0.679 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.675 ' N ' HD13 ' A' ' 49' ' ' LEU . 3.7 mtpp -130.81 111.0 11.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.071 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.957 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -132.02 144.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.533 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -93.29 70.75 4.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.726 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.04 -31.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -177.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.16 -54.41 46.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.731 -1.23 . . . . 0.0 109.114 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' HB3' HG22 ' A' ' 36' ' ' ILE . 5.5 mtm-85 -74.53 -35.86 63.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.092 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.918 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.71 -20.98 66.09 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.8 ttp85 -89.16 -23.34 22.46 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.52 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -60.63 -49.06 79.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 123.394 1.568 . . . . 0.0 107.091 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.981 ' CD2' HG11 ' A' ' 21' ' ' VAL . 85.0 m95 -63.6 -50.99 67.23 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.3 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.715 ' CD1' HD22 ' A' ' 74' ' ' LEU . 6.5 mt -56.07 -21.03 19.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 176.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.6 t -81.23 -21.68 39.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.368 -0.833 . . . . 0.0 110.436 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.9 m -98.86 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.874 -1.141 . . . . 0.0 109.791 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.97 30.8 76.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -64.76 143.84 57.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -1.209 . . . . 0.0 109.624 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.43 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -106.7 99.37 24.87 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.333 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.1 Cg_endo -79.64 125.0 5.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.697 1.367 . . . . 0.0 110.279 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.774 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.6 t -58.86 170.14 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.826 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.88 -20.01 47.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.149 -0.969 . . . . 0.0 110.892 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.99 -53.42 4.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.181 -0.949 . . . . 0.0 110.386 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.774 ' H ' HG23 ' A' ' 67' ' ' THR . . . -69.31 -27.06 65.06 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 9.1 ttp85 -68.95 -39.26 79.62 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.86 -40.84 87.99 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.782 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.0 mt -70.81 -25.13 62.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 4' ' ' ILE . 12.4 mt -70.51 -29.36 65.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 3.6 mtm180 -78.47 -34.4 47.68 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -26.42 37.93 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.739 0.781 . . . . 0.0 110.667 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 79' ' ' VAL . . . -76.19 -1.97 28.95 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.743 -0.598 . . . . 0.0 110.161 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.14 38.03 30.9 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.726 HG22 ' HB ' ' A' ' 53' ' ' VAL . 32.0 t . . . . . 0 C--N 1.308 -1.212 0 O-C-N 121.249 -1.148 . . . . 0.0 111.129 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.122 0.487 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -140.12 135.84 32.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.215 -0.928 . . . . 0.0 110.75 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.975 HD11 ' CB ' ' A' ' 59' ' ' TRP . 63.1 mt -101.98 135.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 109.232 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.526 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 8.7 ptm180 -150.93 178.31 9.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.005 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.5 pp -89.61 131.74 35.46 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.326 -0.949 . . . . 0.0 109.48 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -98.9 164.02 12.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.525 -0.734 . . . . 0.0 109.056 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.346 0 O-C-N 120.913 -1.117 . . . . 0.0 111.562 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 8' ' ' ARG . 13.0 m-85 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' C ' HD13 ' A' ' 19' ' ' ILE . 29.3 mtt-85 -135.13 151.22 50.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.881 -1.137 . . . . 0.0 108.986 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.837 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -97.01 82.9 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.281 0.4 OUTLIER -98.38 163.2 2.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.353 -173.785 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.928 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.94 113.47 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.71 . . . . 0.0 110.322 -178.034 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.395 -0.815 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 2.0 p90 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 121.617 0.722 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.68 -47.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.553 -0.717 . . . . 0.0 109.923 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.88 159.51 41.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.419 -0.801 . . . . 0.0 109.741 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -95.7 109.57 21.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 56' ' ' ALA . 36.2 pt -100.19 -35.19 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.071 -1.018 . . . . 0.0 110.541 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.828 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.14 167.35 14.08 Favored Glycine 0 C--N 1.294 -1.799 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.264 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.421 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.4 t80 -141.06 117.52 10.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.837 ' HB2' HD11 ' A' ' 19' ' ' ILE . 7.8 t80 -109.02 142.47 39.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.277 . . . . 0.0 109.497 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 39.9 t0 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.941 -1.099 . . . . 0.0 110.111 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 77' ' ' ALA . 3.9 tt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.435 0.636 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -131.19 89.33 2.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.399 -0.813 . . . . 0.0 109.144 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.828 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 137.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.108 -0.995 . . . . 0.0 111.07 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.8 t0 -82.44 70.48 9.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.674 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -37.18 -30.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.259 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' ASP . 12.7 mt-10 -63.18 -49.69 73.3 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.812 -1.18 . . . . 0.0 108.786 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.77 -33.51 52.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 108.819 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -69.43 -22.0 63.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.6 ttt-85 -87.49 -23.48 24.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.353 -0.842 . . . . 0.0 109.466 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.666 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -58.87 -50.15 75.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.426 1.584 . . . . 0.0 107.042 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.975 ' CB ' HD11 ' A' ' 4' ' ' ILE . 85.3 m95 -62.62 -55.19 29.33 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.518 HD11 HD13 ' A' ' 74' ' ' LEU . 43.7 mt -52.83 -23.33 6.76 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -78.68 -19.47 52.42 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.503 -0.748 . . . . 0.0 110.12 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.6 m -98.41 31.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.996 -1.065 . . . . 0.0 109.311 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.45 78.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.54 128.37 35.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -1.181 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 10.6 mm-40 -100.39 119.92 57.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.8 Cg_endo -83.39 146.46 12.32 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.505 1.266 . . . . 0.0 110.407 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -71.29 158.44 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.0 109.987 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -55.53 -26.3 42.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 111.219 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 m -90.7 -48.39 7.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.697 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.908 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.13 -26.93 63.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.811 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' CD ' ' HG2' ' A' ' 66' ' ' PRO . 31.9 ttp180 -68.02 -36.79 80.52 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -35.66 76.17 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 70' ' ' ALA . 29.1 mt -73.29 -38.44 65.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 66' ' ' PRO . 66.9 mt -63.25 -28.44 70.03 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -77.13 -32.41 56.38 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.829 ' HB3' HD13 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -76.6 -32.19 57.94 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.15 0.976 . . . . 0.0 109.523 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.856 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.25 -7.99 46.62 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.78 42.31 7.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' A' ' 53' ' ' VAL . 39.7 t . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.176 -1.19 . . . . 0.0 111.157 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.826 ' CG1' HG12 ' A' ' 21' ' ' VAL . 92.3 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -140.67 133.0 28.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.127 -0.983 . . . . 0.0 110.534 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.765 HD11 ' CB ' ' A' ' 59' ' ' TRP . 33.1 mt -103.64 130.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.092 -1.005 . . . . 0.0 109.328 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.1 ptt85 -151.09 -167.46 2.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.652 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.572 HD22 ' HB2' ' A' ' 17' ' ' TYR . 13.1 mt -89.32 126.11 35.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.223 -0.923 . . . . 0.0 111.081 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.0 104.06 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.175 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 8.1 tmm_? . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 0.0 112.241 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB2' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 35' ' ' LYS . 1.4 ttm-85 -100.55 154.08 18.86 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.897 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -97.63 84.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.26 0.4 OUTLIER -98.51 172.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.988 -173.068 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.826 HG12 ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -112.73 105.28 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.597 -0.689 . . . . 0.0 111.037 -177.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.2 -0.938 . . . . 0.0 109.959 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.6 p90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.455 0.645 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.404 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.5 mt -86.02 -49.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.27 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -153.66 172.57 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -0.807 . . . . 0.0 109.778 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HD3' ' A' ' 18' ' ' ARG . 1.8 mtmt -111.82 126.3 54.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.04 -1.037 . . . . 0.0 110.0 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.018 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -129.86 -13.71 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.008 -1.057 . . . . 0.0 111.819 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.878 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -133.89 154.83 21.51 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 119.286 -1.435 . . . . 0.0 109.6 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.459 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 24.2 t80 -128.92 151.81 49.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.268 -1.136 . . . . 0.0 109.13 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 17' ' ' TYR . 38.8 t80 -149.93 116.5 5.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.721 -1.237 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.684 -1.26 . . . . 0.0 110.575 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 77' ' ' ALA . 6.6 tt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.383 0.611 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -140.33 85.9 2.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 109.288 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.897 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -115.85 143.54 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.922 -1.111 . . . . 0.0 111.412 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.8 t0 -94.58 69.8 3.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.719 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -32.9 -32.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.809 -177.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.28 -50.23 74.46 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.695 -1.253 . . . . 0.0 108.562 178.208 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.0 mmm180 -74.44 -36.17 63.38 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 53' ' ' VAL . . . -68.85 -16.57 63.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.944 -1.097 . . . . 0.0 108.129 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -90.38 -21.72 21.83 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 121.362 -0.836 . . . . 0.0 108.908 177.163 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -66.83 -48.22 69.57 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 123.032 1.396 . . . . 0.0 107.658 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.018 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.3 m95 -66.94 -54.36 22.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.424 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.043 HD11 HD13 ' A' ' 74' ' ' LEU . 3.3 mt -56.6 -21.31 26.05 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.537 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 2.8 m -82.34 -20.91 36.37 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.397 -0.814 . . . . 0.0 110.446 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.8 m -99.07 31.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.915 -1.116 . . . . 0.0 109.536 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 26.41 73.75 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -67.14 137.44 56.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.331 . . . . 0.0 109.644 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -103.03 108.26 58.02 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 0.0 110.609 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.0 Cg_endo -79.69 126.62 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.65 1.342 . . . . 0.0 109.736 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 7.6 t -62.21 -175.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.55 51.94 1.77 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 m -164.33 -56.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.33 -25.59 64.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.519 ' HA ' HD12 ' A' ' 74' ' ' LEU . 6.8 tmm_? -66.76 -39.62 87.93 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -40.86 96.57 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.4 mt -69.3 -29.29 67.12 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.515 -0.741 . . . . 0.0 109.348 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.043 HD13 HD11 ' A' ' 60' ' ' LEU . 45.7 mt -69.65 -28.09 65.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -27.05 29.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -83.55 -36.7 23.79 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.597 0.713 . . . . 0.0 110.533 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.19 -6.86 37.45 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.815 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.31 56.37 2.86 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.719 HG22 ' HB ' ' A' ' 53' ' ' VAL . 24.3 t . . . . . 0 N--CA 1.484 1.264 0 O-C-N 121.122 -1.223 . . . . 0.0 111.052 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.765 HG11 ' CE3' ' A' ' 59' ' ' TRP . 66.1 t . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.289 0.566 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 65' ' ' GLN . 3.6 tptm -140.49 128.44 22.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.912 HD11 ' CB ' ' A' ' 59' ' ' TRP . 71.6 mt -99.97 128.91 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.041 -1.037 . . . . 0.0 109.901 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 6.6 ptm180 -151.23 -173.89 4.64 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.6 mp -88.96 126.07 35.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.518 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.34 103.57 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.355 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.482 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 111.179 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.6 m-85 . . . . . 0 C--O 1.214 -0.779 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 6.5 mmt180 -100.68 158.68 15.77 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.759 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.953 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -99.04 78.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.25 0.4 OUTLIER -97.26 163.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.733 -173.474 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.879 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 112.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.286 0.565 . . . . 0.0 110.308 -177.604 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.2 p90 . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.55 0.691 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.706 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.1 mp -84.34 -28.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 109.939 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.91 164.75 1.52 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.975 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.32 113.77 26.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.982 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.991 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -108.24 -34.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.115 -0.99 . . . . 0.0 110.664 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.925 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.27 164.34 15.36 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.342 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.493 ' N ' HG13 ' A' ' 19' ' ' ILE . 11.6 t80 -139.48 142.95 37.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 19.9 t80 -135.64 132.98 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.723 -1.235 . . . . 0.0 110.208 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 120.787 -1.195 . . . . 0.0 110.34 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 49' ' ' LEU . 2.3 tm? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.347 0.594 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 104.24 9.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.102 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.1 t -129.52 139.15 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.099 . . . . 0.0 111.357 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.8 t0 -84.94 70.83 10.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.52 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -31.91 -34.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -59.96 -51.01 71.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.774 -1.204 . . . . 0.0 108.837 178.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.628 ' HB3' HG22 ' A' ' 36' ' ' ILE . 47.1 mmm-85 -71.11 -45.52 63.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.901 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -59.87 -22.38 62.24 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.2 ttt180 -87.78 -26.42 22.88 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.317 -0.864 . . . . 0.0 109.864 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.1 t80 -59.29 -46.67 87.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.32 1.534 . . . . 0.0 107.237 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.991 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.4 m95 -62.85 -54.68 35.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.512 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 74' ' ' LEU . 7.3 mt -56.05 -20.58 17.48 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.583 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -79.02 -24.24 43.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.776 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 59' ' ' TRP . 14.4 m -98.92 33.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.939 -1.101 . . . . 0.0 109.568 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.28 27.15 73.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -68.26 130.93 44.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.004 -1.292 . . . . 0.0 109.964 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' O ' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -98.13 111.25 58.99 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 110.454 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HB3' HD11 ' A' ' 74' ' ' LEU . 53.4 Cg_endo -87.53 125.43 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.616 1.324 . . . . 0.0 109.951 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.783 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.3 t -53.98 166.31 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.016 -1.053 . . . . 0.0 109.767 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -33.8 36.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.041 -1.037 . . . . 0.0 110.919 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.7 m -76.04 -54.82 6.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.975 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.783 ' H ' HG23 ' A' ' 67' ' ' THR . . . -67.1 -23.36 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.475 -0.766 . . . . 0.0 109.222 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.767 ' HA ' HD12 ' A' ' 74' ' ' LEU . 31.0 ttp180 -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 2.0 ttt-85 -69.77 -43.19 72.68 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.676 -0.809 . . . . 0.0 108.977 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD22 HD23 ' A' ' 49' ' ' LEU . 77.5 mt -65.15 -22.89 66.98 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.571 -0.706 . . . . 0.0 109.443 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 71' ' ' ARG . 14.0 mt -70.73 -30.41 66.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.496 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 2.8 mtm180 -72.66 -34.67 67.41 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -77.52 -28.81 52.14 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.91 0.862 . . . . 0.0 110.077 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -73.34 -4.64 34.62 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.199 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.65 20.32 51.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 77' ' ' ALA . 21.1 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.091 -1.241 . . . . 0.0 110.569 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.255 0.55 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -140.2 133.44 29.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.245 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.975 HD11 ' CB ' ' A' ' 59' ' ' TRP . 98.0 mt -102.03 133.26 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.07 -1.019 . . . . 0.0 109.924 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -172.54 4.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 110.893 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -88.73 126.0 35.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.404 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.62 104.45 16.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 111.191 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 2.6 tmm_? . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.787 ' HB2' HD23 ' A' ' 6' ' ' LEU . 7.4 m-85 . . . . . 0 C--O 1.208 -1.131 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -108.41 159.59 16.55 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.66 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.981 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 81.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 177.65 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.264 0.4 OUTLIER -97.81 164.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.572 -174.0 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -111.86 106.1 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 110.471 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.102 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 45.5 p90 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.603 0.716 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.552 HG21 ' HH2' ' A' ' 59' ' ' TRP . 4.6 mt -72.56 -46.31 55.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.662 -0.649 . . . . 0.0 110.036 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -152.41 166.24 32.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 6.6 pttt -104.33 115.77 30.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.175 -0.953 . . . . 0.0 109.998 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.867 HG21 ' CD1' ' A' ' 59' ' ' TRP . 38.7 pt -108.32 -33.71 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.939 -1.1 . . . . 0.0 111.56 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.783 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.69 166.91 18.24 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.859 -1.638 . . . . 0.0 112.76 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.404 ' N ' HG12 ' A' ' 19' ' ' ILE . 53.1 t80 -140.94 121.4 14.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.981 ' HB2' HD11 ' A' ' 19' ' ' ILE . 20.8 t80 -114.94 139.95 49.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.777 -1.202 . . . . 0.0 109.778 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 109.864 178.884 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.649 HD23 ' C ' ' A' ' 49' ' ' LEU . 7.9 tt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.222 0.534 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -120.78 93.58 4.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.408 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.783 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.79 133.01 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.044 -1.035 . . . . 0.0 111.2 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.0 t0 -78.37 69.13 4.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -34.06 -32.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.542 -177.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tt0 -62.42 -52.15 64.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.916 -1.115 . . . . 0.0 109.105 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.1 mtm-85 -75.49 -34.7 60.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.078 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -67.15 -23.48 65.8 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HB2' HG13 ' A' ' 79' ' ' VAL . 40.8 ttt180 -86.15 -20.55 28.46 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.328 -0.857 . . . . 0.0 109.952 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.719 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -62.31 -48.56 79.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 123.078 1.418 . . . . 0.0 107.235 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.975 ' CB ' HD11 ' A' ' 4' ' ' ILE . 89.0 m95 -63.02 -55.92 21.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.714 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.644 HD12 HG11 ' A' ' 79' ' ' VAL . 84.2 mt -53.69 -21.85 7.84 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.5 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -81.96 -20.09 39.28 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.456 -0.778 . . . . 0.0 110.64 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.3 m -99.07 32.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.811 -1.181 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.88 27.1 72.82 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -81.95 117.64 22.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.136 -1.214 . . . . 0.0 109.992 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -91.36 127.75 49.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -83.7 165.42 13.84 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.352 1.185 . . . . 0.0 109.744 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -85.19 -174.94 5.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.226 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.68 46.68 1.19 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -165.7 -55.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 6' ' ' LEU . . . -67.83 -26.07 65.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.427 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 67.1 ttt180 -64.83 -40.53 95.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -39.35 89.64 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.875 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 70' ' ' ALA . 41.7 mt -70.71 -28.28 64.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 60' ' ' LEU . 40.9 mt -70.95 -29.46 65.48 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -28.26 38.44 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -83.86 -32.37 25.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.725 0.774 . . . . 0.0 110.097 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -66.41 -11.39 51.43 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.722 -0.611 . . . . 0.0 109.811 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.16 15.72 29.75 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.867 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 53' ' ' VAL . 17.9 t . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.724 -1.456 . . . . 0.0 110.138 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.056 0.455 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.14 142.18 36.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 110.688 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.919 HD11 ' CB ' ' A' ' 59' ' ' TRP . 84.7 mt -104.06 135.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.142 -0.974 . . . . 0.0 109.409 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -151.22 -168.81 3.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 70' ' ' ALA . 5.1 mp -89.3 127.3 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.846 . . . . 0.0 110.367 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.86 104.27 15.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.088 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.905 . . . . 0.0 112.539 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 14.1 m-85 . . . . . 0 C--O 1.211 -0.931 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.525 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.2 mtt85 -100.29 159.36 15.19 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.83 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.954 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.71 81.43 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 177.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.4 OUTLIER -97.69 171.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.934 -173.745 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.904 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -116.16 108.77 25.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.167 0.508 . . . . 0.0 110.048 -177.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 110.233 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB3' HG13 ' A' ' 20' ' ' VAL . 20.4 p90 . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.555 0.693 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG21 ' HH2' ' A' ' 59' ' ' TRP . 13.2 mt -82.64 -51.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 109.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -152.79 152.72 31.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.959 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -89.57 108.17 19.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.018 . . . . 0.0 110.125 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.898 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.5 pt -100.07 -36.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 111.371 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.803 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -120.78 168.03 13.98 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.021 -1.562 . . . . 0.0 112.392 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 19' ' ' ILE . 10.2 t80 -141.07 124.78 16.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.954 ' HB2' HD11 ' A' ' 19' ' ' ILE . 22.6 t80 -125.85 124.71 41.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.811 -1.18 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 120.731 -1.231 . . . . 0.0 110.69 -179.83 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 76' ' ' GLN . 8.2 tt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.291 0.567 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.91 94.91 3.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.803 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.0 138.56 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.952 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -84.74 72.38 10.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.293 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.753 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.98 -30.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 122.309 -0.245 . . . . 0.0 111.492 -177.498 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 35.1 mt-10 -60.47 -53.75 53.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.77 -1.206 . . . . 0.0 108.771 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.3 mmp_? -71.31 -39.66 71.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.432 -0.792 . . . . 0.0 108.891 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.873 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.74 -17.82 64.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 38.8 ttp180 -89.65 -22.68 22.17 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.19 -0.944 . . . . 0.0 109.594 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.888 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.4 t80 -61.4 -44.86 96.42 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 123.167 1.461 . . . . 0.0 107.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.919 ' CB ' HD11 ' A' ' 4' ' ' ILE . 84.6 m95 -69.84 -56.49 6.95 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.921 -1.491 . . . . 0.0 109.982 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.887 HD21 ' HG3' ' A' ' 66' ' ' PRO . 20.9 mt -53.98 -22.7 11.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.421 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -80.9 -22.3 39.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.474 -0.766 . . . . 0.0 110.56 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.888 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.69 32.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.764 -1.21 . . . . 0.0 109.478 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 30.03 74.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -76.95 128.96 35.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.065 -1.256 . . . . 0.0 110.141 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -94.76 110.24 48.27 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.887 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.3 Cg_endo -82.31 131.09 6.5 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.552 1.29 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 41.2 p -52.54 160.41 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.88 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.27 -16.3 20.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.909 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.446 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 5.4 m -92.34 -52.93 4.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -70.93 -28.48 64.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.4 ttt180 -65.53 -39.89 92.29 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -64.09 -27.6 69.2 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.075 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 70' ' ' ALA . 15.9 mt -85.5 -31.13 22.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.581 -0.699 . . . . 0.0 109.444 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.642 HD22 ' HB1' ' A' ' 56' ' ' ALA . 83.4 mt -69.01 -28.43 66.59 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -29.31 36.47 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HB3' HD11 ' A' ' 49' ' ' LEU . 4.8 tp-100 -77.95 -35.08 50.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.899 0.857 . . . . 0.0 109.316 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -68.63 -9.36 49.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.77 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 88.11 54.54 2.42 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.753 HG22 ' CB ' ' A' ' 53' ' ' VAL . 36.6 t . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.165 -1.197 . . . . 0.0 111.381 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 36.1 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.249 0.547 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -140.5 131.51 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.55 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.97 HD11 ' CB ' ' A' ' 59' ' ' TRP . 40.3 mt -99.76 129.31 50.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.074 -1.016 . . . . 0.0 109.012 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 18.5 ptt85 -150.24 174.04 13.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.774 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.5 pp -88.21 127.03 35.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.96 111.68 23.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 112.427 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.469 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 7.4 ttt-85 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.144 -0.973 . . . . 0.0 110.793 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.211 -0.927 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 12.4 ttm180 -99.93 146.24 26.89 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.398 -1.321 . . . . 0.0 108.107 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.04 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -96.33 80.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 102.164 -3.273 . . . . 0.0 102.164 178.325 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.542 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.289 0.4 OUTLIER -97.22 168.45 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.103 -173.197 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.895 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -114.12 109.76 29.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.49 -0.756 . . . . 0.0 110.507 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.5 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.342 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.542 ' HB3' HG13 ' A' ' 20' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.443 0.64 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.671 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.2 mt -61.3 -39.19 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.831 . . . . 0.0 109.918 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -167.36 170.93 11.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.912 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -110.57 121.02 44.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.005 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.927 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -115.78 -23.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.025 -1.047 . . . . 0.0 110.828 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.91 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.98 162.2 16.89 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 118.803 -1.665 . . . . 0.0 111.072 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' N ' HG12 ' A' ' 19' ' ' ILE . 63.9 t80 -140.22 133.64 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.04 ' HB2' HD11 ' A' ' 19' ' ' ILE . 2.6 t80 -126.93 121.81 32.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 109.906 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.0 110.064 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.652 HD13 ' HB3' ' A' ' 76' ' ' GLN . 1.7 tt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.368 0.604 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -133.48 86.81 2.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.31 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.91 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -115.67 130.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.119 -0.988 . . . . 0.0 111.327 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.6 t70 -74.35 70.82 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.79 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.86 -30.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 122.233 -0.292 . . . . 0.0 111.471 -177.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.8 tp10 -62.83 -50.12 72.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.797 -1.19 . . . . 0.0 108.623 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.669 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -76.72 -33.74 58.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 108.988 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.92 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -70.21 -21.5 63.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' VAL . 23.4 tpt180 -86.28 -22.27 26.9 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.646 ' O ' HG13 ' A' ' 62' ' ' VAL 0.25 0.5 OUTLIER -62.22 -48.08 81.59 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.258 1.504 . . . . 0.0 107.367 178.38 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.97 ' CB ' HD11 ' A' ' 4' ' ' ILE . 77.9 m95 -64.98 -56.08 15.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.788 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.618 ' CD1' HG11 ' A' ' 79' ' ' VAL . 47.2 mt -53.09 -22.47 6.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.561 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -80.71 -22.07 40.66 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.408 -0.808 . . . . 0.0 110.826 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 59' ' ' TRP . 7.2 m -98.89 32.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.813 -1.18 . . . . 0.0 109.543 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.61 70.83 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -73.17 110.75 7.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.073 -1.251 . . . . 0.0 110.136 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 115.61 56.08 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.8 Cg_endo -82.66 144.59 12.58 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.539 1.284 . . . . 0.0 109.992 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.93 165.51 13.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.59 -16.03 59.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 110.9 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -104.28 -46.79 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.175 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.83 -25.95 65.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -65.9 -38.68 89.38 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.251 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.412 ' NH1' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -62.01 -32.84 73.36 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.919 178.829 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.932 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -76.89 -35.67 57.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.512 HD12 ' HB3' ' A' ' 66' ' ' PRO . 76.7 mt -63.89 -28.77 70.07 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -78.4 -29.79 47.44 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.652 ' HB3' HD13 ' A' ' 49' ' ' LEU . 8.1 tp-100 -73.16 -34.04 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.056 0.931 . . . . 0.0 108.928 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -69.57 -7.99 43.4 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.983 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.81 39.13 10.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.79 HG22 HG23 ' A' ' 53' ' ' VAL . 45.5 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.176 -1.191 . . . . 0.0 111.893 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.777 HG11 ' CG2' ' A' ' 62' ' ' VAL . 61.1 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.199 0.524 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 65' ' ' GLN . 3.7 mtmt -140.18 139.5 35.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 110.793 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.944 HD11 ' HB3' ' A' ' 59' ' ' TRP . 1.5 mp -99.96 130.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.85 -176.71 5.63 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.1 -1.0 . . . . 0.0 110.845 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.542 HD22 ' HB2' ' A' ' 17' ' ' TYR . 16.1 mt -89.7 127.14 35.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.847 . . . . 0.0 110.8 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.72 107.08 19.07 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.769 -1.207 . . . . 0.0 112.805 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.542 ' HB2' HD22 ' A' ' 6' ' ' LEU . 11.0 m-85 . . . . . 0 C--O 1.21 -0.995 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 24.2 ttt180 -112.41 152.65 28.41 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.939 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.2 mt -98.73 78.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 34' ' ' GLU 0.271 0.4 OUTLIER -98.07 165.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.179 -173.134 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.951 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.44 106.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.854 -0.529 . . . . 0.0 110.612 -177.896 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.7 t . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.151 -0.968 . . . . 0.0 110.258 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.6 p90 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.475 0.655 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 mt -90.45 -34.39 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.988 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -164.71 -175.54 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -119.18 112.75 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.978 HG21 ' CD1' ' A' ' 59' ' ' TRP . 21.4 pt -108.96 -38.0 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.924 -1.11 . . . . 0.0 111.208 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.79 163.73 19.63 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.81 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 25.0 t80 -133.69 152.54 51.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -143.54 137.86 28.75 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.974 -1.079 . . . . 0.0 109.738 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 t0 . . . . . 0 N--CA 1.496 1.835 0 O-C-N 120.759 -1.213 . . . . 0.0 110.479 179.831 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 77' ' ' ALA . 7.2 tt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.48 0.657 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 94.01 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 108.715 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.939 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -120.58 154.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.255 1.026 . . . . 0.0 111.712 -178.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 9.1 t0 -103.95 68.07 0.9 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -29.95 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.511 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.9 tt0 -60.28 -52.46 65.2 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.771 -1.206 . . . . 0.0 109.197 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.57 ' HB3' HG22 ' A' ' 36' ' ' ILE . 28.0 mmm180 -72.3 -41.01 67.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.967 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -63.37 -20.37 65.47 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 23.2 ttp85 -89.79 -21.95 22.37 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.89 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -63.36 -47.23 82.97 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 123.176 1.465 . . . . 0.0 107.311 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.978 ' CD1' HG21 ' A' ' 36' ' ' ILE . 90.4 m95 -66.81 -55.29 15.54 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.915 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -54.62 -22.82 14.66 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.317 177.014 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -81.67 -19.2 42.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.46 -0.775 . . . . 0.0 110.41 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.4 m -99.0 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.799 -1.188 . . . . 0.0 109.31 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.88 28.05 73.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -71.15 146.12 49.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.072 -1.252 . . . . 0.0 110.301 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 3' ' ' LYS . 1.9 mm100 -113.1 109.59 51.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HG3' HD21 ' A' ' 60' ' ' LEU . 52.2 Cg_endo -86.64 128.38 2.9 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.59 1.311 . . . . 0.0 110.619 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.3 t -54.81 165.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.09 -17.52 27.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.154 -0.966 . . . . 0.0 111.202 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.1 m -90.24 -52.88 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.0 110.487 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.811 ' H ' HG23 ' A' ' 67' ' ' THR . . . -68.99 -28.82 66.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' HA ' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -68.34 -39.16 81.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.291 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -39.57 88.75 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -73.63 -27.3 61.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.41 -0.806 . . . . 0.0 109.267 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.543 HD13 HD11 ' A' ' 60' ' ' LEU . 21.3 mt -69.64 -27.83 65.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -25.83 37.84 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.3 tp-100 -83.85 -36.55 23.35 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.792 0.806 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.631 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -69.01 -6.63 29.1 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.281 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.35 43.88 7.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 53' ' ' VAL . 23.8 t . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.156 -1.202 . . . . 0.0 111.2 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG11 ' CE3' ' A' ' 59' ' ' TRP . 41.0 t . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.267 0.555 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 65' ' ' GLN . 7.3 mttt -140.33 140.37 35.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.982 HD11 ' CB ' ' A' ' 59' ' ' TRP . 95.2 mt -108.18 134.88 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.745 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -150.96 -163.65 1.82 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.312 -0.868 . . . . 0.0 110.112 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.028 HD11 HG21 ' A' ' 69' ' ' THR . 36.4 mt -89.3 136.03 33.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.071 -1.018 . . . . 0.0 110.986 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -106.47 105.22 15.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.59 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.479 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.9 ttp85 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 111.177 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 4.7 m-30 . . . . . 0 C--O 1.212 -0.905 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.624 ' HD3' HG23 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -104.14 164.77 11.49 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.743 -1.583 . . . . 0.0 106.997 176.151 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.701 HD12 HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -98.39 86.39 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.624 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.264 0.4 OUTLIER -98.12 168.72 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.285 -174.782 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.948 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -113.75 106.19 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.673 -177.484 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.952 . . . . 0.0 109.418 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.646 ' HB3' HG22 ' A' ' 22' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.58 0.705 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.529 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.3 mt -92.07 -50.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 110.04 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.1 tt0 -150.15 164.59 35.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.01 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -103.07 116.71 33.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.142 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.995 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.9 pt -110.5 -33.8 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.985 -1.072 . . . . 0.0 111.991 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -128.38 174.46 18.86 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.187 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 85.1 t80 -140.49 142.9 35.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.441 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 7.8 t80 -140.16 132.91 29.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.722 -1.236 . . . . 0.0 110.036 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.8 t0 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 120.835 -1.165 . . . . 0.0 110.236 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' A' ' 77' ' ' ALA . 5.5 tt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.238 0.542 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.39 96.06 4.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.388 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.803 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -120.74 149.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 111.476 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t0 -95.75 68.89 2.88 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.21 -35.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mt-10 -59.68 -52.98 63.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.746 -1.221 . . . . 0.0 109.202 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.66 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.79 -40.86 72.31 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.4 -0.812 . . . . 0.0 109.049 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.09 -18.69 65.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 108.548 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.26 -22.96 23.65 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.242 -0.911 . . . . 0.0 109.524 178.376 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 62' ' ' VAL . 3.7 t80 -61.05 -43.28 99.12 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.139 1.447 . . . . 0.0 107.305 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.995 ' CD1' HG21 ' A' ' 36' ' ' ILE . 78.7 m95 -68.6 -53.31 23.52 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.893 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 74' ' ' LEU . 6.6 mt -57.39 -21.02 33.37 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.574 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -81.58 -23.89 36.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.453 -0.779 . . . . 0.0 110.651 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 59' ' ' TRP . 25.5 m -99.15 32.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 120.817 -1.177 . . . . 0.0 109.649 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.42 31.25 76.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.54 141.68 51.86 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.006 -1.291 . . . . 0.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.453 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -105.91 103.04 42.42 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 110.128 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.4 Cg_endo -81.26 125.14 5.07 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.698 1.367 . . . . 0.0 110.226 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.5 t -54.9 176.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.0 -1.062 . . . . 0.0 109.695 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.79 -19.68 62.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.182 -0.949 . . . . 0.0 111.026 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 1.028 HG21 HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -90.5 -51.17 5.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.686 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.683 ' H ' HG23 ' A' ' 67' ' ' THR . . . -70.4 -27.59 64.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.21 -37.98 78.35 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -69.47 -47.34 64.25 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.545 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 70' ' ' ALA . 15.4 mt -60.48 -25.13 65.81 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 60' ' ' LEU . 23.1 mt -76.19 -25.94 55.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -31.49 30.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.495 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.5 tp-100 -87.18 -36.46 18.01 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.724 0.773 . . . . 0.0 110.7 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.86 -10.78 31.01 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.705 -0.622 . . . . 0.0 110.01 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.64 48.78 5.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.612 HG21 HD23 ' A' ' 74' ' ' LEU . 49.5 t . . . . . 0 N--CA 1.487 1.377 0 O-C-N 121.065 -1.256 . . . . 0.0 111.44 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.904 HG11 HG23 ' A' ' 62' ' ' VAL . 49.9 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.299 0.571 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt -138.6 133.41 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.982 HD11 ' CB ' ' A' ' 59' ' ' TRP . 84.9 mt -106.05 133.37 50.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.162 -0.961 . . . . 0.0 109.649 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.525 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.2 174.33 13.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.956 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.476 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 1.2 pp -89.26 129.43 35.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.1 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -98.65 165.5 11.77 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.473 -0.767 . . . . 0.0 109.334 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 120.974 -1.079 . . . . 0.0 111.483 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 14.5 m-85 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' CD ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -127.69 147.16 50.38 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.006 -1.059 . . . . 0.0 108.384 178.118 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.872 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -97.31 81.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 178.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG23 ' CD ' ' A' ' 18' ' ' ARG 0.29 0.4 OUTLIER -98.2 160.49 3.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.78 -173.347 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.943 HG13 HG12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -104.16 107.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.686 -0.634 . . . . 0.0 109.862 -178.666 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 110.425 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.6 p90 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.539 0.685 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.511 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.6 mt -68.92 -29.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.488 -0.758 . . . . 0.0 109.643 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.37 179.94 4.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 31.9 pttt -120.81 121.82 38.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 56' ' ' ALA . 23.9 pt -116.92 -38.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.135 -0.978 . . . . 0.0 111.607 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.843 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.0 165.64 13.05 Favored Glycine 0 C--N 1.296 -1.686 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.531 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.421 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.6 t80 -139.07 126.68 21.86 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -119.27 136.59 54.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.959 -1.088 . . . . 0.0 110.548 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.633 179.416 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.749 HD11 ' HB3' ' A' ' 73' ' ' LEU . 1.4 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.43 0.633 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.16 94.79 4.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.43 -0.793 . . . . 0.0 108.884 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.872 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -118.51 141.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 111.557 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -85.3 67.19 10.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.879 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.82 -29.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -61.13 -47.32 86.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.78 -1.2 . . . . 0.0 108.567 178.138 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 30.8 mmm180 -76.88 -38.53 53.46 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.68 -21.75 66.81 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.3 -21.16 24.58 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.442 -0.786 . . . . 0.0 109.536 178.252 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.821 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -65.81 -49.39 68.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.242 1.496 . . . . 0.0 107.451 178.617 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.982 ' CB ' HD11 ' A' ' 4' ' ' ILE . 86.7 m95 -63.6 -56.08 18.72 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.748 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.761 HD21 ' HG3' ' A' ' 66' ' ' PRO . 12.4 mt -52.95 -22.79 6.04 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.421 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -81.89 -19.06 41.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.544 -0.722 . . . . 0.0 110.337 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.904 HG23 HG11 ' A' ' 2' ' ' VAL . 3.2 m -98.74 31.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.849 -1.157 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.25 72.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.23 143.57 52.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -1.209 . . . . 0.0 110.109 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -106.54 105.65 55.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 0.0 110.532 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.761 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.3 Cg_endo -80.85 140.48 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.616 1.324 . . . . 0.0 110.335 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 70.5 p -72.24 163.52 27.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.993 -1.067 . . . . 0.0 110.166 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.63 -22.48 61.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.725 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.476 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 12.5 m -92.78 -48.23 6.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.173 -0.954 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.989 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.78 -30.21 67.71 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' A' ' 74' ' ' LEU . 12.2 ttt-85 -66.12 -37.5 85.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -28.9 70.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.989 HD12 ' HA ' ' A' ' 70' ' ' ALA . 14.8 mt -83.94 -33.4 24.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.59 HD13 HD11 ' A' ' 60' ' ' LEU . 80.5 mt -63.99 -30.53 71.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -25.72 41.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.631 ' HB3' HD13 ' A' ' 49' ' ' LEU . 10.3 tp-100 -74.32 -35.01 63.62 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.12 0.962 . . . . 0.0 109.26 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -72.24 -5.8 38.48 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.23 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.45 48.31 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.879 HG22 HG23 ' A' ' 53' ' ' VAL . 44.0 t . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 111.501 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.6 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.304 0.573 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -140.22 129.16 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.924 ' CG1' HG13 ' A' ' 21' ' ' VAL . 74.9 mt -99.8 131.9 46.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.023 -1.048 . . . . 0.0 109.373 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.0 ptm180 -150.42 -167.06 2.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.038 -1.039 . . . . 0.0 110.361 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.723 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.6 mp -89.31 131.22 35.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.356 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -103.08 105.06 15.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 111.206 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.508 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 O-C-N 121.192 -0.943 . . . . 0.0 111.525 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 3.9 m-30 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -104.03 165.91 10.74 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.24 176.55 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.707 HD12 HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -98.46 83.74 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.252 0.3 OUTLIER -97.6 169.73 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.146 -174.943 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.924 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -113.47 104.83 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.56 -0.712 . . . . 0.0 110.496 -177.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.248 -0.907 . . . . 0.0 110.166 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.513 0.673 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.776 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.9 mt -82.77 -43.62 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.482 -0.761 . . . . 0.0 109.37 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.3 161.72 30.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.486 -0.758 . . . . 0.0 109.624 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -98.13 116.74 30.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.101 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 56' ' ' ALA . 35.5 pt -104.66 -36.08 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.975 -1.078 . . . . 0.0 111.472 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.811 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -129.08 177.04 18.14 Favored Glycine 0 C--N 1.294 -1.753 0 C-N-CA 118.917 -1.611 . . . . 0.0 112.291 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 17.2 t80 -140.58 145.63 36.97 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 4.2 t80 -142.92 129.64 20.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.609 -1.307 . . . . 0.0 110.5 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 t0 . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.818 -1.176 . . . . 0.0 110.25 179.834 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 73' ' ' LEU . 11.8 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.579 0.704 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -128.25 110.45 12.41 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.811 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.24 160.96 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.419 1.104 . . . . 0.0 111.72 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.4 t70 -104.91 67.58 0.8 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.05 -32.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.593 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -63.58 -52.06 62.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.9 -1.125 . . . . 0.0 109.232 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.8 mtm-85 -75.69 -33.3 60.35 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.241 -0.912 . . . . 0.0 109.428 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -68.99 -23.8 64.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.5 ttt-85 -86.3 -21.89 27.06 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.24 -0.912 . . . . 0.0 109.726 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -61.02 -50.57 72.8 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.252 1.501 . . . . 0.0 107.039 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.906 ' CD2' HG11 ' A' ' 21' ' ' VAL . 84.5 m95 -60.27 -53.02 62.65 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.576 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 56' ' ' ALA . 1.3 mt -54.42 -22.04 11.43 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -77.97 -22.75 48.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.542 -0.724 . . . . 0.0 110.408 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 59' ' ' TRP . 8.9 m -99.05 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.784 -1.197 . . . . 0.0 109.736 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.58 25.58 74.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -66.84 129.69 40.7 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.237 -1.155 . . . . 0.0 109.763 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.35 116.43 63.75 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.2 Cg_endo -82.77 128.4 5.21 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.526 1.277 . . . . 0.0 109.921 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 t -55.49 176.42 0.06 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.852 -1.155 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 55.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 m -166.67 -59.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.15 -23.16 66.43 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 18.0 ttp85 -65.62 -42.71 91.25 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 3.1 ttm180 -67.46 -42.16 83.47 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.424 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.735 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.1 mt -68.19 -26.16 65.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 60' ' ' LEU . 13.7 mt -67.61 -30.17 69.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 9.0 mtm180 -75.98 -34.52 59.78 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.26 56.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.925 0.869 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.764 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.65 -7.55 39.89 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.306 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.95 19.51 33.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 60' ' ' LEU . 12.2 t . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.256 . . . . 0.0 110.763 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.488 HG11 ' CG2' ' A' ' 62' ' ' VAL . 39.7 t . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.242 0.544 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 65' ' ' GLN . 57.8 mtpt -140.92 134.72 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.993 . . . . 0.0 110.323 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.998 ' CG1' HG13 ' A' ' 21' ' ' VAL . 37.9 mt -99.73 133.99 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 108.917 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.519 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.8 ptt180 -150.35 172.99 14.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.006 -1.059 . . . . 0.0 109.941 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 2.9 pp -89.28 130.84 35.61 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 109.518 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -99.15 162.21 13.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.571 -0.706 . . . . 0.0 109.212 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 70.6 ttt180 . . . . . 0 N--CA 1.486 1.366 0 O-C-N 120.931 -1.106 . . . . 0.0 111.4 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 12.5 m-85 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 38' ' ' TYR . 2.2 ttp180 -132.05 147.19 52.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.017 -1.052 . . . . 0.0 108.18 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.841 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -97.22 83.24 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 178.086 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.291 0.4 OUTLIER -97.56 167.0 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.338 -173.118 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.998 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -112.85 105.65 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.488 -0.758 . . . . 0.0 110.986 -177.034 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' HD12 ' A' ' 33' ' ' ILE . 1.9 t . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.0 110.004 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 31.8 p90 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.419 0.628 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.679 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -62.61 -46.12 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -157.81 171.66 19.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.613 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.63 125.15 53.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.652 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.995 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -120.76 -28.05 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.044 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.916 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.26 158.77 14.86 Favored Glycine 0 C--N 1.297 -1.607 0 C-N-CA 118.945 -1.598 . . . . 0.0 111.078 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 69.2 t80 -132.61 133.2 43.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 17' ' ' TYR . 6.0 t80 -124.39 136.1 53.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.301 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.013 -1.055 . . . . 0.0 110.007 179.562 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 76' ' ' GLN . 3.9 tt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.322 0.582 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -135.33 91.93 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.453 -0.78 . . . . 0.0 109.373 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.916 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -117.86 137.8 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 111.132 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.3 t70 -82.18 70.2 9.06 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.626 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.69 -31.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.556 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.5 tt0 -62.87 -52.05 64.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.869 -1.144 . . . . 0.0 108.902 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.68 -34.78 60.46 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.024 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.941 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -66.67 -18.07 65.18 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 28.9 ttp180 -88.39 -25.19 22.82 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.376 -0.827 . . . . 0.0 109.361 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.916 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -59.06 -44.84 91.88 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.356 1.55 . . . . 0.0 107.096 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.995 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.1 m95 -68.38 -57.88 5.21 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.836 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.425 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.4 mt -52.74 -23.31 6.53 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.314 -0.954 . . . . 0.0 108.612 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 t -80.78 -21.41 41.01 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 110.38 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -98.63 32.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.773 -1.204 . . . . 0.0 109.293 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.05 74.17 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.98 109.33 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 110.312 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -78.08 114.5 42.66 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 110.413 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -82.08 148.76 15.29 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.496 1.261 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.634 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 1.8 p -74.81 161.79 29.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.014 -1.053 . . . . 0.0 109.83 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.41 -25.6 59.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.043 -1.036 . . . . 0.0 110.985 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.474 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 38.4 m -93.28 -47.58 6.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 0.0 110.6 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.964 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.51 -27.63 65.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.8 ttt-85 -65.65 -38.85 90.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -34.77 76.75 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.524 -0.87 . . . . 0.0 108.879 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -76.74 -33.42 58.13 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 66' ' ' PRO . 74.3 mt -65.38 -28.27 69.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' CG ' ' O ' ' A' ' 71' ' ' ARG . 3.7 mmm180 -79.01 -32.15 45.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.691 ' HB3' HD13 ' A' ' 49' ' ' LEU . 8.1 tp-100 -72.06 -34.44 68.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.153 0.978 . . . . 0.0 108.998 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.67 -9.74 46.14 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.148 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 44.36 7.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.597 HG22 ' CB ' ' A' ' 53' ' ' VAL . 47.2 t . . . . . 0 N--CA 1.486 1.346 0 O-C-N 121.193 -1.181 . . . . 0.0 111.394 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.691 HG11 ' CE3' ' A' ' 59' ' ' TRP . 26.9 t . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.23 0.538 . . . . 0.0 109.855 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.653 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.948 HD11 ' CB ' ' A' ' 59' ' ' TRP . 54.8 mt -109.53 133.41 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.146 -0.971 . . . . 0.0 109.48 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 5.2 ptp180 -151.52 -166.79 2.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.781 -1.199 . . . . 0.0 110.69 -178.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 17' ' ' TYR . 41.9 mt -88.67 127.68 35.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.85 107.33 18.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.3 -0.875 . . . . 0.0 110.905 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.499 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ttt180 . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.973 . . . . 0.0 109.97 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.695 ' HB2' HD22 ' A' ' 6' ' ' LEU . 7.5 m-30 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -99.88 156.27 17.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.504 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.923 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.23 75.77 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 176.427 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.257 0.3 OUTLIER -97.27 165.46 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.859 -173.261 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.915 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.7 113.25 42.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.463 0.649 . . . . 0.0 111.407 -176.958 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.665 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 6.3 p90 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 ' HH2' ' A' ' 59' ' ' TRP . 16.3 mt -89.11 -41.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.59 -0.694 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.58 162.22 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.9 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.594 ' HA ' HG23 ' A' ' 20' ' ' VAL . 2.6 mtpt -101.44 113.89 27.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 0.0 109.734 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.949 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.4 pt -107.37 -34.77 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.198 -0.938 . . . . 0.0 111.24 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.85 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.49 165.77 17.37 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.099 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' ILE . 12.7 t80 -137.49 142.46 41.5 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.436 ' CD2' HD13 ' A' ' 73' ' ' LEU . 39.4 t80 -138.11 133.21 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.767 -1.208 . . . . 0.0 110.404 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 120.946 -1.096 . . . . 0.0 109.767 179.54 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.7 tt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.249 0.547 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -118.17 104.3 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.975 . . . . 0.0 109.508 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.923 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.2 t -128.15 149.31 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.347 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 21.8 t0 -94.23 67.99 3.61 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.16 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.6 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -32.96 -34.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.632 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -61.72 -54.17 46.12 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.894 -1.122 . . . . 0.0 108.57 178.333 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -74.32 -33.06 63.06 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.437 -0.79 . . . . 0.0 109.331 178.973 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.848 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -69.02 -23.56 64.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -87.02 -19.78 28.17 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.552 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -62.47 -48.49 79.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.277 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.949 ' CD1' HG21 ' A' ' 36' ' ' ILE . 89.5 m95 -63.08 -55.42 25.62 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.257 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 74' ' ' LEU . 3.9 mt -52.4 -22.91 5.16 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.558 176.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -79.93 -21.9 43.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.433 -0.792 . . . . 0.0 110.797 179.229 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 59' ' ' TRP . 6.4 m -98.79 33.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.843 -1.161 . . . . 0.0 109.227 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.55 27.48 73.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.71 142.54 48.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.192 -1.181 . . . . 0.0 109.833 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.38 114.6 38.28 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 110.523 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.665 ' HB3' HD12 ' A' ' 74' ' ' LEU . 49.5 Cg_endo -79.77 128.95 7.92 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.497 1.261 . . . . 0.0 110.308 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.99 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.516 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.77 53.56 1.14 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -166.77 -59.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -66.52 -22.94 66.17 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 2.5 ttt85 -69.01 -43.24 75.21 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 ttm-85 -66.38 -38.44 87.56 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.731 178.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.6 mt -74.37 -26.37 60.08 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 66' ' ' PRO . 13.7 mt -72.0 -29.84 64.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -28.98 38.31 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.431 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.68 -34.58 30.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.814 0.816 . . . . 0.0 109.932 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -62.19 -14.26 35.95 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.793 -0.567 . . . . 0.0 109.877 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 25.58 8.56 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 53' ' ' VAL . 17.5 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 120.846 -1.385 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.123 0.487 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.565 ' C ' HD12 ' A' ' 4' ' ' ILE . 21.6 ptmt -140.11 143.28 36.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.121 -0.987 . . . . 0.0 110.874 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.999 HD11 HG13 ' A' ' 21' ' ' VAL . 1.7 mp -100.23 139.09 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 108.901 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.3 -166.12 2.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' HD2' ' A' ' 17' ' ' TYR . 31.1 mt -89.5 135.7 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.86 . . . . 0.0 109.904 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -105.42 103.44 12.96 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.802 . . . . 0.0 111.029 -179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.495 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.381 0 O-C-N 121.53 -0.731 . . . . 0.0 110.942 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.546 ' HD2' HD13 ' A' ' 6' ' ' LEU . 3.9 m-30 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 3.9 ptm180 -103.55 167.61 9.69 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 117.453 -1.699 . . . . 0.0 107.571 176.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.842 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.58 86.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 178.907 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.492 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.256 0.3 OUTLIER -98.95 170.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.224 -174.856 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.019 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.8 t -111.95 113.78 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.595 -0.69 . . . . 0.0 110.209 -178.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CD2' HG21 ' A' ' 20' ' ' VAL . 8.6 p90 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.459 0.647 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HG3' ' A' ' 34' ' ' GLU . 4.7 mt -64.63 -63.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.944 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 33' ' ' ILE . 44.1 mt-10 -139.27 161.48 37.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.918 . . . . 0.0 110.255 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 118.92 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -0.948 . . . . 0.0 109.976 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.675 HG21 ' CD1' ' A' ' 59' ' ' TRP . 49.5 pt -99.95 -27.96 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.801 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -150.6 -174.1 21.35 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 117.908 -2.091 . . . . 0.0 112.769 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 31.4 t80 -141.25 151.12 43.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.262 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.842 ' HB2' HD11 ' A' ' 19' ' ' ILE . 2.6 t80 -144.02 124.68 14.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.689 -1.257 . . . . 0.0 109.701 177.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 63.0 t0 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.588 -1.32 . . . . 0.0 110.335 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.804 HD13 ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.47 0.653 . . . . 0.0 110.549 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.804 ' N ' HD13 ' A' ' 49' ' ' LEU . 29.4 tttt -136.69 75.94 1.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.801 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -97.26 134.47 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 110.968 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -80.43 69.07 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 175.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.581 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.47 -31.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.514 -177.326 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.09 -55.98 26.21 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.899 -1.125 . . . . 0.0 108.778 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 5.1 mmp_? -69.28 -41.2 77.16 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.54 -16.7 63.03 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.947 -1.095 . . . . 0.0 108.071 178.563 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.65 -25.73 22.25 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 177.849 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.856 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -59.71 -46.62 88.56 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.23 1.49 . . . . 0.0 107.406 178.747 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.019 ' CD2' HG11 ' A' ' 21' ' ' VAL . 94.6 m95 -67.0 -56.57 9.54 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.259 -178.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 74' ' ' LEU . 1.9 mt -52.45 -23.22 5.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.391 176.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -80.5 -21.0 42.37 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.647 -0.658 . . . . 0.0 110.272 178.938 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.3 m -98.67 32.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.468 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.27 29.36 74.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.592 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -77.66 129.1 35.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.269 -1.136 . . . . 0.0 109.924 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -97.67 108.52 46.03 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.438 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HG3' HD21 ' A' ' 60' ' ' LEU . 50.8 Cg_endo -77.13 135.38 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.613 1.323 . . . . 0.0 110.368 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 2.3 p -54.69 161.08 1.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.892 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.74 -22.62 58.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.009 . . . . 0.0 110.107 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.0 m -89.19 -52.38 5.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.626 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.13 -23.88 65.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -70.06 -38.58 75.81 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.336 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -64.92 -34.24 77.94 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.87 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 70' ' ' ALA . 47.8 mt -74.08 -32.58 63.32 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 60' ' ' LEU . 56.3 mt -68.29 -28.88 67.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -30.4 52.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -29.21 37.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.891 0.853 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -76.98 -1.67 29.91 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.198 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.09 50.08 8.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.581 HG22 ' HB ' ' A' ' 53' ' ' VAL . 58.3 t . . . . . 0 N--CA 1.484 1.272 0 O-C-N 121.291 -1.123 . . . . 0.0 111.336 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.472 HG11 ' CE3' ' A' ' 59' ' ' TRP . 84.1 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.283 0.564 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.548 ' C ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -139.78 137.06 34.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.387 -0.82 . . . . 0.0 109.999 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.891 ' CD1' HG13 ' A' ' 21' ' ' VAL . 1.8 mp -99.63 135.89 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 5.3 ptp180 -151.18 175.39 12.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.707 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD12 ' CD2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -88.17 126.16 34.99 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.935 178.882 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.19 109.84 22.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.56 -0.713 . . . . 0.0 111.917 -177.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 52.6 ttp180 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 111.152 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 6' ' ' LEU . 4.8 m-85 . . . . . 0 C--O 1.21 -1.0 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 2.6 ttt85 -104.64 150.28 24.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.629 178.195 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.086 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -97.35 80.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.288 0.4 OUTLIER -97.35 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.734 -173.821 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.4 t -115.65 107.73 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.516 -176.743 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.268 -0.895 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 20.0 p90 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.349 0.595 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.551 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.4 mt -107.69 -36.43 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 110.329 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.84 176.04 9.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -110.68 109.45 19.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.694 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.976 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.7 pt -106.11 -33.1 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.14 -0.975 . . . . 0.0 111.124 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.37 166.08 20.25 Favored Glycine 0 C--N 1.295 -1.723 0 C-N-CA 118.603 -1.76 . . . . 0.0 111.039 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.483 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.1 t80 -138.45 142.29 39.47 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.086 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.1 t80 -134.47 130.76 37.19 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.056 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.1 t0 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 110.195 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 HD22 ' A' ' 73' ' ' LEU . 9.4 tp . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.589 0.709 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -132.7 97.35 4.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.758 . . . . 0.0 109.148 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.841 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 151.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 110.925 -179.133 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.6 t0 -96.65 67.95 2.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.703 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.99 -30.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 122.252 -0.28 . . . . 0.0 111.509 -177.281 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.7 tp10 -60.45 -54.62 43.33 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.761 -1.212 . . . . 0.0 108.581 178.026 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 47.3 mmm-85 -72.97 -37.06 67.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.825 . . . . 0.0 109.005 178.411 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.54 -20.59 66.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.382 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.8 ttt180 -88.35 -24.37 23.14 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.277 -0.889 . . . . 0.0 109.519 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.684 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -60.06 -46.59 89.04 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 123.5 1.619 . . . . 0.0 106.928 178.288 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.008 ' CD2' HG11 ' A' ' 21' ' ' VAL . 79.1 m95 -63.72 -55.92 19.59 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.952 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -52.8 -22.36 5.26 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.549 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.37 -20.89 43.08 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.0 110.691 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.3 m -99.0 32.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.875 -1.14 . . . . 0.0 109.952 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.85 71.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -77.0 138.51 39.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -1.112 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.435 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 1.5 mm-40 -116.78 118.29 36.76 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.391 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.2 Cg_endo -79.67 140.46 14.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.397 1.209 . . . . 0.0 109.856 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 70' ' ' ALA . 7.2 t -62.56 176.22 0.68 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.96 -1.088 . . . . 0.0 110.468 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -81.58 49.77 1.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.154 -0.966 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.14 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.58 -23.91 66.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.101 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 25.6 ttt85 -63.81 -40.39 96.51 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.105 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -35.83 74.23 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 70' ' ' ALA . 46.6 mt -72.46 -38.58 68.22 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 66' ' ' PRO . 24.8 mt -61.04 -28.15 68.85 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.161 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -31.0 52.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.302 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.453 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.8 tp-100 -75.81 -35.16 60.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.039 0.923 . . . . 0.0 109.866 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.13 -7.02 32.33 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.472 178.953 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.2 8.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 53' ' ' VAL . 57.4 t . . . . . 0 C--N 1.307 -1.275 0 O-C-N 121.356 -1.085 . . . . 0.0 111.572 -179.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.648 HG11 ' CE3' ' A' ' 59' ' ' TRP . 78.0 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.173 0.511 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 59.7 mtpt -140.32 132.39 27.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.926 HD11 ' CB ' ' A' ' 59' ' ' TRP . 61.9 mt -100.17 127.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 121.076 -1.015 . . . . 0.0 109.153 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 1.2 ptm180 -150.74 -170.4 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.017 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -88.49 126.32 35.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 105.8 17.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 111.085 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.446 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 36.8 ttp180 . . . . . 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 109.817 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 13.9 m-85 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HG2' ' CD1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -104.13 158.9 16.12 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.379 -1.329 . . . . 0.0 108.089 177.166 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.904 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.3 77.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.708 HG11 ' CD2' ' A' ' 32' ' ' TYR 0.255 0.3 OUTLIER -97.25 164.69 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.855 -173.398 . . . . . . . . 4 4 . 1 . 024 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.815 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.44 105.48 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 109.967 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.754 HG22 ' HB3' ' A' ' 32' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.649 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.754 ' HB3' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.671 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.9 mt -59.88 -50.01 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.764 . . . . 0.0 109.926 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -178.31 5.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 109.904 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HE2' ' NH2' ' A' ' 18' ' ' ARG . 7.1 mtpt -117.8 125.39 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.943 . . . . 0.0 110.343 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.054 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.48 -33.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.176 -0.953 . . . . 0.0 111.242 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.894 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.5 161.37 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 C-N-CA 118.919 -1.61 . . . . 0.0 110.967 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.491 ' CD1' ' HG2' ' A' ' 18' ' ' ARG . 72.3 t80 -133.62 145.08 49.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.73 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HD2' HD23 ' A' ' 6' ' ' LEU . 17.6 t80 -139.74 134.37 31.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.686 -1.259 . . . . 0.0 109.918 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 0.0 110.61 -179.788 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 76' ' ' GLN . 5.0 tt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.332 0.587 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.76 97.96 3.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.156 -0.965 . . . . 0.0 109.636 178.95 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.904 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.1 t -128.66 130.34 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.864 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 17.2 t0 -80.16 72.29 6.96 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.258 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.653 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.6 -31.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 122.342 -0.224 . . . . 0.0 111.523 -177.108 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -59.93 -51.49 69.46 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.818 -1.176 . . . . 0.0 108.666 177.857 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 36' ' ' ILE . 14.4 mmm180 -73.57 -41.12 63.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.937 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -62.62 -18.43 62.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 52.0 ttp85 -88.34 -26.15 22.37 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.702 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.1 t80 -62.01 -44.72 96.11 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 123.289 1.519 . . . . 0.0 107.462 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.054 ' CD1' HG21 ' A' ' 36' ' ' ILE . 71.9 m95 -68.03 -57.08 6.72 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.038 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.42 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.9 mt -56.67 -21.43 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.524 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 1.6 t -79.25 -23.22 43.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 110.718 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 58' ' ' TYR . 13.9 m -98.9 31.95 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 120.854 -1.154 . . . . 0.0 109.458 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.38 26.73 74.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -63.13 136.27 57.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.314 . . . . 0.0 109.896 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.439 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.52 108.1 48.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 110.551 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 53.0 Cg_endo -81.72 141.18 12.07 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.626 1.329 . . . . 0.0 109.19 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 t -73.77 178.74 4.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.991 -1.068 . . . . 0.0 110.801 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.01 53.67 2.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.1 m -165.73 -59.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.08 -26.85 66.93 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.669 ' HA ' HD12 ' A' ' 74' ' ' LEU . 22.1 ttp85 -62.58 -42.0 99.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.088 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -64.99 -29.15 70.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.3 mt -85.1 -28.41 25.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.376 -0.828 . . . . 0.0 109.234 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 71' ' ' ARG . 21.8 mt -69.05 -27.25 65.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.089 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -82.62 -31.26 28.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.116 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.693 ' HB3' HD11 ' A' ' 49' ' ' LEU . 6.6 tp-100 -76.24 -35.34 59.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.103 0.954 . . . . 0.0 109.452 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.93 -12.48 50.0 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.747 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 91.86 48.6 3.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.639 HG22 ' CB ' ' A' ' 53' ' ' VAL . 34.1 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.918 -1.342 . . . . 0.0 111.496 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 2' ' ' VAL . 12.1 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.371 0.605 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -140.12 128.86 23.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.976 HD11 ' CB ' ' A' ' 59' ' ' TRP . 31.6 mt -100.81 133.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.909 -1.119 . . . . 0.0 109.564 179.158 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.0 ptt180 -151.55 -172.55 4.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.072 -1.018 . . . . 0.0 110.342 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 39' ' ' TYR . 6.0 mp -88.7 126.66 35.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -98.98 104.72 16.79 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 7.2 tmm_? . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 111.66 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 7.0 m-85 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -99.7 156.59 17.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.991 177.521 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.026 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -98.52 79.37 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 178.49 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.274 0.4 OUTLIER -97.98 156.66 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.228 -174.206 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.955 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -105.05 114.76 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.341 0.591 . . . . 0.0 111.066 -177.89 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.412 -0.805 . . . . 0.0 110.049 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB3' HG13 ' A' ' 20' ' ' VAL . 28.1 p90 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.522 0.677 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.658 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -57.57 -61.07 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.11 155.68 42.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.815 . . . . 0.0 110.141 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.4 pttp -89.87 118.57 29.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 0.0 109.77 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.014 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.9 pt -107.9 -32.46 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.138 -0.976 . . . . 0.0 111.524 -179.16 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.825 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.74 167.32 19.21 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 118.813 -1.661 . . . . 0.0 111.388 -178.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 40' ' ' ASP . 12.5 t80 -138.57 139.41 38.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.171 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.026 ' HB2' HD11 ' A' ' 19' ' ' ILE . 40.3 t80 -136.67 124.02 21.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.71 -1.244 . . . . 0.0 109.699 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' HB2' ' CE1' ' A' ' 38' ' ' TYR . 54.9 t0 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 120.753 -1.217 . . . . 0.0 110.762 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 77' ' ' ALA . 6.4 tt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.442 0.639 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.89 99.68 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.143 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.825 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -128.32 142.56 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.035 . . . . 0.0 111.763 -178.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t0 -88.23 69.97 9.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.071 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.3 OUTLIER -34.44 -31.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.808 -177.423 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.0 mt-10 -63.81 -56.18 17.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.82 -1.175 . . . . 0.0 108.953 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -72.26 -36.1 68.95 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.27 -0.894 . . . . 0.0 109.112 178.928 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.86 -20.19 66.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.04 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.3 ttt180 -86.95 -22.33 25.68 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.246 -0.909 . . . . 0.0 109.795 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -62.17 -46.62 88.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.276 1.513 . . . . 0.0 107.523 178.753 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.014 ' CD1' HG21 ' A' ' 36' ' ' ILE . 86.2 m95 -65.64 -58.35 5.94 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.863 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -53.78 -22.55 9.67 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.488 177.366 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 1.1 m -79.2 -20.49 48.21 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.475 -0.766 . . . . 0.0 110.014 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.4 m -98.81 32.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.967 -1.083 . . . . 0.0 109.061 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.31 23.79 71.83 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -61.33 136.77 58.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -1.194 . . . . 0.0 109.759 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.98 108.62 55.2 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 110.163 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 55.2 Cg_endo -83.62 123.69 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.51 1.268 . . . . 0.0 109.745 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -50.17 168.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.1 56.26 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.098 -1.001 . . . . 0.0 110.42 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -166.49 -60.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.779 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -64.23 -24.86 67.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.47 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 74' ' ' LEU . 9.3 ttt-85 -67.06 -44.42 80.17 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -69.25 -11.86 61.17 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.137 179.163 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 70' ' ' ALA . 11.6 mt -101.19 -27.32 13.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 79' ' ' VAL . 13.4 mt -72.8 -29.32 63.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.355 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.4 -30.93 48.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.942 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -78.2 -31.73 49.61 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.846 0.831 . . . . 0.0 109.344 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.653 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -66.58 -10.57 46.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.876 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.36 14.72 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.646 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.2 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.9 -1.353 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 22.5 t . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.151 0.5 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -140.26 133.33 29.46 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.526 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.988 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.0 mt -99.81 137.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.067 -1.021 . . . . 0.0 109.251 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.506 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.5 ptm180 -150.82 178.4 9.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.014 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.79 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.4 pp -89.5 130.92 35.76 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.592 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -99.37 171.97 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.507 -0.746 . . . . 0.0 109.199 -179.164 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 17' ' ' TYR . 1.7 tmt_? . . . . . 0 N--CA 1.488 1.444 0 O-C-N 120.935 -1.103 . . . . 0.0 112.065 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.61 ' CD2' HD13 ' A' ' 6' ' ' LEU 0.255 12.1 m-30 . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 43.2 mtt180 -134.83 153.07 52.19 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.279 177.558 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -96.83 82.65 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 178.174 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -97.95 158.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.162 -174.224 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.951 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.19 111.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.584 -0.698 . . . . 0.0 111.096 -177.524 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.7 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' HB3' HG13 ' A' ' 20' ' ' VAL . 26.9 p90 . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.607 0.718 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.611 HG21 ' HH2' ' A' ' 59' ' ' TRP . 7.2 mt -72.38 -53.32 19.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.625 -0.672 . . . . 0.0 110.262 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -151.87 158.58 43.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 110.119 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.2 pttm -92.47 112.56 24.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.0 pt -104.75 -37.28 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.038 -1.039 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.849 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -116.24 166.34 12.33 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 119.02 -1.562 . . . . 0.0 112.232 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 73.3 t80 -140.95 117.19 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.401 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.88 ' HB2' HD11 ' A' ' 19' ' ' ILE . 14.3 t80 -109.12 147.14 32.92 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.58 -1.325 . . . . 0.0 110.472 -179.302 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.164 -0.96 . . . . 0.0 109.06 178.83 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 50' ' ' LYS . 1.5 tt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.587 0.708 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.747 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.26 86.91 2.37 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.649 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.849 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -115.11 136.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 111.206 -178.963 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -81.23 69.05 7.77 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.729 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -36.53 -29.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 122.226 -0.296 . . . . 0.0 111.268 -177.423 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 15.5 tt0 -61.2 -50.5 72.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.714 -1.241 . . . . 0.0 108.416 177.862 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 22.6 mmm180 -76.23 -37.17 58.05 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.297 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.889 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.83 -19.3 65.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.207 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.6 ttm-85 -89.56 -22.47 22.36 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.289 -0.882 . . . . 0.0 109.552 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.847 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -62.7 -48.33 79.72 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.251 1.5 . . . . 0.0 107.182 178.366 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.988 ' CB ' HD11 ' A' ' 4' ' ' ILE . 84.3 m95 -65.07 -56.31 13.75 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.793 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.59 HD12 HG11 ' A' ' 79' ' ' VAL . 20.5 mt -53.86 -22.07 9.05 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.141 -0.975 . . . . 0.0 108.434 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -82.55 -19.48 38.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.351 -0.843 . . . . 0.0 110.391 179.129 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -98.91 32.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 120.87 -1.144 . . . . 0.0 109.403 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.75 25.56 74.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.79 122.31 21.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.001 -1.293 . . . . 0.0 110.274 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.55 116.05 65.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.223 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.6 Cg_endo -80.01 153.88 22.34 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.425 1.224 . . . . 0.0 110.188 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.591 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -76.57 167.06 22.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.078 -1.014 . . . . 0.0 109.96 179.608 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -28.8 64.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -0.954 . . . . 0.0 110.953 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.0 m -96.25 -44.98 7.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.733 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.48 -28.46 69.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 67' ' ' THR . 1.7 ttm-85 -68.22 -40.35 82.13 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.115 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.64 -15.14 63.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.003 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.2 mt -99.31 -29.46 12.78 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.242 -0.911 . . . . 0.0 108.943 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.479 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 33.4 mt -72.82 -27.74 62.14 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.571 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.96 -29.61 44.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.268 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.8 tp60 -79.2 -35.83 41.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.129 0.966 . . . . 0.0 109.24 179.201 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -57.51 -17.8 15.63 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.627 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.97 16.85 12.64 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 60' ' ' LEU . 21.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 120.911 -1.347 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' HG12 ' A' ' 21' ' ' VAL . 97.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.176 0.512 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -140.62 128.51 21.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 0.0 111.072 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.906 HD11 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -100.04 131.55 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.198 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 9.5 ptm180 -151.78 -165.24 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 110.654 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 39' ' ' TYR . 79.4 mt -89.04 128.43 35.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.79 103.29 14.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.699 -0.626 . . . . 0.0 109.588 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.453 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 49.4 ttt-85 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 112.405 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 7.3 m-85 . . . . . 0 C--O 1.216 -0.7 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 1.6 ttt180 -99.33 159.87 14.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.427 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.944 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.22 83.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.711 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -98.07 169.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.977 -173.908 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.893 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -114.82 114.13 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.271 0.558 . . . . 0.0 110.285 -177.85 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 20.6 p90 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.685 0.755 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.3 mt -89.0 -43.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.603 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' OE1' ' CD ' ' A' ' 55' ' ' ARG . 5.4 tt0 -160.98 169.33 22.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.956 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -103.7 111.76 24.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.949 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.2 pt -101.67 -34.69 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.313 -0.867 . . . . 0.0 110.974 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.796 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.97 165.83 20.02 Favored Glycine 0 C--N 1.294 -1.774 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.547 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 34.4 t80 -134.51 142.3 46.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.127 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.514 ' HD2' HD22 ' A' ' 6' ' ' LEU . 11.3 t80 -140.42 134.13 30.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.812 -1.18 . . . . 0.0 109.974 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t0 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.771 -1.206 . . . . 0.0 110.512 179.671 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 49' ' ' LEU . 9.2 tt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.312 0.577 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 2.0 ttpm? -136.1 87.32 2.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 109.318 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.944 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -112.53 157.82 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.374 1.083 . . . . 0.0 111.567 -179.054 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -106.02 64.91 0.68 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.064 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.728 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.9 -33.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.771 -177.365 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.1 mt-10 -60.77 -52.49 64.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.837 -1.164 . . . . 0.0 108.923 178.408 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.48 -35.56 60.81 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 108.957 178.665 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.909 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.05 -21.45 66.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -86.59 -22.2 26.38 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.336 -0.852 . . . . 0.0 109.836 178.507 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.589 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -61.31 -48.6 80.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.223 1.487 . . . . 0.0 107.2 178.521 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.949 ' CD1' HG21 ' A' ' 36' ' ' ILE . 90.5 m95 -63.54 -53.47 51.31 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.527 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.594 HD11 HD13 ' A' ' 74' ' ' LEU . 5.8 mt -52.86 -23.59 7.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -22.78 45.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.694 -0.629 . . . . 0.0 110.25 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.8 m -98.81 32.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.841 -1.162 . . . . 0.0 109.666 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.11 73.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.37 135.11 53.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.076 -1.249 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.23 111.01 64.39 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.947 . . . . 0.0 110.5 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 52.5 Cg_endo -79.99 127.0 6.69 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.452 1.238 . . . . 0.0 109.894 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -58.6 -177.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.038 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -76.6 52.05 0.78 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.264 -0.898 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.78 -57.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.852 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.75 -23.46 66.74 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.676 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -68.73 -40.75 79.74 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -40.87 88.96 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.639 178.833 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.6 mt -65.52 -31.18 72.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 79' ' ' VAL . 13.8 mt -72.38 -25.38 61.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.73 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.5 -28.82 28.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.9 tp-100 -86.52 -37.28 18.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.674 0.75 . . . . 0.0 110.543 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -10.54 42.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.762 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.01 54.75 3.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.758 HG21 HD23 ' A' ' 74' ' ' LEU . 49.4 t . . . . . 0 N--CA 1.488 1.426 0 O-C-N 121.172 -1.193 . . . . 0.0 111.678 -179.3 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 58.2 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.148 0.499 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -140.32 139.17 35.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.379 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.936 ' CG1' HG13 ' A' ' 21' ' ' VAL . 46.6 mt -100.04 139.06 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.007 -1.058 . . . . 0.0 109.427 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -150.85 -168.38 3.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.839 -1.163 . . . . 0.0 110.873 -179.101 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 70' ' ' ALA . 6.6 mp -89.15 129.21 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -101.31 102.86 13.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.235 -0.916 . . . . 0.0 110.704 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 111.575 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 8.6 m-85 . . . . . 0 C--O 1.213 -0.846 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.503 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -99.98 163.55 12.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.083 -1.447 . . . . 0.0 108.085 177.229 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.936 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -98.4 81.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 103.047 -2.945 . . . . 0.0 103.047 177.359 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -97.71 165.61 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.787 0.803 . . . . 0.0 111.984 -173.96 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.936 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.07 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.251 0.548 . . . . 0.0 110.782 -177.462 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.246 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.7 p90 . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.483 0.658 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.472 HG21 ' HH2' ' A' ' 59' ' ' TRP . 22.3 mt -99.01 -27.25 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.925 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -174.54 165.16 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 109.864 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 6.1 pttt -102.94 111.89 24.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.948 HG21 ' CD1' ' A' ' 59' ' ' TRP . 36.7 pt -106.06 -30.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.976 -1.077 . . . . 0.0 110.883 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.83 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.9 167.38 19.36 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.07 -1.538 . . . . 0.0 112.304 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG12 ' A' ' 19' ' ' ILE . 5.7 t80 -141.24 124.72 16.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.021 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.936 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.7 t80 -124.97 131.6 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.671 -1.268 . . . . 0.0 109.533 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.7 t0 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 110.58 179.857 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 77' ' ' ALA . 5.8 tt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.329 0.585 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -126.9 92.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.06 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.83 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.51 137.41 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.118 -178.906 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.7 t0 -78.43 69.56 4.64 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.294 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -35.2 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.601 -177.773 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.3 mt-10 -65.08 -49.42 70.12 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.96 -1.088 . . . . 0.0 109.276 178.66 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.74 -32.73 52.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 178.75 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -70.04 -23.38 63.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.151 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -85.0 -21.52 29.44 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 178.093 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.659 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -60.77 -48.53 81.38 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.158 1.456 . . . . 0.0 107.147 178.464 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.948 ' CD1' HG21 ' A' ' 36' ' ' ILE . 87.3 m95 -62.88 -55.44 26.09 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.627 -179.481 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -54.24 -21.81 10.03 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.234 -0.986 . . . . 0.0 108.467 177.052 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.49 -20.47 43.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.81 . . . . 0.0 110.589 179.345 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.7 m -98.92 32.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 120.865 -1.147 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.36 74.43 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -77.89 141.18 39.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.122 -1.222 . . . . 0.0 110.035 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 123.79 29.1 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.6 Cg_endo -85.12 145.45 9.78 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.454 1.239 . . . . 0.0 109.938 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -64.65 -178.8 0.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.078 -1.014 . . . . 0.0 110.577 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.04 52.47 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.2 m -165.97 -61.39 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.887 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -64.73 -26.41 68.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 2.8 ttt180 -66.39 -44.75 82.19 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.482 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -67.34 -12.58 60.52 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.106 179.234 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.887 HD12 ' HA ' ' A' ' 70' ' ' ALA . 10.7 mt -99.89 -29.86 12.35 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.681 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 26.5 mt -71.62 -28.46 63.81 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.338 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.28 -29.87 42.7 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.961 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HB3' HD13 ' A' ' 49' ' ' LEU . 2.4 tp-100 -78.36 -31.35 48.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.955 0.883 . . . . 0.0 109.363 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.64 -12.44 45.89 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.978 178.718 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.0 16.59 20.95 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 53' ' ' VAL . 17.1 t . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.362 . . . . 0.0 110.152 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.518 HG11 ' CE3' ' A' ' 59' ' ' TRP . 47.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.16 0.505 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 130.94 25.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 0.0 110.539 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.993 HD11 ' CB ' ' A' ' 59' ' ' TRP . 82.9 mt -102.47 135.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 121.126 -0.984 . . . . 0.0 109.783 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.49 177.87 9.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.941 179.94 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.3 pp -89.13 130.52 35.55 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.035 178.664 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -98.78 165.82 11.6 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.392 -0.817 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 O-C-N 120.967 -1.083 . . . . 0.0 111.673 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 6' ' ' LEU . 17.6 m-30 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.474 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -127.81 149.09 50.42 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.962 -1.086 . . . . 0.0 108.76 177.899 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.979 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -96.94 81.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 178.112 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.291 0.4 OUTLIER -98.3 161.66 2.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.783 -173.526 . . . . . . . . 4 4 . 1 . 029 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.925 HG13 HG12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.12 106.94 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.569 -178.102 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HB3' HG13 ' A' ' 20' ' ' VAL . 22.8 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.428 0.632 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.3 mt -78.36 -37.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.412 -0.805 . . . . 0.0 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 168.07 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -103.7 113.47 27.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.87 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.98 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.3 pt -104.76 -34.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.797 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.9 166.92 15.21 Favored Glycine 0 C--N 1.295 -1.698 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.895 -178.006 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.433 ' N ' HG12 ' A' ' 19' ' ' ILE . 16.3 t80 -140.6 122.34 15.34 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.61 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.979 ' HB2' HD11 ' A' ' 19' ' ' ILE . 7.1 t80 -114.46 141.01 48.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.733 -1.229 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.408 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t70 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.813 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 77' ' ' ALA . 3.8 tt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.438 0.637 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -133.04 88.07 2.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 0.0 108.95 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.797 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -114.11 139.55 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.115 -0.991 . . . . 0.0 111.09 -179.067 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.3 t0 -84.65 70.2 10.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.255 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.681 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.63 -32.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 122.268 -0.27 . . . . 0.0 111.461 -177.467 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tm-20 -61.54 -54.64 40.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.863 -1.148 . . . . 0.0 108.728 178.341 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -69.33 -39.93 77.89 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.717 0.77 . . . . 0.0 109.065 178.685 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.804 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.57 -21.18 66.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.475 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -87.14 -20.5 26.95 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 178.642 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.1 t80 -61.37 -48.94 78.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.362 1.553 . . . . 0.0 107.142 178.365 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.993 ' CB ' HD11 ' A' ' 4' ' ' ILE . 81.9 m95 -63.18 -54.27 40.19 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.768 -178.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 66' ' ' PRO . 10.7 mt -53.86 -21.99 8.86 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.28 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -22.78 38.56 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.471 -0.768 . . . . 0.0 110.679 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 59' ' ' TRP . 5.2 m -99.24 31.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.832 -1.168 . . . . 0.0 109.908 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.82 26.22 71.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 142.81 56.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.873 -1.369 . . . . 0.0 110.324 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 105.99 57.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 60' ' ' LEU . 52.2 Cg_endo -83.2 124.99 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.582 1.306 . . . . 0.0 110.763 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.757 HG23 ' H ' ' A' ' 70' ' ' ALA . 6.3 t -58.73 156.3 11.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.067 -1.02 . . . . 0.0 109.06 179.231 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -48.66 47.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.054 -1.029 . . . . 0.0 111.556 -179.052 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -62.22 -56.42 18.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.1 -1.0 . . . . 0.0 111.825 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.953 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.45 -25.68 65.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 109.093 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 67' ' ' THR . 25.7 ttt180 -69.8 -38.39 76.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -61.53 -30.41 70.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.419 178.615 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.953 HD12 ' HA ' ' A' ' 70' ' ' ALA . 24.7 mt -78.31 -37.6 44.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 68.6 mt -62.42 -30.66 71.38 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.788 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -28.48 44.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.765 ' HB3' HD13 ' A' ' 49' ' ' LEU . 9.7 tp-100 -75.49 -35.76 60.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.069 0.938 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.82 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.2 -8.0 46.45 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.057 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.419 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.93 53.02 3.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.681 HG22 ' CB ' ' A' ' 53' ' ' VAL . 61.9 t . . . . . 0 N--CA 1.487 1.389 0 O-C-N 121.206 -1.173 . . . . 0.0 111.46 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.71 HG11 ' CE3' ' A' ' 59' ' ' TRP . 95.2 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.491 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 16.3 mtpt -140.02 139.25 35.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.867 ' CG1' HG13 ' A' ' 21' ' ' VAL . 41.4 mt -103.51 130.33 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.142 -0.974 . . . . 0.0 109.264 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.52 -165.28 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 110.331 -179.118 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.578 HD13 ' HD2' ' A' ' 17' ' ' TYR . 44.7 mt -89.09 133.81 34.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.99 -1.069 . . . . 0.0 110.695 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -104.95 105.84 16.06 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.518 -0.738 . . . . 0.0 110.996 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 15.6 ttp180 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.894 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' HD2' HD13 ' A' ' 6' ' ' LEU . 5.2 m-30 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.612 ' HD2' HG23 ' A' ' 20' ' ' VAL . 1.1 ptp180 -105.59 165.73 10.95 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.325 176.081 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.855 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -98.11 85.32 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.219 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.261 0.3 OUTLIER -98.05 166.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.152 -175.031 . . . . . . . . 4 4 . 1 . 030 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.877 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.42 107.41 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 110.159 -178.459 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.644 ' CD2' HG21 ' A' ' 20' ' ' VAL . 15.8 p90 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.482 0.658 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.0 mp -98.11 -25.22 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.608 -0.683 . . . . 0.0 109.632 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.26 162.85 6.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 0.0 109.865 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 4.0 ptpt -105.07 115.55 30.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.114 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.786 HG21 ' CD1' ' A' ' 59' ' ' TRP . 42.3 pt -105.09 -31.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.793 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -136.29 177.88 19.24 Favored Glycine 0 C--N 1.295 -1.705 0 C-N-CA 118.215 -1.945 . . . . 0.0 112.583 -178.273 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 71.8 t80 -139.96 147.89 41.14 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.919 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 26.1 t80 -143.01 131.17 21.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.337 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.2 t0 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 120.652 -1.28 . . . . 0.0 110.505 179.695 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 49' ' ' LEU . 4.7 tt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -127.26 86.98 2.57 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 108.971 178.828 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.855 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -116.48 149.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.472 1.13 . . . . 0.0 112.294 -178.528 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.9 t70 -99.16 64.91 1.4 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.584 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.97 -32.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.539 -177.289 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.07 -53.24 59.55 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.816 -1.177 . . . . 0.0 108.756 178.231 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -76.37 -34.03 58.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.434 -0.791 . . . . 0.0 108.869 178.636 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -67.52 -21.22 65.49 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.068 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 50.1 ttp85 -87.98 -21.21 24.97 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.231 -0.918 . . . . 0.0 109.721 178.089 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -60.75 -49.51 77.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.877 ' CD2' HG11 ' A' ' 21' ' ' VAL . 88.6 m95 -61.72 -53.18 59.57 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.315 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.778 HD12 HG11 ' A' ' 79' ' ' VAL . 25.2 mt -53.94 -22.26 9.82 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.762 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.5 -22.89 40.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.561 -0.712 . . . . 0.0 110.973 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.5 m -98.99 32.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.758 -1.214 . . . . 0.0 109.606 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.81 71.53 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -69.37 128.47 36.69 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.269 . . . . 0.0 110.015 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.491 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -97.17 109.52 49.92 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.174 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.585 ' HB3' HD12 ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.41 136.91 10.15 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.519 1.273 . . . . 0.0 110.29 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -62.02 179.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.968 . . . . 0.0 109.525 179.476 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 19.4 p-10 -69.98 -18.98 63.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.075 -1.015 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -50.37 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.256 -0.902 . . . . 0.0 110.503 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -69.01 -25.06 64.31 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.351 -0.843 . . . . 0.0 108.913 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 67' ' ' THR . 7.9 ttt-85 -68.53 -38.31 80.75 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.05 -39.36 90.08 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.511 -0.875 . . . . 0.0 108.76 178.716 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.93 -26.26 60.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.575 -0.703 . . . . 0.0 109.261 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 60' ' ' LEU . 16.4 mt -72.74 -25.94 61.39 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.581 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -32.0 31.19 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.181 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' A' ' 49' ' ' LEU . 7.9 tp-100 -80.1 -37.21 34.17 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.998 0.904 . . . . 0.0 109.964 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -62.47 -12.48 22.31 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.887 178.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.78 38.18 8.91 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.778 HG11 HD12 ' A' ' 60' ' ' LEU . 39.4 t . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.196 -1.179 . . . . 0.0 111.351 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.451 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 14.6 mtpt -140.73 143.02 34.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.637 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.91 HD11 ' CB ' ' A' ' 59' ' ' TRP . 46.7 mt -101.27 135.42 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.104 -0.997 . . . . 0.0 108.941 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -177.76 6.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.107 . . . . 0.0 110.956 -179.04 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.764 HD12 ' HB2' ' A' ' 70' ' ' ALA . 3.6 mp -88.96 125.12 34.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.819 . . . . 0.0 109.887 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.14 111.62 23.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.461 -0.775 . . . . 0.0 110.901 -179.034 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.963 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 m-30 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -104.65 152.99 21.81 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.551 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.072 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.3 mm -98.42 80.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 178.299 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.449 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.28 0.4 OUTLIER -97.36 164.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.937 -173.759 . . . . . . . . 4 4 . 1 . 031 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.941 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -109.94 113.6 44.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.599 -0.688 . . . . 0.0 110.594 -176.92 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.2 t . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.287 -0.883 . . . . 0.0 110.413 179.781 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 8.5 p90 . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.485 0.66 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.728 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -72.97 -59.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.504 -0.748 . . . . 0.0 109.604 179.519 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.725 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -144.98 149.78 35.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 179.869 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HG2' ' NE ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -89.82 126.6 35.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.962 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.003 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.86 -24.78 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.448 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.911 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -128.37 161.44 22.14 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.662 -1.732 . . . . 0.0 110.649 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.498 ' N ' HG12 ' A' ' 19' ' ' ILE . 88.0 t80 -138.41 144.6 40.27 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.894 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.072 ' HB2' HD11 ' A' ' 19' ' ' ILE . 16.0 t80 -137.47 133.26 34.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.45 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t0 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 120.809 -1.182 . . . . 0.0 110.514 179.843 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.449 HD12 HD22 ' A' ' 73' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.319 0.58 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 88.91 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.828 . . . . 0.0 109.095 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.911 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -118.16 129.78 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.051 -1.031 . . . . 0.0 111.369 -178.833 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t70 -75.09 72.15 2.19 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.876 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG23 HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -33.7 -32.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.549 -177.509 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 16.5 tt0 -61.56 -53.15 60.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.855 -1.153 . . . . 0.0 108.857 178.045 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.753 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.89 -37.47 73.0 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.276 178.933 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.969 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -68.82 -20.77 64.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.319 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 29.2 ttt-85 -85.11 -25.16 27.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.672 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 11.1 t80 -60.2 -43.96 95.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 123.211 1.482 . . . . 0.0 107.564 178.307 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.003 ' CD1' HG21 ' A' ' 36' ' ' ILE . 68.9 m95 -68.72 -57.01 6.26 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.934 -179.07 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.969 HD12 ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -55.11 -21.01 11.38 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.333 -0.947 . . . . 0.0 108.873 177.497 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.2 t -81.43 -23.44 37.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.279 -0.888 . . . . 0.0 110.76 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 59' ' ' TRP . 36.0 m -99.09 32.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 120.944 -1.098 . . . . 0.0 109.404 179.571 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.04 30.54 74.08 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -76.32 120.77 22.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.967 -1.314 . . . . 0.0 109.769 179.736 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -92.07 115.83 65.37 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.458 -179.69 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HB3' HD12 ' A' ' 74' ' ' LEU . 52.5 Cg_endo -82.87 133.25 6.7 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.435 1.229 . . . . 0.0 109.687 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 70' ' ' ALA . 9.4 t -53.0 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.008 -1.058 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.96 52.65 1.28 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.3 -0.875 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -167.26 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.825 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.92 -22.96 66.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 5.4 ttt180 -66.99 -42.67 84.63 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.407 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -30.65 71.47 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.825 HD12 ' HA ' ' A' ' 70' ' ' ALA . 23.6 mt -77.59 -31.53 53.09 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.797 HD13 HD11 ' A' ' 60' ' ' LEU . 47.4 mt -67.42 -30.12 69.79 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.575 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -30.56 42.24 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.431 ' HB3' HD13 ' A' ' 49' ' ' LEU . 7.4 tp-100 -77.46 -33.21 54.76 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.996 0.903 . . . . 0.0 109.56 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.53 -12.8 35.23 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.06 178.608 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.38 27.92 10.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 HG23 ' A' ' 53' ' ' VAL . 30.5 t . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.11 -1.23 . . . . 0.0 110.495 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 70.9 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.147 0.498 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -140.82 137.12 33.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.027 -1.046 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.927 ' CG1' HG13 ' A' ' 21' ' ' VAL . 41.4 mt -100.68 134.04 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.125 -0.984 . . . . 0.0 108.494 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 53.9 ptt85 -150.8 -172.44 4.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.835 -1.165 . . . . 0.0 111.159 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.8 mp -88.58 127.43 35.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.239 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -101.22 108.98 20.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.466 -0.771 . . . . 0.0 111.455 -178.865 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.8 ttt-85 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 111.2 179.832 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 5.7 m-30 . . . . . 0 C--O 1.212 -0.88 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HD3' HG23 ' A' ' 20' ' ' VAL . 3.2 ptm180 -104.0 161.74 13.73 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.522 -1.671 . . . . 0.0 107.755 177.142 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.829 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.09 85.37 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 179.397 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.27 0.3 OUTLIER -97.62 170.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.105 -174.324 . . . . . . . . 4 4 . 1 . 032 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.927 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.69 103.43 15.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.84 . . . . 0.0 110.658 -177.292 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.715 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.457 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 14.7 p90 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.356 0.598 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.5 mt -80.25 -29.04 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.528 -0.733 . . . . 0.0 109.7 179.727 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.6 tm-20 -174.37 169.75 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.441 -0.787 . . . . 0.0 109.918 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -110.14 121.99 46.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.782 179.816 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.057 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -119.35 -30.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.145 -0.972 . . . . 0.0 111.179 -179.533 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.913 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.69 164.28 14.88 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.078 -179.838 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 75.2 t80 -137.64 140.43 40.87 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.981 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.493 ' CD2' HD23 ' A' ' 6' ' ' LEU . 54.7 t80 -139.42 113.17 8.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.569 -1.332 . . . . 0.0 109.957 -179.023 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.5 t0 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 120.613 -1.304 . . . . 0.0 110.709 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 50' ' ' LYS . 3.7 tt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.6 0.714 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.723 ' N ' HD23 ' A' ' 49' ' ' LEU . 11.2 mtpt -140.45 94.5 2.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.222 178.833 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.913 HG22 ' CA ' ' A' ' 37' ' ' GLY . 2.2 t -129.94 134.9 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 112.069 -179.025 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 t0 -82.96 71.01 10.08 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.26 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.43 -31.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.04 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 31.8 mt-10 -60.87 -49.57 76.94 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.956 178.224 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.567 ' HB3' HG22 ' A' ' 36' ' ' ILE . 26.6 mmm180 -75.01 -39.73 61.02 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.248 -0.908 . . . . 0.0 109.084 178.51 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.967 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -64.1 -22.87 67.11 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.356 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 7.5 ttt180 -86.35 -23.57 26.15 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.41 -0.806 . . . . 0.0 109.62 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.52 -49.01 75.2 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 123.205 1.478 . . . . 0.0 107.484 178.477 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.057 ' CD1' HG21 ' A' ' 36' ' ' ILE . 71.8 m95 -61.76 -52.57 63.68 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.275 -179.321 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.4 mt -57.01 -21.2 28.91 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.899 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -76.46 -26.17 55.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.333 -0.854 . . . . 0.0 110.311 179.502 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 59' ' ' TRP . 34.4 m -99.08 32.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.048 -1.032 . . . . 0.0 109.581 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.4 76.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -64.69 96.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.353 . . . . 0.0 109.689 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.03 114.7 29.39 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.4 Cg_endo -85.67 130.44 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.528 1.278 . . . . 0.0 109.641 179.391 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -53.18 178.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.085 -1.009 . . . . 0.0 110.651 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.22 54.28 1.94 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.32 -0.862 . . . . 0.0 110.073 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -164.72 -60.29 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 6' ' ' LEU . . . -67.58 -26.34 66.24 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.93 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 33.6 ttp180 -65.41 -43.15 91.49 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.098 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.03 -42.66 99.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.862 178.711 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 70' ' ' ALA . 27.6 mt -70.08 -28.87 65.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.509 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 28.7 mt -69.26 -29.14 66.98 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.841 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.53 -34.23 35.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.157 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -78.06 -26.02 48.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.866 0.841 . . . . 0.0 109.659 179.165 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -68.79 -9.82 53.19 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.211 0.529 . . . . 0.0 110.078 179.01 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.26 21.0 23.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 53' ' ' VAL . 14.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.284 . . . . 0.0 110.538 179.9 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.507 HG11 HG23 ' A' ' 62' ' ' VAL . 59.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.295 0.569 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 6.5 mttt -140.64 124.67 17.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.701 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.884 HD11 ' CB ' ' A' ' 59' ' ' TRP . 49.7 mt -99.88 129.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 120.991 -1.068 . . . . 0.0 109.211 178.843 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -151.07 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.928 . . . . 0.0 110.64 -179.187 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.461 HD22 ' HD2' ' A' ' 39' ' ' TYR . 55.4 mt -88.59 127.96 35.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.706 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.88 100.52 11.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.54 -0.725 . . . . 0.0 110.382 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 41.1 ttt180 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 111.299 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 7.6 m-85 . . . . . 0 C--O 1.213 -0.864 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.603 ' HD2' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -99.81 160.29 14.41 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.231 -1.788 . . . . 0.0 106.751 176.535 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.915 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -97.62 85.44 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 103.487 -2.782 . . . . 0.0 103.487 179.125 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.271 0.3 OUTLIER -97.44 169.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.945 -174.159 . . . . . . . . 4 4 . 1 . 033 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.881 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.91 110.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.434 -0.792 . . . . 0.0 110.634 -177.405 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.0 t . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 21.4 p90 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.758 0.79 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG21 ' HH2' ' A' ' 59' ' ' TRP . 6.2 mt -81.66 -32.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.407 0.623 . . . . 0.0 109.78 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.79 176.75 3.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -113.32 123.86 51.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.983 . . . . 0.0 110.354 -179.822 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.058 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.8 -26.9 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.862 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.85 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.85 166.05 18.76 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 118.765 -1.684 . . . . 0.0 111.325 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 40.5 t80 -138.33 140.76 39.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.103 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HD2' HD22 ' A' ' 6' ' ' LEU . 15.1 t80 -138.17 127.84 25.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.909 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 t0 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.619 -1.3 . . . . 0.0 110.499 -179.862 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 76' ' ' GLN . 5.7 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.221 0.534 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.7 ttpt -136.97 95.84 3.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 179.721 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.915 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.2 t -127.75 128.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.975 -179.48 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.6 t0 -79.1 70.36 5.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.645 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -31.53 -34.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.158 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 mm-40 -60.63 -51.15 70.62 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.809 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.693 ' HB3' HG22 ' A' ' 36' ' ' ILE . 2.6 mmm180 -71.85 -41.85 67.61 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.386 -0.821 . . . . 0.0 108.836 178.398 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.971 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.94 -16.95 62.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.017 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -88.53 -29.03 20.39 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 178.394 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP 0.251 1.7 t80 -57.66 -43.47 84.99 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.331 1.539 . . . . 0.0 107.338 178.399 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.058 ' CD1' HG21 ' A' ' 36' ' ' ILE . 69.7 m95 -69.03 -52.99 22.93 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.282 -179.285 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.555 HD12 HG11 ' A' ' 79' ' ' VAL . 11.2 mt -57.65 -20.37 33.02 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.83 177.148 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.4 t -83.22 -22.77 33.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 59' ' ' TRP . 35.4 m -99.07 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.979 -1.075 . . . . 0.0 109.5 179.602 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.9 72.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -67.76 128.37 36.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.383 . . . . 0.0 109.838 179.621 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 2.4 mm-40 -92.75 109.99 42.53 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.9 Cg_endo -81.17 150.86 17.85 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.468 1.246 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -81.82 170.01 16.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.684 179.564 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -17.88 30.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -99.54 -47.97 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.14 -0.975 . . . . 0.0 110.322 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.94 -25.75 64.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.871 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -38.32 83.38 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.186 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -39.82 94.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.958 178.821 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -70.43 -29.5 66.1 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 179.554 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 60' ' ' LEU . 32.1 mt -72.25 -25.91 61.8 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.638 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -27.0 27.16 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.385 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.568 ' HB3' HD11 ' A' ' 49' ' ' LEU . 5.9 tp-100 -85.21 -36.83 20.73 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.736 0.779 . . . . 0.0 110.212 -179.775 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.13 -10.61 32.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 178.425 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.44 44.83 6.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 60' ' ' LEU . 25.5 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.113 -1.228 . . . . 0.0 111.179 -179.51 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.561 HG11 ' CE3' ' A' ' 59' ' ' TRP . 38.5 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.208 0.528 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.32 136.45 33.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 110.304 -179.923 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.997 ' CG1' HG13 ' A' ' 21' ' ' VAL . 60.8 mt -99.94 138.48 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.293 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.6 ptt180 -150.6 -170.88 3.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.992 -1.068 . . . . 0.0 110.745 -179.175 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.5 mp -89.41 128.78 35.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.341 -0.85 . . . . 0.0 110.991 -179.584 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -99.71 157.26 16.6 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.657 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 3.9 ttp85 . . . . . 0 N--CA 1.488 1.461 0 O-C-N 120.869 -1.145 . . . . 0.0 111.752 -178.744 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 7' ' ' ALA 0.258 17.8 m-30 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.331 0.586 . . . . 0.0 109.678 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 31.0 mtt180 -137.1 156.84 47.87 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.069 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.01 83.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 102.896 -3.002 . . . . 0.0 102.896 177.736 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.266 0.4 OUTLIER -97.8 165.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.582 -173.76 . . . . . . . . 4 4 . 1 . 034 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.997 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.13 104.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 110.716 -177.33 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 179.139 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.3 p90 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.576 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.0 mt -75.92 -39.3 37.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.649 -0.657 . . . . 0.0 110.339 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.65 170.28 21.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 110.353 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -107.29 112.69 25.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 110.024 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.95 HG21 ' CD1' ' A' ' 59' ' ' TRP . 22.6 pt -107.27 -36.35 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 111.338 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.847 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.72 168.2 13.57 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.087 -1.53 . . . . 0.0 112.245 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 49.8 t80 -141.36 125.5 17.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.351 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' ILE . 9.9 t80 -115.72 146.89 41.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.596 -1.315 . . . . 0.0 109.533 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 33.6 t70 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.977 -1.077 . . . . 0.0 109.715 179.077 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 49' ' ' LEU . 14.6 tp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -133.15 102.51 5.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.765 . . . . 0.0 109.256 179.409 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.847 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.47 140.14 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.898 -1.126 . . . . 0.0 111.044 -179.234 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -82.33 69.23 9.03 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.948 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.892 HG23 HG22 ' A' ' 79' ' ' VAL . 1.4 p -34.25 -31.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.858 -177.773 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.1 tp10 -62.95 -53.06 59.86 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.854 -1.154 . . . . 0.0 109.01 178.315 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 2.7 mtm-85 -73.27 -37.36 66.31 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.416 -0.803 . . . . 0.0 108.981 178.734 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.925 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.99 -18.98 65.75 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.754 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -88.95 -23.31 22.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.347 -0.846 . . . . 0.0 109.736 178.446 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.904 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -60.15 -45.83 91.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 123.247 1.499 . . . . 0.0 107.094 178.439 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.95 ' CD1' HG21 ' A' ' 36' ' ' ILE . 85.0 m95 -66.98 -58.48 4.87 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.791 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.766 HD11 HD13 ' A' ' 74' ' ' LEU . 4.1 mt -52.89 -23.19 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.622 177.46 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t -81.13 -20.03 42.24 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.58 -0.7 . . . . 0.0 110.49 179.405 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.9 m -98.74 31.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.767 -1.208 . . . . 0.0 109.382 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.05 75.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.01 143.55 49.13 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.105 -1.232 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.416 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 18.0 mt-30 -117.34 118.19 35.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.552 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.2 Cg_endo -81.29 146.73 15.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.499 1.263 . . . . 0.0 109.881 179.603 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -70.27 -171.7 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.053 . . . . 0.0 109.94 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 50.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.146 -0.971 . . . . 0.0 110.101 179.553 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 28.4 m -165.3 -60.22 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.676 ' HB1' HG22 ' A' ' 19' ' ' ILE . . . -65.44 -23.83 67.03 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.113 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.45 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 6.8 ttt-85 -68.76 -46.22 69.37 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.465 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -71.71 -8.02 51.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.417 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 69' ' ' THR . 25.8 mt -102.7 -26.2 13.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 108.604 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.766 HD13 HD11 ' A' ' 60' ' ' LEU . 41.7 mt -72.01 -30.02 64.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.781 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -77.15 -28.57 54.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.966 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -76.93 -33.23 57.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.108 0.956 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -67.4 -9.38 40.99 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.912 178.885 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.69 17.78 32.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.892 HG22 HG23 ' A' ' 53' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.897 -1.355 . . . . 0.0 110.107 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.13 0.49 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.76 137.23 33.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.462 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.984 HD11 ' CB ' ' A' ' 59' ' ' TRP . 57.0 mt -99.56 140.16 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.098 -1.001 . . . . 0.0 109.081 179.07 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.491 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 2.2 ptt180 -150.64 171.22 17.48 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.965 -1.084 . . . . 0.0 110.266 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.9 pp -89.62 128.35 36.04 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.568 179.484 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -99.02 175.99 5.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.728 . . . . 0.0 109.07 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 4.5 ttt-85 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.927 -1.108 . . . . 0.0 111.357 -179.368 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 7' ' ' ALA 0.267 9.2 m-85 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 . . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -136.71 147.08 46.56 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.825 -1.172 . . . . 0.0 109.257 177.592 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -96.2 82.56 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 177.259 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.284 0.4 OUTLIER -97.8 161.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.204 -173.389 . . . . . . . . 4 4 . 1 . 035 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.938 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -108.46 111.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.61 -0.682 . . . . 0.0 110.599 -177.43 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.94 179.639 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB3' HG13 ' A' ' 20' ' ' VAL . 12.6 p90 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.462 0.649 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.557 HG21 ' HH2' ' A' ' 59' ' ' TRP . 15.2 mt -50.24 -31.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -176.81 171.31 2.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.12 119.48 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.013 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -113.1 -30.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.424 -0.798 . . . . 0.0 110.286 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.925 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -116.28 163.01 12.45 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.267 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 40' ' ' ASP . 85.3 t80 -140.81 117.16 10.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.838 ' HB2' HD11 ' A' ' 19' ' ' ILE . 1.7 t80 -107.44 122.57 46.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.797 -1.189 . . . . 0.0 109.537 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 21.8 t0 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 120.724 -1.235 . . . . 0.0 110.163 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 50' ' ' LYS . 1.3 tm? . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.618 0.723 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.5 ttpt -125.87 94.55 4.14 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.925 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.2 t -116.38 132.52 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.034 -1.041 . . . . 0.0 111.202 -178.967 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -74.2 70.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.972 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.678 HG23 HG22 ' A' ' 79' ' ' VAL . 1.1 p -35.61 -30.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 122.269 -0.269 . . . . 0.0 111.654 -177.377 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -60.63 -54.14 48.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.776 -1.202 . . . . 0.0 108.435 177.949 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.654 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.5 mmp_? -69.65 -41.77 75.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.333 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.943 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.92 -17.29 63.08 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.341 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 15.1 tpt180 -88.35 -26.01 22.43 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 109.423 178.594 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.817 ' O ' HG13 ' A' ' 62' ' ' VAL . 3.0 t80 -59.49 -43.31 93.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.378 1.561 . . . . 0.0 107.302 178.241 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.013 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.8 m95 -69.23 -57.18 5.69 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.987 -178.904 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.749 HD11 HD13 ' A' ' 74' ' ' LEU . 33.1 mt -54.71 -22.08 12.82 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.076 -1.015 . . . . 0.0 108.532 177.338 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -80.93 -22.61 39.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 110.763 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.817 HG13 ' O ' ' A' ' 58' ' ' TYR . 6.0 m -98.88 32.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.828 -1.17 . . . . 0.0 109.585 179.871 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.6 26.49 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -75.11 124.44 27.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.98 -1.306 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 65' ' ' GLN . 7.0 pt20 -98.84 121.01 57.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.785 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.652 ' HB3' HD12 ' A' ' 74' ' ' LEU . 50.8 Cg_endo -80.8 168.05 17.94 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.401 1.211 . . . . 0.0 110.561 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.665 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -88.8 167.92 12.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.76 179.504 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.78 -29.53 40.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 111.28 -179.247 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.468 ' HB ' ' CD2' ' A' ' 6' ' ' LEU . 24.2 m -97.51 -44.74 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.009 . . . . 0.0 110.855 -179.332 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -69.97 -24.61 63.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.405 -0.809 . . . . 0.0 109.038 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 25.1 ttt-85 -70.24 -36.54 74.57 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.577 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -30.59 71.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.002 179.133 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 70' ' ' ALA . 75.1 mt -75.45 -32.04 60.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.565 179.454 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 60' ' ' LEU . 24.6 mt -66.56 -30.0 70.2 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -79.81 -30.67 40.58 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.176 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -27.91 51.26 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.895 0.855 . . . . 0.0 109.703 179.191 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -73.16 -6.34 45.13 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.068 178.937 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 20.35 40.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 180.0 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.718 HG11 ' CD1' ' A' ' 60' ' ' LEU . 21.6 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.933 -1.333 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 99.1 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.311 0.577 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -140.19 138.12 34.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.068 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.979 HD11 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -104.58 133.47 48.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.112 -0.992 . . . . 0.0 109.92 -179.996 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -150.77 -170.65 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 -179.238 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.825 HD21 ' CD1' ' A' ' 73' ' ' LEU . 16.8 mt -88.6 126.64 35.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.069 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' N ' ' HB3' ' A' ' 17' ' ' TYR . . . -99.91 103.09 14.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.93 -179.748 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.1 ttt180 . . . . . 0 N--CA 1.487 1.418 0 O-C-N 121.405 -0.809 . . . . 0.0 110.586 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 1.9 m-85 . . . . . 0 C--O 1.213 -0.844 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.483 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -107.98 160.51 15.72 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.002 176.971 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.039 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -97.91 79.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 102.604 -3.11 . . . . 0.0 102.604 177.503 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.3 OUTLIER -97.44 163.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.299 -173.843 . . . . . . . . 4 4 . 1 . 036 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.939 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -110.46 114.04 45.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.359 0.599 . . . . 0.0 110.84 -176.921 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.3 t . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 2.1 p90 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.2 mt -77.74 -30.26 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.408 -0.807 . . . . 0.0 109.787 179.878 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.32 177.24 3.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 110.108 179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -115.84 123.12 47.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 110.273 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.031 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.49 -27.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.0 110.98 179.815 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.866 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.87 165.85 20.74 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.925 -1.607 . . . . 0.0 112.305 -178.995 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' N ' HG12 ' A' ' 19' ' ' ILE . 25.3 t80 -140.71 138.28 34.11 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.865 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.039 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 t80 -133.32 135.18 44.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.547 -1.345 . . . . 0.0 110.304 179.75 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.7 t0 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 120.974 -1.079 . . . . 0.0 110.337 179.269 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.807 HD13 ' HB3' ' A' ' 76' ' ' GLN . 3.0 tt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.641 0.734 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 2.8 ttpt -137.43 85.67 2.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.485 -0.759 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.866 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -117.5 134.72 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 111.227 -178.974 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -80.81 71.32 7.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.376 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.6 -35.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.505 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.6 mm-40 -59.73 -53.88 52.85 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.621 -1.299 . . . . 0.0 108.967 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.726 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.5 mmp_? -69.45 -41.42 76.28 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.785 . . . . 0.0 109.212 178.737 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.936 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -65.39 -20.69 66.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.044 -1.035 . . . . 0.0 108.406 178.936 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -87.74 -23.48 24.11 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 178.703 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.7 t80 -60.0 -45.13 93.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 123.253 1.502 . . . . 0.0 107.085 178.148 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.031 ' CD1' HG21 ' A' ' 36' ' ' ILE . 78.4 m95 -65.23 -53.76 39.62 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.441 -179.103 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 74' ' ' LEU . 11.4 mt -56.76 -20.93 24.78 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.566 176.844 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.62 -23.73 39.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 59' ' ' TRP . 34.1 m -99.27 33.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.882 -1.136 . . . . 0.0 109.565 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.32 30.62 73.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.03 -1.277 . . . . 0.0 110.079 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.46 106.35 58.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -78.66 129.76 9.38 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.487 1.256 . . . . 0.0 110.238 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.15 174.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 109.9 179.646 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.59 -15.63 63.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.546 ' CG2' HD11 ' A' ' 6' ' ' LEU . 81.1 m -106.12 -45.36 4.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.907 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -63.14 -24.76 68.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -70.0 -40.34 75.32 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -40.81 94.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.931 178.697 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.8 mt -65.99 -33.03 74.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.742 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 60' ' ' LEU . 31.9 mt -68.49 -26.68 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.336 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -28.73 47.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.907 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.807 ' HB3' HD13 ' A' ' 49' ' ' LEU . 4.3 tp60 -80.74 -37.41 30.52 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.955 0.883 . . . . 0.0 109.897 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -68.64 -7.84 36.7 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.071 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 47.68 9.09 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 53' ' ' VAL . 75.4 t . . . . . 0 N--CA 1.487 1.381 0 O-C-N 121.305 -1.115 . . . . 0.0 111.698 -179.092 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.481 HG11 ' CE3' ' A' ' 59' ' ' TRP . 33.6 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.221 0.534 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 65' ' ' GLN . 10.8 mttt -140.75 137.85 33.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.99 -1.069 . . . . 0.0 110.758 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.918 HD11 ' CB ' ' A' ' 59' ' ' TRP . 44.5 mt -103.41 132.7 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.126 -0.984 . . . . 0.0 108.964 178.754 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 10.4 ptt180 -150.85 -169.89 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.102 -0.999 . . . . 0.0 110.391 -179.285 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.584 HD22 ' HD2' ' A' ' 39' ' ' TYR . 52.0 mt -89.7 130.39 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -0.978 . . . . 0.0 111.452 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 104.99 16.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.705 -0.622 . . . . 0.0 110.23 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.012 -1.055 . . . . 0.0 111.253 -179.618 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.9 m-30 . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.5 mtt180 -99.19 160.03 14.56 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.131 176.017 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.912 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -99.21 81.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 176.969 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.257 0.3 OUTLIER -97.26 165.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.397 -173.511 . . . . . . . . 4 4 . 1 . 037 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.928 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -110.02 119.9 60.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.735 -0.603 . . . . 0.0 110.724 -176.941 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.035 -1.041 . . . . 0.0 110.25 179.112 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 4.4 p90 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 121.563 0.697 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.841 HG21 ' HH2' ' A' ' 59' ' ' TRP . 19.7 mm -83.99 -61.66 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.415 -0.803 . . . . 0.0 109.266 179.771 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -151.16 160.48 43.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.751 -0.593 . . . . 0.0 109.593 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -89.83 110.72 21.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.985 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.041 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.7 pp -104.75 -32.41 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.082 -1.011 . . . . 0.0 111.104 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.923 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.04 162.54 15.78 Favored Glycine 0 C--N 1.295 -1.745 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.956 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.449 ' N ' HG13 ' A' ' 19' ' ' ILE . 45.9 t80 -134.35 141.49 46.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.217 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.584 ' HD2' HD22 ' A' ' 6' ' ' LEU . 4.6 t80 -142.27 130.9 22.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.087 -1.445 . . . . 0.0 111.365 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 t0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.25 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 73' ' ' LEU . 12.0 tp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.519 0.676 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -133.41 94.96 3.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.172 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.923 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.6 t -118.41 139.45 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 111.34 -179.037 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -85.01 72.99 10.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 175.776 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.699 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.53 -30.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.06 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -62.46 -48.4 79.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.589 -1.319 . . . . 0.0 108.771 178.257 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.712 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.1 mmp_? -76.22 -36.55 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 178.673 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.868 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -69.54 -20.39 63.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.598 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttp180 -86.78 -23.19 25.5 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.296 -0.877 . . . . 0.0 109.112 178.52 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.632 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.7 t80 -61.93 -45.37 94.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 123.099 1.428 . . . . 0.0 107.502 178.427 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.041 ' CD1' HG21 ' A' ' 36' ' ' ILE . 67.8 m95 -68.07 -57.44 6.1 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.943 -179.166 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.728 HD21 ' HG3' ' A' ' 66' ' ' PRO . 10.9 mt -56.05 -20.82 18.45 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.329 -0.949 . . . . 0.0 108.707 177.335 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 t -79.98 -23.18 41.77 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.363 -0.836 . . . . 0.0 110.623 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 59' ' ' TRP . 18.8 m -98.89 31.93 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.964 -1.085 . . . . 0.0 109.627 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.77 75.17 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -66.56 134.88 53.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.951 -1.323 . . . . 0.0 110.164 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.436 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 2.9 mt-30 -99.88 107.83 48.49 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.728 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.7 Cg_endo -82.4 134.55 7.81 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.46 1.242 . . . . 0.0 110.229 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.49 163.19 0.93 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 110.032 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.07 -16.91 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.245 -0.909 . . . . 0.0 110.717 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.7 m -99.61 -47.8 4.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 110.53 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.55 -28.8 66.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -66.27 -38.6 88.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.318 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -26.74 68.3 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.287 178.939 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.1 mt -88.11 -29.03 20.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.641 HD12 ' HB3' ' A' ' 66' ' ' PRO . 34.0 mt -68.74 -28.24 66.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.733 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -28.86 30.8 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.558 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -72.96 -33.76 66.07 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.142 0.972 . . . . 0.0 108.918 179.218 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.34 -9.59 54.03 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 178.523 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.409 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 84.91 52.9 3.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.699 HG22 ' CB ' ' A' ' 53' ' ' VAL . 43.0 t . . . . . 0 N--CA 1.486 1.358 0 O-C-N 121.12 -1.223 . . . . 0.0 111.716 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 41.6 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.257 0.551 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -140.52 134.9 31.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.888 . . . . 0.0 110.603 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.974 ' CG1' HG13 ' A' ' 21' ' ' VAL . 73.4 mt -102.27 134.79 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.026 . . . . 0.0 109.226 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.5 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.2 ptm180 -150.91 -167.86 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.009 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 70' ' ' ALA . 4.8 mp -89.18 131.62 35.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -0.779 . . . . 0.0 110.518 -179.866 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -107.27 111.23 23.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 19.6 ttt-85 . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 112.313 -178.767 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 15.2 m-30 . . . . . 0 C--O 1.208 -1.101 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -134.32 158.17 44.48 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.193 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.877 HD12 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.51 86.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 178.003 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.268 0.4 OUTLIER -97.94 164.02 2.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.583 -173.945 . . . . . . . . 4 4 . 1 . 038 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.974 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -106.87 108.2 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.738 -0.601 . . . . 0.0 110.188 -178.278 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 33' ' ' ILE . 2.4 t . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.715 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.554 ' HB3' HG13 ' A' ' 20' ' ' VAL . 22.7 p90 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.753 0.787 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 22' ' ' THR . 3.3 mp -91.27 -44.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.649 -0.657 . . . . 0.0 109.994 179.965 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 176.52 11.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -109.14 115.01 29.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 179.847 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.013 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.9 pt -113.06 -31.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 110.825 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.838 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.42 167.08 14.24 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.785 -178.813 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 11.5 t80 -140.61 133.03 28.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.061 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' ILE . 17.5 t80 -126.07 144.66 50.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.772 178.718 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 49' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.567 0.698 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 49' ' ' LEU . 38.0 tttt -134.49 93.29 3.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.545 -0.722 . . . . 0.0 109.102 178.951 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.838 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -113.48 135.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.032 -1.042 . . . . 0.0 111.04 -179.274 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.7 t70 -77.0 70.04 3.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.412 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.13 -30.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 122.265 -0.272 . . . . 0.0 111.42 -177.797 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -61.99 -55.6 27.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.898 -1.126 . . . . 0.0 109.009 178.577 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.664 ' HB3' HG22 ' A' ' 36' ' ' ILE . 28.8 mmm180 -71.56 -39.92 70.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.185 -0.947 . . . . 0.0 108.797 178.571 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -62.59 -18.66 62.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.279 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 25.0 ttm180 -88.58 -24.79 22.76 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 178.218 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.777 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -61.43 -47.2 86.84 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.268 1.509 . . . . 0.0 107.47 178.576 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.013 ' CD1' HG21 ' A' ' 36' ' ' ILE . 83.7 m95 -64.66 -56.61 12.68 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.766 -179.016 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 74' ' ' LEU . 38.4 mt -53.35 -22.68 7.77 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.534 177.238 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -21.13 41.1 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.47 -0.769 . . . . 0.0 110.456 179.177 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.3 m -99.04 32.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.85 -1.156 . . . . 0.0 109.426 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.18 25.12 76.2 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -69.44 128.51 36.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.016 -1.285 . . . . 0.0 109.792 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.37 113.24 65.85 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 0.0 110.669 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -79.68 132.08 9.63 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.526 1.277 . . . . 0.0 109.766 179.467 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 t -62.93 -178.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.53 52.43 1.4 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 0.0 110.239 179.735 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.43 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 6.3 m -166.05 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.55 -23.47 66.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.249 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.578 ' HA ' HD12 ' A' ' 74' ' ' LEU . 26.7 ttp180 -64.79 -41.11 96.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.105 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -63.82 -37.66 88.22 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.284 179.199 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 70' ' ' ALA . 40.3 mt -67.37 -35.79 80.06 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 71' ' ' ARG . 55.0 mt -65.08 -26.85 68.4 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.587 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -28.09 38.24 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.027 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.87 -35.97 42.95 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.958 0.885 . . . . 0.0 109.967 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.749 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -74.62 -2.9 28.13 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.042 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.01 20.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.579 ' HA ' HG23 ' A' ' 53' ' ' VAL . 57.9 t . . . . . 0 C--N 1.306 -1.299 0 O-C-N 121.142 -1.211 . . . . 0.0 111.479 -179.112 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 92.3 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.087 0.47 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.6 ptmt -140.14 137.15 34.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.99 . . . . 0.0 111.044 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.024 HD11 ' CB ' ' A' ' 59' ' ' TRP . 93.6 mt -99.93 133.38 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.183 -0.948 . . . . 0.0 109.013 178.993 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.529 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -150.69 173.83 13.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.383 -179.2 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.0 pp -87.73 124.68 33.84 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.096 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.4 111.93 24.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.73 . . . . 0.0 112.462 -176.807 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.4 ttp180 . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.139 -0.976 . . . . 0.0 111.35 179.452 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.5 m-85 . . . . . 0 C--O 1.213 -0.84 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 14.8 ttm180 -103.12 148.13 26.14 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.422 178.2 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.954 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -96.89 79.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 178.278 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 35' ' ' LYS 0.282 0.4 OUTLIER -97.61 163.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.229 -173.569 . . . . . . . . 4 4 . 1 . 039 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.926 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -110.63 110.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.497 -0.752 . . . . 0.0 110.464 -177.529 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.6 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.222 -0.924 . . . . 0.0 110.366 179.602 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 24.4 p90 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.375 0.607 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG21 ' HH2' ' A' ' 59' ' ' TRP . 1.1 mt -58.91 -36.63 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.592 179.561 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.4 tt0 -170.57 138.71 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' CB ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -89.71 134.58 34.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.597 179.802 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.961 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -124.15 -22.75 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.054 -1.028 . . . . 0.0 111.35 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.915 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.86 162.96 19.0 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.766 -1.683 . . . . 0.0 110.959 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG13 ' A' ' 19' ' ' ILE . 65.2 t80 -136.93 137.72 39.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.357 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 5.2 t80 -131.15 128.36 39.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.934 -1.103 . . . . 0.0 109.869 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 110.866 -179.675 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.5 tt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.287 0.565 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -130.9 90.36 2.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.881 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.954 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.5 t -115.76 139.95 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.033 -1.042 . . . . 0.0 111.025 -179.656 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.5 t70 -85.25 71.79 10.81 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.899 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.623 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.93 -31.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 122.312 -0.242 . . . . 0.0 111.526 -177.31 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.5 tt0 -62.74 -49.81 73.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.788 -1.195 . . . . 0.0 108.928 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.69 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -75.42 -36.17 60.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 108.877 178.63 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.936 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -69.3 -20.35 63.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.393 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.2 tpt180 -85.6 -25.0 26.93 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.239 -0.913 . . . . 0.0 109.216 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.8 t80 -60.12 -44.72 94.69 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 123.169 1.461 . . . . 0.0 107.503 178.563 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.024 ' CB ' HD11 ' A' ' 4' ' ' ILE . 69.2 m95 -68.32 -53.64 22.83 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.254 -179.089 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.565 HD12 HG11 ' A' ' 79' ' ' VAL . 23.4 mt -58.28 -19.44 34.54 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.493 177.437 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 3.7 m -82.78 -22.75 34.17 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.334 -0.854 . . . . 0.0 110.724 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 59' ' ' TRP . 28.0 m -98.92 33.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.835 -1.165 . . . . 0.0 109.376 179.407 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.88 35.04 91.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.865 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -70.37 140.82 52.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.078 -1.248 . . . . 0.0 110.156 179.883 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.59 106.57 40.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.31 179.965 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -81.67 142.66 12.97 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.404 1.213 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -64.15 -176.44 0.21 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.042 . . . . 0.0 110.36 -179.762 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.53 -21.57 48.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.491 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -101.76 -44.44 5.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.688 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.39 -29.03 69.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 67' ' ' THR . 46.5 ttt180 -64.41 -38.32 90.63 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.365 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.35 -29.86 70.76 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.675 178.776 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 70' ' ' ALA . 49.7 mt -81.86 -33.57 30.53 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.857 -0.527 . . . . 0.0 110.0 179.609 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 97.0 mt -67.04 -27.47 67.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.001 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -82.19 -30.93 30.63 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.621 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 22.1 tp60 -78.3 -33.44 49.35 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.898 0.856 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.32 -12.83 45.87 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.93 178.414 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.74 43.5 4.8 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.623 HG22 ' CB ' ' A' ' 53' ' ' VAL . 29.3 t . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.112 -1.228 . . . . 0.0 111.321 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.649 ' CG1' HG12 ' A' ' 21' ' ' VAL . 63.9 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.257 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 65' ' ' GLN . 5.3 mmmm -140.48 130.62 24.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.873 ' CG1' HG13 ' A' ' 21' ' ' VAL . 31.6 mt -99.81 129.45 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.899 -1.126 . . . . 0.0 109.102 178.941 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.7 ptt180 -150.94 -174.96 4.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 110.812 -178.975 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.609 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -88.98 125.36 34.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 110.969 -179.715 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.53 111.23 23.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.511 -0.743 . . . . 0.0 110.104 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 112.044 -178.807 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.609 ' HB2' HD23 ' A' ' 6' ' ' LEU . 8.7 m-85 . . . . . 0 C--O 1.212 -0.906 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 14.2 ttm180 -114.08 151.53 32.39 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.351 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.906 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -97.94 80.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 102.513 -3.144 . . . . 0.0 102.513 178.171 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.27 0.4 OUTLIER -97.57 166.32 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.41 -173.459 . . . . . . . . 4 4 . 1 . 040 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.873 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -111.49 113.42 44.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.595 -0.691 . . . . 0.0 110.627 -177.251 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.259 179.683 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.488 ' HB3' HG13 ' A' ' 20' ' ' VAL . 7.5 p90 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.36 0.6 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.679 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.3 mp -55.08 -33.3 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.12 175.11 2.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 126.05 54.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.034 179.895 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.047 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -120.3 -31.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.158 -0.964 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.933 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -118.43 156.35 15.69 Favored Glycine 0 C--N 1.298 -1.543 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.72 143.5 51.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.752 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -138.6 136.86 36.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.671 -1.268 . . . . 0.0 110.752 -179.602 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.064 -1.022 . . . . 0.0 110.047 179.336 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.656 HD12 HD22 ' A' ' 73' ' ' LEU . 3.1 tt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.354 0.597 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -131.96 98.31 4.41 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.32 179.269 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -122.81 138.1 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 111.324 -179.039 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t70 -83.35 72.12 10.23 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.721 HG23 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.15 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 CA-C-O 120.631 0.253 . . . . 0.0 111.348 -177.409 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 52' ' ' ASP . 17.4 mt-10 -60.5 -52.76 63.84 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.878 -1.138 . . . . 0.0 108.626 178.148 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.58 ' HB3' HG22 ' A' ' 36' ' ' ILE . 53.5 mmm-85 -72.82 -41.05 65.29 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.357 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.941 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -62.25 -18.36 60.98 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.088 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.3 ttp180 -88.85 -27.99 20.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.259 -0.901 . . . . 0.0 109.368 178.566 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.733 ' O ' HG13 ' A' ' 62' ' ' VAL . 2.5 t80 -59.82 -44.33 94.09 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.294 1.521 . . . . 0.0 107.545 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.047 ' CD1' HG21 ' A' ' 36' ' ' ILE . 74.7 m95 -68.4 -56.68 7.66 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.889 -178.91 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.052 HD11 HD13 ' A' ' 74' ' ' LEU . 35.0 mt -54.61 -21.67 11.14 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.006 -1.059 . . . . 0.0 108.647 177.429 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 24.4 t -80.92 -23.42 38.93 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.399 -0.813 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 58' ' ' TYR . 6.0 m -98.95 32.19 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.805 -1.184 . . . . 0.0 109.568 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.0 24.47 75.89 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.68 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -72.02 101.47 2.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.918 -1.343 . . . . 0.0 109.83 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.439 ' HB3' ' CD ' ' A' ' 3' ' ' LYS . 1.7 tt0 -69.84 114.78 27.47 Favored Pre-proline 0 C--N 1.297 -1.701 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.355 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HB3' HD12 ' A' ' 74' ' ' LEU . 53.2 Cg_endo -82.2 124.94 4.45 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.599 1.315 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.63 164.98 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.15 -0.969 . . . . 0.0 110.212 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.1 -18.04 31.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.4 m -95.89 -50.14 5.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.06 -28.5 67.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.389 -0.819 . . . . 0.0 109.206 -179.555 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 8.2 ttp180 -66.86 -38.08 85.66 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.735 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -23.94 65.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.069 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 70' ' ' ALA . 17.9 mt -90.96 -26.39 19.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.459 -0.776 . . . . 0.0 109.621 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 1.052 HD13 HD11 ' A' ' 60' ' ' LEU . 25.6 mt -69.76 -30.12 67.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.996 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.85 -29.16 44.41 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.141 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.42 ' HG2' HD13 ' A' ' 49' ' ' LEU . 5.8 tp-100 -73.34 -34.2 65.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.139 0.971 . . . . 0.0 108.516 178.902 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -72.12 -7.33 48.42 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.692 177.994 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.65 50.07 4.6 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.589 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.721 HG22 HG23 ' A' ' 53' ' ' VAL . 40.6 t . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.197 -1.178 . . . . 0.0 111.442 -179.27 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.662 HG11 ' CE3' ' A' ' 59' ' ' TRP . 61.4 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HG2' ' HB2' ' A' ' 65' ' ' GLN . 28.7 mtpt -140.24 130.62 25.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.511 -179.904 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.964 ' CG1' HG13 ' A' ' 21' ' ' VAL . 77.9 mt -102.37 133.11 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.135 -0.978 . . . . 0.0 109.925 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptt85 -150.8 -165.48 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.63 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 50.5 mt -89.26 132.65 34.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.008 -1.058 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -104.26 100.88 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 179.708 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 111.169 -179.645 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.8 m-85 . . . . . 0 C--O 1.213 -0.832 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.489 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.8 mmt180 -99.81 165.25 11.67 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.147 -1.421 . . . . 0.0 107.999 176.736 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.885 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -98.48 81.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 177.244 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -97.4 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.681 -173.947 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.964 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -111.84 108.65 26.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.748 -0.595 . . . . 0.0 110.947 -176.951 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.004 179.452 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.508 0.671 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.0 mt -82.88 -45.2 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.745 . . . . 0.0 109.667 179.76 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 165.91 32.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.447 -0.783 . . . . 0.0 110.01 179.787 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HD3' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -99.0 108.47 21.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 179.861 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.001 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.9 pt -101.51 -36.22 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.095 -1.003 . . . . 0.0 111.581 -179.566 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.809 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -125.95 172.04 17.78 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.758 -1.687 . . . . 0.0 112.868 -177.934 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 77.9 t80 -141.11 133.26 27.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.237 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.885 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.1 t80 -132.12 133.46 44.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.567 -1.333 . . . . 0.0 110.394 178.853 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.948 . . . . 0.0 109.724 179.138 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' A' ' 73' ' ' LEU . 10.9 tp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.57 0.7 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -128.4 92.64 3.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.134 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.809 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.84 149.07 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 111.29 -179.025 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t0 -93.31 67.04 4.06 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.765 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -32.05 -33.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.667 -177.334 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.34 -53.33 58.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.995 178.537 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 25.7 mmm180 -71.7 -41.87 68.08 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 108.66 178.525 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -61.99 -18.68 61.26 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.222 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.2 ttt-85 -88.27 -27.2 21.89 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.326 -0.859 . . . . 0.0 109.508 178.167 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.808 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -59.49 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.234 1.493 . . . . 0.0 107.564 178.637 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.001 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.5 m95 -66.38 -54.82 19.96 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.511 -178.923 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.665 HD11 HD13 ' A' ' 74' ' ' LEU . 9.1 mt -55.6 -21.49 17.73 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.533 177.081 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 10.8 t -82.57 -20.74 35.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.423 -0.798 . . . . 0.0 110.622 179.687 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.5 m -99.12 32.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.48 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.36 72.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -68.07 142.52 55.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.036 -1.273 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -110.62 109.4 57.97 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 110.645 -179.699 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -80.21 125.41 5.81 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.586 1.308 . . . . 0.0 109.815 179.339 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 t -56.91 178.87 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 0.0 110.539 -179.819 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.74 54.22 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 0.0 109.781 179.172 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -165.64 -58.3 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.761 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.642 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.48 -23.7 66.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.026 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -69.17 -41.79 76.75 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.157 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -65.78 -41.47 91.97 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.652 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.66 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.9 mt -69.97 -28.16 65.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.493 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.665 HD13 HD11 ' A' ' 60' ' ' LEU . 12.8 mt -68.82 -29.05 67.31 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.514 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -30.77 39.11 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.421 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -31.34 34.93 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.847 0.832 . . . . 0.0 109.877 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -70.52 -6.83 39.1 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.051 178.863 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.45 48.6 6.24 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 53' ' ' VAL . 48.4 t . . . . . 0 N--CA 1.485 1.282 0 O-C-N 121.206 -1.173 . . . . 0.0 111.461 -179.385 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.617 HG11 ' CE3' ' A' ' 59' ' ' TRP . 70.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.314 0.578 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.19 135.33 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.005 ' CG1' HG13 ' A' ' 21' ' ' VAL . 86.2 mt -102.86 135.34 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.038 -1.039 . . . . 0.0 109.737 179.433 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.38 -168.78 3.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.373 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 70' ' ' ALA . 7.0 mp -89.45 127.25 35.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 179.916 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -102.21 108.92 20.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.573 -0.705 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 2.8 ttt180 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 111.688 -179.468 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.0 m-85 . . . . . 0 C--O 1.211 -0.942 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' C ' HD13 ' A' ' 19' ' ' ILE . 70.7 mtt180 -131.99 157.15 44.83 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.686 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -98.07 81.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 177.622 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -97.72 168.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.639 -173.785 . . . . . . . . 4 4 . 1 . 042 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.005 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.37 108.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.69 -0.631 . . . . 0.0 110.658 -177.087 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 179.387 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD2' HG21 ' A' ' 20' ' ' VAL . 5.3 p90 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.373 0.606 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.647 HG21 ' HH2' ' A' ' 59' ' ' TRP . 56.3 mt -93.58 -36.31 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.503 -0.748 . . . . 0.0 110.002 -179.876 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.12 167.82 15.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.904 -179.958 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 4.2 pttp -102.05 111.7 24.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 179.902 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.965 HG21 ' CD1' ' A' ' 59' ' ' TRP . 32.2 pt -107.41 -35.21 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.912 -1.117 . . . . 0.0 111.244 -179.648 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.815 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.78 168.05 15.1 Favored Glycine 0 C--N 1.296 -1.648 0 C-N-CA 118.959 -1.591 . . . . 0.0 112.254 -177.887 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.448 ' N ' HG12 ' A' ' 19' ' ' ILE . 90.8 t80 -141.36 125.9 17.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.571 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.77 ' HB2' HD11 ' A' ' 19' ' ' ILE . 10.9 t80 -120.66 130.12 53.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.813 -1.179 . . . . 0.0 109.43 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 N--CA 1.5 2.05 0 O-C-N 120.293 -1.504 . . . . 0.0 111.633 179.851 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 73' ' ' LEU . 6.3 tt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.204 0.526 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.93 95.66 3.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 109.5 179.393 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.815 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.57 143.53 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 111.411 -179.102 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 t70 -87.95 70.16 9.44 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.389 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.11 -32.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.486 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.47 -57.18 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.7 -1.25 . . . . 0.0 108.818 178.526 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.651 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -67.64 -41.3 84.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 108.998 178.538 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.5 -19.35 65.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.615 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.9 ttt180 -89.17 -22.26 22.89 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 178.501 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.939 ' O ' HG13 ' A' ' 62' ' ' VAL . 5.3 t80 -59.95 -44.64 94.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.25 1.5 . . . . 0.0 107.14 178.282 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.965 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.0 m95 -68.43 -58.22 4.67 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.909 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.744 HD11 HD13 ' A' ' 74' ' ' LEU . 30.6 mt -53.13 -23.57 8.44 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.586 177.474 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 19.5 m -80.87 -21.33 40.77 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.484 -0.76 . . . . 0.0 110.348 179.287 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -99.12 31.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.872 -1.143 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.91 24.9 75.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.972 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 138.59 55.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.916 -1.343 . . . . 0.0 110.264 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.465 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -105.47 107.87 60.16 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.912 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HB3' HD12 ' A' ' 74' ' ' LEU . 56.2 Cg_endo -82.38 132.01 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.474 1.25 . . . . 0.0 110.484 179.982 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.1 p -58.97 166.27 2.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 179.417 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.17 -26.31 64.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.913 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -84.87 -51.8 6.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 110.482 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.809 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -70.15 -25.42 63.45 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.441 -0.787 . . . . 0.0 108.942 179.981 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 67' ' ' THR . 8.1 ttm180 -69.39 -36.09 76.44 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.131 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -40.98 92.49 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.557 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.2 mt -69.29 -28.08 65.98 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.267 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.744 HD13 HD11 ' A' ' 60' ' ' LEU . 25.0 mt -73.18 -27.03 61.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.468 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -29.93 29.84 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.117 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -84.37 -31.07 24.94 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.859 0.837 . . . . 0.0 110.045 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.455 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -70.6 -7.9 47.62 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.772 -0.58 . . . . 0.0 109.829 178.667 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.09 50.3 4.64 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.691 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 53' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.119 -1.224 . . . . 0.0 111.206 -179.696 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 46.8 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.213 0.53 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -140.81 141.19 34.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.521 -179.775 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.909 HD11 ' CB ' ' A' ' 59' ' ' TRP . 91.0 mt -108.57 131.11 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.055 -1.028 . . . . 0.0 109.462 178.97 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -151.2 -175.68 5.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 110.69 -179.138 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.533 HD11 HD12 ' A' ' 73' ' ' LEU . 3.9 mp -88.72 122.41 32.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.95 107.15 19.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 112.055 -178.561 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.653 179.036 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 10.2 m-85 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -99.5 153.52 18.96 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.645 177.303 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.031 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.2 mm -97.67 73.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 176.336 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.258 0.4 OUTLIER -97.59 162.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.093 -173.053 . . . . . . . . 4 4 . 1 . 043 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.821 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.15 114.32 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.439 0.638 . . . . 0.0 111.441 -176.883 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.603 178.888 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 35' ' ' LYS . 11.9 p90 . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.576 0.703 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.648 HG21 ' HH2' ' A' ' 59' ' ' TRP . 14.8 mt -88.45 -31.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.514 -0.741 . . . . 0.0 109.878 179.858 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.48 157.14 2.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.487 -0.758 . . . . 0.0 109.877 -179.88 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HA ' HG23 ' A' ' 20' ' ' VAL . 36.3 mtmt -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.911 HG21 ' CD1' ' A' ' 59' ' ' TRP . 29.0 pt -100.0 -35.62 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 110.859 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.858 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.13 166.38 18.92 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.017 -178.453 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.473 ' N ' HG12 ' A' ' 19' ' ' ILE . 84.8 t80 -141.01 137.07 32.71 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.808 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.031 ' HB2' HD11 ' A' ' 19' ' ' ILE . 16.3 t80 -127.08 131.02 50.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 109.296 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.8 t0 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 120.741 -1.224 . . . . 0.0 111.31 179.917 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.618 HD13 ' N ' ' A' ' 50' ' ' LYS . 1.6 tm? . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.618 ' N ' HD13 ' A' ' 49' ' ' LEU . 11.6 tttm -125.7 97.6 5.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.571 -0.706 . . . . 0.0 109.111 179.175 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.858 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.1 t -124.06 144.22 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.031 -1.043 . . . . 0.0 111.396 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.3 t0 -87.66 70.27 9.7 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.794 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.615 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.33 -30.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.471 -177.655 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.6 mt-10 -62.18 -54.74 36.7 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.909 -1.119 . . . . 0.0 108.967 178.092 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 3.4 mtm-85 -74.15 -33.57 63.57 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 178.951 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.901 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -68.24 -24.69 64.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.212 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -84.35 -22.94 30.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 178.285 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -61.65 -51.76 67.13 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.192 1.472 . . . . 0.0 107.722 178.909 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.911 ' CD1' HG21 ' A' ' 36' ' ' ILE . 82.9 m95 -59.81 -53.75 54.33 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.899 -179.183 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.962 HD11 HD13 ' A' ' 74' ' ' LEU . 9.8 mt -55.2 -20.06 9.66 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.559 177.094 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.1 t -81.56 -21.29 38.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 110.682 179.279 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.2 m -98.88 32.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.816 -1.177 . . . . 0.0 109.813 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.04 72.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -73.39 122.62 22.36 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.183 -1.187 . . . . 0.0 110.109 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 112.49 48.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.731 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.8 Cg_endo -82.12 127.31 5.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.518 1.273 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 167.39 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.082 -1.011 . . . . 0.0 109.789 179.677 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.33 -17.35 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.735 -179.626 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' HD13 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -99.06 -49.57 4.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.346 -179.868 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -66.7 -23.08 66.07 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.335 -0.853 . . . . 0.0 109.026 -179.961 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 7.5 tmm_? -71.75 -41.35 68.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.28 83.6 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.291 -0.963 . . . . 0.0 108.962 178.847 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 6' ' ' LEU . 28.5 mt -72.62 -27.05 61.91 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.742 . . . . 0.0 109.15 179.192 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.962 HD13 HD11 ' A' ' 60' ' ' LEU . 15.0 mt -72.37 -29.57 63.9 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 177.763 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -79.59 -31.88 41.85 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.548 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.31 -26.81 47.07 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.016 0.913 . . . . 0.0 109.218 178.69 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.705 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -70.67 -7.74 46.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.78 16.51 45.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.99 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.615 HG22 HG23 ' A' ' 53' ' ' VAL . 22.2 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.308 . . . . 0.0 109.826 179.728 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG11 ' CE3' ' A' ' 59' ' ' TRP . 92.8 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -140.77 142.49 34.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.909 HD11 ' CB ' ' A' ' 59' ' ' TRP . 73.8 mt -109.92 134.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.041 . . . . 0.0 109.825 179.382 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.27 -171.21 3.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.948 -1.095 . . . . 0.0 110.766 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 70' ' ' ALA . 7.1 mp -89.01 126.4 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.92 106.31 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 110.767 -179.634 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.525 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.822 -1.174 . . . . 0.0 111.43 -179.714 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.21 -0.991 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' C ' HD13 ' A' ' 19' ' ' ILE . 16.7 mtt-85 -108.75 160.47 15.94 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.256 -1.378 . . . . 0.0 107.988 176.678 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.994 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.62 81.53 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 177.643 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -97.32 164.38 2.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.611 -173.856 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.92 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -110.09 109.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.76 -0.587 . . . . 0.0 110.181 -177.483 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 5.7 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.818 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 p90 . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.62 0.724 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.724 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.6 mp -83.7 -33.06 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.616 -0.678 . . . . 0.0 109.367 179.383 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.21 156.06 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.559 -0.713 . . . . 0.0 109.688 179.472 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -91.87 111.34 22.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.388 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.033 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.8 pp -102.42 -26.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.203 -0.935 . . . . 0.0 110.59 179.482 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.886 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -123.39 165.96 15.97 Favored Glycine 0 C--N 1.297 -1.637 0 C-N-CA 119.173 -1.489 . . . . 0.0 111.925 -179.468 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.479 ' N ' HG12 ' A' ' 19' ' ' ILE . 6.5 t80 -140.86 132.9 27.82 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.901 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.994 ' HB2' HD11 ' A' ' 19' ' ' ILE . 15.0 t80 -130.7 140.61 50.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.754 -1.216 . . . . 0.0 109.877 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 N--CA 1.496 1.855 0 O-C-N 120.869 -1.145 . . . . 0.0 109.863 179.051 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.468 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.3 tt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.291 0.567 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.46 88.99 2.46 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.886 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -115.53 130.41 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 111.197 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t70 -75.32 71.42 2.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.016 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -34.18 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.681 -177.45 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 39.9 tt0 -62.12 -51.94 65.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.667 -1.271 . . . . 0.0 108.851 178.136 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.667 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -71.41 -39.18 71.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 178.701 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.906 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -66.99 -19.53 65.73 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.335 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.1 ttp85 -87.18 -25.73 23.91 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.402 -0.811 . . . . 0.0 109.377 178.755 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.673 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.9 t80 -59.32 -45.9 90.07 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.231 1.491 . . . . 0.0 107.519 178.539 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.033 ' CD1' HG21 ' A' ' 36' ' ' ILE . 70.9 m95 -66.89 -56.95 8.04 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.415 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 79' ' ' VAL . 12.7 mt -53.67 -22.83 9.71 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.572 177.327 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.59 -23.28 49.95 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.465 -0.772 . . . . 0.0 110.234 179.28 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 59' ' ' TRP . 5.4 m -98.88 32.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.898 -1.126 . . . . 0.0 109.509 179.873 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.43 22.33 77.69 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.901 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -63.53 134.59 55.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.979 -1.306 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -105.83 110.0 63.71 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 110.401 -179.797 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.54 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.1 Cg_endo -83.62 130.71 5.25 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.455 1.24 . . . . 0.0 109.814 179.516 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.8 t -54.76 -177.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -0.942 . . . . 0.0 110.091 -179.853 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.68 0.67 16.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.969 -1.082 . . . . 0.0 111.707 -179.163 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.502 ' H ' HG23 ' A' ' 67' ' ' THR . 2.6 m -110.86 -50.9 2.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.862 -1.149 . . . . 0.0 110.035 179.794 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.868 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -72.04 -26.82 62.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.635 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.6 ttt180 -67.26 -38.12 84.6 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.383 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -66.63 -36.95 83.8 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 108.724 179.061 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 70' ' ' ALA . 12.2 mt -72.79 -28.32 62.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.878 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.518 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 30.9 mt -71.55 -28.69 64.03 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.443 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -30.62 46.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.327 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 15.3 tp60 -84.07 -32.2 24.93 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.881 0.848 . . . . 0.0 110.265 -179.843 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.88 -13.36 44.52 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.766 -0.583 . . . . 0.0 109.999 178.963 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.26 25.03 10.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 60' ' ' LEU . 30.1 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.801 -1.411 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.612 HG21 HG23 ' A' ' 62' ' ' VAL . 14.1 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.317 0.58 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -140.25 132.26 27.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.184 179.667 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.861 ' CG1' HG13 ' A' ' 21' ' ' VAL . 76.3 mt -103.08 132.09 50.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.095 -1.003 . . . . 0.0 109.551 179.351 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.35 -169.07 3.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.2 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 6' ' ' LEU . 36.4 mt -88.81 129.41 35.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 179.752 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.39 101.11 12.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.155 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 1.2 tmm_? . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.722 -0.611 . . . . 0.0 111.538 -179.252 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.1 m-85 . . . . . 0 C--O 1.213 -0.852 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 2.1 mtt180 -106.6 159.56 16.1 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.13 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.886 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.09 78.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 177.628 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.65 167.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.543 -173.845 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.935 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.99 105.58 19.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.285 0.564 . . . . 0.0 110.354 -177.662 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 6.5 t . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.294 179.79 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 20' ' ' VAL . 6.1 p90 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.611 0.72 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.59 -27.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.645 -0.66 . . . . 0.0 109.33 179.751 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.34 166.26 14.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 109.798 179.817 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 117.63 34.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.932 HG21 ' CD1' ' A' ' 59' ' ' TRP . 41.4 pt -112.24 -33.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.091 -1.005 . . . . 0.0 111.153 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.776 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -130.07 170.38 20.78 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.924 -178.362 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.511 ' N ' HG13 ' A' ' 19' ' ' ILE . 68.2 t80 -139.17 143.66 38.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.651 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' HD2' HD22 ' A' ' 6' ' ' LEU . 11.8 t80 -140.04 123.72 17.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.857 -1.152 . . . . 0.0 109.995 -179.85 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 19.7 t0 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.613 -1.304 . . . . 0.0 110.915 -179.865 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 73' ' ' LEU . 7.1 tt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.4 0.619 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -139.46 100.2 3.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.177 179.23 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.886 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -129.68 140.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.047 -179.054 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t0 -90.06 70.23 7.36 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.08 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.512 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -32.07 -33.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.741 -177.458 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mm-40 -60.43 -55.87 28.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.75 -1.219 . . . . 0.0 109.095 178.432 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.62 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -68.94 -40.81 78.74 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.135 178.836 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.81 -20.62 66.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.705 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.7 tpt180 -87.32 -22.52 25.07 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 178.511 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.2 t80 -60.08 -49.21 78.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.317 1.532 . . . . 0.0 107.096 178.553 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.935 ' CD2' HG11 ' A' ' 21' ' ' VAL . 87.7 m95 -61.69 -51.22 69.31 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.292 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 HG11 ' A' ' 79' ' ' VAL . 18.5 mt -54.33 -22.35 11.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 176.669 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -25.09 42.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.494 -0.754 . . . . 0.0 110.777 179.529 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.612 HG23 HG21 ' A' ' 2' ' ' VAL . 7.6 m -99.13 33.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.907 -1.121 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.32 78.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.572 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -63.16 138.5 58.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -1.22 . . . . 0.0 110.172 179.985 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 2.7 mp0 -104.06 103.39 37.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.134 179.94 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -82.2 130.06 6.23 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.499 1.263 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.8 t -64.65 168.44 6.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.983 -1.073 . . . . 0.0 109.739 179.757 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.62 -26.96 24.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 111.582 -178.914 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.26 -50.25 6.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.044 -1.035 . . . . 0.0 110.894 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.765 ' H ' HG23 ' A' ' 67' ' ' THR . . . -66.61 -24.91 66.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.858 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.6 ttp180 -70.75 -39.81 73.05 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.429 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -65.93 -40.66 91.61 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.603 178.539 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 70' ' ' ALA . 14.7 mt -69.7 -29.07 66.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.576 -0.703 . . . . 0.0 109.125 179.017 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 20.8 mt -71.98 -27.58 62.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.565 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -26.77 32.98 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.455 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.1 tp-100 -85.39 -37.68 19.57 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.642 0.734 . . . . 0.0 110.406 -179.58 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -65.43 -10.98 38.41 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.681 178.638 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.4 50.26 3.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 53' ' ' VAL . 43.6 t . . . . . 0 N--CA 1.487 1.39 0 O-C-N 121.087 -1.243 . . . . 0.0 111.12 -179.679 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.41 0.624 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 30.0 mtpt -140.37 134.6 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 179.759 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.936 ' CG1' HG13 ' A' ' 21' ' ' VAL . 74.3 mt -99.99 133.82 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.0 -1.063 . . . . 0.0 109.656 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.601 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -151.4 -172.27 4.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -178.968 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mp -89.1 125.86 35.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.81 102.62 14.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.5 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.506 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.9 ttm180 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 111.577 179.917 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.0 m-85 . . . . . 0 C--O 1.212 -0.875 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 3.4 mmt180 -100.14 157.07 16.84 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.669 176.614 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.956 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.19 77.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 102.469 -3.159 . . . . 0.0 102.469 176.824 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.258 0.4 OUTLIER -97.46 171.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.51 -173.715 . . . . . . . . 4 4 . 1 . 046 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.936 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -115.98 112.81 41.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.769 -0.582 . . . . 0.0 110.633 -177.184 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.9 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 110.492 179.591 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CB ' HG13 ' A' ' 20' ' ' VAL . 23.5 p90 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.615 0.721 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.625 HG21 ' HH2' ' A' ' 59' ' ' TRP . 4.4 mt -82.48 -50.3 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.576 -0.703 . . . . 0.0 109.869 179.658 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.5 mt-10 -156.13 158.98 38.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.85 179.784 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.577 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -93.37 110.22 21.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 110.384 -179.864 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.984 HG21 ' CD1' ' A' ' 59' ' ' TRP . 26.4 pt -99.75 -36.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.22 -0.925 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.818 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -123.23 168.14 15.45 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.361 -178.403 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' N ' HG13 ' A' ' 19' ' ' ILE . 93.0 t80 -140.13 135.78 32.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 12.7 t80 -128.03 133.01 49.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.986 -1.071 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 31.1 t0 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.901 -1.125 . . . . 0.0 110.327 179.768 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 76' ' ' GLN . 7.9 tt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -121.99 97.22 5.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.099 179.175 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.956 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -120.3 159.73 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.334 1.064 . . . . 0.0 111.654 -178.854 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.9 t0 -107.21 65.84 0.66 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.98 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.798 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -35.0 -30.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -177.542 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -59.93 -54.17 49.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.747 -1.221 . . . . 0.0 108.495 178.149 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -75.74 -35.26 60.26 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.413 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.914 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.02 -21.02 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.969 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' VAL . 51.1 ttt-85 -86.61 -25.41 24.95 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.363 -0.836 . . . . 0.0 109.854 178.566 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -58.04 -46.29 85.58 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 123.179 1.466 . . . . 0.0 107.547 178.773 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.984 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.9 m95 -66.14 -52.31 49.62 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.621 -179.259 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.752 HD11 HD22 ' A' ' 74' ' ' LEU . 6.4 mt -55.04 -22.19 14.87 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.441 177.119 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -80.96 -23.54 38.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.482 -0.761 . . . . 0.0 110.612 179.604 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 58' ' ' TYR . 5.1 m -98.9 32.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.925 -1.109 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.3 29.44 73.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.48 126.1 28.67 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.043 -1.269 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -93.68 111.19 51.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.9 Cg_endo -82.29 130.71 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.492 1.259 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.36 168.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -53.75 -30.35 43.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -84.54 -50.4 7.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.433 -0.792 . . . . 0.0 110.384 -179.959 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.27 -22.88 66.91 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.227 -0.92 . . . . 0.0 108.781 179.972 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -40.26 67.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.51 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 -38.86 83.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.921 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -69.05 -28.15 66.29 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.654 -0.654 . . . . 0.0 109.357 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.778 HD23 HG21 ' A' ' 79' ' ' VAL . 13.3 mt -73.07 -26.19 61.17 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.465 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.79 -28.68 30.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.271 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.727 ' HB3' HD13 ' A' ' 49' ' ' LEU . 4.8 tp-100 -83.01 -39.81 20.78 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.764 0.792 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -65.04 -11.28 37.49 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.872 178.433 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.79 51.64 3.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.855 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.778 HG21 HD23 ' A' ' 74' ' ' LEU . 53.6 t . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.076 -1.25 . . . . 0.0 111.221 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.547 HG11 ' CE3' ' A' ' 59' ' ' TRP . 73.8 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.172 0.51 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -137.8 131.01 30.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.018 HD11 ' CB ' ' A' ' 59' ' ' TRP . 93.3 mt -102.69 129.46 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.089 -1.007 . . . . 0.0 109.534 179.251 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 28.1 ptt180 -151.67 -166.63 2.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -89.05 127.41 35.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.26 105.52 17.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 14.9 ttt180 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 111.302 -179.711 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.0 m-85 . . . . . 0 C--O 1.212 -0.908 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' C ' HD13 ' A' ' 19' ' ' ILE . 13.5 mtt-85 -101.12 161.99 13.21 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.064 -1.455 . . . . 0.0 108.457 177.178 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.073 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -99.1 80.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 177.649 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.252 0.4 OUTLIER -97.61 165.25 2.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.155 -173.75 . . . . . . . . 4 4 . 1 . 047 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 115.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.896 -0.503 . . . . 0.0 110.596 -177.659 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.013 . . . . 0.0 110.7 179.116 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.9 p90 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.438 0.637 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.797 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.0 mm -96.53 -41.35 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.576 -179.796 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.15 167.07 10.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.468 -0.77 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.24 107.65 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.988 . . . . 0.0 110.307 -179.89 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.916 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.1 pt -99.91 -36.51 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.157 -0.965 . . . . 0.0 110.571 179.936 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.785 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.78 165.89 15.35 Favored Glycine 0 C--N 1.295 -1.716 0 C-N-CA 119.027 -1.559 . . . . 0.0 111.989 -178.521 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.45 ' N ' HG12 ' A' ' 19' ' ' ILE . 9.3 t80 -140.49 130.53 24.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.066 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 1.073 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.9 t80 -131.58 133.14 44.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.636 -1.29 . . . . 0.0 110.378 -179.738 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 120.918 -1.113 . . . . 0.0 109.997 179.495 . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 10.2 tt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.561 0.696 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.93 93.83 3.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 179.328 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.785 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.03 135.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.607 -179.071 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -84.3 69.83 10.52 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 175.838 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.714 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.6 -29.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 122.135 -0.353 . . . . 0.0 111.496 -177.405 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -59.64 -51.69 68.74 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.7 -1.25 . . . . 0.0 108.745 178.605 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.7 mmm180 -75.9 -38.35 57.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.509 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -63.44 -21.23 66.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.282 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 15.2 ttt180 -88.31 -21.86 24.18 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.315 -0.865 . . . . 0.0 109.732 178.447 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -48.26 73.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 123.194 1.474 . . . . 0.0 107.668 178.704 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 1.018 ' CB ' HD11 ' A' ' 4' ' ' ILE . 81.4 m95 -63.82 -54.03 41.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.834 -179.04 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.501 HD11 HD13 ' A' ' 74' ' ' LEU . 83.4 mt -55.33 -21.04 13.4 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.33 177.256 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.43 -23.91 39.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.4 -0.812 . . . . 0.0 110.773 179.504 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.1 m -99.16 34.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.849 -1.157 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.32 26.06 74.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.588 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.448 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -73.67 112.07 9.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 179.69 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 116.52 64.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.664 -179.521 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.2 Cg_endo -83.61 124.47 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.471 1.248 . . . . 0.0 109.567 179.13 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -55.08 175.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 110.468 -179.47 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.52 56.61 1.13 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 179.993 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 m -165.9 -60.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.745 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.85 -25.2 67.09 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.819 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.8 ttp180 -65.76 -41.56 91.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.065 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.03 -41.51 98.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.682 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.3 mt -70.03 -32.81 71.13 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.983 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 46.9 mt -68.58 -26.83 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.805 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -28.78 32.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.395 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.505 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.52 -36.86 25.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.43 -179.677 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.37 -8.96 36.8 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.986 178.663 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.22 50.75 4.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 53' ' ' VAL . 39.8 t . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.032 -1.275 . . . . 0.0 111.36 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mtp . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.28 0.562 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 64' ' ' ALA . 6.7 m -126.45 119.36 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.03 133.23 29.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.936 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.8 mt -99.74 133.99 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.31 -0.869 . . . . 0.0 109.054 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.28 -171.57 3.97 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.957 -1.089 . . . . 0.0 110.586 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.927 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -88.7 126.75 35.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 110.255 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.05 104.28 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.374 -0.829 . . . . 0.0 110.613 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -72.3 118.49 15.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.306 -0.872 . . . . 0.0 111.15 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 19.1 m-85 -113.51 -61.5 1.73 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.133 -0.98 . . . . 0.0 110.147 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.59 131.63 11.89 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 27.6 p -101.59 -56.3 2.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -1.1 . . . . 0.0 109.72 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.455 ' N ' ' OG ' ' A' ' 11' ' ' SER . 3.7 mtpp -143.27 40.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -135.44 -64.65 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.665 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -138.29 114.43 8.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.59 -0.694 . . . . 0.0 109.472 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.1 102.13 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.464 1.244 . . . . 0.0 111.14 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.655 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 16.4 p-80 -149.41 136.89 20.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.927 ' HB2' HD23 ' A' ' 6' ' ' LEU . 10.7 m-85 -118.94 155.07 31.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.492 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 10.6 mtm-85 -107.99 159.35 16.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.742 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.953 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.78 79.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.261 0.4 OUTLIER -98.04 166.48 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.758 -174.053 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.905 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -109.16 109.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.768 -0.583 . . . . 0.0 110.121 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t -139.3 -166.5 2.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.222 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.6 m-20 -71.69 -161.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.548 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.03 71.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.708 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.68 144.94 12.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.213 -0.929 . . . . 0.0 110.435 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.96 169.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 109.95 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -127.65 -55.02 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.073 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.51 -47.44 2.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.16 -30.08 3.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 110.35 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 108.95 2.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -139.06 148.66 43.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.498 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 20' ' ' VAL . 9.2 p90 -119.85 165.07 15.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -77.3 -23.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.638 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.62 164.35 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 116.04 31.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.956 HG21 ' CD1' ' A' ' 59' ' ' TRP . 22.9 pt -107.01 -37.43 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 0.0 111.351 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.792 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.63 171.04 14.96 Favored Glycine 0 C--N 1.294 -1.758 0 C-N-CA 119.006 -1.569 . . . . 0.0 111.597 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.491 ' N ' HG13 ' A' ' 19' ' ' ILE . 64.7 t80 -139.57 141.96 37.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.598 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 29.3 t80 -135.34 142.6 45.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.718 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 5.3 t0 -140.66 105.39 6.38 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 43.3 Cg_endo -71.7 70.77 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.01 1.005 . . . . 0.0 110.707 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.38 130.67 46.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.112 -0.992 . . . . 0.0 110.162 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -96.97 42.21 1.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 110.433 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -112.41 -66.83 1.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.07 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.9 p -127.45 153.83 77.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.31 73.36 4.52 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.712 1.375 . . . . 0.0 110.385 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -165.02 58.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.598 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 19.1 p-90 -119.41 -14.63 9.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.116 -0.99 . . . . 0.0 110.8 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 77' ' ' ALA . 4.8 tt -83.81 116.84 22.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.029 -1.044 . . . . 0.0 110.419 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 100.9 5.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.295 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -122.82 153.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.976 -1.078 . . . . 0.0 111.336 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.4 t0 -100.04 70.84 1.6 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.638 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -34.93 -30.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 122.312 -0.242 . . . . 0.0 111.57 -177.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 tt0 -60.81 -54.8 40.7 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.713 -1.242 . . . . 0.0 108.804 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.553 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.93 -39.51 72.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.364 -0.835 . . . . 0.0 108.83 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.88 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.76 -17.68 64.79 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 13.4 ttt180 -87.51 -25.15 23.82 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.854 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.7 t80 -60.26 -44.67 95.09 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.246 1.498 . . . . 0.0 107.966 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.956 ' CD1' HG21 ' A' ' 36' ' ' ILE . 84.7 m95 -69.73 -55.87 8.74 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.149 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.521 HD21 ' HG3' ' A' ' 66' ' ' PRO . 13.1 mt -53.33 -22.56 7.48 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.447 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 15.3 t -82.35 -22.75 35.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.455 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.7 m -99.14 32.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 120.839 -1.163 . . . . 0.0 109.572 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.47 29.04 72.91 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -71.65 127.32 32.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.086 -1.244 . . . . 0.0 109.763 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -97.6 110.72 56.25 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.7 Cg_endo -85.61 129.33 3.59 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.752 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.2 t -55.17 168.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.762 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -55.44 -37.7 68.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.739 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -70.41 -58.56 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.729 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.752 ' H ' HG23 ' A' ' 67' ' ' THR . . . -63.76 -23.33 67.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.39 -0.819 . . . . 0.0 109.117 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.531 ' HA ' HD12 ' A' ' 74' ' ' LEU . 4.1 ttt180 -69.71 -42.73 73.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -73.41 -10.04 59.32 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.49 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.1 mt -98.22 -24.89 15.08 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 108.623 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 71' ' ' ARG . 17.9 mt -71.11 -30.43 66.51 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 10.3 ptm180 -77.78 -28.8 50.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 9.2 tp-100 -76.42 -37.22 57.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.055 0.931 . . . . 0.0 109.581 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -75.15 -1.28 22.42 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.059 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 50.33 11.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 53' ' ' VAL . 40.2 t -99.33 -49.94 11.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.301 -1.117 . . . . 0.0 111.721 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 5.4 m-30 -57.86 -32.71 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.118 -0.989 . . . . 0.0 110.421 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 154.68 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -70.25 160.3 32.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -132.21 153.03 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.21 178.97 8.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.14 -0.975 . . . . 0.0 110.565 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -111.02 61.79 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.319 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -52.17 169.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.37 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.49 83.14 0.18 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.187 -1.184 . . . . 0.0 110.203 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptm . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.302 0.572 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.684 HG11 ' CE3' ' A' ' 59' ' ' TRP . 47.9 t -95.16 147.55 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.084 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -140.5 133.1 28.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.85 HD11 ' CB ' ' A' ' 59' ' ' TRP . 68.8 mt -100.26 134.89 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.013 -1.054 . . . . 0.0 109.409 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.7 ptm180 -151.19 -172.72 4.29 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.1 -1.0 . . . . 0.0 110.928 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 70' ' ' ALA . 4.5 mp -89.37 125.87 35.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.379 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.649 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.21 112.87 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.364 -0.835 . . . . 0.0 110.562 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -81.48 122.26 27.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.116 . . . . 0.0 112.892 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.649 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 2.0 m-85 -119.08 -152.97 0.52 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.668 -0.645 . . . . 0.0 109.324 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 102.46 0.01 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -55.49 -42.23 74.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -1.135 . . . . 0.0 109.368 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -176.64 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 109.41 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -123.74 -51.41 1.82 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -0.864 . . . . 0.0 109.741 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.49 138.56 13.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.15 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.46 122.85 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.611 1.321 . . . . 0.0 110.855 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.0 p80 -174.94 124.89 0.26 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 9.3 m-30 -113.78 153.33 29.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.746 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.542 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 2.0 mtt85 -101.35 162.18 13.08 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.26 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.03 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.93 80.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -97.46 164.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.907 -173.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.932 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.36 112.64 40.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t -140.54 -171.17 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.974 -1.079 . . . . 0.0 110.598 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.1 p-10 -78.6 -159.81 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.335 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.83 46.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -173.88 61.35 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.198 -0.939 . . . . 0.0 110.554 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.22 148.3 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.141 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -134.25 57.94 1.79 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.364 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 -60.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -92.73 39.71 1.04 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.65 139.87 41.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.16 95.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -1.138 . . . . 0.0 110.059 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.4 p90 -55.56 178.72 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.697 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.736 HG21 ' HH2' ' A' ' 59' ' ' TRP . 13.3 mm -92.25 -50.2 12.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -157.69 179.19 9.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -106.86 107.23 18.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.292 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 56' ' ' ALA . 20.7 pt -100.55 -39.08 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.146 -0.971 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.819 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -118.2 166.35 12.81 Favored Glycine 0 C--N 1.296 -1.683 0 C-N-CA 118.967 -1.587 . . . . 0.0 112.122 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' N ' HG12 ' A' ' 19' ' ' ILE . 11.4 t80 -140.73 128.79 22.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.03 ' HB2' HD11 ' A' ' 19' ' ' ILE . 38.1 t80 -128.27 142.48 51.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.709 -1.245 . . . . 0.0 109.906 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 20.6 t0 -140.45 103.89 6.53 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 48.5 Cg_endo -76.73 56.71 5.34 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.993 0.996 . . . . 0.0 110.855 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 172.33 8.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.982 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.78 23.79 7.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 t -119.76 -8.5 9.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.963 . . . . 0.0 110.633 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -140.36 128.33 12.71 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.892 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.88 -6.98 19.43 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.437 1.23 . . . . 0.0 110.752 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.02 80.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.568 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 10.8 p-90 -112.43 -1.74 14.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.15 -0.969 . . . . 0.0 110.748 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.599 HD12 ' CD2' ' A' ' 73' ' ' LEU . 9.1 tt -97.35 107.08 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.034 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.18 90.38 3.28 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.682 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.819 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.51 130.93 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.005 . . . . 0.0 111.178 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.0 t0 -78.03 71.01 4.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -35.73 -30.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 122.258 -0.276 . . . . 0.0 111.624 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.8 mt-10 -59.76 -51.03 71.49 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.706 -1.247 . . . . 0.0 108.967 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 27.1 mmm180 -75.52 -38.14 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.263 -0.898 . . . . 0.0 108.713 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.96 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.82 -19.39 65.83 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.2 ttp180 -89.16 -23.81 22.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.808 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.31 -48.71 76.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 123.116 1.436 . . . . 0.0 107.456 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.932 ' CD2' HG11 ' A' ' 21' ' ' VAL . 82.1 m95 -65.29 -56.19 14.1 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.951 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.973 HD11 HD13 ' A' ' 74' ' ' LEU . 35.0 mt -54.55 -21.59 10.69 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.558 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -81.91 -20.45 38.73 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.427 -0.795 . . . . 0.0 110.389 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.8 m -98.7 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.871 -1.143 . . . . 0.0 109.322 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.53 26.61 74.33 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -77.28 115.32 16.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.089 -1.242 . . . . 0.0 109.855 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 126.15 59.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HB3' HD12 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -85.47 162.56 11.04 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.494 1.26 . . . . 0.0 109.483 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 p -83.94 -171.69 3.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.051 -1.031 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.82 48.27 1.42 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.2 m -166.03 -56.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -68.35 -25.62 65.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.4 ttp180 -66.59 -42.25 87.23 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -66.14 -45.81 79.71 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.786 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.599 ' CD2' HD12 ' A' ' 49' ' ' LEU . 51.7 mt -60.29 -31.99 70.77 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.973 HD13 HD11 ' A' ' 60' ' ' LEU . 20.3 mt -69.15 -26.81 65.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.534 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.5 -28.81 30.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.811 0.815 . . . . 0.0 108.82 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -81.84 -36.15 28.6 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.904 0.859 . . . . 0.0 110.062 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.96 -9.21 43.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.751 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.52 48.5 5.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 60' ' ' LEU . 41.4 t -95.3 -66.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.12 -1.224 . . . . 0.0 111.605 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 35.7 m-85 -52.42 -47.97 66.03 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.26 -175.94 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.596 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.12 130.81 51.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.177 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.4 144.15 10.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.412 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.95 -178.96 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -89.61 76.03 7.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.232 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -60.28 2.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.193 -0.942 . . . . 0.0 110.307 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.21 45.44 0.1 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.19 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.325 0.583 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.604 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.2 m -57.93 113.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.839 . . . . 0.0 110.34 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 3.5 mtpt -140.53 133.19 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.216 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.915 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.7 mt -108.34 131.2 59.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.992 -1.068 . . . . 0.0 109.883 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.0 ptm180 -151.08 -169.62 3.44 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.287 -0.883 . . . . 0.0 110.297 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.476 HD22 ' HD2' ' A' ' 39' ' ' TYR . 84.4 mt -89.17 127.69 35.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.519 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.25 102.34 13.95 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.713 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.07 121.76 18.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 112.565 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 4.8 m-85 -122.89 -151.95 0.5 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.464 -0.773 . . . . 0.0 109.379 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 105.5 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 p -56.24 -41.7 76.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 0.0 109.061 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.35 47.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -124.4 -64.86 1.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.283 -0.886 . . . . 0.0 110.1 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -131.33 135.6 27.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -83.54 88.71 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.489 1.258 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.503 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 31.6 p80 -130.93 129.7 42.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 110.108 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 12.4 m-85 -111.5 147.89 34.36 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 108.429 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -99.86 159.08 15.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.312 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.048 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -98.07 81.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -98.47 162.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.024 -174.07 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.866 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -109.29 109.42 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.757 -0.589 . . . . 0.0 110.529 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.5 t -135.7 -169.22 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.983 . . . . 0.0 110.29 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 1.1 t0 -83.8 -176.15 6.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . . . -153.14 43.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.026 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.53 52.74 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -141.0 168.89 18.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 110.359 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -59.79 4.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.938 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -175.28 104.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 110.37 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.83 -36.93 4.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 110.192 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.81 25.8 66.21 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -121.68 140.6 52.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' HG13 ' A' ' 20' ' ' VAL . 23.4 p90 -120.03 168.06 11.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.416 -0.803 . . . . 0.0 110.402 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.616 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.1 mt -70.94 -51.7 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.65 165.45 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -0.774 . . . . 0.0 109.58 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -99.43 116.73 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 109.956 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.005 HG21 ' CD1' ' A' ' 59' ' ' TRP . 44.9 pt -107.18 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 111.152 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.806 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.82 167.94 17.05 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.029 -1.557 . . . . 0.0 112.228 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG12 ' A' ' 19' ' ' ILE . 37.0 t80 -140.67 129.26 22.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.048 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.5 t80 -129.71 134.07 47.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.731 -1.23 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 45.3 t0 -140.19 92.61 9.46 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.919 -1.113 . . . . 0.0 110.884 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.11 85.7 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.575 1.303 . . . . 0.0 110.361 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -96.44 -165.37 1.27 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.209 -0.932 . . . . 0.0 110.442 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -132.77 52.97 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.965 . . . . 0.0 110.197 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.545 HG23 ' N ' ' A' ' 45' ' ' THR . 6.8 t -145.14 -41.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.9 . . . . 0.0 110.565 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.545 ' N ' HG23 ' A' ' 44' ' ' THR . 0.8 OUTLIER -130.14 155.28 81.02 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.624 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 50.6 Cg_endo -78.59 -44.28 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.737 1.388 . . . . 0.0 110.259 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.2 92.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.091 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.837 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -122.43 19.89 10.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.255 -0.903 . . . . 0.0 110.566 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.837 HD13 ' HZ3' ' A' ' 48' ' ' TRP . 8.5 tp -116.48 125.89 52.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.066 . . . . 0.0 110.926 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.05 94.64 3.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 109.217 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.806 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.04 149.87 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -94.81 70.51 3.44 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -32.72 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -60.29 -56.02 26.56 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.802 -1.186 . . . . 0.0 109.159 178.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.743 ' HB3' HG22 ' A' ' 36' ' ' ILE . 4.4 mmp_? -69.92 -42.02 73.87 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 108.872 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.743 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -63.15 -18.36 63.37 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.9 ttp180 -87.87 -25.26 23.36 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.642 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.9 t80 -60.38 -45.83 92.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.359 1.552 . . . . 0.0 107.789 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.005 ' CD1' HG21 ' A' ' 36' ' ' ILE . 79.4 m95 -66.11 -54.48 25.03 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.94 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 60' ' ' LEU . 18.9 mt -54.97 -21.47 11.89 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.495 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 6.5 t -81.46 -23.16 37.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 110.694 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 58' ' ' TYR . 5.5 m -98.96 32.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.797 -1.189 . . . . 0.0 109.568 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.93 29.47 72.48 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.604 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -67.78 135.45 52.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.076 -1.25 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 109.06 61.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 110.389 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 71' ' ' ARG . 53.8 Cg_endo -79.13 128.3 8.14 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.619 1.326 . . . . 0.0 109.871 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 70' ' ' ALA . 7.9 t -54.22 171.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.11 -0.994 . . . . 0.0 110.204 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.47 54.98 0.78 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -167.25 -56.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.5 -24.22 66.36 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HA ' HD12 ' A' ' 74' ' ' LEU . 20.2 ttt85 -67.4 -40.92 85.62 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -42.99 80.33 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.776 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.697 ' HB3' HD21 ' A' ' 49' ' ' LEU . 15.2 mt -67.08 -27.08 67.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.675 HD23 HG21 ' A' ' 79' ' ' VAL . 13.7 mt -69.82 -28.47 65.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.516 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -78.77 -30.54 45.71 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -80.39 -31.84 37.67 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.944 0.878 . . . . 0.0 109.993 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -75.4 -2.13 27.14 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.402 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.5 51.64 9.43 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.675 HG21 HD23 ' A' ' 74' ' ' LEU . 52.6 t -98.95 -60.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.271 -1.134 . . . . 0.0 111.872 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 43.5 m-85 -53.04 155.06 2.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.148 -0.97 . . . . 0.0 110.291 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -149.71 71.63 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.373 -0.83 . . . . 0.0 110.172 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.75 147.07 23.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.881 . . . . 0.0 110.212 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -162.28 150.5 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.88 -174.03 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -121.18 119.26 31.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -169.33 69.56 0.07 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.58 25.8 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.11 . . . . 0.0 110.347 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.342 0.592 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 2' ' ' VAL . 15.9 m -53.82 105.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -140.2 132.83 28.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.425 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.955 HD11 ' CB ' ' A' ' 59' ' ' TRP . 65.8 mt -107.62 133.52 52.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.044 -1.035 . . . . 0.0 110.05 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptm180 -151.07 -173.15 4.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.278 -0.889 . . . . 0.0 110.437 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 70' ' ' ALA . 3.7 mp -89.38 125.49 35.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.447 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.46 107.42 19.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.473 -0.767 . . . . 0.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 36.7 ttp85 -76.02 115.75 16.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 112.936 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.2 m-85 -120.38 -152.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.252 -0.905 . . . . 0.0 108.917 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 116.99 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -63.97 -81.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 109.88 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.5 46.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.465 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 3.9 m-70 -134.81 -65.84 0.61 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.792 . . . . 0.0 109.924 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -120.16 105.31 42.45 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -77.43 116.46 4.11 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.479 1.252 . . . . 0.0 111.041 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.508 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 28.1 p80 -152.16 138.73 18.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.373 -0.829 . . . . 0.0 109.339 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 9.8 m-85 -112.73 165.03 12.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.231 -0.918 . . . . 0.0 108.688 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.2 mtp85 -121.83 156.02 34.13 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.964 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 79.56 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.255 0.4 OUTLIER -97.95 159.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.5 -173.912 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.867 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -107.92 106.03 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.334 0.587 . . . . 0.0 110.387 -177.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t -131.59 -167.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.893 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' N ' ' OG1' ' A' ' 22' ' ' THR . 46.2 p-10 -119.07 176.0 5.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.54 -52.64 4.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 119.53 9.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 110.521 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 113.24 7.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -63.59 -76.13 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.907 . . . . 0.0 110.482 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -119.48 -20.14 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.95 147.87 52.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.66 69.42 0.53 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.44 121.34 30.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -1.121 . . . . 0.0 110.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.533 ' HB3' HG13 ' A' ' 20' ' ' VAL . 32.1 p90 -58.53 150.08 23.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 110.68 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.595 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.3 mt -56.15 -51.93 56.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.565 -0.71 . . . . 0.0 109.204 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.92 149.46 26.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -89.66 119.29 29.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.977 HG21 ' CD1' ' A' ' 59' ' ' TRP . 27.7 pt -105.88 -34.14 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.489 -0.757 . . . . 0.0 111.738 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.821 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -120.64 169.33 14.12 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 119.118 -1.515 . . . . 0.0 112.26 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG12 ' A' ' 19' ' ' ILE . 86.8 t80 -140.46 127.33 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.964 ' HB2' HD11 ' A' ' 19' ' ' ILE . 44.7 t80 -121.28 142.29 50.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.815 -1.178 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 6.2 t0 -140.79 104.38 6.31 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 45.9 Cg_endo -74.98 75.84 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.319 1.168 . . . . 0.0 110.759 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.87 124.18 34.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.156 -0.965 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 43.87 1.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.3 p -133.36 -53.47 0.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.6 p -124.84 146.98 54.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.029 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.82 57.76 5.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.53 1.279 . . . . 0.0 110.631 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -150.31 120.69 7.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.88 . . . . 0.0 109.871 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.584 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 22.1 p-90 -175.22 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.211 -0.93 . . . . 0.0 110.609 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.528 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 5.6 tt -62.95 109.7 1.55 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 110.597 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -131.47 94.66 3.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.293 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.821 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.8 148.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 111.043 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -92.38 70.65 5.15 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.684 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -36.47 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 122.224 -0.297 . . . . 0.0 111.481 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 7.2 mm-40 -61.1 -53.25 59.44 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.693 -1.254 . . . . 0.0 108.522 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -71.29 -40.59 70.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.7 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.65 -16.56 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.1 ttt-85 -88.64 -26.3 21.96 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 62' ' ' VAL . 13.2 t80 -59.43 -42.63 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 123.212 1.482 . . . . 0.0 107.382 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.977 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.3 m95 -69.63 -54.24 14.91 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.13 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 79' ' ' VAL . 7.4 mt -56.56 -20.9 23.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.468 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -80.72 -24.56 38.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.426 -0.796 . . . . 0.0 110.517 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 59' ' ' TRP . 27.3 m -99.01 32.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.879 -1.138 . . . . 0.0 109.606 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.02 31.48 79.57 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -60.99 146.99 45.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.242 . . . . 0.0 110.017 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 2.0 mm-40 -108.88 93.82 13.25 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.43 -0.794 . . . . 0.0 110.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 54.9 Cg_endo -80.34 124.79 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.48 1.253 . . . . 0.0 109.923 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.8 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.7 t -57.82 163.58 2.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.944 -1.097 . . . . 0.0 109.702 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -57.88 -22.87 50.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.3 m -84.55 -53.71 5.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.862 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.8 ' H ' HG23 ' A' ' 67' ' ' THR . . . -70.8 -29.45 65.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -66.9 -37.35 84.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -26.85 67.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.0 mt -86.37 -30.39 22.2 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.541 -0.724 . . . . 0.0 109.247 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 56' ' ' ALA . 80.7 mt -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG3' ' CD1' ' A' ' 80' ' ' PHE . 2.0 mtp85 -78.24 -30.43 48.71 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.1 tp-100 -79.11 -33.58 44.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.942 0.877 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.17 -9.43 52.87 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.704 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 87.48 52.34 3.05 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.684 HG22 ' CB ' ' A' ' 53' ' ' VAL . 40.2 t -115.53 -0.79 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.058 -1.26 . . . . 0.0 111.519 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CD1' ' HG3' ' A' ' 75' ' ' ARG . 11.5 m-85 -115.63 87.66 2.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.843 -1.161 . . . . 0.0 110.38 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -135.22 119.71 18.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -119.89 64.45 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.912 . . . . 0.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -159.22 89.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.22 128.29 6.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.335 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 77.66 8.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.31 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -70.28 -71.49 0.24 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 110.424 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.19 -63.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.131 . . . . 0.0 110.255 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.602 HG11 ' CE3' ' A' ' 59' ' ' TRP . 50.2 t -78.12 128.65 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.982 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -140.16 138.73 35.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.554 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.945 ' CG1' HG13 ' A' ' 21' ' ' VAL . 86.0 mt -103.25 130.92 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.29 -0.881 . . . . 0.0 109.343 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.75 -172.0 4.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 110.65 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 69' ' ' THR . 5.0 mp -88.97 125.56 35.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.425 -0.797 . . . . 0.0 110.469 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.55 112.51 24.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.56 -0.712 . . . . 0.0 109.797 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.3 124.42 28.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 112.675 -178.313 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.681 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m-85 -126.08 -154.43 0.62 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.01 138.55 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.437 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -75.54 -80.52 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.591 -0.947 . . . . 0.0 109.389 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 8.8 mtmt -149.44 57.04 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 5.3 m-70 -143.37 -56.1 0.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.298 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.05 112.25 28.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.412 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.76 112.38 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.538 1.283 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.6 p80 -151.95 132.08 13.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 8.5 m-85 -114.07 153.04 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.546 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 1.5 ttm180 -104.55 153.52 21.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.148 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.957 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -98.53 78.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.272 0.4 OUTLIER -97.98 166.17 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.527 -173.684 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.945 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.36 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.755 -0.59 . . . . 0.0 110.51 -177.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.0 t -137.45 -166.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.4 m-20 -118.29 167.93 11.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.369 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.78 -33.17 6.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -52.3 -27.23 14.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.44 135.49 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.128 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -125.67 -6.81 6.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -93.87 0.22 56.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.871 -1.143 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 126.15 4.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.02 -1.05 . . . . 0.0 110.187 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.84 29.55 9.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -73.1 144.11 47.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -1.181 . . . . 0.0 110.252 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CD2' HG21 ' A' ' 20' ' ' VAL . 17.0 p90 -110.46 155.5 22.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.953 . . . . 0.0 110.418 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.71 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.8 mp -58.87 -53.35 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -149.75 173.74 13.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -109.93 119.7 40.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.951 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 56' ' ' ALA . 21.7 pt -110.7 -38.81 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.049 -1.032 . . . . 0.0 111.656 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.807 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.1 167.83 14.11 Favored Glycine 0 C--N 1.295 -1.72 0 C-N-CA 118.897 -1.621 . . . . 0.0 111.45 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.7 t80 -137.23 141.17 42.06 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.59 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 25.5 t80 -138.5 139.27 38.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.75 -1.218 . . . . 0.0 110.718 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.8 t0 -139.62 104.69 6.98 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 43.8 Cg_endo -72.82 70.3 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 122.985 0.992 . . . . 0.0 110.375 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.81 138.65 31.3 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -98.98 33.54 2.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.519 HG23 ' N ' ' A' ' 45' ' ' THR . 8.8 t -132.65 -40.07 0.98 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.315 -0.866 . . . . 0.0 110.139 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.519 ' N ' HG23 ' A' ' 44' ' ' THR . 22.3 p -135.87 135.5 21.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.17 -9.56 23.46 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.678 1.357 . . . . 0.0 110.926 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.42 64.82 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.636 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.59 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 26.4 p-90 -124.72 -10.07 7.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.994 -1.066 . . . . 0.0 111.132 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 49' ' ' LEU . 10.1 tt -91.94 109.6 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.12 . . . . 0.0 110.557 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 3.7 mmmt -126.88 103.76 7.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.957 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -127.32 149.0 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.877 -1.139 . . . . 0.0 111.4 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.8 t0 -97.56 70.45 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.627 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -33.77 -32.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 120.562 0.22 . . . . 0.0 111.435 -177.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.4 tt0 -60.99 -53.98 50.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.822 -1.173 . . . . 0.0 108.865 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 48.0 mmm-85 -73.72 -38.37 64.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.27 -21.35 66.56 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -89.2 -24.11 22.22 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.104 -0.997 . . . . 0.0 109.932 178.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.546 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -59.01 -49.6 77.26 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 123.269 1.509 . . . . 0.0 107.197 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.885 ' CD2' HG11 ' A' ' 21' ' ' VAL . 84.6 m95 -62.56 -52.29 64.0 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.265 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.885 HD11 HD13 ' A' ' 74' ' ' LEU . 4.0 mt -54.24 -22.41 11.58 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.338 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -80.81 -22.08 40.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 110.743 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.5 m -98.93 33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 120.823 -1.173 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.28 28.17 72.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -68.21 134.01 49.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -1.228 . . . . 0.0 110.081 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.19 109.09 59.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HG3' HD21 ' A' ' 60' ' ' LEU . 51.4 Cg_endo -84.59 126.86 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.616 1.324 . . . . 0.0 110.352 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.753 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.3 t -60.51 173.41 0.71 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 109.89 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -58.21 -27.83 64.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 111.103 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' HD13 ' A' ' 6' ' ' LEU . 1.8 m -83.13 -52.08 6.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.762 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.753 ' H ' HG23 ' A' ' 67' ' ' THR . . . -68.67 -26.47 65.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 67' ' ' THR . 2.4 ttt-85 -68.2 -38.65 82.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -45.22 80.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' CD2' HD12 ' A' ' 49' ' ' LEU . 59.6 mt -65.88 -25.76 67.33 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.885 HD13 HD11 ' A' ' 60' ' ' LEU . 17.2 mt -74.4 -26.06 59.85 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.544 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -84.24 -29.38 26.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.174 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -84.29 -36.08 22.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.823 0.82 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.14 41.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.06 57.14 2.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.635 HG21 HD23 ' A' ' 74' ' ' LEU . 21.7 t -109.77 -59.31 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.176 -1.191 . . . . 0.0 111.092 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.7 m-30 -51.49 -24.48 5.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.112 -0.993 . . . . 0.0 110.499 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -111.86 105.07 13.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.642 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.81 117.54 30.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.788 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 -153.1 0.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.375 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.76 172.66 6.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 26.65 2.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.135 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -57.56 12.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.69 43.9 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.235 -1.156 . . . . 0.0 110.205 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.167 0.508 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.538 HG11 ' CE3' ' A' ' 59' ' ' TRP . 66.3 t -77.23 133.38 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.72 ' C ' HD13 ' A' ' 4' ' ' ILE . 12.9 mtpt -134.04 128.75 34.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.303 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.999 HD12 HG13 ' A' ' 21' ' ' VAL . 1.3 mm -103.74 133.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.551 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 16.5 ptm180 -151.0 177.65 9.95 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.889 -1.132 . . . . 0.0 110.858 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 pp -89.55 132.17 35.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.892 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.05 157.81 16.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.56 -0.712 . . . . 0.0 109.232 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 tmm_? -124.29 109.31 13.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.889 -1.132 . . . . 0.0 111.315 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -119.63 -151.44 0.48 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.897 . . . . 0.0 109.247 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.93 56.64 2.42 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 37.8 p -54.37 -56.74 15.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -1.219 . . . . 0.0 109.714 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . 22.3 mttp -146.14 54.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.4 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.3 m-70 -141.55 -63.43 0.45 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.347 -0.846 . . . . 0.0 109.817 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -165.26 142.15 4.76 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 0.0 109.81 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.09 107.58 2.4 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.64 1.337 . . . . 0.0 111.34 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 27.5 p80 -150.45 147.35 27.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.288 -0.882 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 8' ' ' ARG . 14.0 m-85 -121.74 173.06 7.7 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -137.24 150.83 48.11 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.01 -1.056 . . . . 0.0 108.301 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -97.06 85.95 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 178.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.646 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -98.49 168.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.634 -173.158 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.032 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.7 t -113.81 102.78 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.694 -0.629 . . . . 0.0 110.776 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.6 t -132.45 -173.87 3.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.349 -0.844 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.4 p30 -83.01 -160.33 0.4 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 110.381 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.14 -36.92 12.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.1 131.25 30.24 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.29 -0.881 . . . . 0.0 110.334 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 175.49 10.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 110.146 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -63.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 110.28 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -90.83 -37.45 13.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.999 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.3 140.25 22.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.49 51.97 1.56 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -112.1 115.49 28.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -1.146 . . . . 0.0 110.445 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.646 ' CD2' HG21 ' A' ' 20' ' ' VAL . 12.8 p90 -62.95 166.0 6.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.887 . . . . 0.0 110.289 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.3 -58.63 6.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -145.08 173.91 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.012 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -110.42 115.34 29.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.202 -0.936 . . . . 0.0 109.572 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.973 HD12 ' HA ' ' A' ' 56' ' ' ALA . 18.1 pt -108.98 -40.01 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.108 -0.995 . . . . 0.0 111.243 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.89 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -111.76 167.05 12.31 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.112 -1.518 . . . . 0.0 112.225 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 19' ' ' ILE . 87.5 t80 -140.8 126.18 18.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.804 ' HB2' HD11 ' A' ' 19' ' ' ILE . 13.9 t80 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.726 -1.234 . . . . 0.0 110.046 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 3.2 t0 -140.41 104.94 6.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.071 -1.018 . . . . 0.0 109.848 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 49.8 Cg_endo -77.62 80.1 3.03 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.213 1.112 . . . . 0.0 110.765 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -92.15 158.25 16.28 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.043 -1.036 . . . . 0.0 110.294 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 40.02 2.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.418 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -115.31 -73.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 110.053 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.4 p -127.82 156.26 76.1 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.019 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.06 63.49 4.15 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.658 1.346 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -154.56 80.79 1.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 9.5 p-90 -134.41 -29.24 1.23 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.936 . . . . 0.0 111.38 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -57.24 123.41 15.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -133.36 101.6 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.517 -0.74 . . . . 0.0 109.264 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.89 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -129.22 135.25 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 111.412 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.1 t0 -77.62 70.06 3.95 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.699 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -35.91 -30.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 122.276 -0.265 . . . . 0.0 111.286 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.2 -53.44 57.63 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.834 -1.166 . . . . 0.0 108.723 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmm180 -74.0 -38.17 64.18 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.973 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.23 -17.57 63.7 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.0 ttt180 -89.19 -25.58 21.71 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.282 -0.886 . . . . 0.0 109.324 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.952 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.59 -44.68 93.29 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 123.575 1.655 . . . . 0.0 106.953 178.145 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.032 ' CD2' HG11 ' A' ' 21' ' ' VAL . 80.5 m95 -67.23 -59.5 3.38 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.003 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 74' ' ' LEU . 3.9 mt -54.04 -21.88 9.38 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.826 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 30.6 t -81.27 -19.07 43.83 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.427 -0.796 . . . . 0.0 110.262 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.62 32.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.843 -1.161 . . . . 0.0 109.214 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.33 25.49 75.42 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HB1' ' CG1' ' A' ' 4' ' ' ILE . . . -70.68 126.57 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.178 -1.19 . . . . 0.0 110.026 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.31 111.35 53.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.699 ' HG3' HD21 ' A' ' 60' ' ' LEU . 51.9 Cg_endo -80.86 131.23 7.95 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.48 1.253 . . . . 0.0 110.332 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.9 p -56.92 159.17 4.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.61 -34.23 50.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.991 . . . . 0.0 111.581 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.402 ' HB ' HD23 ' A' ' 6' ' ' LEU . 5.3 m -83.68 -49.9 8.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 111.191 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.26 -22.98 61.9 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.253 -0.904 . . . . 0.0 109.264 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -70.97 -36.14 72.41 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -33.4 74.74 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.3 mt -75.17 -30.24 60.65 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.573 -0.704 . . . . 0.0 109.172 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.864 HD13 HD11 ' A' ' 60' ' ' LEU . 16.1 mt -68.03 -29.43 68.41 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.453 ' HG2' ' CD1' ' A' ' 80' ' ' PHE . 2.7 tmm_? -77.68 -31.03 52.23 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.54 ' HB3' HD13 ' A' ' 49' ' ' LEU . 3.5 tp-100 -77.49 -28.54 52.24 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.986 0.898 . . . . 0.0 109.391 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.07 -8.79 48.44 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.225 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.99 31.43 11.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 53' ' ' VAL . 47.4 t -92.14 -64.98 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -1.166 . . . . 0.0 110.651 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.453 ' CD1' ' HG2' ' A' ' 75' ' ' ARG . 18.8 p90 -133.87 -172.45 2.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.69 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.451 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -117.25 169.28 9.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -70.5 107.65 3.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -130.31 125.35 34.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.128 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.58 101.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 0.0 110.415 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -92.12 68.85 5.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 109.879 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.07 128.22 23.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.5 174.36 2.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.264 -1.139 . . . . 0.0 110.256 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.225 0.536 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 64' ' ' ALA . 17.1 m -74.48 115.9 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 110.588 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.2 ptmt -140.73 138.99 34.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.045 -1.034 . . . . 0.0 110.42 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.939 HG13 HG13 ' A' ' 21' ' ' VAL . 4.5 mt -103.84 135.32 42.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.048 -1.032 . . . . 0.0 108.681 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -150.64 -170.42 3.65 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.861 -1.149 . . . . 0.0 110.777 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -89.03 129.22 35.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -102.85 108.47 19.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 111.453 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 8.6 ttp180 -77.94 122.77 25.95 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.99 -1.069 . . . . 0.0 111.009 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 12.6 m-85 -109.2 -64.66 1.22 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.481 -0.762 . . . . 0.0 110.889 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.93 124.59 10.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 p -66.84 -38.35 86.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -1.104 . . . . 0.0 109.544 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' CD ' ' O ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -178.11 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -123.44 -49.98 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 109.561 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -141.57 126.92 10.81 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.538 -0.726 . . . . 0.0 109.568 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.34 106.19 2.19 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.318 1.167 . . . . 0.0 111.017 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.499 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.3 p80 -161.25 122.96 2.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.851 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 6.5 m-30 -116.99 152.87 33.69 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 108.511 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.626 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -102.85 166.89 10.21 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.058 176.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.925 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.11 85.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.26 0.4 OUTLIER -99.21 164.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.283 -175.011 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.972 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.3 t -107.9 110.87 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 109.961 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t -137.1 -170.7 2.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 110.505 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.8 p30 -143.01 148.12 36.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.81 11.16 39.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.8 50.32 0.97 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.087 -1.008 . . . . 0.0 110.45 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -165.66 76.72 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.38 67.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.287 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -135.91 -42.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -139.78 -59.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 39.03 4.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -103.67 121.55 43.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -1.131 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.509 ' CD2' HG21 ' A' ' 20' ' ' VAL . 7.8 p90 -55.52 170.24 0.26 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 110.47 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.82 -41.93 13.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.573 -0.704 . . . . 0.0 109.303 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.9 tt0 -151.17 150.35 30.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.117 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HG2' ' HD2' ' A' ' 18' ' ' ARG . 3.7 mtpp -96.46 118.88 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.975 . . . . 0.0 109.91 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.672 HD12 ' CB ' ' A' ' 56' ' ' ALA . 43.3 pt -99.84 -27.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 111.756 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -150.64 -174.41 21.66 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.001 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 36.7 t80 -140.83 147.45 39.03 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.872 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.925 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.2 t80 -140.21 132.89 28.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.588 -1.32 . . . . 0.0 109.664 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 27.4 t0 -139.13 97.75 8.58 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.896 -1.127 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.48 72.04 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.657 1.346 . . . . 0.0 110.831 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.51 171.68 8.22 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.205 -0.935 . . . . 0.0 110.069 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 39.92 2.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 p -110.46 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.063 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.7 p -128.12 157.64 73.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.31 -42.32 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.657 1.346 . . . . 0.0 110.016 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.47 99.49 5.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 109.958 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.708 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 1.7 p-90 -122.41 17.14 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.917 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.807 HD21 ' HB3' ' A' ' 73' ' ' LEU . 11.5 tp -118.9 138.53 52.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.988 -1.07 . . . . 0.0 110.789 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -140.1 72.95 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.48 -0.762 . . . . 0.0 110.199 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.772 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -94.69 129.44 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.274 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.6 t0 -73.88 70.12 1.44 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.631 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.36 -29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.149 -0.344 . . . . 0.0 111.606 -177.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -62.99 -55.89 21.81 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.619 -1.301 . . . . 0.0 109.082 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -0.872 . . . . 0.0 108.994 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.672 ' CB ' HD12 ' A' ' 36' ' ' ILE . . . -73.38 -22.93 60.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.947 -1.096 . . . . 0.0 108.082 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttt85 -86.0 -21.35 27.86 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.142 -0.974 . . . . 0.0 108.912 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.972 ' CD2' HG11 ' A' ' 21' ' ' VAL . 81.4 m95 -61.55 -53.33 57.75 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.316 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -52.67 -22.71 5.44 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -22.32 42.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.546 -0.721 . . . . 0.0 110.434 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.4 m -98.85 32.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.74 -1.225 . . . . 0.0 109.52 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.19 27.26 73.11 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -67.95 134.31 50.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.152 -1.205 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -105.94 105.65 54.1 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.3 Cg_endo -79.07 129.51 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.607 1.319 . . . . 0.0 110.051 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.756 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.0 t -58.45 165.8 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.47 -27.89 58.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.164 -0.96 . . . . 0.0 111.515 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -82.24 -52.7 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.934 -1.104 . . . . 0.0 110.806 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 67' ' ' THR . . . -69.49 -26.49 64.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.326 -0.859 . . . . 0.0 108.721 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -66.52 -38.45 87.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -41.16 90.38 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.954 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.807 ' HB3' HD21 ' A' ' 49' ' ' LEU . 14.7 mt -71.13 -27.2 63.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.783 HD23 HG21 ' A' ' 79' ' ' VAL . 12.9 mt -70.52 -27.83 64.48 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.96 -32.83 51.64 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -79.94 -29.34 39.69 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.981 0.896 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 79' ' ' VAL . . . -74.27 -4.47 36.29 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.866 -0.521 . . . . 0.0 110.257 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.53 39.46 30.07 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.783 HG21 HD23 ' A' ' 74' ' ' LEU . 48.2 t -92.39 -35.46 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.282 -1.128 . . . . 0.0 111.459 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.53 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 7.0 m-30 -80.07 103.64 10.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.559 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -89.97 97.46 11.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.871 . . . . 0.0 110.013 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.05 119.73 3.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.378 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.52 92.31 4.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 110.116 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.1 117.42 32.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.387 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.13 121.33 41.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.3 29.25 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.09 -63.85 0.46 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.399 -1.059 . . . . 0.0 110.072 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.645 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 12.7 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.301 0.572 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.452 HG11 ' HE3' ' A' ' 59' ' ' TRP . 60.8 t -84.75 120.57 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.296 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 2.1 mtpt -140.49 129.72 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.784 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.983 ' CG1' HG13 ' A' ' 21' ' ' VAL . 52.1 mt -101.22 132.09 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.06 -1.025 . . . . 0.0 109.132 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.12 -169.47 3.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 110.95 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.7 mp -88.8 125.89 35.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.0 108.51 20.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.756 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.559 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.4 ttt-85 -77.82 121.39 24.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.023 -1.048 . . . . 0.0 111.592 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 13.7 m-85 -113.84 -64.23 1.34 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.606 0.717 . . . . 0.0 110.301 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.69 132.16 39.93 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 34.7 p -87.24 -57.49 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -1.138 . . . . 0.0 109.868 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' N ' ' OG ' ' A' ' 11' ' ' SER . 5.6 mtmt -146.15 42.54 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -0.763 . . . . 0.0 109.092 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -128.53 -50.53 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.483 -0.761 . . . . 0.0 109.48 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -147.79 114.3 4.02 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.642 -0.661 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.79 86.23 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.493 1.259 . . . . 0.0 111.104 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.3 p80 -134.06 125.31 27.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.094 -1.004 . . . . 0.0 110.573 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 11.7 m-30 -114.48 151.24 33.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 5.5 mtp180 -101.46 160.38 14.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.86 -1.536 . . . . 0.0 108.021 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.893 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -98.83 79.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.253 0.4 OUTLIER -97.82 160.63 3.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.886 -174.236 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.983 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -102.73 121.08 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.872 HG22 ' HB3' ' A' ' 32' ' ' TYR . 7.1 p -119.51 -177.81 3.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.943 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -96.61 -169.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.246 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' A' ' 1' ' ' MET . . . -148.2 -47.05 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 110.327 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.51 75.72 5.02 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.098 -1.001 . . . . 0.0 110.481 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -168.93 -158.95 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.287 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -157.32 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.6 84.19 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.326 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.4 -60.36 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.901 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.23 -46.26 1.7 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' A' ' 32' ' ' TYR . 31.2 pttt -67.14 -166.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -1.209 . . . . 0.0 110.346 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.872 ' HB3' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -148.54 -170.78 3.69 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.668 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.8 mt -92.17 -37.43 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.538 -0.727 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -174.6 153.94 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 109.824 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -94.43 116.0 28.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.007 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.869 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.5 pt -103.02 -32.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.811 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.41 169.03 16.44 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 119.218 -1.467 . . . . 0.0 111.341 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' ILE . 48.0 t80 -140.15 134.64 31.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.0 t80 -133.6 131.24 39.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 110.121 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 44.0 t0 -140.29 86.09 13.05 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.581 -1.325 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.05 66.98 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.533 1.28 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 150.49 22.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.892 . . . . 0.0 109.83 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 38.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 110.272 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 45' ' ' THR . 6.9 t -138.09 -41.2 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 44' ' ' THR . 7.4 p -108.54 131.62 21.65 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.998 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.26 -44.51 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.505 1.266 . . . . 0.0 110.493 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.76 90.83 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.404 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.5 p-90 -115.16 -4.26 12.48 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 73' ' ' LEU . 8.3 tt -93.37 106.94 18.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.922 -1.111 . . . . 0.0 110.403 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -122.85 96.59 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.484 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.893 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -120.86 151.04 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 111.499 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.4 t70 -96.88 67.87 2.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.62 -31.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.038 -177.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 27.4 tt0 -62.34 -56.84 14.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.729 -1.232 . . . . 0.0 109.012 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 13.5 mmm180 -72.77 -35.54 67.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.46 -20.78 66.39 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 34.8 ttt85 -88.25 -25.05 23.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.94 -46.72 88.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.152 1.453 . . . . 0.0 107.301 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.959 ' HB3' HD11 ' A' ' 4' ' ' ILE . 87.5 m95 -65.4 -55.52 17.61 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.814 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.8 HD11 HD13 ' A' ' 74' ' ' LEU . 6.4 mt -53.42 -22.6 8.0 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.529 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 8.0 t -82.81 -19.62 37.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.394 -0.816 . . . . 0.0 110.568 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.3 m -98.98 32.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 120.798 -1.189 . . . . 0.0 109.272 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.87 72.93 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -71.42 134.91 46.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 7.1 mt-30 -101.79 108.12 54.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.8 Cg_endo -81.27 140.74 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.536 1.282 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -73.24 169.27 17.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 109.744 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.01 -18.47 34.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.775 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.435 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 3.5 m -95.07 -49.68 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.021 . . . . 0.0 110.515 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.68 -25.48 62.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.343 -0.848 . . . . 0.0 108.768 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -69.12 -35.4 76.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -67.19 -34.47 77.58 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 70' ' ' ALA . 31.6 mt -73.84 -28.0 61.38 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.587 -0.696 . . . . 0.0 109.514 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 60' ' ' LEU . 54.0 mt -71.96 -27.25 62.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -81.49 -30.5 33.26 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -82.51 -38.33 23.99 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.788 0.804 . . . . 0.0 110.015 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -64.23 -12.15 38.15 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.817 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.93 36.41 8.44 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.581 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.9 t -87.02 -59.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.273 . . . . 0.0 111.324 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.541 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.2 m-30 -53.44 122.08 8.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 110.225 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -48.44 9.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -140.83 143.92 35.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -127.44 161.77 27.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.387 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.05 93.01 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.529 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -117.35 50.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.843 . . . . 0.0 109.954 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -160.26 -62.95 0.07 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.94 -121.39 6.91 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.352 -1.087 . . . . 0.0 110.116 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.259 0.552 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.1 m -149.08 116.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.246 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 9.3 mtpt -140.32 136.66 33.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.868 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.918 ' CG1' HD11 ' A' ' 36' ' ' ILE . 1.1 mp -99.62 119.13 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.4 ptt85 -150.33 -179.79 7.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.987 -1.07 . . . . 0.0 110.906 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.0 mp -88.91 124.73 34.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.279 -0.888 . . . . 0.0 111.024 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.7 100.84 11.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.414 -0.804 . . . . 0.0 111.687 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 47.3 ttt180 -67.92 120.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 36.3 m-85 -108.72 -60.9 1.68 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.06 130.05 6.8 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 28.7 p -81.52 -59.39 2.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -1.03 . . . . 0.0 110.045 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -142.73 40.01 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.4 -0.813 . . . . 0.0 109.128 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -127.9 -65.14 0.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 109.609 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 33.3 m120 -136.81 110.42 9.38 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.544 -0.723 . . . . 0.0 109.354 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -70.88 59.1 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.548 1.289 . . . . 0.0 111.396 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 31.5 p80 -95.36 135.31 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 109.524 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 3.5 m-85 -117.84 155.99 29.16 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.751 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 10.1 mmt180 -100.05 156.22 17.29 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.677 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.957 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.4 mt -98.55 77.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.256 0.3 OUTLIER -97.06 176.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.273 -172.869 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.981 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -120.44 115.77 48.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.367 0.603 . . . . 0.0 109.947 -177.384 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -139.35 -177.12 4.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OG1' ' A' ' 22' ' ' THR . 8.2 p-10 -116.96 154.75 30.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.778 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.33 19.25 18.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -75.48 -23.07 56.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -122.65 137.72 54.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.436 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 46.36 2.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -113.48 -62.23 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 110.319 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -106.25 -35.37 7.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.42 94.75 0.18 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 154.21 42.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -1.159 . . . . 0.0 110.062 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -114.96 179.54 3.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.0 111.193 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.4 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.6 mt -95.9 -44.43 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.686 -0.634 . . . . 0.0 110.055 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 166.31 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -101.25 106.79 18.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 110.131 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.947 HG21 ' CD1' ' A' ' 59' ' ' TRP . 16.1 pt -100.12 -34.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.845 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.63 165.41 20.72 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.49 ' N ' HG13 ' A' ' 19' ' ' ILE . 26.9 t80 -139.19 143.45 38.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.925 . . . . 0.0 109.687 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.606 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 13.2 t80 -131.74 132.4 43.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.943 -1.098 . . . . 0.0 109.47 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -140.35 105.54 6.56 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.764 -1.21 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -87.88 41.75 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.554 1.291 . . . . 0.0 110.823 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -89.54 -144.73 0.16 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.955 -1.091 . . . . 0.0 109.727 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' C ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -70.8 62.6 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 43' ' ' LYS . 52.9 p -150.86 97.92 2.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.534 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 19.2 m -88.69 -40.71 0.46 Allowed Pre-proline 0 C--N 1.295 -1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 111.861 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 45' ' ' THR . 52.7 Cg_endo -89.58 -49.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 122.91 0.953 . . . . 0.0 110.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 44' ' ' THR . 61.8 m-20 -106.17 92.08 3.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.251 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.606 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 35.7 p-90 -133.61 6.96 3.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 50' ' ' LYS . 2.3 tm? -122.3 126.94 49.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.976 -1.078 . . . . 0.0 110.29 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.675 ' N ' HD13 ' A' ' 49' ' ' LEU . 3.7 mtpp -130.81 111.0 11.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.071 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.957 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -132.02 144.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.533 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -93.29 70.75 4.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.726 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.04 -31.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -177.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.16 -54.41 46.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.731 -1.23 . . . . 0.0 109.114 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' HB3' HG22 ' A' ' 36' ' ' ILE . 5.5 mtm-85 -74.53 -35.86 63.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.092 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.918 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.71 -20.98 66.09 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.8 ttp85 -89.16 -23.34 22.46 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.52 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -60.63 -49.06 79.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 123.394 1.568 . . . . 0.0 107.091 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.981 ' CD2' HG11 ' A' ' 21' ' ' VAL . 85.0 m95 -63.6 -50.99 67.23 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.3 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.715 ' CD1' HD22 ' A' ' 74' ' ' LEU . 6.5 mt -56.07 -21.03 19.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 176.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.6 t -81.23 -21.68 39.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.368 -0.833 . . . . 0.0 110.436 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.9 m -98.86 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.874 -1.141 . . . . 0.0 109.791 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.97 30.8 76.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -64.76 143.84 57.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -1.209 . . . . 0.0 109.624 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.43 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -106.7 99.37 24.87 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.333 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.1 Cg_endo -79.64 125.0 5.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.697 1.367 . . . . 0.0 110.279 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.774 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.6 t -58.86 170.14 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.826 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.88 -20.01 47.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.149 -0.969 . . . . 0.0 110.892 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.99 -53.42 4.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.181 -0.949 . . . . 0.0 110.386 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.774 ' H ' HG23 ' A' ' 67' ' ' THR . . . -69.31 -27.06 65.06 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 9.1 ttp85 -68.95 -39.26 79.62 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.86 -40.84 87.99 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.782 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.0 mt -70.81 -25.13 62.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 4' ' ' ILE . 12.4 mt -70.51 -29.36 65.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.55 ' HG2' ' CE2' ' A' ' 80' ' ' PHE . 3.6 mtm180 -78.47 -34.4 47.68 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -26.42 37.93 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.739 0.781 . . . . 0.0 110.667 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 79' ' ' VAL . . . -76.19 -1.97 28.95 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.743 -0.598 . . . . 0.0 110.161 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.14 38.03 30.9 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.726 HG22 ' HB ' ' A' ' 53' ' ' VAL . 32.0 t -98.35 -32.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 O-C-N 121.249 -1.148 . . . . 0.0 111.129 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CE2' ' HG2' ' A' ' 75' ' ' ARG . 6.5 m-30 -87.12 -53.26 4.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.67 147.73 22.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.913 . . . . 0.0 110.732 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -173.17 -163.86 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 109.81 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -164.55 137.8 4.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.52 32.49 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.9 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -100.98 -43.59 6.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 110.299 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.06 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.153 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.03 101.44 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.214 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.162 0.506 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.24 114.03 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -140.12 135.84 32.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.215 -0.928 . . . . 0.0 110.75 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.975 HD11 ' CB ' ' A' ' 59' ' ' TRP . 63.1 mt -101.98 135.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 109.232 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 8.7 ptm180 -150.93 178.31 9.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.005 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.5 pp -89.61 131.74 35.46 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.326 -0.949 . . . . 0.0 109.48 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.9 164.02 12.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.525 -0.734 . . . . 0.0 109.056 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -128.38 113.15 15.21 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.913 -1.117 . . . . 0.0 111.562 -179.061 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.99 -152.2 0.51 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.349 -0.845 . . . . 0.0 109.59 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.28 67.12 1.12 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -54.24 -50.68 66.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.171 -1.193 . . . . 0.0 109.834 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -167.12 37.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.481 -0.762 . . . . 0.0 109.527 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 6.8 m-70 -120.38 -57.25 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.52 -0.737 . . . . 0.0 109.293 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.3 135.89 5.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.693 -0.629 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.89 116.82 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.562 1.296 . . . . 0.0 110.863 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 23.1 p80 -158.25 149.31 20.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 110.596 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 8' ' ' ARG . 13.0 m-85 -118.32 172.24 7.59 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 29.3 mtt-85 -135.13 151.22 50.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.881 -1.137 . . . . 0.0 108.986 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.837 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -97.01 82.9 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.281 0.4 OUTLIER -98.38 163.2 2.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.353 -173.785 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.928 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.94 113.47 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.71 . . . . 0.0 110.322 -178.034 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.8 t -140.03 -167.18 2.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.395 -0.815 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' N ' ' OG1' ' A' ' 22' ' ' THR . 75.0 m-20 -95.18 165.35 12.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -0.829 . . . . 0.0 109.989 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . . . -105.11 -50.93 3.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.061 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 59.78 5.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.236 -0.915 . . . . 0.0 110.558 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.8 111.34 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -125.25 21.24 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -87.93 -22.3 24.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.16 -45.96 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.52 70.48 1.25 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 157.99 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -1.16 . . . . 0.0 110.051 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 2.0 p90 -109.32 -175.06 2.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.186 -0.946 . . . . 0.0 110.617 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.68 -47.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.553 -0.717 . . . . 0.0 109.923 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.88 159.51 41.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.419 -0.801 . . . . 0.0 109.741 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -95.7 109.57 21.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 56' ' ' ALA . 36.2 pt -100.19 -35.19 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.071 -1.018 . . . . 0.0 110.541 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.828 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.14 167.35 14.08 Favored Glycine 0 C--N 1.294 -1.799 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.264 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.421 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.4 t80 -141.06 117.52 10.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.837 ' HB2' HD11 ' A' ' 19' ' ' ILE . 7.8 t80 -109.02 142.47 39.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.277 . . . . 0.0 109.497 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 39.9 t0 -134.82 83.08 42.11 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.941 -1.099 . . . . 0.0 110.111 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 42.4 Cg_endo -68.74 61.83 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.573 1.302 . . . . 0.0 110.539 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -95.16 125.03 39.53 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.224 -0.922 . . . . 0.0 110.337 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -71.14 72.08 0.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 109.824 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 p -150.03 -82.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 110.785 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -98.94 161.57 24.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.134 -0.979 . . . . 0.0 110.589 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 51.8 Cg_endo -77.01 -37.34 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.833 1.439 . . . . 0.0 110.602 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 110.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.68 ' HZ3' HD12 ' A' ' 49' ' ' LEU . 6.5 p-90 -133.91 4.29 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 110.714 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 77' ' ' ALA . 3.9 tt -102.58 126.27 49.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 110.877 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -131.19 89.33 2.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.399 -0.813 . . . . 0.0 109.144 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.828 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 137.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.108 -0.995 . . . . 0.0 111.07 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.8 t0 -82.44 70.48 9.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.674 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -37.18 -30.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.259 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' ASP . 12.7 mt-10 -63.18 -49.69 73.3 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.812 -1.18 . . . . 0.0 108.786 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.77 -33.51 52.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 108.819 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -69.43 -22.0 63.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.6 ttt-85 -87.49 -23.48 24.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.353 -0.842 . . . . 0.0 109.466 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.666 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -58.87 -50.15 75.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.426 1.584 . . . . 0.0 107.042 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.975 ' CB ' HD11 ' A' ' 4' ' ' ILE . 85.3 m95 -62.62 -55.19 29.33 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.518 HD11 HD13 ' A' ' 74' ' ' LEU . 43.7 mt -52.83 -23.33 6.76 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -78.68 -19.47 52.42 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.503 -0.748 . . . . 0.0 110.12 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.6 m -98.41 31.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.996 -1.065 . . . . 0.0 109.311 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.45 78.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.54 128.37 35.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -1.181 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 10.6 mm-40 -100.39 119.92 57.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.8 Cg_endo -83.39 146.46 12.32 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.505 1.266 . . . . 0.0 110.407 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -71.29 158.44 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.0 109.987 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -55.53 -26.3 42.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 111.219 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 m -90.7 -48.39 7.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.697 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.908 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.13 -26.93 63.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.811 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' CD ' ' HG2' ' A' ' 66' ' ' PRO . 31.9 ttp180 -68.02 -36.79 80.52 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -35.66 76.17 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 70' ' ' ALA . 29.1 mt -73.29 -38.44 65.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 66' ' ' PRO . 66.9 mt -63.25 -28.44 70.03 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 3.6 mtt180 -77.13 -32.41 56.38 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.829 ' HB3' HD13 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -76.6 -32.19 57.94 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.15 0.976 . . . . 0.0 109.523 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.856 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.25 -7.99 46.62 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.78 42.31 7.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' A' ' 53' ' ' VAL . 39.7 t -100.78 -6.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.176 -1.19 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 10.1 m-85 -115.13 142.72 46.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.302 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -108.12 138.75 43.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -141.89 152.64 43.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.76 85.94 3.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.046 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.7 -167.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -72.46 -68.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -49.9 164.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.57 103.75 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 110.256 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.225 0.536 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.826 ' CG1' HG12 ' A' ' 21' ' ' VAL . 92.3 t -88.75 154.81 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.161 -0.962 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -140.67 133.0 28.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.127 -0.983 . . . . 0.0 110.534 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.765 HD11 ' CB ' ' A' ' 59' ' ' TRP . 33.1 mt -103.64 130.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.092 -1.005 . . . . 0.0 109.328 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.1 ptt85 -151.09 -167.46 2.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.652 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.572 HD22 ' HB2' ' A' ' 17' ' ' TYR . 13.1 mt -89.32 126.11 35.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.223 -0.923 . . . . 0.0 111.081 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.0 104.06 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.175 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 8.1 tmm_? -75.66 125.62 29.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 0.0 112.241 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 2.0 m-85 -125.35 -153.38 0.56 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.458 -0.776 . . . . 0.0 109.331 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 105.57 0.01 OUTLIER Glycine 0 N--CA 1.483 1.825 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.6 p -59.05 -39.75 82.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -1.118 . . . . 0.0 109.033 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.59 57.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.8 -0.563 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -127.26 -64.85 0.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.229 -0.919 . . . . 0.0 110.18 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.69 143.27 31.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 0.0 109.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.92 93.55 1.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.641 1.337 . . . . 0.0 111.243 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.7 p80 -137.54 125.66 22.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.974 -1.078 . . . . 0.0 110.385 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB2' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -113.23 149.15 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.4 ttm-85 -100.55 154.08 18.86 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.897 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -97.63 84.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.26 0.4 OUTLIER -98.51 172.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.988 -173.068 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.826 HG12 ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -112.73 105.28 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.597 -0.689 . . . . 0.0 111.037 -177.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.1 t -129.18 -177.01 4.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.2 -0.938 . . . . 0.0 109.959 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -104.23 -173.36 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.59 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.89 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 0.0 110.119 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -49.23 124.09 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.0 110.572 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -49.92 16.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -151.97 -80.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 110.004 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -120.77 34.85 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 109.738 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 93.08 9.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 61.28 2.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -120.65 70.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -1.138 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.6 p90 -64.0 176.79 0.89 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.013 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.404 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.5 mt -86.02 -49.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.27 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -153.66 172.57 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -0.807 . . . . 0.0 109.778 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HD3' ' A' ' 18' ' ' ARG . 1.8 mtmt -111.82 126.3 54.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.04 -1.037 . . . . 0.0 110.0 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.018 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -129.86 -13.71 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.008 -1.057 . . . . 0.0 111.819 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.878 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -133.89 154.83 21.51 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 119.286 -1.435 . . . . 0.0 109.6 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.459 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 24.2 t80 -128.92 151.81 49.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.268 -1.136 . . . . 0.0 109.13 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' CD2' ' HD3' ' A' ' 41' ' ' PRO . 38.8 t80 -149.93 116.5 5.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.721 -1.237 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 39.1 t0 -130.54 82.07 66.05 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.684 -1.26 . . . . 0.0 110.575 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 41.6 Cg_endo -68.48 78.63 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.681 1.358 . . . . 0.0 110.892 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -164.48 1.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.367 -0.833 . . . . 0.0 110.0 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -132.56 24.41 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 0.0 110.502 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.774 HG23 HG23 ' A' ' 45' ' ' THR . 8.2 t -121.56 -22.54 5.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.526 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.774 HG23 HG23 ' A' ' 44' ' ' THR . 76.6 p -140.56 140.54 22.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.057 . . . . 0.0 110.485 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.09 -13.64 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.657 1.346 . . . . 0.0 110.706 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.16 93.68 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.68 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 6.0 p-90 -120.39 -13.14 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.382 -0.824 . . . . 0.0 110.587 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 77' ' ' ALA . 6.6 tt -77.96 129.04 34.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 111.108 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -140.33 85.9 2.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 109.288 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.897 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -115.85 143.54 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.922 -1.111 . . . . 0.0 111.412 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.8 t0 -94.58 69.8 3.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.719 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -32.9 -32.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.809 -177.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.28 -50.23 74.46 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.695 -1.253 . . . . 0.0 108.562 178.208 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.0 mmm180 -74.44 -36.17 63.38 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 53' ' ' VAL . . . -68.85 -16.57 63.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.944 -1.097 . . . . 0.0 108.129 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -90.38 -21.72 21.83 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 121.362 -0.836 . . . . 0.0 108.908 177.163 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -66.83 -48.22 69.57 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 123.032 1.396 . . . . 0.0 107.658 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.018 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.3 m95 -66.94 -54.36 22.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.424 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.043 HD11 HD13 ' A' ' 74' ' ' LEU . 3.3 mt -56.6 -21.31 26.05 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.537 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 2.8 m -82.34 -20.91 36.37 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.397 -0.814 . . . . 0.0 110.446 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.8 m -99.07 31.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.915 -1.116 . . . . 0.0 109.536 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 26.41 73.75 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -67.14 137.44 56.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.331 . . . . 0.0 109.644 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -103.03 108.26 58.02 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 0.0 110.609 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.0 Cg_endo -79.69 126.62 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.65 1.342 . . . . 0.0 109.736 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 7.6 t -62.21 -175.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.55 51.94 1.77 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 m -164.33 -56.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.33 -25.59 64.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.519 ' HA ' HD12 ' A' ' 74' ' ' LEU . 6.8 tmm_? -66.76 -39.62 87.93 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -40.86 96.57 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.4 mt -69.3 -29.29 67.12 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.515 -0.741 . . . . 0.0 109.348 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.043 HD13 HD11 ' A' ' 60' ' ' LEU . 45.7 mt -69.65 -28.09 65.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.55 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.39 -27.05 29.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -83.55 -36.7 23.79 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.597 0.713 . . . . 0.0 110.533 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.19 -6.86 37.45 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.815 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.31 56.37 2.86 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.719 HG22 ' HB ' ' A' ' 53' ' ' VAL . 24.3 t -107.02 -57.0 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.122 -1.223 . . . . 0.0 111.052 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 7.0 m-30 -52.35 -57.36 10.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 110.389 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -115.4 -179.19 3.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 110.316 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -122.94 156.63 34.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -160.21 65.71 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.012 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.35 -40.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -101.73 88.84 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.72 -167.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.56 -161.0 29.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 110.183 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.168 0.509 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.765 HG11 ' CE3' ' A' ' 59' ' ' TRP . 66.1 t -83.38 137.08 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.05 -1.031 . . . . 0.0 110.443 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 65' ' ' GLN . 3.6 tptm -140.49 128.44 22.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.912 HD11 ' CB ' ' A' ' 59' ' ' TRP . 71.6 mt -99.97 128.91 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.041 -1.037 . . . . 0.0 109.901 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 6.6 ptm180 -151.23 -173.89 4.64 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.6 mp -88.96 126.07 35.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.518 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.34 103.57 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.355 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -71.29 119.55 15.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 111.179 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 27.1 m-85 -108.61 -63.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.61 101.79 0.04 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.5 p -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.165 . . . . 0.0 109.891 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -176.78 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.761 . . . . 0.0 109.42 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.501 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 7.6 m-70 -126.66 -54.13 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.757 0.789 . . . . 0.0 108.89 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 64.9 t-20 -146.69 124.96 6.19 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 46.5 Cg_endo -71.9 122.26 8.33 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.364 1.192 . . . . 0.0 111.144 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 32.0 p80 -176.31 131.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.507 -0.745 . . . . 0.0 109.87 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.6 m-85 -122.5 155.68 35.69 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 6.5 mmt180 -100.68 158.68 15.77 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.759 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.953 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -99.04 78.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.25 0.4 OUTLIER -97.26 163.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.733 -173.474 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.879 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 112.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.286 0.565 . . . . 0.0 110.308 -177.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t -139.17 -178.06 5.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.124 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.29 -179.56 3.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.914 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.98 -54.61 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -58.6 -20.31 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 110.378 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -94.93 143.06 26.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 0.0 110.099 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.36 23.51 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -21.47 29.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.132 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -131.44 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.76 61.84 0.47 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 142.85 42.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -1.181 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.2 p90 -110.38 168.79 9.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.15 -0.968 . . . . 0.0 110.633 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.706 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.1 mp -84.34 -28.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 109.939 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.91 164.75 1.52 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.975 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.32 113.77 26.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.982 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.991 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -108.24 -34.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.115 -0.99 . . . . 0.0 110.664 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.925 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.27 164.34 15.36 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.342 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.493 ' N ' HG13 ' A' ' 19' ' ' ILE . 11.6 t80 -139.48 142.95 37.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 19.9 t80 -135.64 132.98 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.723 -1.235 . . . . 0.0 110.208 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 9.9 t0 -140.55 103.55 6.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.787 -1.195 . . . . 0.0 110.34 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 47.9 Cg_endo -73.15 -4.67 15.83 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.498 1.262 . . . . 0.0 111.42 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HG2' ' HG2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -89.73 -18.3 26.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.865 -1.147 . . . . 0.0 110.284 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.99 123.95 11.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 28.24 1.76 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.86 163.27 43.78 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.804 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.88 64.05 2.45 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.626 1.329 . . . . 0.0 110.287 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -167.47 37.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.575 ' HZ3' HD23 ' A' ' 49' ' ' LEU . 40.8 p-90 -79.03 1.46 23.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.743 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 49' ' ' LEU . 2.3 tm? -119.59 112.52 19.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.955 -1.09 . . . . 0.0 110.523 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 104.24 9.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.102 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.1 t -129.52 139.15 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.099 . . . . 0.0 111.357 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.8 t0 -84.94 70.83 10.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.52 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -31.91 -34.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -59.96 -51.01 71.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.774 -1.204 . . . . 0.0 108.837 178.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.628 ' HB3' HG22 ' A' ' 36' ' ' ILE . 47.1 mmm-85 -71.11 -45.52 63.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.901 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -59.87 -22.38 62.24 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.2 ttt180 -87.78 -26.42 22.88 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.317 -0.864 . . . . 0.0 109.864 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.1 t80 -59.29 -46.67 87.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.32 1.534 . . . . 0.0 107.237 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.991 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.4 m95 -62.85 -54.68 35.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.512 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 74' ' ' LEU . 7.3 mt -56.05 -20.58 17.48 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.583 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -79.02 -24.24 43.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.776 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 59' ' ' TRP . 14.4 m -98.92 33.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.939 -1.101 . . . . 0.0 109.568 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.28 27.15 73.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -68.26 130.93 44.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.004 -1.292 . . . . 0.0 109.964 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' O ' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -98.13 111.25 58.99 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 110.454 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HB3' HD11 ' A' ' 74' ' ' LEU . 53.4 Cg_endo -87.53 125.43 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.616 1.324 . . . . 0.0 109.951 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.783 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.3 t -53.98 166.31 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.016 -1.053 . . . . 0.0 109.767 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -33.8 36.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.041 -1.037 . . . . 0.0 110.919 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.7 m -76.04 -54.82 6.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.975 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.783 ' H ' HG23 ' A' ' 67' ' ' THR . . . -67.1 -23.36 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.475 -0.766 . . . . 0.0 109.222 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.767 ' HA ' HD12 ' A' ' 74' ' ' LEU . 31.0 ttp180 -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 2.0 ttt-85 -69.77 -43.19 72.68 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.676 -0.809 . . . . 0.0 108.977 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.571 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 77.5 mt -65.15 -22.89 66.98 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.571 -0.706 . . . . 0.0 109.443 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 71' ' ' ARG . 14.0 mt -70.73 -30.41 66.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HG2' ' CE1' ' A' ' 80' ' ' PHE . 2.8 mtm180 -72.66 -34.67 67.41 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -77.52 -28.81 52.14 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.91 0.862 . . . . 0.0 110.077 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -73.34 -4.64 34.62 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.199 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.65 20.32 51.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 77' ' ' ALA . 21.1 t -82.76 -60.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.091 -1.241 . . . . 0.0 110.569 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 74' ' ' LEU . 34.2 p90 -149.73 140.87 23.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.972 -1.08 . . . . 0.0 110.865 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -109.1 29.14 7.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 110.013 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -173.5 -166.19 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.348 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.33 177.48 4.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.339 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.66 -26.72 24.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -71.92 100.05 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 110.295 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -176.35 128.5 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.203 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.54 42.86 0.21 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.225 -1.162 . . . . 0.0 110.202 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.296 0.57 . . . . 0.0 110.302 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.448 HG23 ' C ' ' A' ' 1' ' ' MET . 40.2 t -146.88 108.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.968 . . . . 0.0 110.173 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -140.2 133.44 29.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.245 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.975 HD11 ' CB ' ' A' ' 59' ' ' TRP . 98.0 mt -102.03 133.26 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.07 -1.019 . . . . 0.0 109.924 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -172.54 4.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 110.893 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -88.73 126.0 35.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.404 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.62 104.45 16.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 111.191 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 2.6 tmm_? -71.88 118.08 14.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.702 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 20.4 m-85 -112.13 -63.41 1.43 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.152 -0.968 . . . . 0.0 110.368 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.88 103.75 0.15 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 26.9 p -70.6 -59.75 2.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -1.176 . . . . 0.0 109.496 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.0 mttp -141.9 51.81 1.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -140.93 -59.78 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 66.0 t30 -140.2 114.58 7.62 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.07 114.07 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.475 1.25 . . . . 0.0 111.258 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 32.0 p80 -169.52 135.66 1.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.458 -0.776 . . . . 0.0 110.264 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.787 ' HB2' HD23 ' A' ' 6' ' ' LEU . 7.4 m-85 -120.02 156.12 31.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -108.41 159.59 16.55 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.66 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.981 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 81.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 177.65 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.264 0.4 OUTLIER -97.81 164.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.572 -174.0 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -111.86 106.1 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 110.471 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.0 t -134.99 -169.86 2.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.102 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.8 p-10 -89.35 158.94 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.067 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -66.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.442 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -64.82 122.86 17.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.9 . . . . 0.0 110.625 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.1 ptt85 -166.33 151.53 8.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.7 -47.04 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.61 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.51 18.34 10.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.111 -0.993 . . . . 0.0 110.525 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 12.5 p-10 -138.38 98.89 3.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.147 -0.97 . . . . 0.0 109.935 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.67 72.59 0.2 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.06 157.33 39.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 45.5 p90 -116.45 162.95 16.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.934 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.552 HG21 ' HH2' ' A' ' 59' ' ' TRP . 4.6 mt -72.56 -46.31 55.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.662 -0.649 . . . . 0.0 110.036 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -152.41 166.24 32.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 6.6 pttt -104.33 115.77 30.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.175 -0.953 . . . . 0.0 109.998 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.867 HG21 ' CD1' ' A' ' 59' ' ' TRP . 38.7 pt -108.32 -33.71 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.939 -1.1 . . . . 0.0 111.56 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.783 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.69 166.91 18.24 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.859 -1.638 . . . . 0.0 112.76 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.404 ' N ' HG12 ' A' ' 19' ' ' ILE . 53.1 t80 -140.94 121.4 14.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.981 ' HB2' HD11 ' A' ' 19' ' ' ILE . 20.8 t80 -114.94 139.95 49.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.777 -1.202 . . . . 0.0 109.778 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 64.4 t0 -140.56 106.32 6.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 109.864 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 45.5 Cg_endo -76.47 71.08 6.05 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.051 1.027 . . . . 0.0 110.196 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -179.44 5.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.236 -0.915 . . . . 0.0 110.835 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -136.57 18.13 3.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.359 -0.838 . . . . 0.0 110.096 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 p -115.41 -20.12 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.283 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 137.57 27.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.69 -16.9 18.47 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.533 1.28 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.15 82.58 1.86 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 110.836 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.584 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 9.8 p-90 -109.93 -10.55 14.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.271 -0.893 . . . . 0.0 110.142 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.649 HD23 ' C ' ' A' ' 49' ' ' LEU . 7.9 tt -82.53 112.22 19.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.05 . . . . 0.0 109.923 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -120.78 93.58 4.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.408 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.783 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.79 133.01 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.044 -1.035 . . . . 0.0 111.2 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.0 t0 -78.37 69.13 4.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -34.06 -32.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.542 -177.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tt0 -62.42 -52.15 64.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.916 -1.115 . . . . 0.0 109.105 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.1 mtm-85 -75.49 -34.7 60.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.078 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -67.15 -23.48 65.8 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HB2' HG13 ' A' ' 79' ' ' VAL . 40.8 ttt180 -86.15 -20.55 28.46 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.328 -0.857 . . . . 0.0 109.952 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.719 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -62.31 -48.56 79.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 123.078 1.418 . . . . 0.0 107.235 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.975 ' CB ' HD11 ' A' ' 4' ' ' ILE . 89.0 m95 -63.02 -55.92 21.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.714 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.644 HD12 HG11 ' A' ' 79' ' ' VAL . 84.2 mt -53.69 -21.85 7.84 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.5 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -81.96 -20.09 39.28 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.456 -0.778 . . . . 0.0 110.64 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.3 m -99.07 32.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.811 -1.181 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.88 27.1 72.82 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -81.95 117.64 22.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.136 -1.214 . . . . 0.0 109.992 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -91.36 127.75 49.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -83.7 165.42 13.84 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.352 1.185 . . . . 0.0 109.744 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -85.19 -174.94 5.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.226 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.68 46.68 1.19 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -165.7 -55.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 6' ' ' LEU . . . -67.83 -26.07 65.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.427 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 67.1 ttt180 -64.83 -40.53 95.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -39.35 89.64 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.875 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 70' ' ' ALA . 41.7 mt -70.71 -28.28 64.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 60' ' ' LEU . 40.9 mt -70.95 -29.46 65.48 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.27 -28.26 38.44 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.249 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.2 OUTLIER -83.86 -32.37 25.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.725 0.774 . . . . 0.0 110.097 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -66.41 -11.39 51.43 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.722 -0.611 . . . . 0.0 109.811 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.16 15.72 29.75 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.867 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 53' ' ' VAL . 17.9 t -76.12 -54.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.724 -1.456 . . . . 0.0 110.138 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' A' ' 75' ' ' ARG . 21.1 p90 -146.07 -176.48 5.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -140.97 -59.3 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -163.22 77.53 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.453 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.06 177.39 7.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -172.17 42.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.233 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -146.37 45.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.17 158.29 5.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.159 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.32 -77.17 0.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.174 -1.192 . . . . 0.0 110.274 -179.884 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 mtp . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.284 0.564 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.97 118.98 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.14 142.18 36.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 110.688 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.919 HD11 ' CB ' ' A' ' 59' ' ' TRP . 84.7 mt -104.06 135.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.142 -0.974 . . . . 0.0 109.409 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -151.22 -168.81 3.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 70' ' ' ALA . 5.1 mp -89.3 127.3 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.846 . . . . 0.0 110.367 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.86 104.27 15.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.088 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -71.28 122.68 20.68 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.905 . . . . 0.0 112.539 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 6.1 m-85 -124.7 -152.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.16 100.83 0.01 OUTLIER Glycine 0 N--CA 1.483 1.803 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 p -52.17 -42.96 63.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -1.168 . . . . 0.0 109.988 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.41 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.54 -0.725 . . . . 0.0 109.695 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -110.91 -60.6 1.81 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.465 -0.772 . . . . 0.0 109.644 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.26 122.62 16.16 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.56 91.77 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.408 1.215 . . . . 0.0 111.102 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.507 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.9 p80 -137.59 131.37 31.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.323 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 14.1 m-85 -114.6 148.81 37.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 mtt85 -100.29 159.36 15.19 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.83 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.954 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.71 81.43 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 177.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.4 OUTLIER -97.69 171.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.934 -173.745 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.904 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -116.16 108.77 25.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.167 0.508 . . . . 0.0 110.048 -177.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.8 t -140.16 -162.46 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 110.233 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 22' ' ' THR . 17.9 p-10 -93.25 -155.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.929 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.03 -40.14 12.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -175.0 176.71 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -151.22 -70.14 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.075 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.19 -64.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.15 -55.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.913 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 177.39 3.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.735 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.1 116.54 1.13 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -116.38 143.53 45.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -1.118 . . . . 0.0 109.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB3' HG13 ' A' ' 20' ' ' VAL . 20.4 p90 -118.23 176.52 5.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 110.854 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG21 ' HH2' ' A' ' 59' ' ' TRP . 13.2 mt -82.64 -51.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 109.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -152.79 152.72 31.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.959 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -89.57 108.17 19.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.018 . . . . 0.0 110.125 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.898 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.5 pt -100.07 -36.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 111.371 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.803 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -120.78 168.03 13.98 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.021 -1.562 . . . . 0.0 112.392 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 19' ' ' ILE . 10.2 t80 -141.07 124.78 16.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.954 ' HB2' HD11 ' A' ' 19' ' ' ILE . 22.6 t80 -125.85 124.71 41.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.811 -1.18 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 60.0 t0 -140.18 84.85 14.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.731 -1.231 . . . . 0.0 110.69 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 45.2 Cg_endo -72.16 77.69 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.646 1.34 . . . . 0.0 110.179 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' NH2' HG21 ' A' ' 44' ' ' THR . 0.0 OUTLIER -96.02 167.76 11.03 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.34 -0.85 . . . . 0.0 110.528 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 46.36 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.252 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.467 HG21 ' NH2' ' A' ' 42' ' ' ARG . 40.9 p -118.8 -66.95 1.02 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.468 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.17 161.83 59.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.02 -18.95 20.94 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.841 1.443 . . . . 0.0 110.65 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -84.59 87.07 7.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.395 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -121.72 -0.83 9.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 110.904 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 76' ' ' GLN . 8.2 tt -96.69 114.71 26.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.916 -1.115 . . . . 0.0 110.618 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.91 94.91 3.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.803 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.0 138.56 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.952 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -84.74 72.38 10.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.293 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.753 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.98 -30.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 122.309 -0.245 . . . . 0.0 111.492 -177.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 35.1 mt-10 -60.47 -53.75 53.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.77 -1.206 . . . . 0.0 108.771 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.3 mmp_? -71.31 -39.66 71.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.432 -0.792 . . . . 0.0 108.891 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.873 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.74 -17.82 64.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 38.8 ttp180 -89.65 -22.68 22.17 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.19 -0.944 . . . . 0.0 109.594 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.888 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.4 t80 -61.4 -44.86 96.42 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 123.167 1.461 . . . . 0.0 107.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.919 ' CB ' HD11 ' A' ' 4' ' ' ILE . 84.6 m95 -69.84 -56.49 6.95 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.921 -1.491 . . . . 0.0 109.982 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.887 HD21 ' HG3' ' A' ' 66' ' ' PRO . 20.9 mt -53.98 -22.7 11.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.421 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -80.9 -22.3 39.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.474 -0.766 . . . . 0.0 110.56 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.888 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.69 32.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.764 -1.21 . . . . 0.0 109.478 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 30.03 74.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -76.95 128.96 35.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.065 -1.256 . . . . 0.0 110.141 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -94.76 110.24 48.27 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.887 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.3 Cg_endo -82.31 131.09 6.5 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.552 1.29 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 41.2 p -52.54 160.41 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.88 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.27 -16.3 20.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.909 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.446 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 5.4 m -92.34 -52.93 4.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -70.93 -28.48 64.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.4 ttt180 -65.53 -39.89 92.29 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -64.09 -27.6 69.2 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.075 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 70' ' ' ALA . 15.9 mt -85.5 -31.13 22.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.581 -0.699 . . . . 0.0 109.444 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.642 HD22 ' HB1' ' A' ' 56' ' ' ALA . 83.4 mt -69.01 -28.43 66.59 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.501 ' HG3' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.7 -29.31 36.47 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HB3' HD11 ' A' ' 49' ' ' LEU . 4.8 tp-100 -77.95 -35.08 50.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.899 0.857 . . . . 0.0 109.316 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -68.63 -9.36 49.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.77 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 88.11 54.54 2.42 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.753 HG22 ' CB ' ' A' ' 53' ' ' VAL . 36.6 t -116.37 -5.21 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -1.197 . . . . 0.0 111.381 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 7.3 m-85 -112.52 -19.5 12.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.879 -1.138 . . . . 0.0 110.086 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -103.9 152.52 21.86 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.24 -0.912 . . . . 0.0 109.361 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.408 ' N ' ' HG3' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -142.78 112.02 6.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.077 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -123.07 -83.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.249 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -171.71 79.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.54 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -50.75 62.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.789 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.98 -177.63 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 109.999 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.61 0.1 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.19 -1.182 . . . . 0.0 110.128 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.301 0.572 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 36.1 t -61.77 134.8 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -140.5 131.51 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.55 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.97 HD11 ' CB ' ' A' ' 59' ' ' TRP . 40.3 mt -99.76 129.31 50.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.074 -1.016 . . . . 0.0 109.012 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 18.5 ptt85 -150.24 174.04 13.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.774 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.5 pp -88.21 127.03 35.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.96 111.68 23.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 112.427 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.469 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 7.4 ttt-85 -73.91 123.2 23.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.144 -0.973 . . . . 0.0 110.793 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 23.3 m-85 -113.92 -60.09 1.93 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.098 -1.001 . . . . 0.0 110.6 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.55 108.6 0.13 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -57.66 -42.81 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -1.117 . . . . 0.0 109.443 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.503 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -175.92 48.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.403 0.621 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.503 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 10.4 m-70 -128.31 -64.21 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.59 128.42 23.95 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.704 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.61 111.58 3.35 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.422 1.222 . . . . 0.0 110.947 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 32.1 p80 -165.11 132.93 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 0.0 110.716 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.4 m-85 -123.64 152.08 42.36 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 12.4 ttm180 -99.93 146.24 26.89 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.398 -1.321 . . . . 0.0 108.107 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.04 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -96.33 80.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 102.164 -3.273 . . . . 0.0 102.164 178.325 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.289 0.4 OUTLIER -97.22 168.45 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.103 -173.197 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.895 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -114.12 109.76 29.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.49 -0.756 . . . . 0.0 110.507 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.5 t -130.66 -174.26 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.342 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.7 OUTLIER -106.52 -163.24 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.258 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.12 -42.42 1.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.537 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -60.14 3.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.84 94.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 109.847 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 21.92 11.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -0.883 . . . . 0.0 110.645 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -91.82 -26.18 18.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.983 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -148.76 142.39 25.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.036 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 52.27 4.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -88.2 148.89 24.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 110.245 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' HB3' HG13 ' A' ' 20' ' ' VAL . 12.8 p90 -119.81 154.09 34.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 110.612 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.671 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.2 mt -61.3 -39.19 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.831 . . . . 0.0 109.918 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -167.36 170.93 11.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.912 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -110.57 121.02 44.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.005 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.927 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -115.78 -23.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.025 -1.047 . . . . 0.0 110.828 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.91 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.98 162.2 16.89 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 118.803 -1.665 . . . . 0.0 111.072 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' N ' HG12 ' A' ' 19' ' ' ILE . 63.9 t80 -140.22 133.64 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.04 ' HB2' HD11 ' A' ' 19' ' ' ILE . 2.6 t80 -126.93 121.81 32.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 109.906 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 8.7 t0 -134.86 82.36 43.85 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.0 110.064 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 40.9 Cg_endo -67.21 79.81 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.738 1.388 . . . . 0.0 110.922 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB3' HG22 ' A' ' 44' ' ' THR . 6.3 mtt180 -92.82 154.95 17.95 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.425 -0.797 . . . . 0.0 109.988 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -94.19 64.8 3.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.097 -1.002 . . . . 0.0 110.184 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.515 HG23 ' N ' ' A' ' 45' ' ' THR . 6.7 t -149.0 -41.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.288 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.515 ' N ' HG23 ' A' ' 44' ' ' THR . 8.1 p -137.24 149.47 65.99 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.191 -0.943 . . . . 0.0 110.197 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.02 -28.03 13.41 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.28 87.95 6.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.519 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 9.5 p-90 -117.15 -16.37 10.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.152 -0.968 . . . . 0.0 110.684 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.652 HD13 ' HB3' ' A' ' 76' ' ' GLN . 1.7 tt -77.96 127.18 31.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 109.974 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -133.48 86.81 2.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.31 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.91 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -115.67 130.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.119 -0.988 . . . . 0.0 111.327 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.6 t70 -74.35 70.82 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.79 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.86 -30.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 122.233 -0.292 . . . . 0.0 111.471 -177.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.8 tp10 -62.83 -50.12 72.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.797 -1.19 . . . . 0.0 108.623 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.669 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -76.72 -33.74 58.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 108.988 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.92 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -70.21 -21.5 63.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' VAL . 23.4 tpt180 -86.28 -22.27 26.9 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.646 ' O ' HG13 ' A' ' 62' ' ' VAL 0.25 0.5 OUTLIER -62.22 -48.08 81.59 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.258 1.504 . . . . 0.0 107.367 178.38 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.97 ' CB ' HD11 ' A' ' 4' ' ' ILE . 77.9 m95 -64.98 -56.08 15.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.788 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.618 ' CD1' HG11 ' A' ' 79' ' ' VAL . 47.2 mt -53.09 -22.47 6.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.561 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -80.71 -22.07 40.66 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.408 -0.808 . . . . 0.0 110.826 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 59' ' ' TRP . 7.2 m -98.89 32.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.813 -1.18 . . . . 0.0 109.543 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.61 70.83 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -73.17 110.75 7.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.073 -1.251 . . . . 0.0 110.136 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 115.61 56.08 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.8 Cg_endo -82.66 144.59 12.58 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.539 1.284 . . . . 0.0 109.992 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.93 165.51 13.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.59 -16.03 59.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 110.9 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -104.28 -46.79 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.175 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.83 -25.95 65.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -65.9 -38.68 89.38 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.251 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.412 ' NH1' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -62.01 -32.84 73.36 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.919 178.829 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.932 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -76.89 -35.67 57.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.512 HD12 ' HB3' ' A' ' 66' ' ' PRO . 76.7 mt -63.89 -28.77 70.07 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 1.5 mtt180 -78.4 -29.79 47.44 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.652 ' HB3' HD13 ' A' ' 49' ' ' LEU . 8.1 tp-100 -73.16 -34.04 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.056 0.931 . . . . 0.0 108.928 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -69.57 -7.99 43.4 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.983 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.81 39.13 10.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.79 HG22 HG23 ' A' ' 53' ' ' VAL . 45.5 t -97.43 -6.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.176 -1.191 . . . . 0.0 111.893 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 10.9 m-85 -107.81 -169.26 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.871 -1.143 . . . . 0.0 110.304 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -63.48 92.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.334 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.25 135.22 33.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.115 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.86 177.12 5.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.967 . . . . 0.0 110.368 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . . . -144.83 -50.22 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.298 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -161.37 -67.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -171.46 -40.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.947 . . . . 0.0 110.134 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.05 41.02 2.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.179 . . . . 0.0 110.15 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.315 0.578 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.777 HG11 ' CG2' ' A' ' 62' ' ' VAL . 61.1 t -56.67 102.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.825 . . . . 0.0 110.576 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 65' ' ' GLN . 3.7 mtmt -140.18 139.5 35.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 110.793 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.944 HD11 ' HB3' ' A' ' 59' ' ' TRP . 1.5 mp -99.96 130.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.85 -176.71 5.63 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.1 -1.0 . . . . 0.0 110.845 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.542 HD22 ' HB2' ' A' ' 17' ' ' TYR . 16.1 mt -89.7 127.14 35.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.847 . . . . 0.0 110.8 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.72 107.08 19.07 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.89 120.04 22.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.769 -1.207 . . . . 0.0 112.805 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -120.48 -157.13 0.7 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 177.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.47 128.79 0.01 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -61.65 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.178 -1.19 . . . . 0.0 109.78 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 11' ' ' SER . 15.5 mttt -146.41 53.77 1.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 4.2 m-70 -140.76 -53.45 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.666 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -118.19 96.88 50.3 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.855 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.14 101.99 1.54 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.754 1.397 . . . . 0.0 111.256 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 29.5 p80 -145.91 135.02 22.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.0 109.707 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.542 ' HB2' HD22 ' A' ' 6' ' ' LEU . 11.0 m-85 -113.35 162.36 16.16 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 109.295 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 24.2 ttt180 -112.41 152.65 28.41 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.939 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.2 mt -98.73 78.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 34' ' ' GLU 0.271 0.4 OUTLIER -98.07 165.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.179 -173.134 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.951 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.44 106.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.854 -0.529 . . . . 0.0 110.612 -177.896 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.7 t -132.69 -173.44 3.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.151 -0.968 . . . . 0.0 110.258 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 22' ' ' THR . 51.5 p-10 -75.41 -167.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.51 -51.21 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.867 . . . . 0.0 110.143 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -177.57 116.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 110.174 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -62.08 1.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 109.852 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -169.9 -55.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.797 . . . . 0.0 109.933 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.98 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.875 . . . . 0.0 110.103 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -138.52 -166.59 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.73 94.32 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.61 59.71 1.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.44 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.6 p90 -54.47 -179.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.955 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 mt -90.45 -34.39 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.988 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -164.71 -175.54 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -119.18 112.75 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.978 HG21 ' CD1' ' A' ' 59' ' ' TRP . 21.4 pt -108.96 -38.0 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.924 -1.11 . . . . 0.0 111.208 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.79 163.73 19.63 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.81 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 25.0 t80 -133.69 152.54 51.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.47 ' CD2' ' HD3' ' A' ' 41' ' ' PRO . 16.4 t80 -143.54 137.86 28.75 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.974 -1.079 . . . . 0.0 109.738 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 36.0 t0 -139.97 80.8 19.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.759 -1.213 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 40.1 Cg_endo -67.26 62.68 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.494 1.26 . . . . 0.0 110.886 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -99.99 148.62 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.53 67.49 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -126.19 -81.91 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.438 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -137.48 167.24 21.41 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.155 -0.966 . . . . 0.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.32 59.83 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.737 1.388 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -151.5 53.47 0.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.908 . . . . 0.0 109.699 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.58 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 16.0 p-90 -108.52 -12.87 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.748 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 77' ' ' ALA . 7.2 tt -86.61 121.88 29.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 110.791 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 94.01 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 108.715 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.939 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -120.58 154.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.255 1.026 . . . . 0.0 111.712 -178.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 9.1 t0 -103.95 68.07 0.9 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -29.95 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.511 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.9 tt0 -60.28 -52.46 65.2 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.771 -1.206 . . . . 0.0 109.197 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.57 ' HB3' HG22 ' A' ' 36' ' ' ILE . 28.0 mmm180 -72.3 -41.01 67.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.967 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -63.37 -20.37 65.47 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 23.2 ttp85 -89.79 -21.95 22.37 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.89 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -63.36 -47.23 82.97 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 123.176 1.465 . . . . 0.0 107.311 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.978 ' CD1' HG21 ' A' ' 36' ' ' ILE . 90.4 m95 -66.81 -55.29 15.54 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.915 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -54.62 -22.82 14.66 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.317 177.014 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -81.67 -19.2 42.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.46 -0.775 . . . . 0.0 110.41 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.4 m -99.0 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.799 -1.188 . . . . 0.0 109.31 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.88 28.05 73.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -71.15 146.12 49.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.072 -1.252 . . . . 0.0 110.301 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 3' ' ' LYS . 1.9 mm100 -113.1 109.59 51.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HG3' HD21 ' A' ' 60' ' ' LEU . 52.2 Cg_endo -86.64 128.38 2.9 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.59 1.311 . . . . 0.0 110.619 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.3 t -54.81 165.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.09 -17.52 27.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.154 -0.966 . . . . 0.0 111.202 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.1 m -90.24 -52.88 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.0 110.487 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.811 ' H ' HG23 ' A' ' 67' ' ' THR . . . -68.99 -28.82 66.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' HA ' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -68.34 -39.16 81.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.291 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -39.57 88.75 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.58 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 25.4 mt -73.63 -27.3 61.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.41 -0.806 . . . . 0.0 109.267 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.543 HD13 HD11 ' A' ' 60' ' ' LEU . 21.3 mt -69.64 -27.83 65.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.543 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.72 -25.83 37.84 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.3 tp-100 -83.85 -36.55 23.35 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.792 0.806 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.631 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -69.01 -6.63 29.1 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.281 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.35 43.88 7.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 53' ' ' VAL . 23.8 t -94.68 -56.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.156 -1.202 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.543 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.7 m-30 -56.21 120.89 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 110.264 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -96.43 69.12 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.961 . . . . 0.0 109.978 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -173.55 60.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.274 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -70.23 137.89 51.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.98 53.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.36 -41.91 4.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.62 -179.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.138 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.31 95.5 0.45 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 110.283 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 mtt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.217 0.532 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG11 ' CE3' ' A' ' 59' ' ' TRP . 41.0 t -91.78 135.89 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.249 -0.907 . . . . 0.0 110.43 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 65' ' ' GLN . 7.3 mttt -140.33 140.37 35.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.982 HD11 ' CB ' ' A' ' 59' ' ' TRP . 95.2 mt -108.18 134.88 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.745 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -150.96 -163.65 1.82 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.312 -0.868 . . . . 0.0 110.112 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.028 HD11 HG21 ' A' ' 69' ' ' THR . 36.4 mt -89.3 136.03 33.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.071 -1.018 . . . . 0.0 110.986 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -106.47 105.22 15.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.59 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.479 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.9 ttp85 -75.57 120.91 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 111.177 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 16.2 m-85 -108.78 -64.2 1.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.411 -0.806 . . . . 0.0 110.544 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.28 128.82 23.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 3.1 p -63.71 -50.56 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.361 -1.082 . . . . 0.0 109.565 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -167.03 31.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.633 0.73 . . . . 0.0 109.095 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.83 -53.79 2.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.602 0.715 . . . . 0.0 109.455 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -138.55 123.13 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.57 -0.706 . . . . 0.0 109.414 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.03 90.98 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.426 1.224 . . . . 0.0 111.016 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.4 p80 -141.97 124.75 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.557 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 4.7 m-30 -116.34 154.74 29.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 108.456 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.624 ' HD3' HG23 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -104.14 164.77 11.49 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.743 -1.583 . . . . 0.0 106.997 176.151 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.701 HD12 HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -98.39 86.39 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.624 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.264 0.4 OUTLIER -98.12 168.72 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.285 -174.782 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.948 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -113.75 106.19 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.673 -177.484 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -119.78 141.53 49.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.952 . . . . 0.0 109.418 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 110.006 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.34 44.23 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.117 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -69.37 -82.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.814 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.36 -176.18 3.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.552 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -120.48 21.31 11.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 110.29 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.71 59.31 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.53 -50.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.031 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.75 40.63 17.26 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.85 132.27 55.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -1.165 . . . . 0.0 110.432 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.646 ' HB3' HG22 ' A' ' 22' ' ' THR . 2.8 p90 -120.02 -177.24 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.529 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.3 mt -92.07 -50.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 110.04 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.1 tt0 -150.15 164.59 35.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.01 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -103.07 116.71 33.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.142 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.995 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.9 pt -110.5 -33.8 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.985 -1.072 . . . . 0.0 111.991 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -128.38 174.46 18.86 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.187 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 85.1 t80 -140.49 142.9 35.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.522 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 7.8 t80 -140.16 132.91 29.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.722 -1.236 . . . . 0.0 110.036 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 10.8 t0 -140.34 89.46 10.73 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.835 -1.165 . . . . 0.0 110.236 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.8 82.88 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.466 1.245 . . . . 0.0 110.646 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.7 -166.26 1.55 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.306 -0.871 . . . . 0.0 110.279 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.38 59.87 1.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -142.52 -81.56 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.35 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.2 p -132.54 161.6 62.3 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.174 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 66.72 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.611 1.322 . . . . 0.0 110.433 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -140.49 50.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.5 p-90 -121.54 -11.46 8.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.76 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' A' ' 77' ' ' ALA . 5.5 tt -81.34 111.08 17.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.012 -1.055 . . . . 0.0 110.718 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.39 96.06 4.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.388 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.803 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -120.74 149.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 111.476 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t0 -95.75 68.89 2.88 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.21 -35.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mt-10 -59.68 -52.98 63.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.746 -1.221 . . . . 0.0 109.202 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.66 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.79 -40.86 72.31 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.4 -0.812 . . . . 0.0 109.049 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.09 -18.69 65.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 108.548 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.26 -22.96 23.65 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.242 -0.911 . . . . 0.0 109.524 178.376 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 62' ' ' VAL . 3.7 t80 -61.05 -43.28 99.12 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.139 1.447 . . . . 0.0 107.305 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.995 ' CD1' HG21 ' A' ' 36' ' ' ILE . 78.7 m95 -68.6 -53.31 23.52 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.893 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 74' ' ' LEU . 6.6 mt -57.39 -21.02 33.37 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.574 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -81.58 -23.89 36.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.453 -0.779 . . . . 0.0 110.651 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 59' ' ' TRP . 25.5 m -99.15 32.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 120.817 -1.177 . . . . 0.0 109.649 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.42 31.25 76.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.54 141.68 51.86 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.006 -1.291 . . . . 0.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.453 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -105.91 103.04 42.42 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 110.128 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.4 Cg_endo -81.26 125.14 5.07 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.698 1.367 . . . . 0.0 110.226 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.5 t -54.9 176.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.0 -1.062 . . . . 0.0 109.695 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.79 -19.68 62.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.182 -0.949 . . . . 0.0 111.026 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 1.028 HG21 HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -90.5 -51.17 5.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.686 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.683 ' H ' HG23 ' A' ' 67' ' ' THR . . . -70.4 -27.59 64.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.21 -37.98 78.35 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -69.47 -47.34 64.25 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.545 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 70' ' ' ALA . 15.4 mt -60.48 -25.13 65.81 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 60' ' ' LEU . 23.1 mt -76.19 -25.94 55.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.08 -31.49 30.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.495 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.5 tp-100 -87.18 -36.46 18.01 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.724 0.773 . . . . 0.0 110.7 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.86 -10.78 31.01 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.705 -0.622 . . . . 0.0 110.01 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.64 48.78 5.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.612 HG21 HD23 ' A' ' 74' ' ' LEU . 49.5 t -100.39 -62.82 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.065 -1.256 . . . . 0.0 111.44 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 19.8 m-85 -52.9 142.52 19.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.918 -1.114 . . . . 0.0 109.651 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -110.68 72.71 0.79 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.42 102.79 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -98.98 167.35 10.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.169 -0.957 . . . . 0.0 109.882 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.17 -161.9 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.044 . . . . 0.0 110.626 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -112.48 65.13 0.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -53.4 175.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.2 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.24 33.63 76.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 0.0 110.253 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.537 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.904 HG11 HG23 ' A' ' 62' ' ' VAL . 49.9 t -66.41 98.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt -138.6 133.41 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.982 HD11 ' CB ' ' A' ' 59' ' ' TRP . 84.9 mt -106.05 133.37 50.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.162 -0.961 . . . . 0.0 109.649 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.525 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.2 174.33 13.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.956 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.476 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 1.2 pp -89.26 129.43 35.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.1 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.65 165.5 11.77 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.473 -0.767 . . . . 0.0 109.334 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -128.7 117.46 21.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.974 -1.079 . . . . 0.0 111.483 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -129.22 -152.76 0.53 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.32 -0.862 . . . . 0.0 109.564 179.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.1 94.82 1.37 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.411 ' OG ' ' HG2' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -62.29 -52.77 62.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 109.743 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HG2' ' OG ' ' A' ' 11' ' ' SER . 1.9 pttm -173.5 39.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 110.063 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -119.37 -40.45 2.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -172.61 133.23 0.7 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.633 -0.667 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.44 123.54 8.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.48 1.253 . . . . 0.0 111.141 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 30.1 p80 -153.75 143.99 22.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.102 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 14.5 m-85 -117.96 166.61 12.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.429 -0.795 . . . . 0.0 109.083 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.69 147.16 50.38 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.006 -1.059 . . . . 0.0 108.384 178.118 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.872 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -97.31 81.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 178.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG23 ' CD ' ' A' ' 18' ' ' ARG 0.29 0.4 OUTLIER -98.2 160.49 3.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.78 -173.347 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.943 HG13 HG12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -104.16 107.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.686 -0.634 . . . . 0.0 109.862 -178.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t -139.32 -168.6 2.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 110.425 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.9 m-20 -90.47 -167.87 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 26' ' ' ARG . . . -104.85 -22.76 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -60.54 83.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -107.88 53.47 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 110.278 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -27.04 47.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -173.82 38.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.883 . . . . 0.0 110.164 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.64 172.34 14.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.048 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.52 48.57 0.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -83.66 134.32 34.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -1.222 . . . . 0.0 110.082 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.487 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.6 p90 -113.97 155.18 26.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 110.62 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.511 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.6 mt -68.92 -29.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.488 -0.758 . . . . 0.0 109.643 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.37 179.94 4.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 31.9 pttt -120.81 121.82 38.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 56' ' ' ALA . 23.9 pt -116.92 -38.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.135 -0.978 . . . . 0.0 111.607 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.843 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.0 165.64 13.05 Favored Glycine 0 C--N 1.296 -1.686 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.531 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.421 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.6 t80 -139.07 126.68 21.86 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.578 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 5.8 t80 -119.27 136.59 54.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.959 -1.088 . . . . 0.0 110.548 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 32.4 t70 -131.63 87.57 45.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.633 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.5 82.82 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.554 1.292 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -99.66 168.98 9.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -0.774 . . . . 0.0 110.372 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -120.04 16.25 12.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 t -120.94 -27.53 4.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.987 . . . . 0.0 110.649 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 p -126.53 138.98 33.53 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.093 -1.005 . . . . 0.0 110.439 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.21 -41.7 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.697 1.367 . . . . 0.0 110.718 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.37 98.44 6.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.765 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.737 ' HZ3' HD12 ' A' ' 49' ' ' LEU . 5.2 p-90 -132.27 -3.28 3.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 111.3 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.749 HD11 ' HB3' ' A' ' 73' ' ' LEU . 1.4 tt -89.97 118.74 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.781 -1.199 . . . . 0.0 110.93 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.16 94.79 4.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.43 -0.793 . . . . 0.0 108.884 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.872 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -118.51 141.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 111.557 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -85.3 67.19 10.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.879 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.82 -29.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -61.13 -47.32 86.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.78 -1.2 . . . . 0.0 108.567 178.138 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 30.8 mmm180 -76.88 -38.53 53.46 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.68 -21.75 66.81 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.3 -21.16 24.58 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.442 -0.786 . . . . 0.0 109.536 178.252 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.821 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -65.81 -49.39 68.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.242 1.496 . . . . 0.0 107.451 178.617 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.982 ' CB ' HD11 ' A' ' 4' ' ' ILE . 86.7 m95 -63.6 -56.08 18.72 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.748 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.761 HD21 ' HG3' ' A' ' 66' ' ' PRO . 12.4 mt -52.95 -22.79 6.04 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.421 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -81.89 -19.06 41.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.544 -0.722 . . . . 0.0 110.337 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.904 HG23 HG11 ' A' ' 2' ' ' VAL . 3.2 m -98.74 31.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.849 -1.157 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.25 72.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.23 143.57 52.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -1.209 . . . . 0.0 110.109 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -106.54 105.65 55.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 0.0 110.532 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.761 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.3 Cg_endo -80.85 140.48 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.616 1.324 . . . . 0.0 110.335 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 70.5 p -72.24 163.52 27.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.993 -1.067 . . . . 0.0 110.166 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.63 -22.48 61.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.725 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.476 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 12.5 m -92.78 -48.23 6.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.173 -0.954 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.989 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.78 -30.21 67.71 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' A' ' 74' ' ' LEU . 12.2 ttt-85 -66.12 -37.5 85.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -28.9 70.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.989 HD12 ' HA ' ' A' ' 70' ' ' ALA . 14.8 mt -83.94 -33.4 24.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.59 HD13 HD11 ' A' ' 60' ' ' LEU . 80.5 mt -63.99 -30.53 71.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -79.59 -25.72 41.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.631 ' HB3' HD13 ' A' ' 49' ' ' LEU . 10.3 tp-100 -74.32 -35.01 63.62 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.12 0.962 . . . . 0.0 109.26 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -72.24 -5.8 38.48 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.23 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.45 48.31 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.879 HG22 HG23 ' A' ' 53' ' ' VAL . 44.0 t -106.01 -3.49 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 111.501 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 13.1 m-85 -109.82 -14.96 14.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.839 -1.163 . . . . 0.0 110.478 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -171.32 168.63 6.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -173.29 126.8 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.193 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -172.52 -47.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 83' ' ' GLU . . . -176.87 163.79 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -111.09 15.55 21.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -72.95 132.04 42.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 110.238 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.95 -115.3 3.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.217 -1.167 . . . . 0.0 110.254 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.6 m -58.35 116.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.074 -1.016 . . . . 0.0 110.337 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -140.22 129.16 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.924 ' CG1' HG13 ' A' ' 21' ' ' VAL . 74.9 mt -99.8 131.9 46.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.023 -1.048 . . . . 0.0 109.373 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.0 ptm180 -150.42 -167.06 2.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.038 -1.039 . . . . 0.0 110.361 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.723 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.6 mp -89.31 131.22 35.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.356 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -103.08 105.06 15.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 111.206 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.508 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.2 119.49 18.49 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.192 -0.943 . . . . 0.0 111.525 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 11.3 m-85 -108.13 -63.43 1.32 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.516 -0.74 . . . . 0.0 109.793 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.58 104.36 0.42 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 53.1 p -66.92 -55.8 13.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 110.286 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.445 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.9 mmtt -141.1 48.99 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -139.07 -63.01 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.937 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 53.0 t-20 -135.38 125.52 16.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.59 111.31 3.12 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.494 1.26 . . . . 0.0 110.895 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 33.6 p80 -169.63 119.18 0.65 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.26 -0.9 . . . . 0.0 110.393 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 3.9 m-30 -110.28 154.01 24.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.85 -1.156 . . . . 0.0 108.437 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -104.03 165.91 10.74 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.24 176.55 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.707 HD12 HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -98.46 83.74 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.252 0.3 OUTLIER -97.6 169.73 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.146 -174.943 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.924 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -113.47 104.83 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.56 -0.712 . . . . 0.0 110.496 -177.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t -130.6 -173.01 2.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.248 -0.907 . . . . 0.0 110.166 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' ARG . 6.8 p-10 -147.01 -147.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.974 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.07 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' ASP . 23.4 mtm-85 -50.52 146.48 5.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.306 -0.871 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -71.3 -168.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 110.422 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.59 15.66 28.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 110.431 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -140.05 -61.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.175 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -135.38 78.95 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.5 135.08 52.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 -177.48 4.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 110.138 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 -116.88 175.64 5.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 110.285 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.776 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.9 mt -82.77 -43.62 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.482 -0.761 . . . . 0.0 109.37 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.3 161.72 30.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.486 -0.758 . . . . 0.0 109.624 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -98.13 116.74 30.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.101 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 56' ' ' ALA . 35.5 pt -104.66 -36.08 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.975 -1.078 . . . . 0.0 111.472 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.811 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -129.08 177.04 18.14 Favored Glycine 0 C--N 1.294 -1.753 0 C-N-CA 118.917 -1.611 . . . . 0.0 112.291 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 17.2 t80 -140.58 145.63 36.97 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 4.2 t80 -142.92 129.64 20.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.609 -1.307 . . . . 0.0 110.5 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 9.3 t0 -137.41 92.04 13.8 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.818 -1.176 . . . . 0.0 110.25 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.91 69.46 3.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.629 1.331 . . . . 0.0 110.791 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.08 160.99 16.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.83 65.79 1.34 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.518 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -136.3 -58.61 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.1 p -127.23 163.26 43.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.6 -31.3 11.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.706 1.372 . . . . 0.0 110.566 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 119.07 25.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.327 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.705 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -149.09 15.68 0.93 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.12 -0.988 . . . . 0.0 110.945 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 73' ' ' LEU . 11.8 tp -114.23 129.09 56.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.039 -1.038 . . . . 0.0 111.213 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -128.25 110.45 12.41 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.811 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.24 160.96 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.419 1.104 . . . . 0.0 111.72 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.4 t70 -104.91 67.58 0.8 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.05 -32.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.593 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -63.58 -52.06 62.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.9 -1.125 . . . . 0.0 109.232 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.8 mtm-85 -75.69 -33.3 60.35 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.241 -0.912 . . . . 0.0 109.428 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -68.99 -23.8 64.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.5 ttt-85 -86.3 -21.89 27.06 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.24 -0.912 . . . . 0.0 109.726 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -61.02 -50.57 72.8 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.252 1.501 . . . . 0.0 107.039 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.906 ' CD2' HG11 ' A' ' 21' ' ' VAL . 84.5 m95 -60.27 -53.02 62.65 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.576 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 56' ' ' ALA . 1.3 mt -54.42 -22.04 11.43 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -77.97 -22.75 48.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.542 -0.724 . . . . 0.0 110.408 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 59' ' ' TRP . 8.9 m -99.05 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.784 -1.197 . . . . 0.0 109.736 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.58 25.58 74.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -66.84 129.69 40.7 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.237 -1.155 . . . . 0.0 109.763 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.35 116.43 63.75 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.2 Cg_endo -82.77 128.4 5.21 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.526 1.277 . . . . 0.0 109.921 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 t -55.49 176.42 0.06 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.852 -1.155 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 55.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 m -166.67 -59.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.15 -23.16 66.43 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 18.0 ttp85 -65.62 -42.71 91.25 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 3.1 ttm180 -67.46 -42.16 83.47 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.424 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.735 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.1 mt -68.19 -26.16 65.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 60' ' ' LEU . 13.7 mt -67.61 -30.17 69.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG2' ' CE1' ' A' ' 80' ' ' PHE . 9.0 mtm180 -75.98 -34.52 59.78 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.26 56.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.925 0.869 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.764 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.65 -7.55 39.89 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.306 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.95 19.51 33.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 60' ' ' LEU . 12.2 t -86.74 -64.46 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.256 . . . . 0.0 110.763 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 75' ' ' ARG . 43.4 p90 -149.11 143.93 26.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.986 -1.071 . . . . 0.0 111.098 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.02 -177.57 3.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.975 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -135.46 65.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.283 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 128.1 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.264 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -118.77 -25.89 6.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.437 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.34 -61.07 2.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -52.48 134.42 34.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.905 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.42 -141.24 16.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.197 -1.178 . . . . 0.0 110.135 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.488 HG11 ' CG2' ' A' ' 62' ' ' VAL . 39.7 t -54.55 116.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 110.254 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 65' ' ' GLN . 57.8 mtpt -140.92 134.72 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.993 . . . . 0.0 110.323 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.998 ' CG1' HG13 ' A' ' 21' ' ' VAL . 37.9 mt -99.73 133.99 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 108.917 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.8 ptt180 -150.35 172.99 14.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.006 -1.059 . . . . 0.0 109.941 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 2.9 pp -89.28 130.84 35.61 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 109.518 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.15 162.21 13.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.571 -0.706 . . . . 0.0 109.212 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 70.6 ttt180 -127.92 114.45 17.18 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.931 -1.106 . . . . 0.0 111.4 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -127.18 -152.51 0.52 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.301 -0.875 . . . . 0.0 109.119 178.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.81 98.82 0.99 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.488 ' HG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -56.71 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.273 -1.133 . . . . 0.0 110.043 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.6 54.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 108.761 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.488 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 4.3 m-70 -142.51 -47.58 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.601 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -151.06 110.07 3.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.42 122.31 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.51 1.269 . . . . 0.0 110.91 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 27.1 p80 -148.57 152.33 36.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 109.845 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 12.5 m-85 -123.14 168.37 12.49 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.541 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 2.2 ttp180 -132.05 147.19 52.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.017 -1.052 . . . . 0.0 108.18 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.841 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -97.22 83.24 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 178.086 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.291 0.4 OUTLIER -97.56 167.0 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.338 -173.118 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.998 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -112.85 105.65 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.488 -0.758 . . . . 0.0 110.986 -177.034 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' HD12 ' A' ' 33' ' ' ILE . 1.9 t -134.7 -170.23 2.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.0 110.004 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 22' ' ' THR . 75.9 m-20 -102.5 -169.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.14 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.77 27.73 4.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -60.8 -166.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -69.41 -166.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.487 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.4 11.63 10.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -90.95 14.5 13.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.006 -1.059 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.64 -55.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.33 70.71 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -138.47 130.27 28.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -1.17 . . . . 0.0 110.47 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 31.8 p90 -118.72 159.55 23.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.279 -0.888 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.679 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -62.61 -46.12 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -157.81 171.66 19.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.613 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.63 125.15 53.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.652 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.995 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -120.76 -28.05 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.044 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.916 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.26 158.77 14.86 Favored Glycine 0 C--N 1.297 -1.607 0 C-N-CA 118.945 -1.598 . . . . 0.0 111.078 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 69.2 t80 -132.61 133.2 43.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.577 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 t80 -124.39 136.1 53.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.301 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.7 t70 -132.73 83.85 51.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.013 -1.055 . . . . 0.0 110.007 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 43.5 Cg_endo -69.6 61.24 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.519 1.273 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 149.5 21.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 110.347 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -95.5 44.07 1.09 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.999 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.3 p -125.7 -43.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 0.0 110.635 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 p -132.14 152.29 79.91 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 51.0 Cg_endo -78.39 -36.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.808 1.425 . . . . 0.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.19 90.7 4.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.305 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.577 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 6.9 p-90 -125.69 -8.75 6.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 111.172 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 76' ' ' GLN . 3.9 tt -83.73 126.93 33.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.834 -1.166 . . . . 0.0 110.429 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -135.33 91.93 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.453 -0.78 . . . . 0.0 109.373 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.916 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -117.86 137.8 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 111.132 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.3 t70 -82.18 70.2 9.06 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.626 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.69 -31.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.556 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.5 tt0 -62.87 -52.05 64.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.869 -1.144 . . . . 0.0 108.902 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.68 -34.78 60.46 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.024 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.941 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -66.67 -18.07 65.18 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 28.9 ttp180 -88.39 -25.19 22.82 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.376 -0.827 . . . . 0.0 109.361 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.916 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -59.06 -44.84 91.88 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.356 1.55 . . . . 0.0 107.096 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.995 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.1 m95 -68.38 -57.88 5.21 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.836 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.425 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.4 mt -52.74 -23.31 6.53 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.314 -0.954 . . . . 0.0 108.612 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 t -80.78 -21.41 41.01 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 110.38 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -98.63 32.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.773 -1.204 . . . . 0.0 109.293 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.05 74.17 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.98 109.33 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 110.312 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -78.08 114.5 42.66 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 110.413 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -82.08 148.76 15.29 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.496 1.261 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.634 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 1.8 p -74.81 161.79 29.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.014 -1.053 . . . . 0.0 109.83 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.41 -25.6 59.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.043 -1.036 . . . . 0.0 110.985 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.474 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 38.4 m -93.28 -47.58 6.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 0.0 110.6 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.964 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.51 -27.63 65.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.8 ttt-85 -65.65 -38.85 90.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -34.77 76.75 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.524 -0.87 . . . . 0.0 108.879 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -76.74 -33.42 58.13 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 66' ' ' PRO . 74.3 mt -65.38 -28.27 69.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.486 ' HD2' ' CG ' ' A' ' 80' ' ' PHE . 3.7 mmm180 -79.01 -32.15 45.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.691 ' HB3' HD13 ' A' ' 49' ' ' LEU . 8.1 tp-100 -72.06 -34.44 68.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.153 0.978 . . . . 0.0 108.998 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.67 -9.74 46.14 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.148 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 44.36 7.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.597 HG22 ' CB ' ' A' ' 53' ' ' VAL . 47.2 t -103.17 -12.34 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.193 -1.181 . . . . 0.0 111.394 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 11.6 m-85 -104.5 152.34 22.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.08 . . . . 0.0 110.257 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -65.07 79.24 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.079 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 80' ' ' PHE . 6.8 mm-40 -152.82 73.28 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 110.057 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.05 -60.36 1.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 110.205 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.86 161.87 28.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.853 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -137.97 -43.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -176.59 -171.34 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.63 162.58 11.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.144 . . . . 0.0 110.119 179.987 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.255 0.55 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.691 HG11 ' CE3' ' A' ' 59' ' ' TRP . 26.9 t -119.84 134.01 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 109.855 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.653 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.948 HD11 ' CB ' ' A' ' 59' ' ' TRP . 54.8 mt -109.53 133.41 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.146 -0.971 . . . . 0.0 109.48 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 5.2 ptp180 -151.52 -166.79 2.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.781 -1.199 . . . . 0.0 110.69 -178.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 17' ' ' TYR . 41.9 mt -88.67 127.68 35.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.85 107.33 18.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.3 -0.875 . . . . 0.0 110.905 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.499 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ttt180 -62.99 123.97 19.9 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.973 . . . . 0.0 109.97 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.559 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 46.8 m-85 -99.11 -75.05 0.57 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.841 0.829 . . . . 0.0 110.6 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.09 129.12 17.55 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 54.1 p -63.58 -55.55 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -1.145 . . . . 0.0 109.887 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 9.5 mtmm -147.97 48.15 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -0.807 . . . . 0.0 109.135 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -124.13 -65.09 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.461 -0.774 . . . . 0.0 109.601 -178.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' HB3' ' CE1' ' A' ' 16' ' ' HIS . 50.3 t30 -126.08 124.28 24.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.429 -0.795 . . . . 0.0 109.348 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.81 106.32 2.24 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.342 1.18 . . . . 0.0 111.403 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.649 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 25.9 p-80 -171.75 127.09 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 0.0 110.608 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.695 ' HB2' HD22 ' A' ' 6' ' ' LEU . 7.5 m-30 -113.87 159.89 19.35 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 108.854 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.88 156.27 17.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.504 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.923 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.23 75.77 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 176.427 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.257 0.3 OUTLIER -97.27 165.46 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.859 -173.261 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.915 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.7 113.25 42.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.463 0.649 . . . . 0.0 111.407 -176.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.0 t -137.23 -169.85 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.665 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 22' ' ' THR . 18.1 p30 -138.22 170.24 16.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.32 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.22 28.88 3.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 0.0 110.185 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -46.7 73.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.79 -175.34 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.68 166.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -55.53 123.57 14.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.358 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.49 -174.74 5.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.046 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.27 43.09 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -103.55 103.31 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 6.3 p90 -116.09 175.07 5.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.236 -0.915 . . . . 0.0 110.511 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 ' HH2' ' A' ' 59' ' ' TRP . 16.3 mt -89.11 -41.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.59 -0.694 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.58 162.22 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.9 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.594 ' HA ' HG23 ' A' ' 20' ' ' VAL . 2.6 mtpt -101.44 113.89 27.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 0.0 109.734 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.949 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.4 pt -107.37 -34.77 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.198 -0.938 . . . . 0.0 111.24 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.85 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.49 165.77 17.37 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.099 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' ILE . 12.7 t80 -137.49 142.46 41.5 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.603 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 39.4 t80 -138.11 133.21 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.767 -1.208 . . . . 0.0 110.404 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 7.6 t0 -140.24 101.11 6.91 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.946 -1.096 . . . . 0.0 109.767 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 51.9 Cg_endo -78.07 70.9 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.126 1.066 . . . . 0.0 110.568 -179.028 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -91.93 149.24 21.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.024 -1.048 . . . . 0.0 110.661 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.35 39.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 45' ' ' THR . 4.8 t -145.04 -41.19 0.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 44' ' ' THR . 1.2 p -102.6 125.39 36.04 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 110.375 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.25 -4.46 14.79 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.475 1.25 . . . . 0.0 110.76 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -117.71 89.45 3.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.603 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 16.6 p-90 -120.24 -20.07 7.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.24 -0.912 . . . . 0.0 110.756 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.543 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 6.7 tt -75.81 101.03 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.102 -0.999 . . . . 0.0 110.309 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -118.17 104.3 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.975 . . . . 0.0 109.508 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.2 t -128.15 149.31 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.347 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 21.8 t0 -94.23 67.99 3.61 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.16 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.6 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -32.96 -34.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.632 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -61.72 -54.17 46.12 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.894 -1.122 . . . . 0.0 108.57 178.333 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -74.32 -33.06 63.06 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.437 -0.79 . . . . 0.0 109.331 178.973 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.848 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -69.02 -23.56 64.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -87.02 -19.78 28.17 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.552 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -62.47 -48.49 79.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.277 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.949 ' CD1' HG21 ' A' ' 36' ' ' ILE . 89.5 m95 -63.08 -55.42 25.62 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.257 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 74' ' ' LEU . 3.9 mt -52.4 -22.91 5.16 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.558 176.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -79.93 -21.9 43.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.433 -0.792 . . . . 0.0 110.797 179.229 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 59' ' ' TRP . 6.4 m -98.79 33.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.843 -1.161 . . . . 0.0 109.227 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.55 27.48 73.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.71 142.54 48.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.192 -1.181 . . . . 0.0 109.833 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.38 114.6 38.28 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 110.523 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.665 ' HB3' HD12 ' A' ' 74' ' ' LEU . 49.5 Cg_endo -79.77 128.95 7.92 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.497 1.261 . . . . 0.0 110.308 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.99 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.516 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.77 53.56 1.14 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -166.77 -59.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -66.52 -22.94 66.17 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 2.5 ttt85 -69.01 -43.24 75.21 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 ttm-85 -66.38 -38.44 87.56 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.731 178.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.6 mt -74.37 -26.37 60.08 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 66' ' ' PRO . 13.7 mt -72.0 -29.84 64.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.451 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.26 -28.98 38.31 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.126 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.431 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.68 -34.58 30.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.814 0.816 . . . . 0.0 109.932 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -62.19 -14.26 35.95 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.793 -0.567 . . . . 0.0 109.877 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 25.58 8.56 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 53' ' ' VAL . 17.5 t -86.78 -68.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.846 -1.385 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.451 ' CE1' ' CG ' ' A' ' 75' ' ' ARG . 15.5 p90 -126.55 -167.64 1.75 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 122.52 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.004 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.75 53.66 0.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.422 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.77 168.18 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.027 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.85 -176.91 6.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -151.57 126.56 9.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -51.94 157.21 1.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 110.241 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.42 -91.07 1.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 179.872 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpp? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.26 0.552 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.565 ' C ' HD12 ' A' ' 4' ' ' ILE . 21.6 ptmt -140.11 143.28 36.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.121 -0.987 . . . . 0.0 110.874 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.999 HD11 HG13 ' A' ' 21' ' ' VAL . 1.7 mp -100.23 139.09 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 108.901 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.3 -166.12 2.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' HD2' ' A' ' 17' ' ' TYR . 31.1 mt -89.5 135.7 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.86 . . . . 0.0 109.904 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -105.42 103.44 12.96 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.802 . . . . 0.0 111.029 -179.454 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.495 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.55 119.36 17.67 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.53 -0.731 . . . . 0.0 110.942 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 20.0 m-85 -106.07 -63.05 1.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.512 -0.742 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.88 161.09 3.91 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -85.71 -79.24 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -1.009 . . . . 0.0 109.928 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -143.89 40.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 108.851 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.452 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 5.1 m-70 -126.62 -64.65 1.01 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 0.0 109.268 -178.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 22.9 t-20 -105.56 102.05 35.6 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.365 -0.834 . . . . 0.0 109.284 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.63 109.15 2.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.612 1.322 . . . . 0.0 111.163 -179.087 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.1 p80 -164.74 126.89 2.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.247 -0.908 . . . . 0.0 110.575 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.546 ' HD2' HD13 ' A' ' 6' ' ' LEU . 3.9 m-30 -118.76 155.16 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 3.9 ptm180 -103.55 167.61 9.69 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 117.453 -1.699 . . . . 0.0 107.571 176.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.842 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.58 86.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 178.907 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.492 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.256 0.3 OUTLIER -98.95 170.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.224 -174.856 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.019 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.8 t -111.95 113.78 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.595 -0.69 . . . . 0.0 110.209 -178.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -140.49 -168.08 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.438 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.56 174.16 6.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.392 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.48 59.73 2.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.121 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.283 -0.886 . . . . 0.0 110.408 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -127.56 -166.8 1.66 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -100.74 -20.51 15.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.69 52.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.6 -171.27 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.69 57.83 0.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.19 108.99 11.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -1.158 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CD2' HG21 ' A' ' 20' ' ' VAL . 8.6 p90 -113.03 151.42 30.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.177 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HG3' ' A' ' 34' ' ' GLU . 4.7 mt -64.63 -63.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.944 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 33' ' ' ILE . 44.1 mt-10 -139.27 161.48 37.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.918 . . . . 0.0 110.255 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 118.92 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -0.948 . . . . 0.0 109.976 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.675 HG21 ' CD1' ' A' ' 59' ' ' TRP . 49.5 pt -99.95 -27.96 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.801 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -150.6 -174.1 21.35 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 117.908 -2.091 . . . . 0.0 112.769 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 31.4 t80 -141.25 151.12 43.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.262 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.842 ' HB2' HD11 ' A' ' 19' ' ' ILE . 2.6 t80 -144.02 124.68 14.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.689 -1.257 . . . . 0.0 109.701 177.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 63.0 t0 -138.53 94.36 10.63 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.588 -1.32 . . . . 0.0 110.335 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.84 83.15 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.772 1.406 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -89.86 -156.75 0.43 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -141.72 43.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.29 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -121.59 -48.16 2.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.89 166.6 19.64 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.027 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 -16.18 27.19 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.661 1.348 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -80.62 96.01 6.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.309 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.786 ' HZ3' HD23 ' A' ' 49' ' ' LEU . 9.1 p-90 -134.57 10.39 3.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.224 -0.922 . . . . 0.0 110.56 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.804 HD13 ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -118.21 131.98 56.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.016 -1.052 . . . . 0.0 110.549 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.804 ' N ' HD13 ' A' ' 49' ' ' LEU . 29.4 tttt -136.69 75.94 1.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.801 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -97.26 134.47 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 110.968 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -80.43 69.07 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 175.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.581 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.47 -31.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.514 -177.326 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.09 -55.98 26.21 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.899 -1.125 . . . . 0.0 108.778 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 5.1 mmp_? -69.28 -41.2 77.16 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.54 -16.7 63.03 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.947 -1.095 . . . . 0.0 108.071 178.563 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.65 -25.73 22.25 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 177.849 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.856 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -59.71 -46.62 88.56 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.23 1.49 . . . . 0.0 107.406 178.747 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.019 ' CD2' HG11 ' A' ' 21' ' ' VAL . 94.6 m95 -67.0 -56.57 9.54 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.259 -178.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 74' ' ' LEU . 1.9 mt -52.45 -23.22 5.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.391 176.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -80.5 -21.0 42.37 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.647 -0.658 . . . . 0.0 110.272 178.938 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.3 m -98.67 32.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.468 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.27 29.36 74.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.592 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -77.66 129.1 35.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.269 -1.136 . . . . 0.0 109.924 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -97.67 108.52 46.03 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.438 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HG3' HD21 ' A' ' 60' ' ' LEU . 50.8 Cg_endo -77.13 135.38 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.613 1.323 . . . . 0.0 110.368 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 2.3 p -54.69 161.08 1.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.892 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.74 -22.62 58.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.009 . . . . 0.0 110.107 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.0 m -89.19 -52.38 5.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.626 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.13 -23.88 65.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -70.06 -38.58 75.81 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.336 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -64.92 -34.24 77.94 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.87 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 70' ' ' ALA . 47.8 mt -74.08 -32.58 63.32 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 60' ' ' LEU . 56.3 mt -68.29 -28.88 67.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.524 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.56 -30.4 52.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.957 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -29.21 37.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.891 0.853 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -76.98 -1.67 29.91 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.198 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.09 50.08 8.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.581 HG22 ' HB ' ' A' ' 53' ' ' VAL . 58.3 t -98.4 -57.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.291 -1.123 . . . . 0.0 111.336 -179.225 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 4.3 m-30 -61.06 -61.92 2.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.214 -0.929 . . . . 0.0 110.596 -179.09 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.27 174.54 10.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.583 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.48 150.77 23.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.923 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -100.25 132.88 45.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.318 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.98 -168.69 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.084 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -116.84 103.89 10.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -54.5 147.69 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.04 -4.5 88.79 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.328 . . . . 0.0 110.326 -179.905 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.252 0.549 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.472 HG11 ' CE3' ' A' ' 59' ' ' TRP . 84.1 t -102.07 141.36 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.301 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.548 ' C ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -139.78 137.06 34.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.387 -0.82 . . . . 0.0 109.999 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.891 ' CD1' HG13 ' A' ' 21' ' ' VAL . 1.8 mp -99.63 135.89 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 5.3 ptp180 -151.18 175.39 12.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.707 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD12 ' CD2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -88.17 126.16 34.99 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.935 178.882 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.19 109.84 22.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.56 -0.713 . . . . 0.0 111.917 -177.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 52.6 ttp180 -72.87 120.9 19.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 111.152 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 10.5 m-85 -114.25 -63.44 1.45 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.109 -0.994 . . . . 0.0 109.972 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.14 128.94 23.18 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 27.6 p -93.17 -55.67 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -1.111 . . . . 0.0 109.827 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' N ' ' OG ' ' A' ' 11' ' ' SER . 14.8 mttt -143.92 45.61 1.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -137.58 -64.65 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -135.44 114.78 11.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.612 -0.68 . . . . 0.0 109.707 179.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.61 99.55 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.336 1.177 . . . . 0.0 110.947 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.659 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 16.7 p-80 -149.97 134.32 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.191 -0.943 . . . . 0.0 110.403 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 6' ' ' LEU . 4.8 m-85 -117.43 151.78 36.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.269 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 2.6 ttt85 -104.64 150.28 24.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.629 178.195 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.086 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -97.35 80.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.288 0.4 OUTLIER -97.35 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.734 -173.821 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.4 t -115.65 107.73 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.516 -176.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.06 179.56 5.17 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.268 -0.895 . . . . 0.0 110.027 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 178.38 5.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.336 -0.852 . . . . 0.0 110.305 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.33 -45.99 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -52.7 -47.7 67.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.212 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -84.1 141.26 31.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.196 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -139.4 41.03 2.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -35.51 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.366 -0.834 . . . . 0.0 110.209 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -113.05 -66.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.377 -0.827 . . . . 0.0 110.159 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.45 -8.54 28.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 170.38 6.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.0 -1.294 . . . . 0.0 110.567 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 20.0 p90 -109.66 -166.34 1.09 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.382 -0.824 . . . . 0.0 109.933 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.551 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.4 mt -107.69 -36.43 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 110.329 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.84 176.04 9.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -110.68 109.45 19.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.694 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.976 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.7 pt -106.11 -33.1 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.14 -0.975 . . . . 0.0 111.124 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.37 166.08 20.25 Favored Glycine 0 C--N 1.295 -1.723 0 C-N-CA 118.603 -1.76 . . . . 0.0 111.039 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.483 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.1 t80 -138.45 142.29 39.47 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.086 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.1 t80 -134.47 130.76 37.19 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.056 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 65.1 t0 -137.5 90.35 14.98 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 110.195 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 41.3 Cg_endo -67.35 79.1 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.715 1.376 . . . . 0.0 110.797 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -174.88 4.49 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.424 -0.798 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -130.96 69.49 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 45' ' ' THR . 4.0 t -148.29 -42.12 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.38 -0.825 . . . . 0.0 109.905 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.475 ' N ' HG23 ' A' ' 44' ' ' THR . 0.2 OUTLIER -143.8 163.03 38.3 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.494 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.52 -22.24 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.6 1.316 . . . . 0.0 110.515 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 4.3 m-20 -83.03 103.51 12.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 110.078 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.762 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 1.5 p-90 -137.95 20.84 2.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.21 -0.931 . . . . 0.0 110.768 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.762 HD13 ' HZ3' ' A' ' 48' ' ' TRP . 9.4 tp -126.0 134.17 51.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.96 -1.087 . . . . 0.0 111.044 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -132.7 97.35 4.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.758 . . . . 0.0 109.148 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.841 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 151.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 110.925 -179.133 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.6 t0 -96.65 67.95 2.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.703 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.99 -30.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 122.252 -0.28 . . . . 0.0 111.509 -177.281 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.7 tp10 -60.45 -54.62 43.33 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.761 -1.212 . . . . 0.0 108.581 178.026 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 47.3 mmm-85 -72.97 -37.06 67.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.825 . . . . 0.0 109.005 178.411 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.54 -20.59 66.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.382 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.8 ttt180 -88.35 -24.37 23.14 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.277 -0.889 . . . . 0.0 109.519 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.684 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -60.06 -46.59 89.04 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 123.5 1.619 . . . . 0.0 106.928 178.288 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.008 ' CD2' HG11 ' A' ' 21' ' ' VAL . 79.1 m95 -63.72 -55.92 19.59 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.952 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -52.8 -22.36 5.26 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.549 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.37 -20.89 43.08 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.0 110.691 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.3 m -99.0 32.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.875 -1.14 . . . . 0.0 109.952 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.85 71.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -77.0 138.51 39.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -1.112 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.435 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 1.5 mm-40 -116.78 118.29 36.76 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.391 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.2 Cg_endo -79.67 140.46 14.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.397 1.209 . . . . 0.0 109.856 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 70' ' ' ALA . 7.2 t -62.56 176.22 0.68 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.96 -1.088 . . . . 0.0 110.468 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -81.58 49.77 1.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.154 -0.966 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.14 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.58 -23.91 66.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.101 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 25.6 ttt85 -63.81 -40.39 96.51 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.105 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -35.83 74.23 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 70' ' ' ALA . 46.6 mt -72.46 -38.58 68.22 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 66' ' ' PRO . 24.8 mt -61.04 -28.15 68.85 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.161 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.547 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -77.69 -31.0 52.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.453 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.8 tp-100 -75.81 -35.16 60.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.039 0.923 . . . . 0.0 109.866 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.13 -7.02 32.33 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.472 178.953 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.2 8.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 53' ' ' VAL . 57.4 t -96.93 -52.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.356 -1.085 . . . . 0.0 111.572 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.5 m-30 -60.03 174.64 0.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 110.32 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 132.29 35.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.03 109.04 4.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.26 141.94 57.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.893 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.54 -43.93 3.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -79.4 86.82 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.94 -64.87 0.81 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.07 -154.53 3.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.244 . . . . 0.0 110.221 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.226 0.536 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.648 HG11 ' CE3' ' A' ' 59' ' ' TRP . 78.0 t -99.75 139.93 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.294 -0.879 . . . . 0.0 109.904 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 59.7 mtpt -140.32 132.39 27.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.926 HD11 ' CB ' ' A' ' 59' ' ' TRP . 61.9 mt -100.17 127.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 121.076 -1.015 . . . . 0.0 109.153 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 1.2 ptm180 -150.74 -170.4 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.017 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -88.49 126.32 35.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 105.8 17.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 111.085 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.446 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 36.8 ttp180 -63.97 125.84 25.74 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 109.817 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 18' ' ' ARG . 59.3 m-85 -102.62 -75.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 111.205 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 136.22 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 p -62.84 -47.04 85.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.374 -1.074 . . . . 0.0 109.357 179.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -168.37 53.06 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.484 0.659 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -124.44 -54.45 1.67 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.088 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -131.05 124.79 20.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.92 100.86 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.373 1.197 . . . . 0.0 111.479 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.643 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 29.2 p-80 -164.38 127.39 2.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.963 . . . . 0.0 111.061 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 13.9 m-85 -117.45 160.44 21.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.3 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -104.13 158.9 16.12 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.379 -1.329 . . . . 0.0 108.089 177.166 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.904 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.3 77.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.708 HG11 ' CD2' ' A' ' 32' ' ' TYR 0.255 0.3 OUTLIER -97.25 164.69 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.855 -173.398 . . . . . . . . 4 4 . 1 . 024 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.815 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.44 105.48 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 109.967 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.754 HG22 ' HB3' ' A' ' 32' ' ' TYR . 3.0 p -99.99 152.22 20.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.649 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.2 -153.33 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -152.02 25.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -57.47 -18.88 20.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 110.568 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.37 179.18 7.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.565 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.13 80.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.206 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.1 119.03 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -20.41 13.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.344 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 -5.13 84.36 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.51 -166.79 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.957 -1.319 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.754 ' HB3' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER -151.13 168.26 25.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.335 -0.853 . . . . 0.0 110.135 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.671 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.9 mt -59.88 -50.01 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.764 . . . . 0.0 109.926 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -178.31 5.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 109.904 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HE2' ' NH2' ' A' ' 18' ' ' ARG . 7.1 mtpt -117.8 125.39 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.943 . . . . 0.0 110.343 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.054 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.48 -33.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.176 -0.953 . . . . 0.0 111.242 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.894 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.5 161.37 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 C-N-CA 118.919 -1.61 . . . . 0.0 110.967 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.491 ' CD1' ' HG2' ' A' ' 18' ' ' ARG . 72.3 t80 -133.62 145.08 49.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HD2' HD23 ' A' ' 6' ' ' LEU . 17.6 t80 -139.74 134.37 31.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.686 -1.259 . . . . 0.0 109.918 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 3.2 t70 -140.31 77.3 24.64 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 0.0 110.61 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 40.2 Cg_endo -67.94 74.01 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.59 1.311 . . . . 0.0 110.521 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -95.2 -171.05 2.31 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.271 -0.893 . . . . 0.0 110.395 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.31 39.25 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.03 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.3 p -130.33 -49.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 110.253 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -133.64 142.97 45.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.46 -18.64 20.01 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.664 1.35 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.07 70.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.5 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.642 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 8.9 p-90 -116.01 -12.51 11.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.245 -0.909 . . . . 0.0 110.392 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 76' ' ' GLN . 5.0 tt -84.45 120.25 26.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.922 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.76 97.96 3.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.156 -0.965 . . . . 0.0 109.636 178.95 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.904 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.1 t -128.66 130.34 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.864 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 17.2 t0 -80.16 72.29 6.96 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.258 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.653 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.6 -31.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 122.342 -0.224 . . . . 0.0 111.523 -177.108 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -59.93 -51.49 69.46 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.818 -1.176 . . . . 0.0 108.666 177.857 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 36' ' ' ILE . 14.4 mmm180 -73.57 -41.12 63.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.937 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -62.62 -18.43 62.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 52.0 ttp85 -88.34 -26.15 22.37 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.702 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.1 t80 -62.01 -44.72 96.11 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 123.289 1.519 . . . . 0.0 107.462 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.054 ' CD1' HG21 ' A' ' 36' ' ' ILE . 71.9 m95 -68.03 -57.08 6.72 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.038 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.42 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.9 mt -56.67 -21.43 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.524 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 1.6 t -79.25 -23.22 43.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 110.718 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 58' ' ' TYR . 13.9 m -98.9 31.95 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 120.854 -1.154 . . . . 0.0 109.458 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.38 26.73 74.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -63.13 136.27 57.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.314 . . . . 0.0 109.896 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.439 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.52 108.1 48.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 110.551 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 53.0 Cg_endo -81.72 141.18 12.07 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.626 1.329 . . . . 0.0 109.19 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 t -73.77 178.74 4.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.991 -1.068 . . . . 0.0 110.801 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.01 53.67 2.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.1 m -165.73 -59.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.08 -26.85 66.93 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.669 ' HA ' HD12 ' A' ' 74' ' ' LEU . 22.1 ttp85 -62.58 -42.0 99.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.088 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -64.99 -29.15 70.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.3 mt -85.1 -28.41 25.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.376 -0.828 . . . . 0.0 109.234 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 71' ' ' ARG . 21.8 mt -69.05 -27.25 65.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.089 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -82.62 -31.26 28.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.116 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.693 ' HB3' HD11 ' A' ' 49' ' ' LEU . 6.6 tp-100 -76.24 -35.34 59.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.103 0.954 . . . . 0.0 109.452 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.93 -12.48 50.0 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.747 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 91.86 48.6 3.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.639 HG22 ' CB ' ' A' ' 53' ' ' VAL . 34.1 t -114.45 -8.85 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.918 -1.342 . . . . 0.0 111.496 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 6.8 m-85 -112.1 107.43 16.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.95 -1.094 . . . . 0.0 110.063 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -81.5 137.08 35.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.968 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -53.65 155.11 3.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -0.86 . . . . 0.0 110.652 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -118.4 88.96 3.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.919 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.77 170.7 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.454 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 131.78 35.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.76 134.19 56.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 110.362 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.63 29.35 10.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 110.217 179.949 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.201 0.524 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 2' ' ' VAL . 12.1 m -151.22 106.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.216 -0.928 . . . . 0.0 110.492 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -140.12 128.86 23.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.976 HD11 ' CB ' ' A' ' 59' ' ' TRP . 31.6 mt -100.81 133.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.909 -1.119 . . . . 0.0 109.564 179.158 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.0 ptt180 -151.55 -172.55 4.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.072 -1.018 . . . . 0.0 110.342 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 39' ' ' TYR . 6.0 mp -88.7 126.66 35.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.98 104.72 16.79 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 7.2 tmm_? -71.41 121.27 18.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 111.66 -179.025 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 13.5 m-85 -117.61 -61.41 1.7 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.102 -0.998 . . . . 0.0 110.061 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.8 139.69 4.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -91.61 -79.14 0.38 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.949 . . . . 0.0 109.43 179.393 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -136.31 35.97 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.404 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 1.9 m-70 -132.28 -50.4 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 -177.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 12.8 t-20 -133.58 102.29 12.72 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 110.0 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.02 106.98 2.38 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.57 1.3 . . . . 0.0 111.088 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 32.9 p80 -158.83 135.7 9.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.455 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 7.0 m-85 -119.15 148.93 42.54 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -99.7 156.59 17.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.991 177.521 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.026 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -98.52 79.37 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 178.49 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.274 0.4 OUTLIER -97.98 156.66 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.228 -174.206 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.955 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -105.05 114.76 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.341 0.591 . . . . 0.0 111.066 -177.89 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t -134.66 -174.82 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.412 -0.805 . . . . 0.0 110.049 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.8 p30 -114.04 -177.17 3.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.52 -14.94 14.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -55.26 -48.19 74.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 110.393 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -53.15 159.67 1.22 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.02 -1.05 . . . . 0.0 109.679 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -39.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 110.823 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.74 -34.88 5.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.0 -67.45 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.98 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.89 50.86 6.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 155.56 17.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 109.975 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB3' HG13 ' A' ' 20' ' ' VAL . 28.1 p90 -116.73 150.97 37.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.198 -0.939 . . . . 0.0 110.578 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.658 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -57.57 -61.07 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.11 155.68 42.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.815 . . . . 0.0 110.141 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.4 pttp -89.87 118.57 29.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 0.0 109.77 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.014 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.9 pt -107.9 -32.46 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.138 -0.976 . . . . 0.0 111.524 -179.16 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.825 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.74 167.32 19.21 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 118.813 -1.661 . . . . 0.0 111.388 -178.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 40' ' ' ASP . 12.5 t80 -138.57 139.41 38.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.171 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.026 ' HB2' HD11 ' A' ' 19' ' ' ILE . 40.3 t80 -136.67 124.02 21.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.71 -1.244 . . . . 0.0 109.699 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' HB2' ' CE1' ' A' ' 38' ' ' TYR . 54.9 t0 -140.18 84.71 14.44 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.753 -1.217 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 44.1 Cg_endo -71.71 78.32 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.557 1.293 . . . . 0.0 110.436 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -89.82 155.34 19.23 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -87.64 50.57 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.044 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -140.58 -42.13 0.41 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.5 p -142.84 143.68 26.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.39 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.433 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 48.4 Cg_endo -74.04 -19.62 20.17 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.678 1.357 . . . . 0.0 110.35 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.24 82.4 3.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.534 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 7.4 p-90 -122.94 -12.38 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.245 -0.909 . . . . 0.0 111.003 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 77' ' ' ALA . 6.4 tt -81.48 118.35 22.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.0 110.548 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.89 99.68 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.143 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.825 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -128.32 142.56 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.035 . . . . 0.0 111.763 -178.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t0 -88.23 69.97 9.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.071 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.3 OUTLIER -34.44 -31.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.808 -177.423 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.0 mt-10 -63.81 -56.18 17.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.82 -1.175 . . . . 0.0 108.953 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -72.26 -36.1 68.95 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.27 -0.894 . . . . 0.0 109.112 178.928 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.86 -20.19 66.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.04 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.3 ttt180 -86.95 -22.33 25.68 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.246 -0.909 . . . . 0.0 109.795 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -62.17 -46.62 88.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.276 1.513 . . . . 0.0 107.523 178.753 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.014 ' CD1' HG21 ' A' ' 36' ' ' ILE . 86.2 m95 -65.64 -58.35 5.94 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.863 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -53.78 -22.55 9.67 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.488 177.366 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 1.1 m -79.2 -20.49 48.21 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.475 -0.766 . . . . 0.0 110.014 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.4 m -98.81 32.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.967 -1.083 . . . . 0.0 109.061 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.31 23.79 71.83 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -61.33 136.77 58.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -1.194 . . . . 0.0 109.759 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.98 108.62 55.2 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 110.163 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 55.2 Cg_endo -83.62 123.69 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.51 1.268 . . . . 0.0 109.745 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -50.17 168.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.1 56.26 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.098 -1.001 . . . . 0.0 110.42 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -166.49 -60.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.779 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -64.23 -24.86 67.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.47 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 74' ' ' LEU . 9.3 ttt-85 -67.06 -44.42 80.17 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -69.25 -11.86 61.17 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.137 179.163 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 70' ' ' ALA . 11.6 mt -101.19 -27.32 13.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 79' ' ' VAL . 13.4 mt -72.8 -29.32 63.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.355 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.4 -30.93 48.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.942 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -78.2 -31.73 49.61 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.846 0.831 . . . . 0.0 109.344 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.653 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -66.58 -10.57 46.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.876 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.36 14.72 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.646 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.2 t -86.06 -69.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.9 -1.353 . . . . 0.0 110.645 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' A' ' 75' ' ' ARG . 48.5 p90 -132.75 165.62 24.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.46 55.85 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.13 136.36 38.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.674 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.24 -17.77 20.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.746 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -168.14 100.6 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 110.473 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.48 -37.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 0.0 110.103 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 90.17 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.19 136.02 5.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.139 -1.212 . . . . 0.0 110.209 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.234 0.54 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 22.5 t -102.39 122.34 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -140.26 133.33 29.46 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.526 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.988 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.0 mt -99.81 137.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.067 -1.021 . . . . 0.0 109.251 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.506 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.5 ptm180 -150.82 178.4 9.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.014 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.79 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.4 pp -89.5 130.92 35.76 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.592 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.37 171.97 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.507 -0.746 . . . . 0.0 109.199 -179.164 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 17' ' ' TYR . 1.7 tmt_? -133.8 116.88 16.22 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.935 -1.103 . . . . 0.0 112.065 -179.262 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -132.1 -150.65 0.43 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.507 -0.745 . . . . 0.0 109.487 178.737 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.42 55.24 1.27 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.296 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 15.2 p -55.28 -61.69 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -1.2 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' N ' ' OG ' ' A' ' 11' ' ' SER . 23.2 mttm -145.99 50.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -138.9 -56.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.314 -0.866 . . . . 0.0 109.479 -178.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -173.3 142.29 0.98 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.655 -0.653 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 48.7 Cg_endo -72.98 108.32 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.532 1.28 . . . . 0.0 110.357 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 24.9 p80 -147.98 147.39 29.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.025 . . . . 0.0 110.539 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.61 ' CD2' HD13 ' A' ' 6' ' ' LEU 0.255 12.1 m-30 -112.58 170.67 8.02 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.935 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 43.2 mtt180 -134.83 153.07 52.19 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.279 177.558 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -96.83 82.65 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 178.174 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -97.95 158.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.162 -174.224 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.951 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.19 111.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.584 -0.698 . . . . 0.0 111.096 -177.524 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.7 t -136.88 -167.68 2.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.9 p30 -108.42 -163.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.868 . . . . 0.0 110.002 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 85.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -58.43 123.21 15.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.65 -179.751 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -169.85 1.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -95.14 28.6 2.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.228 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.82 -44.34 1.49 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.877 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.36 -168.72 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 110.09 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.68 97.57 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.15 132.85 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -1.176 . . . . 0.0 109.936 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' HB3' HG13 ' A' ' 20' ' ' VAL . 26.9 p90 -101.91 163.82 12.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.278 -0.889 . . . . 0.0 110.637 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.611 HG21 ' HH2' ' A' ' 59' ' ' TRP . 7.2 mt -72.38 -53.32 19.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.625 -0.672 . . . . 0.0 110.262 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -151.87 158.58 43.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 110.119 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.2 pttm -92.47 112.56 24.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.0 pt -104.75 -37.28 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.038 -1.039 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.849 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -116.24 166.34 12.33 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 119.02 -1.562 . . . . 0.0 112.232 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 73.3 t80 -140.95 117.19 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.401 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.88 ' HB2' HD11 ' A' ' 19' ' ' ILE . 14.3 t80 -109.12 147.14 32.92 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.58 -1.325 . . . . 0.0 110.472 -179.302 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 7.0 t70 -139.99 84.93 14.59 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.164 -0.96 . . . . 0.0 109.06 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 43.0 Cg_endo -68.21 -23.9 38.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.6 1.316 . . . . 0.0 112.002 -178.357 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.44 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 18.6 mmt180 -93.04 16.85 11.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.143 . . . . 0.0 111.053 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.81 137.12 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.933 -1.104 . . . . 0.0 109.773 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.1 p -91.61 45.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.533 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.85 162.89 26.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.297 -0.877 . . . . 0.0 110.002 179.654 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.34 -12.95 30.38 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.673 1.354 . . . . 0.0 110.614 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.82 89.23 2.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.942 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 9.2 p-90 -116.44 6.19 13.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.973 . . . . 0.0 111.154 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 50' ' ' LYS . 1.5 tt -112.82 129.04 56.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.819 -1.176 . . . . 0.0 111.007 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.747 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.26 86.91 2.37 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.649 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.849 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -115.11 136.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 111.206 -178.963 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -81.23 69.05 7.77 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.729 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -36.53 -29.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 122.226 -0.296 . . . . 0.0 111.268 -177.423 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 15.5 tt0 -61.2 -50.5 72.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.714 -1.241 . . . . 0.0 108.416 177.862 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 22.6 mmm180 -76.23 -37.17 58.05 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.297 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.889 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.83 -19.3 65.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.207 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.6 ttm-85 -89.56 -22.47 22.36 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.289 -0.882 . . . . 0.0 109.552 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.847 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -62.7 -48.33 79.72 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.251 1.5 . . . . 0.0 107.182 178.366 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.988 ' CB ' HD11 ' A' ' 4' ' ' ILE . 84.3 m95 -65.07 -56.31 13.75 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.793 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.59 HD12 HG11 ' A' ' 79' ' ' VAL . 20.5 mt -53.86 -22.07 9.05 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.141 -0.975 . . . . 0.0 108.434 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -82.55 -19.48 38.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.351 -0.843 . . . . 0.0 110.391 179.129 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -98.91 32.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 120.87 -1.144 . . . . 0.0 109.403 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.75 25.56 74.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.79 122.31 21.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.001 -1.293 . . . . 0.0 110.274 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.55 116.05 65.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.223 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.6 Cg_endo -80.01 153.88 22.34 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.425 1.224 . . . . 0.0 110.188 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.591 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -76.57 167.06 22.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.078 -1.014 . . . . 0.0 109.96 179.608 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -28.8 64.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -0.954 . . . . 0.0 110.953 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.0 m -96.25 -44.98 7.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.733 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.48 -28.46 69.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 67' ' ' THR . 1.7 ttm-85 -68.22 -40.35 82.13 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.115 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.64 -15.14 63.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.003 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.2 mt -99.31 -29.46 12.78 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.242 -0.911 . . . . 0.0 108.943 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.479 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 33.4 mt -72.82 -27.74 62.14 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.571 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.535 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.96 -29.61 44.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.268 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.8 tp60 -79.2 -35.83 41.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.129 0.966 . . . . 0.0 109.24 179.201 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -57.51 -17.8 15.63 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.627 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.97 16.85 12.64 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 60' ' ' LEU . 21.7 t -81.9 -63.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.911 -1.347 . . . . 0.0 110.495 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 45.9 p90 -137.54 125.11 22.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.107 -0.996 . . . . 0.0 110.893 -179.864 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.87 -9.63 7.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.97 168.1 28.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -72.95 105.96 4.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.956 . . . . 0.0 110.451 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.28 110.98 3.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.971 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.14 -62.01 1.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 -178.99 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 110.451 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.05 126.69 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.31 -1.112 . . . . 0.0 110.255 -179.923 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.231 0.539 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' HG12 ' A' ' 21' ' ' VAL . 97.4 t -80.3 148.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.121 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -140.62 128.51 21.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 0.0 111.072 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.906 HD11 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -100.04 131.55 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.198 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 9.5 ptm180 -151.78 -165.24 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 110.654 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 39' ' ' TYR . 79.4 mt -89.04 128.43 35.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.79 103.29 14.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.699 -0.626 . . . . 0.0 109.588 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.453 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 49.4 ttt-85 -71.91 122.63 21.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 112.405 -178.469 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 8.0 m-85 -120.67 -149.84 0.44 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.384 -0.823 . . . . 0.0 109.036 177.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.51 97.22 0.01 OUTLIER Glycine 0 N--CA 1.484 1.879 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.1 p -49.95 -36.02 26.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -1.196 . . . . 0.0 109.557 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 9.8 ptpt 179.81 65.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.682 -0.636 . . . . 0.0 109.843 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.489 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 15.1 m-70 -141.38 -63.21 0.46 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.133 -0.979 . . . . 0.0 109.847 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -128.25 129.84 23.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 110.037 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.39 97.14 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.431 1.227 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.462 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 33.3 p80 -149.65 131.45 15.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 110.586 179.578 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 7.3 m-85 -115.9 150.33 37.26 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.6 ttt180 -99.33 159.87 14.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.427 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.944 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.22 83.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.711 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -98.07 169.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.977 -173.908 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.893 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -114.82 114.13 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.271 0.558 . . . . 0.0 110.285 -177.85 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t -140.17 -164.14 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.025 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.1 m-20 -121.0 165.28 15.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.72 33.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 110.065 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -63.13 134.78 56.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 62.67 1.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.287 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.98 -53.13 5.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.249 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -151.09 21.69 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.72 -71.55 0.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.35 21.25 56.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -176.63 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 20.6 p90 -114.55 177.86 4.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.125 -0.984 . . . . 0.0 110.715 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.3 mt -89.0 -43.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.603 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' OE1' ' CD ' ' A' ' 55' ' ' ARG . 5.4 tt0 -160.98 169.33 22.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.956 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -103.7 111.76 24.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.949 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.2 pt -101.67 -34.69 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.313 -0.867 . . . . 0.0 110.974 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.796 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.97 165.83 20.02 Favored Glycine 0 C--N 1.294 -1.774 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.547 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 34.4 t80 -134.51 142.3 46.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.127 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.514 ' HD2' HD22 ' A' ' 6' ' ' LEU . 11.3 t80 -140.42 134.13 30.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.812 -1.18 . . . . 0.0 109.974 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 20.9 t0 -140.2 84.74 14.37 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.771 -1.206 . . . . 0.0 110.512 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 41.2 Cg_endo -68.77 67.44 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.536 1.282 . . . . 0.0 110.65 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 163.09 15.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.237 -0.914 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.2 30.56 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -102.01 -75.5 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.74 160.66 61.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.123 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -9.99 23.86 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.697 1.367 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.17 73.98 9.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.041 -1.037 . . . . 0.0 110.309 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.542 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -122.36 -4.77 8.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.211 -0.93 . . . . 0.0 111.027 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 49' ' ' LEU . 9.2 tt -91.49 121.52 33.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.895 -1.128 . . . . 0.0 111.03 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 2.0 ttpm? -136.1 87.32 2.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 109.318 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.944 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -112.53 157.82 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.374 1.083 . . . . 0.0 111.567 -179.054 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -106.02 64.91 0.68 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.064 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.728 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.9 -33.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.771 -177.365 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.1 mt-10 -60.77 -52.49 64.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.837 -1.164 . . . . 0.0 108.923 178.408 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.48 -35.56 60.81 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 108.957 178.665 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.909 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.05 -21.45 66.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -86.59 -22.2 26.38 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.336 -0.852 . . . . 0.0 109.836 178.507 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.589 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -61.31 -48.6 80.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.223 1.487 . . . . 0.0 107.2 178.521 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.949 ' CD1' HG21 ' A' ' 36' ' ' ILE . 90.5 m95 -63.54 -53.47 51.31 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.527 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.594 HD11 HD13 ' A' ' 74' ' ' LEU . 5.8 mt -52.86 -23.59 7.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -22.78 45.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.694 -0.629 . . . . 0.0 110.25 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.8 m -98.81 32.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.841 -1.162 . . . . 0.0 109.666 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.11 73.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.37 135.11 53.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.076 -1.249 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.23 111.01 64.39 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.947 . . . . 0.0 110.5 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 52.5 Cg_endo -79.99 127.0 6.69 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.452 1.238 . . . . 0.0 109.894 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -58.6 -177.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.038 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -76.6 52.05 0.78 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.264 -0.898 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.78 -57.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.852 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.75 -23.46 66.74 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.676 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -68.73 -40.75 79.74 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -40.87 88.96 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.639 178.833 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.6 mt -65.52 -31.18 72.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 79' ' ' VAL . 13.8 mt -72.38 -25.38 61.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.73 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.526 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -83.5 -28.82 28.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.439 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.9 tp-100 -86.52 -37.28 18.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.674 0.75 . . . . 0.0 110.543 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -10.54 42.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.762 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.01 54.75 3.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.758 HG21 HD23 ' A' ' 74' ' ' LEU . 49.4 t -103.54 -61.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.172 -1.193 . . . . 0.0 111.678 -179.3 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 36.6 m-85 -49.54 171.86 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.999 -1.063 . . . . 0.0 110.465 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.11 114.86 4.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.208 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -86.0 102.23 13.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -0.908 . . . . 0.0 110.301 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.7 53.99 2.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.72 151.26 22.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 110.285 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -95.78 -69.96 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.67 -172.36 0.62 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.46 -94.6 0.09 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.319 -1.106 . . . . 0.0 110.13 179.974 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.255 0.55 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 58.2 t -65.33 107.45 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -140.32 139.17 35.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.379 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.936 ' CG1' HG13 ' A' ' 21' ' ' VAL . 46.6 mt -100.04 139.06 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.007 -1.058 . . . . 0.0 109.427 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -150.85 -168.38 3.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.839 -1.163 . . . . 0.0 110.873 -179.101 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 70' ' ' ALA . 6.6 mp -89.15 129.21 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -101.31 102.86 13.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.235 -0.916 . . . . 0.0 110.704 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -71.32 119.29 15.24 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 111.575 -179.54 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 15.7 m-85 -114.12 -61.31 1.76 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 178.67 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.19 107.07 0.16 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 45.1 p -75.13 -56.37 4.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -1.102 . . . . 0.0 109.347 179.126 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.2 mtmm -144.83 48.14 1.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.777 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -136.15 -65.73 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.375 -0.828 . . . . 0.0 109.848 -178.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -138.12 133.84 17.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.79 100.64 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.586 1.308 . . . . 0.0 110.845 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 35.3 p80 -153.58 129.8 10.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 0.0 110.552 179.412 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 8.6 m-85 -119.28 151.03 39.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.98 163.55 12.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.083 -1.447 . . . . 0.0 108.085 177.229 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.936 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -98.4 81.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 103.047 -2.945 . . . . 0.0 103.047 177.359 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -97.71 165.61 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.787 0.803 . . . . 0.0 111.984 -173.96 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.936 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.07 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.251 0.548 . . . . 0.0 110.782 -177.462 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t -137.31 -174.29 3.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.246 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -178.75 3.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.21 -57.2 2.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.847 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 96.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.381 -0.824 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.84 166.15 27.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -175.26 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -79.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.38 77.17 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.54 146.11 27.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -1.182 . . . . 0.0 110.459 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.7 p90 -118.26 -172.01 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.418 -0.801 . . . . 0.0 110.417 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG21 ' HH2' ' A' ' 59' ' ' TRP . 22.3 mt -99.01 -27.25 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.925 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -174.54 165.16 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 109.864 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 6.1 pttt -102.94 111.89 24.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.948 HG21 ' CD1' ' A' ' 59' ' ' TRP . 36.7 pt -106.06 -30.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.976 -1.077 . . . . 0.0 110.883 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.83 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.9 167.38 19.36 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.07 -1.538 . . . . 0.0 112.304 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG12 ' A' ' 19' ' ' ILE . 5.7 t80 -141.24 124.72 16.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.021 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.936 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.7 t80 -124.97 131.6 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.671 -1.268 . . . . 0.0 109.533 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 45.7 t0 -140.32 93.34 9.01 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 110.58 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.59 85.36 0.92 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.56 1.295 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -89.71 -148.95 0.19 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 109.969 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -151.11 25.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.41 HG23 HG22 ' A' ' 45' ' ' THR . 4.1 t -125.12 -32.6 2.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 44' ' ' THR . 5.5 t -132.92 149.59 73.31 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.024 . . . . 0.0 110.681 179.777 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.55 -17.01 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.789 1.415 . . . . 0.0 110.617 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -93.52 88.29 5.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.128 -0.983 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.531 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.9 p-90 -121.62 -8.69 9.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 110.691 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 77' ' ' ALA . 5.8 tt -85.17 114.08 22.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.969 -1.082 . . . . 0.0 110.489 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -126.9 92.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.06 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.83 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.51 137.41 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.118 -178.906 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.7 t0 -78.43 69.56 4.64 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.294 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -35.2 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.601 -177.773 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.3 mt-10 -65.08 -49.42 70.12 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.96 -1.088 . . . . 0.0 109.276 178.66 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.74 -32.73 52.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 178.75 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -70.04 -23.38 63.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.151 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -85.0 -21.52 29.44 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 178.093 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.659 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -60.77 -48.53 81.38 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.158 1.456 . . . . 0.0 107.147 178.464 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.948 ' CD1' HG21 ' A' ' 36' ' ' ILE . 87.3 m95 -62.88 -55.44 26.09 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.627 -179.481 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -54.24 -21.81 10.03 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.234 -0.986 . . . . 0.0 108.467 177.052 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.49 -20.47 43.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.81 . . . . 0.0 110.589 179.345 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.7 m -98.92 32.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 120.865 -1.147 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.36 74.43 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -77.89 141.18 39.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.122 -1.222 . . . . 0.0 110.035 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 123.79 29.1 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.6 Cg_endo -85.12 145.45 9.78 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.454 1.239 . . . . 0.0 109.938 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -64.65 -178.8 0.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.078 -1.014 . . . . 0.0 110.577 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.04 52.47 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.2 m -165.97 -61.39 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.887 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -64.73 -26.41 68.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 2.8 ttt180 -66.39 -44.75 82.19 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.482 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -67.34 -12.58 60.52 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.106 179.234 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.887 HD12 ' HA ' ' A' ' 70' ' ' ALA . 10.7 mt -99.89 -29.86 12.35 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.681 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 26.5 mt -71.62 -28.46 63.81 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.338 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -79.28 -29.87 42.7 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.961 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HB3' HD13 ' A' ' 49' ' ' LEU . 2.4 tp-100 -78.36 -31.35 48.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.955 0.883 . . . . 0.0 109.363 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.64 -12.44 45.89 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.978 178.718 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.0 16.59 20.95 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 53' ' ' VAL . 17.1 t -81.25 -59.02 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.362 . . . . 0.0 110.152 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 28.8 p90 -143.03 133.6 25.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 0.0 110.423 179.497 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -71.76 -168.2 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 110.412 -179.934 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -97.68 167.76 10.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -150.46 75.6 1.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.22 93.99 7.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 110.065 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -81.58 -30.61 32.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.69 -61.32 2.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.89 -158.8 29.8 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.318 -1.107 . . . . 0.0 110.259 179.95 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.518 HG11 ' CE3' ' A' ' 59' ' ' TRP . 47.7 t -88.23 144.05 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.195 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 130.94 25.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 0.0 110.539 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.993 HD11 ' CB ' ' A' ' 59' ' ' TRP . 82.9 mt -102.47 135.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 121.126 -0.984 . . . . 0.0 109.783 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.49 177.87 9.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.941 179.94 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.3 pp -89.13 130.52 35.55 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.035 178.664 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.78 165.82 11.6 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.392 -0.817 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -128.36 117.19 20.98 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.967 -1.083 . . . . 0.0 111.673 -178.929 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.728 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -128.22 -154.18 0.62 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.222 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 90.01 0.95 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.72 -48.28 75.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.102 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.35 35.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.548 0.69 . . . . 0.0 109.224 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -111.18 -44.51 3.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 109.563 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.58 132.29 2.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.502 -0.749 . . . . 0.0 109.744 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.72 106.04 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.458 1.241 . . . . 0.0 110.398 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 28.4 p80 -143.49 140.65 30.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.429 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 6' ' ' LEU . 17.6 m-30 -114.64 167.82 10.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.582 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.81 149.09 50.42 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.962 -1.086 . . . . 0.0 108.76 177.899 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.979 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -96.94 81.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 178.112 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.291 0.4 OUTLIER -98.3 161.66 2.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.783 -173.526 . . . . . . . . 4 4 . 1 . 029 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.925 HG13 HG12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.12 106.94 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.569 -178.102 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.8 t -133.31 -169.91 2.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.0 m-20 -99.63 174.47 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.357 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.88 -53.97 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 110.271 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.99 118.99 0.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.301 -0.874 . . . . 0.0 110.493 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.422 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 6.8 mtt180 -106.32 -76.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -0.856 . . . . 0.0 109.983 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 26' ' ' ARG . 2.4 mptp? -123.97 -74.08 0.62 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -164.09 32.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.737 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -89.58 -157.16 0.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.3 88.25 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.87 173.62 6.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -1.203 . . . . 0.0 110.595 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HB3' HG13 ' A' ' 20' ' ' VAL . 22.8 p90 -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.463 -0.773 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.3 mt -78.36 -37.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.412 -0.805 . . . . 0.0 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 168.07 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -103.7 113.47 27.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.87 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.98 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.3 pt -104.76 -34.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.797 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.9 166.92 15.21 Favored Glycine 0 C--N 1.295 -1.698 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.895 -178.006 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.433 ' N ' HG12 ' A' ' 19' ' ' ILE . 16.3 t80 -140.6 122.34 15.34 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.61 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.979 ' HB2' HD11 ' A' ' 19' ' ' ILE . 7.1 t80 -114.46 141.01 48.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.733 -1.229 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.9 t70 -139.21 87.21 13.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.813 179.476 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 40.7 Cg_endo -67.38 79.22 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.48 1.253 . . . . 0.0 110.6 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.77 178.02 5.11 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.454 -0.779 . . . . 0.0 110.311 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.35 19.61 6.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -121.37 -15.62 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.745 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 p -134.6 139.67 33.24 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 0.0 110.333 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.89 -35.11 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.579 1.305 . . . . 0.0 110.102 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.06 99.92 12.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.555 ' HZ3' HD12 ' A' ' 49' ' ' LEU . 5.6 p-90 -124.21 -5.62 7.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.251 -0.906 . . . . 0.0 111.004 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 77' ' ' ALA . 3.8 tt -86.62 127.58 34.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.323 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -133.04 88.07 2.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 0.0 108.95 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.797 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -114.11 139.55 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.115 -0.991 . . . . 0.0 111.09 -179.067 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.3 t0 -84.65 70.2 10.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.255 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.681 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.63 -32.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 122.268 -0.27 . . . . 0.0 111.461 -177.467 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tm-20 -61.54 -54.64 40.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.863 -1.148 . . . . 0.0 108.728 178.341 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -69.33 -39.93 77.89 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.717 0.77 . . . . 0.0 109.065 178.685 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.804 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.57 -21.18 66.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.475 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -87.14 -20.5 26.95 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 178.642 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.1 t80 -61.37 -48.94 78.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.362 1.553 . . . . 0.0 107.142 178.365 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.993 ' CB ' HD11 ' A' ' 4' ' ' ILE . 81.9 m95 -63.18 -54.27 40.19 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.768 -178.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 66' ' ' PRO . 10.7 mt -53.86 -21.99 8.86 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.28 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -22.78 38.56 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.471 -0.768 . . . . 0.0 110.679 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 59' ' ' TRP . 5.2 m -99.24 31.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.832 -1.168 . . . . 0.0 109.908 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.82 26.22 71.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 142.81 56.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.873 -1.369 . . . . 0.0 110.324 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 105.99 57.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 60' ' ' LEU . 52.2 Cg_endo -83.2 124.99 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.582 1.306 . . . . 0.0 110.763 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.757 HG23 ' H ' ' A' ' 70' ' ' ALA . 6.3 t -58.73 156.3 11.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.067 -1.02 . . . . 0.0 109.06 179.231 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -48.66 47.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.054 -1.029 . . . . 0.0 111.556 -179.052 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -62.22 -56.42 18.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.1 -1.0 . . . . 0.0 111.825 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.953 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.45 -25.68 65.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 109.093 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 67' ' ' THR . 25.7 ttt180 -69.8 -38.39 76.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -61.53 -30.41 70.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.419 178.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.953 HD12 ' HA ' ' A' ' 70' ' ' ALA . 24.7 mt -78.31 -37.6 44.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 68.6 mt -62.42 -30.66 71.38 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.788 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.424 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.73 -28.48 44.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.061 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.765 ' HB3' HD13 ' A' ' 49' ' ' LEU . 9.7 tp-100 -75.49 -35.76 60.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.069 0.938 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.82 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.2 -8.0 46.45 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.057 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.93 53.02 3.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.681 HG22 ' CB ' ' A' ' 53' ' ' VAL . 61.9 t -109.44 -4.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.206 -1.173 . . . . 0.0 111.46 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 13.2 m-85 -112.41 39.93 2.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.891 -1.131 . . . . 0.0 110.064 -179.4 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.89 164.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.22 145.87 36.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 110.056 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -50.97 150.58 2.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.443 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.47 -69.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -69.21 -28.11 66.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.311 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -57.2 147.37 25.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.462 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.41 47.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.304 -1.115 . . . . 0.0 110.156 179.969 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.587 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.71 HG11 ' CE3' ' A' ' 59' ' ' TRP . 95.2 t -80.89 132.41 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 0.0 110.021 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 16.3 mtpt -140.02 139.25 35.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.867 ' CG1' HG13 ' A' ' 21' ' ' VAL . 41.4 mt -103.51 130.33 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.142 -0.974 . . . . 0.0 109.264 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.52 -165.28 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 110.331 -179.118 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.578 HD13 ' HD2' ' A' ' 17' ' ' TYR . 44.7 mt -89.09 133.81 34.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.99 -1.069 . . . . 0.0 110.695 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.659 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -104.95 105.84 16.06 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.518 -0.738 . . . . 0.0 110.996 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 15.6 ttp180 -74.43 120.15 19.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.894 . . . . 0.0 111.1 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 18.0 m-85 -108.03 -64.99 1.15 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.326 -0.859 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.65 127.85 27.77 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -178.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 p -62.59 -45.66 91.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -1.09 . . . . 0.0 109.505 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.58 34.47 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.677 0.751 . . . . 0.0 109.296 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -101.93 -51.52 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.802 0.81 . . . . 0.0 108.901 -179.405 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.46 129.7 12.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.079 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.13 113.6 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.345 1.182 . . . . 0.0 111.343 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.1 p80 -167.65 124.63 1.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' HD2' HD13 ' A' ' 6' ' ' LEU . 5.2 m-30 -118.57 156.34 29.33 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.037 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.612 ' HD2' HG23 ' A' ' 20' ' ' VAL . 1.1 ptp180 -105.59 165.73 10.95 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.325 176.081 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.855 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -98.11 85.32 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.219 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.261 0.3 OUTLIER -98.05 166.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.152 -175.031 . . . . . . . . 4 4 . 1 . 030 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.877 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.42 107.41 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 110.159 -178.459 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.2 t -139.94 -170.31 2.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.382 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 22' ' ' THR . 6.7 t0 -104.1 166.21 10.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 109.98 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.66 29.04 4.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.331 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -53.73 41.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -156.16 162.36 40.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 110.121 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 41.08 1.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.23 32.18 1.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.048 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.77 -44.06 2.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.299 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.09 62.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -109.83 130.11 55.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 110.194 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.644 ' CD2' HG21 ' A' ' 20' ' ' VAL . 15.8 p90 -126.09 -176.44 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.338 -0.851 . . . . 0.0 110.796 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.0 mp -98.11 -25.22 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.608 -0.683 . . . . 0.0 109.632 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.26 162.85 6.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 0.0 109.865 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 4.0 ptpt -105.07 115.55 30.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.114 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.786 HG21 ' CD1' ' A' ' 59' ' ' TRP . 42.3 pt -105.09 -31.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.793 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -136.29 177.88 19.24 Favored Glycine 0 C--N 1.295 -1.705 0 C-N-CA 118.215 -1.945 . . . . 0.0 112.583 -178.273 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 71.8 t80 -139.96 147.89 41.14 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.919 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 41' ' ' PRO . 26.1 t80 -143.01 131.17 21.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.337 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 42.2 t0 -140.37 84.84 13.95 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.652 -1.28 . . . . 0.0 110.505 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 41.4 Cg_endo -68.86 73.3 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.511 1.269 . . . . 0.0 110.498 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -100.13 137.69 38.22 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.354 -0.841 . . . . 0.0 110.484 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 60.01 2.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.062 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -143.95 -60.07 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.0 110.692 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -123.31 146.52 49.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.685 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.16 -8.94 20.32 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.747 1.393 . . . . 0.0 110.726 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.69 75.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 110.543 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.705 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 13.8 p-90 -116.72 -13.91 10.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.613 179.549 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 49' ' ' LEU . 4.7 tt -86.17 115.55 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -127.26 86.98 2.57 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 108.971 178.828 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.855 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -116.48 149.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.472 1.13 . . . . 0.0 112.294 -178.528 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.9 t70 -99.16 64.91 1.4 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.584 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.97 -32.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.539 -177.289 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.07 -53.24 59.55 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.816 -1.177 . . . . 0.0 108.756 178.231 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -76.37 -34.03 58.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.434 -0.791 . . . . 0.0 108.869 178.636 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -67.52 -21.22 65.49 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.068 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 50.1 ttp85 -87.98 -21.21 24.97 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.231 -0.918 . . . . 0.0 109.721 178.089 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -60.75 -49.51 77.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.877 ' CD2' HG11 ' A' ' 21' ' ' VAL . 88.6 m95 -61.72 -53.18 59.57 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.315 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.778 HD12 HG11 ' A' ' 79' ' ' VAL . 25.2 mt -53.94 -22.26 9.82 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.762 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.5 -22.89 40.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.561 -0.712 . . . . 0.0 110.973 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.5 m -98.99 32.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.758 -1.214 . . . . 0.0 109.606 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.81 71.53 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -69.37 128.47 36.69 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.269 . . . . 0.0 110.015 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.491 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -97.17 109.52 49.92 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.174 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.585 ' HB3' HD12 ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.41 136.91 10.15 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.519 1.273 . . . . 0.0 110.29 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -62.02 179.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.968 . . . . 0.0 109.525 179.476 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 19.4 p-10 -69.98 -18.98 63.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.075 -1.015 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -50.37 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.256 -0.902 . . . . 0.0 110.503 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -69.01 -25.06 64.31 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.351 -0.843 . . . . 0.0 108.913 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 67' ' ' THR . 7.9 ttt-85 -68.53 -38.31 80.75 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.05 -39.36 90.08 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.511 -0.875 . . . . 0.0 108.76 178.716 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.705 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 40.7 mt -73.93 -26.26 60.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.575 -0.703 . . . . 0.0 109.261 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 60' ' ' LEU . 16.4 mt -72.74 -25.94 61.39 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.581 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.544 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -81.89 -32.0 31.19 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.181 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' A' ' 49' ' ' LEU . 7.9 tp-100 -80.1 -37.21 34.17 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.998 0.904 . . . . 0.0 109.964 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -62.47 -12.48 22.31 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.887 178.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.78 38.18 8.91 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.778 HG11 HD12 ' A' ' 60' ' ' LEU . 39.4 t -91.39 -54.15 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.196 -1.179 . . . . 0.0 111.351 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.5 m-30 -54.32 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -126.78 150.38 49.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.175 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -169.97 67.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.184 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.51 130.87 2.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.97 . . . . 0.0 110.447 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.98 141.75 28.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.855 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 75.07 10.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -176.32 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.12 -77.37 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.319 0.581 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t -85.52 133.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.293 179.964 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 14.6 mtpt -140.73 143.02 34.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.637 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.91 HD11 ' CB ' ' A' ' 59' ' ' TRP . 46.7 mt -101.27 135.42 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.104 -0.997 . . . . 0.0 108.941 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -177.76 6.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.107 . . . . 0.0 110.956 -179.04 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.764 HD12 ' HB2' ' A' ' 70' ' ' ALA . 3.6 mp -88.96 125.12 34.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.819 . . . . 0.0 109.887 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.715 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.14 111.62 23.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.461 -0.775 . . . . 0.0 110.901 -179.034 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -78.16 119.43 21.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.963 . . . . 0.0 111.628 -179.382 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 8.0 m-85 -112.77 -63.88 1.38 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.376 179.482 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.53 134.06 20.35 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.513 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -77.24 -154.48 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -1.067 . . . . 0.0 109.456 179.548 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -45.54 -31.54 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.634 0.731 . . . . 0.0 110.305 178.538 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 3.8 m-70 -53.99 -68.35 0.19 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -178.239 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -127.2 103.02 23.33 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.917 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.35 122.85 6.77 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.597 1.314 . . . . 0.0 111.3 -179.416 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.5 p80 -172.7 125.55 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.926 178.84 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 m-30 -114.28 155.16 26.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.408 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -104.65 152.99 21.81 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.551 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.072 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.3 mm -98.42 80.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 178.299 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.28 0.4 OUTLIER -97.36 164.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.937 -173.759 . . . . . . . . 4 4 . 1 . 031 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.941 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -109.94 113.6 44.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.599 -0.688 . . . . 0.0 110.594 -176.92 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.2 t -139.96 -166.35 2.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.287 -0.883 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.3 m-20 -128.2 -165.24 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.007 179.817 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.91 25.76 3.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.963 . . . . 0.0 110.347 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.72 -39.13 87.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 110.229 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -128.38 126.34 40.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.101 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.91 -7.81 51.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 110.679 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.35 -69.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.001 . . . . 0.0 110.339 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.21 160.17 16.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.411 -179.81 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.75 125.28 4.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 78.75 1.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -1.23 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 8.5 p90 -54.62 159.53 2.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.066 -1.021 . . . . 0.0 110.681 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.728 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -72.97 -59.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.504 -0.748 . . . . 0.0 109.604 179.519 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.725 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -144.98 149.78 35.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 179.869 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HG2' ' NE ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -89.82 126.6 35.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.962 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.003 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.86 -24.78 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.448 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.911 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -128.37 161.44 22.14 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.662 -1.732 . . . . 0.0 110.649 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.498 ' N ' HG12 ' A' ' 19' ' ' ILE . 88.0 t80 -138.41 144.6 40.27 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.894 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.072 ' HB2' HD11 ' A' ' 19' ' ' ILE . 16.0 t80 -137.47 133.26 34.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.45 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 34.1 t0 -140.55 106.43 6.49 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.809 -1.182 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 48.0 Cg_endo -76.36 1.19 8.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.48 1.253 . . . . 0.0 110.848 179.844 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 -30.17 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.016 -1.052 . . . . 0.0 109.421 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -51.53 116.5 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.029 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.8 p -89.34 49.83 1.82 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 -178.392 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 159.23 35.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.692 -0.63 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.32 60.19 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.611 1.322 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.25 30.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.981 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.579 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 32.5 p-90 -68.0 -8.65 39.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.423 -0.798 . . . . 0.0 111.34 -179.623 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.3 tt -98.81 130.12 45.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.264 179.867 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 88.91 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.828 . . . . 0.0 109.095 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.911 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -118.16 129.78 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.051 -1.031 . . . . 0.0 111.369 -178.833 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t70 -75.09 72.15 2.19 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.876 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG23 HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -33.7 -32.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.549 -177.509 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 16.5 tt0 -61.56 -53.15 60.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.855 -1.153 . . . . 0.0 108.857 178.045 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.753 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.89 -37.47 73.0 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.276 178.933 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.969 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -68.82 -20.77 64.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.319 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 29.2 ttt-85 -85.11 -25.16 27.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.672 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 11.1 t80 -60.2 -43.96 95.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 123.211 1.482 . . . . 0.0 107.564 178.307 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.003 ' CD1' HG21 ' A' ' 36' ' ' ILE . 68.9 m95 -68.72 -57.01 6.26 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.934 -179.07 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.969 HD12 ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -55.11 -21.01 11.38 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.333 -0.947 . . . . 0.0 108.873 177.497 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.2 t -81.43 -23.44 37.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.279 -0.888 . . . . 0.0 110.76 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 59' ' ' TRP . 36.0 m -99.09 32.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 120.944 -1.098 . . . . 0.0 109.404 179.571 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.04 30.54 74.08 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -76.32 120.77 22.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.967 -1.314 . . . . 0.0 109.769 179.736 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -92.07 115.83 65.37 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.458 -179.69 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HB3' HD12 ' A' ' 74' ' ' LEU . 52.5 Cg_endo -82.87 133.25 6.7 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.435 1.229 . . . . 0.0 109.687 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 70' ' ' ALA . 9.4 t -53.0 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.008 -1.058 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.96 52.65 1.28 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.3 -0.875 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -167.26 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.825 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.92 -22.96 66.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 5.4 ttt180 -66.99 -42.67 84.63 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.407 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -30.65 71.47 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.825 HD12 ' HA ' ' A' ' 70' ' ' ALA . 23.6 mt -77.59 -31.53 53.09 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.797 HD13 HD11 ' A' ' 60' ' ' LEU . 47.4 mt -67.42 -30.12 69.79 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.575 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -79.45 -30.56 42.24 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.431 ' HB3' HD13 ' A' ' 49' ' ' LEU . 7.4 tp-100 -77.46 -33.21 54.76 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.996 0.903 . . . . 0.0 109.56 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.53 -12.8 35.23 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.06 178.608 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.38 27.92 10.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 HG23 ' A' ' 53' ' ' VAL . 30.5 t -87.72 -62.29 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -1.23 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.489 ' CE1' ' HG3' ' A' ' 75' ' ' ARG . 18.1 p90 -135.67 -177.05 4.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.347 -179.848 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -135.41 -50.58 0.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.323 -0.861 . . . . 0.0 109.88 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.51 170.63 20.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.892 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 41.21 3.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.139 -0.976 . . . . 0.0 110.308 -179.726 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.48 104.28 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.254 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -60.16 -31.16 69.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.866 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.66 100.17 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.832 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.99 120.66 6.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 110.245 179.956 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.257 0.551 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 70.9 t -68.03 127.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.09 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -140.82 137.12 33.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.027 -1.046 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.927 ' CG1' HG13 ' A' ' 21' ' ' VAL . 41.4 mt -100.68 134.04 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.125 -0.984 . . . . 0.0 108.494 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 53.9 ptt85 -150.8 -172.44 4.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.835 -1.165 . . . . 0.0 111.159 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.8 mp -88.58 127.43 35.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.239 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -101.22 108.98 20.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.466 -0.771 . . . . 0.0 111.455 -178.865 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.8 ttt-85 -74.78 121.15 21.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 111.2 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.695 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 15.1 m-85 -110.26 -63.16 1.42 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 0.0 110.891 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -45.78 147.48 2.27 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -178.395 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.539 ' HG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -60.2 -73.08 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.914 . . . . 0.0 109.632 178.991 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -165.88 52.22 0.1 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.567 -0.708 . . . . 0.0 109.809 -179.815 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.539 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 17.2 m-70 -130.44 -52.43 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.446 -0.784 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.26 109.68 42.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.142 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.61 91.35 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.527 1.277 . . . . 0.0 111.64 -178.711 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 33.7 p80 -135.25 118.56 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.288 178.723 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 5.7 m-30 -115.67 154.68 29.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.623 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 3.2 ptm180 -104.0 161.74 13.73 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.522 -1.671 . . . . 0.0 107.755 177.142 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.829 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.09 85.37 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 179.397 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.27 0.3 OUTLIER -97.62 170.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.105 -174.324 . . . . . . . . 4 4 . 1 . 032 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.927 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.69 103.43 15.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.84 . . . . 0.0 110.658 -177.292 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t -128.53 -168.54 1.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.715 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' OD1' HD11 ' A' ' 33' ' ' ILE . 1.1 m-20 -121.57 160.09 25.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.213 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.85 -69.68 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -60.26 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -166.84 -65.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.71 -166.79 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -90.86 7.24 40.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.751 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -62.49 -178.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 0.0 110.259 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.48 26.04 1.22 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.92 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 148.17 22.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -1.105 . . . . 0.0 110.117 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 14.7 p90 -110.29 170.16 8.26 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 110.54 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.5 mt -80.25 -29.04 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.528 -0.733 . . . . 0.0 109.7 179.727 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.6 tm-20 -174.37 169.75 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.441 -0.787 . . . . 0.0 109.918 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -110.14 121.99 46.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.782 179.816 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.057 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -119.35 -30.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.145 -0.972 . . . . 0.0 111.179 -179.533 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.913 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.69 164.28 14.88 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.078 -179.838 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 75.2 t80 -137.64 140.43 40.87 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.981 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE2' ' HD3' ' A' ' 41' ' ' PRO . 54.7 t80 -139.42 113.17 8.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.569 -1.332 . . . . 0.0 109.957 -179.023 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.5 t0 -126.24 83.62 63.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.613 -1.304 . . . . 0.0 110.709 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 40.8 Cg_endo -66.72 78.04 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.708 1.373 . . . . 0.0 111.1 -179.681 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.88 124.42 40.85 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.275 -0.891 . . . . 0.0 109.939 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 44' ' ' THR . 0.2 OUTLIER -69.56 74.88 0.4 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.952 . . . . 0.0 110.431 -179.753 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 43' ' ' LYS . 4.9 p -150.03 -55.16 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 p -140.32 150.99 63.15 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.89 59.31 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.713 1.375 . . . . 0.0 110.642 179.92 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -153.39 75.29 1.05 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.281 -0.887 . . . . 0.0 109.738 179.808 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.578 ' CZ3' HD22 ' A' ' 73' ' ' LEU . 12.7 p-90 -124.2 -15.13 6.85 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.272 -0.893 . . . . 0.0 111.321 -179.104 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 50' ' ' LYS . 3.7 tt -79.42 127.59 32.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.941 -1.099 . . . . 0.0 111.027 -178.877 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.723 ' N ' HD23 ' A' ' 49' ' ' LEU . 11.2 mtpt -140.45 94.5 2.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.222 178.833 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.913 HG22 ' CA ' ' A' ' 37' ' ' GLY . 2.2 t -129.94 134.9 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 112.069 -179.025 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 t0 -82.96 71.01 10.08 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.26 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.43 -31.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.04 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 31.8 mt-10 -60.87 -49.57 76.94 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.956 178.224 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.567 ' HB3' HG22 ' A' ' 36' ' ' ILE . 26.6 mmm180 -75.01 -39.73 61.02 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.248 -0.908 . . . . 0.0 109.084 178.51 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.967 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -64.1 -22.87 67.11 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.356 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 7.5 ttt180 -86.35 -23.57 26.15 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.41 -0.806 . . . . 0.0 109.62 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.52 -49.01 75.2 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 123.205 1.478 . . . . 0.0 107.484 178.477 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.057 ' CD1' HG21 ' A' ' 36' ' ' ILE . 71.8 m95 -61.76 -52.57 63.68 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.275 -179.321 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 ' HE2' ' A' ' 80' ' ' PHE . 7.4 mt -57.01 -21.2 28.91 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.899 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -76.46 -26.17 55.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.333 -0.854 . . . . 0.0 110.311 179.502 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 59' ' ' TRP . 34.4 m -99.08 32.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.048 -1.032 . . . . 0.0 109.581 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.4 76.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -64.69 96.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.353 . . . . 0.0 109.689 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.03 114.7 29.39 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.4 Cg_endo -85.67 130.44 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.528 1.278 . . . . 0.0 109.641 179.391 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -53.18 178.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.085 -1.009 . . . . 0.0 110.651 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.22 54.28 1.94 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.32 -0.862 . . . . 0.0 110.073 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -164.72 -60.29 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 6' ' ' LEU . . . -67.58 -26.34 66.24 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.93 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 33.6 ttp180 -65.41 -43.15 91.49 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.098 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.03 -42.66 99.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.862 178.711 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.578 HD22 ' CZ3' ' A' ' 48' ' ' TRP . 27.6 mt -70.08 -28.87 65.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.509 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 28.7 mt -69.26 -29.14 66.98 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.841 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG2' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.53 -34.23 35.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.157 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -78.06 -26.02 48.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.866 0.841 . . . . 0.0 109.659 179.165 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -68.79 -9.82 53.19 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.211 0.529 . . . . 0.0 110.078 179.01 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.26 21.0 23.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 53' ' ' VAL . 14.0 t -85.8 -68.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.284 . . . . 0.0 110.538 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CD1' ' HG2' ' A' ' 75' ' ' ARG . 21.1 p90 -129.02 -167.61 1.81 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.082 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.411 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -163.35 178.06 8.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 110.293 -179.825 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -146.87 46.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -0.894 . . . . 0.0 110.12 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -143.49 106.9 4.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.64 39.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.085 -1.009 . . . . 0.0 110.417 -179.745 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -8.44 53.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.37 -65.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 0.0 110.358 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.25 168.47 37.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.246 -1.15 . . . . 0.0 110.282 -179.93 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 mmm . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.507 HG11 HG23 ' A' ' 62' ' ' VAL . 59.6 t -55.28 119.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 6.5 mttt -140.64 124.67 17.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.701 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.884 HD11 ' CB ' ' A' ' 59' ' ' TRP . 49.7 mt -99.88 129.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 120.991 -1.068 . . . . 0.0 109.211 178.843 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -151.07 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.928 . . . . 0.0 110.64 -179.187 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD22 ' HD2' ' A' ' 39' ' ' TYR . 55.4 mt -88.59 127.96 35.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.706 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.88 100.52 11.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.54 -0.725 . . . . 0.0 110.382 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 41.1 ttt180 -69.07 122.62 19.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 111.299 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 15.5 m-85 -114.46 -63.49 1.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.22 -0.925 . . . . 0.0 110.168 179.164 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.63 115.04 2.29 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 24.6 p -63.69 -59.5 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -1.161 . . . . 0.0 109.839 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' N ' ' OG ' ' A' ' 11' ' ' SER . 7.8 mttp -147.68 59.8 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.462 -0.773 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.41 ' ND1' ' O ' ' A' ' 12' ' ' LYS . 4.4 m-70 -143.5 -65.96 0.37 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 109.965 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -125.76 118.41 24.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.385 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.7 79.56 1.88 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.432 1.227 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.5 p80 -129.78 128.02 41.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.973 . . . . 0.0 110.543 179.391 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 7.6 m-85 -117.21 150.87 38.03 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.603 ' HD2' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -99.81 160.29 14.41 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.231 -1.788 . . . . 0.0 106.751 176.535 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.915 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -97.62 85.44 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 103.487 -2.782 . . . . 0.0 103.487 179.125 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.271 0.3 OUTLIER -97.44 169.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.945 -174.159 . . . . . . . . 4 4 . 1 . 033 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.881 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.91 110.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.434 -0.792 . . . . 0.0 110.634 -177.405 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.0 t -139.84 -167.47 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.6 p-10 -113.98 -169.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.496 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.48 37.17 2.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.998 -1.064 . . . . 0.0 110.361 179.999 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -51.0 65.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.083 -1.011 . . . . 0.0 110.418 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -135.93 177.51 7.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -122.54 67.76 0.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.53 -53.7 0.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 179.841 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -122.4 98.0 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 179.811 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.63 85.32 0.07 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -94.76 101.32 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -1.145 . . . . 0.0 109.919 179.581 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 21.4 p90 -87.86 165.61 15.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 111.09 -179.529 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG21 ' HH2' ' A' ' 59' ' ' TRP . 6.2 mt -81.66 -32.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.407 0.623 . . . . 0.0 109.78 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.79 176.75 3.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -113.32 123.86 51.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.983 . . . . 0.0 110.354 -179.822 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.058 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.8 -26.9 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.862 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.85 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.85 166.05 18.76 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 118.765 -1.684 . . . . 0.0 111.325 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 40.5 t80 -138.33 140.76 39.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.103 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HD2' HD22 ' A' ' 6' ' ' LEU . 15.1 t80 -138.17 127.84 25.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.909 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 32.1 t0 -137.63 83.62 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.619 -1.3 . . . . 0.0 110.499 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 41.1 Cg_endo -68.48 80.38 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.517 1.272 . . . . 0.0 111.106 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.49 158.64 15.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.247 -0.908 . . . . 0.0 109.849 179.392 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.62 37.67 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -126.83 -56.57 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.062 179.867 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -131.74 140.22 37.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 48' ' ' TRP . 47.8 Cg_endo -73.88 -15.57 23.66 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.529 1.278 . . . . 0.0 110.348 179.835 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -69.85 64.11 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.116 -0.99 . . . . 0.0 110.299 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 5.4 p-90 -116.59 -13.16 10.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.16 -0.962 . . . . 0.0 110.86 179.854 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 76' ' ' GLN . 5.7 tt -79.28 121.62 25.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 110.43 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.7 ttpt -136.97 95.84 3.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 179.721 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.915 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.2 t -127.75 128.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.975 -179.48 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.6 t0 -79.1 70.36 5.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.645 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -31.53 -34.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.158 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 mm-40 -60.63 -51.15 70.62 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.809 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.693 ' HB3' HG22 ' A' ' 36' ' ' ILE . 2.6 mmm180 -71.85 -41.85 67.61 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.386 -0.821 . . . . 0.0 108.836 178.398 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.971 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.94 -16.95 62.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.017 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -88.53 -29.03 20.39 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 178.394 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP 0.251 1.7 t80 -57.66 -43.47 84.99 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.331 1.539 . . . . 0.0 107.338 178.399 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.058 ' CD1' HG21 ' A' ' 36' ' ' ILE . 69.7 m95 -69.03 -52.99 22.93 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.282 -179.285 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.555 HD12 HG11 ' A' ' 79' ' ' VAL . 11.2 mt -57.65 -20.37 33.02 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.83 177.148 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.4 t -83.22 -22.77 33.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 59' ' ' TRP . 35.4 m -99.07 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.979 -1.075 . . . . 0.0 109.5 179.602 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.9 72.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -67.76 128.37 36.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.383 . . . . 0.0 109.838 179.621 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 2.4 mm-40 -92.75 109.99 42.53 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.9 Cg_endo -81.17 150.86 17.85 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.468 1.246 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -81.82 170.01 16.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.684 179.564 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -17.88 30.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -99.54 -47.97 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.14 -0.975 . . . . 0.0 110.322 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.94 -25.75 64.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.871 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -38.32 83.38 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.186 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -39.82 94.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.958 178.821 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -70.43 -29.5 66.1 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 179.554 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 60' ' ' LEU . 32.1 mt -72.25 -25.91 61.8 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.638 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.55 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -84.79 -27.0 27.16 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.385 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.568 ' HB3' HD11 ' A' ' 49' ' ' LEU . 5.9 tp-100 -85.21 -36.83 20.73 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.736 0.779 . . . . 0.0 110.212 -179.775 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.13 -10.61 32.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 178.425 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.44 44.83 6.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 60' ' ' LEU . 25.5 t -97.73 -51.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.113 -1.228 . . . . 0.0 111.179 -179.51 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.4 m-30 -59.26 99.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.468 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.412 ' NE ' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -103.32 29.47 5.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.949 . . . . 0.0 109.936 179.516 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.03 -175.68 2.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 135.54 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.149 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.73 -72.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -157.29 -139.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.38 -0.825 . . . . 0.0 109.888 -179.72 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.24 -72.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.878 -1.139 . . . . 0.0 110.449 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.15 46.72 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.207 -1.172 . . . . 0.0 110.237 179.825 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.235 0.54 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.561 HG11 ' CE3' ' A' ' 59' ' ' TRP . 38.5 t -69.06 134.36 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.878 . . . . 0.0 110.031 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.32 136.45 33.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 110.304 -179.923 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.997 ' CG1' HG13 ' A' ' 21' ' ' VAL . 60.8 mt -99.94 138.48 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.293 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.6 ptt180 -150.6 -170.88 3.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.992 -1.068 . . . . 0.0 110.745 -179.175 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.5 mp -89.41 128.78 35.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.341 -0.85 . . . . 0.0 110.991 -179.584 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.71 157.26 16.6 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.657 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 3.9 ttp85 -126.35 109.35 12.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.869 -1.145 . . . . 0.0 111.752 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -118.85 -151.0 0.47 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.251 -0.906 . . . . 0.0 109.566 179.008 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.38 100.28 0.78 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -65.27 -55.22 19.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 109.918 -179.937 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 5.1 ptpt -169.65 43.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 110.004 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -123.81 -57.14 1.64 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.935 . . . . 0.0 109.186 -179.486 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -152.62 126.23 4.3 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' O ' ' HD2' ' A' ' 41' ' ' PRO . 47.2 Cg_endo -72.89 114.49 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.309 1.163 . . . . 0.0 111.122 -179.127 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 25.3 p80 -141.72 144.77 34.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.193 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 7' ' ' ALA 0.258 17.8 m-30 -115.32 178.06 4.43 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 31.0 mtt180 -137.1 156.84 47.87 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.069 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.01 83.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 102.896 -3.002 . . . . 0.0 102.896 177.736 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.266 0.4 OUTLIER -97.8 165.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.582 -173.76 . . . . . . . . 4 4 . 1 . 034 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.997 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.13 104.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 110.716 -177.33 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t -131.11 -165.76 1.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 179.139 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.2 m-20 -124.42 158.96 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.027 -1.046 . . . . 0.0 110.618 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.77 -51.77 7.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.664 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 124.0 19.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.886 . . . . 0.0 110.117 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -174.26 123.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.218 -179.817 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -68.75 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.22 -51.69 3.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.16 144.74 54.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.93 81.62 0.17 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.49 140.41 23.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.137 -1.213 . . . . 0.0 110.347 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.3 p90 -71.48 163.45 27.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.213 -0.929 . . . . 0.0 110.479 -179.959 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.576 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.0 mt -75.92 -39.3 37.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.649 -0.657 . . . . 0.0 110.339 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.65 170.28 21.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 110.353 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -107.29 112.69 25.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 110.024 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.95 HG21 ' CD1' ' A' ' 59' ' ' TRP . 22.6 pt -107.27 -36.35 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 111.338 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.847 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.72 168.2 13.57 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.087 -1.53 . . . . 0.0 112.245 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 49.8 t80 -141.36 125.5 17.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.351 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' ILE . 9.9 t80 -115.72 146.89 41.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.596 -1.315 . . . . 0.0 109.533 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 33.6 t70 -136.68 102.18 9.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.977 -1.077 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 15' ' ' PRO . 49.8 Cg_endo -88.43 28.01 0.51 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.686 1.361 . . . . 0.0 111.32 -179.346 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -89.66 -156.64 0.42 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.838 -1.164 . . . . 0.0 110.326 -179.682 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' C ' HG23 ' A' ' 44' ' ' THR . 7.7 ttpt -68.66 70.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.503 HG23 ' C ' ' A' ' 43' ' ' LYS . 61.3 p -150.54 97.48 2.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.538 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 39.1 m -88.89 -40.54 0.45 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 111.78 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.3 Cg_endo -87.22 -45.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 122.745 0.866 . . . . 0.0 111.239 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 44' ' ' THR . 2.5 m-20 -111.04 92.48 4.06 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.216 -0.927 . . . . 0.0 110.512 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.564 ' CZ3' HD13 ' A' ' 49' ' ' LEU . 55.2 p-90 -140.75 11.16 2.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.88 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.564 HD13 ' CZ3' ' A' ' 48' ' ' TRP . 14.6 tp -135.23 121.05 19.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 110.987 -179.697 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -133.15 102.51 5.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.765 . . . . 0.0 109.256 179.409 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.847 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.47 140.14 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.898 -1.126 . . . . 0.0 111.044 -179.234 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -82.33 69.23 9.03 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.948 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.892 HG23 HG22 ' A' ' 79' ' ' VAL . 1.4 p -34.25 -31.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.858 -177.773 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.1 tp10 -62.95 -53.06 59.86 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.854 -1.154 . . . . 0.0 109.01 178.315 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 2.7 mtm-85 -73.27 -37.36 66.31 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.416 -0.803 . . . . 0.0 108.981 178.734 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.925 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.99 -18.98 65.75 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.754 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -88.95 -23.31 22.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.347 -0.846 . . . . 0.0 109.736 178.446 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.904 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -60.15 -45.83 91.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 123.247 1.499 . . . . 0.0 107.094 178.439 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.95 ' CD1' HG21 ' A' ' 36' ' ' ILE . 85.0 m95 -66.98 -58.48 4.87 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.791 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.766 HD11 HD13 ' A' ' 74' ' ' LEU . 4.1 mt -52.89 -23.19 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.622 177.46 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t -81.13 -20.03 42.24 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.58 -0.7 . . . . 0.0 110.49 179.405 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.9 m -98.74 31.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.767 -1.208 . . . . 0.0 109.382 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.05 75.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.01 143.55 49.13 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.105 -1.232 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.416 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 18.0 mt-30 -117.34 118.19 35.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.552 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.2 Cg_endo -81.29 146.73 15.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.499 1.263 . . . . 0.0 109.881 179.603 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -70.27 -171.7 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.053 . . . . 0.0 109.94 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 50.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.146 -0.971 . . . . 0.0 110.101 179.553 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 28.4 m -165.3 -60.22 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.676 ' HB1' HG22 ' A' ' 19' ' ' ILE . . . -65.44 -23.83 67.03 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.113 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.45 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 6.8 ttt-85 -68.76 -46.22 69.37 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.465 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -71.71 -8.02 51.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.417 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.467 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 25.8 mt -102.7 -26.2 13.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 108.604 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.766 HD13 HD11 ' A' ' 60' ' ' LEU . 41.7 mt -72.01 -30.02 64.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.781 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.547 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.15 -28.57 54.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.966 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -76.93 -33.23 57.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.108 0.956 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -67.4 -9.38 40.99 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.912 178.885 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.69 17.78 32.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.892 HG22 HG23 ' A' ' 53' ' ' VAL . 22.8 t -78.5 -67.0 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.897 -1.355 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 75' ' ' ARG . 40.1 p90 -135.59 -169.94 2.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.22 140.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.203 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.69 135.29 29.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.372 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -106.26 58.01 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.51 176.28 8.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -53.13 -26.46 16.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -54.68 151.99 7.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.286 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.75 -157.63 22.69 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 110.26 -179.954 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.241 0.543 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t -73.93 125.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.591 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -140.76 137.23 33.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.462 179.832 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.984 HD11 ' CB ' ' A' ' 59' ' ' TRP . 57.0 mt -99.56 140.16 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.098 -1.001 . . . . 0.0 109.081 179.07 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 2.2 ptt180 -150.64 171.22 17.48 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.965 -1.084 . . . . 0.0 110.266 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.9 pp -89.62 128.35 36.04 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.568 179.484 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.02 175.99 5.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.728 . . . . 0.0 109.07 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 4.5 ttt-85 -140.76 116.48 10.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.927 -1.108 . . . . 0.0 111.357 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -134.2 -153.54 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 109.806 179.302 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.62 120.27 4.74 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.442 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -65.88 -87.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.227 -1.161 . . . . 0.0 110.289 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -148.83 30.01 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.092 -179.695 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.442 ' CE1' ' HG ' ' A' ' 11' ' ' SER . 1.8 m80 -120.24 -38.71 2.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.475 -0.766 . . . . 0.0 109.482 -178.5 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.68 104.29 0.94 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.54 114.26 3.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.464 -179.543 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 24.9 p80 -122.54 159.93 26.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 110.237 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 7' ' ' ALA 0.267 9.2 m-85 -120.26 169.26 10.43 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.685 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -136.71 147.08 46.56 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.825 -1.172 . . . . 0.0 109.257 177.592 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -96.2 82.56 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 177.259 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.284 0.4 OUTLIER -97.8 161.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.204 -173.389 . . . . . . . . 4 4 . 1 . 035 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.938 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -108.46 111.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.61 -0.682 . . . . 0.0 110.599 -177.43 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.403 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.4 t -140.02 -164.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.94 179.639 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 22' ' ' THR . 28.2 t70 -104.91 138.31 41.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 110.142 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . . . -80.1 -33.4 38.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.065 179.946 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -26.75 68.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 110.188 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 64.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.9 72.75 10.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.875 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.11 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.173 -0.955 . . . . 0.0 110.269 -179.911 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.05 -48.73 64.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.18 47.35 5.26 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.929 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.56 124.4 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB3' HG13 ' A' ' 20' ' ' VAL . 12.6 p90 -108.33 141.75 39.68 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.557 HG21 ' HH2' ' A' ' 59' ' ' TRP . 15.2 mt -50.24 -31.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -176.81 171.31 2.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.12 119.48 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.013 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -113.1 -30.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.424 -0.798 . . . . 0.0 110.286 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.925 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -116.28 163.01 12.45 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.267 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 40' ' ' ASP . 85.3 t80 -140.81 117.16 10.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.838 ' HB2' HD11 ' A' ' 19' ' ' ILE . 1.7 t80 -107.44 122.57 46.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.797 -1.189 . . . . 0.0 109.537 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 21.8 t0 -140.29 91.2 9.97 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.724 -1.235 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.28 79.03 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.78 1.41 . . . . 0.0 110.934 -179.64 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.4 OUTLIER -89.92 120.58 31.26 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 110.12 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.14 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' ARG . 41.0 p -146.79 -63.71 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -150.0 170.45 7.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 109.747 -179.973 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 45' ' ' THR . 43.6 Cg_endo -69.5 62.76 1.63 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.536 1.282 . . . . 0.0 110.457 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -161.88 83.38 0.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.438 -0.788 . . . . 0.0 109.634 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.713 ' HZ3' HD23 ' A' ' 49' ' ' LEU . 17.4 p-90 -124.8 -11.85 7.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 111.139 -179.262 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.713 HD23 ' HZ3' ' A' ' 48' ' ' TRP . 1.3 tm? -94.48 119.79 33.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.945 -1.097 . . . . 0.0 110.702 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.5 ttpt -125.87 94.55 4.14 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.925 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.2 t -116.38 132.52 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.034 -1.041 . . . . 0.0 111.202 -178.967 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -74.2 70.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.972 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.678 HG23 HG22 ' A' ' 79' ' ' VAL . 1.1 p -35.61 -30.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 122.269 -0.269 . . . . 0.0 111.654 -177.377 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -60.63 -54.14 48.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.776 -1.202 . . . . 0.0 108.435 177.949 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.654 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.5 mmp_? -69.65 -41.77 75.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.333 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.943 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.92 -17.29 63.08 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.341 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 15.1 tpt180 -88.35 -26.01 22.43 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 109.423 178.594 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.817 ' O ' HG13 ' A' ' 62' ' ' VAL . 3.0 t80 -59.49 -43.31 93.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.378 1.561 . . . . 0.0 107.302 178.241 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.013 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.8 m95 -69.23 -57.18 5.69 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.987 -178.904 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.749 HD11 HD13 ' A' ' 74' ' ' LEU . 33.1 mt -54.71 -22.08 12.82 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.076 -1.015 . . . . 0.0 108.532 177.338 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -80.93 -22.61 39.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 110.763 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.817 HG13 ' O ' ' A' ' 58' ' ' TYR . 6.0 m -98.88 32.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.828 -1.17 . . . . 0.0 109.585 179.871 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.6 26.49 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -75.11 124.44 27.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.98 -1.306 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 65' ' ' GLN . 5.3 pt20 -98.84 121.01 57.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.785 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.652 ' HB3' HD12 ' A' ' 74' ' ' LEU . 50.8 Cg_endo -80.8 168.05 17.94 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.401 1.211 . . . . 0.0 110.561 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.665 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -88.8 167.92 12.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.76 179.504 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.78 -29.53 40.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 111.28 -179.247 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.468 ' HB ' ' CD2' ' A' ' 6' ' ' LEU . 24.2 m -97.51 -44.74 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.009 . . . . 0.0 110.855 -179.332 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -69.97 -24.61 63.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.405 -0.809 . . . . 0.0 109.038 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 25.1 ttt-85 -70.24 -36.54 74.57 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.577 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -30.59 71.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.002 179.133 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 70' ' ' ALA . 75.1 mt -75.45 -32.04 60.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.565 179.454 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 60' ' ' LEU . 24.6 mt -66.56 -30.0 70.2 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 4.7 tmm_? -79.81 -30.67 40.58 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.176 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -27.91 51.26 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.895 0.855 . . . . 0.0 109.703 179.191 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -73.16 -6.34 45.13 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.068 178.937 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 20.35 40.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 180.0 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.718 HG11 ' CD1' ' A' ' 60' ' ' LEU . 21.6 t -78.52 -63.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.933 -1.333 . . . . 0.0 110.289 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' CE1' ' CG ' ' A' ' 75' ' ' ARG . 14.3 p90 -133.72 -166.24 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 110.632 179.932 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 8.9 mmt180 -121.19 -77.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.249 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -169.51 150.44 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.905 . . . . 0.0 110.114 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.73 165.41 14.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 146.49 46.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.46 111.52 2.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.374 -0.829 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 4.4 pt-20 -60.19 -19.3 53.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.426 ' N ' ' HG3' ' A' ' 86' ' ' GLU . . . -53.5 -78.91 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.852 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.262 -1.14 . . . . 0.0 110.133 -179.886 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.308 0.575 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 99.1 t -53.94 111.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.49 -179.868 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -140.19 138.12 34.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.068 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.979 HD11 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -104.58 133.47 48.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.112 -0.992 . . . . 0.0 109.92 -179.996 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -150.77 -170.65 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 -179.238 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.825 HD21 ' CD1' ' A' ' 73' ' ' LEU . 16.8 mt -88.6 126.64 35.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.069 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' N ' ' HB3' ' A' ' 17' ' ' TYR . . . -99.91 103.09 14.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.93 -179.748 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.1 ttt180 -72.38 113.47 9.44 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.405 -0.809 . . . . 0.0 110.586 -179.921 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 66.1 m-85 -91.79 -63.91 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 109.995 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.59 134.59 42.57 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -178.828 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.42 ' OG ' ' HG2' ' A' ' 12' ' ' LYS . 1.6 p -62.23 -50.45 71.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -1.18 . . . . 0.0 109.65 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HG2' ' OG ' ' A' ' 11' ' ' SER . 9.5 ptpp? -171.21 41.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -119.4 -63.5 1.38 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 109.509 -179.311 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -107.74 120.95 45.63 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.485 -0.759 . . . . 0.0 109.592 179.577 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.78 112.81 3.52 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.421 1.221 . . . . 0.0 111.297 -179.197 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.672 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 29.0 p-80 -175.57 125.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 0.0 110.581 178.979 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 1.9 m-85 -121.23 165.17 15.82 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.884 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -107.98 160.51 15.72 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.002 176.971 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.039 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -97.91 79.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 102.604 -3.11 . . . . 0.0 102.604 177.503 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.3 OUTLIER -97.44 163.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.299 -173.843 . . . . . . . . 4 4 . 1 . 036 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.939 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -110.46 114.04 45.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.359 0.599 . . . . 0.0 110.84 -176.921 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.3 t -137.43 -177.76 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 179.602 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.58 -174.55 4.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.865 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.74 65.91 5.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.358 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -53.33 -179.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.09 -83.8 0.56 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 110.482 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -168.52 33.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -138.79 -53.49 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.12 -167.14 1.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.97 111.98 0.34 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -154.07 136.04 14.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 109.788 179.733 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 2.1 p90 -116.0 163.0 16.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.236 -0.915 . . . . 0.0 110.79 -179.642 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.2 mt -77.74 -30.26 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.408 -0.807 . . . . 0.0 109.787 179.878 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.32 177.24 3.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 110.108 179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -115.84 123.12 47.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 110.273 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.031 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.49 -27.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.0 110.98 179.815 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.866 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.87 165.85 20.74 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.925 -1.607 . . . . 0.0 112.305 -178.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' N ' HG12 ' A' ' 19' ' ' ILE . 25.3 t80 -140.71 138.28 34.11 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.865 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.039 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 t80 -133.32 135.18 44.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.547 -1.345 . . . . 0.0 110.304 179.75 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 26.7 t0 -140.93 95.0 7.77 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.974 -1.079 . . . . 0.0 110.337 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 46.4 Cg_endo -73.34 67.68 4.35 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.568 1.299 . . . . 0.0 110.596 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -174.14 4.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 110.298 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.14 57.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 110.452 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 p -125.01 -43.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.194 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -145.05 163.73 31.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.919 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.6 -17.82 33.49 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.604 1.318 . . . . 0.0 110.47 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.29 105.74 18.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.195 -0.94 . . . . 0.0 110.143 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.709 ' HZ3' HD12 ' A' ' 49' ' ' LEU . 4.8 p-90 -133.6 11.64 4.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.261 -0.899 . . . . 0.0 110.856 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.807 HD13 ' HB3' ' A' ' 76' ' ' GLN . 3.0 tt -112.66 134.59 54.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 0.0 110.617 -179.436 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 2.8 ttpt -137.43 85.67 2.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.485 -0.759 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.866 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -117.5 134.72 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 111.227 -178.974 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -80.81 71.32 7.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.376 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.6 -35.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.505 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.6 mm-40 -59.73 -53.88 52.85 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.621 -1.299 . . . . 0.0 108.967 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.726 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.5 mmp_? -69.45 -41.42 76.28 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.785 . . . . 0.0 109.212 178.737 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.936 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -65.39 -20.69 66.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.044 -1.035 . . . . 0.0 108.406 178.936 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -87.74 -23.48 24.11 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 178.703 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.7 t80 -60.0 -45.13 93.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 123.253 1.502 . . . . 0.0 107.085 178.148 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.031 ' CD1' HG21 ' A' ' 36' ' ' ILE . 78.4 m95 -65.23 -53.76 39.62 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.441 -179.103 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 74' ' ' LEU . 11.4 mt -56.76 -20.93 24.78 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.566 176.844 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.62 -23.73 39.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 59' ' ' TRP . 34.1 m -99.27 33.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.882 -1.136 . . . . 0.0 109.565 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.32 30.62 73.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.03 -1.277 . . . . 0.0 110.079 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.46 106.35 58.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -78.66 129.76 9.38 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.487 1.256 . . . . 0.0 110.238 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.15 174.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 109.9 179.646 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.59 -15.63 63.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.546 ' CG2' HD11 ' A' ' 6' ' ' LEU . 81.1 m -106.12 -45.36 4.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.907 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -63.14 -24.76 68.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -70.0 -40.34 75.32 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -40.81 94.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.931 178.697 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.8 mt -65.99 -33.03 74.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.742 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 60' ' ' LEU . 31.9 mt -68.49 -26.68 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.336 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.33 -28.73 47.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.907 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.807 ' HB3' HD13 ' A' ' 49' ' ' LEU . 4.3 tp60 -80.74 -37.41 30.52 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.955 0.883 . . . . 0.0 109.897 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -68.64 -7.84 36.7 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.071 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 47.68 9.09 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 53' ' ' VAL . 75.4 t -92.97 -57.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.305 -1.115 . . . . 0.0 111.698 -179.092 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.499 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 44.7 m-85 -53.02 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.107 -0.996 . . . . 0.0 110.486 -179.275 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.7 175.46 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 163.04 38.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 110.094 179.926 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -103.01 91.01 3.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.043 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.35 -173.55 2.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 110.114 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.11 64.28 1.28 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 110.366 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -54.29 147.57 13.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.9 24.86 22.4 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 110.136 179.935 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.2 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.269 0.557 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.481 HG11 ' CE3' ' A' ' 59' ' ' TRP . 33.6 t -86.11 140.94 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.922 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 65' ' ' GLN . 10.8 mttt -140.75 137.85 33.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.99 -1.069 . . . . 0.0 110.758 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.918 HD11 ' CB ' ' A' ' 59' ' ' TRP . 44.5 mt -103.41 132.7 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.126 -0.984 . . . . 0.0 108.964 178.754 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 10.4 ptt180 -150.85 -169.89 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.102 -0.999 . . . . 0.0 110.391 -179.285 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.584 HD22 ' HD2' ' A' ' 39' ' ' TYR . 52.0 mt -89.7 130.39 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -0.978 . . . . 0.0 111.452 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.74 104.99 16.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.705 -0.622 . . . . 0.0 110.23 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -75.74 120.48 21.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.012 -1.055 . . . . 0.0 111.253 -179.618 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 15.8 m-85 -110.24 -64.8 1.22 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.506 -0.746 . . . . 0.0 110.797 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.11 134.14 27.97 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -178.431 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 66.9 p -89.12 -59.17 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 0.0 109.291 179.191 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 11' ' ' SER . 11.4 mtpt -141.82 61.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.408 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 5.0 m-70 -142.14 -64.66 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.403 -0.81 . . . . 0.0 109.467 -178.597 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.71 130.15 10.27 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 179.655 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.62 102.24 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.427 1.225 . . . . 0.0 111.097 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.7 p80 -149.41 125.41 10.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.697 179.086 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.9 m-30 -117.92 154.18 32.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.047 -1.033 . . . . 0.0 108.554 178.408 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 9.5 mtt180 -99.19 160.03 14.56 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.131 176.017 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.912 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -99.21 81.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 176.969 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.257 0.3 OUTLIER -97.26 165.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.397 -173.511 . . . . . . . . 4 4 . 1 . 037 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.928 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -110.02 119.9 60.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.735 -0.603 . . . . 0.0 110.724 -176.941 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.0 OUTLIER -140.21 -176.34 4.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.035 -1.041 . . . . 0.0 110.25 179.112 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 22' ' ' THR . 5.7 m-20 -102.23 158.33 16.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 110.513 -179.554 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.55 -60.1 2.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.883 . . . . 0.0 109.939 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -52.1 132.63 33.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.203 -0.935 . . . . 0.0 110.087 179.78 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -155.03 140.68 17.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 0.0 110.598 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.62 -34.91 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 0.0 109.948 179.687 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.72 -42.0 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.971 179.725 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -72.0 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 110.012 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.07 77.33 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 113.11 11.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -1.16 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 4.4 p90 -50.36 172.58 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.841 HG21 ' HH2' ' A' ' 59' ' ' TRP . 19.7 mm -83.99 -61.66 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.415 -0.803 . . . . 0.0 109.266 179.771 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -151.16 160.48 43.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.751 -0.593 . . . . 0.0 109.593 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -89.83 110.72 21.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.985 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.041 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.7 pp -104.75 -32.41 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.082 -1.011 . . . . 0.0 111.104 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.923 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.04 162.54 15.78 Favored Glycine 0 C--N 1.295 -1.745 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.956 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.449 ' N ' HG13 ' A' ' 19' ' ' ILE . 45.9 t80 -134.35 141.49 46.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.217 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.584 ' HD2' HD22 ' A' ' 6' ' ' LEU . 4.6 t80 -142.27 130.9 22.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.087 -1.445 . . . . 0.0 111.365 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 46.3 t0 -131.64 94.97 24.32 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.25 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 41.7 Cg_endo -68.32 78.46 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.569 1.3 . . . . 0.0 110.972 -179.357 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.13 165.77 12.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -117.15 54.43 0.87 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 45' ' ' THR . 4.3 t -139.21 -41.75 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.311 -0.868 . . . . 0.0 110.06 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 44' ' ' THR . 72.1 p -133.18 146.36 60.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.45 -14.25 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.675 1.355 . . . . 0.0 110.78 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -97.37 103.42 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.926 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.753 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -142.31 13.79 2.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 -179.823 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.753 HD13 ' HZ3' ' A' ' 48' ' ' TRP . 12.0 tp -111.14 132.58 54.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.114 . . . . 0.0 111.34 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -133.41 94.96 3.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.172 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.923 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.6 t -118.41 139.45 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 111.34 -179.037 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -85.01 72.99 10.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 175.776 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.699 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.53 -30.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.06 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -62.46 -48.4 79.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.589 -1.319 . . . . 0.0 108.771 178.257 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.712 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.1 mmp_? -76.22 -36.55 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 178.673 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.868 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -69.54 -20.39 63.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.598 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttp180 -86.78 -23.19 25.5 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.296 -0.877 . . . . 0.0 109.112 178.52 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.632 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.7 t80 -61.93 -45.37 94.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 123.099 1.428 . . . . 0.0 107.502 178.427 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.041 ' CD1' HG21 ' A' ' 36' ' ' ILE . 67.8 m95 -68.07 -57.44 6.1 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.943 -179.166 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.728 HD21 ' HG3' ' A' ' 66' ' ' PRO . 10.9 mt -56.05 -20.82 18.45 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.329 -0.949 . . . . 0.0 108.707 177.335 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 t -79.98 -23.18 41.77 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.363 -0.836 . . . . 0.0 110.623 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 59' ' ' TRP . 18.8 m -98.89 31.93 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.964 -1.085 . . . . 0.0 109.627 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.77 75.17 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -66.56 134.88 53.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.951 -1.323 . . . . 0.0 110.164 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.436 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 2.9 mt-30 -99.88 107.83 48.49 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.728 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.7 Cg_endo -82.4 134.55 7.81 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.46 1.242 . . . . 0.0 110.229 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.49 163.19 0.93 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 110.032 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.07 -16.91 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.245 -0.909 . . . . 0.0 110.717 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.7 m -99.61 -47.8 4.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 110.53 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.55 -28.8 66.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -66.27 -38.6 88.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.318 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -26.74 68.3 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.287 178.939 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.1 mt -88.11 -29.03 20.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.641 HD12 ' HB3' ' A' ' 66' ' ' PRO . 34.0 mt -68.74 -28.24 66.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.733 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.52 -28.86 30.8 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.558 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -72.96 -33.76 66.07 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.142 0.972 . . . . 0.0 108.918 179.218 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.34 -9.59 54.03 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 178.523 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.409 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 84.91 52.9 3.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.699 HG22 ' CB ' ' A' ' 53' ' ' VAL . 43.0 t -114.91 -6.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.12 -1.223 . . . . 0.0 111.716 -179.272 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 10.3 m-85 -104.08 -27.2 12.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 0.0 110.663 -178.733 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -130.52 98.44 4.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -58.96 123.07 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.08 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -99.92 -167.24 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.29 -161.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.195 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.16 102.82 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -176.67 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 110.113 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -55.9 -40.68 82.19 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.903 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.193 -1.181 . . . . 0.0 110.158 -179.972 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 mtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.197 0.522 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 41.6 t -60.12 121.52 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 110.087 179.968 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -140.52 134.9 31.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.888 . . . . 0.0 110.603 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.974 ' CG1' HG13 ' A' ' 21' ' ' VAL . 73.4 mt -102.27 134.79 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.026 . . . . 0.0 109.226 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.5 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.2 ptm180 -150.91 -167.86 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.009 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 70' ' ' ALA . 4.8 mp -89.18 131.62 35.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -0.779 . . . . 0.0 110.518 -179.866 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -107.27 111.23 23.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 19.6 ttt-85 -86.17 115.01 23.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 112.313 -178.767 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.1 m-85 -114.07 -149.69 0.45 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.489 -0.757 . . . . 0.0 109.196 178.117 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.2 102.45 0.01 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 178.552 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.99 -50.42 66.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 0.0 109.698 179.575 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.505 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -176.77 55.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.749 -179.886 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 13.7 m-70 -133.76 -64.71 0.7 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.189 -179.658 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -123.8 120.1 26.75 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.323 179.447 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.6 120.51 6.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.46 1.242 . . . . 0.0 111.296 -179.217 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.0 p80 -164.48 131.54 3.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.405 178.836 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 15.2 m-30 -114.43 175.12 5.62 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.353 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.6 OUTLIER -134.32 158.17 44.48 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.193 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.877 HD12 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.51 86.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 178.003 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.268 0.4 OUTLIER -97.94 164.02 2.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.583 -173.945 . . . . . . . . 4 4 . 1 . 038 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.974 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -106.87 108.2 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.738 -0.601 . . . . 0.0 110.188 -178.278 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 33' ' ' ILE . 2.4 t -133.93 -172.71 3.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.715 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' OD1' HD11 ' A' ' 33' ' ' ILE . 1.1 m-20 -117.25 162.7 17.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.593 -0.692 . . . . 0.0 109.715 179.665 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.52 14.45 14.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.763 -179.778 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -58.13 -30.0 65.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.993 -1.067 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.3 167.95 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.27 1.4 4.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.582 -179.996 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -95.99 -71.05 0.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.238 179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.09 145.3 26.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 0.0 110.095 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.2 108.8 1.5 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.86 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -133.56 141.24 47.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -1.155 . . . . 0.0 109.849 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.554 ' HB3' HG13 ' A' ' 20' ' ' VAL . 22.7 p90 -106.34 177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.157 -0.965 . . . . 0.0 111.037 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 22' ' ' THR . 3.3 mp -91.27 -44.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.649 -0.657 . . . . 0.0 109.994 179.965 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 176.52 11.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -109.14 115.01 29.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 179.847 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.013 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.9 pt -113.06 -31.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 110.825 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.838 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.42 167.08 14.24 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.785 -178.813 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 11.5 t80 -140.61 133.03 28.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.061 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' ILE . 17.5 t80 -126.07 144.66 50.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.2 t0 -140.91 107.44 6.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.772 178.718 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 43.8 Cg_endo -73.57 69.77 4.25 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.163 1.086 . . . . 0.0 110.828 -179.389 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 125.74 43.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.059 -1.026 . . . . 0.0 110.206 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -93.62 27.48 2.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.318 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.84 HG23 HG23 ' A' ' 45' ' ' THR . 7.2 t -121.28 -14.28 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 0.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.84 HG23 HG23 ' A' ' 44' ' ' THR . 71.4 p -136.83 149.83 68.01 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.515 -179.859 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.416 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 47.1 Cg_endo -73.73 -51.88 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.772 1.406 . . . . 0.0 110.62 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -76.88 107.93 9.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 0.0 110.274 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.599 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 19.0 p-90 -132.15 2.89 3.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.886 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 49' ' ' LEU . 3.4 tm? -109.26 129.0 55.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.972 -1.08 . . . . 0.0 110.935 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 49' ' ' LEU . 38.0 tttt -134.49 93.29 3.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.545 -0.722 . . . . 0.0 109.102 178.951 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.838 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -113.48 135.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.032 -1.042 . . . . 0.0 111.04 -179.274 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.7 t70 -77.0 70.04 3.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.412 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.13 -30.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 122.265 -0.272 . . . . 0.0 111.42 -177.797 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -61.99 -55.6 27.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.898 -1.126 . . . . 0.0 109.009 178.577 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.664 ' HB3' HG22 ' A' ' 36' ' ' ILE . 28.8 mmm180 -71.56 -39.92 70.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.185 -0.947 . . . . 0.0 108.797 178.571 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -62.59 -18.66 62.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.279 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 25.0 ttm180 -88.58 -24.79 22.76 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 178.218 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.777 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -61.43 -47.2 86.84 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.268 1.509 . . . . 0.0 107.47 178.576 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.013 ' CD1' HG21 ' A' ' 36' ' ' ILE . 83.7 m95 -64.66 -56.61 12.68 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.766 -179.016 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 74' ' ' LEU . 38.4 mt -53.35 -22.68 7.77 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.534 177.238 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -21.13 41.1 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.47 -0.769 . . . . 0.0 110.456 179.177 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.3 m -99.04 32.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.85 -1.156 . . . . 0.0 109.426 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.18 25.12 76.2 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -69.44 128.51 36.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.016 -1.285 . . . . 0.0 109.792 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.37 113.24 65.85 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 0.0 110.669 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -79.68 132.08 9.63 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.526 1.277 . . . . 0.0 109.766 179.467 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 t -62.93 -178.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.53 52.43 1.4 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 0.0 110.239 179.735 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.43 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 6.3 m -166.05 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.55 -23.47 66.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.249 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.578 ' HA ' HD12 ' A' ' 74' ' ' LEU . 26.7 ttp180 -64.79 -41.11 96.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.105 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -63.82 -37.66 88.22 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.284 179.199 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 70' ' ' ALA . 40.3 mt -67.37 -35.79 80.06 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 71' ' ' ARG . 55.0 mt -65.08 -26.85 68.4 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.587 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.549 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.32 -28.09 38.24 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.027 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -78.87 -35.97 42.95 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.958 0.885 . . . . 0.0 109.967 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.749 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -74.62 -2.9 28.13 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.042 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.01 20.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.579 ' HA ' HG23 ' A' ' 53' ' ' VAL . 57.9 t -91.44 -60.17 2.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.142 -1.211 . . . . 0.0 111.479 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 46.9 m-85 -50.41 165.73 0.09 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 -179.249 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.62 113.25 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -109.11 150.29 28.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.44 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 83' ' ' GLU . 1.2 pm0 -109.35 66.81 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.21 37.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.621 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 27.72 7.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 110.024 179.847 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.81 129.71 23.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.31 -0.869 . . . . 0.0 110.408 -179.759 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.35 60.27 0.68 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.282 -1.128 . . . . 0.0 110.228 -179.903 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.179 0.514 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 92.3 t -61.56 109.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 179.876 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.6 ptmt -140.14 137.15 34.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.99 . . . . 0.0 111.044 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.024 HD11 ' CB ' ' A' ' 59' ' ' TRP . 93.6 mt -99.93 133.38 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.183 -0.948 . . . . 0.0 109.013 178.993 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -150.69 173.83 13.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.383 -179.2 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.0 pp -87.73 124.68 33.84 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.096 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.4 111.93 24.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.73 . . . . 0.0 112.462 -176.807 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.4 ttp180 -72.81 122.41 21.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.139 -0.976 . . . . 0.0 111.35 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.711 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 18.6 m-85 -114.03 -62.66 1.56 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.119 -0.988 . . . . 0.0 110.028 178.961 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 107.99 1.37 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.837 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 34.7 p -70.52 -53.42 16.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -1.197 . . . . 0.0 109.764 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' N ' ' OG ' ' A' ' 11' ' ' SER . 28.2 mttp -148.07 51.78 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -141.1 -51.45 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 -178.442 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 6.4 t-20 -145.23 116.4 5.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.603 -0.686 . . . . 0.0 109.36 179.614 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.41 115.33 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.404 1.212 . . . . 0.0 111.033 -179.074 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 32.2 p80 -176.68 136.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 179.139 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.5 m-85 -122.33 154.5 37.56 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.727 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 14.8 ttm180 -103.12 148.13 26.14 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.422 178.2 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.954 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -96.89 79.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 178.278 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 35' ' ' LYS 0.282 0.4 OUTLIER -97.61 163.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.229 -173.569 . . . . . . . . 4 4 . 1 . 039 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.926 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -110.63 110.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.497 -0.752 . . . . 0.0 110.464 -177.529 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.6 t -139.94 -174.56 3.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.222 -0.924 . . . . 0.0 110.366 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 22' ' ' THR . 56.7 m-20 -111.46 160.19 17.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 110.106 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.94 25.95 6.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -60.36 2.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 110.531 -179.805 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -131.35 155.39 47.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.694 -179.504 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -125.19 34.52 4.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.457 -0.777 . . . . 0.0 109.966 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 -18.33 13.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.648 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -108.69 -43.32 4.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.334 -179.873 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.87 90.99 0.12 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.43 128.7 9.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 110.178 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 24.4 p90 -110.21 145.94 36.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.438 179.856 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG21 ' HH2' ' A' ' 59' ' ' TRP . 1.1 mt -58.91 -36.63 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.592 179.561 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.4 tt0 -170.57 138.71 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' CB ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -89.71 134.58 34.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.597 179.802 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.961 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -124.15 -22.75 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.054 -1.028 . . . . 0.0 111.35 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.915 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.86 162.96 19.0 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.766 -1.683 . . . . 0.0 110.959 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG13 ' A' ' 19' ' ' ILE . 65.2 t80 -136.93 137.72 39.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.357 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 5.2 t80 -131.15 128.36 39.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.934 -1.103 . . . . 0.0 109.869 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 8.4 t0 -140.07 76.14 28.02 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 110.866 -179.675 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 42.3 Cg_endo -69.89 76.91 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.544 1.287 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -94.8 162.82 13.61 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -89.79 69.75 7.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 179.87 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 p -137.94 -67.32 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 110.348 -179.899 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -146.37 158.31 47.53 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.56 62.37 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.736 1.388 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -156.98 68.43 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.92 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.576 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.7 p-90 -122.54 -14.72 7.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.322 -0.861 . . . . 0.0 111.092 -179.415 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.544 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 5.5 tt -74.13 115.1 13.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.968 -1.082 . . . . 0.0 110.321 -179.295 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -130.9 90.36 2.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.881 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.954 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.5 t -115.76 139.95 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.033 -1.042 . . . . 0.0 111.025 -179.656 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.5 t70 -85.25 71.79 10.81 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.899 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.623 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.93 -31.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 122.312 -0.242 . . . . 0.0 111.526 -177.31 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.5 tt0 -62.74 -49.81 73.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.788 -1.195 . . . . 0.0 108.928 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.69 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -75.42 -36.17 60.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 108.877 178.63 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.936 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -69.3 -20.35 63.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.393 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.2 tpt180 -85.6 -25.0 26.93 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.239 -0.913 . . . . 0.0 109.216 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.8 t80 -60.12 -44.72 94.69 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 123.169 1.461 . . . . 0.0 107.503 178.563 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.024 ' CB ' HD11 ' A' ' 4' ' ' ILE . 69.2 m95 -68.32 -53.64 22.83 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.254 -179.089 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.565 HD12 HG11 ' A' ' 79' ' ' VAL . 23.4 mt -58.28 -19.44 34.54 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.493 177.437 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 3.7 m -82.78 -22.75 34.17 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.334 -0.854 . . . . 0.0 110.724 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 59' ' ' TRP . 28.0 m -98.92 33.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.835 -1.165 . . . . 0.0 109.376 179.407 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.88 35.04 91.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.865 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -70.37 140.82 52.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.078 -1.248 . . . . 0.0 110.156 179.883 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.59 106.57 40.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.31 179.965 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -81.67 142.66 12.97 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.404 1.213 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -64.15 -176.44 0.21 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.042 . . . . 0.0 110.36 -179.762 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.53 -21.57 48.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.491 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -101.76 -44.44 5.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.688 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.39 -29.03 69.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 67' ' ' THR . 46.5 ttt180 -64.41 -38.32 90.63 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.365 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.35 -29.86 70.76 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.675 178.776 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 70' ' ' ALA . 49.7 mt -81.86 -33.57 30.53 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.857 -0.527 . . . . 0.0 110.0 179.609 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 97.0 mt -67.04 -27.47 67.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.001 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG3' ' CG ' ' A' ' 80' ' ' PHE . 7.3 mtp180 -82.19 -30.93 30.63 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.621 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 22.1 tp60 -78.3 -33.44 49.35 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.898 0.856 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.32 -12.83 45.87 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.93 178.414 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.74 43.5 4.8 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.623 HG22 ' CB ' ' A' ' 53' ' ' VAL . 29.3 t -107.61 -16.58 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -1.228 . . . . 0.0 111.321 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CG ' ' HG3' ' A' ' 75' ' ' ARG . 6.9 m-85 -96.95 81.6 3.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.261 -178.733 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -93.22 21.81 5.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 110.025 179.688 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -139.19 109.97 6.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.851 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.69 128.58 20.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -119.67 164.03 16.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -140.76 -48.9 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.88 120.21 7.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.27 65.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.163 179.935 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.288 0.566 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.649 ' CG1' HG12 ' A' ' 21' ' ' VAL . 63.9 t -81.13 148.17 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 65' ' ' GLN . 5.3 mmmm -140.48 130.62 24.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.873 ' CG1' HG13 ' A' ' 21' ' ' VAL . 31.6 mt -99.81 129.45 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.899 -1.126 . . . . 0.0 109.102 178.941 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.7 ptt180 -150.94 -174.96 4.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 110.812 -178.975 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.609 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -88.98 125.36 34.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 110.969 -179.715 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.53 111.23 23.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.511 -0.743 . . . . 0.0 110.104 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -80.04 120.33 24.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 112.044 -178.807 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.8 m-85 -118.68 -155.01 0.59 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 178.345 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.68 113.84 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.281 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 p -56.7 -47.73 79.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.203 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.04 48.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.688 -0.632 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -116.75 -60.72 1.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.388 -0.82 . . . . 0.0 109.689 -179.198 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -133.13 130.19 21.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 0.0 109.769 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.09 114.45 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.467 1.246 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 34.4 p80 -160.35 126.81 4.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 110.245 178.98 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.609 ' HB2' HD23 ' A' ' 6' ' ' LEU . 8.7 m-85 -114.06 161.44 17.71 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.089 -1.007 . . . . 0.0 108.534 178.931 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 14.2 ttm180 -114.08 151.53 32.39 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.351 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.906 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -97.94 80.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 102.513 -3.144 . . . . 0.0 102.513 178.171 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.27 0.4 OUTLIER -97.57 166.32 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.41 -173.459 . . . . . . . . 4 4 . 1 . 040 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.873 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -111.49 113.42 44.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.595 -0.691 . . . . 0.0 110.627 -177.251 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.3 t -136.03 -176.23 4.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.259 179.683 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER -91.58 -165.76 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.02 179.814 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.16 28.52 3.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -79.73 0.38 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.329 -0.857 . . . . 0.0 110.833 -179.539 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 123.43 18.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 0.0 110.625 -179.521 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.94 45.21 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.036 179.817 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -136.97 -50.52 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.296 -179.792 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.53 173.95 7.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.5 40.91 1.99 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.96 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.47 121.52 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -1.131 . . . . 0.0 110.594 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.488 ' HB3' HG13 ' A' ' 20' ' ' VAL . 7.5 p90 -120.35 143.69 48.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.499 179.896 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.679 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.3 mp -55.08 -33.3 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.12 175.11 2.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 126.05 54.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.034 179.895 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.047 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -120.3 -31.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.158 -0.964 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.933 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -118.43 156.35 15.69 Favored Glycine 0 C--N 1.298 -1.543 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.72 143.5 51.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.752 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.607 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 33.9 t80 -138.6 136.86 36.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.671 -1.268 . . . . 0.0 110.752 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.6 t0 -140.39 102.83 6.61 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.064 -1.022 . . . . 0.0 110.047 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.444 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 48.0 Cg_endo -78.9 82.09 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.073 1.038 . . . . 0.0 110.574 -179.253 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -91.7 170.3 10.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.044 -1.035 . . . . 0.0 110.451 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 46.62 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -143.81 -63.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -126.01 144.12 47.72 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HA ' ' CD1' ' A' ' 48' ' ' TRP . 46.4 Cg_endo -73.51 -8.72 22.06 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.67 1.353 . . . . 0.0 110.806 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.11 61.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.983 -1.073 . . . . 0.0 110.384 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.607 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 13.9 p-90 -121.88 -13.31 8.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.191 -0.943 . . . . 0.0 110.802 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.656 HD12 HD22 ' A' ' 73' ' ' LEU . 3.1 tt -81.01 117.91 22.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 110.293 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -131.96 98.31 4.41 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.32 179.269 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -122.81 138.1 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 111.324 -179.039 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t70 -83.35 72.12 10.23 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.721 HG23 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.15 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 CA-C-O 120.631 0.253 . . . . 0.0 111.348 -177.409 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 52' ' ' ASP . 17.4 mt-10 -60.5 -52.76 63.84 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.878 -1.138 . . . . 0.0 108.626 178.148 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.58 ' HB3' HG22 ' A' ' 36' ' ' ILE . 53.5 mmm-85 -72.82 -41.05 65.29 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.357 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.941 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -62.25 -18.36 60.98 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.088 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.3 ttp180 -88.85 -27.99 20.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.259 -0.901 . . . . 0.0 109.368 178.566 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.733 ' O ' HG13 ' A' ' 62' ' ' VAL . 2.5 t80 -59.82 -44.33 94.09 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.294 1.521 . . . . 0.0 107.545 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.047 ' CD1' HG21 ' A' ' 36' ' ' ILE . 74.7 m95 -68.4 -56.68 7.66 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.889 -178.91 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.052 HD11 HD13 ' A' ' 74' ' ' LEU . 35.0 mt -54.61 -21.67 11.14 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.006 -1.059 . . . . 0.0 108.647 177.429 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 24.4 t -80.92 -23.42 38.93 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.399 -0.813 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 58' ' ' TYR . 6.0 m -98.95 32.19 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.805 -1.184 . . . . 0.0 109.568 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.0 24.47 75.89 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.68 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -72.02 101.47 2.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.918 -1.343 . . . . 0.0 109.83 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.439 ' HB3' ' CD ' ' A' ' 3' ' ' LYS . 1.7 tt0 -69.84 114.78 27.47 Favored Pre-proline 0 C--N 1.297 -1.701 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.355 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HB3' HD12 ' A' ' 74' ' ' LEU . 53.2 Cg_endo -82.2 124.94 4.45 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.599 1.315 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.63 164.98 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.15 -0.969 . . . . 0.0 110.212 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.1 -18.04 31.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.4 m -95.89 -50.14 5.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.06 -28.5 67.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.389 -0.819 . . . . 0.0 109.206 -179.555 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 8.2 ttp180 -66.86 -38.08 85.66 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.735 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -23.94 65.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.069 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 70' ' ' ALA . 17.9 mt -90.96 -26.39 19.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.459 -0.776 . . . . 0.0 109.621 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.052 HD13 HD11 ' A' ' 60' ' ' LEU . 25.6 mt -69.76 -30.12 67.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.996 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.85 -29.16 44.41 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.141 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.42 ' HG2' HD13 ' A' ' 49' ' ' LEU . 5.8 tp-100 -73.34 -34.2 65.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.139 0.971 . . . . 0.0 108.516 178.902 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -72.12 -7.33 48.42 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.692 177.994 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.65 50.07 4.6 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.589 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.721 HG22 HG23 ' A' ' 53' ' ' VAL . 40.6 t -112.45 10.67 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -1.178 . . . . 0.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 12.1 m-85 -121.67 15.28 11.05 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.908 -1.12 . . . . 0.0 110.441 -179.785 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -80.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.78 -179.526 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -96.93 158.5 15.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.51 -179.434 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -148.48 178.55 8.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.17 54.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.285 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -131.24 -43.55 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.964 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.57 49.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.984 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 49.49 0.91 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 110.181 179.993 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.204 0.526 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.662 HG11 ' CE3' ' A' ' 59' ' ' TRP . 61.4 t -89.75 140.6 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.939 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.793 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 28.7 mtpt -140.24 130.62 25.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.511 -179.904 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.964 ' CG1' HG13 ' A' ' 21' ' ' VAL . 77.9 mt -102.37 133.11 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.135 -0.978 . . . . 0.0 109.925 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptt85 -150.8 -165.48 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.63 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 50.5 mt -89.26 132.65 34.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.008 -1.058 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -104.26 100.88 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 179.708 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -71.32 119.61 15.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 111.169 -179.645 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.532 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 33.6 m-85 -105.26 -63.94 1.18 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 179.217 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.26 130.3 28.95 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.547 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' NH1' ' A' ' 8' ' ' ARG . 1.5 p -68.87 -42.78 76.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -1.065 . . . . 0.0 109.504 179.389 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.62 36.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.662 0.744 . . . . 0.0 109.353 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -115.46 -59.68 1.97 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.35 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 10.9 t-20 -123.81 113.82 28.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.061 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.09 109.28 2.79 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.387 1.204 . . . . 0.0 111.255 -179.006 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 33.5 p80 -164.88 131.8 3.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.351 179.164 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.8 m-85 -122.55 155.01 37.13 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.549 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 1.8 mmt180 -99.81 165.25 11.67 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.147 -1.421 . . . . 0.0 107.999 176.736 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.885 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -98.48 81.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 177.244 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -97.4 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.681 -173.947 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.964 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -111.84 108.65 26.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.748 -0.595 . . . . 0.0 110.947 -176.951 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t -138.93 -164.99 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.004 179.452 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 22' ' ' THR . 5.0 t70 -96.63 177.1 5.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 110.206 -179.942 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.793 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . . . -117.07 -51.53 2.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.165 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -34.8 37.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 110.293 179.965 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -89.96 98.16 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.892 . . . . 0.0 110.038 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 -13.86 19.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.713 -179.737 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -83.69 -21.79 32.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.078 -1.014 . . . . 0.0 110.364 -179.836 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -76.83 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 179.884 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.04 16.59 40.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -112.36 144.99 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.061 -1.258 . . . . 0.0 110.277 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 -113.61 178.32 4.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.199 -0.938 . . . . 0.0 110.495 179.951 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.0 mt -82.88 -45.2 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.745 . . . . 0.0 109.667 179.76 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 165.91 32.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.447 -0.783 . . . . 0.0 110.01 179.787 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HD3' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -99.0 108.47 21.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 179.861 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.001 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.9 pt -101.51 -36.22 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.095 -1.003 . . . . 0.0 111.581 -179.566 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.809 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -125.95 172.04 17.78 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.758 -1.687 . . . . 0.0 112.868 -177.934 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 77.9 t80 -141.11 133.26 27.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.237 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.885 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.1 t80 -132.12 133.46 44.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.567 -1.333 . . . . 0.0 110.394 178.853 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 5.9 t0 -140.26 100.96 6.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.948 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.69 82.78 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.569 1.3 . . . . 0.0 111.026 -179.315 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.843 ' NH2' HG21 ' A' ' 45' ' ' THR . 19.5 mtp180 -89.94 155.24 19.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.381 -0.824 . . . . 0.0 109.851 179.509 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 49.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.516 HG23 ' N ' ' A' ' 45' ' ' THR . 6.9 t -149.86 -41.6 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.028 -1.045 . . . . 0.0 110.795 -179.881 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.843 HG21 ' NH2' ' A' ' 42' ' ' ARG . 3.9 t -110.25 152.74 43.38 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.571 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.96 -49.03 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.751 1.395 . . . . 0.0 110.19 179.701 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.89 105.29 8.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.734 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 1.6 p-90 -126.58 17.11 7.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.867 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.734 HD13 ' HZ3' ' A' ' 48' ' ' TRP . 10.9 tp -120.78 130.71 54.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.932 -1.105 . . . . 0.0 111.028 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -128.4 92.64 3.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.134 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.809 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.84 149.07 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 111.29 -179.025 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t0 -93.31 67.04 4.06 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.765 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -32.05 -33.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.667 -177.334 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.34 -53.33 58.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.995 178.537 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 25.7 mmm180 -71.7 -41.87 68.08 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 108.66 178.525 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -61.99 -18.68 61.26 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.222 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.2 ttt-85 -88.27 -27.2 21.89 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.326 -0.859 . . . . 0.0 109.508 178.167 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.808 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -59.49 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.234 1.493 . . . . 0.0 107.564 178.637 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.001 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.5 m95 -66.38 -54.82 19.96 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.511 -178.923 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.665 HD11 HD13 ' A' ' 74' ' ' LEU . 9.1 mt -55.6 -21.49 17.73 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.533 177.081 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 10.8 t -82.57 -20.74 35.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.423 -0.798 . . . . 0.0 110.622 179.687 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.5 m -99.12 32.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.48 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.36 72.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -68.07 142.52 55.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.036 -1.273 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -110.62 109.4 57.97 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 110.645 -179.699 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -80.21 125.41 5.81 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.586 1.308 . . . . 0.0 109.815 179.339 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 t -56.91 178.87 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 0.0 110.539 -179.819 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.74 54.22 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 0.0 109.781 179.172 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -165.64 -58.3 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.761 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.642 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.48 -23.7 66.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.026 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -69.17 -41.79 76.75 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.157 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -65.78 -41.47 91.97 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.652 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.66 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.9 mt -69.97 -28.16 65.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.493 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.665 HD13 HD11 ' A' ' 60' ' ' LEU . 12.8 mt -68.82 -29.05 67.31 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.514 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.532 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.12 -30.77 39.11 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.421 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -31.34 34.93 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.847 0.832 . . . . 0.0 109.877 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -70.52 -6.83 39.1 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.051 178.863 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.45 48.6 6.24 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 53' ' ' VAL . 48.4 t -100.64 -62.18 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.206 -1.173 . . . . 0.0 111.461 -179.385 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.532 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.6 m-30 -52.74 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.077 -1.015 . . . . 0.0 110.225 -179.234 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' VAL . 58.6 mtt180 -153.78 -165.56 2.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 -179.998 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -126.22 64.26 1.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -100.44 73.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.252 -179.97 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.63 -159.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.438 -179.937 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.57 -14.29 49.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.469 -179.84 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.64 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.208 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.84 -92.69 0.56 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.155 -1.203 . . . . 0.0 110.183 -179.97 . . . . . . . . 0 0 . 1 . 042 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.308 0.575 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.617 HG11 ' CE3' ' A' ' 59' ' ' TRP . 70.3 t -58.67 132.51 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 110.146 -179.965 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.19 135.33 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.005 ' CG1' HG13 ' A' ' 21' ' ' VAL . 86.2 mt -102.86 135.34 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.038 -1.039 . . . . 0.0 109.737 179.433 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.38 -168.78 3.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.373 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 70' ' ' ALA . 7.0 mp -89.45 127.25 35.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 179.916 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -102.21 108.92 20.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.573 -0.705 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 2.8 ttt180 -82.02 113.57 20.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 111.688 -179.468 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.498 ' HB2' ' CE1' ' A' ' 16' ' ' HIS . 11.3 m-85 -100.38 -62.96 1.17 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 178.43 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 124.93 33.33 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.495 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -52.31 -40.23 61.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.851 179.405 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 -35.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.191 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -44.37 -64.61 0.65 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.601 0.715 . . . . 0.0 109.489 -179.634 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -106.68 96.0 13.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.586 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.05 96.17 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.788 1.415 . . . . 0.0 111.271 -178.636 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 29.9 p80 -150.75 134.87 16.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.284 178.994 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.0 m-85 -121.32 -179.27 4.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.247 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 70.7 mtt180 -131.99 157.15 44.83 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.686 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -98.07 81.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 177.622 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -97.72 168.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.639 -173.785 . . . . . . . . 4 4 . 1 . 042 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.005 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.37 108.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.69 -0.631 . . . . 0.0 110.658 -177.087 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t -140.19 -165.85 1.99 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 25.4 t0 -109.05 117.91 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.84 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.57 -47.37 82.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -29.92 21.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.494 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 85.25 6.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 179.805 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.9 78.27 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -169.9 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.249 179.8 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.98 -23.79 65.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.02 47.99 76.53 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.887 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.14 137.05 55.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -1.171 . . . . 0.0 110.179 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD2' HG21 ' A' ' 20' ' ' VAL . 5.3 p90 -110.17 -173.82 2.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.647 HG21 ' HH2' ' A' ' 59' ' ' TRP . 56.3 mt -93.58 -36.31 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.503 -0.748 . . . . 0.0 110.002 -179.876 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.12 167.82 15.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.904 -179.958 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 4.2 pttp -102.05 111.7 24.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 179.902 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.965 HG21 ' CD1' ' A' ' 59' ' ' TRP . 32.2 pt -107.41 -35.21 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.912 -1.117 . . . . 0.0 111.244 -179.648 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.815 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.78 168.05 15.1 Favored Glycine 0 C--N 1.296 -1.648 0 C-N-CA 118.959 -1.591 . . . . 0.0 112.254 -177.887 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.448 ' N ' HG12 ' A' ' 19' ' ' ILE . 90.8 t80 -141.36 125.9 17.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.571 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.77 ' HB2' HD11 ' A' ' 19' ' ' ILE . 10.9 t80 -120.66 130.12 53.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.813 -1.179 . . . . 0.0 109.43 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 14.8 t0 -140.68 82.14 16.12 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.293 -1.504 . . . . 0.0 111.633 179.851 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 44.1 Cg_endo -71.24 76.65 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.343 1.181 . . . . 0.0 110.647 179.439 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -178.91 4.96 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.2 -0.938 . . . . 0.0 110.307 -179.968 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -111.73 50.77 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.036 -179.972 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -134.81 -49.79 0.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.496 -179.743 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -144.98 152.4 51.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.911 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.83 -11.32 21.8 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.75 1.395 . . . . 0.0 110.694 -179.885 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.43 74.89 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.817 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.512 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 10.9 p-90 -117.69 -21.17 8.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.18 -0.95 . . . . 0.0 110.509 179.841 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.3 tt -75.01 112.62 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.438 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.93 95.66 3.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 109.5 179.393 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.815 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.57 143.53 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 111.411 -179.102 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 t70 -87.95 70.16 9.44 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.389 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.11 -32.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.486 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.47 -57.18 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.7 -1.25 . . . . 0.0 108.818 178.526 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.651 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -67.64 -41.3 84.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 108.998 178.538 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.5 -19.35 65.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.615 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.9 ttt180 -89.17 -22.26 22.89 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 178.501 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.939 ' O ' HG13 ' A' ' 62' ' ' VAL . 5.3 t80 -59.95 -44.64 94.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.25 1.5 . . . . 0.0 107.14 178.282 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.965 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.0 m95 -68.43 -58.22 4.67 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.909 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.744 HD11 HD13 ' A' ' 74' ' ' LEU . 30.6 mt -53.13 -23.57 8.44 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.586 177.474 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 19.5 m -80.87 -21.33 40.77 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.484 -0.76 . . . . 0.0 110.348 179.287 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -99.12 31.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.872 -1.143 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.91 24.9 75.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.972 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 138.59 55.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.916 -1.343 . . . . 0.0 110.264 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.465 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -105.47 107.87 60.16 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.912 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HB3' HD12 ' A' ' 74' ' ' LEU . 56.2 Cg_endo -82.38 132.01 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.474 1.25 . . . . 0.0 110.484 179.982 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.1 p -58.97 166.27 2.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 179.417 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.17 -26.31 64.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.913 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -84.87 -51.8 6.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 110.482 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.809 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -70.15 -25.42 63.45 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.441 -0.787 . . . . 0.0 108.942 179.981 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 67' ' ' THR . 8.1 ttm180 -69.39 -36.09 76.44 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.131 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -40.98 92.49 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.557 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.2 mt -69.29 -28.08 65.98 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.267 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.744 HD13 HD11 ' A' ' 60' ' ' LEU . 25.0 mt -73.18 -27.03 61.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.468 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.6 -29.93 29.84 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.117 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -84.37 -31.07 24.94 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.859 0.837 . . . . 0.0 110.045 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.455 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -70.6 -7.9 47.62 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.772 -0.58 . . . . 0.0 109.829 178.667 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.09 50.3 4.64 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.691 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 53' ' ' VAL . 21.8 t -102.74 -59.87 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.119 -1.224 . . . . 0.0 111.206 -179.696 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 2.9 m-30 -56.41 -33.27 65.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.05 . . . . 0.0 109.603 -179.6 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -80.21 -168.65 1.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 110.216 -179.602 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -111.94 -174.18 2.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.892 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.82 147.72 6.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.157 179.836 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.74 111.29 5.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.268 -179.951 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.96 42.45 0.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 110.322 -179.93 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.87 77.57 1.59 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 179.987 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -116.89 -168.79 14.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.202 -1.176 . . . . 0.0 110.227 -179.905 . . . . . . . . 0 0 . 1 . 043 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.304 0.573 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 46.8 t -62.43 116.31 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.177 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -140.81 141.19 34.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.521 -179.775 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.909 HD11 ' CB ' ' A' ' 59' ' ' TRP . 91.0 mt -108.57 131.11 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.055 -1.028 . . . . 0.0 109.462 178.97 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -151.2 -175.68 5.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 110.69 -179.138 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.533 HD11 HD12 ' A' ' 73' ' ' LEU . 3.9 mp -88.72 122.41 32.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.95 107.15 19.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 112.055 -178.561 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -57.21 127.79 33.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.653 179.036 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.554 ' CE2' ' HB2' ' A' ' 18' ' ' ARG . 27.6 m-85 -101.65 -79.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.451 -0.781 . . . . 0.0 111.834 -178.588 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.04 168.14 0.73 Allowed Glycine 0 N--CA 1.482 1.756 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -177.901 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 p -85.56 -42.7 14.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.559 -0.965 . . . . 0.0 109.755 179.682 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.07 47.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.619 -0.676 . . . . 0.0 109.981 -179.562 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -125.83 -64.36 1.06 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.435 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.0 m-20 -118.3 106.56 44.71 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.606 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' PRO . 43.8 Cg_endo -70.15 66.45 2.0 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.503 1.265 . . . . 0.0 112.667 -177.893 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.43 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 24.6 p-80 -109.95 134.83 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.93 -1.106 . . . . 0.0 109.441 177.987 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 10.2 m-85 -117.82 157.84 25.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.069 179.74 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.554 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.5 153.52 18.96 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.645 177.303 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.031 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.2 mm -97.67 73.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 176.336 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.258 0.4 OUTLIER -97.59 162.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.093 -173.053 . . . . . . . . 4 4 . 1 . 043 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.821 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.15 114.32 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.439 0.638 . . . . 0.0 111.441 -176.883 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.2 t -140.03 -173.03 3.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.603 178.888 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 15.6 p30 -104.66 176.25 5.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.178 -0.951 . . . . 0.0 110.323 -179.841 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.16 22.51 15.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.528 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -77.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 110.248 179.943 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.61 130.94 54.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.169 179.966 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -101.45 44.84 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.34 -60.4 1.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 179.885 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.68 -71.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.895 . . . . 0.0 110.211 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.74 28.87 3.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.976 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 136.54 54.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 -179.885 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 35' ' ' LYS . 11.9 p90 -122.5 177.66 5.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.367 -0.833 . . . . 0.0 110.549 -179.851 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.648 HG21 ' HH2' ' A' ' 59' ' ' TRP . 14.8 mt -88.45 -31.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.514 -0.741 . . . . 0.0 109.878 179.858 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.48 157.14 2.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.487 -0.758 . . . . 0.0 109.877 -179.88 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HA ' HG23 ' A' ' 20' ' ' VAL . 36.3 mtmt -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.911 HG21 ' CD1' ' A' ' 59' ' ' TRP . 29.0 pt -100.0 -35.62 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 110.859 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.858 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.13 166.38 18.92 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.017 -178.453 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.473 ' N ' HG12 ' A' ' 19' ' ' ILE . 84.8 t80 -141.01 137.07 32.71 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.808 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.031 ' HB2' HD11 ' A' ' 19' ' ' ILE . 16.3 t80 -127.08 131.02 50.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 109.296 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.8 t0 -140.67 107.13 6.45 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.741 -1.224 . . . . 0.0 111.31 179.917 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' CD ' ' O ' ' A' ' 15' ' ' PRO . 54.4 Cg_endo -86.75 39.15 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.521 1.274 . . . . 0.0 110.69 179.089 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -89.69 -135.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.481 ' C ' HG23 ' A' ' 44' ' ' THR . 5.6 mttt -70.99 62.04 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.736 -1.227 . . . . 0.0 109.246 179.378 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.481 HG23 ' C ' ' A' ' 43' ' ' LYS . 56.5 p -150.94 96.4 2.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.431 -0.793 . . . . 0.0 109.387 -179.602 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' A' ' 46' ' ' PRO . 8.9 m -88.67 -43.23 0.46 Allowed Pre-proline 0 C--N 1.295 -1.776 0 O-C-N 121.191 -0.943 . . . . 0.0 110.544 -179.824 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' A' ' 45' ' ' THR . 51.3 Cg_endo -91.45 -55.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.046 1.024 . . . . 0.0 110.654 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 44' ' ' THR . 7.9 m-20 -101.62 90.47 4.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.355 -0.841 . . . . 0.0 110.352 -179.429 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.781 ' HZ3' HD23 ' A' ' 49' ' ' LEU . 27.3 p-90 -129.3 5.54 5.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.792 . . . . 0.0 110.831 -179.793 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.781 HD23 ' HZ3' ' A' ' 48' ' ' TRP . 1.6 tm? -118.23 123.47 45.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.89 -1.131 . . . . 0.0 110.508 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.618 ' N ' HD13 ' A' ' 49' ' ' LEU . 11.6 tttm -125.7 97.6 5.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.571 -0.706 . . . . 0.0 109.111 179.175 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.858 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.1 t -124.06 144.22 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.031 -1.043 . . . . 0.0 111.396 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.3 t0 -87.66 70.27 9.7 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.794 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.615 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.33 -30.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.471 -177.655 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.6 mt-10 -62.18 -54.74 36.7 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.909 -1.119 . . . . 0.0 108.967 178.092 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 3.4 mtm-85 -74.15 -33.57 63.57 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 178.951 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.901 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -68.24 -24.69 64.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.212 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -84.35 -22.94 30.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 178.285 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -61.65 -51.76 67.13 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.192 1.472 . . . . 0.0 107.722 178.909 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.911 ' CD1' HG21 ' A' ' 36' ' ' ILE . 82.9 m95 -59.81 -53.75 54.33 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.899 -179.183 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.962 HD11 HD13 ' A' ' 74' ' ' LEU . 9.8 mt -55.2 -20.06 9.66 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.559 177.094 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.1 t -81.56 -21.29 38.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 110.682 179.279 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.2 m -98.88 32.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.816 -1.177 . . . . 0.0 109.813 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.04 72.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -73.39 122.62 22.36 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.183 -1.187 . . . . 0.0 110.109 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 112.49 48.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.731 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.8 Cg_endo -82.12 127.31 5.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.518 1.273 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 167.39 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.082 -1.011 . . . . 0.0 109.789 179.677 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.33 -17.35 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.735 -179.626 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' HD13 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -99.06 -49.57 4.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.346 -179.868 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -66.7 -23.08 66.07 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.335 -0.853 . . . . 0.0 109.026 -179.961 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 7.5 tmm_? -71.75 -41.35 68.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.28 83.6 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.291 -0.963 . . . . 0.0 108.962 178.847 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.568 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 28.5 mt -72.62 -27.05 61.91 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.742 . . . . 0.0 109.15 179.192 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.962 HD13 HD11 ' A' ' 60' ' ' LEU . 15.0 mt -72.37 -29.57 63.9 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 177.763 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 1.4 tmm_? -79.59 -31.88 41.85 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.548 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.31 -26.81 47.07 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.016 0.913 . . . . 0.0 109.218 178.69 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.705 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -70.67 -7.74 46.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.78 16.51 45.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.99 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.615 HG22 HG23 ' A' ' 53' ' ' VAL . 22.2 t -77.12 -66.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.308 . . . . 0.0 109.826 179.728 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.452 ' CE1' ' HG3' ' A' ' 75' ' ' ARG . 15.9 p90 -129.37 60.74 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.349 -0.844 . . . . 0.0 110.431 179.331 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.67 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.507 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -149.39 122.85 9.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.021 -1.049 . . . . 0.0 110.429 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -129.74 104.42 7.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.974 179.784 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.16 157.41 16.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.298 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.43 70.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 179.941 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -178.63 60.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 179.959 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.13 69.48 3.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.867 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.339 -1.095 . . . . 0.0 110.315 179.896 . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.249 0.547 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 044 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG11 ' CE3' ' A' ' 59' ' ' TRP . 92.8 t -80.0 131.56 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.24 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -140.77 142.49 34.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.909 HD11 ' CB ' ' A' ' 59' ' ' TRP . 73.8 mt -109.92 134.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.041 . . . . 0.0 109.825 179.382 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.27 -171.21 3.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.948 -1.095 . . . . 0.0 110.766 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 70' ' ' ALA . 7.1 mp -89.01 126.4 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.679 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.92 106.31 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 110.767 -179.634 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.525 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -75.77 119.0 19.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.822 -1.174 . . . . 0.0 111.43 -179.714 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.679 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 9.0 m-85 -113.68 -63.5 1.44 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.139 -0.975 . . . . 0.0 110.463 178.935 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.2 115.25 2.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.449 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 36.2 p -81.18 -60.86 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 11' ' ' SER . 12.9 mtmt -141.91 41.26 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.508 -0.745 . . . . 0.0 109.035 -179.876 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.6 m-70 -128.23 -44.68 1.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.796 0.808 . . . . 0.0 109.137 -178.672 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -162.88 117.29 1.15 Allowed Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.718 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.49 107.39 2.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.304 1.16 . . . . 0.0 111.359 -178.93 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 33.6 p80 -153.14 131.39 11.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.124 178.945 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.4 m-85 -117.54 155.49 29.7 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.864 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' C ' HD13 ' A' ' 19' ' ' ILE . 16.7 mtt-85 -108.75 160.47 15.94 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.256 -1.378 . . . . 0.0 107.988 176.678 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.994 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.62 81.53 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 177.643 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -97.32 164.38 2.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.611 -173.856 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.92 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -110.09 109.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.76 -0.587 . . . . 0.0 110.181 -177.483 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 5.7 t -140.06 -158.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.818 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.3 OUTLIER -96.72 162.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 109.939 179.658 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.49 74.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.547 -179.706 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.14 123.54 1.98 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.223 -0.923 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.13 156.18 44.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.968 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.82 -1.04 33.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -97.54 -43.5 7.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -172.77 167.61 5.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.294 -0.879 . . . . 0.0 110.147 -179.971 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.0 58.92 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.954 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 105.18 16.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 110.157 179.925 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 p90 -51.86 172.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.699 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.724 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.6 mp -83.7 -33.06 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.616 -0.678 . . . . 0.0 109.367 179.383 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.21 156.06 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.559 -0.713 . . . . 0.0 109.688 179.472 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -91.87 111.34 22.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.388 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.033 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.8 pp -102.42 -26.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.203 -0.935 . . . . 0.0 110.59 179.482 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.886 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -123.39 165.96 15.97 Favored Glycine 0 C--N 1.297 -1.637 0 C-N-CA 119.173 -1.489 . . . . 0.0 111.925 -179.468 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.479 ' N ' HG12 ' A' ' 19' ' ' ILE . 6.5 t80 -140.86 132.9 27.82 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.901 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.994 ' HB2' HD11 ' A' ' 19' ' ' ILE . 15.0 t80 -130.7 140.61 50.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.754 -1.216 . . . . 0.0 109.877 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 29.8 t0 -140.34 93.24 9.01 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.869 -1.145 . . . . 0.0 109.863 179.051 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 40.9 Cg_endo -67.17 82.27 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.285 1.15 . . . . 0.0 111.014 -179.184 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -104.54 156.6 17.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.338 -0.851 . . . . 0.0 110.246 179.73 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -106.94 60.71 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.394 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -140.16 -81.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.141 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -118.14 149.37 45.51 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.872 . . . . 0.0 110.025 179.899 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.44 61.26 3.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.675 1.355 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.1 60.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -123.39 -11.37 7.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.152 -0.968 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.3 tt -84.58 116.25 23.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 110.229 179.903 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.46 88.99 2.46 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.886 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -115.53 130.41 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 111.197 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t70 -75.32 71.42 2.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.016 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -34.18 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.681 -177.45 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 39.9 tt0 -62.12 -51.94 65.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.667 -1.271 . . . . 0.0 108.851 178.136 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.667 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -71.41 -39.18 71.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 178.701 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.906 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -66.99 -19.53 65.73 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.335 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.1 ttp85 -87.18 -25.73 23.91 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.402 -0.811 . . . . 0.0 109.377 178.755 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.673 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.9 t80 -59.32 -45.9 90.07 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.231 1.491 . . . . 0.0 107.519 178.539 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.033 ' CD1' HG21 ' A' ' 36' ' ' ILE . 70.9 m95 -66.89 -56.95 8.04 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.415 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 79' ' ' VAL . 12.7 mt -53.67 -22.83 9.71 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.572 177.327 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.59 -23.28 49.95 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.465 -0.772 . . . . 0.0 110.234 179.28 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 59' ' ' TRP . 5.4 m -98.88 32.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.898 -1.126 . . . . 0.0 109.509 179.873 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.43 22.33 77.69 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.901 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -63.53 134.59 55.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.979 -1.306 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -105.83 110.0 63.71 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 110.401 -179.797 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.54 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.1 Cg_endo -83.62 130.71 5.25 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.455 1.24 . . . . 0.0 109.814 179.516 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.8 t -54.76 -177.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -0.942 . . . . 0.0 110.091 -179.853 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.68 0.67 16.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.969 -1.082 . . . . 0.0 111.707 -179.163 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.502 ' H ' HG23 ' A' ' 67' ' ' THR . 2.6 m -110.86 -50.9 2.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.862 -1.149 . . . . 0.0 110.035 179.794 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.868 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -72.04 -26.82 62.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.635 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.6 ttt180 -67.26 -38.12 84.6 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.383 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -66.63 -36.95 83.8 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 108.724 179.061 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 70' ' ' ALA . 12.2 mt -72.79 -28.32 62.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.878 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.518 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 30.9 mt -71.55 -28.69 64.03 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.443 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.71 -30.62 46.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.327 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 15.3 tp60 -84.07 -32.2 24.93 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.881 0.848 . . . . 0.0 110.265 -179.843 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.88 -13.36 44.52 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.766 -0.583 . . . . 0.0 109.999 178.963 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.26 25.03 10.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 60' ' ' LEU . 30.1 t -85.43 -68.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.801 -1.411 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.422 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 17.8 p90 -126.83 149.91 49.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.153 -179.98 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 4.0 mtt180 -158.48 -79.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.411 -0.806 . . . . 0.0 109.904 179.932 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -164.72 1.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.044 179.727 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -96.39 76.84 2.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.862 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.77 123.62 26.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 179.693 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -107.68 132.87 52.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -62.44 -48.75 78.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.375 -0.828 . . . . 0.0 110.059 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.74 -90.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.959 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.264 -1.139 . . . . 0.0 110.323 179.972 . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.229 0.538 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG21 HG23 ' A' ' 62' ' ' VAL . 14.1 m -119.0 116.49 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.333 -0.854 . . . . 0.0 110.596 -179.692 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -140.25 132.26 27.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.184 179.667 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.861 ' CG1' HG13 ' A' ' 21' ' ' VAL . 76.3 mt -103.08 132.09 50.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.095 -1.003 . . . . 0.0 109.551 179.351 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.35 -169.07 3.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.2 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 6' ' ' LEU . 36.4 mt -88.81 129.41 35.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 179.752 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.39 101.11 12.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.155 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 1.2 tmm_? -71.18 115.14 9.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.722 -0.611 . . . . 0.0 111.538 -179.252 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.524 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 27.6 m-85 -102.77 -62.33 1.29 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 178.698 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.86 140.15 38.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.679 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 55.2 p -92.75 -56.64 2.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.0 109.595 179.403 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 1.1 mtmt -144.49 55.95 1.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.936 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -140.46 -64.28 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -178.615 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -135.38 116.69 12.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.629 -0.67 . . . . 0.0 109.33 179.481 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.97 83.6 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.362 1.191 . . . . 0.0 111.1 -179.18 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 34.6 p80 -131.69 129.81 41.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 110.285 179.128 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.1 m-85 -121.4 162.17 20.87 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.224 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 2.1 mtt180 -106.6 159.56 16.1 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.13 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.886 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.09 78.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 177.628 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.65 167.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.543 -173.845 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.935 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.99 105.58 19.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.285 0.564 . . . . 0.0 110.354 -177.662 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 6.5 t -138.77 -165.85 1.9 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' ARG . 7.9 p-10 -140.57 -159.82 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.783 . . . . 0.0 109.955 179.936 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.68 85.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -48.64 147.31 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.888 . . . . 0.0 110.49 -179.515 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.14 -63.16 1.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.595 -179.475 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -101.85 -162.52 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.421 -179.761 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -80.52 79.77 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.807 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.84 135.45 13.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.957 -179.948 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 64.06 3.75 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.831 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -73.93 -171.51 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -1.195 . . . . 0.0 109.852 179.776 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 20' ' ' VAL . 6.1 p90 179.45 178.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 110.777 -179.941 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.59 -27.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.645 -0.66 . . . . 0.0 109.33 179.751 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.34 166.26 14.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 109.798 179.817 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 117.63 34.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.932 HG21 ' CD1' ' A' ' 59' ' ' TRP . 41.4 pt -112.24 -33.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.091 -1.005 . . . . 0.0 111.153 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.776 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -130.07 170.38 20.78 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.924 -178.362 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.511 ' N ' HG13 ' A' ' 19' ' ' ILE . 68.2 t80 -139.17 143.66 38.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.651 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.479 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 11.8 t80 -140.04 123.72 17.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.857 -1.152 . . . . 0.0 109.995 -179.85 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 19.7 t0 -140.3 79.82 20.59 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.613 -1.304 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 39' ' ' TYR . 48.1 Cg_endo -72.7 65.41 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.55 1.289 . . . . 0.0 110.654 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -89.65 -164.6 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.205 -0.934 . . . . 0.0 110.339 -179.828 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.3 pttm -121.51 38.42 4.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.884 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.454 HG23 ' OG1' ' A' ' 45' ' ' THR . 14.8 t -117.37 -32.32 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 110.141 179.99 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.454 ' OG1' HG23 ' A' ' 44' ' ' THR . 1.3 p -145.79 146.17 28.03 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 110.011 179.846 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.81 -29.57 15.34 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.651 1.343 . . . . 0.0 110.445 179.771 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.13 101.3 13.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.108 179.97 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.504 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 6.2 p-90 -121.81 -11.2 8.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.823 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 73' ' ' LEU . 7.1 tt -79.75 127.83 32.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.05 -1.031 . . . . 0.0 110.743 -179.481 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -139.46 100.2 3.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.177 179.23 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.886 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -129.68 140.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.047 -179.054 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t0 -90.06 70.23 7.36 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.08 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.512 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -32.07 -33.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.741 -177.458 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mm-40 -60.43 -55.87 28.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.75 -1.219 . . . . 0.0 109.095 178.432 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -68.94 -40.81 78.74 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.135 178.836 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.81 -20.62 66.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.705 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.7 tpt180 -87.32 -22.52 25.07 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 178.511 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.2 t80 -60.08 -49.21 78.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.317 1.532 . . . . 0.0 107.096 178.553 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.935 ' CD2' HG11 ' A' ' 21' ' ' VAL . 87.7 m95 -61.69 -51.22 69.31 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.292 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 HG11 ' A' ' 79' ' ' VAL . 18.5 mt -54.33 -22.35 11.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 176.669 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -25.09 42.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.494 -0.754 . . . . 0.0 110.777 179.529 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.612 HG23 HG21 ' A' ' 2' ' ' VAL . 7.6 m -99.13 33.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.907 -1.121 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.32 78.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.572 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -63.16 138.5 58.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -1.22 . . . . 0.0 110.172 179.985 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 2.7 mp0 -104.06 103.39 37.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.134 179.94 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -82.2 130.06 6.23 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.499 1.263 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.8 t -64.65 168.44 6.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.983 -1.073 . . . . 0.0 109.739 179.757 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.62 -26.96 24.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 111.582 -178.914 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.26 -50.25 6.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.044 -1.035 . . . . 0.0 110.894 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.765 ' H ' HG23 ' A' ' 67' ' ' THR . . . -66.61 -24.91 66.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.858 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.6 ttp180 -70.75 -39.81 73.05 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.429 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -65.93 -40.66 91.61 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.603 178.539 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 70' ' ' ALA . 14.7 mt -69.7 -29.07 66.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.576 -0.703 . . . . 0.0 109.125 179.017 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 20.8 mt -71.98 -27.58 62.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.565 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.22 -26.77 32.98 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.455 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.1 tp-100 -85.39 -37.68 19.57 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.642 0.734 . . . . 0.0 110.406 -179.58 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -65.43 -10.98 38.41 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.681 178.638 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.4 50.26 3.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 53' ' ' VAL . 43.6 t -101.96 -56.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.087 -1.243 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.2 m-30 -54.66 -175.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 109.948 -179.379 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 42.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.46 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -88.71 48.24 1.61 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 179.837 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -97.11 76.21 2.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.319 -179.792 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.98 177.84 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.171 179.935 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.58 0.98 16.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.703 -179.928 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -52.27 152.86 3.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 0.0 110.334 -179.958 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.14 89.87 0.2 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.953 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.325 -1.103 . . . . 0.0 110.155 -179.956 . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' C ' HG23 ' A' ' 2' ' ' VAL . 2.5 mmm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.112 0.482 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.496 HG23 ' C ' ' A' ' 1' ' ' MET . 57.9 t -149.71 134.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.557 -179.933 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 30.0 mtpt -140.37 134.6 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 179.759 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.936 ' CG1' HG13 ' A' ' 21' ' ' VAL . 74.3 mt -99.99 133.82 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.0 -1.063 . . . . 0.0 109.656 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.601 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -151.4 -172.27 4.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -178.968 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mp -89.1 125.86 35.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.81 102.62 14.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.5 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.506 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.9 ttm180 -68.97 119.12 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 111.577 179.917 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.525 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 25.7 m-85 -109.93 -62.86 1.45 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.156 -0.965 . . . . 0.0 110.13 178.569 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.35 20.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.679 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 36.9 p -84.66 -60.64 2.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -1.1 . . . . 0.0 109.84 179.714 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.2 mttt -144.19 25.94 1.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 109.271 -179.79 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -109.97 -48.46 3.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.749 0.785 . . . . 0.0 109.21 -178.863 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 10.5 m120 -150.64 103.51 3.06 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.475 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' CG ' ' A' ' 41' ' ' PRO . 43.3 Cg_endo -69.22 64.84 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.595 1.313 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 31.4 p80 -104.63 136.12 44.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 178.895 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.0 m-85 -119.3 154.94 32.73 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.144 -0.972 . . . . 0.0 108.465 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 3.4 mmt180 -100.14 157.07 16.84 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.669 176.614 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.956 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.19 77.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 102.469 -3.159 . . . . 0.0 102.469 176.824 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.258 0.4 OUTLIER -97.46 171.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.51 -173.715 . . . . . . . . 4 4 . 1 . 046 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.936 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -115.98 112.81 41.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.769 -0.582 . . . . 0.0 110.633 -177.184 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.9 t -136.81 -177.18 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 110.492 179.591 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -134.49 -170.63 2.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.518 -0.739 . . . . 0.0 110.189 -179.839 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.59 25.34 6.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -62.64 -67.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 -179.907 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -73.91 -171.73 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 0.0 110.217 179.968 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -65.37 150.7 47.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.927 . . . . 0.0 110.328 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -71.82 110.1 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.891 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -123.17 -51.8 1.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.97 83.04 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.942 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -156.86 -163.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -1.162 . . . . 0.0 110.222 -179.878 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CB ' HG13 ' A' ' 20' ' ' VAL . 23.5 p90 179.74 176.57 0.67 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.356 -0.84 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.625 HG21 ' HH2' ' A' ' 59' ' ' TRP . 4.4 mt -82.48 -50.3 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.576 -0.703 . . . . 0.0 109.869 179.658 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.5 mt-10 -156.13 158.98 38.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.85 179.784 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.577 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -93.37 110.22 21.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 110.384 -179.864 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.984 HG21 ' CD1' ' A' ' 59' ' ' TRP . 26.4 pt -99.75 -36.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.22 -0.925 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.818 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -123.23 168.14 15.45 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.361 -178.403 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' N ' HG13 ' A' ' 19' ' ' ILE . 93.0 t80 -140.13 135.78 32.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.604 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 12.7 t80 -128.03 133.01 49.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.986 -1.071 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 31.1 t0 -140.31 105.62 6.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.901 -1.125 . . . . 0.0 110.327 179.768 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 49.1 Cg_endo -77.42 1.81 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.571 1.301 . . . . 0.0 111.083 -179.818 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -89.45 -21.06 23.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.922 -1.111 . . . . 0.0 110.091 -179.956 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -50.47 129.81 22.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.848 179.647 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -90.7 22.42 3.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.576 -179.503 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 171.64 7.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.602 179.445 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.75 -14.07 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.587 1.309 . . . . 0.0 110.764 -179.945 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -106.79 90.32 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.604 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 13.1 p-90 -113.64 3.5 15.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.249 -0.907 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 76' ' ' GLN . 7.9 tt -104.4 120.06 40.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 110.195 -179.859 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -121.99 97.22 5.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.099 179.175 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.956 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -120.3 159.73 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.334 1.064 . . . . 0.0 111.654 -178.854 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.9 t0 -107.21 65.84 0.66 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.98 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.798 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -35.0 -30.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -177.542 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -59.93 -54.17 49.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.747 -1.221 . . . . 0.0 108.495 178.149 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -75.74 -35.26 60.26 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.413 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.914 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.02 -21.02 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.969 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' VAL . 51.1 ttt-85 -86.61 -25.41 24.95 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.363 -0.836 . . . . 0.0 109.854 178.566 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -58.04 -46.29 85.58 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 123.179 1.466 . . . . 0.0 107.547 178.773 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.984 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.9 m95 -66.14 -52.31 49.62 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.621 -179.259 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.752 HD11 HD22 ' A' ' 74' ' ' LEU . 6.4 mt -55.04 -22.19 14.87 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.441 177.119 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -80.96 -23.54 38.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.482 -0.761 . . . . 0.0 110.612 179.604 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 58' ' ' TYR . 5.1 m -98.9 32.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.925 -1.109 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.3 29.44 73.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.48 126.1 28.67 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.043 -1.269 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -93.68 111.19 51.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.9 Cg_endo -82.29 130.71 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.492 1.259 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.36 168.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -53.75 -30.35 43.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -84.54 -50.4 7.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.433 -0.792 . . . . 0.0 110.384 -179.959 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.27 -22.88 66.91 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.227 -0.92 . . . . 0.0 108.781 179.972 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -40.26 67.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.51 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 -38.86 83.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.921 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -69.05 -28.15 66.29 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.654 -0.654 . . . . 0.0 109.357 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.778 HD23 HG21 ' A' ' 79' ' ' VAL . 13.3 mt -73.07 -26.19 61.17 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.465 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.538 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.79 -28.68 30.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.271 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.727 ' HB3' HD13 ' A' ' 49' ' ' LEU . 4.8 tp-100 -83.01 -39.81 20.78 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.764 0.792 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -65.04 -11.28 37.49 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.872 178.433 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.79 51.64 3.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.855 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.778 HG21 HD23 ' A' ' 74' ' ' LEU . 53.6 t -102.48 -55.84 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.076 -1.25 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.3 m-30 -52.94 -25.15 10.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.136 -0.978 . . . . 0.0 110.423 -179.267 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.81 -39.66 39.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.874 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -90.13 115.07 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 179.845 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.02 179.8 3.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.126 -0.984 . . . . 0.0 110.494 -179.806 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -155.43 -79.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.59 -69.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.477 -179.917 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -169.66 -175.13 2.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 110.208 -179.961 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.31 -141.53 3.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.382 -1.069 . . . . 0.0 110.227 179.898 . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.244 0.545 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 047 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG11 ' CE3' ' A' ' 59' ' ' TRP . 73.8 t -110.57 141.19 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.016 179.937 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -137.8 131.01 30.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.018 HD11 ' CB ' ' A' ' 59' ' ' TRP . 93.3 mt -102.69 129.46 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.089 -1.007 . . . . 0.0 109.534 179.251 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 28.1 ptt180 -151.67 -166.63 2.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -89.05 127.41 35.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.26 105.52 17.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 14.9 ttt180 -75.08 121.93 22.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 111.302 -179.711 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 16.5 m-85 -114.09 -61.61 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.29 -0.881 . . . . 0.0 110.6 179.313 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.78 134.44 5.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.269 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 24.1 p -96.4 -56.43 2.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.444 -1.033 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' N ' ' OG ' ' A' ' 11' ' ' SER . 39.2 mttt -145.3 49.17 1.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.719 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.405 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.0 m-70 -138.33 -58.74 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -177.963 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -148.29 127.06 6.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.806 179.823 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.19 90.67 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.471 1.248 . . . . 0.0 111.361 -179.423 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' HIS . . . . . 0.501 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 35.3 p80 -132.31 129.22 39.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 110.053 178.847 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.0 m-85 -119.25 149.29 42.01 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.406 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' C ' HD13 ' A' ' 19' ' ' ILE . 13.5 mtt-85 -101.12 161.99 13.21 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.064 -1.455 . . . . 0.0 108.457 177.178 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.073 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -99.1 80.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 177.649 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.252 0.4 OUTLIER -97.61 165.25 2.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.155 -173.75 . . . . . . . . 4 4 . 1 . 047 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 115.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.896 -0.503 . . . . 0.0 110.596 -177.659 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.1 t -140.66 -177.64 5.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.013 . . . . 0.0 110.7 179.116 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.6 164.41 12.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 110.526 -179.696 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.02 31.26 6.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 110.047 179.913 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.93 -59.96 3.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 110.589 -179.878 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.35 136.95 16.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -64.26 94.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 110.04 179.619 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.23 -38.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 -179.862 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -101.9 177.06 5.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.063 179.783 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.86 55.09 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.59 122.62 44.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -1.079 . . . . 0.0 110.383 -179.698 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.9 p90 -111.74 179.63 3.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.797 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.0 mm -96.53 -41.35 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.576 -179.796 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.15 167.07 10.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.468 -0.77 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.24 107.65 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.988 . . . . 0.0 110.307 -179.89 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.916 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.1 pt -99.91 -36.51 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.157 -0.965 . . . . 0.0 110.571 179.936 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.785 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.78 165.89 15.35 Favored Glycine 0 C--N 1.295 -1.716 0 C-N-CA 119.027 -1.559 . . . . 0.0 111.989 -178.521 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.45 ' N ' HG12 ' A' ' 19' ' ' ILE . 9.3 t80 -140.49 130.53 24.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.066 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 1.073 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.9 t80 -131.58 133.14 44.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.636 -1.29 . . . . 0.0 110.378 -179.738 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.2 t0 -133.01 89.21 34.67 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.918 -1.113 . . . . 0.0 109.997 179.495 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 41.7 Cg_endo -68.98 74.37 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.54 1.284 . . . . 0.0 110.921 -179.686 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 177.25 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.3 -0.875 . . . . 0.0 109.976 179.683 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -119.56 45.86 2.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.958 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 45' ' ' THR . 64.4 p -131.48 -69.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.036 179.888 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.406 ' N ' ' OG1' ' A' ' 44' ' ' THR . 45.8 p -112.56 144.82 31.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.118 179.848 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.01 -20.84 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.654 1.344 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 77.3 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.19 -0.944 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 8.2 p-90 -123.25 4.28 9.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -0.859 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 10.2 tt -100.51 123.61 44.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.809 -1.182 . . . . 0.0 111.071 -179.033 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.93 93.83 3.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 179.328 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.785 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.03 135.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.607 -179.071 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -84.3 69.83 10.52 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 175.838 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.714 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.6 -29.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 122.135 -0.353 . . . . 0.0 111.496 -177.405 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -59.64 -51.69 68.74 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.7 -1.25 . . . . 0.0 108.745 178.605 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.7 mmm180 -75.9 -38.35 57.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.509 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -63.44 -21.23 66.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.282 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 15.2 ttt180 -88.31 -21.86 24.18 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.315 -0.865 . . . . 0.0 109.732 178.447 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -48.26 73.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 123.194 1.474 . . . . 0.0 107.668 178.704 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 1.018 ' CB ' HD11 ' A' ' 4' ' ' ILE . 81.4 m95 -63.82 -54.03 41.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.834 -179.04 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.501 HD11 HD13 ' A' ' 74' ' ' LEU . 83.4 mt -55.33 -21.04 13.4 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.33 177.256 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.43 -23.91 39.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.4 -0.812 . . . . 0.0 110.773 179.504 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.1 m -99.16 34.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.849 -1.157 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.32 26.06 74.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.588 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.448 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -73.67 112.07 9.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 179.69 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 116.52 64.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.664 -179.521 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.2 Cg_endo -83.61 124.47 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.471 1.248 . . . . 0.0 109.567 179.13 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -55.08 175.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 110.468 -179.47 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.52 56.61 1.13 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 179.993 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 m -165.9 -60.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.745 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.85 -25.2 67.09 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.819 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.8 ttp180 -65.76 -41.56 91.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.065 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.03 -41.51 98.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.682 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.3 mt -70.03 -32.81 71.13 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.983 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 46.9 mt -68.58 -26.83 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.805 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.534 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -82.13 -28.78 32.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.395 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.505 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.52 -36.86 25.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.43 -179.677 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.37 -8.96 36.8 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.986 178.663 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.22 50.75 4.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 53' ' ' VAL . 39.8 t -101.11 -55.5 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.032 -1.275 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.0 m-30 -54.56 140.14 35.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 110.149 -179.44 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -68.69 161.37 28.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -68.45 158.01 34.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 110.682 -179.624 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -95.74 113.53 25.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 179.584 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.84 -26.41 44.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 110.362 -179.764 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -54.99 -63.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.01 -64.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.76 113.95 3.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.861 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.313 -1.11 . . . . 0.0 110.194 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 64' ' ' ALA . 6.7 m . . . . . 0 N--CA 1.495 1.783 0 CA-C-O 121.307 0.575 . . . . 0.0 110.131 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.03 133.23 29.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.936 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.8 mt -99.74 133.99 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.31 -0.869 . . . . 0.0 109.054 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.28 -171.57 3.97 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.957 -1.089 . . . . 0.0 110.586 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.927 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -88.7 126.75 35.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 110.255 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.05 104.28 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.374 -0.829 . . . . 0.0 110.613 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.471 0 O-C-N 121.306 -0.872 . . . . 0.0 111.15 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.927 ' HB2' HD23 ' A' ' 6' ' ' LEU . 10.7 m-85 . . . . . 0 N--CA 1.476 0.852 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 10.6 mtm-85 -107.99 159.35 16.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.742 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.953 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.78 79.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.261 0.4 OUTLIER -98.04 166.48 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.758 -174.053 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.905 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -109.16 109.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.768 -0.583 . . . . 0.0 110.121 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.222 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 20' ' ' VAL . 9.2 p90 . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.426 0.631 . . . . 0.0 110.524 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -77.3 -23.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.638 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.62 164.35 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 116.04 31.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.956 HG21 ' CD1' ' A' ' 59' ' ' TRP . 22.9 pt -107.01 -37.43 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 0.0 111.351 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.792 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.63 171.04 14.96 Favored Glycine 0 C--N 1.294 -1.758 0 C-N-CA 119.006 -1.569 . . . . 0.0 111.597 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.491 ' N ' HG13 ' A' ' 19' ' ' ILE . 64.7 t80 -139.57 141.96 37.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CG ' HD21 ' A' ' 6' ' ' LEU . 29.3 t80 -135.34 142.6 45.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.718 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t0 . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 178.764 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 77' ' ' ALA . 4.8 tt . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.214 0.53 . . . . 0.0 110.419 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 100.9 5.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.295 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -122.82 153.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.976 -1.078 . . . . 0.0 111.336 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.4 t0 -100.04 70.84 1.6 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.638 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -34.93 -30.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 122.312 -0.242 . . . . 0.0 111.57 -177.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 tt0 -60.81 -54.8 40.7 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.713 -1.242 . . . . 0.0 108.804 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.553 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.93 -39.51 72.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.364 -0.835 . . . . 0.0 108.83 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.88 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.76 -17.68 64.79 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 13.4 ttt180 -87.51 -25.15 23.82 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.854 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.7 t80 -60.26 -44.67 95.09 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.246 1.498 . . . . 0.0 107.966 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.956 ' CD1' HG21 ' A' ' 36' ' ' ILE . 84.7 m95 -69.73 -55.87 8.74 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.149 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.521 HD21 ' HG3' ' A' ' 66' ' ' PRO . 13.1 mt -53.33 -22.56 7.48 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.447 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 15.3 t -82.35 -22.75 35.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.455 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.7 m -99.14 32.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 120.839 -1.163 . . . . 0.0 109.572 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.47 29.04 72.91 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -71.65 127.32 32.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.086 -1.244 . . . . 0.0 109.763 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -97.6 110.72 56.25 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.7 Cg_endo -85.61 129.33 3.59 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.752 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.2 t -55.17 168.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.762 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -55.44 -37.7 68.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.739 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -70.41 -58.56 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.729 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.752 ' H ' HG23 ' A' ' 67' ' ' THR . . . -63.76 -23.33 67.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.39 -0.819 . . . . 0.0 109.117 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.531 ' HA ' HD12 ' A' ' 74' ' ' LEU . 4.1 ttt180 -69.71 -42.73 73.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -73.41 -10.04 59.32 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.49 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.1 mt -98.22 -24.89 15.08 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 108.623 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 71' ' ' ARG . 17.9 mt -71.11 -30.43 66.51 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.528 ' HG2' ' HA ' ' A' ' 72' ' ' ARG . 10.3 ptm180 -77.78 -28.8 50.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 9.2 tp-100 -76.42 -37.22 57.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.055 0.931 . . . . 0.0 109.581 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -75.15 -1.28 22.42 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.059 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 50.33 11.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 53' ' ' VAL . 40.2 t . . . . . 0 C--N 1.307 -1.272 0 O-C-N 121.301 -1.117 . . . . 0.0 111.721 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.684 HG11 ' CE3' ' A' ' 59' ' ' TRP . 47.9 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.215 0.531 . . . . 0.0 110.084 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -140.5 133.1 28.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.85 HD11 ' CB ' ' A' ' 59' ' ' TRP . 68.8 mt -100.26 134.89 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.013 -1.054 . . . . 0.0 109.409 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.7 ptm180 -151.19 -172.72 4.29 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.1 -1.0 . . . . 0.0 110.928 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 70' ' ' ALA . 4.5 mp -89.37 125.87 35.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.379 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.21 112.87 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.364 -0.835 . . . . 0.0 110.562 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.116 . . . . 0.0 112.892 -178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 9.3 m-30 . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' C ' HD13 ' A' ' 19' ' ' ILE . 2.0 mtt85 -101.35 162.18 13.08 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.26 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.03 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.93 80.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -97.46 164.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.907 -173.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.932 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.36 112.64 40.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.493 1.701 0 O-C-N 120.974 -1.079 . . . . 0.0 110.598 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.4 p90 . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.631 0.729 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.736 HG21 ' HH2' ' A' ' 59' ' ' TRP . 13.3 mm -92.25 -50.2 12.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -157.69 179.19 9.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -106.86 107.23 18.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.292 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 56' ' ' ALA . 20.7 pt -100.55 -39.08 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.146 -0.971 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.819 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -118.2 166.35 12.81 Favored Glycine 0 C--N 1.296 -1.683 0 C-N-CA 118.967 -1.587 . . . . 0.0 112.122 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' N ' HG12 ' A' ' 19' ' ' ILE . 11.4 t80 -140.73 128.79 22.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.03 ' HB2' HD11 ' A' ' 19' ' ' ILE . 38.1 t80 -128.27 142.48 51.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.709 -1.245 . . . . 0.0 109.906 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.6 t0 . . . . . 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.222 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.599 HD12 ' CD2' ' A' ' 73' ' ' LEU . 9.1 tt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.228 0.537 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.18 90.38 3.28 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.682 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.819 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.51 130.93 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.005 . . . . 0.0 111.178 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.0 t0 -78.03 71.01 4.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -35.73 -30.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 122.258 -0.276 . . . . 0.0 111.624 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.8 mt-10 -59.76 -51.03 71.49 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.706 -1.247 . . . . 0.0 108.967 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 27.1 mmm180 -75.52 -38.14 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.263 -0.898 . . . . 0.0 108.713 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.96 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.82 -19.39 65.83 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.2 ttp180 -89.16 -23.81 22.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.808 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.31 -48.71 76.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 123.116 1.436 . . . . 0.0 107.456 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.932 ' CD2' HG11 ' A' ' 21' ' ' VAL . 82.1 m95 -65.29 -56.19 14.1 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.951 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.973 HD11 HD13 ' A' ' 74' ' ' LEU . 35.0 mt -54.55 -21.59 10.69 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.558 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -81.91 -20.45 38.73 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.427 -0.795 . . . . 0.0 110.389 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.8 m -98.7 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.871 -1.143 . . . . 0.0 109.322 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.53 26.61 74.33 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -77.28 115.32 16.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.089 -1.242 . . . . 0.0 109.855 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 126.15 59.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HB3' HD12 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -85.47 162.56 11.04 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.494 1.26 . . . . 0.0 109.483 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 p -83.94 -171.69 3.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.051 -1.031 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.82 48.27 1.42 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.2 m -166.03 -56.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -68.35 -25.62 65.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.4 ttp180 -66.59 -42.25 87.23 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -66.14 -45.81 79.71 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.786 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.599 ' CD2' HD12 ' A' ' 49' ' ' LEU . 51.7 mt -60.29 -31.99 70.77 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.973 HD13 HD11 ' A' ' 60' ' ' LEU . 20.3 mt -69.15 -26.81 65.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.5 -28.81 30.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.811 0.815 . . . . 0.0 108.82 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -81.84 -36.15 28.6 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.904 0.859 . . . . 0.0 110.062 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.96 -9.21 43.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.751 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.52 48.5 5.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 60' ' ' LEU . 41.4 t . . . . . 0 N--CA 1.487 1.379 0 O-C-N 121.12 -1.224 . . . . 0.0 111.605 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.604 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.2 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.306 0.574 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.5 mtpt -140.53 133.19 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.915 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.7 mt -108.34 131.2 59.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.992 -1.068 . . . . 0.0 109.883 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.0 ptm180 -151.08 -169.62 3.44 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.287 -0.883 . . . . 0.0 110.297 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.476 HD22 ' HD2' ' A' ' 39' ' ' TYR . 84.4 mt -89.17 127.69 35.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.519 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.25 102.34 13.95 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.713 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 112.565 -178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 12.4 m-85 . . . . . 0 C--O 1.213 -0.838 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.7 OUTLIER -99.86 159.08 15.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.048 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -98.07 81.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -98.47 162.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.024 -174.07 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.866 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -109.29 109.42 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.757 -0.589 . . . . 0.0 110.529 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.5 t . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.983 . . . . 0.0 110.29 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' HG13 ' A' ' 20' ' ' VAL . 23.4 p90 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.547 0.689 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.616 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.1 mt -70.94 -51.7 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.65 165.45 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -0.774 . . . . 0.0 109.58 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -99.43 116.73 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 109.956 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.005 HG21 ' CD1' ' A' ' 59' ' ' TRP . 44.9 pt -107.18 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 111.152 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.806 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.82 167.94 17.05 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.029 -1.557 . . . . 0.0 112.228 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG12 ' A' ' 19' ' ' ILE . 37.0 t80 -140.67 129.26 22.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.048 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.5 t80 -129.71 134.07 47.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.731 -1.23 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.3 t0 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.919 -1.113 . . . . 0.0 110.884 -179.809 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.697 HD21 ' HB3' ' A' ' 73' ' ' LEU . 8.5 tp . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.629 0.728 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.05 94.64 3.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 109.217 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.806 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.04 149.87 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -94.81 70.51 3.44 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -32.72 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -60.29 -56.02 26.56 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.802 -1.186 . . . . 0.0 109.159 178.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.743 ' HB3' HG22 ' A' ' 36' ' ' ILE . 4.4 mmp_? -69.92 -42.02 73.87 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 108.872 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.743 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -63.15 -18.36 63.37 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.9 ttp180 -87.87 -25.26 23.36 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.642 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.9 t80 -60.38 -45.83 92.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.359 1.552 . . . . 0.0 107.789 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.005 ' CD1' HG21 ' A' ' 36' ' ' ILE . 79.4 m95 -66.11 -54.48 25.03 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.94 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 60' ' ' LEU . 18.9 mt -54.97 -21.47 11.89 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.495 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 6.5 t -81.46 -23.16 37.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 110.694 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 58' ' ' TYR . 5.5 m -98.96 32.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.797 -1.189 . . . . 0.0 109.568 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.93 29.47 72.48 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.604 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -67.78 135.45 52.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.076 -1.25 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 109.06 61.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 110.389 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 71' ' ' ARG . 53.8 Cg_endo -79.13 128.3 8.14 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.619 1.326 . . . . 0.0 109.871 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 70' ' ' ALA . 7.9 t -54.22 171.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.11 -0.994 . . . . 0.0 110.204 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.47 54.98 0.78 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -167.25 -56.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.5 -24.22 66.36 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HA ' HD12 ' A' ' 74' ' ' LEU . 20.2 ttt85 -67.4 -40.92 85.62 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -42.99 80.33 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.776 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.697 ' HB3' HD21 ' A' ' 49' ' ' LEU . 15.2 mt -67.08 -27.08 67.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.675 HD23 HG21 ' A' ' 79' ' ' VAL . 13.7 mt -69.82 -28.47 65.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.77 -30.54 45.71 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -80.39 -31.84 37.67 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.944 0.878 . . . . 0.0 109.993 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -75.4 -2.13 27.14 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.402 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.5 51.64 9.43 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.675 HG21 HD23 ' A' ' 74' ' ' LEU . 52.6 t . . . . . 0 C--N 1.307 -1.253 0 O-C-N 121.271 -1.134 . . . . 0.0 111.872 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 2' ' ' VAL . 15.9 m . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.458 0.647 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -140.2 132.83 28.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.425 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.955 HD11 ' CB ' ' A' ' 59' ' ' TRP . 65.8 mt -107.62 133.52 52.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.044 -1.035 . . . . 0.0 110.05 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptm180 -151.07 -173.15 4.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.278 -0.889 . . . . 0.0 110.437 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 70' ' ' ALA . 3.7 mp -89.38 125.49 35.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.447 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.46 107.42 19.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.473 -0.767 . . . . 0.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 36.7 ttp85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 112.936 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 9.8 m-85 . . . . . 0 C--O 1.209 -1.06 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.519 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.2 mtp85 -121.83 156.02 34.13 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.964 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 79.56 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.255 0.4 OUTLIER -97.95 159.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.5 -173.912 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.867 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -107.92 106.03 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.334 0.587 . . . . 0.0 110.387 -177.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.893 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.533 ' HB3' HG13 ' A' ' 20' ' ' VAL . 32.1 p90 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.471 0.653 . . . . 0.0 110.68 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.595 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.3 mt -56.15 -51.93 56.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.565 -0.71 . . . . 0.0 109.204 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.92 149.46 26.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -89.66 119.29 29.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.977 HG21 ' CD1' ' A' ' 59' ' ' TRP . 27.7 pt -105.88 -34.14 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.489 -0.757 . . . . 0.0 111.738 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.821 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -120.64 169.33 14.12 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 119.118 -1.515 . . . . 0.0 112.26 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG12 ' A' ' 19' ' ' ILE . 86.8 t80 -140.46 127.33 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.964 ' HB2' HD11 ' A' ' 19' ' ' ILE . 44.7 t80 -121.28 142.29 50.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.815 -1.178 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 t0 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 178.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.452 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.6 tt . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.336 0.588 . . . . 0.0 110.597 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -131.47 94.66 3.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.293 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.821 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.8 148.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 111.043 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -92.38 70.65 5.15 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.684 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -36.47 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 122.224 -0.297 . . . . 0.0 111.481 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 7.2 mm-40 -61.1 -53.25 59.44 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.693 -1.254 . . . . 0.0 108.522 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -71.29 -40.59 70.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.7 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.65 -16.56 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.46 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.1 ttt-85 -88.64 -26.3 21.96 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 62' ' ' VAL . 13.2 t80 -59.43 -42.63 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 123.212 1.482 . . . . 0.0 107.382 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.977 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.3 m95 -69.63 -54.24 14.91 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.13 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 79' ' ' VAL . 7.4 mt -56.56 -20.9 23.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.468 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -80.72 -24.56 38.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.426 -0.796 . . . . 0.0 110.517 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 59' ' ' TRP . 27.3 m -99.01 32.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.879 -1.138 . . . . 0.0 109.606 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.02 31.48 79.57 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -60.99 146.99 45.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.242 . . . . 0.0 110.017 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 2.0 mm-40 -108.88 93.82 13.25 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.43 -0.794 . . . . 0.0 110.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 54.9 Cg_endo -80.34 124.79 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.48 1.253 . . . . 0.0 109.923 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.8 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.7 t -57.82 163.58 2.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.944 -1.097 . . . . 0.0 109.702 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -57.88 -22.87 50.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.3 m -84.55 -53.71 5.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.862 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.8 ' H ' HG23 ' A' ' 67' ' ' THR . . . -70.8 -29.45 65.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -66.9 -37.35 84.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -26.85 67.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.0 mt -86.37 -30.39 22.2 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.541 -0.724 . . . . 0.0 109.247 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 56' ' ' ALA . 80.7 mt -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.0 mtp85 -78.24 -30.43 48.71 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.1 tp-100 -79.11 -33.58 44.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.942 0.877 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.17 -9.43 52.87 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.704 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 87.48 52.34 3.05 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.684 HG22 ' CB ' ' A' ' 53' ' ' VAL . 40.2 t . . . . . 0 N--CA 1.488 1.445 0 O-C-N 121.058 -1.26 . . . . 0.0 111.519 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.602 HG11 ' CE3' ' A' ' 59' ' ' TRP . 50.2 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.148 0.499 . . . . 0.0 109.982 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -140.16 138.73 35.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.554 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.945 ' CG1' HG13 ' A' ' 21' ' ' VAL . 86.0 mt -103.25 130.92 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.29 -0.881 . . . . 0.0 109.343 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.75 -172.0 4.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 110.65 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 69' ' ' THR . 5.0 mp -88.97 125.56 35.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.425 -0.797 . . . . 0.0 110.469 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.55 112.51 24.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.56 -0.712 . . . . 0.0 109.797 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 112.675 -178.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.477 0.889 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.5 ttm180 -104.55 153.52 21.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.148 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.957 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -98.53 78.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.272 0.4 OUTLIER -97.98 166.17 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.527 -173.684 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.945 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.36 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.755 -0.59 . . . . 0.0 110.51 -177.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 110.179 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CD2' HG21 ' A' ' 20' ' ' VAL . 17.0 p90 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 121.462 0.649 . . . . 0.0 110.418 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.71 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.8 mp -58.87 -53.35 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -149.75 173.74 13.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -109.93 119.7 40.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.951 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 56' ' ' ALA . 21.7 pt -110.7 -38.81 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.049 -1.032 . . . . 0.0 111.656 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.807 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.1 167.83 14.11 Favored Glycine 0 C--N 1.295 -1.72 0 C-N-CA 118.897 -1.621 . . . . 0.0 111.45 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.456 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.7 t80 -137.23 141.17 42.06 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 25.5 t80 -138.5 139.27 38.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.75 -1.218 . . . . 0.0 110.718 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 178.869 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 49' ' ' LEU . 10.1 tt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.229 0.537 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 3.7 mmmt -126.88 103.76 7.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.957 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -127.32 149.0 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.877 -1.139 . . . . 0.0 111.4 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.8 t0 -97.56 70.45 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.627 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -33.77 -32.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 120.562 0.22 . . . . 0.0 111.435 -177.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.4 tt0 -60.99 -53.98 50.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.822 -1.173 . . . . 0.0 108.865 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 48.0 mmm-85 -73.72 -38.37 64.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.27 -21.35 66.56 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -89.2 -24.11 22.22 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.104 -0.997 . . . . 0.0 109.932 178.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.546 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -59.01 -49.6 77.26 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 123.269 1.509 . . . . 0.0 107.197 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.885 ' CD2' HG11 ' A' ' 21' ' ' VAL . 84.6 m95 -62.56 -52.29 64.0 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.265 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.885 HD11 HD13 ' A' ' 74' ' ' LEU . 4.0 mt -54.24 -22.41 11.58 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.338 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -80.81 -22.08 40.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 110.743 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.5 m -98.93 33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 120.823 -1.173 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.28 28.17 72.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -68.21 134.01 49.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -1.228 . . . . 0.0 110.081 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.19 109.09 59.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HG3' HD21 ' A' ' 60' ' ' LEU . 51.4 Cg_endo -84.59 126.86 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.616 1.324 . . . . 0.0 110.352 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.753 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.3 t -60.51 173.41 0.71 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 109.89 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -58.21 -27.83 64.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 111.103 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' HD13 ' A' ' 6' ' ' LEU . 1.8 m -83.13 -52.08 6.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.762 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.753 ' H ' HG23 ' A' ' 67' ' ' THR . . . -68.67 -26.47 65.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 67' ' ' THR . 2.4 ttt-85 -68.2 -38.65 82.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -45.22 80.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.493 ' CD2' HD12 ' A' ' 49' ' ' LEU . 59.6 mt -65.88 -25.76 67.33 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.885 HD13 HD11 ' A' ' 60' ' ' LEU . 17.2 mt -74.4 -26.06 59.85 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 -29.38 26.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -84.29 -36.08 22.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.823 0.82 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.14 41.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.06 57.14 2.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.635 HG21 HD23 ' A' ' 74' ' ' LEU . 21.7 t . . . . . 0 N--CA 1.486 1.337 0 O-C-N 121.176 -1.191 . . . . 0.0 111.092 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.538 HG11 ' CE3' ' A' ' 59' ' ' TRP . 66.3 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.309 0.576 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.72 ' C ' HD13 ' A' ' 4' ' ' ILE . 12.9 mtpt -134.04 128.75 34.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.303 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.999 HD12 HG13 ' A' ' 21' ' ' VAL . 1.3 mm -103.74 133.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.551 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 16.5 ptm180 -151.0 177.65 9.95 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.889 -1.132 . . . . 0.0 110.858 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 pp -89.55 132.17 35.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.892 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -99.05 157.81 16.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.56 -0.712 . . . . 0.0 109.232 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 tmm_? . . . . . 0 C--N 1.303 -1.418 0 O-C-N 120.889 -1.132 . . . . 0.0 111.315 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 8' ' ' ARG . 14.0 m-85 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -137.24 150.83 48.11 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.01 -1.056 . . . . 0.0 108.301 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -97.06 85.95 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 178.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.646 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -98.49 168.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.634 -173.158 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.032 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.7 t -113.81 102.78 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.694 -0.629 . . . . 0.0 110.776 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.402 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.6 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.349 -0.844 . . . . 0.0 110.391 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.646 ' CD2' HG21 ' A' ' 20' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.311 0.576 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.3 -58.63 6.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -145.08 173.91 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.012 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -110.42 115.34 29.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.202 -0.936 . . . . 0.0 109.572 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.973 HD12 ' HA ' ' A' ' 56' ' ' ALA . 18.1 pt -108.98 -40.01 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.108 -0.995 . . . . 0.0 111.243 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.89 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -111.76 167.05 12.31 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.112 -1.518 . . . . 0.0 112.225 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 19' ' ' ILE . 87.5 t80 -140.8 126.18 18.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.804 ' HB2' HD11 ' A' ' 19' ' ' ILE . 13.9 t80 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.726 -1.234 . . . . 0.0 110.046 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t0 . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.071 -1.018 . . . . 0.0 109.848 179.298 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 73' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.449 0.642 . . . . 0.0 111.008 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -133.36 101.6 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.517 -0.74 . . . . 0.0 109.264 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.89 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -129.22 135.25 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 111.412 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.1 t0 -77.62 70.06 3.95 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.699 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -35.91 -30.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 122.276 -0.265 . . . . 0.0 111.286 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.2 -53.44 57.63 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.834 -1.166 . . . . 0.0 108.723 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmm180 -74.0 -38.17 64.18 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.973 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.23 -17.57 63.7 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.0 ttt180 -89.19 -25.58 21.71 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.282 -0.886 . . . . 0.0 109.324 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.952 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.59 -44.68 93.29 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 123.575 1.655 . . . . 0.0 106.953 178.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.032 ' CD2' HG11 ' A' ' 21' ' ' VAL . 80.5 m95 -67.23 -59.5 3.38 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.003 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 74' ' ' LEU . 3.9 mt -54.04 -21.88 9.38 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.826 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 30.6 t -81.27 -19.07 43.83 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.427 -0.796 . . . . 0.0 110.262 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.62 32.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.843 -1.161 . . . . 0.0 109.214 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.33 25.49 75.42 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HB1' ' CG1' ' A' ' 4' ' ' ILE . . . -70.68 126.57 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.178 -1.19 . . . . 0.0 110.026 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.31 111.35 53.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.699 ' HG3' HD21 ' A' ' 60' ' ' LEU . 51.9 Cg_endo -80.86 131.23 7.95 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.48 1.253 . . . . 0.0 110.332 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.9 p -56.92 159.17 4.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.61 -34.23 50.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.991 . . . . 0.0 111.581 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.402 ' HB ' HD23 ' A' ' 6' ' ' LEU . 5.3 m -83.68 -49.9 8.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 111.191 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.26 -22.98 61.9 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.253 -0.904 . . . . 0.0 109.264 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -70.97 -36.14 72.41 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -33.4 74.74 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.3 mt -75.17 -30.24 60.65 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.573 -0.704 . . . . 0.0 109.172 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.864 HD13 HD11 ' A' ' 60' ' ' LEU . 16.1 mt -68.03 -29.43 68.41 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.7 tmm_? -77.68 -31.03 52.23 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.54 ' HB3' HD13 ' A' ' 49' ' ' LEU . 3.5 tp-100 -77.49 -28.54 52.24 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.986 0.898 . . . . 0.0 109.391 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.07 -8.79 48.44 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.225 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.99 31.43 11.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 53' ' ' VAL . 47.4 t . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.218 -1.166 . . . . 0.0 110.651 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 64' ' ' ALA . 17.1 m . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.449 0.642 . . . . 0.0 110.588 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.2 ptmt -140.73 138.99 34.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.045 -1.034 . . . . 0.0 110.42 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.939 HG13 HG13 ' A' ' 21' ' ' VAL . 4.5 mt -103.84 135.32 42.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.048 -1.032 . . . . 0.0 108.681 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -150.64 -170.42 3.65 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.861 -1.149 . . . . 0.0 110.777 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -89.03 129.22 35.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -102.85 108.47 19.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 111.453 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 8.6 ttp180 . . . . . 0 N--CA 1.487 1.42 0 O-C-N 120.99 -1.069 . . . . 0.0 111.009 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 6.5 m-30 . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.626 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -102.85 166.89 10.21 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.058 176.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.925 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.11 85.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.527 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.26 0.4 OUTLIER -99.21 164.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.283 -175.011 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.972 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.3 t -107.9 110.87 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 109.961 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 110.505 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.509 ' CD2' HG21 ' A' ' 20' ' ' VAL . 7.8 p90 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 121.629 0.728 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.82 -41.93 13.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.573 -0.704 . . . . 0.0 109.303 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.9 tt0 -151.17 150.35 30.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.117 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HG2' ' HD2' ' A' ' 18' ' ' ARG . 3.7 mtpp -96.46 118.88 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.975 . . . . 0.0 109.91 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.672 HD12 ' CB ' ' A' ' 56' ' ' ALA . 43.3 pt -99.84 -27.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 111.756 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -150.64 -174.41 21.66 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.001 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 36.7 t80 -140.83 147.45 39.03 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.872 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.925 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.2 t80 -140.21 132.89 28.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.588 -1.32 . . . . 0.0 109.664 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 27.4 t0 . . . . . 0 N--CA 1.495 1.776 0 O-C-N 120.896 -1.127 . . . . 0.0 110.401 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.807 HD21 ' HB3' ' A' ' 73' ' ' LEU . 11.5 tp . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.558 0.694 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -140.1 72.95 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.48 -0.762 . . . . 0.0 110.199 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.772 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -94.69 129.44 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.274 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.6 t0 -73.88 70.12 1.44 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.631 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.36 -29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.149 -0.344 . . . . 0.0 111.606 -177.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -62.99 -55.89 21.81 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.619 -1.301 . . . . 0.0 109.082 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -0.872 . . . . 0.0 108.994 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.672 ' CB ' HD12 ' A' ' 36' ' ' ILE . . . -73.38 -22.93 60.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.947 -1.096 . . . . 0.0 108.082 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttt85 -86.0 -21.35 27.86 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.142 -0.974 . . . . 0.0 108.912 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.972 ' CD2' HG11 ' A' ' 21' ' ' VAL . 81.4 m95 -61.55 -53.33 57.75 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.316 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -52.67 -22.71 5.44 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -22.32 42.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.546 -0.721 . . . . 0.0 110.434 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.4 m -98.85 32.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.74 -1.225 . . . . 0.0 109.52 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.19 27.26 73.11 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -67.95 134.31 50.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.152 -1.205 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -105.94 105.65 54.1 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.3 Cg_endo -79.07 129.51 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.607 1.319 . . . . 0.0 110.051 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.756 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.0 t -58.45 165.8 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.47 -27.89 58.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.164 -0.96 . . . . 0.0 111.515 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -82.24 -52.7 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.934 -1.104 . . . . 0.0 110.806 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 67' ' ' THR . . . -69.49 -26.49 64.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.326 -0.859 . . . . 0.0 108.721 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -66.52 -38.45 87.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -41.16 90.38 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.954 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.807 ' HB3' HD21 ' A' ' 49' ' ' LEU . 14.7 mt -71.13 -27.2 63.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.783 HD23 HG21 ' A' ' 79' ' ' VAL . 12.9 mt -70.52 -27.83 64.48 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -32.83 51.64 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -79.94 -29.34 39.69 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.981 0.896 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 79' ' ' VAL . . . -74.27 -4.47 36.29 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.866 -0.521 . . . . 0.0 110.257 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.53 39.46 30.07 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.783 HG21 HD23 ' A' ' 74' ' ' LEU . 48.2 t . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.282 -1.128 . . . . 0.0 111.459 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.452 HG11 ' HE3' ' A' ' 59' ' ' TRP . 60.8 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.198 0.523 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 2.1 mtpt -140.49 129.72 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.784 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.983 ' CG1' HG13 ' A' ' 21' ' ' VAL . 52.1 mt -101.22 132.09 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.06 -1.025 . . . . 0.0 109.132 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.12 -169.47 3.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 110.95 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.7 mp -88.8 125.89 35.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.0 108.51 20.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.756 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.559 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.4 ttt-85 . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.023 -1.048 . . . . 0.0 111.592 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 11.7 m-30 . . . . . 0 C--O 1.211 -0.925 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 5.5 mtp180 -101.46 160.38 14.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.86 -1.536 . . . . 0.0 108.021 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.893 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -98.83 79.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.253 0.4 OUTLIER -97.82 160.63 3.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.886 -174.236 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.983 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -102.73 121.08 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.872 HG22 ' HB3' ' A' ' 32' ' ' TYR . 7.1 p . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.943 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.872 ' HB3' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.46 0.648 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.668 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.8 mt -92.17 -37.43 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.538 -0.727 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -174.6 153.94 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 109.824 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -94.43 116.0 28.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.007 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.869 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.5 pt -103.02 -32.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.811 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.41 169.03 16.44 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 119.218 -1.467 . . . . 0.0 111.341 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' ILE . 48.0 t80 -140.15 134.64 31.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.0 t80 -133.6 131.24 39.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 110.121 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 44.0 t0 . . . . . 0 N--CA 1.496 1.852 0 O-C-N 120.581 -1.325 . . . . 0.0 110.758 179.995 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 73' ' ' LEU . 8.3 tt . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.301 0.572 . . . . 0.0 110.403 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -122.85 96.59 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.484 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.893 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -120.86 151.04 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 111.499 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.4 t70 -96.88 67.87 2.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.62 -31.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.038 -177.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 27.4 tt0 -62.34 -56.84 14.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.729 -1.232 . . . . 0.0 109.012 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 13.5 mmm180 -72.77 -35.54 67.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.46 -20.78 66.39 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 34.8 ttt85 -88.25 -25.05 23.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.94 -46.72 88.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.152 1.453 . . . . 0.0 107.301 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.959 ' HB3' HD11 ' A' ' 4' ' ' ILE . 87.5 m95 -65.4 -55.52 17.61 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.814 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.8 HD11 HD13 ' A' ' 74' ' ' LEU . 6.4 mt -53.42 -22.6 8.0 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.529 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 8.0 t -82.81 -19.62 37.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.394 -0.816 . . . . 0.0 110.568 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.3 m -98.98 32.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 120.798 -1.189 . . . . 0.0 109.272 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.87 72.93 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -71.42 134.91 46.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.462 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 7.1 mt-30 -101.79 108.12 54.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.8 Cg_endo -81.27 140.74 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.536 1.282 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -73.24 169.27 17.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 109.744 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.01 -18.47 34.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.775 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.435 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 3.5 m -95.07 -49.68 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.021 . . . . 0.0 110.515 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.68 -25.48 62.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.343 -0.848 . . . . 0.0 108.768 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -69.12 -35.4 76.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -67.19 -34.47 77.58 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 70' ' ' ALA . 31.6 mt -73.84 -28.0 61.38 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.587 -0.696 . . . . 0.0 109.514 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 60' ' ' LEU . 54.0 mt -71.96 -27.25 62.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.49 -30.5 33.26 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -82.51 -38.33 23.99 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.788 0.804 . . . . 0.0 110.015 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.425 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -64.23 -12.15 38.15 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.817 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.93 36.41 8.44 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.581 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.9 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.273 . . . . 0.0 111.324 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.1 m . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 121.236 0.541 . . . . 0.0 110.246 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 9.3 mtpt -140.32 136.66 33.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.868 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.918 ' CG1' HD11 ' A' ' 36' ' ' ILE . 1.1 mp -99.62 119.13 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.4 ptt85 -150.33 -179.79 7.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.987 -1.07 . . . . 0.0 110.906 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.0 mp -88.91 124.73 34.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.279 -0.888 . . . . 0.0 111.024 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.7 100.84 11.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.414 -0.804 . . . . 0.0 111.687 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 47.3 ttt180 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 111.533 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 3.5 m-85 . . . . . 0 C--O 1.214 -0.812 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 10.1 mmt180 -100.05 156.22 17.29 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.677 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.957 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.4 mt -98.55 77.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.256 0.3 OUTLIER -97.06 176.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.273 -172.869 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.981 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -120.44 115.77 48.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.367 0.603 . . . . 0.0 109.947 -177.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.8 p90 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 121.884 0.85 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.4 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.6 mt -95.9 -44.43 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.686 -0.634 . . . . 0.0 110.055 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 166.31 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -101.25 106.79 18.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 110.131 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.947 HG21 ' CD1' ' A' ' 59' ' ' TRP . 16.1 pt -100.12 -34.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.845 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.63 165.41 20.72 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.49 ' N ' HG13 ' A' ' 19' ' ' ILE . 26.9 t80 -139.19 143.45 38.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.925 . . . . 0.0 109.687 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.427 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 13.2 t80 -131.74 132.4 43.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.943 -1.098 . . . . 0.0 109.47 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 t0 . . . . . 0 N--CA 1.494 1.773 0 O-C-N 120.764 -1.21 . . . . 0.0 110.907 179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 50' ' ' LYS . 2.3 tm? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.526 0.679 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.675 ' N ' HD13 ' A' ' 49' ' ' LEU . 3.7 mtpp -130.81 111.0 11.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.071 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.957 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -132.02 144.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.533 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -93.29 70.75 4.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.726 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.04 -31.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -177.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.16 -54.41 46.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.731 -1.23 . . . . 0.0 109.114 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' HB3' HG22 ' A' ' 36' ' ' ILE . 5.5 mtm-85 -74.53 -35.86 63.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.092 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.918 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.71 -20.98 66.09 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.8 ttp85 -89.16 -23.34 22.46 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.52 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -60.63 -49.06 79.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 123.394 1.568 . . . . 0.0 107.091 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.981 ' CD2' HG11 ' A' ' 21' ' ' VAL . 85.0 m95 -63.6 -50.99 67.23 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.3 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.715 ' CD1' HD22 ' A' ' 74' ' ' LEU . 6.5 mt -56.07 -21.03 19.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 176.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.6 t -81.23 -21.68 39.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.368 -0.833 . . . . 0.0 110.436 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.9 m -98.86 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.874 -1.141 . . . . 0.0 109.791 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.97 30.8 76.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -64.76 143.84 57.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -1.209 . . . . 0.0 109.624 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.43 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -106.7 99.37 24.87 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.333 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.1 Cg_endo -79.64 125.0 5.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.697 1.367 . . . . 0.0 110.279 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.774 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.6 t -58.86 170.14 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.826 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.88 -20.01 47.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.149 -0.969 . . . . 0.0 110.892 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.99 -53.42 4.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.181 -0.949 . . . . 0.0 110.386 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.774 ' H ' HG23 ' A' ' 67' ' ' THR . . . -69.31 -27.06 65.06 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 9.1 ttp85 -68.95 -39.26 79.62 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.86 -40.84 87.99 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.782 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.0 mt -70.81 -25.13 62.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 4' ' ' ILE . 12.4 mt -70.51 -29.36 65.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 3.6 mtm180 -78.47 -34.4 47.68 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -26.42 37.93 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.739 0.781 . . . . 0.0 110.667 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 79' ' ' VAL . . . -76.19 -1.97 28.95 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.743 -0.598 . . . . 0.0 110.161 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.14 38.03 30.9 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.726 HG22 ' HB ' ' A' ' 53' ' ' VAL . 32.0 t . . . . . 0 C--N 1.308 -1.212 0 O-C-N 121.249 -1.148 . . . . 0.0 111.129 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.122 0.487 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.406 ' HG3' ' HB2' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -140.12 135.84 32.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.215 -0.928 . . . . 0.0 110.75 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.975 HD11 ' CB ' ' A' ' 59' ' ' TRP . 63.1 mt -101.98 135.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 109.232 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.526 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 8.7 ptm180 -150.93 178.31 9.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.005 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.5 pp -89.61 131.74 35.46 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.326 -0.949 . . . . 0.0 109.48 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.485 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -98.9 164.02 12.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.525 -0.734 . . . . 0.0 109.056 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.346 0 O-C-N 120.913 -1.117 . . . . 0.0 111.562 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 8' ' ' ARG . 13.0 m-85 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' C ' HD13 ' A' ' 19' ' ' ILE . 29.3 mtt-85 -135.13 151.22 50.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.881 -1.137 . . . . 0.0 108.986 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.837 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -97.01 82.9 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.281 0.4 OUTLIER -98.38 163.2 2.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.353 -173.785 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.928 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.94 113.47 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.71 . . . . 0.0 110.322 -178.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.395 -0.815 . . . . 0.0 110.068 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 2.0 p90 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 121.617 0.722 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.68 -47.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.553 -0.717 . . . . 0.0 109.923 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.88 159.51 41.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.419 -0.801 . . . . 0.0 109.741 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -95.7 109.57 21.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 56' ' ' ALA . 36.2 pt -100.19 -35.19 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.071 -1.018 . . . . 0.0 110.541 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.828 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.14 167.35 14.08 Favored Glycine 0 C--N 1.294 -1.799 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.264 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.421 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.4 t80 -141.06 117.52 10.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.837 ' HB2' HD11 ' A' ' 19' ' ' ILE . 7.8 t80 -109.02 142.47 39.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.277 . . . . 0.0 109.497 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 39.9 t0 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 120.941 -1.099 . . . . 0.0 110.111 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 77' ' ' ALA . 3.9 tt . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.435 0.636 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -131.19 89.33 2.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.399 -0.813 . . . . 0.0 109.144 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.828 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 137.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.108 -0.995 . . . . 0.0 111.07 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.8 t0 -82.44 70.48 9.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.674 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -37.18 -30.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.259 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' ASP . 12.7 mt-10 -63.18 -49.69 73.3 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.812 -1.18 . . . . 0.0 108.786 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.77 -33.51 52.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 108.819 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -69.43 -22.0 63.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.6 ttt-85 -87.49 -23.48 24.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.353 -0.842 . . . . 0.0 109.466 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.666 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -58.87 -50.15 75.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.426 1.584 . . . . 0.0 107.042 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.975 ' CB ' HD11 ' A' ' 4' ' ' ILE . 85.3 m95 -62.62 -55.19 29.33 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.518 HD11 HD13 ' A' ' 74' ' ' LEU . 43.7 mt -52.83 -23.33 6.76 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -78.68 -19.47 52.42 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.503 -0.748 . . . . 0.0 110.12 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.6 m -98.41 31.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.996 -1.065 . . . . 0.0 109.311 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.45 78.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.54 128.37 35.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -1.181 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 10.6 mm-40 -100.39 119.92 57.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.8 Cg_endo -83.39 146.46 12.32 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.505 1.266 . . . . 0.0 110.407 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -71.29 158.44 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.0 109.987 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -55.53 -26.3 42.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 111.219 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 m -90.7 -48.39 7.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.697 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.908 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.13 -26.93 63.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.811 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' CD ' ' HG2' ' A' ' 66' ' ' PRO . 31.9 ttp180 -68.02 -36.79 80.52 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -35.66 76.17 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 70' ' ' ALA . 29.1 mt -73.29 -38.44 65.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 66' ' ' PRO . 66.9 mt -63.25 -28.44 70.03 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -77.13 -32.41 56.38 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.829 ' HB3' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -76.6 -32.19 57.94 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.15 0.976 . . . . 0.0 109.523 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.856 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.25 -7.99 46.62 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.78 42.31 7.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' A' ' 53' ' ' VAL . 39.7 t . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.176 -1.19 . . . . 0.0 111.157 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.826 ' CG1' HG12 ' A' ' 21' ' ' VAL . 92.3 t . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.209 0.528 . . . . 0.0 110.172 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -140.67 133.0 28.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.127 -0.983 . . . . 0.0 110.534 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.765 HD11 ' CB ' ' A' ' 59' ' ' TRP . 33.1 mt -103.64 130.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.092 -1.005 . . . . 0.0 109.328 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.1 ptt85 -151.09 -167.46 2.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.652 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.572 HD22 ' HB2' ' A' ' 17' ' ' TYR . 13.1 mt -89.32 126.11 35.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.223 -0.923 . . . . 0.0 111.081 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.402 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.0 104.06 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.175 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.518 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 8.1 tmm_? . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 0.0 112.241 -178.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB2' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 . . . . . 0 N--CA 1.478 0.935 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.446 ' HD3' ' HB3' ' A' ' 35' ' ' LYS . 1.4 ttm-85 -100.55 154.08 18.86 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.897 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -97.63 84.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.26 0.4 OUTLIER -98.51 172.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.988 -173.068 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.826 HG12 ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -112.73 105.28 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.597 -0.689 . . . . 0.0 111.037 -177.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.2 -0.938 . . . . 0.0 109.959 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.6 p90 . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.455 0.645 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.404 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.5 mt -86.02 -49.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.27 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -153.66 172.57 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -0.807 . . . . 0.0 109.778 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HD3' ' A' ' 18' ' ' ARG . 1.8 mtmt -111.82 126.3 54.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.04 -1.037 . . . . 0.0 110.0 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.018 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -129.86 -13.71 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.008 -1.057 . . . . 0.0 111.819 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.878 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -133.89 154.83 21.51 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 119.286 -1.435 . . . . 0.0 109.6 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.459 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 24.2 t80 -128.92 151.81 49.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.268 -1.136 . . . . 0.0 109.13 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.405 ' O ' ' N ' ' A' ' 17' ' ' TYR . 38.8 t80 -149.93 116.5 5.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.721 -1.237 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 39.1 t0 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 120.684 -1.26 . . . . 0.0 110.575 179.836 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 77' ' ' ALA . 6.6 tt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.383 0.611 . . . . 0.0 111.108 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -140.33 85.9 2.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 109.288 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.897 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -115.85 143.54 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.922 -1.111 . . . . 0.0 111.412 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.8 t0 -94.58 69.8 3.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.719 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -32.9 -32.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.809 -177.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.28 -50.23 74.46 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.695 -1.253 . . . . 0.0 108.562 178.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.0 mmm180 -74.44 -36.17 63.38 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 53' ' ' VAL . . . -68.85 -16.57 63.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.944 -1.097 . . . . 0.0 108.129 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -90.38 -21.72 21.83 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 121.362 -0.836 . . . . 0.0 108.908 177.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -66.83 -48.22 69.57 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 123.032 1.396 . . . . 0.0 107.658 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.018 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.3 m95 -66.94 -54.36 22.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.424 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.043 HD11 HD13 ' A' ' 74' ' ' LEU . 3.3 mt -56.6 -21.31 26.05 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.537 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 2.8 m -82.34 -20.91 36.37 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.397 -0.814 . . . . 0.0 110.446 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.8 m -99.07 31.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.915 -1.116 . . . . 0.0 109.536 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 26.41 73.75 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -67.14 137.44 56.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.331 . . . . 0.0 109.644 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -103.03 108.26 58.02 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 0.0 110.609 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.0 Cg_endo -79.69 126.62 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.65 1.342 . . . . 0.0 109.736 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 7.6 t -62.21 -175.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.55 51.94 1.77 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 m -164.33 -56.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.33 -25.59 64.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.519 ' HA ' HD12 ' A' ' 74' ' ' LEU . 6.8 tmm_? -66.76 -39.62 87.93 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -40.86 96.57 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.4 mt -69.3 -29.29 67.12 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.515 -0.741 . . . . 0.0 109.348 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.043 HD13 HD11 ' A' ' 60' ' ' LEU . 45.7 mt -69.65 -28.09 65.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.39 -27.05 29.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -83.55 -36.7 23.79 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.597 0.713 . . . . 0.0 110.533 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.19 -6.86 37.45 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.815 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.31 56.37 2.86 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.719 HG22 ' HB ' ' A' ' 53' ' ' VAL . 24.3 t . . . . . 0 N--CA 1.484 1.264 0 O-C-N 121.122 -1.223 . . . . 0.0 111.052 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.765 HG11 ' CE3' ' A' ' 59' ' ' TRP . 66.1 t . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.289 0.566 . . . . 0.0 110.443 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 65' ' ' GLN . 3.6 tptm -140.49 128.44 22.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.912 HD11 ' CB ' ' A' ' 59' ' ' TRP . 71.6 mt -99.97 128.91 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.041 -1.037 . . . . 0.0 109.901 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 6.6 ptm180 -151.23 -173.89 4.64 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.6 mp -88.96 126.07 35.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.518 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.34 103.57 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.355 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.482 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 111.179 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.6 m-85 . . . . . 0 C--O 1.214 -0.779 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 6.5 mmt180 -100.68 158.68 15.77 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.759 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.953 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -99.04 78.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.25 0.4 OUTLIER -97.26 163.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.733 -173.474 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.879 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 112.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.286 0.565 . . . . 0.0 110.308 -177.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.2 p90 . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.55 0.691 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.706 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.1 mp -84.34 -28.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 109.939 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.91 164.75 1.52 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.975 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.32 113.77 26.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.982 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.991 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -108.24 -34.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.115 -0.99 . . . . 0.0 110.664 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.925 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.27 164.34 15.36 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.342 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.493 ' N ' HG13 ' A' ' 19' ' ' ILE . 11.6 t80 -139.48 142.95 37.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.443 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 19.9 t80 -135.64 132.98 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.723 -1.235 . . . . 0.0 110.208 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.498 1.938 0 O-C-N 120.787 -1.195 . . . . 0.0 110.34 179.491 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 49' ' ' LEU . 2.3 tm? . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.347 0.594 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 104.24 9.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.102 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.1 t -129.52 139.15 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.099 . . . . 0.0 111.357 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.8 t0 -84.94 70.83 10.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.52 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -31.91 -34.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -59.96 -51.01 71.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.774 -1.204 . . . . 0.0 108.837 178.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.628 ' HB3' HG22 ' A' ' 36' ' ' ILE . 47.1 mmm-85 -71.11 -45.52 63.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.901 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -59.87 -22.38 62.24 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.2 ttt180 -87.78 -26.42 22.88 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.317 -0.864 . . . . 0.0 109.864 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.1 t80 -59.29 -46.67 87.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.32 1.534 . . . . 0.0 107.237 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.991 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.4 m95 -62.85 -54.68 35.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.512 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 74' ' ' LEU . 7.3 mt -56.05 -20.58 17.48 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.583 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -79.02 -24.24 43.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.776 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 59' ' ' TRP . 14.4 m -98.92 33.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.939 -1.101 . . . . 0.0 109.568 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.28 27.15 73.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -68.26 130.93 44.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.004 -1.292 . . . . 0.0 109.964 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.411 ' O ' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -98.13 111.25 58.99 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 110.454 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HB3' HD11 ' A' ' 74' ' ' LEU . 53.4 Cg_endo -87.53 125.43 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.616 1.324 . . . . 0.0 109.951 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.783 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.3 t -53.98 166.31 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.016 -1.053 . . . . 0.0 109.767 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -33.8 36.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.041 -1.037 . . . . 0.0 110.919 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.7 m -76.04 -54.82 6.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.975 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.783 ' H ' HG23 ' A' ' 67' ' ' THR . . . -67.1 -23.36 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.475 -0.766 . . . . 0.0 109.222 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.767 ' HA ' HD12 ' A' ' 74' ' ' LEU . 31.0 ttp180 -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 2.0 ttt-85 -69.77 -43.19 72.68 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.676 -0.809 . . . . 0.0 108.977 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD22 HD23 ' A' ' 49' ' ' LEU . 77.5 mt -65.15 -22.89 66.98 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.571 -0.706 . . . . 0.0 109.443 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 71' ' ' ARG . 14.0 mt -70.73 -30.41 66.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.496 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 2.8 mtm180 -72.66 -34.67 67.41 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -77.52 -28.81 52.14 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.91 0.862 . . . . 0.0 110.077 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -73.34 -4.64 34.62 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.199 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.65 20.32 51.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 77' ' ' ALA . 21.1 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.091 -1.241 . . . . 0.0 110.569 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 40.2 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.255 0.55 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -140.2 133.44 29.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.245 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.975 HD11 ' CB ' ' A' ' 59' ' ' TRP . 98.0 mt -102.03 133.26 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.07 -1.019 . . . . 0.0 109.924 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -172.54 4.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 110.893 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -88.73 126.0 35.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.404 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.62 104.45 16.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 111.191 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 2.6 tmm_? . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.787 ' HB2' HD23 ' A' ' 6' ' ' LEU . 7.4 m-85 . . . . . 0 C--O 1.208 -1.131 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -108.41 159.59 16.55 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.66 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.981 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 81.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 177.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.264 0.4 OUTLIER -97.81 164.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.572 -174.0 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -111.86 106.1 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 110.471 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.102 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 45.5 p90 . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.603 0.716 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.552 HG21 ' HH2' ' A' ' 59' ' ' TRP . 4.6 mt -72.56 -46.31 55.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.662 -0.649 . . . . 0.0 110.036 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -152.41 166.24 32.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 6.6 pttt -104.33 115.77 30.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.175 -0.953 . . . . 0.0 109.998 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.867 HG21 ' CD1' ' A' ' 59' ' ' TRP . 38.7 pt -108.32 -33.71 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.939 -1.1 . . . . 0.0 111.56 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.783 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.69 166.91 18.24 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.859 -1.638 . . . . 0.0 112.76 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.404 ' N ' HG12 ' A' ' 19' ' ' ILE . 53.1 t80 -140.94 121.4 14.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.981 ' HB2' HD11 ' A' ' 19' ' ' ILE . 20.8 t80 -114.94 139.95 49.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.777 -1.202 . . . . 0.0 109.778 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 64.4 t0 . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 109.864 178.884 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.649 HD23 ' C ' ' A' ' 49' ' ' LEU . 7.9 tt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.222 0.534 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -120.78 93.58 4.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.408 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.783 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.79 133.01 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.044 -1.035 . . . . 0.0 111.2 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.0 t0 -78.37 69.13 4.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -34.06 -32.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.542 -177.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tt0 -62.42 -52.15 64.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.916 -1.115 . . . . 0.0 109.105 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.1 mtm-85 -75.49 -34.7 60.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.078 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -67.15 -23.48 65.8 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HB2' HG13 ' A' ' 79' ' ' VAL . 40.8 ttt180 -86.15 -20.55 28.46 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.328 -0.857 . . . . 0.0 109.952 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.719 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -62.31 -48.56 79.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 123.078 1.418 . . . . 0.0 107.235 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.975 ' CB ' HD11 ' A' ' 4' ' ' ILE . 89.0 m95 -63.02 -55.92 21.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.714 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.644 HD12 HG11 ' A' ' 79' ' ' VAL . 84.2 mt -53.69 -21.85 7.84 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.5 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -81.96 -20.09 39.28 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.456 -0.778 . . . . 0.0 110.64 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.3 m -99.07 32.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.811 -1.181 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.88 27.1 72.82 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -81.95 117.64 22.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.136 -1.214 . . . . 0.0 109.992 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -91.36 127.75 49.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -83.7 165.42 13.84 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.352 1.185 . . . . 0.0 109.744 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -85.19 -174.94 5.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.226 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.68 46.68 1.19 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -165.7 -55.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 6' ' ' LEU . . . -67.83 -26.07 65.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.427 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 67.1 ttt180 -64.83 -40.53 95.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -39.35 89.64 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.875 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 70' ' ' ALA . 41.7 mt -70.71 -28.28 64.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 60' ' ' LEU . 40.9 mt -70.95 -29.46 65.48 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.27 -28.26 38.44 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -83.86 -32.37 25.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.725 0.774 . . . . 0.0 110.097 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -66.41 -11.39 51.43 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.722 -0.611 . . . . 0.0 109.811 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.16 15.72 29.75 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.867 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 53' ' ' VAL . 17.9 t . . . . . 0 N--CA 1.492 1.668 0 O-C-N 120.724 -1.456 . . . . 0.0 110.138 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.056 0.455 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.14 142.18 36.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 110.688 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.919 HD11 ' CB ' ' A' ' 59' ' ' TRP . 84.7 mt -104.06 135.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.142 -0.974 . . . . 0.0 109.409 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -151.22 -168.81 3.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 70' ' ' ALA . 5.1 mp -89.3 127.3 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.846 . . . . 0.0 110.367 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.86 104.27 15.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.088 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.531 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.905 . . . . 0.0 112.539 -178.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 14.1 m-85 . . . . . 0 C--O 1.211 -0.931 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.525 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.2 mtt85 -100.29 159.36 15.19 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.83 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.954 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.71 81.43 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 177.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.4 OUTLIER -97.69 171.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.934 -173.745 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.904 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -116.16 108.77 25.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.167 0.508 . . . . 0.0 110.048 -177.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.8 t . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 110.233 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB3' HG13 ' A' ' 20' ' ' VAL . 20.4 p90 . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 121.555 0.693 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.605 HG21 ' HH2' ' A' ' 59' ' ' TRP . 13.2 mt -82.64 -51.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 109.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -152.79 152.72 31.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.959 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -89.57 108.17 19.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.018 . . . . 0.0 110.125 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.898 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.5 pt -100.07 -36.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 111.371 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.803 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -120.78 168.03 13.98 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.021 -1.562 . . . . 0.0 112.392 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 19' ' ' ILE . 10.2 t80 -141.07 124.78 16.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.954 ' HB2' HD11 ' A' ' 19' ' ' ILE . 22.6 t80 -125.85 124.71 41.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.811 -1.18 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 60.0 t0 . . . . . 0 N--CA 1.494 1.752 0 O-C-N 120.731 -1.231 . . . . 0.0 110.69 -179.83 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 76' ' ' GLN . 8.2 tt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.291 0.567 . . . . 0.0 110.618 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.91 94.91 3.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.803 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.0 138.56 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.952 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -84.74 72.38 10.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.753 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.98 -30.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 122.309 -0.245 . . . . 0.0 111.492 -177.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 35.1 mt-10 -60.47 -53.75 53.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.77 -1.206 . . . . 0.0 108.771 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.3 mmp_? -71.31 -39.66 71.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.432 -0.792 . . . . 0.0 108.891 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.873 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.74 -17.82 64.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 38.8 ttp180 -89.65 -22.68 22.17 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.19 -0.944 . . . . 0.0 109.594 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.888 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.4 t80 -61.4 -44.86 96.42 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 123.167 1.461 . . . . 0.0 107.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.919 ' CB ' HD11 ' A' ' 4' ' ' ILE . 84.6 m95 -69.84 -56.49 6.95 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.921 -1.491 . . . . 0.0 109.982 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.887 HD21 ' HG3' ' A' ' 66' ' ' PRO . 20.9 mt -53.98 -22.7 11.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.421 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -80.9 -22.3 39.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.474 -0.766 . . . . 0.0 110.56 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.888 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.69 32.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.764 -1.21 . . . . 0.0 109.478 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 30.03 74.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -76.95 128.96 35.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.065 -1.256 . . . . 0.0 110.141 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -94.76 110.24 48.27 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.887 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.3 Cg_endo -82.31 131.09 6.5 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.552 1.29 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 41.2 p -52.54 160.41 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.88 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.27 -16.3 20.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.909 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.446 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 5.4 m -92.34 -52.93 4.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -70.93 -28.48 64.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.4 ttt180 -65.53 -39.89 92.29 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -64.09 -27.6 69.2 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.075 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 70' ' ' ALA . 15.9 mt -85.5 -31.13 22.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.581 -0.699 . . . . 0.0 109.444 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.642 HD22 ' HB1' ' A' ' 56' ' ' ALA . 83.4 mt -69.01 -28.43 66.59 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.7 -29.31 36.47 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HB3' HD11 ' A' ' 49' ' ' LEU . 4.8 tp-100 -77.95 -35.08 50.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.899 0.857 . . . . 0.0 109.316 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -68.63 -9.36 49.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.77 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.501 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 88.11 54.54 2.42 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.753 HG22 ' CB ' ' A' ' 53' ' ' VAL . 36.6 t . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.165 -1.197 . . . . 0.0 111.381 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 36.1 t . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.249 0.547 . . . . 0.0 109.839 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -140.5 131.51 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.55 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.97 HD11 ' CB ' ' A' ' 59' ' ' TRP . 40.3 mt -99.76 129.31 50.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.074 -1.016 . . . . 0.0 109.012 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 18.5 ptt85 -150.24 174.04 13.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.774 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.5 pp -88.21 127.03 35.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.96 111.68 23.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 112.427 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.469 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 7.4 ttt-85 . . . . . 0 C--N 1.302 -1.478 0 O-C-N 121.144 -0.973 . . . . 0.0 110.793 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.211 -0.927 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 12.4 ttm180 -99.93 146.24 26.89 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.398 -1.321 . . . . 0.0 108.107 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.04 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -96.33 80.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 102.164 -3.273 . . . . 0.0 102.164 178.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.542 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.289 0.4 OUTLIER -97.22 168.45 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.103 -173.197 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.895 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -114.12 109.76 29.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.49 -0.756 . . . . 0.0 110.507 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.5 t . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.342 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.542 ' HB3' HG13 ' A' ' 20' ' ' VAL . 12.8 p90 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.443 0.64 . . . . 0.0 110.612 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.671 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.2 mt -61.3 -39.19 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.831 . . . . 0.0 109.918 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -167.36 170.93 11.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.912 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -110.57 121.02 44.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.005 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.927 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -115.78 -23.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.025 -1.047 . . . . 0.0 110.828 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.91 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.98 162.2 16.89 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 118.803 -1.665 . . . . 0.0 111.072 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.47 ' N ' HG12 ' A' ' 19' ' ' ILE . 63.9 t80 -140.22 133.64 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.04 ' HB2' HD11 ' A' ' 19' ' ' ILE . 2.6 t80 -126.93 121.81 32.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 109.906 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.7 t0 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.0 110.064 179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.652 HD13 ' HB3' ' A' ' 76' ' ' GLN . 1.7 tt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.368 0.604 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -133.48 86.81 2.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.31 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.91 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -115.67 130.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.119 -0.988 . . . . 0.0 111.327 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.6 t70 -74.35 70.82 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.79 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.86 -30.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 122.233 -0.292 . . . . 0.0 111.471 -177.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.8 tp10 -62.83 -50.12 72.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.797 -1.19 . . . . 0.0 108.623 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.669 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -76.72 -33.74 58.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 108.988 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.92 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -70.21 -21.5 63.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' VAL . 23.4 tpt180 -86.28 -22.27 26.9 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.646 ' O ' HG13 ' A' ' 62' ' ' VAL 0.25 0.5 OUTLIER -62.22 -48.08 81.59 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.258 1.504 . . . . 0.0 107.367 178.38 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.97 ' CB ' HD11 ' A' ' 4' ' ' ILE . 77.9 m95 -64.98 -56.08 15.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.788 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.618 ' CD1' HG11 ' A' ' 79' ' ' VAL . 47.2 mt -53.09 -22.47 6.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.561 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -80.71 -22.07 40.66 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.408 -0.808 . . . . 0.0 110.826 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 59' ' ' TRP . 7.2 m -98.89 32.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.813 -1.18 . . . . 0.0 109.543 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.61 70.83 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -73.17 110.75 7.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.073 -1.251 . . . . 0.0 110.136 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 115.61 56.08 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.8 Cg_endo -82.66 144.59 12.58 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.539 1.284 . . . . 0.0 109.992 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.93 165.51 13.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.59 -16.03 59.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 110.9 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -104.28 -46.79 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.175 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.83 -25.95 65.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -65.9 -38.68 89.38 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.412 ' NH1' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -62.01 -32.84 73.36 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.919 178.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.932 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -76.89 -35.67 57.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.512 HD12 ' HB3' ' A' ' 66' ' ' PRO . 76.7 mt -63.89 -28.77 70.07 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -78.4 -29.79 47.44 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.652 ' HB3' HD13 ' A' ' 49' ' ' LEU . 8.1 tp-100 -73.16 -34.04 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.056 0.931 . . . . 0.0 108.928 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -69.57 -7.99 43.4 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.983 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.81 39.13 10.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.79 HG22 HG23 ' A' ' 53' ' ' VAL . 45.5 t . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.176 -1.191 . . . . 0.0 111.893 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.777 HG11 ' CG2' ' A' ' 62' ' ' VAL . 61.1 t . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.199 0.524 . . . . 0.0 110.576 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 65' ' ' GLN . 3.7 mtmt -140.18 139.5 35.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 110.793 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.944 HD11 ' HB3' ' A' ' 59' ' ' TRP . 1.5 mp -99.96 130.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.85 -176.71 5.63 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.1 -1.0 . . . . 0.0 110.845 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.542 HD22 ' HB2' ' A' ' 17' ' ' TYR . 16.1 mt -89.7 127.14 35.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.847 . . . . 0.0 110.8 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.72 107.08 19.07 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.519 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.769 -1.207 . . . . 0.0 112.805 -177.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.542 ' HB2' HD22 ' A' ' 6' ' ' LEU . 11.0 m-85 . . . . . 0 C--O 1.21 -0.995 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.461 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 24.2 ttt180 -112.41 152.65 28.41 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.939 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.2 mt -98.73 78.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 34' ' ' GLU 0.271 0.4 OUTLIER -98.07 165.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.179 -173.134 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.951 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.44 106.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.854 -0.529 . . . . 0.0 110.612 -177.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.7 t . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.151 -0.968 . . . . 0.0 110.258 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.6 p90 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.475 0.655 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 mt -90.45 -34.39 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.988 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -164.71 -175.54 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -119.18 112.75 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.978 HG21 ' CD1' ' A' ' 59' ' ' TRP . 21.4 pt -108.96 -38.0 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.924 -1.11 . . . . 0.0 111.208 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.79 163.73 19.63 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.81 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 25.0 t80 -133.69 152.54 51.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -143.54 137.86 28.75 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.974 -1.079 . . . . 0.0 109.738 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 36.0 t0 . . . . . 0 N--CA 1.496 1.835 0 O-C-N 120.759 -1.213 . . . . 0.0 110.479 179.831 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 77' ' ' ALA . 7.2 tt . . . . . 0 N--CA 1.488 1.431 0 CA-C-O 121.48 0.657 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 94.01 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 108.715 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.939 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -120.58 154.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.255 1.026 . . . . 0.0 111.712 -178.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 9.1 t0 -103.95 68.07 0.9 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -29.95 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.9 tt0 -60.28 -52.46 65.2 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.771 -1.206 . . . . 0.0 109.197 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.57 ' HB3' HG22 ' A' ' 36' ' ' ILE . 28.0 mmm180 -72.3 -41.01 67.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.967 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -63.37 -20.37 65.47 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 23.2 ttp85 -89.79 -21.95 22.37 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.89 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -63.36 -47.23 82.97 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 123.176 1.465 . . . . 0.0 107.311 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.978 ' CD1' HG21 ' A' ' 36' ' ' ILE . 90.4 m95 -66.81 -55.29 15.54 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.915 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -54.62 -22.82 14.66 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.317 177.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -81.67 -19.2 42.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.46 -0.775 . . . . 0.0 110.41 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.4 m -99.0 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.799 -1.188 . . . . 0.0 109.31 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.88 28.05 73.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -71.15 146.12 49.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.072 -1.252 . . . . 0.0 110.301 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 3' ' ' LYS . 1.9 mm100 -113.1 109.59 51.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HG3' HD21 ' A' ' 60' ' ' LEU . 52.2 Cg_endo -86.64 128.38 2.9 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.59 1.311 . . . . 0.0 110.619 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.3 t -54.81 165.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.09 -17.52 27.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.154 -0.966 . . . . 0.0 111.202 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.1 m -90.24 -52.88 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.0 110.487 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.811 ' H ' HG23 ' A' ' 67' ' ' THR . . . -68.99 -28.82 66.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' HA ' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -68.34 -39.16 81.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -39.57 88.75 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 25.4 mt -73.63 -27.3 61.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.41 -0.806 . . . . 0.0 109.267 178.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.543 HD13 HD11 ' A' ' 60' ' ' LEU . 21.3 mt -69.64 -27.83 65.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.72 -25.83 37.84 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.3 tp-100 -83.85 -36.55 23.35 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.792 0.806 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.631 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -69.01 -6.63 29.1 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.281 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.35 43.88 7.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 53' ' ' VAL . 23.8 t . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.156 -1.202 . . . . 0.0 111.2 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.574 HG11 ' CE3' ' A' ' 59' ' ' TRP . 41.0 t . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 121.267 0.555 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 65' ' ' GLN . 7.3 mttt -140.33 140.37 35.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.982 HD11 ' CB ' ' A' ' 59' ' ' TRP . 95.2 mt -108.18 134.88 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.745 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -150.96 -163.65 1.82 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.312 -0.868 . . . . 0.0 110.112 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.028 HD11 HG21 ' A' ' 69' ' ' THR . 36.4 mt -89.3 136.03 33.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.071 -1.018 . . . . 0.0 110.986 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -106.47 105.22 15.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.59 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.479 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.9 ttp85 . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 111.177 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 4.7 m-30 . . . . . 0 C--O 1.212 -0.905 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.624 ' HD3' HG23 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -104.14 164.77 11.49 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.743 -1.583 . . . . 0.0 106.997 176.151 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.701 HD12 HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -98.39 86.39 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.624 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.264 0.4 OUTLIER -98.12 168.72 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.285 -174.782 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.948 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -113.75 106.19 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.673 -177.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 32' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.952 . . . . 0.0 109.418 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.646 ' HB3' HG22 ' A' ' 22' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.58 0.705 . . . . 0.0 110.467 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.529 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.3 mt -92.07 -50.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 110.04 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.1 tt0 -150.15 164.59 35.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.01 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -103.07 116.71 33.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.142 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.995 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.9 pt -110.5 -33.8 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.985 -1.072 . . . . 0.0 111.991 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -128.38 174.46 18.86 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.187 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 85.1 t80 -140.49 142.9 35.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.441 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 7.8 t80 -140.16 132.91 29.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.722 -1.236 . . . . 0.0 110.036 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.8 t0 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 120.835 -1.165 . . . . 0.0 110.236 179.877 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' A' ' 77' ' ' ALA . 5.5 tt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.238 0.542 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.39 96.06 4.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.388 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.803 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -120.74 149.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 111.476 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t0 -95.75 68.89 2.88 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.21 -35.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mt-10 -59.68 -52.98 63.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.746 -1.221 . . . . 0.0 109.202 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.66 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.79 -40.86 72.31 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.4 -0.812 . . . . 0.0 109.049 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.09 -18.69 65.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 108.548 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.26 -22.96 23.65 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.242 -0.911 . . . . 0.0 109.524 178.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 62' ' ' VAL . 3.7 t80 -61.05 -43.28 99.12 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.139 1.447 . . . . 0.0 107.305 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.995 ' CD1' HG21 ' A' ' 36' ' ' ILE . 78.7 m95 -68.6 -53.31 23.52 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.893 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 74' ' ' LEU . 6.6 mt -57.39 -21.02 33.37 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.574 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -81.58 -23.89 36.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.453 -0.779 . . . . 0.0 110.651 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 59' ' ' TRP . 25.5 m -99.15 32.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 120.817 -1.177 . . . . 0.0 109.649 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.42 31.25 76.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.54 141.68 51.86 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.006 -1.291 . . . . 0.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.453 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -105.91 103.04 42.42 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 110.128 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.4 Cg_endo -81.26 125.14 5.07 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.698 1.367 . . . . 0.0 110.226 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.5 t -54.9 176.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.0 -1.062 . . . . 0.0 109.695 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.79 -19.68 62.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.182 -0.949 . . . . 0.0 111.026 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 1.028 HG21 HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -90.5 -51.17 5.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.686 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.683 ' H ' HG23 ' A' ' 67' ' ' THR . . . -70.4 -27.59 64.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.21 -37.98 78.35 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -69.47 -47.34 64.25 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.545 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 70' ' ' ALA . 15.4 mt -60.48 -25.13 65.81 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 60' ' ' LEU . 23.1 mt -76.19 -25.94 55.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -31.49 30.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.495 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.5 tp-100 -87.18 -36.46 18.01 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.724 0.773 . . . . 0.0 110.7 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.86 -10.78 31.01 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.705 -0.622 . . . . 0.0 110.01 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.64 48.78 5.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.612 HG21 HD23 ' A' ' 74' ' ' LEU . 49.5 t . . . . . 0 N--CA 1.487 1.377 0 O-C-N 121.065 -1.256 . . . . 0.0 111.44 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.904 HG11 HG23 ' A' ' 62' ' ' VAL . 49.9 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.299 0.571 . . . . 0.0 110.216 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt -138.6 133.41 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.982 HD11 ' CB ' ' A' ' 59' ' ' TRP . 84.9 mt -106.05 133.37 50.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.162 -0.961 . . . . 0.0 109.649 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.525 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.2 174.33 13.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.956 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.476 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 1.2 pp -89.26 129.43 35.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.1 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.502 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -98.65 165.5 11.77 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.473 -0.767 . . . . 0.0 109.334 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.392 0 O-C-N 120.974 -1.079 . . . . 0.0 111.483 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 14.5 m-85 . . . . . 0 N--CA 1.482 1.133 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' CD ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -127.69 147.16 50.38 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.006 -1.059 . . . . 0.0 108.384 178.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.872 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -97.31 81.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 178.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG23 ' CD ' ' A' ' 18' ' ' ARG 0.29 0.4 OUTLIER -98.2 160.49 3.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.78 -173.347 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.943 HG13 HG12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -104.16 107.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.686 -0.634 . . . . 0.0 109.862 -178.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 110.425 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.6 p90 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.539 0.685 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.511 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.6 mt -68.92 -29.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.488 -0.758 . . . . 0.0 109.643 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.37 179.94 4.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 31.9 pttt -120.81 121.82 38.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 56' ' ' ALA . 23.9 pt -116.92 -38.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.135 -0.978 . . . . 0.0 111.607 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.843 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.0 165.64 13.05 Favored Glycine 0 C--N 1.296 -1.686 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.531 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.421 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.6 t80 -139.07 126.68 21.86 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -119.27 136.59 54.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.959 -1.088 . . . . 0.0 110.548 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.633 179.416 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.749 HD11 ' HB3' ' A' ' 73' ' ' LEU . 1.4 tt . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.43 0.633 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.16 94.79 4.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.43 -0.793 . . . . 0.0 108.884 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.872 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -118.51 141.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 111.557 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -85.3 67.19 10.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.879 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.82 -29.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -61.13 -47.32 86.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.78 -1.2 . . . . 0.0 108.567 178.138 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 30.8 mmm180 -76.88 -38.53 53.46 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.68 -21.75 66.81 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.3 -21.16 24.58 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.442 -0.786 . . . . 0.0 109.536 178.252 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.821 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -65.81 -49.39 68.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.242 1.496 . . . . 0.0 107.451 178.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.982 ' CB ' HD11 ' A' ' 4' ' ' ILE . 86.7 m95 -63.6 -56.08 18.72 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.748 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.761 HD21 ' HG3' ' A' ' 66' ' ' PRO . 12.4 mt -52.95 -22.79 6.04 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.421 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -81.89 -19.06 41.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.544 -0.722 . . . . 0.0 110.337 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.904 HG23 HG11 ' A' ' 2' ' ' VAL . 3.2 m -98.74 31.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.849 -1.157 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.25 72.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.23 143.57 52.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -1.209 . . . . 0.0 110.109 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -106.54 105.65 55.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 0.0 110.532 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.761 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.3 Cg_endo -80.85 140.48 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.616 1.324 . . . . 0.0 110.335 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 70.5 p -72.24 163.52 27.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.993 -1.067 . . . . 0.0 110.166 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.63 -22.48 61.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.725 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.476 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 12.5 m -92.78 -48.23 6.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.173 -0.954 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.989 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.78 -30.21 67.71 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' A' ' 74' ' ' LEU . 12.2 ttt-85 -66.12 -37.5 85.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -28.9 70.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.989 HD12 ' HA ' ' A' ' 70' ' ' ALA . 14.8 mt -83.94 -33.4 24.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.59 HD13 HD11 ' A' ' 60' ' ' LEU . 80.5 mt -63.99 -30.53 71.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -25.72 41.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.631 ' HB3' HD13 ' A' ' 49' ' ' LEU . 10.3 tp-100 -74.32 -35.01 63.62 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.12 0.962 . . . . 0.0 109.26 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -72.24 -5.8 38.48 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.23 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.45 48.31 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.879 HG22 HG23 ' A' ' 53' ' ' VAL . 44.0 t . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 111.501 -179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.6 m . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.304 0.573 . . . . 0.0 110.337 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -140.22 129.16 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.924 ' CG1' HG13 ' A' ' 21' ' ' VAL . 74.9 mt -99.8 131.9 46.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.023 -1.048 . . . . 0.0 109.373 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.0 ptm180 -150.42 -167.06 2.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.038 -1.039 . . . . 0.0 110.361 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.723 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.6 mp -89.31 131.22 35.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.356 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -103.08 105.06 15.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 111.206 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.508 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 O-C-N 121.192 -0.943 . . . . 0.0 111.525 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 3.9 m-30 . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -104.03 165.91 10.74 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.24 176.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.707 HD12 HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -98.46 83.74 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.252 0.3 OUTLIER -97.6 169.73 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.146 -174.943 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.924 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -113.47 104.83 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.56 -0.712 . . . . 0.0 110.496 -177.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.248 -0.907 . . . . 0.0 110.166 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 121.513 0.673 . . . . 0.0 110.285 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.776 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.9 mt -82.77 -43.62 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.482 -0.761 . . . . 0.0 109.37 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.3 161.72 30.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.486 -0.758 . . . . 0.0 109.624 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -98.13 116.74 30.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.101 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 56' ' ' ALA . 35.5 pt -104.66 -36.08 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.975 -1.078 . . . . 0.0 111.472 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.811 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -129.08 177.04 18.14 Favored Glycine 0 C--N 1.294 -1.753 0 C-N-CA 118.917 -1.611 . . . . 0.0 112.291 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 17.2 t80 -140.58 145.63 36.97 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 4.2 t80 -142.92 129.64 20.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.609 -1.307 . . . . 0.0 110.5 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.3 t0 . . . . . 0 N--CA 1.493 1.713 0 O-C-N 120.818 -1.176 . . . . 0.0 110.25 179.834 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 73' ' ' LEU . 11.8 tp . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.579 0.704 . . . . 0.0 111.213 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -128.25 110.45 12.41 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.811 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.24 160.96 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.419 1.104 . . . . 0.0 111.72 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.4 t70 -104.91 67.58 0.8 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.05 -32.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.593 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -63.58 -52.06 62.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.9 -1.125 . . . . 0.0 109.232 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.8 mtm-85 -75.69 -33.3 60.35 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.241 -0.912 . . . . 0.0 109.428 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -68.99 -23.8 64.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.5 ttt-85 -86.3 -21.89 27.06 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.24 -0.912 . . . . 0.0 109.726 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -61.02 -50.57 72.8 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.252 1.501 . . . . 0.0 107.039 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.906 ' CD2' HG11 ' A' ' 21' ' ' VAL . 84.5 m95 -60.27 -53.02 62.65 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.576 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 56' ' ' ALA . 1.3 mt -54.42 -22.04 11.43 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -77.97 -22.75 48.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.542 -0.724 . . . . 0.0 110.408 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 59' ' ' TRP . 8.9 m -99.05 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.784 -1.197 . . . . 0.0 109.736 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.58 25.58 74.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -66.84 129.69 40.7 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.237 -1.155 . . . . 0.0 109.763 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.35 116.43 63.75 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.2 Cg_endo -82.77 128.4 5.21 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.526 1.277 . . . . 0.0 109.921 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 t -55.49 176.42 0.06 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.852 -1.155 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 55.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 m -166.67 -59.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.15 -23.16 66.43 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 18.0 ttp85 -65.62 -42.71 91.25 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 3.1 ttm180 -67.46 -42.16 83.47 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.424 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.735 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.1 mt -68.19 -26.16 65.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 60' ' ' LEU . 13.7 mt -67.61 -30.17 69.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 72' ' ' ARG . 9.0 mtm180 -75.98 -34.52 59.78 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.26 56.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.925 0.869 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.764 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.65 -7.55 39.89 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.306 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.95 19.51 33.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 60' ' ' LEU . 12.2 t . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.256 . . . . 0.0 110.763 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.488 HG11 ' CG2' ' A' ' 62' ' ' VAL . 39.7 t . . . . . 0 N--CA 1.493 1.688 0 CA-C-O 121.242 0.544 . . . . 0.0 110.254 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 65' ' ' GLN . 57.8 mtpt -140.92 134.72 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.993 . . . . 0.0 110.323 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.998 ' CG1' HG13 ' A' ' 21' ' ' VAL . 37.9 mt -99.73 133.99 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 108.917 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.519 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.8 ptt180 -150.35 172.99 14.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.006 -1.059 . . . . 0.0 109.941 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 2.9 pp -89.28 130.84 35.61 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 109.518 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -99.15 162.21 13.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.571 -0.706 . . . . 0.0 109.212 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 70.6 ttt180 . . . . . 0 N--CA 1.486 1.366 0 O-C-N 120.931 -1.106 . . . . 0.0 111.4 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 12.5 m-85 . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HG3' ' HA ' ' A' ' 38' ' ' TYR . 2.2 ttp180 -132.05 147.19 52.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.017 -1.052 . . . . 0.0 108.18 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.841 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -97.22 83.24 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 178.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.291 0.4 OUTLIER -97.56 167.0 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.338 -173.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.998 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -112.85 105.65 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.488 -0.758 . . . . 0.0 110.986 -177.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' HD12 ' A' ' 33' ' ' ILE . 1.9 t . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.0 110.004 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 31.8 p90 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.419 0.628 . . . . 0.0 110.616 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.679 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -62.61 -46.12 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -157.81 171.66 19.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.613 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.63 125.15 53.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.652 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.995 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -120.76 -28.05 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.044 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.916 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.26 158.77 14.86 Favored Glycine 0 C--N 1.297 -1.607 0 C-N-CA 118.945 -1.598 . . . . 0.0 111.078 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 69.2 t80 -132.61 133.2 43.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.432 ' CD2' ' HB2' ' A' ' 17' ' ' TYR . 6.0 t80 -124.39 136.1 53.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.301 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.013 -1.055 . . . . 0.0 110.007 179.562 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 76' ' ' GLN . 3.9 tt . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.322 0.582 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -135.33 91.93 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.453 -0.78 . . . . 0.0 109.373 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.916 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -117.86 137.8 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 111.132 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.3 t70 -82.18 70.2 9.06 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.626 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.69 -31.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.556 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.5 tt0 -62.87 -52.05 64.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.869 -1.144 . . . . 0.0 108.902 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.68 -34.78 60.46 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.024 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.941 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -66.67 -18.07 65.18 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 28.9 ttp180 -88.39 -25.19 22.82 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.376 -0.827 . . . . 0.0 109.361 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.916 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -59.06 -44.84 91.88 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.356 1.55 . . . . 0.0 107.096 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.995 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.1 m95 -68.38 -57.88 5.21 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.836 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.425 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.4 mt -52.74 -23.31 6.53 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.314 -0.954 . . . . 0.0 108.612 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 t -80.78 -21.41 41.01 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 110.38 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -98.63 32.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.773 -1.204 . . . . 0.0 109.293 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.05 74.17 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.98 109.33 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 110.312 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -78.08 114.5 42.66 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 110.413 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -82.08 148.76 15.29 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.496 1.261 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.634 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 1.8 p -74.81 161.79 29.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.014 -1.053 . . . . 0.0 109.83 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.41 -25.6 59.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.043 -1.036 . . . . 0.0 110.985 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.474 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 38.4 m -93.28 -47.58 6.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 0.0 110.6 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.964 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.51 -27.63 65.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.8 ttt-85 -65.65 -38.85 90.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -34.77 76.75 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.524 -0.87 . . . . 0.0 108.879 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -76.74 -33.42 58.13 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 66' ' ' PRO . 74.3 mt -65.38 -28.27 69.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' CG ' ' O ' ' A' ' 71' ' ' ARG . 3.7 mmm180 -79.01 -32.15 45.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.691 ' HB3' HD13 ' A' ' 49' ' ' LEU . 8.1 tp-100 -72.06 -34.44 68.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.153 0.978 . . . . 0.0 108.998 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.67 -9.74 46.14 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.148 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 44.36 7.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.597 HG22 ' CB ' ' A' ' 53' ' ' VAL . 47.2 t . . . . . 0 N--CA 1.486 1.346 0 O-C-N 121.193 -1.181 . . . . 0.0 111.394 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.691 HG11 ' CE3' ' A' ' 59' ' ' TRP . 26.9 t . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.23 0.538 . . . . 0.0 109.855 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.653 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.948 HD11 ' CB ' ' A' ' 59' ' ' TRP . 54.8 mt -109.53 133.41 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.146 -0.971 . . . . 0.0 109.48 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 5.2 ptp180 -151.52 -166.79 2.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.781 -1.199 . . . . 0.0 110.69 -178.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 17' ' ' TYR . 41.9 mt -88.67 127.68 35.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.85 107.33 18.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.3 -0.875 . . . . 0.0 110.905 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.499 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ttt180 . . . . . 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.973 . . . . 0.0 109.97 179.608 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.695 ' HB2' HD22 ' A' ' 6' ' ' LEU . 7.5 m-30 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.448 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -99.88 156.27 17.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.504 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.923 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.23 75.77 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 176.427 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.257 0.3 OUTLIER -97.27 165.46 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.859 -173.261 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.915 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.7 113.25 42.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.463 0.649 . . . . 0.0 111.407 -176.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.0 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.665 178.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 6.3 p90 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 121.478 0.656 . . . . 0.0 110.511 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 ' HH2' ' A' ' 59' ' ' TRP . 16.3 mt -89.11 -41.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.59 -0.694 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.58 162.22 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.9 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.594 ' HA ' HG23 ' A' ' 20' ' ' VAL . 2.6 mtpt -101.44 113.89 27.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 0.0 109.734 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.949 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.4 pt -107.37 -34.77 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.198 -0.938 . . . . 0.0 111.24 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.85 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.49 165.77 17.37 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.099 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' ILE . 12.7 t80 -137.49 142.46 41.5 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.436 ' CD2' HD13 ' A' ' 73' ' ' LEU . 39.4 t80 -138.11 133.21 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.767 -1.208 . . . . 0.0 110.404 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t0 . . . . . 0 N--CA 1.498 1.959 0 O-C-N 120.946 -1.096 . . . . 0.0 109.767 179.54 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.431 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.7 tt . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.249 0.547 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -118.17 104.3 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.975 . . . . 0.0 109.508 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.923 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.2 t -128.15 149.31 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.347 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 21.8 t0 -94.23 67.99 3.61 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.6 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -32.96 -34.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.632 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -61.72 -54.17 46.12 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.894 -1.122 . . . . 0.0 108.57 178.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -74.32 -33.06 63.06 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.437 -0.79 . . . . 0.0 109.331 178.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.848 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -69.02 -23.56 64.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -87.02 -19.78 28.17 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.552 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -62.47 -48.49 79.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.277 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.949 ' CD1' HG21 ' A' ' 36' ' ' ILE . 89.5 m95 -63.08 -55.42 25.62 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.257 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 74' ' ' LEU . 3.9 mt -52.4 -22.91 5.16 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.558 176.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -79.93 -21.9 43.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.433 -0.792 . . . . 0.0 110.797 179.229 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 59' ' ' TRP . 6.4 m -98.79 33.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.843 -1.161 . . . . 0.0 109.227 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.55 27.48 73.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.71 142.54 48.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.192 -1.181 . . . . 0.0 109.833 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.38 114.6 38.28 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 110.523 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.665 ' HB3' HD12 ' A' ' 74' ' ' LEU . 49.5 Cg_endo -79.77 128.95 7.92 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.497 1.261 . . . . 0.0 110.308 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.99 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.516 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.77 53.56 1.14 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -166.77 -59.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -66.52 -22.94 66.17 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 2.5 ttt85 -69.01 -43.24 75.21 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 ttm-85 -66.38 -38.44 87.56 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.731 178.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.6 mt -74.37 -26.37 60.08 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 66' ' ' PRO . 13.7 mt -72.0 -29.84 64.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.26 -28.98 38.31 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.431 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.68 -34.58 30.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.814 0.816 . . . . 0.0 109.932 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -62.19 -14.26 35.95 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.793 -0.567 . . . . 0.0 109.877 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 25.58 8.56 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 53' ' ' VAL . 17.5 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 120.846 -1.385 . . . . 0.0 110.686 179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 N--CA 1.494 1.725 0 CA-C-O 121.123 0.487 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.565 ' C ' HD12 ' A' ' 4' ' ' ILE . 21.6 ptmt -140.11 143.28 36.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.121 -0.987 . . . . 0.0 110.874 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.999 HD11 HG13 ' A' ' 21' ' ' VAL . 1.7 mp -100.23 139.09 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 108.901 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.3 -166.12 2.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' HD2' ' A' ' 17' ' ' TYR . 31.1 mt -89.5 135.7 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.86 . . . . 0.0 109.904 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -105.42 103.44 12.96 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.802 . . . . 0.0 111.029 -179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.495 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.381 0 O-C-N 121.53 -0.731 . . . . 0.0 110.942 -179.972 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.546 ' HD2' HD13 ' A' ' 6' ' ' LEU . 3.9 m-30 . . . . . 0 N--CA 1.478 0.946 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 3.9 ptm180 -103.55 167.61 9.69 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 117.453 -1.699 . . . . 0.0 107.571 176.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.842 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.58 86.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 178.907 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.492 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.256 0.3 OUTLIER -98.95 170.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.224 -174.856 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.019 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.8 t -111.95 113.78 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.595 -0.69 . . . . 0.0 110.209 -178.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.8 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.438 179.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CD2' HG21 ' A' ' 20' ' ' VAL . 8.6 p90 . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.459 0.647 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HG3' ' A' ' 34' ' ' GLU . 4.7 mt -64.63 -63.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.944 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 33' ' ' ILE . 44.1 mt-10 -139.27 161.48 37.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.918 . . . . 0.0 110.255 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 118.92 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -0.948 . . . . 0.0 109.976 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.675 HG21 ' CD1' ' A' ' 59' ' ' TRP . 49.5 pt -99.95 -27.96 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.801 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -150.6 -174.1 21.35 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 117.908 -2.091 . . . . 0.0 112.769 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 31.4 t80 -141.25 151.12 43.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.262 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.842 ' HB2' HD11 ' A' ' 19' ' ' ILE . 2.6 t80 -144.02 124.68 14.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.689 -1.257 . . . . 0.0 109.701 177.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 63.0 t0 . . . . . 0 N--CA 1.495 1.778 0 O-C-N 120.588 -1.32 . . . . 0.0 110.335 179.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.804 HD13 ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.47 0.653 . . . . 0.0 110.549 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.804 ' N ' HD13 ' A' ' 49' ' ' LEU . 29.4 tttt -136.69 75.94 1.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.801 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -97.26 134.47 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 110.968 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -80.43 69.07 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 175.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.581 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.47 -31.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.514 -177.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.09 -55.98 26.21 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.899 -1.125 . . . . 0.0 108.778 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 5.1 mmp_? -69.28 -41.2 77.16 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.54 -16.7 63.03 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.947 -1.095 . . . . 0.0 108.071 178.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.65 -25.73 22.25 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 177.849 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.856 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -59.71 -46.62 88.56 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.23 1.49 . . . . 0.0 107.406 178.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.019 ' CD2' HG11 ' A' ' 21' ' ' VAL . 94.6 m95 -67.0 -56.57 9.54 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.259 -178.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 74' ' ' LEU . 1.9 mt -52.45 -23.22 5.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.391 176.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -80.5 -21.0 42.37 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.647 -0.658 . . . . 0.0 110.272 178.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.3 m -98.67 32.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.468 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.27 29.36 74.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.592 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -77.66 129.1 35.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.269 -1.136 . . . . 0.0 109.924 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -97.67 108.52 46.03 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.438 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HG3' HD21 ' A' ' 60' ' ' LEU . 50.8 Cg_endo -77.13 135.38 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.613 1.323 . . . . 0.0 110.368 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 2.3 p -54.69 161.08 1.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.892 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.74 -22.62 58.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.009 . . . . 0.0 110.107 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.0 m -89.19 -52.38 5.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.626 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.13 -23.88 65.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -70.06 -38.58 75.81 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.336 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -64.92 -34.24 77.94 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.87 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 70' ' ' ALA . 47.8 mt -74.08 -32.58 63.32 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 60' ' ' LEU . 56.3 mt -68.29 -28.88 67.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.56 -30.4 52.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -29.21 37.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.891 0.853 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -76.98 -1.67 29.91 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.198 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.09 50.08 8.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.581 HG22 ' HB ' ' A' ' 53' ' ' VAL . 58.3 t . . . . . 0 N--CA 1.484 1.272 0 O-C-N 121.291 -1.123 . . . . 0.0 111.336 -179.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.472 HG11 ' CE3' ' A' ' 59' ' ' TRP . 84.1 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.283 0.564 . . . . 0.0 110.301 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.548 ' C ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -139.78 137.06 34.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.387 -0.82 . . . . 0.0 109.999 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.891 ' CD1' HG13 ' A' ' 21' ' ' VAL . 1.8 mp -99.63 135.89 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 5.3 ptp180 -151.18 175.39 12.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.707 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.597 HD12 ' CD2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -88.17 126.16 34.99 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.935 178.882 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.19 109.84 22.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.56 -0.713 . . . . 0.0 111.917 -177.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 52.6 ttp180 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 111.152 179.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 6' ' ' LEU . 4.8 m-85 . . . . . 0 C--O 1.21 -1.0 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.496 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 2.6 ttt85 -104.64 150.28 24.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.629 178.195 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.086 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -97.35 80.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.288 0.4 OUTLIER -97.35 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.734 -173.821 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.4 t -115.65 107.73 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.516 -176.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.496 1.828 0 O-C-N 121.268 -0.895 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 20.0 p90 . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.349 0.595 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.551 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.4 mt -107.69 -36.43 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 110.329 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.84 176.04 9.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -110.68 109.45 19.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.694 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.976 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.7 pt -106.11 -33.1 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.14 -0.975 . . . . 0.0 111.124 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.37 166.08 20.25 Favored Glycine 0 C--N 1.295 -1.723 0 C-N-CA 118.603 -1.76 . . . . 0.0 111.039 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.483 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.1 t80 -138.45 142.29 39.47 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.086 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.1 t80 -134.47 130.76 37.19 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.056 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 65.1 t0 . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 110.195 179.978 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.715 HD13 HD22 ' A' ' 73' ' ' LEU . 9.4 tp . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 121.589 0.709 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -132.7 97.35 4.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.758 . . . . 0.0 109.148 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.841 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 151.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 110.925 -179.133 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.6 t0 -96.65 67.95 2.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.703 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.99 -30.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 122.252 -0.28 . . . . 0.0 111.509 -177.281 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.7 tp10 -60.45 -54.62 43.33 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.761 -1.212 . . . . 0.0 108.581 178.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 47.3 mmm-85 -72.97 -37.06 67.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.825 . . . . 0.0 109.005 178.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.54 -20.59 66.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.8 ttt180 -88.35 -24.37 23.14 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.277 -0.889 . . . . 0.0 109.519 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.684 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -60.06 -46.59 89.04 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 123.5 1.619 . . . . 0.0 106.928 178.288 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.008 ' CD2' HG11 ' A' ' 21' ' ' VAL . 79.1 m95 -63.72 -55.92 19.59 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.952 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -52.8 -22.36 5.26 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.549 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.37 -20.89 43.08 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.0 110.691 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.3 m -99.0 32.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.875 -1.14 . . . . 0.0 109.952 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.85 71.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -77.0 138.51 39.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -1.112 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.435 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 1.5 mm-40 -116.78 118.29 36.76 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.391 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.2 Cg_endo -79.67 140.46 14.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.397 1.209 . . . . 0.0 109.856 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 70' ' ' ALA . 7.2 t -62.56 176.22 0.68 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.96 -1.088 . . . . 0.0 110.468 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -81.58 49.77 1.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.154 -0.966 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.14 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.58 -23.91 66.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 25.6 ttt85 -63.81 -40.39 96.51 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -35.83 74.23 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 70' ' ' ALA . 46.6 mt -72.46 -38.58 68.22 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 66' ' ' PRO . 24.8 mt -61.04 -28.15 68.85 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.69 -31.0 52.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.453 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.8 tp-100 -75.81 -35.16 60.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.039 0.923 . . . . 0.0 109.866 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.13 -7.02 32.33 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.472 178.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.2 8.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 53' ' ' VAL . 57.4 t . . . . . 0 C--N 1.307 -1.275 0 O-C-N 121.356 -1.085 . . . . 0.0 111.572 -179.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.648 HG11 ' CE3' ' A' ' 59' ' ' TRP . 78.0 t . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 121.173 0.511 . . . . 0.0 109.904 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 59.7 mtpt -140.32 132.39 27.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.926 HD11 ' CB ' ' A' ' 59' ' ' TRP . 61.9 mt -100.17 127.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 121.076 -1.015 . . . . 0.0 109.153 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 1.2 ptm180 -150.74 -170.4 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.017 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -88.49 126.32 35.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 105.8 17.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 111.085 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.446 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 36.8 ttp180 . . . . . 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 109.817 179.295 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 13.9 m-85 . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HG2' ' CD1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -104.13 158.9 16.12 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.379 -1.329 . . . . 0.0 108.089 177.166 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.904 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.3 77.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.708 HG11 ' CD2' ' A' ' 32' ' ' TYR 0.255 0.3 OUTLIER -97.25 164.69 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.855 -173.398 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.815 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.44 105.48 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 109.967 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.754 HG22 ' HB3' ' A' ' 32' ' ' TYR . 3.0 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.649 -179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.754 ' HB3' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 121.515 0.674 . . . . 0.0 110.135 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.671 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.9 mt -59.88 -50.01 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.764 . . . . 0.0 109.926 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -178.31 5.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 109.904 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HE2' ' NH2' ' A' ' 18' ' ' ARG . 7.1 mtpt -117.8 125.39 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.943 . . . . 0.0 110.343 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.054 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.48 -33.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.176 -0.953 . . . . 0.0 111.242 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.894 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.5 161.37 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 C-N-CA 118.919 -1.61 . . . . 0.0 110.967 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.491 ' CD1' ' HG2' ' A' ' 18' ' ' ARG . 72.3 t80 -133.62 145.08 49.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HD2' HD23 ' A' ' 6' ' ' LEU . 17.6 t80 -139.74 134.37 31.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.686 -1.259 . . . . 0.0 109.918 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.2 t70 . . . . . 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 0.0 110.61 -179.788 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 76' ' ' GLN . 5.0 tt . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.332 0.587 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.76 97.96 3.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.156 -0.965 . . . . 0.0 109.636 178.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.904 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.1 t -128.66 130.34 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.864 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 17.2 t0 -80.16 72.29 6.96 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.653 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.6 -31.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 122.342 -0.224 . . . . 0.0 111.523 -177.108 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -59.93 -51.49 69.46 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.818 -1.176 . . . . 0.0 108.666 177.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 36' ' ' ILE . 14.4 mmm180 -73.57 -41.12 63.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.937 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -62.62 -18.43 62.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 52.0 ttp85 -88.34 -26.15 22.37 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.702 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.1 t80 -62.01 -44.72 96.11 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 123.289 1.519 . . . . 0.0 107.462 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.054 ' CD1' HG21 ' A' ' 36' ' ' ILE . 71.9 m95 -68.03 -57.08 6.72 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.038 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.42 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.9 mt -56.67 -21.43 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.524 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 1.6 t -79.25 -23.22 43.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 110.718 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 58' ' ' TYR . 13.9 m -98.9 31.95 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 120.854 -1.154 . . . . 0.0 109.458 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.38 26.73 74.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -63.13 136.27 57.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.314 . . . . 0.0 109.896 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.439 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.52 108.1 48.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 110.551 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 53.0 Cg_endo -81.72 141.18 12.07 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.626 1.329 . . . . 0.0 109.19 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 t -73.77 178.74 4.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.991 -1.068 . . . . 0.0 110.801 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.01 53.67 2.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.1 m -165.73 -59.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.08 -26.85 66.93 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.669 ' HA ' HD12 ' A' ' 74' ' ' LEU . 22.1 ttp85 -62.58 -42.0 99.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -64.99 -29.15 70.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.3 mt -85.1 -28.41 25.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.376 -0.828 . . . . 0.0 109.234 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 71' ' ' ARG . 21.8 mt -69.05 -27.25 65.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 71' ' ' ARG . 0.8 OUTLIER -82.62 -31.26 28.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.116 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.693 ' HB3' HD11 ' A' ' 49' ' ' LEU . 6.6 tp-100 -76.24 -35.34 59.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.103 0.954 . . . . 0.0 109.452 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.93 -12.48 50.0 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.747 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 91.86 48.6 3.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.639 HG22 ' CB ' ' A' ' 53' ' ' VAL . 34.1 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.918 -1.342 . . . . 0.0 111.496 -179.719 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 2' ' ' VAL . 12.1 m . . . . . 0 N--CA 1.494 1.763 0 CA-C-O 121.371 0.605 . . . . 0.0 110.492 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -140.12 128.86 23.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.976 HD11 ' CB ' ' A' ' 59' ' ' TRP . 31.6 mt -100.81 133.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.909 -1.119 . . . . 0.0 109.564 179.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.0 ptt180 -151.55 -172.55 4.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.072 -1.018 . . . . 0.0 110.342 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 39' ' ' TYR . 6.0 mp -88.7 126.66 35.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.465 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -98.98 104.72 16.79 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 7.2 tmm_? . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 111.66 -179.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 7.0 m-85 . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.445 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -99.7 156.59 17.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.991 177.521 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.026 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -98.52 79.37 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 178.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.274 0.4 OUTLIER -97.98 156.66 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.228 -174.206 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.955 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -105.05 114.76 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.341 0.591 . . . . 0.0 111.066 -177.89 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.412 -0.805 . . . . 0.0 110.049 179.362 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB3' HG13 ' A' ' 20' ' ' VAL . 28.1 p90 . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 121.522 0.677 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.658 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -57.57 -61.07 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.11 155.68 42.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.815 . . . . 0.0 110.141 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.4 pttp -89.87 118.57 29.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 0.0 109.77 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.014 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.9 pt -107.9 -32.46 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.138 -0.976 . . . . 0.0 111.524 -179.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.825 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.74 167.32 19.21 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 118.813 -1.661 . . . . 0.0 111.388 -178.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 40' ' ' ASP . 12.5 t80 -138.57 139.41 38.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.026 ' HB2' HD11 ' A' ' 19' ' ' ILE . 40.3 t80 -136.67 124.02 21.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.71 -1.244 . . . . 0.0 109.699 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' HB2' ' CE1' ' A' ' 38' ' ' TYR . 54.9 t0 . . . . . 0 N--CA 1.496 1.849 0 O-C-N 120.753 -1.217 . . . . 0.0 110.762 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 77' ' ' ALA . 6.4 tt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.442 0.639 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.89 99.68 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.143 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.825 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -128.32 142.56 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.035 . . . . 0.0 111.763 -178.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t0 -88.23 69.97 9.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.071 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.3 OUTLIER -34.44 -31.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.808 -177.423 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.0 mt-10 -63.81 -56.18 17.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.82 -1.175 . . . . 0.0 108.953 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -72.26 -36.1 68.95 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.27 -0.894 . . . . 0.0 109.112 178.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.86 -20.19 66.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.3 ttt180 -86.95 -22.33 25.68 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.246 -0.909 . . . . 0.0 109.795 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -62.17 -46.62 88.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.276 1.513 . . . . 0.0 107.523 178.753 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.014 ' CD1' HG21 ' A' ' 36' ' ' ILE . 86.2 m95 -65.64 -58.35 5.94 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.863 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -53.78 -22.55 9.67 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.488 177.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 1.1 m -79.2 -20.49 48.21 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.475 -0.766 . . . . 0.0 110.014 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.4 m -98.81 32.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.967 -1.083 . . . . 0.0 109.061 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.31 23.79 71.83 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -61.33 136.77 58.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -1.194 . . . . 0.0 109.759 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.98 108.62 55.2 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 110.163 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 55.2 Cg_endo -83.62 123.69 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.51 1.268 . . . . 0.0 109.745 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -50.17 168.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.1 56.26 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.098 -1.001 . . . . 0.0 110.42 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -166.49 -60.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.779 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -64.23 -24.86 67.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 74' ' ' LEU . 9.3 ttt-85 -67.06 -44.42 80.17 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -69.25 -11.86 61.17 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.137 179.163 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 70' ' ' ALA . 11.6 mt -101.19 -27.32 13.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 79' ' ' VAL . 13.4 mt -72.8 -29.32 63.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG2' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.4 -30.93 48.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.942 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -78.2 -31.73 49.61 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.846 0.831 . . . . 0.0 109.344 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.653 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -66.58 -10.57 46.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.876 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.36 14.72 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.646 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.2 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.9 -1.353 . . . . 0.0 110.645 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 22.5 t . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.151 0.5 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -140.26 133.33 29.46 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.526 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.988 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.0 mt -99.81 137.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.067 -1.021 . . . . 0.0 109.251 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.506 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.5 ptm180 -150.82 178.4 9.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.014 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.79 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.4 pp -89.5 130.92 35.76 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.592 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -99.37 171.97 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.507 -0.746 . . . . 0.0 109.199 -179.164 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 17' ' ' TYR . 1.7 tmt_? . . . . . 0 N--CA 1.488 1.444 0 O-C-N 120.935 -1.103 . . . . 0.0 112.065 -179.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.61 ' CD2' HD13 ' A' ' 6' ' ' LEU 0.255 12.1 m-30 . . . . . 0 N--CA 1.484 1.255 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 43.2 mtt180 -134.83 153.07 52.19 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.279 177.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -96.83 82.65 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 178.174 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -97.95 158.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.162 -174.224 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.951 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.19 111.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.584 -0.698 . . . . 0.0 111.096 -177.524 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.7 t . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' HB3' HG13 ' A' ' 20' ' ' VAL . 26.9 p90 . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 121.607 0.718 . . . . 0.0 110.637 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.611 HG21 ' HH2' ' A' ' 59' ' ' TRP . 7.2 mt -72.38 -53.32 19.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.625 -0.672 . . . . 0.0 110.262 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -151.87 158.58 43.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 110.119 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.2 pttm -92.47 112.56 24.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.0 pt -104.75 -37.28 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.038 -1.039 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.849 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -116.24 166.34 12.33 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 119.02 -1.562 . . . . 0.0 112.232 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 73.3 t80 -140.95 117.19 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.88 ' HB2' HD11 ' A' ' 19' ' ' ILE . 14.3 t80 -109.12 147.14 32.92 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.58 -1.325 . . . . 0.0 110.472 -179.302 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 t70 . . . . . 0 N--CA 1.494 1.751 0 O-C-N 121.164 -0.96 . . . . 0.0 109.06 178.83 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 50' ' ' LYS . 1.5 tt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.587 0.708 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.747 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.26 86.91 2.37 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.649 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.849 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -115.11 136.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 111.206 -178.963 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -81.23 69.05 7.77 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.729 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -36.53 -29.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 122.226 -0.296 . . . . 0.0 111.268 -177.423 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 15.5 tt0 -61.2 -50.5 72.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.714 -1.241 . . . . 0.0 108.416 177.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 22.6 mmm180 -76.23 -37.17 58.05 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.297 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.889 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.83 -19.3 65.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.207 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.6 ttm-85 -89.56 -22.47 22.36 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.289 -0.882 . . . . 0.0 109.552 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.847 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -62.7 -48.33 79.72 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.251 1.5 . . . . 0.0 107.182 178.366 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.988 ' CB ' HD11 ' A' ' 4' ' ' ILE . 84.3 m95 -65.07 -56.31 13.75 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.793 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.59 HD12 HG11 ' A' ' 79' ' ' VAL . 20.5 mt -53.86 -22.07 9.05 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.141 -0.975 . . . . 0.0 108.434 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -82.55 -19.48 38.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.351 -0.843 . . . . 0.0 110.391 179.129 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -98.91 32.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 120.87 -1.144 . . . . 0.0 109.403 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.75 25.56 74.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.79 122.31 21.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.001 -1.293 . . . . 0.0 110.274 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.55 116.05 65.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.223 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.6 Cg_endo -80.01 153.88 22.34 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.425 1.224 . . . . 0.0 110.188 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.591 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -76.57 167.06 22.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.078 -1.014 . . . . 0.0 109.96 179.608 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -28.8 64.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -0.954 . . . . 0.0 110.953 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.0 m -96.25 -44.98 7.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.733 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.48 -28.46 69.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 67' ' ' THR . 1.7 ttm-85 -68.22 -40.35 82.13 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.64 -15.14 63.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.003 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.2 mt -99.31 -29.46 12.78 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.242 -0.911 . . . . 0.0 108.943 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.479 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 33.4 mt -72.82 -27.74 62.14 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -78.96 -29.61 44.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.268 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -79.2 -35.83 41.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.129 0.966 . . . . 0.0 109.24 179.201 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -57.51 -17.8 15.63 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.627 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.97 16.85 12.64 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 60' ' ' LEU . 21.7 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 120.911 -1.347 . . . . 0.0 110.495 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' HG12 ' A' ' 21' ' ' VAL . 97.4 t . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.176 0.512 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -140.62 128.51 21.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 0.0 111.072 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.906 HD11 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -100.04 131.55 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.198 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 9.5 ptm180 -151.78 -165.24 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 110.654 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 39' ' ' TYR . 79.4 mt -89.04 128.43 35.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.79 103.29 14.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.699 -0.626 . . . . 0.0 109.588 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.453 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 49.4 ttt-85 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 112.405 -178.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 7.3 m-85 . . . . . 0 C--O 1.216 -0.7 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 1.6 ttt180 -99.33 159.87 14.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.944 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.22 83.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.711 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -98.07 169.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.977 -173.908 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.893 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -114.82 114.13 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.271 0.558 . . . . 0.0 110.285 -177.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.025 179.811 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 20.6 p90 . . . . . 0 N--CA 1.497 1.875 0 CA-C-O 121.685 0.755 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.3 mt -89.0 -43.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.603 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.416 ' OE1' ' CD ' ' A' ' 55' ' ' ARG . 5.4 tt0 -160.98 169.33 22.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.956 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -103.7 111.76 24.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.949 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.2 pt -101.67 -34.69 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.313 -0.867 . . . . 0.0 110.974 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.796 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.97 165.83 20.02 Favored Glycine 0 C--N 1.294 -1.774 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.547 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 34.4 t80 -134.51 142.3 46.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.127 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.514 ' HD2' HD22 ' A' ' 6' ' ' LEU . 11.3 t80 -140.42 134.13 30.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.812 -1.18 . . . . 0.0 109.974 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.9 t0 . . . . . 0 N--CA 1.493 1.709 0 O-C-N 120.771 -1.206 . . . . 0.0 110.512 179.671 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 49' ' ' LEU . 9.2 tt . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.312 0.577 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 2.0 ttpm? -136.1 87.32 2.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 109.318 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.944 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -112.53 157.82 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.374 1.083 . . . . 0.0 111.567 -179.054 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -106.02 64.91 0.68 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.064 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.728 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.9 -33.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.771 -177.365 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.1 mt-10 -60.77 -52.49 64.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.837 -1.164 . . . . 0.0 108.923 178.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.48 -35.56 60.81 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 108.957 178.665 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.909 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.05 -21.45 66.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -86.59 -22.2 26.38 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.336 -0.852 . . . . 0.0 109.836 178.507 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.589 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -61.31 -48.6 80.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.223 1.487 . . . . 0.0 107.2 178.521 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.949 ' CD1' HG21 ' A' ' 36' ' ' ILE . 90.5 m95 -63.54 -53.47 51.31 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.527 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.594 HD11 HD13 ' A' ' 74' ' ' LEU . 5.8 mt -52.86 -23.59 7.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -22.78 45.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.694 -0.629 . . . . 0.0 110.25 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.8 m -98.81 32.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.841 -1.162 . . . . 0.0 109.666 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.11 73.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.37 135.11 53.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.076 -1.249 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.23 111.01 64.39 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.947 . . . . 0.0 110.5 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 52.5 Cg_endo -79.99 127.0 6.69 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.452 1.238 . . . . 0.0 109.894 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -58.6 -177.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.038 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -76.6 52.05 0.78 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.264 -0.898 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.78 -57.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.852 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.75 -23.46 66.74 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -68.73 -40.75 79.74 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -40.87 88.96 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.639 178.833 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.6 mt -65.52 -31.18 72.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 79' ' ' VAL . 13.8 mt -72.38 -25.38 61.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.5 -28.82 28.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.439 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.9 tp-100 -86.52 -37.28 18.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.674 0.75 . . . . 0.0 110.543 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -10.54 42.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.762 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.01 54.75 3.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.758 HG21 HD23 ' A' ' 74' ' ' LEU . 49.4 t . . . . . 0 N--CA 1.488 1.426 0 O-C-N 121.172 -1.193 . . . . 0.0 111.678 -179.3 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 58.2 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.148 0.499 . . . . 0.0 110.205 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -140.32 139.17 35.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.379 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.936 ' CG1' HG13 ' A' ' 21' ' ' VAL . 46.6 mt -100.04 139.06 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.007 -1.058 . . . . 0.0 109.427 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -150.85 -168.38 3.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.839 -1.163 . . . . 0.0 110.873 -179.101 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 70' ' ' ALA . 6.6 mp -89.15 129.21 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -101.31 102.86 13.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.235 -0.916 . . . . 0.0 110.704 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 111.575 -179.54 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 8.6 m-85 . . . . . 0 C--O 1.213 -0.846 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.503 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -99.98 163.55 12.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.083 -1.447 . . . . 0.0 108.085 177.229 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.936 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -98.4 81.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 103.047 -2.945 . . . . 0.0 103.047 177.359 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -97.71 165.61 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.787 0.803 . . . . 0.0 111.984 -173.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.936 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.07 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.251 0.548 . . . . 0.0 110.782 -177.462 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.246 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.7 p90 . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 121.483 0.658 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.472 HG21 ' HH2' ' A' ' 59' ' ' TRP . 22.3 mt -99.01 -27.25 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.925 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -174.54 165.16 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 109.864 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 6.1 pttt -102.94 111.89 24.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.948 HG21 ' CD1' ' A' ' 59' ' ' TRP . 36.7 pt -106.06 -30.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.976 -1.077 . . . . 0.0 110.883 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.83 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.9 167.38 19.36 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.07 -1.538 . . . . 0.0 112.304 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG12 ' A' ' 19' ' ' ILE . 5.7 t80 -141.24 124.72 16.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.021 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.936 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.7 t80 -124.97 131.6 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.671 -1.268 . . . . 0.0 109.533 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 45.7 t0 . . . . . 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 110.58 179.857 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 77' ' ' ALA . 5.8 tt . . . . . 0 N--CA 1.493 1.691 0 CA-C-O 121.329 0.585 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -126.9 92.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.06 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.83 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.51 137.41 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.118 -178.906 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.7 t0 -78.43 69.56 4.64 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -35.2 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.601 -177.773 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.3 mt-10 -65.08 -49.42 70.12 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.96 -1.088 . . . . 0.0 109.276 178.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.74 -32.73 52.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 178.75 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -70.04 -23.38 63.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -85.0 -21.52 29.44 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 178.093 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.659 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -60.77 -48.53 81.38 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.158 1.456 . . . . 0.0 107.147 178.464 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.948 ' CD1' HG21 ' A' ' 36' ' ' ILE . 87.3 m95 -62.88 -55.44 26.09 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.627 -179.481 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -54.24 -21.81 10.03 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.234 -0.986 . . . . 0.0 108.467 177.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.49 -20.47 43.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.81 . . . . 0.0 110.589 179.345 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.7 m -98.92 32.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 120.865 -1.147 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.36 74.43 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -77.89 141.18 39.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.122 -1.222 . . . . 0.0 110.035 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 123.79 29.1 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.6 Cg_endo -85.12 145.45 9.78 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.454 1.239 . . . . 0.0 109.938 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -64.65 -178.8 0.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.078 -1.014 . . . . 0.0 110.577 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.04 52.47 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.2 m -165.97 -61.39 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.887 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -64.73 -26.41 68.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 2.8 ttt180 -66.39 -44.75 82.19 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.482 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -67.34 -12.58 60.52 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.106 179.234 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.887 HD12 ' HA ' ' A' ' 70' ' ' ALA . 10.7 mt -99.89 -29.86 12.35 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 26.5 mt -71.62 -28.46 63.81 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.482 ' HG2' ' HA ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -79.28 -29.87 42.7 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HB3' HD13 ' A' ' 49' ' ' LEU . 2.4 tp-100 -78.36 -31.35 48.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.955 0.883 . . . . 0.0 109.363 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.64 -12.44 45.89 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.978 178.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.0 16.59 20.95 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 53' ' ' VAL . 17.1 t . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.362 . . . . 0.0 110.152 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.518 HG11 ' CE3' ' A' ' 59' ' ' TRP . 47.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.16 0.505 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 130.94 25.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 0.0 110.539 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.993 HD11 ' CB ' ' A' ' 59' ' ' TRP . 82.9 mt -102.47 135.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 121.126 -0.984 . . . . 0.0 109.783 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.49 177.87 9.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.941 179.94 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.3 pp -89.13 130.52 35.55 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.035 178.664 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.486 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -98.78 165.82 11.6 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.392 -0.817 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.487 1.392 0 O-C-N 120.967 -1.083 . . . . 0.0 111.673 -178.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 6' ' ' LEU . 17.6 m-30 . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.474 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -127.81 149.09 50.42 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.962 -1.086 . . . . 0.0 108.76 177.899 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.979 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -96.94 81.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 178.112 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.291 0.4 OUTLIER -98.3 161.66 2.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.783 -173.526 . . . . . . . . 4 4 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.925 HG13 HG12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.12 106.94 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.569 -178.102 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.415 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HB3' HG13 ' A' ' 20' ' ' VAL . 22.8 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.428 0.632 . . . . 0.0 110.339 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.3 mt -78.36 -37.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.412 -0.805 . . . . 0.0 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 168.07 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -103.7 113.47 27.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.87 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.98 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.3 pt -104.76 -34.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.797 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.9 166.92 15.21 Favored Glycine 0 C--N 1.295 -1.698 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.895 -178.006 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.433 ' N ' HG12 ' A' ' 19' ' ' ILE . 16.3 t80 -140.6 122.34 15.34 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.979 ' HB2' HD11 ' A' ' 19' ' ' ILE . 7.1 t80 -114.46 141.01 48.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.733 -1.229 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.408 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 1.9 t70 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.813 179.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 77' ' ' ALA . 3.8 tt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.438 0.637 . . . . 0.0 110.876 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -133.04 88.07 2.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 0.0 108.95 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.797 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -114.11 139.55 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.115 -0.991 . . . . 0.0 111.09 -179.067 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.3 t0 -84.65 70.2 10.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.681 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.63 -32.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 122.268 -0.27 . . . . 0.0 111.461 -177.467 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tm-20 -61.54 -54.64 40.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.863 -1.148 . . . . 0.0 108.728 178.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -69.33 -39.93 77.89 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.717 0.77 . . . . 0.0 109.065 178.685 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.804 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.57 -21.18 66.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.475 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -87.14 -20.5 26.95 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 178.642 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.1 t80 -61.37 -48.94 78.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.362 1.553 . . . . 0.0 107.142 178.365 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.993 ' CB ' HD11 ' A' ' 4' ' ' ILE . 81.9 m95 -63.18 -54.27 40.19 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.768 -178.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 66' ' ' PRO . 10.7 mt -53.86 -21.99 8.86 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.28 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -22.78 38.56 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.471 -0.768 . . . . 0.0 110.679 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 59' ' ' TRP . 5.2 m -99.24 31.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.832 -1.168 . . . . 0.0 109.908 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.82 26.22 71.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 142.81 56.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.873 -1.369 . . . . 0.0 110.324 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 105.99 57.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 60' ' ' LEU . 52.2 Cg_endo -83.2 124.99 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.582 1.306 . . . . 0.0 110.763 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.757 HG23 ' H ' ' A' ' 70' ' ' ALA . 6.3 t -58.73 156.3 11.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.067 -1.02 . . . . 0.0 109.06 179.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -48.66 47.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.054 -1.029 . . . . 0.0 111.556 -179.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -62.22 -56.42 18.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.1 -1.0 . . . . 0.0 111.825 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.953 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.45 -25.68 65.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 109.093 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 67' ' ' THR . 25.7 ttt180 -69.8 -38.39 76.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -61.53 -30.41 70.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.419 178.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.953 HD12 ' HA ' ' A' ' 70' ' ' ALA . 24.7 mt -78.31 -37.6 44.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 68.6 mt -62.42 -30.66 71.38 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -28.48 44.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.061 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.765 ' HB3' HD13 ' A' ' 49' ' ' LEU . 9.7 tp-100 -75.49 -35.76 60.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.069 0.938 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.82 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.2 -8.0 46.45 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.057 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.419 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.93 53.02 3.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.681 HG22 ' CB ' ' A' ' 53' ' ' VAL . 61.9 t . . . . . 0 N--CA 1.487 1.389 0 O-C-N 121.206 -1.173 . . . . 0.0 111.46 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.71 HG11 ' CE3' ' A' ' 59' ' ' TRP . 95.2 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 110.021 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.491 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 16.3 mtpt -140.02 139.25 35.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.867 ' CG1' HG13 ' A' ' 21' ' ' VAL . 41.4 mt -103.51 130.33 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.142 -0.974 . . . . 0.0 109.264 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.52 -165.28 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 110.331 -179.118 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.578 HD13 ' HD2' ' A' ' 17' ' ' TYR . 44.7 mt -89.09 133.81 34.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.99 -1.069 . . . . 0.0 110.695 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -104.95 105.84 16.06 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.518 -0.738 . . . . 0.0 110.996 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 15.6 ttp180 . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.894 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.578 ' HD2' HD13 ' A' ' 6' ' ' LEU . 5.2 m-30 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.612 ' HD2' HG23 ' A' ' 20' ' ' VAL . 1.1 ptp180 -105.59 165.73 10.95 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.325 176.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.855 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -98.11 85.32 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.219 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.261 0.3 OUTLIER -98.05 166.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.152 -175.031 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.877 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.42 107.41 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 110.159 -178.459 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.2 t . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.382 -179.851 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.644 ' CD2' HG21 ' A' ' 20' ' ' VAL . 15.8 p90 . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.482 0.658 . . . . 0.0 110.796 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.435 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.0 mp -98.11 -25.22 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.608 -0.683 . . . . 0.0 109.632 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.26 162.85 6.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 0.0 109.865 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 4.0 ptpt -105.07 115.55 30.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.114 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.786 HG21 ' CD1' ' A' ' 59' ' ' TRP . 42.3 pt -105.09 -31.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.793 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -136.29 177.88 19.24 Favored Glycine 0 C--N 1.295 -1.705 0 C-N-CA 118.215 -1.945 . . . . 0.0 112.583 -178.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 71.8 t80 -139.96 147.89 41.14 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 26.1 t80 -143.01 131.17 21.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.337 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 42.2 t0 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 120.652 -1.28 . . . . 0.0 110.505 179.695 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 49' ' ' LEU . 4.7 tt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.254 0.55 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -127.26 86.98 2.57 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 108.971 178.828 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.855 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -116.48 149.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.472 1.13 . . . . 0.0 112.294 -178.528 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.9 t70 -99.16 64.91 1.4 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.97 -32.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.539 -177.289 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.07 -53.24 59.55 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.816 -1.177 . . . . 0.0 108.756 178.231 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -76.37 -34.03 58.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.434 -0.791 . . . . 0.0 108.869 178.636 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -67.52 -21.22 65.49 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.068 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 50.1 ttp85 -87.98 -21.21 24.97 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.231 -0.918 . . . . 0.0 109.721 178.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -60.75 -49.51 77.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.877 ' CD2' HG11 ' A' ' 21' ' ' VAL . 88.6 m95 -61.72 -53.18 59.57 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.315 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.778 HD12 HG11 ' A' ' 79' ' ' VAL . 25.2 mt -53.94 -22.26 9.82 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.762 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.5 -22.89 40.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.561 -0.712 . . . . 0.0 110.973 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.5 m -98.99 32.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.758 -1.214 . . . . 0.0 109.606 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.81 71.53 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -69.37 128.47 36.69 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.269 . . . . 0.0 110.015 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.491 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -97.17 109.52 49.92 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.174 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.585 ' HB3' HD12 ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.41 136.91 10.15 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.519 1.273 . . . . 0.0 110.29 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -62.02 179.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.968 . . . . 0.0 109.525 179.476 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 19.4 p-10 -69.98 -18.98 63.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.075 -1.015 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -50.37 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.256 -0.902 . . . . 0.0 110.503 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -69.01 -25.06 64.31 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.351 -0.843 . . . . 0.0 108.913 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 67' ' ' THR . 7.9 ttt-85 -68.53 -38.31 80.75 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.05 -39.36 90.08 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.511 -0.875 . . . . 0.0 108.76 178.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.7 mt -73.93 -26.26 60.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.575 -0.703 . . . . 0.0 109.261 179.22 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 60' ' ' LEU . 16.4 mt -72.74 -25.94 61.39 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -32.0 31.19 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.181 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' A' ' 49' ' ' LEU . 7.9 tp-100 -80.1 -37.21 34.17 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.998 0.904 . . . . 0.0 109.964 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -62.47 -12.48 22.31 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.887 178.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.78 38.18 8.91 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.778 HG11 HD12 ' A' ' 60' ' ' LEU . 39.4 t . . . . . 0 N--CA 1.488 1.461 0 O-C-N 121.196 -1.179 . . . . 0.0 111.351 -179.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.188 0.518 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.451 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 14.6 mtpt -140.73 143.02 34.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.637 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.91 HD11 ' CB ' ' A' ' 59' ' ' TRP . 46.7 mt -101.27 135.42 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.104 -0.997 . . . . 0.0 108.941 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -177.76 6.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.107 . . . . 0.0 110.956 -179.04 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.764 HD12 ' HB2' ' A' ' 70' ' ' ALA . 3.6 mp -88.96 125.12 34.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.819 . . . . 0.0 109.887 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.14 111.62 23.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.461 -0.775 . . . . 0.0 110.901 -179.034 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.963 . . . . 0.0 111.628 -179.382 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 m-30 . . . . . 0 N--CA 1.476 0.853 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.466 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.5 OUTLIER -104.65 152.99 21.81 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.551 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.072 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.3 mm -98.42 80.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 178.299 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.449 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.28 0.4 OUTLIER -97.36 164.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.937 -173.759 . . . . . . . . 4 4 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.941 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -109.94 113.6 44.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.599 -0.688 . . . . 0.0 110.594 -176.92 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.2 t . . . . . 0 N--CA 1.495 1.778 0 O-C-N 121.287 -0.883 . . . . 0.0 110.413 179.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 8.5 p90 . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 121.485 0.66 . . . . 0.0 110.681 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.728 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -72.97 -59.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.504 -0.748 . . . . 0.0 109.604 179.519 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.725 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -144.98 149.78 35.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 179.869 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HG2' ' NE ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -89.82 126.6 35.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.962 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.003 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.86 -24.78 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.448 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.911 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -128.37 161.44 22.14 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.662 -1.732 . . . . 0.0 110.649 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.498 ' N ' HG12 ' A' ' 19' ' ' ILE . 88.0 t80 -138.41 144.6 40.27 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.894 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.072 ' HB2' HD11 ' A' ' 19' ' ' ILE . 16.0 t80 -137.47 133.26 34.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.45 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.1 t0 . . . . . 0 N--CA 1.494 1.769 0 O-C-N 120.809 -1.182 . . . . 0.0 110.514 179.843 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.449 HD12 HD22 ' A' ' 73' ' ' LEU . 3.3 tt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 121.319 0.58 . . . . 0.0 110.264 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 88.91 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.828 . . . . 0.0 109.095 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.911 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -118.16 129.78 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.051 -1.031 . . . . 0.0 111.369 -178.833 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t70 -75.09 72.15 2.19 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.618 HG23 HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -33.7 -32.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.549 -177.509 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 16.5 tt0 -61.56 -53.15 60.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.855 -1.153 . . . . 0.0 108.857 178.045 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.753 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.89 -37.47 73.0 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.276 178.933 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.969 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -68.82 -20.77 64.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.319 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 29.2 ttt-85 -85.11 -25.16 27.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.672 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 11.1 t80 -60.2 -43.96 95.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 123.211 1.482 . . . . 0.0 107.564 178.307 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.003 ' CD1' HG21 ' A' ' 36' ' ' ILE . 68.9 m95 -68.72 -57.01 6.26 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.934 -179.07 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.969 HD12 ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -55.11 -21.01 11.38 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.333 -0.947 . . . . 0.0 108.873 177.497 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.2 t -81.43 -23.44 37.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.279 -0.888 . . . . 0.0 110.76 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 59' ' ' TRP . 36.0 m -99.09 32.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 120.944 -1.098 . . . . 0.0 109.404 179.571 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.04 30.54 74.08 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -76.32 120.77 22.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.967 -1.314 . . . . 0.0 109.769 179.736 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -92.07 115.83 65.37 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.458 -179.69 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HB3' HD12 ' A' ' 74' ' ' LEU . 52.5 Cg_endo -82.87 133.25 6.7 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.435 1.229 . . . . 0.0 109.687 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 70' ' ' ALA . 9.4 t -53.0 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.008 -1.058 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.96 52.65 1.28 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.3 -0.875 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -167.26 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.825 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.92 -22.96 66.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 5.4 ttt180 -66.99 -42.67 84.63 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.407 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -30.65 71.47 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.825 HD12 ' HA ' ' A' ' 70' ' ' ALA . 23.6 mt -77.59 -31.53 53.09 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.797 HD13 HD11 ' A' ' 60' ' ' LEU . 47.4 mt -67.42 -30.12 69.79 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.575 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -30.56 42.24 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.431 ' HB3' HD13 ' A' ' 49' ' ' LEU . 7.4 tp-100 -77.46 -33.21 54.76 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.996 0.903 . . . . 0.0 109.56 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.461 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.53 -12.8 35.23 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.06 178.608 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.38 27.92 10.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 HG23 ' A' ' 53' ' ' VAL . 30.5 t . . . . . 0 N--CA 1.488 1.441 0 O-C-N 121.11 -1.23 . . . . 0.0 110.495 -179.771 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 70.9 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.147 0.498 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -140.82 137.12 33.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.027 -1.046 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.927 ' CG1' HG13 ' A' ' 21' ' ' VAL . 41.4 mt -100.68 134.04 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.125 -0.984 . . . . 0.0 108.494 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 53.9 ptt85 -150.8 -172.44 4.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.835 -1.165 . . . . 0.0 111.159 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.8 mp -88.58 127.43 35.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.239 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -101.22 108.98 20.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.466 -0.771 . . . . 0.0 111.455 -178.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.8 ttt-85 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 111.2 179.832 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 5.7 m-30 . . . . . 0 C--O 1.212 -0.88 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HD3' HG23 ' A' ' 20' ' ' VAL . 3.2 ptm180 -104.0 161.74 13.73 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.522 -1.671 . . . . 0.0 107.755 177.142 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.829 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.09 85.37 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 179.397 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.27 0.3 OUTLIER -97.62 170.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.105 -174.324 . . . . . . . . 4 4 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.927 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.69 103.43 15.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.84 . . . . 0.0 110.658 -177.292 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.715 179.424 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.457 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 14.7 p90 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 121.356 0.598 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.489 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.5 mt -80.25 -29.04 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.528 -0.733 . . . . 0.0 109.7 179.727 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.6 tm-20 -174.37 169.75 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.441 -0.787 . . . . 0.0 109.918 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -110.14 121.99 46.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.782 179.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.057 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -119.35 -30.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.145 -0.972 . . . . 0.0 111.179 -179.533 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.913 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.69 164.28 14.88 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.078 -179.838 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 75.2 t80 -137.64 140.43 40.87 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.493 ' CD2' HD23 ' A' ' 6' ' ' LEU . 54.7 t80 -139.42 113.17 8.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.569 -1.332 . . . . 0.0 109.957 -179.023 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.5 t0 . . . . . 0 N--CA 1.498 1.94 0 O-C-N 120.613 -1.304 . . . . 0.0 110.709 -179.729 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 50' ' ' LYS . 3.7 tt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.6 0.714 . . . . 0.0 111.027 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.723 ' N ' HD23 ' A' ' 49' ' ' LEU . 11.2 mtpt -140.45 94.5 2.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.222 178.833 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.913 HG22 ' CA ' ' A' ' 37' ' ' GLY . 2.2 t -129.94 134.9 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 112.069 -179.025 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 t0 -82.96 71.01 10.08 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.43 -31.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.04 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 31.8 mt-10 -60.87 -49.57 76.94 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.956 178.224 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.567 ' HB3' HG22 ' A' ' 36' ' ' ILE . 26.6 mmm180 -75.01 -39.73 61.02 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.248 -0.908 . . . . 0.0 109.084 178.51 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.967 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -64.1 -22.87 67.11 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.356 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 7.5 ttt180 -86.35 -23.57 26.15 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.41 -0.806 . . . . 0.0 109.62 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.52 -49.01 75.2 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 123.205 1.478 . . . . 0.0 107.484 178.477 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.057 ' CD1' HG21 ' A' ' 36' ' ' ILE . 71.8 m95 -61.76 -52.57 63.68 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.275 -179.321 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.43 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.4 mt -57.01 -21.2 28.91 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.899 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -76.46 -26.17 55.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.333 -0.854 . . . . 0.0 110.311 179.502 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 59' ' ' TRP . 34.4 m -99.08 32.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.048 -1.032 . . . . 0.0 109.581 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.4 76.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -64.69 96.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.353 . . . . 0.0 109.689 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.03 114.7 29.39 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.4 Cg_endo -85.67 130.44 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.528 1.278 . . . . 0.0 109.641 179.391 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -53.18 178.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.085 -1.009 . . . . 0.0 110.651 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.22 54.28 1.94 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.32 -0.862 . . . . 0.0 110.073 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -164.72 -60.29 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 6' ' ' LEU . . . -67.58 -26.34 66.24 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 33.6 ttp180 -65.41 -43.15 91.49 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.098 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.03 -42.66 99.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.862 178.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 70' ' ' ALA . 27.6 mt -70.08 -28.87 65.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.509 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 28.7 mt -69.26 -29.14 66.98 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.841 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.53 -34.23 35.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.157 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -78.06 -26.02 48.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.866 0.841 . . . . 0.0 109.659 179.165 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -68.79 -9.82 53.19 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.211 0.529 . . . . 0.0 110.078 179.01 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.26 21.0 23.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 53' ' ' VAL . 14.0 t . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.284 . . . . 0.0 110.538 179.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.507 HG11 HG23 ' A' ' 62' ' ' VAL . 59.6 t . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.295 0.569 . . . . 0.0 110.211 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 6.5 mttt -140.64 124.67 17.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.701 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.884 HD11 ' CB ' ' A' ' 59' ' ' TRP . 49.7 mt -99.88 129.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 120.991 -1.068 . . . . 0.0 109.211 178.843 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -151.07 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.928 . . . . 0.0 110.64 -179.187 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.461 HD22 ' HD2' ' A' ' 39' ' ' TYR . 55.4 mt -88.59 127.96 35.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.706 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.88 100.52 11.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.54 -0.725 . . . . 0.0 110.382 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 41.1 ttt180 . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 111.299 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 7.6 m-85 . . . . . 0 C--O 1.213 -0.864 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.603 ' HD2' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -99.81 160.29 14.41 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.231 -1.788 . . . . 0.0 106.751 176.535 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.915 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -97.62 85.44 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 103.487 -2.782 . . . . 0.0 103.487 179.125 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.271 0.3 OUTLIER -97.44 169.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.945 -174.159 . . . . . . . . 4 4 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.881 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.91 110.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.434 -0.792 . . . . 0.0 110.634 -177.405 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.0 t . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 -179.961 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 21.4 p90 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.758 0.79 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.519 HG21 ' HH2' ' A' ' 59' ' ' TRP . 6.2 mt -81.66 -32.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.407 0.623 . . . . 0.0 109.78 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.79 176.75 3.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -113.32 123.86 51.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.983 . . . . 0.0 110.354 -179.822 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.058 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.8 -26.9 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.862 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.85 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.85 166.05 18.76 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 118.765 -1.684 . . . . 0.0 111.325 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 40.5 t80 -138.33 140.76 39.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.103 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HD2' HD22 ' A' ' 6' ' ' LEU . 15.1 t80 -138.17 127.84 25.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.909 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.1 t0 . . . . . 0 N--CA 1.495 1.797 0 O-C-N 120.619 -1.3 . . . . 0.0 110.499 -179.862 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 76' ' ' GLN . 5.7 tt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.221 0.534 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.7 ttpt -136.97 95.84 3.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 179.721 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.915 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.2 t -127.75 128.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.975 -179.48 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.6 t0 -79.1 70.36 5.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.645 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -31.53 -34.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.158 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 mm-40 -60.63 -51.15 70.62 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.809 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.693 ' HB3' HG22 ' A' ' 36' ' ' ILE . 2.6 mmm180 -71.85 -41.85 67.61 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.386 -0.821 . . . . 0.0 108.836 178.398 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.971 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.94 -16.95 62.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.017 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -88.53 -29.03 20.39 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 178.394 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP 0.251 1.7 t80 -57.66 -43.47 84.99 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.331 1.539 . . . . 0.0 107.338 178.399 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.058 ' CD1' HG21 ' A' ' 36' ' ' ILE . 69.7 m95 -69.03 -52.99 22.93 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.282 -179.285 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.555 HD12 HG11 ' A' ' 79' ' ' VAL . 11.2 mt -57.65 -20.37 33.02 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.83 177.148 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.4 t -83.22 -22.77 33.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 59' ' ' TRP . 35.4 m -99.07 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.979 -1.075 . . . . 0.0 109.5 179.602 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.9 72.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -67.76 128.37 36.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.383 . . . . 0.0 109.838 179.621 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.437 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 2.4 mm-40 -92.75 109.99 42.53 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.9 Cg_endo -81.17 150.86 17.85 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.468 1.246 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -81.82 170.01 16.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.684 179.564 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -17.88 30.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -99.54 -47.97 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.14 -0.975 . . . . 0.0 110.322 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.94 -25.75 64.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.871 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -38.32 83.38 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.186 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -39.82 94.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.958 178.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -70.43 -29.5 66.1 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 179.554 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 60' ' ' LEU . 32.1 mt -72.25 -25.91 61.8 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.638 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.79 -27.0 27.16 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.385 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.568 ' HB3' HD11 ' A' ' 49' ' ' LEU . 5.9 tp-100 -85.21 -36.83 20.73 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.736 0.779 . . . . 0.0 110.212 -179.775 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.13 -10.61 32.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 178.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.44 44.83 6.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 60' ' ' LEU . 25.5 t . . . . . 0 N--CA 1.489 1.489 0 O-C-N 121.113 -1.228 . . . . 0.0 111.179 -179.51 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.561 HG11 ' CE3' ' A' ' 59' ' ' TRP . 38.5 t . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.208 0.528 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.416 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.32 136.45 33.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 110.304 -179.923 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.997 ' CG1' HG13 ' A' ' 21' ' ' VAL . 60.8 mt -99.94 138.48 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.293 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.6 ptt180 -150.6 -170.88 3.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.992 -1.068 . . . . 0.0 110.745 -179.175 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.5 mp -89.41 128.78 35.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.341 -0.85 . . . . 0.0 110.991 -179.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.458 ' O ' ' CB ' ' A' ' 17' ' ' TYR . . . -99.71 157.26 16.6 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.657 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 3.9 ttp85 . . . . . 0 N--CA 1.488 1.461 0 O-C-N 120.869 -1.145 . . . . 0.0 111.752 -178.744 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 7' ' ' ALA 0.258 17.8 m-30 . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 121.331 0.586 . . . . 0.0 109.678 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 31.0 mtt180 -137.1 156.84 47.87 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.069 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.01 83.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 102.896 -3.002 . . . . 0.0 102.896 177.736 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.266 0.4 OUTLIER -97.8 165.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.582 -173.76 . . . . . . . . 4 4 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.997 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.13 104.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 110.716 -177.33 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t . . . . . 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 179.139 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.3 p90 . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.576 0.703 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.576 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.0 mt -75.92 -39.3 37.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.649 -0.657 . . . . 0.0 110.339 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.65 170.28 21.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 110.353 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -107.29 112.69 25.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 110.024 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.95 HG21 ' CD1' ' A' ' 59' ' ' TRP . 22.6 pt -107.27 -36.35 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 111.338 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.847 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.72 168.2 13.57 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.087 -1.53 . . . . 0.0 112.245 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 49.8 t80 -141.36 125.5 17.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.351 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' ILE . 9.9 t80 -115.72 146.89 41.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.596 -1.315 . . . . 0.0 109.533 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 33.6 t70 . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.977 -1.077 . . . . 0.0 109.715 179.077 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 49' ' ' LEU . 14.6 tp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.532 0.682 . . . . 0.0 110.987 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -133.15 102.51 5.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.765 . . . . 0.0 109.256 179.409 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.847 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.47 140.14 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.898 -1.126 . . . . 0.0 111.044 -179.234 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -82.33 69.23 9.03 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.948 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.892 HG23 HG22 ' A' ' 79' ' ' VAL . 1.4 p -34.25 -31.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.858 -177.773 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.1 tp10 -62.95 -53.06 59.86 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.854 -1.154 . . . . 0.0 109.01 178.315 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 2.7 mtm-85 -73.27 -37.36 66.31 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.416 -0.803 . . . . 0.0 108.981 178.734 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.925 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.99 -18.98 65.75 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.754 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -88.95 -23.31 22.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.347 -0.846 . . . . 0.0 109.736 178.446 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.904 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -60.15 -45.83 91.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 123.247 1.499 . . . . 0.0 107.094 178.439 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.95 ' CD1' HG21 ' A' ' 36' ' ' ILE . 85.0 m95 -66.98 -58.48 4.87 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.791 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.766 HD11 HD13 ' A' ' 74' ' ' LEU . 4.1 mt -52.89 -23.19 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.622 177.46 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t -81.13 -20.03 42.24 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.58 -0.7 . . . . 0.0 110.49 179.405 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.9 m -98.74 31.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.767 -1.208 . . . . 0.0 109.382 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.05 75.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.01 143.55 49.13 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.105 -1.232 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.416 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 18.0 mt-30 -117.34 118.19 35.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.552 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.2 Cg_endo -81.29 146.73 15.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.499 1.263 . . . . 0.0 109.881 179.603 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -70.27 -171.7 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.053 . . . . 0.0 109.94 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 50.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.146 -0.971 . . . . 0.0 110.101 179.553 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 28.4 m -165.3 -60.22 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.676 ' HB1' HG22 ' A' ' 19' ' ' ILE . . . -65.44 -23.83 67.03 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.113 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.45 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 6.8 ttt-85 -68.76 -46.22 69.37 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.465 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -71.71 -8.02 51.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.417 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 69' ' ' THR . 25.8 mt -102.7 -26.2 13.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 108.604 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.766 HD13 HD11 ' A' ' 60' ' ' LEU . 41.7 mt -72.01 -30.02 64.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.455 ' HG3' ' O ' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -77.15 -28.57 54.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.966 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -76.93 -33.23 57.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.108 0.956 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -67.4 -9.38 40.99 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.912 178.885 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.69 17.78 32.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.892 HG22 HG23 ' A' ' 53' ' ' VAL . 22.8 t . . . . . 0 N--CA 1.49 1.532 0 O-C-N 120.897 -1.355 . . . . 0.0 110.107 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.13 0.49 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.76 137.23 33.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.462 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.984 HD11 ' CB ' ' A' ' 59' ' ' TRP . 57.0 mt -99.56 140.16 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.098 -1.001 . . . . 0.0 109.081 179.07 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.491 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 2.2 ptt180 -150.64 171.22 17.48 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.965 -1.084 . . . . 0.0 110.266 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.9 pp -89.62 128.35 36.04 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.568 179.484 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.515 ' O ' ' CD2' ' A' ' 17' ' ' TYR . . . -99.02 175.99 5.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.728 . . . . 0.0 109.07 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 4.5 ttt-85 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.927 -1.108 . . . . 0.0 111.357 -179.368 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 7' ' ' ALA 0.267 9.2 m-85 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -136.71 147.08 46.56 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.825 -1.172 . . . . 0.0 109.257 177.592 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -96.2 82.56 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 177.259 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.284 0.4 OUTLIER -97.8 161.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.204 -173.389 . . . . . . . . 4 4 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.938 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -108.46 111.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.61 -0.682 . . . . 0.0 110.599 -177.43 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.4 t . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.94 179.639 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB3' HG13 ' A' ' 20' ' ' VAL . 12.6 p90 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.462 0.649 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.557 HG21 ' HH2' ' A' ' 59' ' ' TRP . 15.2 mt -50.24 -31.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -176.81 171.31 2.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.12 119.48 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.013 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -113.1 -30.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.424 -0.798 . . . . 0.0 110.286 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.925 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -116.28 163.01 12.45 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.267 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 40' ' ' ASP . 85.3 t80 -140.81 117.16 10.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.838 ' HB2' HD11 ' A' ' 19' ' ' ILE . 1.7 t80 -107.44 122.57 46.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.797 -1.189 . . . . 0.0 109.537 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 21.8 t0 . . . . . 0 N--CA 1.494 1.763 0 O-C-N 120.724 -1.235 . . . . 0.0 110.163 179.907 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 50' ' ' LYS . 1.3 tm? . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.618 0.723 . . . . 0.0 110.702 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.5 ttpt -125.87 94.55 4.14 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.925 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.2 t -116.38 132.52 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.034 -1.041 . . . . 0.0 111.202 -178.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -74.2 70.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.678 HG23 HG22 ' A' ' 79' ' ' VAL . 1.1 p -35.61 -30.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 122.269 -0.269 . . . . 0.0 111.654 -177.377 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -60.63 -54.14 48.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.776 -1.202 . . . . 0.0 108.435 177.949 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.654 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.5 mmp_? -69.65 -41.77 75.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.333 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.943 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.92 -17.29 63.08 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.341 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 15.1 tpt180 -88.35 -26.01 22.43 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 109.423 178.594 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.817 ' O ' HG13 ' A' ' 62' ' ' VAL . 3.0 t80 -59.49 -43.31 93.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.378 1.561 . . . . 0.0 107.302 178.241 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.013 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.8 m95 -69.23 -57.18 5.69 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.987 -178.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.749 HD11 HD13 ' A' ' 74' ' ' LEU . 33.1 mt -54.71 -22.08 12.82 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.076 -1.015 . . . . 0.0 108.532 177.338 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -80.93 -22.61 39.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 110.763 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.817 HG13 ' O ' ' A' ' 58' ' ' TYR . 6.0 m -98.88 32.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.828 -1.17 . . . . 0.0 109.585 179.871 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.6 26.49 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -75.11 124.44 27.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.98 -1.306 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 65' ' ' GLN . 7.0 pt20 -98.84 121.01 57.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.785 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.652 ' HB3' HD12 ' A' ' 74' ' ' LEU . 50.8 Cg_endo -80.8 168.05 17.94 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.401 1.211 . . . . 0.0 110.561 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.665 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -88.8 167.92 12.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.76 179.504 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.78 -29.53 40.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 111.28 -179.247 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.468 ' HB ' ' CD2' ' A' ' 6' ' ' LEU . 24.2 m -97.51 -44.74 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.009 . . . . 0.0 110.855 -179.332 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -69.97 -24.61 63.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.405 -0.809 . . . . 0.0 109.038 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.458 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 25.1 ttt-85 -70.24 -36.54 74.57 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.577 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -30.59 71.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.002 179.133 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 70' ' ' ALA . 75.1 mt -75.45 -32.04 60.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.565 179.454 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 60' ' ' LEU . 24.6 mt -66.56 -30.0 70.2 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -79.81 -30.67 40.58 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.176 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -27.91 51.26 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.895 0.855 . . . . 0.0 109.703 179.191 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -73.16 -6.34 45.13 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.068 178.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 20.35 40.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 180.0 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.718 HG11 ' CD1' ' A' ' 60' ' ' LEU . 21.6 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 120.933 -1.333 . . . . 0.0 110.289 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 99.1 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.311 0.577 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -140.19 138.12 34.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.068 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.979 HD11 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -104.58 133.47 48.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.112 -0.992 . . . . 0.0 109.92 -179.996 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -150.77 -170.65 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 -179.238 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.825 HD21 ' CD1' ' A' ' 73' ' ' LEU . 16.8 mt -88.6 126.64 35.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.069 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.462 ' N ' ' HB3' ' A' ' 17' ' ' TYR . . . -99.91 103.09 14.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.93 -179.748 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.1 ttt180 . . . . . 0 N--CA 1.487 1.418 0 O-C-N 121.405 -0.809 . . . . 0.0 110.586 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 1.9 m-85 . . . . . 0 C--O 1.213 -0.844 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.483 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -107.98 160.51 15.72 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.002 176.971 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.039 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -97.91 79.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 102.604 -3.11 . . . . 0.0 102.604 177.503 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.3 OUTLIER -97.44 163.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.299 -173.843 . . . . . . . . 4 4 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.939 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -110.46 114.04 45.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.359 0.599 . . . . 0.0 110.84 -176.921 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.3 t . . . . . 0 N--CA 1.494 1.768 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 179.602 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 2.1 p90 . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 121.572 0.701 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.2 mt -77.74 -30.26 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.408 -0.807 . . . . 0.0 109.787 179.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.32 177.24 3.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 110.108 179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -115.84 123.12 47.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 110.273 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.031 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.49 -27.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.0 110.98 179.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.866 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.87 165.85 20.74 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.925 -1.607 . . . . 0.0 112.305 -178.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' N ' HG12 ' A' ' 19' ' ' ILE . 25.3 t80 -140.71 138.28 34.11 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.039 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 t80 -133.32 135.18 44.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.547 -1.345 . . . . 0.0 110.304 179.75 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.7 t0 . . . . . 0 N--CA 1.494 1.726 0 O-C-N 120.974 -1.079 . . . . 0.0 110.337 179.269 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.807 HD13 ' HB3' ' A' ' 76' ' ' GLN . 3.0 tt . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.641 0.734 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 2.8 ttpt -137.43 85.67 2.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.485 -0.759 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.866 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -117.5 134.72 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 111.227 -178.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -80.81 71.32 7.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.376 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.6 -35.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.505 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.6 mm-40 -59.73 -53.88 52.85 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.621 -1.299 . . . . 0.0 108.967 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.726 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.5 mmp_? -69.45 -41.42 76.28 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.785 . . . . 0.0 109.212 178.737 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.936 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -65.39 -20.69 66.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.044 -1.035 . . . . 0.0 108.406 178.936 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -87.74 -23.48 24.11 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 178.703 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.7 t80 -60.0 -45.13 93.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 123.253 1.502 . . . . 0.0 107.085 178.148 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.031 ' CD1' HG21 ' A' ' 36' ' ' ILE . 78.4 m95 -65.23 -53.76 39.62 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.441 -179.103 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 74' ' ' LEU . 11.4 mt -56.76 -20.93 24.78 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.566 176.844 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.62 -23.73 39.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 59' ' ' TRP . 34.1 m -99.27 33.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.882 -1.136 . . . . 0.0 109.565 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.32 30.62 73.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.03 -1.277 . . . . 0.0 110.079 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.46 106.35 58.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -78.66 129.76 9.38 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.487 1.256 . . . . 0.0 110.238 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.15 174.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 109.9 179.646 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.59 -15.63 63.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.546 ' CG2' HD11 ' A' ' 6' ' ' LEU . 81.1 m -106.12 -45.36 4.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.907 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -63.14 -24.76 68.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -70.0 -40.34 75.32 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -40.81 94.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.931 178.697 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.8 mt -65.99 -33.03 74.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.742 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 60' ' ' LEU . 31.9 mt -68.49 -26.68 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.336 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.33 -28.73 47.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.807 ' HB3' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -80.74 -37.41 30.52 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.955 0.883 . . . . 0.0 109.897 179.938 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -68.64 -7.84 36.7 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.071 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 47.68 9.09 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 53' ' ' VAL . 75.4 t . . . . . 0 N--CA 1.487 1.381 0 O-C-N 121.305 -1.115 . . . . 0.0 111.698 -179.092 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.481 HG11 ' CE3' ' A' ' 59' ' ' TRP . 33.6 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.221 0.534 . . . . 0.0 109.922 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 65' ' ' GLN . 10.8 mttt -140.75 137.85 33.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.99 -1.069 . . . . 0.0 110.758 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.918 HD11 ' CB ' ' A' ' 59' ' ' TRP . 44.5 mt -103.41 132.7 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.126 -0.984 . . . . 0.0 108.964 178.754 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 10.4 ptt180 -150.85 -169.89 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.102 -0.999 . . . . 0.0 110.391 -179.285 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.584 HD22 ' HD2' ' A' ' 39' ' ' TYR . 52.0 mt -89.7 130.39 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -0.978 . . . . 0.0 111.452 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 104.99 16.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.705 -0.622 . . . . 0.0 110.23 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.012 -1.055 . . . . 0.0 111.253 -179.618 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.9 m-30 . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 9.5 mtt180 -99.19 160.03 14.56 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.131 176.017 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.912 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -99.21 81.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 176.969 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.257 0.3 OUTLIER -97.26 165.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.397 -173.511 . . . . . . . . 4 4 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.928 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -110.02 119.9 60.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.735 -0.603 . . . . 0.0 110.724 -176.941 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.738 0 O-C-N 121.035 -1.041 . . . . 0.0 110.25 179.112 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 4.4 p90 . . . . . 0 N--CA 1.497 1.878 0 CA-C-O 121.563 0.697 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.841 HG21 ' HH2' ' A' ' 59' ' ' TRP . 19.7 mm -83.99 -61.66 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.415 -0.803 . . . . 0.0 109.266 179.771 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -151.16 160.48 43.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.751 -0.593 . . . . 0.0 109.593 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -89.83 110.72 21.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.985 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.041 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.7 pp -104.75 -32.41 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.082 -1.011 . . . . 0.0 111.104 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.923 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.04 162.54 15.78 Favored Glycine 0 C--N 1.295 -1.745 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.956 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.449 ' N ' HG13 ' A' ' 19' ' ' ILE . 45.9 t80 -134.35 141.49 46.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.217 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.584 ' HD2' HD22 ' A' ' 6' ' ' LEU . 4.6 t80 -142.27 130.9 22.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.087 -1.445 . . . . 0.0 111.365 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 46.3 t0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.25 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.63 HD21 ' HB3' ' A' ' 73' ' ' LEU . 12.0 tp . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.519 0.676 . . . . 0.0 111.34 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -133.41 94.96 3.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.923 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.6 t -118.41 139.45 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 111.34 -179.037 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -85.01 72.99 10.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 175.776 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.699 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.53 -30.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.06 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -62.46 -48.4 79.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.589 -1.319 . . . . 0.0 108.771 178.257 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.712 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.1 mmp_? -76.22 -36.55 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 178.673 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.868 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -69.54 -20.39 63.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.598 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttp180 -86.78 -23.19 25.5 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.296 -0.877 . . . . 0.0 109.112 178.52 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.632 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.7 t80 -61.93 -45.37 94.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 123.099 1.428 . . . . 0.0 107.502 178.427 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.041 ' CD1' HG21 ' A' ' 36' ' ' ILE . 67.8 m95 -68.07 -57.44 6.1 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.943 -179.166 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.728 HD21 ' HG3' ' A' ' 66' ' ' PRO . 10.9 mt -56.05 -20.82 18.45 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.329 -0.949 . . . . 0.0 108.707 177.335 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 t -79.98 -23.18 41.77 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.363 -0.836 . . . . 0.0 110.623 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 59' ' ' TRP . 18.8 m -98.89 31.93 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.964 -1.085 . . . . 0.0 109.627 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.77 75.17 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -66.56 134.88 53.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.951 -1.323 . . . . 0.0 110.164 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.436 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 2.9 mt-30 -99.88 107.83 48.49 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.728 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.7 Cg_endo -82.4 134.55 7.81 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.46 1.242 . . . . 0.0 110.229 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.49 163.19 0.93 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 110.032 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.07 -16.91 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.245 -0.909 . . . . 0.0 110.717 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.7 m -99.61 -47.8 4.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 110.53 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.55 -28.8 66.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -66.27 -38.6 88.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.318 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -26.74 68.3 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.287 178.939 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.1 mt -88.11 -29.03 20.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.641 HD12 ' HB3' ' A' ' 66' ' ' PRO . 34.0 mt -68.74 -28.24 66.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.733 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.52 -28.86 30.8 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.558 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -72.96 -33.76 66.07 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.142 0.972 . . . . 0.0 108.918 179.218 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.34 -9.59 54.03 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 178.523 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.409 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 84.91 52.9 3.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.699 HG22 ' CB ' ' A' ' 53' ' ' VAL . 43.0 t . . . . . 0 N--CA 1.486 1.358 0 O-C-N 121.12 -1.223 . . . . 0.0 111.716 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 41.6 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.257 0.551 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -140.52 134.9 31.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.888 . . . . 0.0 110.603 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.974 ' CG1' HG13 ' A' ' 21' ' ' VAL . 73.4 mt -102.27 134.79 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.026 . . . . 0.0 109.226 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.5 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.2 ptm180 -150.91 -167.86 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.009 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 70' ' ' ALA . 4.8 mp -89.18 131.62 35.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -0.779 . . . . 0.0 110.518 -179.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -107.27 111.23 23.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 19.6 ttt-85 . . . . . 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 112.313 -178.767 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 15.2 m-30 . . . . . 0 C--O 1.208 -1.101 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.463 ' HG3' ' HA ' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -134.32 158.17 44.48 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.193 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.877 HD12 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.51 86.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 178.003 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.268 0.4 OUTLIER -97.94 164.02 2.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.583 -173.945 . . . . . . . . 4 4 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.974 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -106.87 108.2 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.738 -0.601 . . . . 0.0 110.188 -178.278 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 33' ' ' ILE . 2.4 t . . . . . 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.715 -179.97 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.554 ' HB3' HG13 ' A' ' 20' ' ' VAL . 22.7 p90 . . . . . 0 N--CA 1.496 1.871 0 CA-C-O 121.753 0.787 . . . . 0.0 111.037 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 22' ' ' THR . 3.3 mp -91.27 -44.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.649 -0.657 . . . . 0.0 109.994 179.965 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 176.52 11.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -109.14 115.01 29.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 179.847 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.013 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.9 pt -113.06 -31.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 110.825 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.838 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.42 167.08 14.24 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.785 -178.813 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 11.5 t80 -140.61 133.03 28.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.061 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' ILE . 17.5 t80 -126.07 144.66 50.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.772 178.718 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 49' ' ' LEU . 3.4 tm? . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.567 0.698 . . . . 0.0 110.935 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 49' ' ' LEU . 38.0 tttt -134.49 93.29 3.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.545 -0.722 . . . . 0.0 109.102 178.951 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.838 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -113.48 135.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.032 -1.042 . . . . 0.0 111.04 -179.274 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.7 t70 -77.0 70.04 3.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.412 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.13 -30.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 122.265 -0.272 . . . . 0.0 111.42 -177.797 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -61.99 -55.6 27.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.898 -1.126 . . . . 0.0 109.009 178.577 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.664 ' HB3' HG22 ' A' ' 36' ' ' ILE . 28.8 mmm180 -71.56 -39.92 70.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.185 -0.947 . . . . 0.0 108.797 178.571 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -62.59 -18.66 62.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.279 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 25.0 ttm180 -88.58 -24.79 22.76 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 178.218 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.777 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -61.43 -47.2 86.84 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.268 1.509 . . . . 0.0 107.47 178.576 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.013 ' CD1' HG21 ' A' ' 36' ' ' ILE . 83.7 m95 -64.66 -56.61 12.68 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.766 -179.016 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 74' ' ' LEU . 38.4 mt -53.35 -22.68 7.77 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.534 177.238 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -21.13 41.1 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.47 -0.769 . . . . 0.0 110.456 179.177 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.3 m -99.04 32.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.85 -1.156 . . . . 0.0 109.426 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.18 25.12 76.2 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -69.44 128.51 36.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.016 -1.285 . . . . 0.0 109.792 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.37 113.24 65.85 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 0.0 110.669 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -79.68 132.08 9.63 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.526 1.277 . . . . 0.0 109.766 179.467 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 t -62.93 -178.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.53 52.43 1.4 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 0.0 110.239 179.735 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.43 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 6.3 m -166.05 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.55 -23.47 66.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.249 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.578 ' HA ' HD12 ' A' ' 74' ' ' LEU . 26.7 ttp180 -64.79 -41.11 96.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.105 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -63.82 -37.66 88.22 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.284 179.199 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 70' ' ' ALA . 40.3 mt -67.37 -35.79 80.06 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 71' ' ' ARG . 55.0 mt -65.08 -26.85 68.4 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.587 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.32 -28.09 38.24 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.027 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -35.97 42.95 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.958 0.885 . . . . 0.0 109.967 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.749 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -74.62 -2.9 28.13 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.042 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.01 20.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.579 ' HA ' HG23 ' A' ' 53' ' ' VAL . 57.9 t . . . . . 0 C--N 1.306 -1.299 0 O-C-N 121.142 -1.211 . . . . 0.0 111.479 -179.112 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 92.3 t . . . . . 0 N--CA 1.493 1.706 0 CA-C-O 121.087 0.47 . . . . 0.0 109.87 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.6 ptmt -140.14 137.15 34.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.99 . . . . 0.0 111.044 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.024 HD11 ' CB ' ' A' ' 59' ' ' TRP . 93.6 mt -99.93 133.38 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.183 -0.948 . . . . 0.0 109.013 178.993 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.529 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -150.69 173.83 13.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.383 -179.2 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.0 pp -87.73 124.68 33.84 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.096 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.4 111.93 24.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.73 . . . . 0.0 112.462 -176.807 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.4 ttp180 . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.139 -0.976 . . . . 0.0 111.35 179.452 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.5 m-85 . . . . . 0 C--O 1.213 -0.84 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 14.8 ttm180 -103.12 148.13 26.14 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.422 178.2 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.954 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -96.89 79.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 178.278 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 35' ' ' LYS 0.282 0.4 OUTLIER -97.61 163.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.229 -173.569 . . . . . . . . 4 4 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.926 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -110.63 110.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.497 -0.752 . . . . 0.0 110.464 -177.529 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.409 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.6 t . . . . . 0 N--CA 1.494 1.728 0 O-C-N 121.222 -0.924 . . . . 0.0 110.366 179.602 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 24.4 p90 . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.375 0.607 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG21 ' HH2' ' A' ' 59' ' ' TRP . 1.1 mt -58.91 -36.63 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.592 179.561 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.4 tt0 -170.57 138.71 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' CB ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -89.71 134.58 34.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.597 179.802 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.961 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -124.15 -22.75 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.054 -1.028 . . . . 0.0 111.35 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.915 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.86 162.96 19.0 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.766 -1.683 . . . . 0.0 110.959 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG13 ' A' ' 19' ' ' ILE . 65.2 t80 -136.93 137.72 39.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.357 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 5.2 t80 -131.15 128.36 39.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.934 -1.103 . . . . 0.0 109.869 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 110.866 -179.675 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.475 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 5.5 tt . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.287 0.565 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -130.9 90.36 2.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.881 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.954 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.5 t -115.76 139.95 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.033 -1.042 . . . . 0.0 111.025 -179.656 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.5 t70 -85.25 71.79 10.81 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.623 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.93 -31.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 122.312 -0.242 . . . . 0.0 111.526 -177.31 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.5 tt0 -62.74 -49.81 73.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.788 -1.195 . . . . 0.0 108.928 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.69 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -75.42 -36.17 60.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 108.877 178.63 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.936 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -69.3 -20.35 63.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.393 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.2 tpt180 -85.6 -25.0 26.93 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.239 -0.913 . . . . 0.0 109.216 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.8 t80 -60.12 -44.72 94.69 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 123.169 1.461 . . . . 0.0 107.503 178.563 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.024 ' CB ' HD11 ' A' ' 4' ' ' ILE . 69.2 m95 -68.32 -53.64 22.83 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.254 -179.089 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.565 HD12 HG11 ' A' ' 79' ' ' VAL . 23.4 mt -58.28 -19.44 34.54 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.493 177.437 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 3.7 m -82.78 -22.75 34.17 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.334 -0.854 . . . . 0.0 110.724 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 59' ' ' TRP . 28.0 m -98.92 33.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.835 -1.165 . . . . 0.0 109.376 179.407 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.88 35.04 91.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.865 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -70.37 140.82 52.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.078 -1.248 . . . . 0.0 110.156 179.883 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.59 106.57 40.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.31 179.965 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -81.67 142.66 12.97 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.404 1.213 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -64.15 -176.44 0.21 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.042 . . . . 0.0 110.36 -179.762 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.53 -21.57 48.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.491 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -101.76 -44.44 5.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.688 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.39 -29.03 69.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 67' ' ' THR . 46.5 ttt180 -64.41 -38.32 90.63 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.365 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.35 -29.86 70.76 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.675 178.776 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 70' ' ' ALA . 49.7 mt -81.86 -33.57 30.53 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.857 -0.527 . . . . 0.0 110.0 179.609 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 97.0 mt -67.04 -27.47 67.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.001 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -82.19 -30.93 30.63 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.621 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 3.1 tp-100 -78.3 -33.44 49.35 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.898 0.856 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.32 -12.83 45.87 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.93 178.414 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.74 43.5 4.8 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.623 HG22 ' CB ' ' A' ' 53' ' ' VAL . 29.3 t . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.112 -1.228 . . . . 0.0 111.321 -179.548 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.649 ' CG1' HG12 ' A' ' 21' ' ' VAL . 63.9 t . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.257 0.551 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 65' ' ' GLN . 5.3 mmmm -140.48 130.62 24.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.873 ' CG1' HG13 ' A' ' 21' ' ' VAL . 31.6 mt -99.81 129.45 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.899 -1.126 . . . . 0.0 109.102 178.941 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.7 ptt180 -150.94 -174.96 4.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 110.812 -178.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.609 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -88.98 125.36 34.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 110.969 -179.715 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.53 111.23 23.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.511 -0.743 . . . . 0.0 110.104 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 112.044 -178.807 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.609 ' HB2' HD23 ' A' ' 6' ' ' LEU . 8.7 m-85 . . . . . 0 C--O 1.212 -0.906 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 14.2 ttm180 -114.08 151.53 32.39 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.351 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.906 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -97.94 80.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 102.513 -3.144 . . . . 0.0 102.513 178.171 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.27 0.4 OUTLIER -97.57 166.32 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.41 -173.459 . . . . . . . . 4 4 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.873 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -111.49 113.42 44.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.595 -0.691 . . . . 0.0 110.627 -177.251 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 t . . . . . 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.259 179.683 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.488 ' HB3' HG13 ' A' ' 20' ' ' VAL . 7.5 p90 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 121.36 0.6 . . . . 0.0 110.499 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.679 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.3 mp -55.08 -33.3 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.12 175.11 2.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 126.05 54.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.034 179.895 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.047 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -120.3 -31.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.158 -0.964 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.933 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -118.43 156.35 15.69 Favored Glycine 0 C--N 1.298 -1.543 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.72 143.5 51.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -138.6 136.86 36.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.671 -1.268 . . . . 0.0 110.752 -179.602 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.6 t0 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.064 -1.022 . . . . 0.0 110.047 179.336 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.656 HD12 HD22 ' A' ' 73' ' ' LEU . 3.1 tt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.354 0.597 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -131.96 98.31 4.41 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.32 179.269 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -122.81 138.1 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 111.324 -179.039 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t70 -83.35 72.12 10.23 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.721 HG23 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.15 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 CA-C-O 120.631 0.253 . . . . 0.0 111.348 -177.409 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 52' ' ' ASP . 17.4 mt-10 -60.5 -52.76 63.84 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.878 -1.138 . . . . 0.0 108.626 178.148 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.58 ' HB3' HG22 ' A' ' 36' ' ' ILE . 53.5 mmm-85 -72.82 -41.05 65.29 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.357 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.941 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -62.25 -18.36 60.98 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.088 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.3 ttp180 -88.85 -27.99 20.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.259 -0.901 . . . . 0.0 109.368 178.566 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.733 ' O ' HG13 ' A' ' 62' ' ' VAL . 2.5 t80 -59.82 -44.33 94.09 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.294 1.521 . . . . 0.0 107.545 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.047 ' CD1' HG21 ' A' ' 36' ' ' ILE . 74.7 m95 -68.4 -56.68 7.66 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.889 -178.91 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.052 HD11 HD13 ' A' ' 74' ' ' LEU . 35.0 mt -54.61 -21.67 11.14 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.006 -1.059 . . . . 0.0 108.647 177.429 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 24.4 t -80.92 -23.42 38.93 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.399 -0.813 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 58' ' ' TYR . 6.0 m -98.95 32.19 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.805 -1.184 . . . . 0.0 109.568 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.0 24.47 75.89 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.68 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -72.02 101.47 2.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.918 -1.343 . . . . 0.0 109.83 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.439 ' HB3' ' CD ' ' A' ' 3' ' ' LYS . 1.7 tt0 -69.84 114.78 27.47 Favored Pre-proline 0 C--N 1.297 -1.701 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.355 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HB3' HD12 ' A' ' 74' ' ' LEU . 53.2 Cg_endo -82.2 124.94 4.45 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.599 1.315 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.63 164.98 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.15 -0.969 . . . . 0.0 110.212 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.1 -18.04 31.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.4 m -95.89 -50.14 5.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.06 -28.5 67.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.389 -0.819 . . . . 0.0 109.206 -179.555 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.41 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 8.2 ttp180 -66.86 -38.08 85.66 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.735 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -23.94 65.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.069 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 70' ' ' ALA . 17.9 mt -90.96 -26.39 19.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.459 -0.776 . . . . 0.0 109.621 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 1.052 HD13 HD11 ' A' ' 60' ' ' LEU . 25.6 mt -69.76 -30.12 67.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.85 -29.16 44.41 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.141 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.42 ' HG2' HD13 ' A' ' 49' ' ' LEU . 5.8 tp-100 -73.34 -34.2 65.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.139 0.971 . . . . 0.0 108.516 178.902 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -72.12 -7.33 48.42 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.692 177.994 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.65 50.07 4.6 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.589 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.721 HG22 HG23 ' A' ' 53' ' ' VAL . 40.6 t . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.197 -1.178 . . . . 0.0 111.442 -179.27 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.662 HG11 ' CE3' ' A' ' 59' ' ' TRP . 61.4 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 121.242 0.544 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HG2' ' HB2' ' A' ' 65' ' ' GLN . 28.7 mtpt -140.24 130.62 25.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.511 -179.904 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.964 ' CG1' HG13 ' A' ' 21' ' ' VAL . 77.9 mt -102.37 133.11 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.135 -0.978 . . . . 0.0 109.925 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptt85 -150.8 -165.48 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.63 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 50.5 mt -89.26 132.65 34.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.008 -1.058 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -104.26 100.88 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 179.708 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 111.169 -179.645 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.8 m-85 . . . . . 0 C--O 1.213 -0.832 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.489 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.8 mmt180 -99.81 165.25 11.67 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.147 -1.421 . . . . 0.0 107.999 176.736 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.885 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -98.48 81.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 177.244 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -97.4 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.681 -173.947 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.964 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -111.84 108.65 26.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.748 -0.595 . . . . 0.0 110.947 -176.951 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.004 179.452 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.508 0.671 . . . . 0.0 110.495 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.0 mt -82.88 -45.2 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.745 . . . . 0.0 109.667 179.76 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 165.91 32.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.447 -0.783 . . . . 0.0 110.01 179.787 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HD3' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -99.0 108.47 21.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 179.861 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.001 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.9 pt -101.51 -36.22 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.095 -1.003 . . . . 0.0 111.581 -179.566 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.809 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -125.95 172.04 17.78 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.758 -1.687 . . . . 0.0 112.868 -177.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 77.9 t80 -141.11 133.26 27.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.237 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.885 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.1 t80 -132.12 133.46 44.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.567 -1.333 . . . . 0.0 110.394 178.853 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.948 . . . . 0.0 109.724 179.138 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.66 HD21 ' HB3' ' A' ' 73' ' ' LEU . 10.9 tp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.57 0.7 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -128.4 92.64 3.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.134 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.809 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.84 149.07 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 111.29 -179.025 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t0 -93.31 67.04 4.06 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.765 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -32.05 -33.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.667 -177.334 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.34 -53.33 58.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.995 178.537 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 25.7 mmm180 -71.7 -41.87 68.08 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 108.66 178.525 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -61.99 -18.68 61.26 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.222 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.452 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.2 ttt-85 -88.27 -27.2 21.89 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.326 -0.859 . . . . 0.0 109.508 178.167 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.808 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -59.49 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.234 1.493 . . . . 0.0 107.564 178.637 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.001 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.5 m95 -66.38 -54.82 19.96 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.511 -178.923 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.665 HD11 HD13 ' A' ' 74' ' ' LEU . 9.1 mt -55.6 -21.49 17.73 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.533 177.081 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 10.8 t -82.57 -20.74 35.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.423 -0.798 . . . . 0.0 110.622 179.687 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.5 m -99.12 32.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.48 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.36 72.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -68.07 142.52 55.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.036 -1.273 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -110.62 109.4 57.97 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 110.645 -179.699 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -80.21 125.41 5.81 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.586 1.308 . . . . 0.0 109.815 179.339 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 t -56.91 178.87 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 0.0 110.539 -179.819 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.74 54.22 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 0.0 109.781 179.172 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -165.64 -58.3 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.761 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.642 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.48 -23.7 66.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.026 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -69.17 -41.79 76.75 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.157 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -65.78 -41.47 91.97 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.652 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.66 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.9 mt -69.97 -28.16 65.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.493 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.665 HD13 HD11 ' A' ' 60' ' ' LEU . 12.8 mt -68.82 -29.05 67.31 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.514 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -30.77 39.11 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.421 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -31.34 34.93 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.847 0.832 . . . . 0.0 109.877 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -70.52 -6.83 39.1 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.051 178.863 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.45 48.6 6.24 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 53' ' ' VAL . 48.4 t . . . . . 0 N--CA 1.485 1.282 0 O-C-N 121.206 -1.173 . . . . 0.0 111.461 -179.385 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.617 HG11 ' CE3' ' A' ' 59' ' ' TRP . 70.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.314 0.578 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.19 135.33 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.005 ' CG1' HG13 ' A' ' 21' ' ' VAL . 86.2 mt -102.86 135.34 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.038 -1.039 . . . . 0.0 109.737 179.433 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.38 -168.78 3.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.373 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 70' ' ' ALA . 7.0 mp -89.45 127.25 35.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 179.916 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -102.21 108.92 20.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.573 -0.705 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.488 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 2.8 ttt180 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 111.688 -179.468 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.0 m-85 . . . . . 0 C--O 1.211 -0.942 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' C ' HD13 ' A' ' 19' ' ' ILE . 70.7 mtt180 -131.99 157.15 44.83 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.686 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -98.07 81.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 177.622 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -97.72 168.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.639 -173.785 . . . . . . . . 4 4 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.005 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.37 108.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.69 -0.631 . . . . 0.0 110.658 -177.087 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t . . . . . 0 N--CA 1.493 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 179.387 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD2' HG21 ' A' ' 20' ' ' VAL . 5.3 p90 . . . . . 0 N--CA 1.495 1.823 0 CA-C-O 121.373 0.606 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.647 HG21 ' HH2' ' A' ' 59' ' ' TRP . 56.3 mt -93.58 -36.31 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.503 -0.748 . . . . 0.0 110.002 -179.876 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.12 167.82 15.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.904 -179.958 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 4.2 pttp -102.05 111.7 24.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 179.902 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.965 HG21 ' CD1' ' A' ' 59' ' ' TRP . 32.2 pt -107.41 -35.21 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.912 -1.117 . . . . 0.0 111.244 -179.648 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.815 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.78 168.05 15.1 Favored Glycine 0 C--N 1.296 -1.648 0 C-N-CA 118.959 -1.591 . . . . 0.0 112.254 -177.887 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.448 ' N ' HG12 ' A' ' 19' ' ' ILE . 90.8 t80 -141.36 125.9 17.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.571 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.77 ' HB2' HD11 ' A' ' 19' ' ' ILE . 10.9 t80 -120.66 130.12 53.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.813 -1.179 . . . . 0.0 109.43 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.8 t0 . . . . . 0 N--CA 1.5 2.05 0 O-C-N 120.293 -1.504 . . . . 0.0 111.633 179.851 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.467 HD12 HD23 ' A' ' 73' ' ' LEU . 6.3 tt . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.204 0.526 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.93 95.66 3.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 109.5 179.393 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.815 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.57 143.53 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 111.411 -179.102 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 t70 -87.95 70.16 9.44 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.389 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.11 -32.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.486 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.47 -57.18 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.7 -1.25 . . . . 0.0 108.818 178.526 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.651 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -67.64 -41.3 84.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 108.998 178.538 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.5 -19.35 65.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.615 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.9 ttt180 -89.17 -22.26 22.89 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 178.501 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.939 ' O ' HG13 ' A' ' 62' ' ' VAL . 5.3 t80 -59.95 -44.64 94.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.25 1.5 . . . . 0.0 107.14 178.282 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.965 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.0 m95 -68.43 -58.22 4.67 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.909 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.744 HD11 HD13 ' A' ' 74' ' ' LEU . 30.6 mt -53.13 -23.57 8.44 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.586 177.474 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 19.5 m -80.87 -21.33 40.77 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.484 -0.76 . . . . 0.0 110.348 179.287 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -99.12 31.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.872 -1.143 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.91 24.9 75.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.972 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 138.59 55.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.916 -1.343 . . . . 0.0 110.264 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.465 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -105.47 107.87 60.16 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.912 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HB3' HD12 ' A' ' 74' ' ' LEU . 56.2 Cg_endo -82.38 132.01 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.474 1.25 . . . . 0.0 110.484 179.982 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.1 p -58.97 166.27 2.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 179.417 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.17 -26.31 64.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.913 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -84.87 -51.8 6.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 110.482 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.809 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -70.15 -25.42 63.45 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.441 -0.787 . . . . 0.0 108.942 179.981 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 67' ' ' THR . 8.1 ttm180 -69.39 -36.09 76.44 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.131 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -40.98 92.49 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.557 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.2 mt -69.29 -28.08 65.98 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.267 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.744 HD13 HD11 ' A' ' 60' ' ' LEU . 25.0 mt -73.18 -27.03 61.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.468 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -29.93 29.84 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.117 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -84.37 -31.07 24.94 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.859 0.837 . . . . 0.0 110.045 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.455 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -70.6 -7.9 47.62 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.772 -0.58 . . . . 0.0 109.829 178.667 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.09 50.3 4.64 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.691 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 53' ' ' VAL . 21.8 t . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.119 -1.224 . . . . 0.0 111.206 -179.696 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 46.8 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.213 0.53 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -140.81 141.19 34.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.521 -179.775 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.909 HD11 ' CB ' ' A' ' 59' ' ' TRP . 91.0 mt -108.57 131.11 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.055 -1.028 . . . . 0.0 109.462 178.97 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -151.2 -175.68 5.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 110.69 -179.138 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.533 HD11 HD12 ' A' ' 73' ' ' LEU . 3.9 mp -88.72 122.41 32.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.95 107.15 19.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 112.055 -178.561 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.653 179.036 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 10.2 m-85 . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -99.5 153.52 18.96 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.645 177.303 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.031 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.2 mm -97.67 73.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 176.336 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.258 0.4 OUTLIER -97.59 162.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.093 -173.053 . . . . . . . . 4 4 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.821 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.15 114.32 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.439 0.638 . . . . 0.0 111.441 -176.883 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.603 178.888 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 35' ' ' LYS . 11.9 p90 . . . . . 0 N--CA 1.495 1.794 0 CA-C-O 121.576 0.703 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.648 HG21 ' HH2' ' A' ' 59' ' ' TRP . 14.8 mt -88.45 -31.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.514 -0.741 . . . . 0.0 109.878 179.858 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.48 157.14 2.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.487 -0.758 . . . . 0.0 109.877 -179.88 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HA ' HG23 ' A' ' 20' ' ' VAL . 36.3 mtmt -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.911 HG21 ' CD1' ' A' ' 59' ' ' TRP . 29.0 pt -100.0 -35.62 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 110.859 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.858 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.13 166.38 18.92 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.017 -178.453 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.473 ' N ' HG12 ' A' ' 19' ' ' ILE . 84.8 t80 -141.01 137.07 32.71 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.808 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.031 ' HB2' HD11 ' A' ' 19' ' ' ILE . 16.3 t80 -127.08 131.02 50.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 109.296 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.8 t0 . . . . . 0 N--CA 1.496 1.827 0 O-C-N 120.741 -1.224 . . . . 0.0 111.31 179.917 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.618 HD13 ' N ' ' A' ' 50' ' ' LYS . 1.6 tm? . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.467 0.651 . . . . 0.0 110.508 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.618 ' N ' HD13 ' A' ' 49' ' ' LEU . 11.6 tttm -125.7 97.6 5.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.571 -0.706 . . . . 0.0 109.111 179.175 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.858 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.1 t -124.06 144.22 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.031 -1.043 . . . . 0.0 111.396 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.3 t0 -87.66 70.27 9.7 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.794 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.615 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.33 -30.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.471 -177.655 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.6 mt-10 -62.18 -54.74 36.7 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.909 -1.119 . . . . 0.0 108.967 178.092 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 3.4 mtm-85 -74.15 -33.57 63.57 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 178.951 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.901 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -68.24 -24.69 64.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.212 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -84.35 -22.94 30.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 178.285 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -61.65 -51.76 67.13 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.192 1.472 . . . . 0.0 107.722 178.909 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.911 ' CD1' HG21 ' A' ' 36' ' ' ILE . 82.9 m95 -59.81 -53.75 54.33 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.899 -179.183 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.962 HD11 HD13 ' A' ' 74' ' ' LEU . 9.8 mt -55.2 -20.06 9.66 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.559 177.094 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.1 t -81.56 -21.29 38.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 110.682 179.279 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.2 m -98.88 32.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.816 -1.177 . . . . 0.0 109.813 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.04 72.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -73.39 122.62 22.36 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.183 -1.187 . . . . 0.0 110.109 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 112.49 48.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.731 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.8 Cg_endo -82.12 127.31 5.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.518 1.273 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 167.39 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.082 -1.011 . . . . 0.0 109.789 179.677 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.33 -17.35 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.735 -179.626 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' HD13 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -99.06 -49.57 4.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.346 -179.868 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -66.7 -23.08 66.07 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.335 -0.853 . . . . 0.0 109.026 -179.961 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 7.5 tmm_? -71.75 -41.35 68.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.28 83.6 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.291 -0.963 . . . . 0.0 108.962 178.847 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.533 HD12 HD11 ' A' ' 6' ' ' LEU . 28.5 mt -72.62 -27.05 61.91 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.742 . . . . 0.0 109.15 179.192 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.962 HD13 HD11 ' A' ' 60' ' ' LEU . 15.0 mt -72.37 -29.57 63.9 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 177.763 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -79.59 -31.88 41.85 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.548 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.31 -26.81 47.07 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.016 0.913 . . . . 0.0 109.218 178.69 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.705 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -70.67 -7.74 46.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.78 16.51 45.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.99 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.615 HG22 HG23 ' A' ' 53' ' ' VAL . 22.2 t . . . . . 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.308 . . . . 0.0 109.826 179.728 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.465 HG11 ' CE3' ' A' ' 59' ' ' TRP . 92.8 t . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.197 0.523 . . . . 0.0 110.24 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -140.77 142.49 34.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.909 HD11 ' CB ' ' A' ' 59' ' ' TRP . 73.8 mt -109.92 134.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.041 . . . . 0.0 109.825 179.382 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.27 -171.21 3.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.948 -1.095 . . . . 0.0 110.766 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 70' ' ' ALA . 7.1 mp -89.01 126.4 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.92 106.31 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 110.767 -179.634 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.525 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 120.822 -1.174 . . . . 0.0 111.43 -179.714 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.21 -0.991 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.528 ' C ' HD13 ' A' ' 19' ' ' ILE . 16.7 mtt-85 -108.75 160.47 15.94 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.256 -1.378 . . . . 0.0 107.988 176.678 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.994 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.62 81.53 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 177.643 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -97.32 164.38 2.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.611 -173.856 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.92 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -110.09 109.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.76 -0.587 . . . . 0.0 110.181 -177.483 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 5.7 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.818 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 p90 . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.62 0.724 . . . . 0.0 110.699 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.724 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.6 mp -83.7 -33.06 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.616 -0.678 . . . . 0.0 109.367 179.383 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.21 156.06 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.559 -0.713 . . . . 0.0 109.688 179.472 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -91.87 111.34 22.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.388 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.033 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.8 pp -102.42 -26.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.203 -0.935 . . . . 0.0 110.59 179.482 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.886 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -123.39 165.96 15.97 Favored Glycine 0 C--N 1.297 -1.637 0 C-N-CA 119.173 -1.489 . . . . 0.0 111.925 -179.468 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.479 ' N ' HG12 ' A' ' 19' ' ' ILE . 6.5 t80 -140.86 132.9 27.82 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.901 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.994 ' HB2' HD11 ' A' ' 19' ' ' ILE . 15.0 t80 -130.7 140.61 50.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.754 -1.216 . . . . 0.0 109.877 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.8 t0 . . . . . 0 N--CA 1.496 1.855 0 O-C-N 120.869 -1.145 . . . . 0.0 109.863 179.051 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.468 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 6.3 tt . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.291 0.567 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.46 88.99 2.46 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.886 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -115.53 130.41 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 111.197 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t70 -75.32 71.42 2.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.016 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -34.18 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.681 -177.45 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 39.9 tt0 -62.12 -51.94 65.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.667 -1.271 . . . . 0.0 108.851 178.136 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.667 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -71.41 -39.18 71.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 178.701 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.906 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -66.99 -19.53 65.73 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.335 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.1 ttp85 -87.18 -25.73 23.91 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.402 -0.811 . . . . 0.0 109.377 178.755 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.673 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.9 t80 -59.32 -45.9 90.07 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.231 1.491 . . . . 0.0 107.519 178.539 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.033 ' CD1' HG21 ' A' ' 36' ' ' ILE . 70.9 m95 -66.89 -56.95 8.04 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.415 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 79' ' ' VAL . 12.7 mt -53.67 -22.83 9.71 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.572 177.327 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.59 -23.28 49.95 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.465 -0.772 . . . . 0.0 110.234 179.28 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 59' ' ' TRP . 5.4 m -98.88 32.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.898 -1.126 . . . . 0.0 109.509 179.873 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.43 22.33 77.69 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.901 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -63.53 134.59 55.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.979 -1.306 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -105.83 110.0 63.71 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 110.401 -179.797 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.54 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.1 Cg_endo -83.62 130.71 5.25 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.455 1.24 . . . . 0.0 109.814 179.516 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.8 t -54.76 -177.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -0.942 . . . . 0.0 110.091 -179.853 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.68 0.67 16.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.969 -1.082 . . . . 0.0 111.707 -179.163 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.502 ' H ' HG23 ' A' ' 67' ' ' THR . 2.6 m -110.86 -50.9 2.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.862 -1.149 . . . . 0.0 110.035 179.794 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.868 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -72.04 -26.82 62.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.635 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.6 ttt180 -67.26 -38.12 84.6 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.383 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -66.63 -36.95 83.8 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 108.724 179.061 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 70' ' ' ALA . 12.2 mt -72.79 -28.32 62.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.878 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.518 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 30.9 mt -71.55 -28.69 64.03 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.443 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -30.62 46.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.327 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.2 tp-100 -84.07 -32.2 24.93 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.881 0.848 . . . . 0.0 110.265 -179.843 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.88 -13.36 44.52 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.766 -0.583 . . . . 0.0 109.999 178.963 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.26 25.03 10.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 60' ' ' LEU . 30.1 t . . . . . 0 N--CA 1.492 1.627 0 O-C-N 120.801 -1.411 . . . . 0.0 110.348 179.982 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.612 HG21 HG23 ' A' ' 62' ' ' VAL . 14.1 m . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.317 0.58 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -140.25 132.26 27.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.184 179.667 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.861 ' CG1' HG13 ' A' ' 21' ' ' VAL . 76.3 mt -103.08 132.09 50.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.095 -1.003 . . . . 0.0 109.551 179.351 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.35 -169.07 3.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.2 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 6' ' ' LEU . 36.4 mt -88.81 129.41 35.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 179.752 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.39 101.11 12.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.155 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 1.2 tmm_? . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.722 -0.611 . . . . 0.0 111.538 -179.252 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.1 m-85 . . . . . 0 C--O 1.213 -0.852 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 2.1 mtt180 -106.6 159.56 16.1 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.13 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.886 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.09 78.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 177.628 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.65 167.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.543 -173.845 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.935 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.99 105.58 19.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.285 0.564 . . . . 0.0 110.354 -177.662 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 6.5 t . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.294 179.79 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 20' ' ' VAL . 6.1 p90 . . . . . 0 N--CA 1.497 1.92 0 CA-C-O 121.611 0.72 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.59 -27.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.645 -0.66 . . . . 0.0 109.33 179.751 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.34 166.26 14.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 109.798 179.817 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 117.63 34.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.932 HG21 ' CD1' ' A' ' 59' ' ' TRP . 41.4 pt -112.24 -33.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.091 -1.005 . . . . 0.0 111.153 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.776 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -130.07 170.38 20.78 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.924 -178.362 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.511 ' N ' HG13 ' A' ' 19' ' ' ILE . 68.2 t80 -139.17 143.66 38.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.651 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.437 ' HD2' HD22 ' A' ' 6' ' ' LEU . 11.8 t80 -140.04 123.72 17.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.857 -1.152 . . . . 0.0 109.995 -179.85 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 19.7 t0 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.613 -1.304 . . . . 0.0 110.915 -179.865 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 73' ' ' LEU . 7.1 tt . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.4 0.619 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -139.46 100.2 3.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.177 179.23 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.886 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -129.68 140.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.047 -179.054 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t0 -90.06 70.23 7.36 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.08 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.512 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -32.07 -33.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.741 -177.458 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mm-40 -60.43 -55.87 28.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.75 -1.219 . . . . 0.0 109.095 178.432 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.62 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -68.94 -40.81 78.74 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.135 178.836 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.81 -20.62 66.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.705 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.7 tpt180 -87.32 -22.52 25.07 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 178.511 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.2 t80 -60.08 -49.21 78.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.317 1.532 . . . . 0.0 107.096 178.553 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.935 ' CD2' HG11 ' A' ' 21' ' ' VAL . 87.7 m95 -61.69 -51.22 69.31 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.292 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 HG11 ' A' ' 79' ' ' VAL . 18.5 mt -54.33 -22.35 11.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 176.669 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -25.09 42.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.494 -0.754 . . . . 0.0 110.777 179.529 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.612 HG23 HG21 ' A' ' 2' ' ' VAL . 7.6 m -99.13 33.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.907 -1.121 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.32 78.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.572 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -63.16 138.5 58.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -1.22 . . . . 0.0 110.172 179.985 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 2.7 mp0 -104.06 103.39 37.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.134 179.94 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -82.2 130.06 6.23 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.499 1.263 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.8 t -64.65 168.44 6.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.983 -1.073 . . . . 0.0 109.739 179.757 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.62 -26.96 24.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 111.582 -178.914 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.26 -50.25 6.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.044 -1.035 . . . . 0.0 110.894 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.765 ' H ' HG23 ' A' ' 67' ' ' THR . . . -66.61 -24.91 66.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.858 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.6 ttp180 -70.75 -39.81 73.05 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.429 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -65.93 -40.66 91.61 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.603 178.539 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 70' ' ' ALA . 14.7 mt -69.7 -29.07 66.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.576 -0.703 . . . . 0.0 109.125 179.017 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 20.8 mt -71.98 -27.58 62.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.565 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.22 -26.77 32.98 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.455 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.1 tp-100 -85.39 -37.68 19.57 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.642 0.734 . . . . 0.0 110.406 -179.58 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -65.43 -10.98 38.41 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.681 178.638 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.4 50.26 3.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 53' ' ' VAL . 43.6 t . . . . . 0 N--CA 1.487 1.39 0 O-C-N 121.087 -1.243 . . . . 0.0 111.12 -179.679 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.41 0.624 . . . . 0.0 110.557 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 30.0 mtpt -140.37 134.6 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 179.759 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.936 ' CG1' HG13 ' A' ' 21' ' ' VAL . 74.3 mt -99.99 133.82 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.0 -1.063 . . . . 0.0 109.656 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.601 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -151.4 -172.27 4.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -178.968 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mp -89.1 125.86 35.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.81 102.62 14.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.5 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.506 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.9 ttm180 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 111.577 179.917 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.0 m-85 . . . . . 0 C--O 1.212 -0.875 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 6' ' ' LEU . 3.4 mmt180 -100.14 157.07 16.84 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.669 176.614 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.956 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.19 77.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 102.469 -3.159 . . . . 0.0 102.469 176.824 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.258 0.4 OUTLIER -97.46 171.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.51 -173.715 . . . . . . . . 4 4 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.936 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -115.98 112.81 41.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.769 -0.582 . . . . 0.0 110.633 -177.184 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.9 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 110.492 179.591 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CB ' HG13 ' A' ' 20' ' ' VAL . 23.5 p90 . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 121.615 0.721 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.625 HG21 ' HH2' ' A' ' 59' ' ' TRP . 4.4 mt -82.48 -50.3 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.576 -0.703 . . . . 0.0 109.869 179.658 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.5 mt-10 -156.13 158.98 38.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.85 179.784 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.577 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -93.37 110.22 21.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 110.384 -179.864 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.984 HG21 ' CD1' ' A' ' 59' ' ' TRP . 26.4 pt -99.75 -36.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.22 -0.925 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.818 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -123.23 168.14 15.45 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.361 -178.403 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.465 ' N ' HG13 ' A' ' 19' ' ' ILE . 93.0 t80 -140.13 135.78 32.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.458 ' CD1' ' C ' ' A' ' 39' ' ' TYR . 12.7 t80 -128.03 133.01 49.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.986 -1.071 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 31.1 t0 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 120.901 -1.125 . . . . 0.0 110.327 179.768 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 76' ' ' GLN . 7.9 tt . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -121.99 97.22 5.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.099 179.175 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.956 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -120.3 159.73 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.334 1.064 . . . . 0.0 111.654 -178.854 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.9 t0 -107.21 65.84 0.66 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.98 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.798 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -35.0 -30.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -177.542 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -59.93 -54.17 49.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.747 -1.221 . . . . 0.0 108.495 178.149 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -75.74 -35.26 60.26 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.413 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.914 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.02 -21.02 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.969 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' VAL . 51.1 ttt-85 -86.61 -25.41 24.95 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.363 -0.836 . . . . 0.0 109.854 178.566 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -58.04 -46.29 85.58 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 123.179 1.466 . . . . 0.0 107.547 178.773 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.984 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.9 m95 -66.14 -52.31 49.62 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.621 -179.259 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.752 HD11 HD22 ' A' ' 74' ' ' LEU . 6.4 mt -55.04 -22.19 14.87 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.441 177.119 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -80.96 -23.54 38.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.482 -0.761 . . . . 0.0 110.612 179.604 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 58' ' ' TYR . 5.1 m -98.9 32.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.925 -1.109 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.3 29.44 73.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.48 126.1 28.67 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.043 -1.269 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -93.68 111.19 51.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.9 Cg_endo -82.29 130.71 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.492 1.259 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.36 168.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -53.75 -30.35 43.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -84.54 -50.4 7.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.433 -0.792 . . . . 0.0 110.384 -179.959 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.27 -22.88 66.91 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.227 -0.92 . . . . 0.0 108.781 179.972 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -40.26 67.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.51 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 -38.86 83.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.921 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -69.05 -28.15 66.29 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.654 -0.654 . . . . 0.0 109.357 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.778 HD23 HG21 ' A' ' 79' ' ' VAL . 13.3 mt -73.07 -26.19 61.17 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.465 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.79 -28.68 30.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.271 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.727 ' HB3' HD13 ' A' ' 49' ' ' LEU . 4.8 tp-100 -83.01 -39.81 20.78 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.764 0.792 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -65.04 -11.28 37.49 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.872 178.433 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.79 51.64 3.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.855 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.778 HG21 HD23 ' A' ' 74' ' ' LEU . 53.6 t . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.076 -1.25 . . . . 0.0 111.221 -179.686 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.547 HG11 ' CE3' ' A' ' 59' ' ' TRP . 73.8 t . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.172 0.51 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -137.8 131.01 30.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.018 HD11 ' CB ' ' A' ' 59' ' ' TRP . 93.3 mt -102.69 129.46 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.089 -1.007 . . . . 0.0 109.534 179.251 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 28.1 ptt180 -151.67 -166.63 2.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -89.05 127.41 35.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.26 105.52 17.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 14.9 ttt180 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 111.302 -179.711 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.0 m-85 . . . . . 0 C--O 1.212 -0.908 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.539 ' C ' HD13 ' A' ' 19' ' ' ILE . 13.5 mtt-85 -101.12 161.99 13.21 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.064 -1.455 . . . . 0.0 108.457 177.178 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.073 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -99.1 80.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 177.649 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.252 0.4 OUTLIER -97.61 165.25 2.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.155 -173.75 . . . . . . . . 4 4 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 115.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.896 -0.503 . . . . 0.0 110.596 -177.659 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.1 t . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.013 . . . . 0.0 110.7 179.116 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.9 p90 . . . . . 0 N--CA 1.494 1.775 0 CA-C-O 121.438 0.637 . . . . 0.0 110.336 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.797 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.0 mm -96.53 -41.35 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.576 -179.796 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.15 167.07 10.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.468 -0.77 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.24 107.65 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.988 . . . . 0.0 110.307 -179.89 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.916 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.1 pt -99.91 -36.51 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.157 -0.965 . . . . 0.0 110.571 179.936 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.785 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.78 165.89 15.35 Favored Glycine 0 C--N 1.295 -1.716 0 C-N-CA 119.027 -1.559 . . . . 0.0 111.989 -178.521 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.45 ' N ' HG12 ' A' ' 19' ' ' ILE . 9.3 t80 -140.49 130.53 24.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.066 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 1.073 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.9 t80 -131.58 133.14 44.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.636 -1.29 . . . . 0.0 110.378 -179.738 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.2 t0 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 120.918 -1.113 . . . . 0.0 109.997 179.495 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 10.2 tt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 121.561 0.696 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.93 93.83 3.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 179.328 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.785 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.03 135.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.607 -179.071 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -84.3 69.83 10.52 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 175.838 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.714 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.6 -29.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 122.135 -0.353 . . . . 0.0 111.496 -177.405 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -59.64 -51.69 68.74 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.7 -1.25 . . . . 0.0 108.745 178.605 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.7 mmm180 -75.9 -38.35 57.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.509 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -63.44 -21.23 66.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.282 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 15.2 ttt180 -88.31 -21.86 24.18 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.315 -0.865 . . . . 0.0 109.732 178.447 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -48.26 73.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 123.194 1.474 . . . . 0.0 107.668 178.704 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 1.018 ' CB ' HD11 ' A' ' 4' ' ' ILE . 81.4 m95 -63.82 -54.03 41.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.834 -179.04 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.501 HD11 HD13 ' A' ' 74' ' ' LEU . 83.4 mt -55.33 -21.04 13.4 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.33 177.256 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.43 -23.91 39.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.4 -0.812 . . . . 0.0 110.773 179.504 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.1 m -99.16 34.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.849 -1.157 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.32 26.06 74.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.588 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.448 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -73.67 112.07 9.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 179.69 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 116.52 64.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.664 -179.521 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.2 Cg_endo -83.61 124.47 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.471 1.248 . . . . 0.0 109.567 179.13 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -55.08 175.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 110.468 -179.47 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.52 56.61 1.13 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 179.993 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 m -165.9 -60.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.745 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.85 -25.2 67.09 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.819 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.8 ttp180 -65.76 -41.56 91.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.065 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.03 -41.51 98.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.682 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.3 mt -70.03 -32.81 71.13 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.983 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 46.9 mt -68.58 -26.83 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.805 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -82.13 -28.78 32.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.395 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.505 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.52 -36.86 25.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.43 -179.677 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.37 -8.96 36.8 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.986 178.663 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.22 50.75 4.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 53' ' ' VAL . 39.8 t . . . . . 0 N--CA 1.487 1.406 0 O-C-N 121.032 -1.275 . . . . 0.0 111.36 -179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.3 mtp . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.28 0.562 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 64' ' ' ALA . 6.7 m -126.45 119.36 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.26 -0.9 . . . . 0.0 110.131 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.463 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.03 133.23 29.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.201 -0.937 . . . . 0.0 110.522 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.936 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.8 mt -99.74 133.99 40.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.31 -0.869 . . . . 0.0 109.054 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.28 -171.57 3.97 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 120.957 -1.089 . . . . 0.0 110.586 -178.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.927 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -88.7 126.75 35.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.371 -0.83 . . . . 0.0 110.255 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.693 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.05 104.28 16.29 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.374 -0.829 . . . . 0.0 110.613 -179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -72.3 118.49 15.26 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.306 -0.872 . . . . 0.0 111.15 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.693 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 19.1 m-85 -113.51 -61.5 1.73 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.133 -0.98 . . . . 0.0 110.147 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.59 131.63 11.89 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.455 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 27.6 p -101.59 -56.3 2.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -1.1 . . . . 0.0 109.72 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.455 ' N ' ' OG ' ' A' ' 11' ' ' SER . 3.7 mtpp -143.27 40.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -135.44 -64.65 0.63 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.483 -0.761 . . . . 0.0 109.665 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.407 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 41.8 t30 -138.29 114.43 8.99 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.59 -0.694 . . . . 0.0 109.472 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -74.1 102.13 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.464 1.244 . . . . 0.0 111.14 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.486 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.0 p80 -149.41 136.89 20.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.293 -0.879 . . . . 0.0 110.213 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.927 ' HB2' HD23 ' A' ' 6' ' ' LEU . 10.7 m-85 -118.94 155.07 31.97 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.492 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 10.6 mtm-85 -107.99 159.35 16.62 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 118.22 -1.392 . . . . 0.0 107.742 176.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.953 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.78 79.77 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 103.868 -2.642 . . . . 0.0 103.868 178.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.261 0.4 OUTLIER -98.04 166.48 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-N 114.611 -1.177 . . . . 0.0 111.758 -174.053 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.905 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -109.16 109.55 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.768 -0.583 . . . . 0.0 110.121 -178.364 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t -139.3 -166.5 2.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.139 -0.976 . . . . 0.0 110.222 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.6 m-20 -71.69 -161.53 0.07 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.548 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.03 71.82 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 0.0 110.708 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.68 144.94 12.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.213 -0.929 . . . . 0.0 110.435 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -53.96 169.28 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 109.95 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 mttt -127.65 -55.02 1.32 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.191 -0.943 . . . . 0.0 110.073 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -120.51 -47.44 2.34 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -123.16 -30.08 3.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.378 -0.826 . . . . 0.0 110.35 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.15 108.95 2.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -139.06 148.66 43.65 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.247 -1.149 . . . . 0.0 110.498 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.532 ' HB3' HG13 ' A' ' 20' ' ' VAL . 9.2 p90 -119.85 165.07 15.07 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.458 -0.776 . . . . 0.0 110.524 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.504 ' H ' HD12 ' A' ' 33' ' ' ILE . 3.9 mp -77.3 -23.86 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.497 -0.752 . . . . 0.0 109.638 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.62 164.35 3.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 110.02 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 116.04 31.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.198 -0.939 . . . . 0.0 109.625 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.956 HG21 ' CD1' ' A' ' 59' ' ' TRP . 22.9 pt -107.01 -37.43 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.151 -0.968 . . . . 0.0 111.351 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.792 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.63 171.04 14.96 Favored Glycine 0 C--N 1.294 -1.758 0 C-N-CA 119.006 -1.569 . . . . 0.0 111.597 -177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.491 ' N ' HG13 ' A' ' 19' ' ' ILE . 64.7 t80 -139.57 141.96 37.18 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.598 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 29.3 t80 -135.34 142.6 45.8 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.656 -1.218 . . . . 0.0 110.718 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 5.3 t0 -140.66 105.39 6.38 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.534 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.438 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 43.3 Cg_endo -71.7 70.77 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.01 1.005 . . . . 0.0 110.707 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.38 130.67 46.5 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.112 -0.992 . . . . 0.0 110.162 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.6 mttt -96.97 42.21 1.09 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 110.433 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -112.41 -66.83 1.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 110.07 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 80.9 p -127.45 153.83 77.33 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.098 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.31 73.36 4.52 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.712 1.375 . . . . 0.0 110.385 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -165.02 58.86 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.17 -0.956 . . . . 0.0 110.467 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.598 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 19.1 p-90 -119.41 -14.63 9.16 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.116 -0.99 . . . . 0.0 110.8 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.595 HD21 ' HB2' ' A' ' 77' ' ' ALA . 4.8 tt -83.81 116.84 22.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.029 -1.044 . . . . 0.0 110.419 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.41 100.9 5.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.295 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -122.82 153.09 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.976 -1.078 . . . . 0.0 111.336 -179.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.4 t0 -100.04 70.84 1.6 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 176.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.638 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -34.93 -30.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.359 0 O-C-N 122.312 -0.242 . . . . 0.0 111.57 -177.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 tt0 -60.81 -54.8 40.7 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.713 -1.242 . . . . 0.0 108.804 178.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.553 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -70.93 -39.51 72.63 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.364 -0.835 . . . . 0.0 108.83 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.88 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.76 -17.68 64.79 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 13.4 ttt180 -87.51 -25.15 23.82 Favored 'General case' 0 N--CA 1.483 1.179 0 O-C-N 121.321 -0.862 . . . . 0.0 109.476 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.854 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.7 t80 -60.26 -44.67 95.09 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.246 1.498 . . . . 0.0 107.966 178.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.956 ' CD1' HG21 ' A' ' 36' ' ' ILE . 84.7 m95 -69.73 -55.87 8.74 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 113.894 -1.503 . . . . 0.0 110.149 -178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.521 HD21 ' HG3' ' A' ' 66' ' ' PRO . 13.1 mt -53.33 -22.56 7.48 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 119.274 -0.97 . . . . 0.0 108.447 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 15.3 t -82.35 -22.75 35.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.404 -0.81 . . . . 0.0 110.455 179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.854 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.7 m -99.14 32.7 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 120.839 -1.163 . . . . 0.0 109.572 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.47 29.04 72.91 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.611 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -71.65 127.32 32.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.086 -1.244 . . . . 0.0 109.763 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.463 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -97.6 110.72 56.25 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 110.249 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.7 Cg_endo -85.61 129.33 3.59 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.605 1.318 . . . . 0.0 110.293 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.752 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.2 t -55.17 168.59 0.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.14 -0.975 . . . . 0.0 109.762 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -55.44 -37.7 68.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.062 -1.024 . . . . 0.0 110.739 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.451 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -70.41 -58.56 3.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.729 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.752 ' H ' HG23 ' A' ' 67' ' ' THR . . . -63.76 -23.33 67.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.39 -0.819 . . . . 0.0 109.117 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.531 ' HA ' HD12 ' A' ' 74' ' ' LEU . 4.1 ttt180 -69.71 -42.73 73.64 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.528 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -73.41 -10.04 59.32 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.49 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.719 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.1 mt -98.22 -24.89 15.08 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.08 -1.013 . . . . 0.0 108.623 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.531 HD12 ' HA ' ' A' ' 71' ' ' ARG . 17.9 mt -71.11 -30.43 66.51 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 177.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 10.3 ptm180 -77.78 -28.8 50.62 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 177.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' N ' ' HG3' ' A' ' 75' ' ' ARG . 9.2 tp-100 -76.42 -37.22 57.38 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 122.055 0.931 . . . . 0.0 109.581 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -75.15 -1.28 22.42 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 120.117 -0.633 . . . . 0.0 110.059 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.75 50.33 11.63 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 53' ' ' VAL . 40.2 t -99.33 -49.94 11.14 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.301 -1.117 . . . . 0.0 111.721 -178.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 5.4 m-30 -57.86 -32.71 67.92 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.118 -0.989 . . . . 0.0 110.421 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.98 154.68 36.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -70.25 160.3 32.44 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.214 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -132.21 153.03 51.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.231 -0.918 . . . . 0.0 109.896 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -149.21 178.97 8.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.14 -0.975 . . . . 0.0 110.565 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -111.02 61.79 0.61 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.305 -0.872 . . . . 0.0 110.319 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -52.17 169.31 0.08 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.297 -0.877 . . . . 0.0 110.37 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.49 83.14 0.18 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.187 -1.184 . . . . 0.0 110.203 179.898 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.4 ptm . . . . . 0 N--CA 1.496 1.825 0 CA-C-O 121.302 0.572 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.684 HG11 ' CE3' ' A' ' 59' ' ' TRP . 47.9 t -95.16 147.55 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.202 -0.936 . . . . 0.0 110.084 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -140.5 133.1 28.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.85 HD11 ' CB ' ' A' ' 59' ' ' TRP . 68.8 mt -100.26 134.89 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.013 -1.054 . . . . 0.0 109.409 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.419 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.7 ptm180 -151.19 -172.72 4.29 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.1 -1.0 . . . . 0.0 110.928 -178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 70' ' ' ALA . 4.5 mp -89.37 125.87 35.31 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 0.0 110.379 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.649 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.21 112.87 25.21 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.364 -0.835 . . . . 0.0 110.562 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -81.48 122.26 27.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.915 -1.116 . . . . 0.0 112.892 -178.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.649 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 2.0 m-85 -119.08 -152.97 0.52 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.668 -0.645 . . . . 0.0 109.324 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.72 102.46 0.01 OUTLIER Glycine 0 N--CA 1.485 1.905 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.9 p -55.49 -42.23 74.13 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -1.135 . . . . 0.0 109.368 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.9 pttp -176.64 51.06 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 121.455 0.645 . . . . 0.0 109.41 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.4 m-70 -123.74 -51.41 1.82 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -0.864 . . . . 0.0 109.741 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -146.49 138.56 13.59 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.15 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -82.46 122.85 3.69 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 O-C-N 123.611 1.321 . . . . 0.0 110.855 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.488 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.0 p80 -174.94 124.89 0.26 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.209 -0.932 . . . . 0.0 110.479 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.553 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 9.3 m-30 -113.78 153.33 29.26 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.905 -1.122 . . . . 0.0 108.746 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.542 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 2.0 mtt85 -101.35 162.18 13.08 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.048 -1.461 . . . . 0.0 108.26 176.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.03 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.93 80.53 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 102.808 -3.034 . . . . 0.0 102.808 177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.504 HG23 ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -97.46 164.84 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.907 -173.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.932 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.36 112.64 40.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.611 -177.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t -140.54 -171.17 3.16 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.974 -1.079 . . . . 0.0 110.598 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.1 p-10 -78.6 -159.81 0.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.285 -0.884 . . . . 0.0 110.335 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.83 46.12 0.2 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.277 -0.889 . . . . 0.0 110.311 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -173.88 61.35 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.315 0 O-C-N 121.198 -0.939 . . . . 0.0 110.554 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.22 148.3 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -0.904 . . . . 0.0 110.141 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -134.25 57.94 1.79 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 110.364 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.66 -60.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.0 110.134 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -92.73 39.71 1.04 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.252 -0.905 . . . . 0.0 110.191 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -55.65 139.87 41.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.16 95.53 0.07 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.266 -1.138 . . . . 0.0 110.059 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.4 p90 -55.56 178.72 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 0.0 110.697 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.736 HG21 ' HH2' ' A' ' 59' ' ' TRP . 13.3 mm -92.25 -50.2 12.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -157.69 179.19 9.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.574 -0.704 . . . . 0.0 109.6 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.504 ' HG3' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -106.86 107.23 18.14 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.057 -1.027 . . . . 0.0 110.292 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 56' ' ' ALA . 20.7 pt -100.55 -39.08 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.146 -0.971 . . . . 0.0 110.877 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.819 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -118.2 166.35 12.81 Favored Glycine 0 C--N 1.296 -1.683 0 C-N-CA 118.967 -1.587 . . . . 0.0 112.122 -178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' N ' HG12 ' A' ' 19' ' ' ILE . 11.4 t80 -140.73 128.79 22.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.03 ' HB2' HD11 ' A' ' 19' ' ' ILE . 38.1 t80 -128.27 142.48 51.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.709 -1.245 . . . . 0.0 109.906 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 20.6 t0 -140.45 103.89 6.53 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.007 . . . . 0.0 109.414 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 48.5 Cg_endo -76.73 56.71 5.34 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 122.993 0.996 . . . . 0.0 110.855 -178.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.82 172.33 8.97 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.128 -0.982 . . . . 0.0 110.09 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.78 23.79 7.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.163 -0.96 . . . . 0.0 110.404 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.8 t -119.76 -8.5 9.89 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.16 -0.963 . . . . 0.0 110.633 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.4 p -140.36 128.33 12.71 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 0.0 109.892 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.88 -6.98 19.43 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.437 1.23 . . . . 0.0 110.752 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.02 80.22 1.33 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.989 -1.07 . . . . 0.0 110.504 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.568 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 10.8 p-90 -112.43 -1.74 14.92 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.15 -0.969 . . . . 0.0 110.748 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.599 HD12 ' CD2' ' A' ' 73' ' ' LEU . 9.1 tt -97.35 107.08 19.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.952 -1.092 . . . . 0.0 110.034 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.18 90.38 3.28 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.305 -0.872 . . . . 0.0 109.682 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.819 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.51 130.93 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.005 . . . . 0.0 111.178 -179.615 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.0 t0 -78.03 71.01 4.48 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.666 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -35.73 -30.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.379 0 O-C-N 122.258 -0.276 . . . . 0.0 111.624 -177.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.8 mt-10 -59.76 -51.03 71.49 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 120.706 -1.247 . . . . 0.0 108.967 178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 27.1 mmm180 -75.52 -38.14 59.6 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.263 -0.898 . . . . 0.0 108.713 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.96 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.82 -19.39 65.83 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.2 ttp180 -89.16 -23.81 22.35 Favored 'General case' 0 N--CA 1.481 1.087 0 O-C-N 121.378 -0.826 . . . . 0.0 109.49 178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.808 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -63.31 -48.71 76.92 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 123.116 1.436 . . . . 0.0 107.456 178.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.932 ' CD2' HG11 ' A' ' 21' ' ' VAL . 82.1 m95 -65.29 -56.19 14.1 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.951 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.973 HD11 HD13 ' A' ' 74' ' ' LEU . 35.0 mt -54.55 -21.59 10.69 Favored 'General case' 0 C--N 1.294 -1.821 0 C-N-CA 119.161 -1.016 . . . . 0.0 108.558 177.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.8 OUTLIER -81.91 -20.45 38.73 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.427 -0.795 . . . . 0.0 110.389 179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.8 m -98.7 32.25 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 O-C-N 120.871 -1.143 . . . . 0.0 109.322 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.53 26.61 74.33 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.473 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -77.28 115.32 16.95 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.089 -1.242 . . . . 0.0 109.855 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.52 126.15 59.11 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.229 -0.92 . . . . 0.0 110.429 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.451 ' HB3' HD12 ' A' ' 74' ' ' LEU . 53.3 Cg_endo -85.47 162.56 11.04 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 123.494 1.26 . . . . 0.0 109.483 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.1 p -83.94 -171.69 3.74 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.051 -1.031 . . . . 0.0 110.175 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.82 48.27 1.42 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.25 -0.906 . . . . 0.0 110.008 179.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.2 m -166.03 -56.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -68.35 -25.62 65.18 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.403 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.4 ttp180 -66.59 -42.25 87.23 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -66.14 -45.81 79.71 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.296 -0.962 . . . . 0.0 108.786 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.599 ' CD2' HD12 ' A' ' 49' ' ' LEU . 51.7 mt -60.29 -31.99 70.77 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.973 HD13 HD11 ' A' ' 60' ' ' LEU . 20.3 mt -69.15 -26.81 65.05 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.534 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.5 -28.81 30.91 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 121.811 0.815 . . . . 0.0 108.82 178.166 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -81.84 -36.15 28.6 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.904 0.859 . . . . 0.0 110.062 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.96 -9.21 43.58 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 120.104 -0.638 . . . . 0.0 109.751 178.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.52 48.5 5.56 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.659 HG11 HD12 ' A' ' 60' ' ' LEU . 41.4 t -95.3 -66.91 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.12 -1.224 . . . . 0.0 111.605 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 35.7 m-85 -52.42 -47.97 66.03 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.26 -175.94 3.26 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.359 -0.838 . . . . 0.0 110.596 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -126.12 130.81 51.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.395 -0.816 . . . . 0.0 110.177 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.4 144.15 10.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.265 -0.897 . . . . 0.0 110.412 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -100.95 -178.96 3.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.301 -0.874 . . . . 0.0 110.297 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 -89.61 76.03 7.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.902 . . . . 0.0 110.232 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.57 -60.28 2.32 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.193 -0.942 . . . . 0.0 110.307 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 135.21 45.44 0.1 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.247 -1.149 . . . . 0.0 110.19 179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.325 0.583 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.604 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.2 m -57.93 113.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.357 -0.839 . . . . 0.0 110.34 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 3.5 mtpt -140.53 133.19 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.156 -0.965 . . . . 0.0 110.216 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.915 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.7 mt -108.34 131.2 59.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 O-C-N 120.992 -1.068 . . . . 0.0 109.883 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.0 ptm180 -151.08 -169.62 3.44 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.287 -0.883 . . . . 0.0 110.297 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.476 HD22 ' HD2' ' A' ' 39' ' ' TYR . 84.4 mt -89.17 127.69 35.75 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 110.519 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.663 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.25 102.34 13.95 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.713 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.07 121.76 18.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.136 -0.977 . . . . 0.0 112.565 -178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.663 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 4.8 m-85 -122.89 -151.95 0.5 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.464 -0.773 . . . . 0.0 109.379 178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 68.62 105.5 0.03 OUTLIER Glycine 0 N--CA 1.483 1.816 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 p -56.24 -41.7 76.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -1.175 . . . . 0.0 109.061 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -179.35 47.98 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 16.4 m-70 -124.4 -64.86 1.09 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.283 -0.886 . . . . 0.0 110.1 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -131.33 135.6 27.34 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 110.213 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -83.54 88.71 1.12 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 123.489 1.258 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.503 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 31.6 p80 -130.93 129.7 42.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.139 -0.976 . . . . 0.0 110.108 179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 12.4 m-85 -111.5 147.89 34.36 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.165 -0.959 . . . . 0.0 108.429 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -99.86 159.08 15.34 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.048 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -98.07 81.69 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 103.707 -2.701 . . . . 0.0 103.707 178.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -98.47 162.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 114.537 -1.211 . . . . 0.0 112.024 -174.07 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.866 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -109.29 109.42 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.757 -0.589 . . . . 0.0 110.529 -178.032 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.421 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.5 t -135.7 -169.22 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.128 -0.983 . . . . 0.0 110.29 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 1.1 t0 -83.8 -176.15 6.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.871 . . . . 0.0 110.394 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . . . -153.14 43.21 0.61 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.026 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -163.53 52.74 0.16 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.329 -0.857 . . . . 0.0 110.08 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -141.0 168.89 18.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 110.359 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -59.79 4.13 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.32 -0.862 . . . . 0.0 109.938 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -175.28 104.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 0.0 110.37 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -115.83 -36.93 4.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.163 -0.961 . . . . 0.0 110.192 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.81 25.8 66.21 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -121.68 140.6 52.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 110.387 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' HG13 ' A' ' 20' ' ' VAL . 23.4 p90 -120.03 168.06 11.55 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.416 -0.803 . . . . 0.0 110.402 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.616 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.1 mt -70.94 -51.7 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -154.65 165.45 36.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.462 -0.774 . . . . 0.0 109.58 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.9 OUTLIER -99.43 116.73 32.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.917 -1.114 . . . . 0.0 109.956 179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.005 HG21 ' CD1' ' A' ' 59' ' ' TRP . 44.9 pt -107.18 -34.16 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.126 -0.984 . . . . 0.0 111.152 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.806 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.82 167.94 17.05 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.029 -1.557 . . . . 0.0 112.228 -178.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG12 ' A' ' 19' ' ' ILE . 37.0 t80 -140.67 129.26 22.8 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.048 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.5 t80 -129.71 134.07 47.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.731 -1.23 . . . . 0.0 110.042 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 45.3 t0 -140.19 92.61 9.46 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.919 -1.113 . . . . 0.0 110.884 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.11 85.7 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.575 1.303 . . . . 0.0 110.361 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -96.44 -165.37 1.27 Allowed 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.209 -0.932 . . . . 0.0 110.442 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 mttt -132.77 52.97 2.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.965 . . . . 0.0 110.197 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.545 HG23 ' N ' ' A' ' 45' ' ' THR . 6.8 t -145.14 -41.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.9 . . . . 0.0 110.565 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.545 ' N ' HG23 ' A' ' 44' ' ' THR . 0.8 OUTLIER -130.14 155.28 81.02 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 0.0 110.624 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.474 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 50.6 Cg_endo -78.59 -44.28 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.737 1.388 . . . . 0.0 110.259 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -73.2 92.69 1.77 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.313 -0.867 . . . . 0.0 110.091 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.837 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 0.7 OUTLIER -122.43 19.89 10.46 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.255 -0.903 . . . . 0.0 110.566 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.837 HD13 ' HZ3' ' A' ' 48' ' ' TRP . 8.5 tp -116.48 125.89 52.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.994 -1.066 . . . . 0.0 110.926 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -130.05 94.64 3.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.465 -0.772 . . . . 0.0 109.217 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.806 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.04 149.87 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 0.0 110.816 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -94.81 70.51 3.44 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -32.72 -32.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -60.29 -56.02 26.56 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.802 -1.186 . . . . 0.0 109.159 178.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.743 ' HB3' HG22 ' A' ' 36' ' ' ILE . 4.4 mmp_? -69.92 -42.02 73.87 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.428 -0.795 . . . . 0.0 108.872 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.743 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -63.15 -18.36 63.37 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.9 ttp180 -87.87 -25.26 23.36 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.125 -0.984 . . . . 0.0 109.833 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.642 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.9 t80 -60.38 -45.83 92.13 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 123.359 1.552 . . . . 0.0 107.789 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.005 ' CD1' HG21 ' A' ' 36' ' ' ILE . 79.4 m95 -66.11 -54.48 25.03 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 113.591 -1.641 . . . . 0.0 109.94 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 60' ' ' LEU . 18.9 mt -54.97 -21.47 11.89 Favored 'General case' 0 C--N 1.293 -1.858 0 C-N-CA 119.128 -1.029 . . . . 0.0 108.495 177.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 6.5 t -81.46 -23.16 37.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.485 -0.759 . . . . 0.0 110.694 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 58' ' ' TYR . 5.5 m -98.96 32.61 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.797 -1.189 . . . . 0.0 109.568 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.93 29.47 72.48 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.604 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -67.78 135.45 52.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.076 -1.25 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.45 109.06 61.16 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 110.389 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HG2' ' HG3' ' A' ' 71' ' ' ARG . 53.8 Cg_endo -79.13 128.3 8.14 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 O-C-N 123.619 1.326 . . . . 0.0 109.871 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 70' ' ' ALA . 7.9 t -54.22 171.73 0.1 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.11 -0.994 . . . . 0.0 110.204 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.47 54.98 0.78 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.224 -0.922 . . . . 0.0 110.43 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 4.3 m -167.25 -56.61 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.59 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.5 -24.22 66.36 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.556 ' HA ' HD12 ' A' ' 74' ' ' LEU . 20.2 ttt85 -67.4 -40.92 85.62 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.9 -42.99 80.33 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.776 178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.697 ' HB3' HD21 ' A' ' 49' ' ' LEU . 15.2 mt -67.08 -27.08 67.07 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.675 HD23 HG21 ' A' ' 79' ' ' VAL . 13.7 mt -69.82 -28.47 65.74 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.516 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -78.77 -30.54 45.71 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -80.39 -31.84 37.67 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 121.944 0.878 . . . . 0.0 109.993 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.569 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -75.4 -2.13 27.14 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.402 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.5 51.64 9.43 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 -179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.675 HG21 HD23 ' A' ' 74' ' ' LEU . 52.6 t -98.95 -60.71 2.61 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.271 -1.134 . . . . 0.0 111.872 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 43.5 m-85 -53.04 155.06 2.65 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.148 -0.97 . . . . 0.0 110.291 -179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 28.9 mtt180 -149.71 71.63 1.1 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.373 -0.83 . . . . 0.0 110.172 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -56.75 147.07 23.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.291 -0.881 . . . . 0.0 110.212 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -162.28 150.5 14.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 110.245 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -88.88 -174.03 4.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.182 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -121.18 119.26 31.82 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.313 -0.867 . . . . 0.0 109.837 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -169.33 69.56 0.07 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.155 -0.966 . . . . 0.0 110.304 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.36 -46.58 25.8 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.314 -1.11 . . . . 0.0 110.347 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.342 0.592 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 2' ' ' VAL . 15.9 m -53.82 105.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 110.442 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HG3' ' O ' ' A' ' 65' ' ' GLN . 0.1 OUTLIER -140.2 132.83 28.83 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.407 -0.808 . . . . 0.0 109.425 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.955 HD11 ' CB ' ' A' ' 59' ' ' TRP . 65.8 mt -107.62 133.52 52.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.044 -1.035 . . . . 0.0 110.05 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptm180 -151.07 -173.15 4.4 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.278 -0.889 . . . . 0.0 110.437 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.622 HD12 ' HB2' ' A' ' 70' ' ' ALA . 3.7 mp -89.38 125.49 35.16 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.277 -0.889 . . . . 0.0 110.447 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.46 107.42 19.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.473 -0.767 . . . . 0.0 110.054 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 36.7 ttp85 -76.02 115.75 16.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.063 -1.023 . . . . 0.0 112.936 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.2 m-85 -120.38 -152.16 0.5 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.252 -0.905 . . . . 0.0 108.917 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 66.26 116.99 0.01 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.465 ' HG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -63.97 -81.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.27 -1.135 . . . . 0.0 109.88 179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.5 46.79 1.29 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.465 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 3.9 m-70 -134.81 -65.84 0.61 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.432 -0.792 . . . . 0.0 109.924 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -120.16 105.31 42.45 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.385 -0.822 . . . . 0.0 109.913 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -77.43 116.46 4.11 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.479 1.252 . . . . 0.0 111.041 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.508 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 28.1 p80 -152.16 138.73 18.68 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.373 -0.829 . . . . 0.0 109.339 179.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 9.8 m-85 -112.73 165.03 12.66 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.231 -0.918 . . . . 0.0 108.688 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.519 ' C ' HD13 ' A' ' 19' ' ' ILE . 1.2 mtp85 -121.83 156.02 34.13 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.964 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 79.56 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 103.004 -2.961 . . . . 0.0 103.004 177.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.255 0.4 OUTLIER -97.95 159.47 3.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.5 -173.912 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.867 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -107.92 106.03 19.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 CA-C-O 121.334 0.587 . . . . 0.0 110.387 -177.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t -131.59 -167.76 1.91 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.34 -0.85 . . . . 0.0 109.893 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.423 ' N ' ' OG1' ' A' ' 22' ' ' THR . 46.2 p-10 -119.07 176.0 5.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 110.087 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.54 -52.64 4.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -0.945 . . . . 0.0 110.226 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 119.53 9.13 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 110.521 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.68 113.24 7.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.901 . . . . 0.0 110.088 179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -63.59 -76.13 0.07 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.25 -0.907 . . . . 0.0 110.482 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -119.48 -20.14 7.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.327 -0.858 . . . . 0.0 110.504 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.95 147.87 52.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 110.191 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -130.66 69.42 0.53 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.44 121.34 30.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -1.121 . . . . 0.0 110.291 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.533 ' HB3' HG13 ' A' ' 20' ' ' VAL . 32.1 p90 -58.53 150.08 23.75 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.275 -0.891 . . . . 0.0 110.68 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.595 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.3 mt -56.15 -51.93 56.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.565 -0.71 . . . . 0.0 109.204 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -154.92 149.46 26.36 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.375 -0.828 . . . . 0.0 109.933 179.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.3 pttt -89.66 119.29 29.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.126 -0.984 . . . . 0.0 110.074 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.977 HG21 ' CD1' ' A' ' 59' ' ' TRP . 27.7 pt -105.88 -34.14 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.489 -0.757 . . . . 0.0 111.738 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.821 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -120.64 169.33 14.12 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 119.118 -1.515 . . . . 0.0 112.26 -177.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' N ' HG12 ' A' ' 19' ' ' ILE . 86.8 t80 -140.46 127.33 20.6 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 177.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.964 ' HB2' HD11 ' A' ' 19' ' ' ILE . 44.7 t80 -121.28 142.29 50.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.815 -1.178 . . . . 0.0 109.91 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 6.2 t0 -140.79 104.38 6.31 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 45.9 Cg_endo -74.98 75.84 3.57 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.319 1.168 . . . . 0.0 110.759 -178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.87 124.18 34.46 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.156 -0.965 . . . . 0.0 110.167 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -91.98 43.87 1.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 0.0 110.443 -179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.3 p -133.36 -53.47 0.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.229 -0.92 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.6 p -124.84 146.98 54.92 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.258 -0.901 . . . . 0.0 110.029 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -75.82 57.76 5.18 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.53 1.279 . . . . 0.0 110.631 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -150.31 120.69 7.36 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.88 . . . . 0.0 109.871 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.584 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 22.1 p-90 -175.22 -35.04 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.211 -0.93 . . . . 0.0 110.609 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.528 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 5.6 tt -62.95 109.7 1.55 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.097 -1.002 . . . . 0.0 110.597 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -131.47 94.66 3.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.293 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.821 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.8 148.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.129 -0.982 . . . . 0.0 111.043 -179.235 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -92.38 70.65 5.15 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 176.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.684 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -36.47 -29.67 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 122.224 -0.297 . . . . 0.0 111.481 -177.379 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 7.2 mm-40 -61.1 -53.25 59.44 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.693 -1.254 . . . . 0.0 108.522 177.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.744 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -71.29 -40.59 70.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.7 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.65 -16.56 63.85 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.1 ttt-85 -88.64 -26.3 21.96 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 121.156 -0.965 . . . . 0.0 109.29 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 62' ' ' VAL . 13.2 t80 -59.43 -42.63 92.29 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 123.212 1.482 . . . . 0.0 107.382 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.977 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.3 m95 -69.63 -54.24 14.91 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.13 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 79' ' ' VAL . 7.4 mt -56.56 -20.9 23.0 Favored 'General case' 0 C--N 1.292 -1.911 0 C-N-CA 119.149 -1.02 . . . . 0.0 108.468 177.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -80.72 -24.56 38.69 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.426 -0.796 . . . . 0.0 110.517 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 59' ' ' TRP . 27.3 m -99.01 32.11 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 O-C-N 120.879 -1.138 . . . . 0.0 109.606 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.02 31.48 79.57 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.549 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -60.99 146.99 45.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.088 -1.242 . . . . 0.0 110.017 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.404 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 2.0 mm-40 -108.88 93.82 13.25 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.43 -0.794 . . . . 0.0 110.03 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 64' ' ' ALA . 54.9 Cg_endo -80.34 124.79 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.48 1.253 . . . . 0.0 109.923 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.8 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.7 t -57.82 163.58 2.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.944 -1.097 . . . . 0.0 109.702 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -57.88 -22.87 50.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.056 -1.027 . . . . 0.0 111.312 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.3 m -84.55 -53.71 5.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.862 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.8 ' H ' HG23 ' A' ' 67' ' ' THR . . . -70.8 -29.45 65.62 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -66.9 -37.35 84.21 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 178.507 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.94 -26.85 67.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.0 mt -86.37 -30.39 22.2 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.541 -0.724 . . . . 0.0 109.247 179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.436 HD22 ' HB1' ' A' ' 56' ' ' ALA . 80.7 mt -68.59 -28.37 66.87 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 177.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG3' ' CD1' ' A' ' 80' ' ' PHE . 2.0 mtp85 -78.24 -30.43 48.71 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.452 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.1 tp-100 -79.11 -33.58 44.21 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.942 0.877 . . . . 0.0 109.55 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.17 -9.43 52.87 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 120.064 -0.654 . . . . 0.0 109.704 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 87.48 52.34 3.05 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.684 HG22 ' CB ' ' A' ' 53' ' ' VAL . 40.2 t -115.53 -0.79 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.058 -1.26 . . . . 0.0 111.519 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CD1' ' HG3' ' A' ' 75' ' ' ARG . 11.5 m-85 -115.63 87.66 2.72 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.843 -1.161 . . . . 0.0 110.38 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -135.22 119.71 18.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.844 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -119.89 64.45 0.82 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.912 . . . . 0.0 110.265 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -159.22 89.11 0.9 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 110.152 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -158.22 128.29 6.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -0.883 . . . . 0.0 110.335 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 77.66 8.07 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.271 -0.893 . . . . 0.0 110.31 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -70.28 -71.49 0.24 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.182 -0.949 . . . . 0.0 110.424 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -134.19 -63.38 0.07 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.278 -1.131 . . . . 0.0 110.255 -179.855 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mtt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.226 0.536 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.602 HG11 ' CE3' ' A' ' 59' ' ' TRP . 50.2 t -78.12 128.65 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 0.0 109.982 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt -140.16 138.73 35.42 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.085 -1.009 . . . . 0.0 110.554 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.945 ' CG1' HG13 ' A' ' 21' ' ' VAL . 86.0 mt -103.25 130.92 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.29 -0.881 . . . . 0.0 109.343 179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.75 -172.0 4.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.247 -0.908 . . . . 0.0 110.65 -179.04 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.512 HD13 ' HB ' ' A' ' 69' ' ' THR . 5.0 mp -88.97 125.56 35.03 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.425 -0.797 . . . . 0.0 110.469 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.681 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.55 112.51 24.71 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.56 -0.712 . . . . 0.0 109.797 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.3 124.42 28.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.903 -1.123 . . . . 0.0 112.675 -178.313 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.681 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.3 m-85 -126.08 -154.43 0.62 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.45 -0.781 . . . . 0.0 109.349 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.01 138.55 0.02 OUTLIER Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.437 ' OG ' ' NE2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -75.54 -80.52 0.09 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.591 -0.947 . . . . 0.0 109.389 178.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 8.8 mtmt -149.44 57.04 0.99 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.437 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 5.3 m-70 -143.37 -56.1 0.4 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.298 -178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -124.05 112.25 28.54 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.295 -0.878 . . . . 0.0 110.412 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -79.76 112.38 2.9 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.538 1.283 . . . . 0.0 110.881 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.471 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.6 p80 -151.95 132.08 13.53 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 110.119 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 8.5 m-85 -114.07 153.04 30.14 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.324 -0.86 . . . . 0.0 109.321 179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.546 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 1.5 ttm180 -104.55 153.52 21.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.013 -1.075 . . . . 0.0 108.148 178.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.957 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -98.53 78.65 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.607 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.272 0.4 OUTLIER -97.98 166.17 2.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.196 -1.365 . . . . 0.0 111.527 -173.684 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.945 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.36 109.6 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.755 -0.59 . . . . 0.0 110.51 -177.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.0 t -137.45 -166.06 1.87 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.013 -1.054 . . . . 0.0 110.179 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.422 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.4 m-20 -118.29 167.93 11.08 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.915 . . . . 0.0 110.369 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -110.78 -33.17 6.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.275 -0.891 . . . . 0.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 19.2 ttp180 -52.3 -27.23 14.39 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.168 -0.957 . . . . 0.0 110.197 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -86.44 135.49 33.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.251 -0.906 . . . . 0.0 110.128 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.6 mtpm? -125.67 -6.81 6.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.117 -0.99 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -93.87 0.22 56.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.871 -1.143 . . . . 0.0 110.779 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.79 126.15 4.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.02 -1.05 . . . . 0.0 110.187 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.84 29.55 9.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.2 tttm -73.1 144.11 47.12 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.192 -1.181 . . . . 0.0 110.252 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.607 ' CD2' HG21 ' A' ' 20' ' ' VAL . 17.0 p90 -110.46 155.5 22.14 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.176 -0.953 . . . . 0.0 110.418 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.71 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.8 mp -58.87 -53.35 48.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.397 -0.814 . . . . 0.0 109.589 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -149.75 173.74 13.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 109.989 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -109.93 119.7 40.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.184 -0.948 . . . . 0.0 109.951 179.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 56' ' ' ALA . 21.7 pt -110.7 -38.81 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.049 -1.032 . . . . 0.0 111.656 -179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.807 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.1 167.83 14.11 Favored Glycine 0 C--N 1.295 -1.72 0 C-N-CA 118.897 -1.621 . . . . 0.0 111.45 -178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.456 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.7 t80 -137.23 141.17 42.06 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.59 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 25.5 t80 -138.5 139.27 38.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.75 -1.218 . . . . 0.0 110.718 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.8 t0 -139.62 104.69 6.98 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.252 -0.905 . . . . 0.0 109.481 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 43.8 Cg_endo -72.82 70.3 3.55 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 122.985 0.992 . . . . 0.0 110.375 -179.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -89.81 138.65 31.3 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.337 -0.852 . . . . 0.0 110.22 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -98.98 33.54 2.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 110.2 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.519 HG23 ' N ' ' A' ' 45' ' ' THR . 8.8 t -132.65 -40.07 0.98 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.315 -0.866 . . . . 0.0 110.139 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.519 ' N ' HG23 ' A' ' 44' ' ' THR . 22.3 p -135.87 135.5 21.75 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.263 -0.898 . . . . 0.0 110.011 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.17 -9.56 23.46 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.678 1.357 . . . . 0.0 110.926 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.42 64.82 1.18 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.636 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.59 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 26.4 p-90 -124.72 -10.07 7.3 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.994 -1.066 . . . . 0.0 111.132 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 49' ' ' LEU . 10.1 tt -91.94 109.6 20.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.907 -1.12 . . . . 0.0 110.557 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 3.7 mmmt -126.88 103.76 7.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.334 -0.854 . . . . 0.0 109.639 179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.957 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -127.32 149.0 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.877 -1.139 . . . . 0.0 111.4 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.8 t0 -97.56 70.45 2.24 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.627 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -33.77 -32.5 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 120.562 0.22 . . . . 0.0 111.435 -177.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 52' ' ' ASP . 6.4 tt0 -60.99 -53.98 50.53 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.822 -1.173 . . . . 0.0 108.865 178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.468 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 48.0 mmm-85 -73.72 -38.37 64.82 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.296 -0.877 . . . . 0.0 108.833 178.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.911 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.27 -21.35 66.56 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -89.2 -24.11 22.22 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.104 -0.997 . . . . 0.0 109.932 178.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.546 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -59.01 -49.6 77.26 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 123.269 1.509 . . . . 0.0 107.197 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.885 ' CD2' HG11 ' A' ' 21' ' ' VAL . 84.6 m95 -62.56 -52.29 64.0 Favored 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.265 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.885 HD11 HD13 ' A' ' 74' ' ' LEU . 4.0 mt -54.24 -22.41 11.58 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.338 176.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -80.81 -22.08 40.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.437 -0.79 . . . . 0.0 110.743 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.5 m -98.93 33.24 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 O-C-N 120.823 -1.173 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.28 28.17 72.93 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -68.21 134.01 49.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.112 -1.228 . . . . 0.0 110.081 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.19 109.09 59.33 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.113 -0.992 . . . . 0.0 110.316 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.481 ' HG3' HD21 ' A' ' 60' ' ' LEU . 51.4 Cg_endo -84.59 126.86 3.61 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.616 1.324 . . . . 0.0 110.352 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.753 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.3 t -60.51 173.41 0.71 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.03 -1.044 . . . . 0.0 109.89 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -58.21 -27.83 64.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.223 -0.923 . . . . 0.0 111.103 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.512 ' HB ' HD13 ' A' ' 6' ' ' LEU . 1.8 m -83.13 -52.08 6.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.176 -0.953 . . . . 0.0 110.762 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.753 ' H ' HG23 ' A' ' 67' ' ' THR . . . -68.67 -26.47 65.33 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 67' ' ' THR . 2.4 ttt-85 -68.2 -38.65 82.18 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.42 -45.22 80.64 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.493 ' CD2' HD12 ' A' ' 49' ' ' LEU . 59.6 mt -65.88 -25.76 67.33 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.474 -0.766 . . . . 0.0 109.78 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.885 HD13 HD11 ' A' ' 60' ' ' LEU . 17.2 mt -74.4 -26.06 59.85 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.544 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -84.24 -29.38 26.55 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.174 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -84.29 -36.08 22.88 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.823 0.82 . . . . 0.0 110.196 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.76 -9.14 41.44 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.769 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.06 57.14 2.57 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.635 HG21 HD23 ' A' ' 74' ' ' LEU . 21.7 t -109.77 -59.31 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.176 -1.191 . . . . 0.0 111.092 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.7 m-30 -51.49 -24.48 5.17 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.112 -0.993 . . . . 0.0 110.499 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -111.86 105.07 13.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 110.642 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -93.81 117.54 30.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.186 -0.946 . . . . 0.0 109.788 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -115.91 -153.1 0.52 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.195 -0.941 . . . . 0.0 110.375 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -113.76 172.66 6.85 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.273 -0.892 . . . . 0.0 110.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 26.65 2.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.301 -0.874 . . . . 0.0 110.135 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.44 -57.56 12.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.327 -0.858 . . . . 0.0 110.513 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 172.69 43.9 0.04 OUTLIER Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.235 -1.156 . . . . 0.0 110.205 179.956 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.167 0.508 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.538 HG11 ' CE3' ' A' ' 59' ' ' TRP . 66.3 t -77.23 133.38 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 0.0 110.228 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.72 ' C ' HD13 ' A' ' 4' ' ' ILE . 12.9 mtpt -134.04 128.75 34.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 110.303 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.999 HD12 HG13 ' A' ' 21' ' ' VAL . 1.3 mm -103.74 133.79 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.551 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 16.5 ptm180 -151.0 177.65 9.95 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.889 -1.132 . . . . 0.0 110.858 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 pp -89.55 132.17 35.21 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.453 -0.899 . . . . 0.0 108.892 178.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.05 157.81 16.09 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.56 -0.712 . . . . 0.0 109.232 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 8.8 tmm_? -124.29 109.31 13.2 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.889 -1.132 . . . . 0.0 111.315 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -119.63 -151.44 0.48 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.264 -0.897 . . . . 0.0 109.247 179.051 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 84.93 56.64 2.42 Favored Glycine 0 N--CA 1.482 1.758 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.447 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 37.8 p -54.37 -56.74 15.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.128 -1.219 . . . . 0.0 109.714 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.447 ' N ' ' OG ' ' A' ' 11' ' ' SER . 22.3 mttp -146.14 54.43 1.15 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.4 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.3 m-70 -141.55 -63.43 0.45 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.347 -0.846 . . . . 0.0 109.817 -178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.405 ' ND2' ' HD2' ' A' ' 15' ' ' PRO . 0.7 OUTLIER -165.26 142.15 4.76 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.438 -0.789 . . . . 0.0 109.81 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD2' ' ND2' ' A' ' 14' ' ' ASN . 46.3 Cg_endo -73.09 107.58 2.4 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.64 1.337 . . . . 0.0 111.34 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 27.5 p80 -150.45 147.35 27.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.288 -0.882 . . . . 0.0 110.03 179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 8' ' ' ARG . 14.0 m-85 -121.74 173.06 7.7 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -137.24 150.83 48.11 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 121.01 -1.056 . . . . 0.0 108.301 177.269 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.804 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -97.06 85.95 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 178.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.646 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -98.49 168.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 113.816 -1.538 . . . . 0.0 111.634 -173.158 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.032 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.7 t -113.81 102.78 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.694 -0.629 . . . . 0.0 110.776 -177.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.415 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.6 t -132.45 -173.87 3.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.349 -0.844 . . . . 0.0 110.391 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.415 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.4 p30 -83.01 -160.33 0.4 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.346 -0.846 . . . . 0.0 110.381 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -93.14 -36.92 12.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.223 -0.923 . . . . 0.0 110.321 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.1 131.25 30.24 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.29 -0.881 . . . . 0.0 110.334 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 175.49 10.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 110.146 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.29 -63.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 110.28 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -90.83 -37.45 13.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.242 -0.911 . . . . 0.0 109.999 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -149.3 140.25 22.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.881 . . . . 0.0 110.066 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.49 51.97 1.56 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -112.1 115.49 28.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.252 -1.146 . . . . 0.0 110.445 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.646 ' CD2' HG21 ' A' ' 20' ' ' VAL . 12.8 p90 -62.95 166.0 6.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.28 -0.887 . . . . 0.0 110.289 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.5 mp -63.3 -58.63 6.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.319 -0.863 . . . . 0.0 109.582 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -145.08 173.91 11.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.313 -0.867 . . . . 0.0 110.012 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HG3' ' HD3' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -110.42 115.34 29.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.202 -0.936 . . . . 0.0 109.572 179.691 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.973 HD12 ' HA ' ' A' ' 56' ' ' ALA . 18.1 pt -108.98 -40.01 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.108 -0.995 . . . . 0.0 111.243 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.89 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -111.76 167.05 12.31 Favored Glycine 0 C--N 1.293 -1.827 0 C-N-CA 119.112 -1.518 . . . . 0.0 112.225 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.452 ' N ' HG12 ' A' ' 19' ' ' ILE . 87.5 t80 -140.8 126.18 18.74 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.804 ' HB2' HD11 ' A' ' 19' ' ' ILE . 13.9 t80 -117.81 139.89 50.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.726 -1.234 . . . . 0.0 110.046 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 3.2 t0 -140.41 104.94 6.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.071 -1.018 . . . . 0.0 109.848 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.468 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 49.8 Cg_endo -77.62 80.1 3.03 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.213 1.112 . . . . 0.0 110.765 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -92.15 158.25 16.28 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.043 -1.036 . . . . 0.0 110.294 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.0 40.02 2.02 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.138 -0.976 . . . . 0.0 110.418 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.2 p -115.31 -73.56 0.65 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 110.053 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 66.4 p -127.82 156.26 76.1 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.276 -0.89 . . . . 0.0 110.019 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.06 63.49 4.15 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.658 1.346 . . . . 0.0 110.394 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -154.56 80.79 1.1 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.179 -0.951 . . . . 0.0 110.447 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 9.5 p-90 -134.41 -29.24 1.23 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.203 -0.936 . . . . 0.0 111.38 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 73' ' ' LEU . 0.9 OUTLIER -57.24 123.41 15.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.908 -1.12 . . . . 0.0 111.008 -179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.1 mtmm -133.36 101.6 5.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.517 -0.74 . . . . 0.0 109.264 179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.89 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -129.22 135.25 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.053 -1.029 . . . . 0.0 111.412 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.441 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.1 t0 -77.62 70.06 3.95 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 175.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.699 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -35.91 -30.93 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 122.276 -0.265 . . . . 0.0 111.286 -177.394 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.2 -53.44 57.63 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.834 -1.166 . . . . 0.0 108.723 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.5 mmm180 -74.0 -38.17 64.18 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.973 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.23 -17.57 63.7 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.0 ttt180 -89.19 -25.58 21.71 Favored 'General case' 0 N--CA 1.481 1.102 0 O-C-N 121.282 -0.886 . . . . 0.0 109.324 178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.952 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.59 -44.68 93.29 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 123.575 1.655 . . . . 0.0 106.953 178.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.032 ' CD2' HG11 ' A' ' 21' ' ' VAL . 80.5 m95 -67.23 -59.5 3.38 Favored 'General case' 0 C--N 1.28 -2.423 0 CA-C-N 113.404 -1.726 . . . . 0.0 110.003 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.864 HD11 HD13 ' A' ' 74' ' ' LEU . 3.9 mt -54.04 -21.88 9.38 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.147 -1.021 . . . . 0.0 108.826 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 58' ' ' TYR . 30.6 t -81.27 -19.07 43.83 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.427 -0.796 . . . . 0.0 110.262 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.952 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.62 32.01 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 O-C-N 120.843 -1.161 . . . . 0.0 109.214 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.33 25.49 75.42 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.233 -1.547 . . . . 0.0 109.233 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.459 ' HB1' ' CG1' ' A' ' 4' ' ' ILE . . . -70.68 126.57 29.98 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.178 -1.19 . . . . 0.0 110.026 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -94.31 111.35 53.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.0 110.331 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.699 ' HG3' HD21 ' A' ' 60' ' ' LEU . 51.9 Cg_endo -80.86 131.23 7.95 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.48 1.253 . . . . 0.0 110.332 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.9 p -56.92 159.17 4.28 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.941 -1.099 . . . . 0.0 110.075 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -52.61 -34.23 50.07 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.114 -0.991 . . . . 0.0 111.581 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.402 ' HB ' HD23 ' A' ' 6' ' ' LEU . 5.3 m -83.68 -49.9 8.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 111.191 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.882 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.26 -22.98 61.9 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.253 -0.904 . . . . 0.0 109.264 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -70.97 -36.14 72.41 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.78 -33.4 74.74 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.882 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.3 mt -75.17 -30.24 60.65 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.573 -0.704 . . . . 0.0 109.172 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.864 HD13 HD11 ' A' ' 60' ' ' LEU . 16.1 mt -68.03 -29.43 68.41 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.453 ' HG2' ' CD1' ' A' ' 80' ' ' PHE . 2.7 tmm_? -77.68 -31.03 52.23 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 177.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.54 ' HB3' HD13 ' A' ' 49' ' ' LEU . 3.5 tp-100 -77.49 -28.54 52.24 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.986 0.898 . . . . 0.0 109.391 178.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.07 -8.79 48.44 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.225 178.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 89.99 31.43 11.0 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.639 HG22 HG23 ' A' ' 53' ' ' VAL . 47.4 t -92.14 -64.98 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.218 -1.166 . . . . 0.0 110.651 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.453 ' CD1' ' HG2' ' A' ' 75' ' ' ARG . 18.8 p90 -133.87 -172.45 2.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.16 -0.963 . . . . 0.0 110.69 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.451 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -117.25 169.28 9.59 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.503 -0.748 . . . . 0.0 109.88 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -70.5 107.65 3.95 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.171 -0.955 . . . . 0.0 110.303 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -130.31 125.35 34.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.287 -0.883 . . . . 0.0 110.128 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.58 101.03 0.73 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -0.905 . . . . 0.0 110.415 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 38.8 mtp85 -92.12 68.85 5.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.21 -0.931 . . . . 0.0 109.879 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -52.07 128.22 23.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.0 110.446 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 62.5 174.36 2.15 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.264 -1.139 . . . . 0.0 110.256 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.225 0.536 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 64' ' ' ALA . 17.1 m -74.48 115.9 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.203 -0.936 . . . . 0.0 110.588 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.2 ptmt -140.73 138.99 34.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.045 -1.034 . . . . 0.0 110.42 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.939 HG13 HG13 ' A' ' 21' ' ' VAL . 4.5 mt -103.84 135.32 42.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.048 -1.032 . . . . 0.0 108.681 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -150.64 -170.42 3.65 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.861 -1.149 . . . . 0.0 110.777 -179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.687 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -89.03 129.22 35.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.322 -0.861 . . . . 0.0 109.857 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -102.85 108.47 19.69 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.345 -0.847 . . . . 0.0 111.453 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 8.6 ttp180 -77.94 122.77 25.95 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.99 -1.069 . . . . 0.0 111.009 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.628 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 12.6 m-85 -109.2 -64.66 1.22 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.481 -0.762 . . . . 0.0 110.889 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -47.93 124.59 10.72 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.6 p -66.84 -38.35 86.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.323 -1.104 . . . . 0.0 109.544 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.414 ' CD ' ' O ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -178.11 47.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.658 -0.651 . . . . 0.0 109.448 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -123.44 -49.98 1.89 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.44 -0.787 . . . . 0.0 109.561 -179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 49.7 t-20 -141.57 126.92 10.81 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.538 -0.726 . . . . 0.0 109.568 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.34 106.19 2.19 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.318 1.167 . . . . 0.0 111.017 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.499 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.3 p80 -161.25 122.96 2.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.23 -0.919 . . . . 0.0 110.851 179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 6.5 m-30 -116.99 152.87 33.69 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.961 -1.087 . . . . 0.0 108.511 178.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.626 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.8 OUTLIER -102.85 166.89 10.21 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 117.645 -1.622 . . . . 0.0 108.058 176.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.925 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.11 85.64 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 N-CA-C 104.521 -2.4 . . . . 0.0 104.521 179.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.527 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.26 0.4 OUTLIER -99.21 164.48 2.5 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.283 -175.011 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.972 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.3 t -107.9 110.87 33.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.562 -0.711 . . . . 0.0 109.961 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t -137.1 -170.7 2.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.399 -0.813 . . . . 0.0 110.505 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.8 p30 -143.01 148.12 36.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.396 -0.815 . . . . 0.0 109.88 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.81 11.16 39.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.187 -0.946 . . . . 0.0 110.674 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.8 50.32 0.97 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.087 -1.008 . . . . 0.0 110.45 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -165.66 76.72 0.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.105 -0.997 . . . . 0.0 110.287 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -69.38 67.48 0.2 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.202 -0.936 . . . . 0.0 110.287 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -135.91 -42.64 0.66 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.229 -0.919 . . . . 0.0 110.423 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -139.78 -59.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.119 -0.988 . . . . 0.0 110.452 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.26 39.03 4.11 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -103.67 121.55 43.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -1.131 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.509 ' CD2' HG21 ' A' ' 20' ' ' VAL . 7.8 p90 -55.52 170.24 0.26 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 110.47 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.1 mp -91.82 -41.93 13.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.573 -0.704 . . . . 0.0 109.303 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.9 tt0 -151.17 150.35 30.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.295 -0.878 . . . . 0.0 110.117 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' HG2' ' HD2' ' A' ' 18' ' ' ARG . 3.7 mtpp -96.46 118.88 33.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.141 -0.975 . . . . 0.0 109.91 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.672 HD12 ' CB ' ' A' ' 56' ' ' ALA . 43.3 pt -99.84 -27.66 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.002 -1.061 . . . . 0.0 111.756 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -150.64 -174.41 21.66 Favored Glycine 0 N--CA 1.481 1.665 0 C-N-CA 117.693 -2.194 . . . . 0.0 113.001 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.626 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 36.7 t80 -140.83 147.45 39.03 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.996 -0.602 . . . . 0.0 109.872 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.925 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.2 t80 -140.21 132.89 28.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.588 -1.32 . . . . 0.0 109.664 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 27.4 t0 -139.13 97.75 8.58 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.896 -1.127 . . . . 0.0 110.401 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.48 72.04 1.83 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.657 1.346 . . . . 0.0 110.831 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.51 171.68 8.22 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.205 -0.935 . . . . 0.0 110.069 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.75 39.92 2.56 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.247 -0.908 . . . . 0.0 110.152 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 p -110.46 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.935 . . . . 0.0 110.063 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.7 p -128.12 157.64 73.49 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.899 . . . . 0.0 110.075 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.31 -42.32 2.01 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.657 1.346 . . . . 0.0 110.016 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.47 99.49 5.67 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.37 -0.831 . . . . 0.0 109.958 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.708 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 1.7 p-90 -122.41 17.14 10.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.227 -0.921 . . . . 0.0 110.917 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.807 HD21 ' HB3' ' A' ' 73' ' ' LEU . 11.5 tp -118.9 138.53 52.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.988 -1.07 . . . . 0.0 110.789 -179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -140.1 72.95 1.41 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.48 -0.762 . . . . 0.0 110.199 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.772 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -94.69 129.44 44.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.092 -1.005 . . . . 0.0 110.274 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.6 t0 -73.88 70.12 1.44 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 176.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.631 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.36 -29.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.341 0 O-C-N 122.149 -0.344 . . . . 0.0 111.606 -177.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -62.99 -55.89 21.81 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.619 -1.301 . . . . 0.0 109.082 178.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -75.45 -29.75 59.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.305 -0.872 . . . . 0.0 108.994 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.672 ' CB ' HD12 ' A' ' 36' ' ' ILE . . . -73.38 -22.93 60.14 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.947 -1.096 . . . . 0.0 108.082 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttt85 -86.0 -21.35 27.86 Favored 'General case' 0 N--CA 1.483 1.186 0 O-C-N 121.142 -0.974 . . . . 0.0 108.912 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.58 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -60.34 -49.44 77.58 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 178.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.972 ' CD2' HG11 ' A' ' 21' ' ' VAL . 81.4 m95 -61.55 -53.33 57.75 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.316 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.3 mt -52.67 -22.71 5.44 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.1 -22.32 42.29 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.546 -0.721 . . . . 0.0 110.434 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.4 m -98.85 32.01 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 O-C-N 120.74 -1.225 . . . . 0.0 109.52 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.19 27.26 73.11 Favored Glycine 0 N--CA 1.488 2.103 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.663 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -67.95 134.31 50.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.152 -1.205 . . . . 0.0 110.109 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -105.94 105.65 54.1 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.497 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.3 Cg_endo -79.07 129.51 8.89 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.607 1.319 . . . . 0.0 110.051 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.756 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.0 t -58.45 165.8 1.98 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.055 -1.028 . . . . 0.0 109.846 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -56.47 -27.89 58.23 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.164 -0.96 . . . . 0.0 111.515 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.3 m -82.24 -52.7 6.69 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.934 -1.104 . . . . 0.0 110.806 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.756 ' H ' HG23 ' A' ' 67' ' ' THR . . . -69.49 -26.49 64.58 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.326 -0.859 . . . . 0.0 108.721 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.424 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.9 OUTLIER -66.52 -38.45 87.23 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 178.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.25 -41.16 90.38 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.585 -0.846 . . . . 0.0 108.954 178.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.807 ' HB3' HD21 ' A' ' 49' ' ' LEU . 14.7 mt -71.13 -27.2 63.4 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.783 HD23 HG21 ' A' ' 79' ' ' VAL . 12.9 mt -70.52 -27.83 64.48 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.53 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.96 -32.83 51.64 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -79.94 -29.34 39.69 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.981 0.896 . . . . 0.0 109.907 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' HB3' HG23 ' A' ' 79' ' ' VAL . . . -74.27 -4.47 36.29 Favored 'General case' 0 C--N 1.29 -2.002 0 O-C-N 121.866 -0.521 . . . . 0.0 110.257 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 76.53 39.46 30.07 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.783 HG21 HD23 ' A' ' 74' ' ' LEU . 48.2 t -92.39 -35.46 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.282 -1.128 . . . . 0.0 111.459 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.53 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 7.0 m-30 -80.07 103.64 10.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.964 -1.085 . . . . 0.0 110.559 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.6 mtt85 -89.97 97.46 11.2 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.307 -0.871 . . . . 0.0 110.013 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.05 119.73 3.6 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.378 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -78.52 92.31 4.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.317 -0.864 . . . . 0.0 110.116 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -98.1 117.42 32.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 110.387 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.13 121.33 41.82 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.881 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -168.3 29.25 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.237 -0.915 . . . . 0.0 110.309 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 145.09 -63.85 0.46 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.399 -1.059 . . . . 0.0 110.072 -179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.645 ' HA ' ' HB3' ' A' ' 24' ' ' ALA . 12.7 mtt . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.301 0.572 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.452 HG11 ' HE3' ' A' ' 59' ' ' TRP . 60.8 t -84.75 120.57 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.94 . . . . 0.0 110.296 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 2.1 mtpt -140.49 129.72 23.7 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.784 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.983 ' CG1' HG13 ' A' ' 21' ' ' VAL . 52.1 mt -101.22 132.09 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.06 -1.025 . . . . 0.0 109.132 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.12 -169.47 3.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.993 -1.067 . . . . 0.0 110.95 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.7 mp -88.8 125.89 35.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.361 -0.837 . . . . 0.0 111.005 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.0 108.51 20.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.49 -0.756 . . . . 0.0 110.944 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.559 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 53.4 ttt-85 -77.82 121.39 24.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.023 -1.048 . . . . 0.0 111.592 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 13.7 m-85 -113.84 -64.23 1.34 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.606 0.717 . . . . 0.0 110.301 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.69 132.16 39.93 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 34.7 p -87.24 -57.49 2.94 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.266 -1.138 . . . . 0.0 109.868 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' N ' ' OG ' ' A' ' 11' ' ' SER . 5.6 mtmt -146.15 42.54 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -0.763 . . . . 0.0 109.092 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -128.53 -50.53 1.27 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.483 -0.761 . . . . 0.0 109.48 -178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -147.79 114.3 4.02 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.642 -0.661 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.79 86.23 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.493 1.259 . . . . 0.0 111.104 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.525 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.3 p80 -134.06 125.31 27.79 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.094 -1.004 . . . . 0.0 110.573 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 11.7 m-30 -114.48 151.24 33.58 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.47 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 5.5 mtp180 -101.46 160.38 14.48 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.86 -1.536 . . . . 0.0 108.021 177.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.893 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -98.83 79.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 177.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.537 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.253 0.4 OUTLIER -97.82 160.63 3.02 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.886 -174.236 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.983 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -102.73 121.08 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.872 HG22 ' HB3' ' A' ' 32' ' ' TYR . 7.1 p -119.51 -177.81 3.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.212 -0.93 . . . . 0.0 109.943 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -96.61 -169.57 1.92 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.304 -0.872 . . . . 0.0 110.246 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' A' ' 1' ' ' MET . . . -148.2 -47.05 0.16 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.865 . . . . 0.0 110.327 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.51 75.72 5.02 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.098 -1.001 . . . . 0.0 110.481 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -168.93 -158.95 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.086 -1.009 . . . . 0.0 110.287 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.24 -157.32 0.6 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.306 -0.871 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.6 84.19 3.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.379 -0.826 . . . . 0.0 110.326 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -84.4 -60.36 2.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 109.901 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.23 -46.26 1.7 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' C ' ' CD1' ' A' ' 32' ' ' TYR . 31.2 pttt -67.14 -166.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.144 -1.209 . . . . 0.0 110.346 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.872 ' HB3' HG22 ' A' ' 22' ' ' THR . 0.0 OUTLIER -148.54 -170.78 3.69 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.261 -0.899 . . . . 0.0 110.159 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.668 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.8 mt -92.17 -37.43 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.538 -0.727 . . . . 0.0 110.01 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -174.6 153.94 1.93 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.375 -0.828 . . . . 0.0 109.824 179.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -94.43 116.0 28.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.088 -1.007 . . . . 0.0 110.277 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.869 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.5 pt -103.02 -32.43 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.514 -0.741 . . . . 0.0 110.448 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.811 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.41 169.03 16.44 Favored Glycine 0 C--N 1.294 -1.764 0 C-N-CA 119.218 -1.467 . . . . 0.0 111.341 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' ILE . 48.0 t80 -140.15 134.64 31.52 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.0 t80 -133.6 131.24 39.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.736 -1.228 . . . . 0.0 110.121 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 44.0 t0 -140.29 86.09 13.05 Favored Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 120.581 -1.325 . . . . 0.0 110.758 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.05 66.98 1.34 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.533 1.28 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 150.49 22.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.274 -0.892 . . . . 0.0 109.83 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.0 38.68 1.03 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 110.272 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 45' ' ' THR . 6.9 t -138.09 -41.2 0.53 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.321 -0.862 . . . . 0.0 110.16 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.524 ' N ' HG23 ' A' ' 44' ' ' THR . 7.4 p -108.54 131.62 21.65 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.14 -0.975 . . . . 0.0 109.998 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.26 -44.51 0.42 Allowed 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.505 1.266 . . . . 0.0 110.493 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.76 90.83 5.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 110.404 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.5 p-90 -115.16 -4.26 12.48 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.186 -0.946 . . . . 0.0 110.924 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.552 HD12 ' CD2' ' A' ' 73' ' ' LEU . 8.3 tt -93.37 106.94 18.85 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.922 -1.111 . . . . 0.0 110.403 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 38' ' ' TYR . 0.7 OUTLIER -122.85 96.59 5.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.146 -0.971 . . . . 0.0 109.484 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.893 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -120.86 151.04 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 0.0 111.499 -179.012 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.4 t70 -96.88 67.87 2.31 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.62 -31.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 112.038 -177.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 27.4 tt0 -62.34 -56.84 14.49 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.729 -1.232 . . . . 0.0 109.012 178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 13.5 mmm180 -72.77 -35.54 67.47 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.263 -0.898 . . . . 0.0 109.063 178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.46 -20.78 66.39 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 34.8 ttt85 -88.25 -25.05 23.06 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -59.94 -46.72 88.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.152 1.453 . . . . 0.0 107.301 178.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.959 ' HB3' HD11 ' A' ' 4' ' ' ILE . 87.5 m95 -65.4 -55.52 17.61 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-N 113.852 -1.522 . . . . 0.0 109.814 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.8 HD11 HD13 ' A' ' 74' ' ' LEU . 6.4 mt -53.42 -22.6 8.0 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.183 -1.007 . . . . 0.0 108.529 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 8.0 t -82.81 -19.62 37.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.394 -0.816 . . . . 0.0 110.568 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.3 m -98.98 32.9 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.235 0 O-C-N 120.798 -1.189 . . . . 0.0 109.272 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.57 27.87 72.93 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -71.42 134.91 46.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.139 -1.212 . . . . 0.0 109.9 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.462 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 7.1 mt-30 -101.79 108.12 54.74 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 110.502 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.636 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.8 Cg_endo -81.27 140.74 12.4 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.536 1.282 . . . . 0.0 110.249 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -73.24 169.27 17.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.09 -1.006 . . . . 0.0 109.744 179.417 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.01 -18.47 34.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.145 -0.972 . . . . 0.0 110.775 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.435 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 3.5 m -95.07 -49.68 5.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.066 -1.021 . . . . 0.0 110.515 -179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.68 -25.48 62.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.343 -0.848 . . . . 0.0 108.768 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -69.12 -35.4 76.37 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtt180 -67.19 -34.47 77.58 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.774 178.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 70' ' ' ALA . 31.6 mt -73.84 -28.0 61.38 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.587 -0.696 . . . . 0.0 109.514 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.8 HD13 HD11 ' A' ' 60' ' ' LEU . 54.0 mt -71.96 -27.25 62.65 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.541 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -81.49 -30.5 33.26 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 6.0 tp-100 -82.51 -38.33 23.99 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-O 121.788 0.804 . . . . 0.0 110.015 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.425 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -64.23 -12.15 38.15 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.817 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.93 36.41 8.44 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.581 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.9 t -87.02 -59.36 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.035 -1.273 . . . . 0.0 111.324 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.541 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.2 m-30 -53.44 122.08 8.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.012 -1.055 . . . . 0.0 110.225 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.58 -48.44 9.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.249 -0.907 . . . . 0.0 109.945 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -140.83 143.92 35.07 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.859 . . . . 0.0 109.985 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -127.44 161.77 27.92 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.387 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -85.05 93.01 8.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.284 -0.885 . . . . 0.0 110.529 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.1 mmt180 -117.35 50.82 1.07 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.352 -0.843 . . . . 0.0 109.954 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -160.26 -62.95 0.07 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 95.94 -121.39 6.91 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.352 -1.087 . . . . 0.0 110.116 179.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.259 0.552 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.558 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.1 m -149.08 116.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.246 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 9.3 mtpt -140.32 136.66 33.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 110.868 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.918 ' CG1' HD11 ' A' ' 36' ' ' ILE . 1.1 mp -99.62 119.13 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 13.4 ptt85 -150.33 -179.79 7.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.987 -1.07 . . . . 0.0 110.906 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.0 mp -88.91 124.73 34.5 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.279 -0.888 . . . . 0.0 111.024 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.7 100.84 11.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.414 -0.804 . . . . 0.0 111.687 -179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 47.3 ttt180 -67.92 120.43 14.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.331 -0.856 . . . . 0.0 111.533 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 36.3 m-85 -108.72 -60.9 1.68 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.236 -0.915 . . . . 0.0 110.247 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.06 130.05 6.8 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 28.7 p -81.52 -59.39 2.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.449 -1.03 . . . . 0.0 110.045 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.9 OUTLIER -142.73 40.01 1.53 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.4 -0.813 . . . . 0.0 109.128 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -127.9 -65.14 0.93 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.359 -0.838 . . . . 0.0 109.609 -178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.409 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 33.3 m120 -136.81 110.42 9.38 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.544 -0.723 . . . . 0.0 109.354 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' O ' ' CE1' ' A' ' 17' ' ' TYR . 44.2 Cg_endo -70.88 59.1 2.16 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.548 1.289 . . . . 0.0 111.396 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 31.5 p80 -95.36 135.31 37.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.152 -0.968 . . . . 0.0 109.524 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 3.5 m-85 -117.84 155.99 29.16 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.495 -0.882 . . . . 0.0 108.751 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.517 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 10.1 mmt180 -100.05 156.22 17.29 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 118.443 -1.303 . . . . 0.0 107.677 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.957 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.4 mt -98.55 77.08 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 101.841 -3.392 . . . . 0.0 101.841 176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.256 0.3 OUTLIER -97.06 176.8 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 CA-C-N 113.72 -1.582 . . . . 0.0 112.273 -172.869 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.981 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -120.44 115.77 48.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 CA-C-O 121.367 0.603 . . . . 0.0 109.947 -177.384 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.409 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 0.9 OUTLIER -139.35 -177.12 4.78 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.336 -0.853 . . . . 0.0 110.4 -179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.409 ' N ' ' OG1' ' A' ' 22' ' ' THR . 8.2 p-10 -116.96 154.75 30.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.457 -0.777 . . . . 0.0 109.778 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -101.33 19.25 18.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.201 -0.937 . . . . 0.0 110.406 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -75.48 -23.07 56.78 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.245 -0.909 . . . . 0.0 110.472 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.2 mtt-85 -122.65 137.72 54.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.169 -0.957 . . . . 0.0 110.436 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.93 46.36 2.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.871 . . . . 0.0 109.617 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.6 tpm_? -113.48 -62.23 1.62 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.425 -0.797 . . . . 0.0 110.319 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -106.25 -35.37 7.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.249 -0.907 . . . . 0.0 110.275 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.42 94.75 0.18 Allowed Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.42 154.21 42.29 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.23 -1.159 . . . . 0.0 110.062 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -114.96 179.54 3.92 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.154 -0.966 . . . . 0.0 111.193 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.4 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.6 mt -95.9 -44.43 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.686 -0.634 . . . . 0.0 110.055 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.04 166.31 33.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.964 . . . . 0.0 110.371 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -101.25 106.79 18.03 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.278 -0.889 . . . . 0.0 110.131 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.947 HG21 ' CD1' ' A' ' 59' ' ' TRP . 16.1 pt -100.12 -34.82 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.245 -0.909 . . . . 0.0 110.832 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.845 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.63 165.41 20.72 Favored Glycine 0 C--N 1.295 -1.748 0 C-N-CA 118.909 -1.615 . . . . 0.0 110.255 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.49 ' N ' HG13 ' A' ' 19' ' ' ILE . 26.9 t80 -139.19 143.45 38.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.628 -0.925 . . . . 0.0 109.687 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.606 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 13.2 t80 -131.74 132.4 43.81 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.943 -1.098 . . . . 0.0 109.47 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -140.35 105.54 6.56 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 120.764 -1.21 . . . . 0.0 110.907 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -87.88 41.75 0.69 Allowed 'Trans proline' 0 C--N 1.315 -1.22 0 O-C-N 123.554 1.291 . . . . 0.0 110.823 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -89.54 -144.73 0.16 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.955 -1.091 . . . . 0.0 109.727 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.477 ' C ' HG23 ' A' ' 44' ' ' THR . 0.0 OUTLIER -70.8 62.6 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.94 -1.1 . . . . 0.0 109.477 179.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.477 HG23 ' C ' ' A' ' 43' ' ' LYS . 52.9 p -150.86 97.92 2.53 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.534 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 19.2 m -88.69 -40.71 0.46 Allowed Pre-proline 0 C--N 1.295 -1.769 0 O-C-N 121.418 -0.801 . . . . 0.0 111.861 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.534 ' CD ' ' N ' ' A' ' 45' ' ' THR . 52.7 Cg_endo -89.58 -49.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 122.91 0.953 . . . . 0.0 110.941 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.411 ' O ' ' HB ' ' A' ' 44' ' ' THR . 61.8 m-20 -106.17 92.08 3.99 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.222 -0.924 . . . . 0.0 110.251 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.606 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 35.7 p-90 -133.61 6.96 3.79 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.348 -0.845 . . . . 0.0 110.886 -179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.675 HD13 ' N ' ' A' ' 50' ' ' LYS . 2.3 tm? -122.3 126.94 49.2 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.976 -1.078 . . . . 0.0 110.29 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.675 ' N ' HD13 ' A' ' 49' ' ' LEU . 3.7 mtpp -130.81 111.0 11.72 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.071 179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.957 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -132.02 144.27 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 119.051 -1.059 . . . . 0.0 111.533 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.6 OUTLIER -93.29 70.75 4.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.726 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.04 -31.62 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.398 0 N-CA-C 111.667 0.247 . . . . 0.0 111.667 -177.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.16 -54.41 46.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.731 -1.23 . . . . 0.0 109.114 178.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' HB3' HG22 ' A' ' 36' ' ' ILE . 5.5 mtm-85 -74.53 -35.86 63.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.363 -0.836 . . . . 0.0 109.092 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.918 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.71 -20.98 66.09 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.8 ttp85 -89.16 -23.34 22.46 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.239 -0.913 . . . . 0.0 109.504 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.52 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -60.63 -49.06 79.04 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 123.394 1.568 . . . . 0.0 107.091 178.305 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.981 ' CD2' HG11 ' A' ' 21' ' ' VAL . 85.0 m95 -63.6 -50.99 67.23 Favored 'General case' 0 C--N 1.284 -2.24 0 CA-C-N 113.7 -1.591 . . . . 0.0 109.3 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.715 ' CD1' HD22 ' A' ' 74' ' ' LEU . 6.5 mt -56.07 -21.03 19.59 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 176.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 2.6 t -81.23 -21.68 39.33 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.368 -0.833 . . . . 0.0 110.436 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.685 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.9 m -98.86 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.874 -1.141 . . . . 0.0 109.791 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.97 30.8 76.52 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.558 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -64.76 143.84 57.66 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.145 -1.209 . . . . 0.0 109.624 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.43 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -106.7 99.37 24.87 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.167 -0.958 . . . . 0.0 110.333 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.1 Cg_endo -79.64 125.0 5.95 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.697 1.367 . . . . 0.0 110.279 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.774 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.6 t -58.86 170.14 0.88 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.938 . . . . 0.0 109.826 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.88 -20.01 47.37 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.149 -0.969 . . . . 0.0 110.892 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.99 -53.42 4.74 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.181 -0.949 . . . . 0.0 110.386 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.774 ' H ' HG23 ' A' ' 67' ' ' THR . . . -69.31 -27.06 65.06 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 9.1 ttp85 -68.95 -39.26 79.62 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 178.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.49 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.86 -40.84 87.99 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.782 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.0 mt -70.81 -25.13 62.72 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.817 HD11 HG21 ' A' ' 4' ' ' ILE . 12.4 mt -70.51 -29.36 65.84 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.55 ' HG2' ' CE2' ' A' ' 80' ' ' PHE . 3.6 mtm180 -78.47 -34.4 47.68 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.57 -26.42 37.93 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.739 0.781 . . . . 0.0 110.667 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.485 ' HB3' HG23 ' A' ' 79' ' ' VAL . . . -76.19 -1.97 28.95 Favored 'General case' 0 C--N 1.29 -1.994 0 O-C-N 121.743 -0.598 . . . . 0.0 110.161 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.14 38.03 30.9 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.726 HG22 ' HB ' ' A' ' 53' ' ' VAL . 32.0 t -98.35 -32.23 3.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.212 0 O-C-N 121.249 -1.148 . . . . 0.0 111.129 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CE2' ' HG2' ' A' ' 75' ' ' ARG . 6.5 m-30 -87.12 -53.26 4.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.028 -1.045 . . . . 0.0 110.276 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.67 147.73 22.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.24 -0.913 . . . . 0.0 110.732 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -173.17 -163.86 0.21 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.367 -0.833 . . . . 0.0 109.81 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -164.55 137.8 4.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.126 -0.984 . . . . 0.0 110.41 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -97.52 32.49 2.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.329 -0.857 . . . . 0.0 109.9 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -100.98 -43.59 6.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.897 . . . . 0.0 110.299 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -176.06 -45.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 110.153 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.03 101.44 0.17 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.231 -1.158 . . . . 0.0 110.214 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.162 0.506 . . . . 0.0 110.224 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.6 t -75.24 114.03 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.286 -0.884 . . . . 0.0 109.82 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -140.12 135.84 32.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.215 -0.928 . . . . 0.0 110.75 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.975 HD11 ' CB ' ' A' ' 59' ' ' TRP . 63.1 mt -101.98 135.82 37.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.26 -0.9 . . . . 0.0 109.232 179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.526 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 8.7 ptm180 -150.93 178.31 9.28 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.161 -0.962 . . . . 0.0 110.005 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.5 pp -89.61 131.74 35.46 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.326 -0.949 . . . . 0.0 109.48 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.655 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.9 164.02 12.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.525 -0.734 . . . . 0.0 109.056 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -128.38 113.15 15.21 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 120.913 -1.117 . . . . 0.0 111.562 -179.061 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.655 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -124.99 -152.2 0.51 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.349 -0.845 . . . . 0.0 109.59 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.28 67.12 1.12 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -54.24 -50.68 66.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.171 -1.193 . . . . 0.0 109.834 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.5 OUTLIER -167.12 37.46 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.481 -0.762 . . . . 0.0 109.527 -179.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 6.8 m-70 -120.38 -57.25 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.52 -0.737 . . . . 0.0 109.293 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.3 135.89 5.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.693 -0.629 . . . . 0.0 109.481 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.89 116.82 4.86 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.562 1.296 . . . . 0.0 110.863 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 23.1 p80 -158.25 149.31 20.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.175 -0.953 . . . . 0.0 110.596 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 8' ' ' ARG . 13.0 m-85 -118.32 172.24 7.59 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 29.3 mtt-85 -135.13 151.22 50.5 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.881 -1.137 . . . . 0.0 108.986 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.837 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -97.01 82.9 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 177.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.404 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.281 0.4 OUTLIER -98.38 163.2 2.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 CA-C-N 113.9 -1.5 . . . . 0.0 111.353 -173.785 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.928 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -109.94 113.47 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.565 -0.71 . . . . 0.0 110.322 -178.034 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.434 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.8 t -140.03 -167.18 2.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.395 -0.815 . . . . 0.0 110.068 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' N ' ' OG1' ' A' ' 22' ' ' THR . 75.0 m-20 -95.18 165.35 12.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.373 -0.829 . . . . 0.0 109.989 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.44 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . . . -105.11 -50.93 3.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 110.061 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.41 59.78 5.62 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.236 -0.915 . . . . 0.0 110.558 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -155.8 111.34 3.01 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.249 -0.907 . . . . 0.0 110.219 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 mttp -125.25 21.24 8.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 110.301 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -87.93 -22.3 24.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.165 -0.959 . . . . 0.0 110.263 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -134.16 -45.96 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 110.286 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.52 70.48 1.25 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.67 157.99 44.85 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.229 -1.16 . . . . 0.0 110.051 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 2.0 p90 -109.32 -175.06 2.66 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.186 -0.946 . . . . 0.0 110.617 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.8 mt -100.68 -47.13 11.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.553 -0.717 . . . . 0.0 109.923 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.88 159.51 41.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.419 -0.801 . . . . 0.0 109.741 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -95.7 109.57 21.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.083 -1.011 . . . . 0.0 110.328 -179.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.864 HD12 ' HA ' ' A' ' 56' ' ' ALA . 36.2 pt -100.19 -35.19 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.071 -1.018 . . . . 0.0 110.541 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.828 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.14 167.35 14.08 Favored Glycine 0 C--N 1.294 -1.799 0 C-N-CA 119.074 -1.536 . . . . 0.0 112.264 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.421 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.4 t80 -141.06 117.52 10.81 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.837 ' HB2' HD11 ' A' ' 19' ' ' ILE . 7.8 t80 -109.02 142.47 39.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.658 -1.277 . . . . 0.0 109.497 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 39.9 t0 -134.82 83.08 42.11 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.941 -1.099 . . . . 0.0 110.111 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HG3' ' CD1' ' A' ' 17' ' ' TYR . 42.4 Cg_endo -68.74 61.83 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.573 1.302 . . . . 0.0 110.539 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -95.16 125.03 39.53 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.224 -0.922 . . . . 0.0 110.337 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.5 ttmm -71.14 72.08 0.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.245 -0.91 . . . . 0.0 109.824 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.8 p -150.03 -82.23 0.11 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.124 -0.985 . . . . 0.0 110.785 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -98.94 161.57 24.43 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.134 -0.979 . . . . 0.0 110.589 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.424 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 51.8 Cg_endo -77.01 -37.34 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.833 1.439 . . . . 0.0 110.602 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 110.604 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.68 ' HZ3' HD12 ' A' ' 49' ' ' LEU . 6.5 p-90 -133.91 4.29 3.54 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.173 -0.954 . . . . 0.0 110.714 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 77' ' ' ALA . 3.9 tt -102.58 126.27 49.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.919 -1.113 . . . . 0.0 110.877 -179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -131.19 89.33 2.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.399 -0.813 . . . . 0.0 109.144 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.828 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 137.54 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.108 -0.995 . . . . 0.0 111.07 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.432 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.8 t0 -82.44 70.48 9.4 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 175.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.674 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -37.18 -30.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 122.091 -0.38 . . . . 0.0 111.259 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 52' ' ' ASP . 12.7 mt-10 -63.18 -49.69 73.3 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.812 -1.18 . . . . 0.0 108.786 177.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.77 -33.51 52.71 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.373 -0.829 . . . . 0.0 108.819 178.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -69.43 -22.0 63.71 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.6 ttt-85 -87.49 -23.48 24.41 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.353 -0.842 . . . . 0.0 109.466 178.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.666 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -58.87 -50.15 75.08 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 123.426 1.584 . . . . 0.0 107.042 178.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.975 ' CB ' HD11 ' A' ' 4' ' ' ILE . 85.3 m95 -62.62 -55.19 29.33 Favored 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 113.702 -1.59 . . . . 0.0 109.205 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.518 HD11 HD13 ' A' ' 74' ' ' LEU . 43.7 mt -52.83 -23.33 6.76 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -78.68 -19.47 52.42 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.503 -0.748 . . . . 0.0 110.12 178.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.794 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.6 m -98.41 31.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 120.996 -1.065 . . . . 0.0 109.311 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.73 22.45 78.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.54 128.37 35.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.193 -1.181 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 10.6 mm-40 -100.39 119.92 57.67 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.068 -1.02 . . . . 0.0 110.177 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.8 Cg_endo -83.39 146.46 12.32 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.505 1.266 . . . . 0.0 110.407 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.514 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -71.29 158.44 36.36 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.045 -1.034 . . . . 0.0 109.987 179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -55.53 -26.3 42.32 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.89 -1.131 . . . . 0.0 111.219 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 m -90.7 -48.39 7.08 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.09 -1.006 . . . . 0.0 110.697 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.908 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -71.13 -26.93 63.23 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.324 -0.86 . . . . 0.0 108.811 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' CD ' ' HG2' ' A' ' 66' ' ' PRO . 31.9 ttp180 -68.02 -36.79 80.52 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -35.66 76.17 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.908 HD12 ' HA ' ' A' ' 70' ' ' ALA . 29.1 mt -73.29 -38.44 65.89 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 66' ' ' PRO . 66.9 mt -63.25 -28.44 70.03 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 3.6 mtt180 -77.13 -32.41 56.38 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.829 ' HB3' HD13 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -76.6 -32.19 57.94 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.15 0.976 . . . . 0.0 109.523 179.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.856 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.25 -7.99 46.62 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.316 179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.78 42.31 7.3 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.61 HG22 ' HB ' ' A' ' 53' ' ' VAL . 39.7 t -100.78 -6.8 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.176 -1.19 . . . . 0.0 111.157 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 10.1 m-85 -115.13 142.72 46.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.302 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.1 mmm180 -108.12 138.75 43.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.291 -0.881 . . . . 0.0 109.903 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -141.89 152.64 43.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -0.924 . . . . 0.0 110.505 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -76.76 85.94 3.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.316 -0.865 . . . . 0.0 110.046 179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -114.7 -167.7 1.26 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.233 -0.917 . . . . 0.0 110.394 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 69.0 mtm-85 -72.46 -68.77 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.302 -0.874 . . . . 0.0 110.144 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -49.9 164.58 0.1 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.299 -0.875 . . . . 0.0 110.44 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 153.57 103.75 0.23 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.238 -1.154 . . . . 0.0 110.256 -179.926 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 tpt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.225 0.536 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.826 ' CG1' HG12 ' A' ' 21' ' ' VAL . 92.3 t -88.75 154.81 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.161 -0.962 . . . . 0.0 110.172 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -140.67 133.0 28.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.127 -0.983 . . . . 0.0 110.534 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.765 HD11 ' CB ' ' A' ' 59' ' ' TRP . 33.1 mt -103.64 130.29 54.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.092 -1.005 . . . . 0.0 109.328 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 4.1 ptt85 -151.09 -167.46 2.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.15 -0.969 . . . . 0.0 110.652 -179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.572 HD22 ' HB2' ' A' ' 17' ' ' TYR . 13.1 mt -89.32 126.11 35.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.223 -0.923 . . . . 0.0 111.081 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.607 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.0 104.06 15.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.554 -0.716 . . . . 0.0 109.175 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.518 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 8.1 tmm_? -75.66 125.62 29.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.955 -1.091 . . . . 0.0 112.241 -178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 2.0 m-85 -125.35 -153.38 0.56 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.458 -0.776 . . . . 0.0 109.331 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 65.07 105.57 0.01 OUTLIER Glycine 0 N--CA 1.483 1.825 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.6 p -59.05 -39.75 82.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.3 -1.118 . . . . 0.0 109.033 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.59 57.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.8 -0.563 . . . . 0.0 109.483 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -127.26 -64.85 0.97 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.229 -0.919 . . . . 0.0 110.18 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -140.69 143.27 31.65 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.393 -0.817 . . . . 0.0 109.985 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -78.92 93.55 1.1 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.641 1.337 . . . . 0.0 111.243 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.47 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.7 p80 -137.54 125.66 22.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.974 -1.078 . . . . 0.0 110.385 178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB2' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -113.23 149.15 34.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.4 ttm-85 -100.55 154.08 18.86 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 176.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.897 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -97.63 84.14 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 102.096 -3.298 . . . . 0.0 102.096 178.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.26 0.4 OUTLIER -98.51 172.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.988 -173.068 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.826 HG12 ' CG1' ' A' ' 2' ' ' VAL . 0.2 OUTLIER -112.73 105.28 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.597 -0.689 . . . . 0.0 111.037 -177.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.1 t -129.18 -177.01 4.05 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.2 -0.938 . . . . 0.0 109.959 178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 25' ' ' ARG . 0.2 OUTLIER -104.23 -173.36 2.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.214 -0.929 . . . . 0.0 110.59 -179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -54.89 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.479 -0.763 . . . . 0.0 110.119 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -49.23 124.09 8.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.0 110.572 -179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -49.92 16.31 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.382 -0.824 . . . . 0.0 110.258 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -151.97 -80.64 0.1 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 110.004 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 mtt180 -120.77 34.85 5.06 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.418 -0.801 . . . . 0.0 109.738 179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.75 93.08 9.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.375 -0.828 . . . . 0.0 110.32 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -92.6 61.28 2.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -120.65 70.28 0.89 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -1.138 . . . . 0.0 110.562 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.6 p90 -64.0 176.79 0.89 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.139 -0.976 . . . . 0.0 110.013 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.404 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.5 mt -86.02 -49.14 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.335 -0.853 . . . . 0.0 109.27 179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.412 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -153.66 172.57 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -0.807 . . . . 0.0 109.778 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HB3' ' HD3' ' A' ' 18' ' ' ARG . 1.8 mtmt -111.82 126.3 54.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.04 -1.037 . . . . 0.0 110.0 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.018 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -129.86 -13.71 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 121.008 -1.057 . . . . 0.0 111.819 -179.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.878 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -133.89 154.83 21.51 Favored Glycine 0 C--N 1.299 -1.486 0 C-N-CA 119.286 -1.435 . . . . 0.0 109.6 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.459 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 24.2 t80 -128.92 151.81 49.24 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.268 -1.136 . . . . 0.0 109.13 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.421 ' CD2' ' HD3' ' A' ' 41' ' ' PRO . 38.8 t80 -149.93 116.5 5.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.721 -1.237 . . . . 0.0 110.417 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 39.1 t0 -130.54 82.07 66.05 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 120.684 -1.26 . . . . 0.0 110.575 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 41.6 Cg_endo -68.48 78.63 0.65 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 O-C-N 123.681 1.358 . . . . 0.0 110.892 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.2 -164.48 1.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.367 -0.833 . . . . 0.0 110.0 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -132.56 24.41 4.39 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 0.0 110.502 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.774 HG23 HG23 ' A' ' 45' ' ' THR . 8.2 t -121.56 -22.54 5.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.526 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.774 HG23 HG23 ' A' ' 44' ' ' THR . 76.6 p -140.56 140.54 22.72 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.008 -1.057 . . . . 0.0 110.485 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -76.09 -13.64 19.13 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.657 1.346 . . . . 0.0 110.706 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -98.16 93.68 6.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.68 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.514 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 6.0 p-90 -120.39 -13.14 8.88 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.382 -0.824 . . . . 0.0 110.587 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 77' ' ' ALA . 6.6 tt -77.96 129.04 34.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.93 . . . . 0.0 111.108 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -140.33 85.9 2.04 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.527 -0.733 . . . . 0.0 109.288 178.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.897 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -115.85 143.54 25.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.922 -1.111 . . . . 0.0 111.412 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' N ' ' A' ' 54' ' ' GLU . 4.8 t0 -94.58 69.8 3.54 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 175.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.719 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -32.9 -32.03 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.809 -177.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -60.28 -50.23 74.46 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.695 -1.253 . . . . 0.0 108.562 178.208 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.0 mmm180 -74.44 -36.17 63.38 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.675 ' HB3' ' HA ' ' A' ' 53' ' ' VAL . . . -68.85 -16.57 63.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.944 -1.097 . . . . 0.0 108.129 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.7 OUTLIER -90.38 -21.72 21.83 Favored 'General case' 0 C--N 1.312 -1.046 0 O-C-N 121.362 -0.836 . . . . 0.0 108.908 177.163 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -66.83 -48.22 69.57 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 123.032 1.396 . . . . 0.0 107.658 178.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.018 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.3 m95 -66.94 -54.36 22.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.424 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.043 HD11 HD13 ' A' ' 74' ' ' LEU . 3.3 mt -56.6 -21.31 26.05 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.537 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 2.8 m -82.34 -20.91 36.37 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.397 -0.814 . . . . 0.0 110.446 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.8 m -99.07 31.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 O-C-N 120.915 -1.116 . . . . 0.0 109.536 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.17 26.41 73.75 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.961 -1.255 . . . . 0.0 109.961 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -67.14 137.44 56.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.937 -1.331 . . . . 0.0 109.644 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -103.03 108.26 58.02 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.15 -0.969 . . . . 0.0 110.609 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.0 Cg_endo -79.69 126.62 6.73 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 O-C-N 123.65 1.342 . . . . 0.0 109.736 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.415 ' O ' ' HB2' ' A' ' 71' ' ' ARG . 7.6 t -62.21 -175.66 0.08 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.143 -0.973 . . . . 0.0 110.481 -179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -81.55 51.94 1.77 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.207 -0.933 . . . . 0.0 110.163 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 m -164.33 -56.93 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.725 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.33 -25.59 64.28 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.519 ' HA ' HD12 ' A' ' 74' ' ' LEU . 6.8 tmm_? -66.76 -39.62 87.93 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.43 -40.86 96.57 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 70' ' ' ALA . 21.4 mt -69.3 -29.29 67.12 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.515 -0.741 . . . . 0.0 109.348 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.043 HD13 HD11 ' A' ' 60' ' ' LEU . 45.7 mt -69.65 -28.09 65.6 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.55 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -83.39 -27.05 29.9 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 178.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -83.55 -36.7 23.79 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.597 0.713 . . . . 0.0 110.533 -179.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.19 -6.86 37.45 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.815 178.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.31 56.37 2.86 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.719 HG22 ' HB ' ' A' ' 53' ' ' VAL . 24.3 t -107.02 -57.0 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 121.122 -1.223 . . . . 0.0 111.052 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 7.0 m-30 -52.35 -57.36 10.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.165 -0.96 . . . . 0.0 110.389 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.8 mtt180 -115.4 -179.19 3.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.254 -0.904 . . . . 0.0 110.316 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -122.94 156.63 34.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -0.89 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -160.21 65.71 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.26 -0.9 . . . . 0.0 110.012 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -164.35 -40.17 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.279 -0.888 . . . . 0.0 110.253 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.4 ttp180 -101.73 88.84 3.5 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.291 -0.881 . . . . 0.0 110.317 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -57.72 -167.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 0.0 110.179 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 152.56 -161.0 29.28 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.232 -1.158 . . . . 0.0 110.183 179.936 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.168 0.509 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.765 HG11 ' CE3' ' A' ' 59' ' ' TRP . 66.1 t -83.38 137.08 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.05 -1.031 . . . . 0.0 110.443 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' CE ' ' O ' ' A' ' 65' ' ' GLN . 3.6 tptm -140.49 128.44 22.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.254 -0.904 . . . . 0.0 109.851 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.912 HD11 ' CB ' ' A' ' 59' ' ' TRP . 71.6 mt -99.97 128.91 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.041 -1.037 . . . . 0.0 109.901 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 6.6 ptm180 -151.23 -173.89 4.64 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.217 -0.927 . . . . 0.0 110.372 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.6 mp -88.96 126.07 35.24 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.257 -0.902 . . . . 0.0 110.518 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.34 103.57 15.4 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.415 -0.803 . . . . 0.0 111.355 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 1.0 OUTLIER -71.29 119.55 15.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.35 -0.844 . . . . 0.0 111.179 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 27.1 m-85 -108.61 -63.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.218 -0.926 . . . . 0.0 110.378 179.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.61 101.79 0.04 OUTLIER Glycine 0 N--CA 1.489 2.174 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.5 p -60.64 -33.81 73.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.219 -1.165 . . . . 0.0 109.891 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.0 OUTLIER -176.78 45.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.483 -0.761 . . . . 0.0 109.42 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.501 ' CE1' ' HG2' ' A' ' 12' ' ' LYS . 7.6 m-70 -126.66 -54.13 1.44 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.757 0.789 . . . . 0.0 108.89 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 64.9 t-20 -146.69 124.96 6.19 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.432 ' HG2' ' HG2' ' A' ' 42' ' ' ARG . 46.5 Cg_endo -71.9 122.26 8.33 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.364 1.192 . . . . 0.0 111.144 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.467 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 32.0 p80 -176.31 131.2 0.22 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.507 -0.745 . . . . 0.0 109.87 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.563 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.6 m-85 -122.5 155.68 35.69 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 6.5 mmt180 -100.68 158.68 15.77 Favored 'General case' 0 C--N 1.293 -1.872 0 C-N-CA 117.888 -1.525 . . . . 0.0 107.759 176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.953 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.1 mt -99.04 78.36 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.326 0 N-CA-C 102.301 -3.222 . . . . 0.0 102.301 177.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.25 0.4 OUTLIER -97.26 163.72 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.336 -1.302 . . . . 0.0 111.733 -173.474 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.879 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 112.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-O 121.286 0.565 . . . . 0.0 110.308 -177.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t -139.17 -178.06 5.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.319 -0.863 . . . . 0.0 110.124 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.5 p30 -73.29 -179.56 3.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.408 -0.807 . . . . 0.0 109.914 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.98 -54.61 1.13 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.196 -0.94 . . . . 0.0 110.181 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -58.6 -20.31 46.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.33 -0.857 . . . . 0.0 110.378 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -94.93 143.06 26.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.183 -0.948 . . . . 0.0 110.099 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.36 23.51 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.261 -0.899 . . . . 0.0 110.217 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.77 -21.47 29.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.169 -0.957 . . . . 0.0 110.132 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -131.44 -68.1 0.67 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.32 -0.863 . . . . 0.0 110.075 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.76 61.84 0.47 Allowed Glycine 0 N--CA 1.493 2.444 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.17 142.85 42.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.193 -1.181 . . . . 0.0 110.331 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 22.2 p90 -110.38 168.79 9.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.15 -0.968 . . . . 0.0 110.633 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.706 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.1 mp -84.34 -28.84 7.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.674 -0.641 . . . . 0.0 109.939 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -178.91 164.75 1.52 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.372 -0.83 . . . . 0.0 109.975 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.32 113.77 26.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.128 -0.982 . . . . 0.0 110.098 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.991 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -108.24 -34.04 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.115 -0.99 . . . . 0.0 110.664 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.925 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.27 164.34 15.36 Favored Glycine 0 C--N 1.296 -1.671 0 C-N-CA 118.949 -1.596 . . . . 0.0 110.342 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.493 ' N ' HG13 ' A' ' 19' ' ' ILE . 11.6 t80 -139.48 142.95 37.31 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 177.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.567 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 19.9 t80 -135.64 132.98 37.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.723 -1.235 . . . . 0.0 110.208 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 9.9 t0 -140.55 103.55 6.47 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.787 -1.195 . . . . 0.0 110.34 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.446 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 47.9 Cg_endo -73.15 -4.67 15.83 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 O-C-N 123.498 1.262 . . . . 0.0 111.42 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.432 ' HG2' ' HG2' ' A' ' 15' ' ' PRO . 0.2 OUTLIER -89.73 -18.3 26.62 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.865 -1.147 . . . . 0.0 110.284 -179.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.99 123.95 11.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.031 -1.043 . . . . 0.0 109.879 179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.0 p -91.45 28.24 1.76 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 0.0 110.512 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.86 163.27 43.78 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 0.0 109.804 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.88 64.05 2.45 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 123.626 1.329 . . . . 0.0 110.287 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -167.47 37.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 110.181 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.575 ' HZ3' HD23 ' A' ' 49' ' ' LEU . 40.8 p-90 -79.03 1.46 23.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.163 -0.961 . . . . 0.0 110.743 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 49' ' ' LEU . 2.3 tm? -119.59 112.52 19.44 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.955 -1.09 . . . . 0.0 110.523 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.94 104.24 9.67 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.387 -0.821 . . . . 0.0 109.102 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.953 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.1 t -129.52 139.15 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.099 . . . . 0.0 111.357 -179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.8 t0 -84.94 70.83 10.94 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.52 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -31.91 -34.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.444 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -177.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -59.96 -51.01 71.48 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.774 -1.204 . . . . 0.0 108.837 178.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.628 ' HB3' HG22 ' A' ' 36' ' ' ILE . 47.1 mmm-85 -71.11 -45.52 63.49 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.377 -0.827 . . . . 0.0 108.963 178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.901 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -59.87 -22.38 62.24 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.2 ttt180 -87.78 -26.42 22.88 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.317 -0.864 . . . . 0.0 109.864 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.1 t80 -59.29 -46.67 87.93 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 123.32 1.534 . . . . 0.0 107.237 178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.991 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.4 m95 -62.85 -54.68 35.07 Favored 'General case' 0 C--N 1.284 -2.251 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.512 -179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 74' ' ' LEU . 7.3 mt -56.05 -20.58 17.48 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 118.912 -1.115 . . . . 0.0 108.583 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -79.02 -24.24 43.79 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 110.776 179.669 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 59' ' ' TRP . 14.4 m -98.92 33.45 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 O-C-N 120.939 -1.101 . . . . 0.0 109.568 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.28 27.15 73.87 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -68.26 130.93 44.39 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.004 -1.292 . . . . 0.0 109.964 179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.411 ' O ' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -98.13 111.25 58.99 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 0.0 110.454 -179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.587 ' HB3' HD11 ' A' ' 74' ' ' LEU . 53.4 Cg_endo -87.53 125.43 2.09 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.616 1.324 . . . . 0.0 109.951 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.783 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.3 t -53.98 166.31 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.016 -1.053 . . . . 0.0 109.767 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -33.8 36.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.041 -1.037 . . . . 0.0 110.919 -179.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.408 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.7 m -76.04 -54.82 6.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.212 -0.93 . . . . 0.0 110.975 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.783 ' H ' HG23 ' A' ' 67' ' ' THR . . . -67.1 -23.36 65.83 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.475 -0.766 . . . . 0.0 109.222 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.767 ' HA ' HD12 ' A' ' 74' ' ' LEU . 31.0 ttp180 -71.04 -38.57 72.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 178.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.496 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 2.0 ttt-85 -69.77 -43.19 72.68 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.676 -0.809 . . . . 0.0 108.977 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.571 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 77.5 mt -65.15 -22.89 66.98 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.571 -0.706 . . . . 0.0 109.443 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 71' ' ' ARG . 14.0 mt -70.73 -30.41 66.93 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.027 -1.472 . . . . 0.0 107.027 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.502 ' HG2' ' CE1' ' A' ' 80' ' ' PHE . 2.8 mtm180 -72.66 -34.67 67.41 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -77.52 -28.81 52.14 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.91 0.862 . . . . 0.0 110.077 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.79 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -73.34 -4.64 34.62 Favored 'General case' 0 C--N 1.29 -2.013 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.199 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 87.65 20.32 51.45 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 77' ' ' ALA . 21.1 t -82.76 -60.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.091 -1.241 . . . . 0.0 110.569 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.542 ' CE2' ' HB3' ' A' ' 74' ' ' LEU . 34.2 p90 -149.73 140.87 23.03 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.972 -1.08 . . . . 0.0 110.865 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -109.1 29.14 7.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.345 -0.847 . . . . 0.0 110.013 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -173.5 -166.19 0.31 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 0.0 110.348 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.33 177.48 4.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.208 -0.933 . . . . 0.0 110.339 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -86.66 -26.72 24.18 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.289 -0.882 . . . . 0.0 110.399 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.8 tpt180 -71.92 100.05 2.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.169 -0.957 . . . . 0.0 110.295 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.3 tt0 -176.35 128.5 0.2 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 110.203 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.54 42.86 0.21 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.225 -1.162 . . . . 0.0 110.202 179.949 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' C ' HG23 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.296 0.57 . . . . 0.0 110.302 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.448 HG23 ' C ' ' A' ' 1' ' ' MET . 40.2 t -146.88 108.6 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.15 -0.968 . . . . 0.0 110.173 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -140.2 133.44 29.71 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 110.245 -179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.975 HD11 ' CB ' ' A' ' 59' ' ' TRP . 98.0 mt -102.03 133.26 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.07 -1.019 . . . . 0.0 109.924 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -172.54 4.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.0 110.893 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.787 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -88.73 126.0 35.12 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.218 -0.926 . . . . 0.0 110.404 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.62 104.45 16.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.317 -0.865 . . . . 0.0 111.191 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.52 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 2.6 tmm_? -71.88 118.08 14.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.212 -0.93 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.702 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 20.4 m-85 -112.13 -63.41 1.43 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.152 -0.968 . . . . 0.0 110.368 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.88 103.75 0.15 Allowed Glycine 0 N--CA 1.484 1.842 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 26.9 p -70.6 -59.75 2.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.2 -1.176 . . . . 0.0 109.496 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.467 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.0 mttp -141.9 51.81 1.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -140.93 -59.78 0.5 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.419 -0.801 . . . . 0.0 109.127 -178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.465 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 66.0 t30 -140.2 114.58 7.62 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.07 114.07 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.475 1.25 . . . . 0.0 111.258 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.465 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 32.0 p80 -169.52 135.66 1.58 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.458 -0.776 . . . . 0.0 110.264 178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.787 ' HB2' HD23 ' A' ' 6' ' ' LEU . 7.4 m-85 -120.02 156.12 31.54 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' C ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -108.41 159.59 16.55 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 118.143 -1.423 . . . . 0.0 108.66 177.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.981 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -98.17 81.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 177.65 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.264 0.4 OUTLIER -97.81 164.89 2.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.572 -174.0 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -111.86 106.1 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.0 110.471 -178.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.0 t -134.99 -169.86 2.45 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.24 -0.913 . . . . 0.0 110.102 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.8 p-10 -89.35 158.94 17.59 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.067 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -83.82 -66.52 0.88 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.198 -0.939 . . . . 0.0 110.442 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.1 ttt180 -64.82 122.86 17.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.9 . . . . 0.0 110.625 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.1 ptt85 -166.33 151.53 8.22 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.0 109.99 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.7 -47.04 0.96 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.086 -1.009 . . . . 0.0 110.61 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.51 18.34 10.48 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.111 -0.993 . . . . 0.0 110.525 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 29' ' ' ASP . 12.5 p-10 -138.38 98.89 3.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.147 -0.97 . . . . 0.0 109.935 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.67 72.59 0.2 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.974 -1.25 . . . . 0.0 109.974 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -127.06 157.33 39.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -1.134 . . . . 0.0 109.671 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 45.5 p90 -116.45 162.95 16.77 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.072 -1.018 . . . . 0.0 110.934 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.552 HG21 ' HH2' ' A' ' 59' ' ' TRP . 4.6 mt -72.56 -46.31 55.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.662 -0.649 . . . . 0.0 110.036 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.1 OUTLIER -152.41 166.24 32.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.221 -0.924 . . . . 0.0 110.232 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 6.6 pttt -104.33 115.77 30.96 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.175 -0.953 . . . . 0.0 109.998 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.867 HG21 ' CD1' ' A' ' 59' ' ' TRP . 38.7 pt -108.32 -33.71 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.939 -1.1 . . . . 0.0 111.56 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.783 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.69 166.91 18.24 Favored Glycine 0 C--N 1.297 -1.633 0 C-N-CA 118.859 -1.638 . . . . 0.0 112.76 -177.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.404 ' N ' HG12 ' A' ' 19' ' ' ILE . 53.1 t80 -140.94 121.4 14.08 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.981 ' HB2' HD11 ' A' ' 19' ' ' ILE . 20.8 t80 -114.94 139.95 49.4 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.777 -1.202 . . . . 0.0 109.778 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 64.4 t0 -140.56 106.32 6.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.047 -1.033 . . . . 0.0 109.864 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 45.5 Cg_endo -76.47 71.08 6.05 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.051 1.027 . . . . 0.0 110.196 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -93.39 -179.44 5.05 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.236 -0.915 . . . . 0.0 110.835 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.9 pttt -136.57 18.13 3.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.359 -0.838 . . . . 0.0 110.096 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 61.5 p -115.41 -20.12 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.283 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.2 p -134.6 137.57 27.93 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.164 -0.96 . . . . 0.0 110.114 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.69 -16.9 18.47 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.533 1.28 . . . . 0.0 110.558 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -105.15 82.58 1.86 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -0.937 . . . . 0.0 110.836 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.584 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 9.8 p-90 -109.93 -10.55 14.73 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.271 -0.893 . . . . 0.0 110.142 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.649 HD23 ' C ' ' A' ' 49' ' ' LEU . 7.9 tt -82.53 112.22 19.25 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.021 -1.05 . . . . 0.0 109.923 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -120.78 93.58 4.08 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.408 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.783 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.79 133.01 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.044 -1.035 . . . . 0.0 111.2 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.0 t0 -78.37 69.13 4.52 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 176.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.723 HG23 HG22 ' A' ' 79' ' ' VAL . 1.0 OUTLIER -34.06 -32.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.542 -177.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tt0 -62.42 -52.15 64.69 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.916 -1.115 . . . . 0.0 109.105 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.498 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.1 mtm-85 -75.49 -34.7 60.88 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.31 -0.869 . . . . 0.0 109.078 178.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.801 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -67.15 -23.48 65.8 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.459 ' HB2' HG13 ' A' ' 79' ' ' VAL . 40.8 ttt180 -86.15 -20.55 28.46 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.328 -0.857 . . . . 0.0 109.952 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.719 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -62.31 -48.56 79.33 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 123.078 1.418 . . . . 0.0 107.235 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.975 ' CB ' HD11 ' A' ' 4' ' ' ILE . 89.0 m95 -63.02 -55.92 21.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.714 -179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.644 HD12 HG11 ' A' ' 79' ' ' VAL . 84.2 mt -53.69 -21.85 7.84 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.5 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -81.96 -20.09 39.28 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.456 -0.778 . . . . 0.0 110.64 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.3 m -99.07 32.43 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 120.811 -1.181 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.88 27.1 72.82 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.528 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -81.95 117.64 22.34 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.136 -1.214 . . . . 0.0 109.992 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.417 ' O ' ' HG2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -91.36 127.75 49.7 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.321 -0.862 . . . . 0.0 110.611 -179.68 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -83.7 165.42 13.84 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.352 1.185 . . . . 0.0 109.744 179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.3 p -85.19 -174.94 5.51 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.976 -1.077 . . . . 0.0 110.226 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.68 46.68 1.19 Allowed 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.222 -0.924 . . . . 0.0 110.537 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m -165.7 -55.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.964 -1.125 . . . . 0.0 107.964 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.528 ' HB2' HD12 ' A' ' 6' ' ' LEU . . . -67.83 -26.07 65.87 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.427 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 67.1 ttt180 -64.83 -40.53 95.34 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 178.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -39.35 89.64 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.266 -0.974 . . . . 0.0 108.875 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' A' ' 70' ' ' ALA . 41.7 mt -70.71 -28.28 64.62 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.372 -0.83 . . . . 0.0 109.234 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.495 HD13 HD11 ' A' ' 60' ' ' LEU . 40.9 mt -70.95 -29.46 65.48 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.471 ' HB2' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.27 -28.26 38.44 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.249 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -83.86 -32.37 25.27 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.725 0.774 . . . . 0.0 110.097 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.463 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -66.41 -11.39 51.43 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.722 -0.611 . . . . 0.0 109.811 178.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.16 15.72 29.75 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.867 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.723 HG22 HG23 ' A' ' 53' ' ' VAL . 17.9 t -76.12 -54.32 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.724 -1.456 . . . . 0.0 110.138 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' A' ' 75' ' ' ARG . 21.1 p90 -146.07 -176.48 5.17 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.177 -0.952 . . . . 0.0 110.123 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -140.97 -59.3 0.5 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.268 -0.895 . . . . 0.0 110.325 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -163.22 77.53 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 110.453 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -87.06 177.39 7.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 0.0 110.017 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -172.17 42.0 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.267 -0.896 . . . . 0.0 110.233 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -146.37 45.01 1.23 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.257 -0.902 . . . . 0.0 110.17 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -57.17 158.29 5.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.256 -0.903 . . . . 0.0 110.159 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 137.32 -77.17 0.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.174 -1.192 . . . . 0.0 110.274 -179.884 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 mtp . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.284 0.564 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 t -108.97 118.98 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.14 142.18 36.02 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.223 -0.923 . . . . 0.0 110.688 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.919 HD11 ' CB ' ' A' ' 59' ' ' TRP . 84.7 mt -104.06 135.75 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 O-C-N 121.142 -0.974 . . . . 0.0 109.409 179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.45 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.5 OUTLIER -151.22 -168.81 3.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.153 -0.967 . . . . 0.0 110.498 -179.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.494 HD12 ' HB2' ' A' ' 70' ' ' ALA . 5.1 mp -89.3 127.3 35.77 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.347 -0.846 . . . . 0.0 110.367 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.86 104.27 15.93 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.364 -0.835 . . . . 0.0 110.088 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.531 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -71.28 122.68 20.68 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.253 -0.905 . . . . 0.0 112.539 -178.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 6.1 m-85 -124.7 -152.64 0.52 Allowed 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 177.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 54.16 100.83 0.01 OUTLIER Glycine 0 N--CA 1.483 1.803 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.9 p -52.17 -42.96 63.86 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -1.168 . . . . 0.0 109.988 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.41 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.54 -0.725 . . . . 0.0 109.695 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.7 m-70 -110.91 -60.6 1.81 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.465 -0.772 . . . . 0.0 109.644 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.26 122.62 16.16 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.596 -0.69 . . . . 0.0 109.517 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.56 91.77 0.97 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.408 1.215 . . . . 0.0 111.102 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.507 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.9 p80 -137.59 131.37 31.54 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.323 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.532 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 14.1 m-85 -114.6 148.81 37.54 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.2 mtt85 -100.29 159.36 15.19 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.306 -1.357 . . . . 0.0 107.83 177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.954 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.71 81.43 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 177.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.4 OUTLIER -97.69 171.35 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.934 -173.745 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.904 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -116.16 108.77 25.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 CA-C-O 121.167 0.508 . . . . 0.0 110.048 -177.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.421 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.8 t -140.16 -162.46 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.209 -0.932 . . . . 0.0 110.233 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 22' ' ' THR . 17.9 p-10 -93.25 -155.65 0.45 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.234 -0.916 . . . . 0.0 109.929 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -90.03 -40.14 12.5 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 110.395 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -175.0 176.71 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 0.0 110.429 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.1 ttm-85 -151.22 -70.14 0.17 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.329 -0.857 . . . . 0.0 110.075 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.19 -64.06 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.067 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.15 -55.68 0.41 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.303 -0.873 . . . . 0.0 109.913 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.29 177.39 3.91 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 0.0 109.735 179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.1 116.54 1.13 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -116.38 143.53 45.44 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.3 -1.118 . . . . 0.0 109.952 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' HB3' HG13 ' A' ' 20' ' ' VAL . 20.4 p90 -118.23 176.52 5.19 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.235 -0.916 . . . . 0.0 110.854 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.605 HG21 ' HH2' ' A' ' 59' ' ' TRP . 13.2 mt -82.64 -51.01 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.507 -0.746 . . . . 0.0 109.876 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -152.79 152.72 31.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.286 -0.884 . . . . 0.0 109.959 179.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -89.57 108.17 19.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.018 . . . . 0.0 110.125 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.898 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.5 pt -100.07 -36.58 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.993 -1.067 . . . . 0.0 111.371 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.803 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -120.78 168.03 13.98 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.021 -1.562 . . . . 0.0 112.392 -177.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.468 ' N ' HG12 ' A' ' 19' ' ' ILE . 10.2 t80 -141.07 124.78 16.9 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 177.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.954 ' HB2' HD11 ' A' ' 19' ' ' ILE . 22.6 t80 -125.85 124.71 41.5 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.811 -1.18 . . . . 0.0 108.893 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 60.0 t0 -140.18 84.85 14.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.731 -1.231 . . . . 0.0 110.69 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.483 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 45.2 Cg_endo -72.16 77.69 1.97 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.646 1.34 . . . . 0.0 110.179 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' NH2' HG21 ' A' ' 44' ' ' THR . 0.0 OUTLIER -96.02 167.76 11.03 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.34 -0.85 . . . . 0.0 110.528 -179.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.05 46.36 1.26 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.294 -0.879 . . . . 0.0 110.252 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.467 HG21 ' NH2' ' A' ' 42' ' ' ARG . 40.9 p -118.8 -66.95 1.02 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 0.0 110.468 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.17 161.83 59.4 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.195 -0.941 . . . . 0.0 110.481 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.02 -18.95 20.94 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.841 1.443 . . . . 0.0 110.65 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -84.59 87.07 7.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.955 . . . . 0.0 110.395 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -121.72 -0.83 9.57 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.894 . . . . 0.0 110.904 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 76' ' ' GLN . 8.2 tt -96.69 114.71 26.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.916 -1.115 . . . . 0.0 110.618 -179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -131.91 94.91 3.58 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.307 -0.871 . . . . 0.0 109.42 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.803 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -118.0 138.56 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.143 -0.973 . . . . 0.0 110.952 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.7 OUTLIER -84.74 72.38 10.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 176.293 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.753 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.98 -30.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 O-C-N 122.309 -0.245 . . . . 0.0 111.492 -177.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 52' ' ' ASP . 35.1 mt-10 -60.47 -53.75 53.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.77 -1.206 . . . . 0.0 108.771 178.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.3 mmp_? -71.31 -39.66 71.28 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.432 -0.792 . . . . 0.0 108.891 178.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.873 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.74 -17.82 64.89 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 38.8 ttp180 -89.65 -22.68 22.17 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.19 -0.944 . . . . 0.0 109.594 178.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.888 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.4 t80 -61.4 -44.86 96.42 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 123.167 1.461 . . . . 0.0 107.401 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.919 ' CB ' HD11 ' A' ' 4' ' ' ILE . 84.6 m95 -69.84 -56.49 6.95 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-N 113.921 -1.491 . . . . 0.0 109.982 -179.136 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.887 HD21 ' HG3' ' A' ' 66' ' ' PRO . 20.9 mt -53.98 -22.7 11.01 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.257 -0.977 . . . . 0.0 108.421 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 m -80.9 -22.3 39.87 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.474 -0.766 . . . . 0.0 110.56 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.888 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.0 m -98.69 32.12 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.764 -1.21 . . . . 0.0 109.478 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 30.03 74.61 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.401 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -76.95 128.96 35.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.065 -1.256 . . . . 0.0 110.141 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? -94.76 110.24 48.27 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.253 -0.904 . . . . 0.0 110.47 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.887 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.3 Cg_endo -82.31 131.09 6.5 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.552 1.29 . . . . 0.0 110.194 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.434 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 41.2 p -52.54 160.41 0.87 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 0.0 109.88 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -59.27 -16.3 20.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.047 -1.033 . . . . 0.0 110.909 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.446 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 5.4 m -92.34 -52.93 4.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.002 -1.061 . . . . 0.0 110.464 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -70.93 -28.48 64.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.4 ttt180 -65.53 -39.89 92.29 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -64.09 -27.6 69.2 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.075 178.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 70' ' ' ALA . 15.9 mt -85.5 -31.13 22.93 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.581 -0.699 . . . . 0.0 109.444 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.642 HD22 ' HB1' ' A' ' 56' ' ' ALA . 83.4 mt -69.01 -28.43 66.59 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.501 ' HG3' ' CG ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.7 -29.31 36.47 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.501 ' HB3' HD11 ' A' ' 49' ' ' LEU . 4.8 tp-100 -77.95 -35.08 50.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.899 0.857 . . . . 0.0 109.316 179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -68.63 -9.36 49.4 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.133 -0.627 . . . . 0.0 109.77 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.501 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 88.11 54.54 2.42 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.753 HG22 ' CB ' ' A' ' 53' ' ' VAL . 36.6 t -116.37 -5.21 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.165 -1.197 . . . . 0.0 111.381 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 7.3 m-85 -112.52 -19.5 12.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.879 -1.138 . . . . 0.0 110.086 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.408 ' HG3' ' N ' ' A' ' 82' ' ' GLN . 0.5 OUTLIER -103.9 152.52 21.86 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.24 -0.912 . . . . 0.0 109.361 -179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.408 ' N ' ' HG3' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -142.78 112.02 6.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 110.077 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -123.07 -83.2 0.65 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.0 110.249 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -171.71 79.18 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.154 -0.966 . . . . 0.0 110.54 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.53 -50.75 62.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.124 -0.985 . . . . 0.0 109.789 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -178.98 -177.63 0.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.391 -0.818 . . . . 0.0 109.999 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 138.13 82.61 0.1 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.19 -1.182 . . . . 0.0 110.128 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 tpt . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.301 0.572 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 36.1 t -61.77 134.8 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 0.0 109.839 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -140.5 131.51 26.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 0.0 110.55 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.97 HD11 ' CB ' ' A' ' 59' ' ' TRP . 40.3 mt -99.76 129.31 50.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.074 -1.016 . . . . 0.0 109.012 178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.527 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 18.5 ptt85 -150.24 174.04 13.27 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.2 -0.937 . . . . 0.0 110.405 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.774 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.5 pp -88.21 127.03 35.44 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.96 111.68 23.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.486 -0.759 . . . . 0.0 112.427 -177.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.469 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 7.4 ttt-85 -73.91 123.2 23.8 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.144 -0.973 . . . . 0.0 110.793 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 23.3 m-85 -113.92 -60.09 1.93 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.098 -1.001 . . . . 0.0 110.6 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -41.55 108.6 0.13 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.8 p -57.66 -42.81 84.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -1.117 . . . . 0.0 109.443 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.503 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -175.92 48.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.403 0.621 . . . . 0.0 109.455 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.503 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 10.4 m-70 -128.31 -64.21 0.96 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.437 -0.789 . . . . 0.0 109.442 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -127.59 128.42 23.95 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.407 -0.808 . . . . 0.0 109.704 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.61 111.58 3.35 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.422 1.222 . . . . 0.0 110.947 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.458 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 32.1 p80 -165.11 132.93 3.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.206 -0.934 . . . . 0.0 110.716 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.4 m-85 -123.64 152.08 42.36 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 12.4 ttm180 -99.93 146.24 26.89 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 118.398 -1.321 . . . . 0.0 108.107 178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.04 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -96.33 80.57 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 N-CA-C 102.164 -3.273 . . . . 0.0 102.164 178.325 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.289 0.4 OUTLIER -97.22 168.45 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 113.103 -1.862 . . . . 0.0 111.103 -173.197 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.895 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -114.12 109.76 29.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.49 -0.756 . . . . 0.0 110.507 -177.317 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.5 t -130.66 -174.26 3.31 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.245 -0.909 . . . . 0.0 110.342 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.7 OUTLIER -106.52 -163.24 0.91 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.437 -0.789 . . . . 0.0 110.258 -179.934 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -131.12 -42.42 1.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.144 -0.973 . . . . 0.0 110.537 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.8 -60.14 3.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.087 -1.008 . . . . 0.0 110.42 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.84 94.42 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 109.847 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.92 21.92 11.94 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.287 -0.883 . . . . 0.0 110.645 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.7 tpp180 -91.82 -26.18 18.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.079 -1.013 . . . . 0.0 109.983 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -148.76 142.39 25.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.396 -0.815 . . . . 0.0 110.036 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.49 52.27 4.45 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -88.2 148.89 24.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -1.17 . . . . 0.0 110.245 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.542 ' HB3' HG13 ' A' ' 20' ' ' VAL . 12.8 p90 -119.81 154.09 34.79 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.293 -0.879 . . . . 0.0 110.612 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.671 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.2 mt -61.3 -39.19 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.831 . . . . 0.0 109.918 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -167.36 170.93 11.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.332 -0.855 . . . . 0.0 109.912 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -110.57 121.02 44.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.168 -0.958 . . . . 0.0 110.005 179.782 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.927 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -115.78 -23.5 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.025 -1.047 . . . . 0.0 110.828 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.91 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.98 162.2 16.89 Favored Glycine 0 C--N 1.296 -1.646 0 C-N-CA 118.803 -1.665 . . . . 0.0 111.072 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.47 ' N ' HG12 ' A' ' 19' ' ' ILE . 63.9 t80 -140.22 133.64 29.98 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.04 ' HB2' HD11 ' A' ' 19' ' ' ILE . 2.6 t80 -126.93 121.81 32.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 109.906 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 8.7 t0 -134.86 82.36 43.85 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.011 -1.056 . . . . 0.0 110.064 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.442 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 40.9 Cg_endo -67.21 79.81 0.41 Allowed 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.738 1.388 . . . . 0.0 110.922 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.495 ' HB3' HG22 ' A' ' 44' ' ' THR . 6.3 mtt180 -92.82 154.95 17.95 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.425 -0.797 . . . . 0.0 109.988 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -94.19 64.8 3.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.097 -1.002 . . . . 0.0 110.184 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.515 HG23 ' N ' ' A' ' 45' ' ' THR . 6.7 t -149.0 -41.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.288 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.515 ' N ' HG23 ' A' ' 44' ' ' THR . 8.1 p -137.24 149.47 65.99 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.191 -0.943 . . . . 0.0 110.197 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.02 -28.03 13.41 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.638 1.336 . . . . 0.0 110.522 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -83.28 87.95 6.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.203 -0.936 . . . . 0.0 110.323 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.519 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 9.5 p-90 -117.15 -16.37 10.42 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.152 -0.968 . . . . 0.0 110.684 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.652 HD13 ' HB3' ' A' ' 76' ' ' GLN . 1.7 tt -77.96 127.18 31.95 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -0.99 . . . . 0.0 109.974 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -133.48 86.81 2.33 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.31 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.91 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -115.67 130.61 70.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.119 -0.988 . . . . 0.0 111.327 -179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 11.6 t70 -74.35 70.82 1.72 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.79 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.86 -30.98 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.355 0 O-C-N 122.233 -0.292 . . . . 0.0 111.471 -177.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.8 tp10 -62.83 -50.12 72.23 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 120.797 -1.19 . . . . 0.0 108.623 178.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.669 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -76.72 -33.74 58.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.365 -0.834 . . . . 0.0 108.988 178.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.92 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -70.21 -21.5 63.01 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 53' ' ' VAL . 23.4 tpt180 -86.28 -22.27 26.9 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 121.259 -0.901 . . . . 0.0 109.312 178.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.646 ' O ' HG13 ' A' ' 62' ' ' VAL 0.25 0.5 OUTLIER -62.22 -48.08 81.59 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 123.258 1.504 . . . . 0.0 107.367 178.38 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.97 ' CB ' HD11 ' A' ' 4' ' ' ILE . 77.9 m95 -64.98 -56.08 15.26 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 113.834 -1.53 . . . . 0.0 109.788 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.618 ' CD1' HG11 ' A' ' 79' ' ' VAL . 47.2 mt -53.09 -22.47 6.16 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 119.323 -0.951 . . . . 0.0 108.561 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -80.71 -22.07 40.66 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.408 -0.808 . . . . 0.0 110.826 179.538 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 59' ' ' TRP . 7.2 m -98.89 32.32 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 O-C-N 120.813 -1.18 . . . . 0.0 109.543 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.85 26.61 70.83 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -73.17 110.75 7.7 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.073 -1.251 . . . . 0.0 110.136 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 115.61 56.08 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 0.0 110.241 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.512 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.8 Cg_endo -82.66 144.59 12.58 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.539 1.284 . . . . 0.0 109.992 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.637 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -65.93 165.51 13.01 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.007 -1.058 . . . . 0.0 109.83 179.796 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -63.59 -16.03 59.74 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.228 -0.92 . . . . 0.0 110.9 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.8 m -104.28 -46.79 4.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.187 -0.946 . . . . 0.0 110.175 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.932 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.83 -25.95 65.81 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.3 OUTLIER -65.9 -38.68 89.38 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 178.251 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.412 ' NH1' ' HG3' ' A' ' 72' ' ' ARG . 0.0 OUTLIER -62.01 -32.84 73.36 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 119.483 -0.887 . . . . 0.0 108.919 178.829 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.932 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -76.89 -35.67 57.24 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.512 HD12 ' HB3' ' A' ' 66' ' ' PRO . 76.7 mt -63.89 -28.77 70.07 Favored 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 1.5 mtt180 -78.4 -29.79 47.44 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.652 ' HB3' HD13 ' A' ' 49' ' ' LEU . 8.1 tp-100 -73.16 -34.04 65.81 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 122.056 0.931 . . . . 0.0 108.928 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.603 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -69.57 -7.99 43.4 Favored 'General case' 0 C--N 1.291 -1.977 0 C-N-CA 120.041 -0.664 . . . . 0.0 109.983 178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.81 39.13 10.69 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.79 HG22 HG23 ' A' ' 53' ' ' VAL . 45.5 t -97.43 -6.23 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.176 -1.191 . . . . 0.0 111.893 -179.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 10.9 m-85 -107.81 -169.26 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.871 -1.143 . . . . 0.0 110.304 -179.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.4 mtm180 -63.48 92.58 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -0.926 . . . . 0.0 110.334 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.25 135.22 33.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.247 -0.908 . . . . 0.0 110.115 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -167.86 177.12 5.87 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.154 -0.967 . . . . 0.0 110.368 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . . . -144.83 -50.22 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.322 -0.861 . . . . 0.0 110.298 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 12.4 mtm-85 -161.37 -67.39 0.06 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.156 -0.965 . . . . 0.0 110.513 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -171.46 -40.47 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.186 -0.947 . . . . 0.0 110.134 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -103.05 41.02 2.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 84' ' ' ALA . . . . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.195 -1.179 . . . . 0.0 110.15 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmt . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.315 0.578 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.777 HG11 ' CG2' ' A' ' 62' ' ' VAL . 61.1 t -56.67 102.69 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.825 . . . . 0.0 110.576 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 65' ' ' GLN . 3.7 mtmt -140.18 139.5 35.71 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.203 -0.935 . . . . 0.0 110.793 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.944 HD11 ' HB3' ' A' ' 59' ' ' TRP . 1.5 mp -99.96 130.27 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.097 -1.002 . . . . 0.0 108.849 178.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.417 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.85 -176.71 5.63 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.1 -1.0 . . . . 0.0 110.845 -178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.542 HD22 ' HB2' ' A' ' 17' ' ' TYR . 16.1 mt -89.7 127.14 35.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.344 -0.847 . . . . 0.0 110.8 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.72 107.08 19.07 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.519 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -77.89 120.04 22.22 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.769 -1.207 . . . . 0.0 112.805 -177.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -120.48 -157.13 0.7 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.434 -0.791 . . . . 0.0 109.091 177.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.47 128.79 0.01 OUTLIER Glycine 0 N--CA 1.488 2.128 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.48 ' HG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -61.65 -85.2 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.178 -1.19 . . . . 0.0 109.78 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 11' ' ' SER . 15.5 mttt -146.41 53.77 1.13 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.48 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 4.2 m-70 -140.76 -53.45 0.49 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 109.666 -178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.434 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -118.19 96.88 50.3 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.855 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.14 101.99 1.54 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.754 1.397 . . . . 0.0 111.256 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.439 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 29.5 p80 -145.91 135.02 22.75 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.0 109.707 179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.542 ' HB2' HD22 ' A' ' 6' ' ' LEU . 11.0 m-85 -113.35 162.36 16.16 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.226 -0.922 . . . . 0.0 109.295 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 24.2 ttt180 -112.41 152.65 28.41 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.939 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.2 mt -98.73 78.35 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 102.57 -3.122 . . . . 0.0 102.57 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 34' ' ' GLU 0.271 0.4 OUTLIER -98.07 165.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.179 -173.134 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.951 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -106.44 106.35 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.854 -0.529 . . . . 0.0 110.612 -177.896 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.7 t -132.69 -173.44 3.18 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.151 -0.968 . . . . 0.0 110.258 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 22' ' ' THR . 51.5 p-10 -75.41 -167.61 0.68 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.436 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.51 -51.21 9.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.867 . . . . 0.0 110.143 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 ttp85 -177.57 116.79 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 110.174 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.16 -62.08 1.52 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.28 -0.887 . . . . 0.0 109.852 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -169.9 -55.06 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.797 . . . . 0.0 109.933 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -175.98 56.13 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.299 -0.875 . . . . 0.0 110.103 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -138.52 -166.59 2.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.262 -0.899 . . . . 0.0 110.319 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -152.73 94.32 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.61 59.71 1.62 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -1.154 . . . . 0.0 110.44 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.6 p90 -54.47 -179.02 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.955 . . . . 0.0 110.245 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.1 mt -90.45 -34.39 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.38 -0.825 . . . . 0.0 109.988 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.56 ' O ' HG22 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -164.71 -175.54 3.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.447 -0.783 . . . . 0.0 110.007 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -119.18 112.75 19.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.229 -0.92 . . . . 0.0 110.173 -179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.978 HG21 ' CD1' ' A' ' 59' ' ' TRP . 21.4 pt -108.96 -38.0 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 120.924 -1.11 . . . . 0.0 111.208 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.79 163.73 19.63 Favored Glycine 0 C--N 1.295 -1.695 0 C-N-CA 118.675 -1.726 . . . . 0.0 110.81 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 25.0 t80 -133.69 152.54 51.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.47 ' CD2' ' HD3' ' A' ' 41' ' ' PRO . 16.4 t80 -143.54 137.86 28.75 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.974 -1.079 . . . . 0.0 109.738 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 36.0 t0 -139.97 80.8 19.95 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 120.759 -1.213 . . . . 0.0 110.479 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 40.1 Cg_endo -67.26 62.68 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.494 1.26 . . . . 0.0 110.886 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 40' ' ' ASP . 0.9 OUTLIER -99.99 148.62 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.53 67.49 9.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.18 -0.95 . . . . 0.0 110.222 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.1 p -126.19 -81.91 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.168 -0.957 . . . . 0.0 110.438 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.1 p -137.48 167.24 21.41 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.155 -0.966 . . . . 0.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.32 59.83 3.92 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.737 1.388 . . . . 0.0 110.446 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -151.5 53.47 0.84 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.908 . . . . 0.0 109.699 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.58 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 16.0 p-90 -108.52 -12.87 14.94 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.438 -0.789 . . . . 0.0 110.748 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.631 HD21 ' HB2' ' A' ' 77' ' ' ALA . 7.2 tt -86.61 121.88 29.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.0 . . . . 0.0 110.791 -179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.85 94.01 2.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.344 -0.847 . . . . 0.0 108.715 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.939 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -120.58 154.52 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 122.255 1.026 . . . . 0.0 111.712 -178.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 54' ' ' GLU . 9.1 t0 -103.95 68.07 0.9 Allowed 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 176.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.2 OUTLIER -29.95 -35.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.48 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.9 tt0 -60.28 -52.46 65.2 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.771 -1.206 . . . . 0.0 109.197 178.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.57 ' HB3' HG22 ' A' ' 36' ' ' ILE . 28.0 mmm180 -72.3 -41.01 67.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.213 -0.929 . . . . 0.0 108.967 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.967 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -63.37 -20.37 65.47 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.436 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 23.2 ttp85 -89.79 -21.95 22.37 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 121.233 -0.917 . . . . 0.0 109.648 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.89 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -63.36 -47.23 82.97 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-O 123.176 1.465 . . . . 0.0 107.311 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.978 ' CD1' HG21 ' A' ' 36' ' ' ILE . 90.4 m95 -66.81 -55.29 15.54 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 113.934 -1.485 . . . . 0.0 109.915 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -54.62 -22.82 14.66 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 119.178 -1.009 . . . . 0.0 108.317 177.014 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 t -81.67 -19.2 42.14 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.46 -0.775 . . . . 0.0 110.41 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.4 m -99.0 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 O-C-N 120.799 -1.188 . . . . 0.0 109.31 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.88 28.05 73.38 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -71.15 146.12 49.34 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.072 -1.252 . . . . 0.0 110.301 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 3' ' ' LYS . 1.9 mm100 -113.1 109.59 51.96 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.254 -0.904 . . . . 0.0 110.321 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HG3' HD21 ' A' ' 60' ' ' LEU . 52.2 Cg_endo -86.64 128.38 2.9 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.59 1.311 . . . . 0.0 110.619 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.811 HG23 ' H ' ' A' ' 70' ' ' ALA . 2.3 t -54.81 165.95 0.55 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.234 -0.916 . . . . 0.0 109.802 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -59.09 -17.52 27.01 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.154 -0.966 . . . . 0.0 111.202 -179.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 73.1 m -90.24 -52.88 4.71 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.075 -1.016 . . . . 0.0 110.487 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.811 ' H ' HG23 ' A' ' 67' ' ' THR . . . -68.99 -28.82 66.95 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' HA ' HD12 ' A' ' 74' ' ' LEU . 0.1 OUTLIER -68.34 -39.16 81.98 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 178.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -66.51 -39.57 88.75 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.58 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 25.4 mt -73.63 -27.3 61.19 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.41 -0.806 . . . . 0.0 109.267 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.543 HD13 HD11 ' A' ' 60' ' ' LEU . 21.3 mt -69.64 -27.83 65.39 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.543 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.72 -25.83 37.84 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.055 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 8.3 tp-100 -83.85 -36.55 23.35 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 121.792 0.806 . . . . 0.0 110.671 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.631 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -69.01 -6.63 29.1 Favored 'General case' 0 C--N 1.288 -2.079 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.281 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.35 43.88 7.75 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.559 ' HA ' HG23 ' A' ' 53' ' ' VAL . 23.8 t -94.68 -56.15 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.156 -1.202 . . . . 0.0 111.2 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.543 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.7 m-30 -56.21 120.89 8.28 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.121 -0.987 . . . . 0.0 110.264 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -96.43 69.12 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -0.961 . . . . 0.0 109.978 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -173.55 60.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 110.274 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -70.23 137.89 51.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.129 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -106.98 53.77 0.69 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.219 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -107.36 -41.91 4.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.218 -0.926 . . . . 0.0 110.324 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -61.62 -179.42 0.18 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 110.138 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -126.31 95.5 0.45 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.25 -1.147 . . . . 0.0 110.283 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.6 mtt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.217 0.532 . . . . 0.0 110.264 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.574 HG11 ' CE3' ' A' ' 59' ' ' TRP . 41.0 t -91.78 135.89 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.249 -0.907 . . . . 0.0 110.43 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HG3' ' HB2' ' A' ' 65' ' ' GLN . 7.3 mttt -140.33 140.37 35.6 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.24 -0.912 . . . . 0.0 110.276 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.982 HD11 ' CB ' ' A' ' 59' ' ' TRP . 95.2 mt -108.18 134.88 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.932 . . . . 0.0 109.745 179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.4 OUTLIER -150.96 -163.65 1.82 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.312 -0.868 . . . . 0.0 110.112 -179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.028 HD11 HG21 ' A' ' 69' ' ' THR . 36.4 mt -89.3 136.03 33.25 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.071 -1.018 . . . . 0.0 110.986 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.648 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -106.47 105.22 15.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.757 -0.59 . . . . 0.0 110.911 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.479 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.9 ttp85 -75.57 120.91 21.63 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.123 -0.986 . . . . 0.0 111.177 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.648 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 16.2 m-85 -108.78 -64.2 1.26 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.411 -0.806 . . . . 0.0 110.544 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.28 128.82 23.57 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 3.1 p -63.71 -50.56 68.7 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.361 -1.082 . . . . 0.0 109.565 179.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' CD ' ' O ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -167.03 31.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.633 0.73 . . . . 0.0 109.095 179.821 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -101.83 -53.79 2.87 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.602 0.715 . . . . 0.0 109.455 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -138.55 123.13 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.57 -0.706 . . . . 0.0 109.414 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.03 90.98 0.84 Allowed 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.426 1.224 . . . . 0.0 111.016 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.4 p80 -141.97 124.75 16.01 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.144 -0.972 . . . . 0.0 110.557 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 4.7 m-30 -116.34 154.74 29.69 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.988 -1.07 . . . . 0.0 108.456 178.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.624 ' HD3' HG23 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -104.14 164.77 11.49 Favored 'General case' 0 C--N 1.294 -1.817 0 C-N-CA 117.743 -1.583 . . . . 0.0 106.997 176.151 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.701 HD12 HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -98.39 86.39 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 179.494 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.624 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.264 0.4 OUTLIER -98.12 168.72 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.285 -174.782 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.948 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -113.75 106.19 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.464 -0.773 . . . . 0.0 110.673 -177.484 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.646 HG22 ' HB3' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -119.78 141.53 49.4 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.952 . . . . 0.0 109.418 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.26 -157.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.885 . . . . 0.0 110.006 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.34 44.23 2.74 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.247 -0.908 . . . . 0.0 110.117 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -69.37 -82.06 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.282 -0.886 . . . . 0.0 110.814 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -123.36 -176.18 3.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.206 -0.934 . . . . 0.0 110.552 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.1 mmtt -120.48 21.31 11.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.344 -0.848 . . . . 0.0 110.29 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.71 59.31 1.59 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.233 -0.917 . . . . 0.0 110.151 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -150.53 -50.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 110.031 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.75 40.63 17.26 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.85 132.27 55.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.22 -1.165 . . . . 0.0 110.432 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.646 ' HB3' HG22 ' A' ' 22' ' ' THR . 2.8 p90 -120.02 -177.24 3.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.245 -0.909 . . . . 0.0 110.467 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.529 HG21 ' HH2' ' A' ' 59' ' ' TRP . 8.3 mt -92.07 -50.72 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.471 -0.768 . . . . 0.0 110.04 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.1 tt0 -150.15 164.59 35.23 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -0.804 . . . . 0.0 110.01 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.44 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -103.07 116.71 33.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.153 -0.967 . . . . 0.0 109.142 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.995 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.9 pt -110.5 -33.8 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.985 -1.072 . . . . 0.0 111.991 -178.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -128.38 174.46 18.86 Favored Glycine 0 C--N 1.293 -1.844 0 C-N-CA 118.591 -1.766 . . . . 0.0 112.187 -177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 85.1 t80 -140.49 142.9 35.24 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.522 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 7.8 t80 -140.16 132.91 29.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.722 -1.236 . . . . 0.0 110.036 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 10.8 t0 -140.34 89.46 10.73 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 120.835 -1.165 . . . . 0.0 110.236 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.8 82.88 0.55 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.466 1.245 . . . . 0.0 110.646 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.7 mtt180 -89.7 -166.26 1.55 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.306 -0.871 . . . . 0.0 110.279 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -128.38 59.87 1.51 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.6 p -142.52 -81.56 0.2 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.934 . . . . 0.0 110.35 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 44.2 p -132.54 161.6 62.3 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.22 -0.925 . . . . 0.0 110.174 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.13 66.72 3.4 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.611 1.322 . . . . 0.0 110.433 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -140.49 50.21 1.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.18 -0.95 . . . . 0.0 110.0 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.522 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.5 p-90 -121.54 -11.46 8.68 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.329 -0.857 . . . . 0.0 110.76 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.584 HD21 ' HB2' ' A' ' 77' ' ' ALA . 5.5 tt -81.34 111.08 17.38 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.012 -1.055 . . . . 0.0 110.718 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.39 96.06 4.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.0 109.388 179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.803 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -120.74 149.11 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.11 -0.994 . . . . 0.0 111.476 -179.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t0 -95.75 68.89 2.88 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.583 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.21 -35.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -177.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mt-10 -59.68 -52.98 63.18 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.746 -1.221 . . . . 0.0 109.202 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.66 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.79 -40.86 72.31 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.4 -0.812 . . . . 0.0 109.049 178.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.09 -18.69 65.51 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.145 -0.972 . . . . 0.0 108.548 178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.8 OUTLIER -88.26 -22.96 23.65 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.242 -0.911 . . . . 0.0 109.524 178.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 62' ' ' VAL . 3.7 t80 -61.05 -43.28 99.12 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.139 1.447 . . . . 0.0 107.305 178.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.995 ' CD1' HG21 ' A' ' 36' ' ' ILE . 78.7 m95 -68.6 -53.31 23.52 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 113.809 -1.541 . . . . 0.0 109.893 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.625 HD11 HD13 ' A' ' 74' ' ' LEU . 6.6 mt -57.39 -21.02 33.37 Favored 'General case' 0 C--N 1.293 -1.868 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.574 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 t -81.58 -23.89 36.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.453 -0.779 . . . . 0.0 110.651 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 59' ' ' TRP . 25.5 m -99.15 32.99 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 O-C-N 120.817 -1.177 . . . . 0.0 109.649 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.42 31.25 76.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 59' ' ' TRP . . . -70.54 141.68 51.86 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.006 -1.291 . . . . 0.0 110.18 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.453 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 0.5 OUTLIER -105.91 103.04 42.42 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 110.128 179.901 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.4 Cg_endo -81.26 125.14 5.07 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 123.698 1.367 . . . . 0.0 110.226 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.683 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.5 t -54.9 176.02 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.0 -1.062 . . . . 0.0 109.695 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.79 -19.68 62.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.182 -0.949 . . . . 0.0 111.026 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 1.028 HG21 HD11 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -90.5 -51.17 5.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.126 -0.984 . . . . 0.0 110.686 -179.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.683 ' H ' HG23 ' A' ' 67' ' ' THR . . . -70.4 -27.59 64.41 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' HA ' HD12 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -69.21 -37.98 78.35 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 178.24 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.7 mtp180 -69.47 -47.34 64.25 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.545 178.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 70' ' ' ALA . 15.4 mt -60.48 -25.13 65.81 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.625 HD13 HD11 ' A' ' 60' ' ' LEU . 23.1 mt -76.19 -25.94 55.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 177.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -82.08 -31.49 30.75 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.495 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.5 tp-100 -87.18 -36.46 18.01 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-O 121.724 0.773 . . . . 0.0 110.7 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.584 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.86 -10.78 31.01 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.705 -0.622 . . . . 0.0 110.01 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.64 48.78 5.13 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.612 HG21 HD23 ' A' ' 74' ' ' LEU . 49.5 t -100.39 -62.82 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.065 -1.256 . . . . 0.0 111.44 -179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 19.8 m-85 -52.9 142.52 19.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.918 -1.114 . . . . 0.0 109.651 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -110.68 72.71 0.79 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.112 -0.993 . . . . 0.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -168.42 102.79 0.43 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.924 . . . . 0.0 110.64 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -98.98 167.35 10.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.169 -0.957 . . . . 0.0 109.882 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -133.17 -161.9 1.19 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.029 -1.044 . . . . 0.0 110.626 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -112.48 65.13 0.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.352 -0.842 . . . . 0.0 110.331 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -53.4 175.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -0.959 . . . . 0.0 110.2 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 59.24 33.63 76.23 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.323 -1.104 . . . . 0.0 110.253 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.229 0.537 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.904 HG11 HG23 ' A' ' 62' ' ' VAL . 49.9 t -66.41 98.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.261 -0.899 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 mtpt -138.6 133.41 32.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.321 -0.862 . . . . 0.0 110.117 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.982 HD11 ' CB ' ' A' ' 59' ' ' TRP . 84.9 mt -106.05 133.37 50.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.162 -0.961 . . . . 0.0 109.649 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.525 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.2 174.33 13.38 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.349 -0.845 . . . . 0.0 109.956 -179.514 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.476 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 1.2 pp -89.26 129.43 35.83 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.1 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.722 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.65 165.5 11.77 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.473 -0.767 . . . . 0.0 109.334 -178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.463 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -128.7 117.46 21.19 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.974 -1.079 . . . . 0.0 111.483 -179.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.722 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -129.22 -152.76 0.53 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.32 -0.862 . . . . 0.0 109.564 179.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.1 94.82 1.37 Allowed Glycine 0 N--CA 1.487 2.059 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.411 ' OG ' ' HG2' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -62.29 -52.77 62.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.147 -1.208 . . . . 0.0 109.743 179.644 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.411 ' HG2' ' OG ' ' A' ' 11' ' ' SER . 1.9 pttm -173.5 39.15 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.367 -0.833 . . . . 0.0 110.063 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -119.37 -40.45 2.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.29 -0.881 . . . . 0.0 109.45 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -172.61 133.23 0.7 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.633 -0.667 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.44 123.54 8.74 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.48 1.253 . . . . 0.0 111.141 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 30.1 p80 -153.75 143.99 22.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 0.0 110.102 179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 14.5 m-85 -117.96 166.61 12.31 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.429 -0.795 . . . . 0.0 109.083 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.69 147.16 50.38 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.006 -1.059 . . . . 0.0 108.384 178.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.872 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -97.31 81.05 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 178.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG23 ' CD ' ' A' ' 18' ' ' ARG 0.29 0.4 OUTLIER -98.2 160.49 3.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 113.476 -1.693 . . . . 0.0 111.78 -173.347 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.943 HG13 HG12 ' A' ' 4' ' ' ILE . 0.1 OUTLIER -104.16 107.91 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.686 -0.634 . . . . 0.0 109.862 -178.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.437 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.9 t -139.32 -168.6 2.49 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.207 -0.933 . . . . 0.0 110.425 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.9 m-20 -90.47 -167.87 1.95 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.404 -0.81 . . . . 0.0 110.224 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 26' ' ' ARG . . . -104.85 -22.76 13.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.89 . . . . 0.0 110.179 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -60.54 83.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.0 110.38 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -107.88 53.47 0.69 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.14 -0.975 . . . . 0.0 110.278 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.24 -27.04 47.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.0 110.149 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -173.82 38.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -0.883 . . . . 0.0 110.164 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -163.64 172.34 14.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.33 -0.856 . . . . 0.0 110.048 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -157.52 48.57 0.45 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -83.66 134.32 34.78 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.123 -1.222 . . . . 0.0 110.082 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.487 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.6 p90 -113.97 155.18 26.32 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.259 -0.901 . . . . 0.0 110.62 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.511 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.6 mt -68.92 -29.0 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.488 -0.758 . . . . 0.0 109.643 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -168.37 179.94 4.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.443 -0.786 . . . . 0.0 109.965 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 31.9 pttt -120.81 121.82 38.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.232 -0.918 . . . . 0.0 109.743 179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 56' ' ' ALA . 23.9 pt -116.92 -38.52 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.135 -0.978 . . . . 0.0 111.607 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.843 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.0 165.64 13.05 Favored Glycine 0 C--N 1.296 -1.686 0 C-N-CA 118.928 -1.606 . . . . 0.0 111.531 -178.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.421 ' N ' HG13 ' A' ' 19' ' ' ILE . 42.6 t80 -139.07 126.68 21.86 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 177.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.578 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 5.8 t80 -119.27 136.59 54.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.959 -1.088 . . . . 0.0 110.548 -178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 32.4 t70 -131.63 87.57 45.55 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.633 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.5 82.82 0.4 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.554 1.292 . . . . 0.0 110.655 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -99.66 168.98 9.59 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.462 -0.774 . . . . 0.0 110.372 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -120.04 16.25 12.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.28 -0.887 . . . . 0.0 110.135 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.5 t -120.94 -27.53 4.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.122 -0.987 . . . . 0.0 110.649 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.1 p -126.53 138.98 33.53 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.093 -1.005 . . . . 0.0 110.439 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.21 -41.7 0.46 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.697 1.367 . . . . 0.0 110.718 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.37 98.44 6.73 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 110.765 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.737 ' HZ3' HD12 ' A' ' 49' ' ' LEU . 5.2 p-90 -132.27 -3.28 3.47 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.219 -0.926 . . . . 0.0 111.3 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.749 HD11 ' HB3' ' A' ' 73' ' ' LEU . 1.4 tt -89.97 118.74 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.781 -1.199 . . . . 0.0 110.93 -179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -124.16 94.79 4.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.43 -0.793 . . . . 0.0 108.884 178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.872 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -118.51 141.23 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.166 -0.959 . . . . 0.0 111.557 -178.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -85.3 67.19 10.06 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.259 -2.126 . . . . 0.0 105.259 175.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.879 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.82 -29.43 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -176.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -61.13 -47.32 86.78 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.78 -1.2 . . . . 0.0 108.567 178.138 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.505 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 30.8 mmm180 -76.88 -38.53 53.46 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.68 -21.75 66.81 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.3 -21.16 24.58 Favored 'General case' 0 N--CA 1.48 1.064 0 O-C-N 121.442 -0.786 . . . . 0.0 109.536 178.252 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.821 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -65.81 -49.39 68.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.242 1.496 . . . . 0.0 107.451 178.617 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.982 ' CB ' HD11 ' A' ' 4' ' ' ILE . 86.7 m95 -63.6 -56.08 18.72 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 113.859 -1.519 . . . . 0.0 109.748 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.761 HD21 ' HG3' ' A' ' 66' ' ' PRO . 12.4 mt -52.95 -22.79 6.04 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.26 -0.976 . . . . 0.0 108.421 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -81.89 -19.06 41.66 Favored 'General case' 0 N--CA 1.484 1.275 0 O-C-N 121.544 -0.722 . . . . 0.0 110.337 179.003 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.904 HG23 HG11 ' A' ' 2' ' ' VAL . 3.2 m -98.74 31.74 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 O-C-N 120.849 -1.157 . . . . 0.0 109.612 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.64 28.25 72.42 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.23 143.57 52.13 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -1.209 . . . . 0.0 110.109 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -106.54 105.65 55.24 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 0.0 110.532 -179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.761 ' HG3' HD21 ' A' ' 60' ' ' LEU . 55.3 Cg_endo -80.85 140.48 12.86 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.616 1.324 . . . . 0.0 110.335 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.449 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 70.5 p -72.24 163.52 27.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.993 -1.067 . . . . 0.0 110.166 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -59.63 -22.48 61.92 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.004 -1.06 . . . . 0.0 110.725 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.476 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 12.5 m -92.78 -48.23 6.67 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.173 -0.954 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.989 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.78 -30.21 67.71 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.522 ' HA ' HD12 ' A' ' 74' ' ' LEU . 12.2 ttt-85 -66.12 -37.5 85.89 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.34 -28.9 70.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.989 HD12 ' HA ' ' A' ' 70' ' ' ALA . 14.8 mt -83.94 -33.4 24.69 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.59 HD13 HD11 ' A' ' 60' ' ' LEU . 80.5 mt -63.99 -30.53 71.6 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.464 ' HG3' ' CG ' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -79.59 -25.72 41.45 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.631 ' HB3' HD13 ' A' ' 49' ' ' LEU . 10.3 tp-100 -74.32 -35.01 63.62 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 122.12 0.962 . . . . 0.0 109.26 179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.595 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -72.24 -5.8 38.48 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.23 178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.45 48.31 5.66 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.879 HG22 HG23 ' A' ' 53' ' ' VAL . 44.0 t -106.01 -3.49 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.288 -1.125 . . . . 0.0 111.501 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 13.1 m-85 -109.82 -14.96 14.21 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.839 -1.163 . . . . 0.0 110.478 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? -171.32 168.63 6.57 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.133 -0.979 . . . . 0.0 110.175 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -173.29 126.8 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 110.193 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 0.0 OUTLIER -172.52 -47.7 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.231 -0.918 . . . . 0.0 110.16 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 83' ' ' GLU . . . -176.87 163.79 2.28 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.414 -0.804 . . . . 0.0 110.067 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.3 mmt180 -111.09 15.55 21.57 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -72.95 132.04 42.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.147 -0.971 . . . . 0.0 110.238 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 116.95 -115.3 3.23 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.217 -1.167 . . . . 0.0 110.254 179.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.413 ' HB2' ' HB2' ' A' ' 23' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.026 0.441 . . . . 0.0 110.68 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 64' ' ' ALA . 16.6 m -58.35 116.37 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.074 -1.016 . . . . 0.0 110.337 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 mtpt -140.22 129.16 23.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.314 -0.866 . . . . 0.0 110.119 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.924 ' CG1' HG13 ' A' ' 21' ' ' VAL . 74.9 mt -99.8 131.9 46.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 O-C-N 121.023 -1.048 . . . . 0.0 109.373 179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.0 ptm180 -150.42 -167.06 2.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.038 -1.039 . . . . 0.0 110.361 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.723 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.6 mp -89.31 131.22 35.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.353 -0.842 . . . . 0.0 110.356 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.647 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -103.08 105.06 15.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.366 -0.834 . . . . 0.0 111.206 -179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.508 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.2 119.49 18.49 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.192 -0.943 . . . . 0.0 111.525 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.647 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 11.3 m-85 -108.13 -63.43 1.32 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.516 -0.74 . . . . 0.0 109.793 179.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -57.58 104.36 0.42 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.445 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 53.1 p -66.92 -55.8 13.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -1.145 . . . . 0.0 110.286 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.445 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.9 mmtt -141.1 48.99 1.67 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -139.07 -63.01 0.53 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 109.937 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 53.0 t-20 -135.38 125.52 16.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.425 -0.797 . . . . 0.0 109.905 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -77.59 111.31 3.12 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.494 1.26 . . . . 0.0 110.895 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 33.6 p80 -169.63 119.18 0.65 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.26 -0.9 . . . . 0.0 110.393 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 3.9 m-30 -110.28 154.01 24.05 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.85 -1.156 . . . . 0.0 108.437 178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -104.03 165.91 10.74 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.64 -1.624 . . . . 0.0 107.24 176.55 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.707 HD12 HG21 ' A' ' 51' ' ' VAL . 0.2 OUTLIER -98.46 83.74 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 N-CA-C 104.328 -2.471 . . . . 0.0 104.328 179.165 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.252 0.3 OUTLIER -97.6 169.73 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.146 -174.943 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.924 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -113.47 104.83 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.56 -0.712 . . . . 0.0 110.496 -177.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.441 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t -130.6 -173.01 2.95 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.248 -0.907 . . . . 0.0 110.166 179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 25' ' ' ARG . 6.8 p-10 -147.01 -147.39 0.22 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.851 . . . . 0.0 109.974 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -52.07 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.428 ' N ' ' O ' ' A' ' 23' ' ' ASP . 23.4 mtm-85 -50.52 146.48 5.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.306 -0.871 . . . . 0.0 110.299 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -71.3 -168.68 0.33 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 0.0 110.422 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.59 15.66 28.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.399 -0.813 . . . . 0.0 110.431 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -140.05 -61.26 0.52 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -0.98 . . . . 0.0 110.175 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -135.38 78.95 1.76 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.261 -0.899 . . . . 0.0 110.193 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -57.5 135.08 52.06 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.68 -177.48 4.5 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.0 110.138 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.441 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 -116.88 175.64 5.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 110.285 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.776 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.9 mt -82.77 -43.62 18.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.482 -0.761 . . . . 0.0 109.37 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -161.3 161.72 30.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.486 -0.758 . . . . 0.0 109.624 179.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' HB2' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -98.13 116.74 30.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.0 -1.062 . . . . 0.0 110.101 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 56' ' ' ALA . 35.5 pt -104.66 -36.08 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.975 -1.078 . . . . 0.0 111.472 -179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.811 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -129.08 177.04 18.14 Favored Glycine 0 C--N 1.294 -1.753 0 C-N-CA 118.917 -1.611 . . . . 0.0 112.291 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 17.2 t80 -140.58 145.63 36.97 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 177.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 4.2 t80 -142.92 129.64 20.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.609 -1.307 . . . . 0.0 110.5 179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 9.3 t0 -137.41 92.04 13.8 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.818 -1.176 . . . . 0.0 110.25 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.91 69.46 3.01 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.629 1.331 . . . . 0.0 110.791 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.08 160.99 16.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.225 -0.922 . . . . 0.0 110.302 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -99.83 65.79 1.34 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.161 -0.962 . . . . 0.0 110.518 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 18.3 p -136.3 -58.61 0.74 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.225 -0.922 . . . . 0.0 110.077 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.1 p -127.23 163.26 43.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.262 -0.899 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.6 -31.3 11.01 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.706 1.372 . . . . 0.0 110.566 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.06 119.07 25.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.327 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.705 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 1.0 OUTLIER -149.09 15.68 0.93 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.12 -0.988 . . . . 0.0 110.945 -179.813 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 73' ' ' LEU . 11.8 tp -114.23 129.09 56.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.039 -1.038 . . . . 0.0 111.213 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -128.25 110.45 12.41 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.811 HG22 ' HA3' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.24 160.96 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-O 122.419 1.104 . . . . 0.0 111.72 -178.745 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.458 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.4 t70 -104.91 67.58 0.8 Allowed 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 175.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.05 -32.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.593 -177.321 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.458 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -63.58 -52.06 62.63 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.9 -1.125 . . . . 0.0 109.232 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.493 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 1.8 mtm-85 -75.69 -33.3 60.35 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.241 -0.912 . . . . 0.0 109.428 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -68.99 -23.8 64.15 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.45 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.5 ttt-85 -86.3 -21.89 27.06 Favored 'General case' 0 N--CA 1.483 1.195 0 O-C-N 121.24 -0.912 . . . . 0.0 109.726 178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.573 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -61.02 -50.57 72.8 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 123.252 1.501 . . . . 0.0 107.039 178.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.906 ' CD2' HG11 ' A' ' 21' ' ' VAL . 84.5 m95 -60.27 -53.02 62.65 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.756 -1.566 . . . . 0.0 109.576 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.775 HD12 ' O ' ' A' ' 56' ' ' ALA . 1.3 mt -54.42 -22.04 11.43 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -77.97 -22.75 48.97 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.542 -0.724 . . . . 0.0 110.408 179.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.718 HG22 ' O ' ' A' ' 59' ' ' TRP . 8.9 m -99.05 32.67 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 O-C-N 120.784 -1.197 . . . . 0.0 109.736 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.58 25.58 74.89 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -66.84 129.69 40.7 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.237 -1.155 . . . . 0.0 109.763 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 10.5 mt-30 -101.35 116.43 63.75 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.168 -0.958 . . . . 0.0 110.638 -179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.2 Cg_endo -82.77 128.4 5.21 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.526 1.277 . . . . 0.0 109.921 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 4.9 t -55.49 176.42 0.06 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.852 -1.155 . . . . 0.0 110.194 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.64 55.37 1.04 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.204 -0.935 . . . . 0.0 110.548 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 m -166.67 -59.95 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.692 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.15 -23.16 66.43 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 18.0 ttp85 -65.62 -42.71 91.25 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 75' ' ' ARG . 3.1 ttm180 -67.46 -42.16 83.47 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.286 -0.965 . . . . 0.0 109.424 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.735 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.1 mt -68.19 -26.16 65.59 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 60' ' ' LEU . 13.7 mt -67.61 -30.17 69.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG2' ' CE1' ' A' ' 80' ' ' PHE . 9.0 mtm180 -75.98 -34.52 59.78 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.39 -28.26 56.66 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.925 0.869 . . . . 0.0 109.9 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.764 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -69.65 -7.55 39.89 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.306 179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.95 19.51 33.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.471 HG11 HD13 ' A' ' 60' ' ' LEU . 12.2 t -86.74 -64.46 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.065 -1.256 . . . . 0.0 110.763 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.506 ' CE1' ' HG2' ' A' ' 75' ' ' ARG . 43.4 p90 -149.11 143.93 26.32 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.986 -1.071 . . . . 0.0 111.098 -179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -118.02 -177.57 3.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.37 -0.831 . . . . 0.0 109.975 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -135.46 65.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.126 -0.984 . . . . 0.0 110.283 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.43 128.1 35.18 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.264 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -118.77 -25.89 6.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.293 -0.879 . . . . 0.0 110.437 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.34 -61.07 2.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.243 -0.911 . . . . 0.0 110.386 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -52.48 134.42 34.86 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.253 -0.905 . . . . 0.0 110.35 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 110.42 -141.24 16.25 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.197 -1.178 . . . . 0.0 110.135 179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 121.158 0.504 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.488 HG11 ' CG2' ' A' ' 62' ' ' VAL . 39.7 t -54.55 116.12 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.282 -0.886 . . . . 0.0 110.254 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.429 ' HG2' ' HB2' ' A' ' 65' ' ' GLN . 57.8 mtpt -140.92 134.72 30.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.11 -0.993 . . . . 0.0 110.323 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.998 ' CG1' HG13 ' A' ' 21' ' ' VAL . 37.9 mt -99.73 133.99 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 108.917 178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.519 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 3.8 ptt180 -150.35 172.99 14.51 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.006 -1.059 . . . . 0.0 109.941 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' CD2' ' CG2' ' A' ' 69' ' ' THR . 2.9 pp -89.28 130.84 35.61 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.167 -0.958 . . . . 0.0 109.518 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.15 162.21 13.18 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.571 -0.706 . . . . 0.0 109.212 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 70.6 ttt180 -127.92 114.45 17.18 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.931 -1.106 . . . . 0.0 111.4 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -127.18 -152.51 0.52 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.301 -0.875 . . . . 0.0 109.119 178.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.81 98.82 0.99 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.488 ' HG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -56.71 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.273 -1.133 . . . . 0.0 110.043 179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.6 54.2 1.0 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.206 -0.934 . . . . 0.0 108.761 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.488 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 4.3 m-70 -142.51 -47.58 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.756 -0.777 . . . . 0.0 109.601 -178.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -151.06 110.07 3.05 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.71 . . . . 0.0 109.828 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.42 122.31 8.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.51 1.269 . . . . 0.0 110.91 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 27.1 p80 -148.57 152.33 36.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.396 -0.815 . . . . 0.0 109.845 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 7' ' ' ALA . 12.5 m-85 -123.14 168.37 12.49 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.541 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 2.2 ttp180 -132.05 147.19 52.43 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.017 -1.052 . . . . 0.0 108.18 177.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.841 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.5 OUTLIER -97.22 83.24 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 178.086 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.291 0.4 OUTLIER -97.56 167.0 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 113.316 -1.765 . . . . 0.0 111.338 -173.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.998 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -112.85 105.65 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.488 -0.758 . . . . 0.0 110.986 -177.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HA ' HD12 ' A' ' 33' ' ' ILE . 1.9 t -134.7 -170.23 2.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.203 -0.936 . . . . 0.0 110.004 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 22' ' ' THR . 75.9 m-20 -102.5 -169.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 110.14 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.77 27.73 4.73 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.205 -0.934 . . . . 0.0 110.202 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.3 mtt180 -60.8 -166.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 110.554 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.7 mtm-85 -69.41 -166.26 0.09 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.338 -0.851 . . . . 0.0 110.487 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.4 11.63 10.02 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.461 -0.774 . . . . 0.0 110.518 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mtp85 -90.95 14.5 13.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.006 -1.059 . . . . 0.0 110.465 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.64 -55.41 1.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 110.007 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.33 70.71 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -138.47 130.27 28.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.211 -1.17 . . . . 0.0 110.47 -179.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 31.8 p90 -118.72 159.55 23.46 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.279 -0.888 . . . . 0.0 110.616 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.679 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -62.61 -46.12 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.492 -0.755 . . . . 0.0 109.539 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -157.81 171.66 19.9 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.401 -0.812 . . . . 0.0 109.613 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -112.63 125.15 53.97 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.652 179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.995 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -120.76 -28.05 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.029 -1.044 . . . . 0.0 111.093 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.916 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.26 158.77 14.86 Favored Glycine 0 C--N 1.297 -1.607 0 C-N-CA 118.945 -1.598 . . . . 0.0 111.078 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.443 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 69.2 t80 -132.61 133.2 43.35 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.577 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 6.0 t80 -124.39 136.1 53.81 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.301 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.435 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.7 t70 -132.73 83.85 51.94 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.013 -1.055 . . . . 0.0 110.007 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 43.5 Cg_endo -69.6 61.24 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.519 1.273 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.52 149.5 21.65 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 110.347 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -95.5 44.07 1.09 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.106 -0.996 . . . . 0.0 109.999 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.3 p -125.7 -43.3 1.87 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.169 -0.957 . . . . 0.0 110.635 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 53.6 p -132.14 152.29 79.91 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.212 -0.93 . . . . 0.0 110.383 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 51.0 Cg_endo -78.39 -36.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.808 1.425 . . . . 0.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.19 90.7 4.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 0.0 110.305 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.577 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 6.9 p-90 -125.69 -8.75 6.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 0.0 111.172 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 76' ' ' GLN . 3.9 tt -83.73 126.93 33.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.834 -1.166 . . . . 0.0 110.429 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -135.33 91.93 2.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.453 -0.78 . . . . 0.0 109.373 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.916 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -117.86 137.8 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.186 -0.946 . . . . 0.0 111.132 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.3 t70 -82.18 70.2 9.06 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 175.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.626 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.69 -31.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 CA-C-O 120.616 0.246 . . . . 0.0 111.556 -177.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.5 tt0 -62.87 -52.05 64.63 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 120.869 -1.144 . . . . 0.0 108.902 178.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -75.68 -34.78 60.46 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.229 -0.92 . . . . 0.0 109.024 178.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.941 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -66.67 -18.07 65.18 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.415 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 28.9 ttp180 -88.39 -25.19 22.82 Favored 'General case' 0 N--CA 1.482 1.145 0 O-C-N 121.376 -0.827 . . . . 0.0 109.361 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.916 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -59.06 -44.84 91.88 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.356 1.55 . . . . 0.0 107.096 178.277 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.995 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.1 m95 -68.38 -57.88 5.21 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.567 -1.651 . . . . 0.0 109.836 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.425 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.4 mt -52.74 -23.31 6.53 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.314 -0.954 . . . . 0.0 108.612 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.7 t -80.78 -21.41 41.01 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.44 -0.788 . . . . 0.0 110.38 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.916 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -98.63 32.85 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 O-C-N 120.773 -1.204 . . . . 0.0 109.293 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.13 27.05 74.17 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.98 109.33 5.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 110.312 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.429 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -78.08 114.5 42.66 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.314 -0.866 . . . . 0.0 110.413 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.493 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.0 Cg_endo -82.08 148.76 15.29 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 123.496 1.261 . . . . 0.0 110.275 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.634 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 1.8 p -74.81 161.79 29.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.014 -1.053 . . . . 0.0 109.83 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -57.41 -25.6 59.81 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.043 -1.036 . . . . 0.0 110.985 -179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.474 ' CG2' ' CD2' ' A' ' 6' ' ' LEU . 38.4 m -93.28 -47.58 6.84 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.097 -1.002 . . . . 0.0 110.6 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.964 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.51 -27.63 65.35 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.454 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.8 ttt-85 -65.65 -38.85 90.51 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 178.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.97 -34.77 76.75 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.524 -0.87 . . . . 0.0 108.879 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.7 mt -76.74 -33.42 58.13 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' A' ' 66' ' ' PRO . 74.3 mt -65.38 -28.27 69.15 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.486 ' HD2' ' CG ' ' A' ' 80' ' ' PHE . 3.7 mmm180 -79.01 -32.15 45.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.691 ' HB3' HD13 ' A' ' 49' ' ' LEU . 8.1 tp-100 -72.06 -34.44 68.74 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.153 0.978 . . . . 0.0 108.998 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.67 -9.74 46.14 Favored 'General case' 0 C--N 1.287 -2.111 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.148 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.3 44.36 7.03 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.597 HG22 ' CB ' ' A' ' 53' ' ' VAL . 47.2 t -103.17 -12.34 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.193 -1.181 . . . . 0.0 111.394 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 11.6 m-85 -104.5 152.34 22.49 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.08 . . . . 0.0 110.257 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -65.07 79.24 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.208 -0.932 . . . . 0.0 110.079 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . 0.404 ' N ' ' O ' ' A' ' 80' ' ' PHE . 6.8 mm-40 -152.82 73.28 1.0 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.286 -0.884 . . . . 0.0 110.057 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -107.05 -60.36 1.69 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 110.205 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.86 161.87 28.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.334 -0.853 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -137.97 -43.97 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.19 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -176.59 -171.34 0.39 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.27 -0.894 . . . . 0.0 110.039 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 128.63 162.58 11.03 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.254 -1.144 . . . . 0.0 110.119 179.987 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 ptp . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 121.255 0.55 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.691 HG11 ' CE3' ' A' ' 59' ' ' TRP . 26.9 t -119.84 134.01 64.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.282 -0.887 . . . . 0.0 109.855 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -140.07 143.72 36.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.126 -0.984 . . . . 0.0 110.653 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.948 HD11 ' CB ' ' A' ' 59' ' ' TRP . 54.8 mt -109.53 133.41 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.146 -0.971 . . . . 0.0 109.48 179.082 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 5.2 ptp180 -151.52 -166.79 2.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.781 -1.199 . . . . 0.0 110.69 -178.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 17' ' ' TYR . 41.9 mt -88.67 127.68 35.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.85 107.33 18.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.3 -0.875 . . . . 0.0 110.905 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.499 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 4.1 ttt180 -62.99 123.97 19.9 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.142 -0.973 . . . . 0.0 109.97 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.568 ' HB2' ' CE1' ' A' ' 16' ' ' HIS . 46.8 m-85 -99.11 -75.05 0.57 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 121.841 0.829 . . . . 0.0 110.6 -179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.09 129.12 17.55 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 54.1 p -63.58 -55.55 22.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.253 -1.145 . . . . 0.0 109.887 179.584 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 9.5 mtmm -147.97 48.15 1.07 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.409 -0.807 . . . . 0.0 109.135 -179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -124.13 -65.09 1.08 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.461 -0.774 . . . . 0.0 109.601 -178.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 50.3 t30 -126.08 124.28 24.58 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.429 -0.795 . . . . 0.0 109.348 179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -74.81 106.32 2.24 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.342 1.18 . . . . 0.0 111.403 -179.232 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.568 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.8 p80 -171.75 127.09 0.61 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.161 -0.962 . . . . 0.0 110.608 178.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.695 ' HB2' HD22 ' A' ' 6' ' ' LEU . 7.5 m-30 -113.87 159.89 19.35 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.422 -0.799 . . . . 0.0 108.854 178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.88 156.27 17.22 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 176.504 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.923 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.23 75.77 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 101.925 -3.361 . . . . 0.0 101.925 176.427 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.257 0.3 OUTLIER -97.27 165.46 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.859 -173.261 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.915 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.7 113.25 42.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.463 0.649 . . . . 0.0 111.407 -176.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.0 t -137.23 -169.85 2.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.87 . . . . 0.0 109.665 178.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.411 ' N ' ' OG1' ' A' ' 22' ' ' THR . 18.1 p30 -138.22 170.24 16.38 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.0 110.32 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.22 28.88 3.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.339 -0.851 . . . . 0.0 110.185 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.57 -46.7 73.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 110.55 -179.824 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.79 -175.34 2.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.961 . . . . 0.0 110.684 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.68 166.95 0.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 110.273 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.2 mtp180 -55.53 123.57 14.42 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 110.358 -179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.49 -174.74 5.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 110.046 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.27 43.09 1.76 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -103.55 103.31 13.25 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.223 -1.163 . . . . 0.0 110.333 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 6.3 p90 -116.09 175.07 5.71 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.236 -0.915 . . . . 0.0 110.511 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 ' HH2' ' A' ' 59' ' ' TRP . 16.3 mt -89.11 -41.18 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.59 -0.694 . . . . 0.0 109.882 179.886 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -157.58 162.22 38.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.291 -0.881 . . . . 0.0 109.9 179.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.594 ' HA ' HG23 ' A' ' 20' ' ' VAL . 2.6 mtpt -101.44 113.89 27.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 0.0 109.734 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.949 HG21 ' CD1' ' A' ' 59' ' ' TRP . 39.4 pt -107.37 -34.77 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.198 -0.938 . . . . 0.0 111.24 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.85 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.49 165.77 17.37 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.099 -178.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.482 ' N ' HG13 ' A' ' 19' ' ' ILE . 12.7 t80 -137.49 142.46 41.5 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 177.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.603 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 39.4 t80 -138.11 133.21 33.14 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.767 -1.208 . . . . 0.0 110.404 -179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 7.6 t0 -140.24 101.11 6.91 Favored Pre-proline 0 N--CA 1.498 1.959 0 O-C-N 120.946 -1.096 . . . . 0.0 109.767 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 51.9 Cg_endo -78.07 70.9 6.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.126 1.066 . . . . 0.0 110.568 -179.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 mtt180 -91.93 149.24 21.66 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.024 -1.048 . . . . 0.0 110.661 -179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.35 39.76 1.18 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 45' ' ' THR . 4.8 t -145.04 -41.19 0.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.476 -179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 44' ' ' THR . 1.2 p -102.6 125.39 36.04 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.162 -0.961 . . . . 0.0 110.375 -179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.25 -4.46 14.79 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.475 1.25 . . . . 0.0 110.76 179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -117.71 89.45 3.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.089 -1.007 . . . . 0.0 110.281 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.603 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 16.6 p-90 -120.24 -20.07 7.46 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.24 -0.912 . . . . 0.0 110.756 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.543 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 6.7 tt -75.81 101.03 4.94 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.102 -0.999 . . . . 0.0 110.309 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -118.17 104.3 10.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.141 -0.975 . . . . 0.0 109.508 179.624 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.923 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.2 t -128.15 149.31 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 119.176 -1.01 . . . . 0.0 111.347 -179.481 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 21.8 t0 -94.23 67.99 3.61 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 176.16 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.6 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -32.96 -34.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.387 0 N-CA-C 111.551 0.204 . . . . 0.0 111.551 -177.632 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.1 OUTLIER -61.72 -54.17 46.12 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.894 -1.122 . . . . 0.0 108.57 178.333 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -74.32 -33.06 63.06 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.437 -0.79 . . . . 0.0 109.331 178.973 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.848 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -69.02 -23.56 64.1 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 178.177 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.1 OUTLIER -87.02 -19.78 28.17 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 121.357 -0.839 . . . . 0.0 109.491 178.036 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.552 ' CE2' ' CE2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -62.47 -48.49 79.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 178.277 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.949 ' CD1' HG21 ' A' ' 36' ' ' ILE . 89.5 m95 -63.08 -55.42 25.62 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.257 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.664 HD11 HD13 ' A' ' 74' ' ' LEU . 3.9 mt -52.4 -22.91 5.16 Favored 'General case' 0 C--N 1.296 -1.721 0 C-N-CA 119.308 -0.957 . . . . 0.0 108.558 176.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -79.93 -21.9 43.33 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.433 -0.792 . . . . 0.0 110.797 179.229 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 59' ' ' TRP . 6.4 m -98.79 33.9 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.843 -1.161 . . . . 0.0 109.227 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.55 27.48 73.78 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.71 142.54 48.2 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.192 -1.181 . . . . 0.0 109.833 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -117.38 114.6 38.28 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 110.523 -179.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.665 ' HB3' HD12 ' A' ' 74' ' ' LEU . 49.5 Cg_endo -79.77 128.95 7.92 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.497 1.261 . . . . 0.0 110.308 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -52.99 -178.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.207 -0.933 . . . . 0.0 110.516 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.77 53.56 1.14 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.387 -0.821 . . . . 0.0 110.362 179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.1 m -166.77 -59.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' A' ' 19' ' ' ILE . . . -66.52 -22.94 66.17 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 2.5 ttt85 -69.01 -43.24 75.21 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 178.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 ttm-85 -66.38 -38.44 87.56 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.212 -0.995 . . . . 0.0 108.731 178.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.6 mt -74.37 -26.37 60.08 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 66' ' ' PRO . 13.7 mt -72.0 -29.84 64.63 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 177.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.451 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.26 -28.98 38.31 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.126 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.431 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.3 OUTLIER -81.68 -34.58 30.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.814 0.816 . . . . 0.0 109.932 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.452 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -62.19 -14.26 35.95 Favored 'General case' 0 C--N 1.29 -1.979 0 O-C-N 121.793 -0.567 . . . . 0.0 109.877 178.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.63 25.58 8.56 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 53' ' ' VAL . 17.5 t -86.78 -68.76 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.846 -1.385 . . . . 0.0 110.686 179.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.451 ' CE1' ' CG ' ' A' ' 75' ' ' ARG . 15.5 p90 -126.55 -167.64 1.75 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.103 -0.998 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.62 122.52 0.12 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.004 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -102.75 53.66 0.78 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.128 -0.982 . . . . 0.0 110.422 -179.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -61.77 168.18 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 110.027 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.85 -176.91 6.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.267 -0.896 . . . . 0.0 110.276 -179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -151.57 126.56 9.75 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.138 -0.976 . . . . 0.0 110.143 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -51.94 157.21 1.31 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.0 110.241 -179.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -117.42 -91.07 1.52 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.257 -1.143 . . . . 0.0 110.088 179.872 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpp? . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.26 0.552 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 38.3 t -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.186 -0.946 . . . . 0.0 110.04 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.565 ' C ' HD12 ' A' ' 4' ' ' ILE . 21.6 ptmt -140.11 143.28 36.16 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.121 -0.987 . . . . 0.0 110.874 -179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.999 HD11 HG13 ' A' ' 21' ' ' VAL . 1.7 mp -100.23 139.09 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 108.901 179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.3 -166.12 2.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 110.806 -179.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.546 HD13 ' HD2' ' A' ' 17' ' ' TYR . 31.1 mt -89.5 135.7 33.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.86 . . . . 0.0 109.904 179.379 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -105.42 103.44 12.96 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.418 -0.802 . . . . 0.0 111.029 -179.454 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.495 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.55 119.36 17.67 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.53 -0.731 . . . . 0.0 110.942 -179.972 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 20.0 m-85 -106.07 -63.05 1.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.512 -0.742 . . . . 0.0 110.136 179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.88 161.09 3.91 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.239 -1.144 . . . . 0.0 110.239 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -85.71 -79.24 0.25 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.484 -1.009 . . . . 0.0 109.928 179.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -143.89 40.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.414 -0.804 . . . . 0.0 108.851 -179.676 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.452 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 5.1 m-70 -126.62 -64.65 1.01 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.511 -0.743 . . . . 0.0 109.268 -178.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 22.9 t-20 -105.56 102.05 35.6 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.365 -0.834 . . . . 0.0 109.284 178.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.63 109.15 2.8 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.612 1.322 . . . . 0.0 111.163 -179.087 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.5 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.1 p80 -164.74 126.89 2.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.247 -0.908 . . . . 0.0 110.575 178.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.546 ' HD2' HD13 ' A' ' 6' ' ' LEU . 3.9 m-30 -118.76 155.16 31.61 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.493 178.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 3.9 ptm180 -103.55 167.61 9.69 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 117.453 -1.699 . . . . 0.0 107.571 176.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.842 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.58 86.77 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 178.907 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.492 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.256 0.3 OUTLIER -98.95 170.64 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.224 -174.856 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.019 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.8 t -111.95 113.78 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.595 -0.69 . . . . 0.0 110.209 -178.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 2.8 t -140.49 -168.08 2.48 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.167 -0.958 . . . . 0.0 110.438 179.864 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.56 174.16 6.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.0 110.392 -179.806 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -94.48 59.73 2.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.884 . . . . 0.0 110.121 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.75 -83.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.283 -0.886 . . . . 0.0 110.408 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.1 mtt180 -127.56 -166.8 1.66 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.179 -0.951 . . . . 0.0 110.409 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -100.74 -20.51 15.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.44 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.69 52.12 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.195 -0.941 . . . . 0.0 110.233 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.6 -171.27 2.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.31 -0.868 . . . . 0.0 110.363 -179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.69 57.83 0.12 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -128.19 108.99 11.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -1.158 . . . . 0.0 110.668 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' CD2' HG21 ' A' ' 20' ' ' VAL . 8.6 p90 -113.03 151.42 30.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.25 -0.906 . . . . 0.0 110.177 179.364 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HG3' ' A' ' 34' ' ' GLU . 4.7 mt -64.63 -63.29 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.457 -0.777 . . . . 0.0 109.944 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' HG3' HG22 ' A' ' 33' ' ' ILE . 44.1 mt-10 -139.27 161.48 37.34 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.918 . . . . 0.0 110.255 179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.23 118.92 34.74 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.183 -0.948 . . . . 0.0 109.976 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.675 HG21 ' CD1' ' A' ' 59' ' ' TRP . 49.5 pt -99.95 -27.96 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.047 -1.033 . . . . 0.0 111.089 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.801 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -150.6 -174.1 21.35 Favored Glycine 0 C--N 1.297 -1.621 0 C-N-CA 117.908 -2.091 . . . . 0.0 112.769 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 31.4 t80 -141.25 151.12 43.44 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 114.959 -0.62 . . . . 0.0 110.262 179.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.842 ' HB2' HD11 ' A' ' 19' ' ' ILE . 2.6 t80 -144.02 124.68 14.1 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.689 -1.257 . . . . 0.0 109.701 177.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HB2' ' CZ ' ' A' ' 38' ' ' TYR . 63.0 t0 -138.53 94.36 10.63 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.588 -1.32 . . . . 0.0 110.335 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -68.84 83.15 0.55 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.772 1.406 . . . . 0.0 110.81 -179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -89.86 -156.75 0.43 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.294 -0.879 . . . . 0.0 110.113 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -141.72 43.75 1.72 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.207 -0.933 . . . . 0.0 110.29 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.2 p -121.59 -48.16 2.18 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.237 -0.914 . . . . 0.0 110.017 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -142.89 166.6 19.64 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.348 -0.845 . . . . 0.0 110.027 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.57 -16.18 27.19 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 O-C-N 123.661 1.348 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -80.62 96.01 6.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.175 -0.953 . . . . 0.0 110.309 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.786 ' HZ3' HD23 ' A' ' 49' ' ' LEU . 9.1 p-90 -134.57 10.39 3.71 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.224 -0.922 . . . . 0.0 110.56 179.769 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.804 HD13 ' N ' ' A' ' 50' ' ' LYS . 1.0 OUTLIER -118.21 131.98 56.35 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.016 -1.052 . . . . 0.0 110.549 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.804 ' N ' HD13 ' A' ' 49' ' ' LEU . 29.4 tttt -136.69 75.94 1.56 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.488 -0.758 . . . . 0.0 109.547 179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.801 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -97.26 134.47 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.069 -1.019 . . . . 0.0 110.968 -179.451 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -80.43 69.07 6.82 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 175.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.581 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.47 -31.99 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.36 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.514 -177.326 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.09 -55.98 26.21 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.899 -1.125 . . . . 0.0 108.778 178.226 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 5.1 mmp_? -69.28 -41.2 77.16 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.599 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.54 -16.7 63.03 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.947 -1.095 . . . . 0.0 108.071 178.563 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.462 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -88.65 -25.73 22.25 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.221 -0.925 . . . . 0.0 109.185 177.849 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.856 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.8 OUTLIER -59.71 -46.62 88.56 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 123.23 1.49 . . . . 0.0 107.406 178.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.019 ' CD2' HG11 ' A' ' 21' ' ' VAL . 94.6 m95 -67.0 -56.57 9.54 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.717 -1.583 . . . . 0.0 110.259 -178.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.773 HD11 HD13 ' A' ' 74' ' ' LEU . 1.9 mt -52.45 -23.22 5.76 Favored 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 119.235 -0.986 . . . . 0.0 108.391 176.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.4 OUTLIER -80.5 -21.0 42.37 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.647 -0.658 . . . . 0.0 110.272 178.938 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.3 m -98.67 32.41 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.468 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.27 29.36 74.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.592 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -77.66 129.1 35.14 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.269 -1.136 . . . . 0.0 109.924 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -97.67 108.52 46.03 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.171 -0.956 . . . . 0.0 110.438 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HG3' HD21 ' A' ' 60' ' ' LEU . 50.8 Cg_endo -77.13 135.38 15.26 Favored 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 123.613 1.323 . . . . 0.0 110.368 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 2.3 p -54.69 161.08 1.63 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.189 -0.945 . . . . 0.0 109.892 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -58.74 -22.62 58.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.086 -1.009 . . . . 0.0 110.107 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.417 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 4.0 m -89.19 -52.38 5.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 110.123 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.626 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.13 -23.88 65.86 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 179.548 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 67' ' ' THR . 0.4 OUTLIER -70.06 -38.58 75.81 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 178.336 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -64.92 -34.24 77.94 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.572 -0.851 . . . . 0.0 108.87 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 70' ' ' ALA . 47.8 mt -74.08 -32.58 63.32 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.425 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.773 HD13 HD11 ' A' ' 60' ' ' LEU . 56.3 mt -68.29 -28.88 67.56 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.247 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.524 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.56 -30.4 52.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 177.957 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.55 -29.21 37.11 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-O 121.891 0.853 . . . . 0.0 109.989 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.542 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -76.98 -1.67 29.91 Favored 'General case' 0 C--N 1.289 -2.041 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.198 179.096 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 75.09 50.08 8.93 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.581 HG22 ' HB ' ' A' ' 53' ' ' VAL . 58.3 t -98.4 -57.24 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 O-C-N 121.291 -1.123 . . . . 0.0 111.336 -179.225 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 4.3 m-30 -61.06 -61.92 2.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.214 -0.929 . . . . 0.0 110.596 -179.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.27 174.54 10.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.344 -0.848 . . . . 0.0 110.583 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.48 150.77 23.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.339 -0.85 . . . . 0.0 109.923 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -100.25 132.88 45.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.318 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -81.98 -168.69 2.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.263 -0.898 . . . . 0.0 110.084 179.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.0 mtp180 -116.84 103.89 10.77 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.123 -0.986 . . . . 0.0 110.293 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -54.5 147.69 13.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 110.109 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -79.04 -4.5 88.79 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 120.942 -1.328 . . . . 0.0 110.326 -179.905 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.252 0.549 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.472 HG11 ' CE3' ' A' ' 59' ' ' TRP . 84.1 t -102.07 141.36 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.228 -0.92 . . . . 0.0 110.301 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.548 ' C ' HD12 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -139.78 137.06 34.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.387 -0.82 . . . . 0.0 109.999 179.761 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.891 ' CD1' HG13 ' A' ' 21' ' ' VAL . 1.8 mp -99.63 135.89 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.543 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 5.3 ptp180 -151.18 175.39 12.2 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.079 -1.013 . . . . 0.0 110.707 -179.05 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.597 HD12 ' CD2' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -88.17 126.16 34.99 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.436 -0.906 . . . . 0.0 108.935 178.882 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.725 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.19 109.84 22.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.56 -0.713 . . . . 0.0 111.917 -177.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 52.6 ttp180 -72.87 120.9 19.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.084 -1.01 . . . . 0.0 111.152 179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.725 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 10.5 m-85 -114.25 -63.44 1.45 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.109 -0.994 . . . . 0.0 109.972 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.14 128.94 23.18 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 110.486 -1.046 . . . . 0.0 110.486 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.436 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 27.6 p -93.17 -55.67 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -1.111 . . . . 0.0 109.827 179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.436 ' N ' ' OG ' ' A' ' 11' ' ' SER . 14.8 mttt -143.92 45.61 1.46 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -137.58 -64.65 0.55 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.532 -0.73 . . . . 0.0 109.45 -178.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 56.0 t30 -135.44 114.78 11.47 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.612 -0.68 . . . . 0.0 109.707 179.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -73.61 99.55 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 O-C-N 123.336 1.177 . . . . 0.0 110.947 -179.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.459 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 32.1 p80 -149.97 134.32 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.191 -0.943 . . . . 0.0 110.403 179.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.597 ' CD2' HD12 ' A' ' 6' ' ' LEU . 4.8 m-85 -117.43 151.78 36.35 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.269 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 2.6 ttt85 -104.64 150.28 24.82 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.441 -1.304 . . . . 0.0 108.629 178.195 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.086 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -97.35 80.93 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 178.132 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.288 0.4 OUTLIER -97.35 170.18 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.79 0 CA-C-N 113.535 -1.666 . . . . 0.0 110.734 -173.821 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.008 HG11 ' CD2' ' A' ' 59' ' ' TRP . 1.4 t -115.65 107.73 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.516 -176.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.06 179.56 5.17 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.268 -0.895 . . . . 0.0 110.027 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.15 178.38 5.27 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.336 -0.852 . . . . 0.0 110.305 -179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.33 -45.99 0.91 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.208 -0.932 . . . . 0.0 110.519 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -52.7 -47.7 67.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.0 110.212 -179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -84.1 141.26 31.24 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.196 179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.0 ttmt -139.4 41.03 2.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.243 -0.911 . . . . 0.0 110.152 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.58 -35.51 14.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.366 -0.834 . . . . 0.0 110.209 179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -113.05 -66.65 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.377 -0.827 . . . . 0.0 110.159 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.45 -8.54 28.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.32 170.38 6.03 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.0 -1.294 . . . . 0.0 110.567 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 20.0 p90 -109.66 -166.34 1.09 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.382 -0.824 . . . . 0.0 109.933 179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.551 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.4 mt -107.69 -36.43 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.307 -0.871 . . . . 0.0 110.329 -179.586 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -163.84 176.04 9.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.419 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -110.68 109.45 19.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.444 -0.785 . . . . 0.0 109.694 179.852 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.976 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.7 pt -106.11 -33.1 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.14 -0.975 . . . . 0.0 111.124 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.841 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.37 166.08 20.25 Favored Glycine 0 C--N 1.295 -1.723 0 C-N-CA 118.603 -1.76 . . . . 0.0 111.039 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.483 ' N ' HG12 ' A' ' 19' ' ' ILE . 55.1 t80 -138.45 142.29 39.47 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.086 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.1 t80 -134.47 130.76 37.19 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.056 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 65.1 t0 -137.5 90.35 14.98 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.068 -1.02 . . . . 0.0 110.195 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 41.3 Cg_endo -67.35 79.1 0.44 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.715 1.376 . . . . 0.0 110.797 -179.641 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.59 -174.88 4.49 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.424 -0.798 . . . . 0.0 109.966 179.783 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -130.96 69.49 1.47 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.285 -0.884 . . . . 0.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.475 HG23 ' N ' ' A' ' 45' ' ' THR . 4.0 t -148.29 -42.12 0.16 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.38 -0.825 . . . . 0.0 109.905 179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.475 ' N ' HG23 ' A' ' 44' ' ' THR . 0.2 OUTLIER -143.8 163.03 38.3 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 0.0 109.687 179.494 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.52 -22.24 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.6 1.316 . . . . 0.0 110.515 -179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 4.3 m-20 -83.03 103.51 12.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.141 -0.975 . . . . 0.0 110.078 179.841 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.762 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 1.5 p-90 -137.95 20.84 2.84 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.21 -0.931 . . . . 0.0 110.768 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.762 HD13 ' HZ3' ' A' ' 48' ' ' TRP . 9.4 tp -126.0 134.17 51.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.96 -1.087 . . . . 0.0 111.044 -179.564 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -132.7 97.35 4.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.486 -0.758 . . . . 0.0 109.148 179.096 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.841 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -116.77 151.68 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.143 -0.973 . . . . 0.0 110.925 -179.133 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.6 t0 -96.65 67.95 2.41 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 175.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.703 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.99 -30.76 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 122.252 -0.28 . . . . 0.0 111.509 -177.281 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.7 tp10 -60.45 -54.62 43.33 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.761 -1.212 . . . . 0.0 108.581 178.026 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.499 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 47.3 mmm-85 -72.97 -37.06 67.21 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.379 -0.825 . . . . 0.0 109.005 178.411 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.864 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.54 -20.59 66.4 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.382 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.8 ttt180 -88.35 -24.37 23.14 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.277 -0.889 . . . . 0.0 109.519 178.315 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.684 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -60.06 -46.59 89.04 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 123.5 1.619 . . . . 0.0 106.928 178.288 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.008 ' CD2' HG11 ' A' ' 21' ' ' VAL . 79.1 m95 -63.72 -55.92 19.59 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.952 -179.284 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.6 mt -52.8 -22.36 5.26 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 119.091 -1.044 . . . . 0.0 108.549 176.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.37 -20.89 43.08 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.0 110.691 179.437 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.695 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.3 m -99.0 32.81 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.875 -1.14 . . . . 0.0 109.952 -179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.65 28.85 71.72 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -77.0 138.51 39.65 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.31 -1.112 . . . . 0.0 110.247 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.435 ' HB2' ' HG3' ' A' ' 3' ' ' LYS . 1.5 mm-40 -116.78 118.29 36.76 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.362 -0.836 . . . . 0.0 110.391 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HB3' HD12 ' A' ' 74' ' ' LEU . 54.2 Cg_endo -79.67 140.46 14.82 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.397 1.209 . . . . 0.0 109.856 179.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 70' ' ' ALA . 7.2 t -62.56 176.22 0.68 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.96 -1.088 . . . . 0.0 110.468 -179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.7 p30 -81.58 49.77 1.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.154 -0.966 . . . . 0.0 110.911 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -164.14 -59.09 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.85 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.58 -23.91 66.27 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.101 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 25.6 ttt85 -63.81 -40.39 96.51 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.105 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.17 -35.83 74.23 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 178.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 70' ' ' ALA . 46.6 mt -72.46 -38.58 68.22 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.44 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.469 HD12 ' HB3' ' A' ' 66' ' ' PRO . 24.8 mt -61.04 -28.15 68.85 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.161 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.547 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.1 OUTLIER -77.69 -31.0 52.17 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.302 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.453 ' HB3' ' CD2' ' A' ' 49' ' ' LEU . 8.8 tp-100 -75.81 -35.16 60.12 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 122.039 0.923 . . . . 0.0 109.866 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.13 -7.02 32.33 Favored 'General case' 0 C--N 1.287 -2.143 0 C-N-CA 120.221 -0.591 . . . . 0.0 110.472 178.953 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 78.24 47.2 8.44 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.636 -1.786 . . . . 0.0 108.636 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.691 HG22 ' HB ' ' A' ' 53' ' ' VAL . 57.4 t -96.93 -52.68 8.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 O-C-N 121.356 -1.085 . . . . 0.0 111.572 -179.018 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.5 m-30 -60.03 174.64 0.48 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.138 -0.976 . . . . 0.0 110.32 -179.299 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 132.29 35.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.302 -0.874 . . . . 0.0 109.843 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -71.03 109.04 4.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.126 -0.984 . . . . 0.0 110.353 -179.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.26 141.94 57.85 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.893 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -110.54 -43.93 3.78 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.19 -0.944 . . . . 0.0 110.21 -179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -79.4 86.82 5.08 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 110.237 179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.94 -64.87 0.81 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.209 -0.932 . . . . 0.0 110.134 -179.911 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -74.07 -154.53 3.49 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.085 -1.244 . . . . 0.0 110.221 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.226 0.536 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.648 HG11 ' CE3' ' A' ' 59' ' ' TRP . 78.0 t -99.75 139.93 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.294 -0.879 . . . . 0.0 109.904 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 59.7 mtpt -140.32 132.39 27.91 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.19 -0.944 . . . . 0.0 110.528 -179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.926 HD11 ' CB ' ' A' ' 59' ' ' TRP . 61.9 mt -100.17 127.99 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 O-C-N 121.076 -1.015 . . . . 0.0 109.153 179.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 1.2 ptm180 -150.74 -170.4 3.65 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.017 . . . . 0.0 110.555 -178.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.68 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -88.49 126.32 35.19 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.129 -0.982 . . . . 0.0 110.698 -179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -100.74 105.8 17.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 111.085 -179.595 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.446 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 36.8 ttp180 -63.97 125.84 25.74 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.149 -0.969 . . . . 0.0 109.817 179.295 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.598 ' HB2' ' CE1' ' A' ' 16' ' ' HIS . 59.3 m-85 -102.62 -75.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.416 -0.803 . . . . 0.0 111.205 -179.422 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.25 136.22 42.78 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.9 p -62.84 -47.04 85.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.374 -1.074 . . . . 0.0 109.357 179.06 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -168.37 53.06 0.05 Allowed 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 121.484 0.659 . . . . 0.0 109.479 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 14.5 m-70 -124.44 -54.45 1.67 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.462 -0.774 . . . . 0.0 109.088 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 64.6 t30 -131.05 124.79 20.77 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.92 100.86 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.373 1.197 . . . . 0.0 111.479 -179.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 34.6 p80 -164.38 127.39 2.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.158 -0.963 . . . . 0.0 111.061 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.55 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 13.9 m-85 -117.45 160.44 21.19 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 178.3 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.549 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -104.13 158.9 16.12 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 118.379 -1.329 . . . . 0.0 108.089 177.166 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.904 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.3 77.75 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.042 0 N-CA-C 102.196 -3.261 . . . . 0.0 102.196 177.059 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.708 HG11 ' CD2' ' A' ' 32' ' ' TYR 0.255 0.3 OUTLIER -97.25 164.69 2.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.855 -173.398 . . . . . . . . 4 4 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.815 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.44 105.48 18.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.206 0.527 . . . . 0.0 109.967 -177.63 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.754 HG22 ' HB3' ' A' ' 32' ' ' TYR . 3.0 p -99.99 152.22 20.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.207 -0.933 . . . . 0.0 109.649 -179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.2 -153.33 0.37 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 110.132 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -152.02 25.83 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.243 -0.911 . . . . 0.0 110.036 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -57.47 -18.88 20.83 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.403 -0.811 . . . . 0.0 110.568 -179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.37 179.18 7.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.182 -0.948 . . . . 0.0 110.565 -179.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.13 80.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 110.206 -179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.1 119.03 0.59 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.22 -0.925 . . . . 0.0 110.169 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.32 -20.41 13.28 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.274 -0.891 . . . . 0.0 110.344 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.41 -5.13 84.36 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 -179.862 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.51 -166.79 1.52 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.957 -1.319 . . . . 0.0 110.422 -179.84 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.754 ' HB3' HG22 ' A' ' 22' ' ' THR . 0.1 OUTLIER -151.13 168.26 25.19 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.335 -0.853 . . . . 0.0 110.135 179.895 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.671 HG21 ' CH2' ' A' ' 59' ' ' TRP . 4.9 mt -59.88 -50.01 81.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.478 -0.764 . . . . 0.0 109.926 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -165.05 -178.31 5.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.401 -0.812 . . . . 0.0 109.904 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HE2' ' NH2' ' A' ' 18' ' ' ARG . 7.1 mtpt -117.8 125.39 50.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.19 -0.943 . . . . 0.0 110.343 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.054 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.48 -33.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.176 -0.953 . . . . 0.0 111.242 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.894 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.5 161.37 14.11 Favored Glycine 0 C--N 1.297 -1.609 0 C-N-CA 118.919 -1.61 . . . . 0.0 110.967 -179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.491 ' CD1' ' HG2' ' A' ' 18' ' ' ARG . 72.3 t80 -133.62 145.08 49.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 177.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' HD2' HD23 ' A' ' 6' ' ' LEU . 17.6 t80 -139.74 134.37 31.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.686 -1.259 . . . . 0.0 109.918 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.44 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 3.2 t70 -140.31 77.3 24.64 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 120.858 -1.151 . . . . 0.0 110.61 -179.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 40.2 Cg_endo -67.94 74.01 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.59 1.311 . . . . 0.0 110.521 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -95.2 -171.05 2.31 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.271 -0.893 . . . . 0.0 110.395 -179.942 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.31 39.25 4.01 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.322 -0.861 . . . . 0.0 110.03 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.3 p -130.33 -49.22 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.351 -0.843 . . . . 0.0 110.253 -179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.9 p -133.64 142.97 45.83 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.933 . . . . 0.0 110.184 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -74.46 -18.64 20.01 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.664 1.35 . . . . 0.0 110.522 -179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.07 70.79 1.58 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.5 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.642 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 8.9 p-90 -116.01 -12.51 11.32 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.245 -0.909 . . . . 0.0 110.392 179.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 76' ' ' GLN . 5.0 tt -84.45 120.25 26.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 110.922 -179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -135.76 97.96 3.79 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.156 -0.965 . . . . 0.0 109.636 178.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.904 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.1 t -128.66 130.34 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.051 -1.06 . . . . 0.0 111.864 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 17.2 t0 -80.16 72.29 6.96 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.258 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.653 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -34.6 -31.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 122.342 -0.224 . . . . 0.0 111.523 -177.108 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.4 OUTLIER -59.93 -51.49 69.46 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.818 -1.176 . . . . 0.0 108.666 177.857 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.588 ' HB3' HG22 ' A' ' 36' ' ' ILE . 14.4 mmm180 -73.57 -41.12 63.33 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.559 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.937 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -62.62 -18.43 62.21 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 52.0 ttp85 -88.34 -26.15 22.37 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 121.358 -0.839 . . . . 0.0 109.372 178.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.702 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.1 t80 -62.01 -44.72 96.11 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 123.289 1.519 . . . . 0.0 107.462 178.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.054 ' CD1' HG21 ' A' ' 36' ' ' ILE . 71.9 m95 -68.03 -57.08 6.72 Favored 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 113.638 -1.619 . . . . 0.0 110.038 -178.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.42 HD21 ' HG3' ' A' ' 66' ' ' PRO . 7.9 mt -56.67 -21.43 27.52 Favored 'General case' 0 C--N 1.293 -1.853 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.524 177.147 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 57' ' ' ARG . 1.6 t -79.25 -23.22 43.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.46 -0.775 . . . . 0.0 110.718 179.797 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.702 HG13 ' O ' ' A' ' 58' ' ' TYR . 13.9 m -98.9 31.95 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 O-C-N 120.854 -1.154 . . . . 0.0 109.458 179.785 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.38 26.73 74.29 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -63.13 136.27 57.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.966 -1.314 . . . . 0.0 109.896 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.439 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.52 108.1 48.87 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.256 -0.902 . . . . 0.0 110.551 -179.62 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 53.0 Cg_endo -81.72 141.18 12.07 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.626 1.329 . . . . 0.0 109.19 179.185 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.7 t -73.77 178.74 4.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.991 -1.068 . . . . 0.0 110.801 -179.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.01 53.67 2.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.251 -0.906 . . . . 0.0 110.055 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 60.1 m -165.73 -59.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.741 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -67.08 -26.85 66.93 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 177.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.669 ' HA ' HD12 ' A' ' 74' ' ' LEU . 22.1 ttp85 -62.58 -42.0 99.29 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 178.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ttt180 -64.99 -29.15 70.05 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.741 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.3 mt -85.1 -28.41 25.61 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.376 -0.828 . . . . 0.0 109.234 179.114 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.669 HD12 ' HA ' ' A' ' 71' ' ' ARG . 21.8 mt -69.05 -27.25 65.48 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 178.089 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.518 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -82.62 -31.26 28.92 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.116 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.693 ' HB3' HD11 ' A' ' 49' ' ' LEU . 6.6 tp-100 -76.24 -35.34 59.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.103 0.954 . . . . 0.0 109.452 -179.561 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.492 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.93 -12.48 50.0 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.747 178.395 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 91.86 48.6 3.11 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 179.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.639 HG22 ' CB ' ' A' ' 53' ' ' VAL . 34.1 t -114.45 -8.85 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.918 -1.342 . . . . 0.0 111.496 -179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 6.8 m-85 -112.1 107.43 16.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.95 -1.094 . . . . 0.0 110.063 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 4.4 ptt180 -81.5 137.08 35.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 0.0 109.968 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -53.65 155.11 3.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.324 -0.86 . . . . 0.0 110.652 -179.668 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -118.4 88.96 3.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.919 179.597 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -51.77 170.7 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.196 -0.94 . . . . 0.0 110.454 -179.748 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.67 131.78 35.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 110.193 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -61.76 134.19 56.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.314 -0.866 . . . . 0.0 110.362 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -96.63 29.35 10.54 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.659 -1.376 . . . . 0.0 109.659 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 110.217 179.949 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.1 mtp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.201 0.524 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 2' ' ' VAL . 12.1 m -151.22 106.79 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.216 -0.928 . . . . 0.0 110.492 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.1 mttt -140.12 128.86 23.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.204 179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.976 HD11 ' CB ' ' A' ' 59' ' ' TRP . 31.6 mt -100.81 133.19 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.909 -1.119 . . . . 0.0 109.564 179.158 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.0 ptt180 -151.55 -172.55 4.25 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.072 -1.018 . . . . 0.0 110.342 -179.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.543 HD23 ' CD2' ' A' ' 39' ' ' TYR . 6.0 mp -88.7 126.66 35.42 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.332 -0.855 . . . . 0.0 110.232 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.708 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.98 104.72 16.79 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.412 -0.805 . . . . 0.0 109.918 -179.903 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 7.2 tmm_? -71.41 121.27 18.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.147 -0.971 . . . . 0.0 111.66 -179.025 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.708 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 13.5 m-85 -117.61 -61.41 1.7 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.102 -0.998 . . . . 0.0 110.061 178.768 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -44.8 139.69 4.69 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 -178.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.404 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -91.61 -79.14 0.38 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.949 . . . . 0.0 109.43 179.393 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -136.31 35.97 2.75 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.404 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 1.9 m-70 -132.28 -50.4 0.93 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.483 -0.761 . . . . 0.0 109.837 -177.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 12.8 t-20 -133.58 102.29 12.72 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.811 . . . . 0.0 110.0 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -75.02 106.98 2.38 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.57 1.3 . . . . 0.0 111.088 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.447 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 32.9 p80 -158.83 135.7 9.61 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 0.0 110.455 179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CE2' ' CG ' ' A' ' 8' ' ' ARG . 7.0 m-85 -119.15 148.93 42.54 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.861 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -99.7 156.59 17.0 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.189 -1.404 . . . . 0.0 107.991 177.521 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.026 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.6 mm -98.52 79.37 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 N-CA-C 103.757 -2.683 . . . . 0.0 103.757 178.49 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.274 0.4 OUTLIER -97.98 156.66 3.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-N 114.058 -1.428 . . . . 0.0 111.228 -174.206 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.955 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.5 OUTLIER -105.05 114.76 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.341 0.591 . . . . 0.0 111.066 -177.89 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.4 t -134.66 -174.82 3.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.412 -0.805 . . . . 0.0 110.049 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.402 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.8 p30 -114.04 -177.17 3.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.184 179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.52 -14.94 14.92 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 110.316 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -55.26 -48.19 74.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.163 -0.961 . . . . 0.0 110.393 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.4 mmt180 -53.15 159.67 1.22 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.02 -1.05 . . . . 0.0 109.679 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.6 -39.3 0.72 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.977 -1.077 . . . . 0.0 110.823 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.74 -34.88 5.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.946 -1.096 . . . . 0.0 110.368 179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.0 -67.45 0.44 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.98 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.89 50.86 6.65 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.91 155.56 17.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 109.975 179.757 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB3' HG13 ' A' ' 20' ' ' VAL . 28.1 p90 -116.73 150.97 37.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.198 -0.939 . . . . 0.0 110.578 -179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.658 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -57.57 -61.07 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.589 -0.694 . . . . 0.0 109.441 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -147.11 155.68 42.37 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.395 -0.815 . . . . 0.0 110.141 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.4 pttp -89.87 118.57 29.55 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 0.0 109.77 179.744 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.014 HG21 ' CD1' ' A' ' 59' ' ' TRP . 31.9 pt -107.9 -32.46 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.138 -0.976 . . . . 0.0 111.524 -179.16 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.825 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.74 167.32 19.21 Favored Glycine 0 C--N 1.297 -1.625 0 C-N-CA 118.813 -1.661 . . . . 0.0 111.388 -178.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 40' ' ' ASP . 12.5 t80 -138.57 139.41 38.63 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.026 ' HB2' HD11 ' A' ' 19' ' ' ILE . 40.3 t80 -136.67 124.02 21.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.71 -1.244 . . . . 0.0 109.699 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' HB2' ' CE1' ' A' ' 38' ' ' TYR . 54.9 t0 -140.18 84.71 14.44 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.753 -1.217 . . . . 0.0 110.762 179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 44.1 Cg_endo -71.71 78.32 1.71 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.557 1.293 . . . . 0.0 110.436 179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -89.82 155.34 19.23 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.254 -0.904 . . . . 0.0 110.288 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -87.64 50.57 2.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.259 -0.901 . . . . 0.0 110.044 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.8 p -140.58 -42.13 0.41 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.448 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.5 p -142.84 143.68 26.5 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.149 -0.969 . . . . 0.0 110.39 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.433 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 48.4 Cg_endo -74.04 -19.62 20.17 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.678 1.357 . . . . 0.0 110.35 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -77.24 82.4 3.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.241 -0.912 . . . . 0.0 110.289 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.534 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 7.4 p-90 -122.94 -12.38 8.0 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.245 -0.909 . . . . 0.0 111.003 -179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 77' ' ' ALA . 6.4 tt -81.48 118.35 22.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.054 -1.029 . . . . 0.0 110.548 -179.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -132.89 99.68 4.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.333 -0.854 . . . . 0.0 109.143 179.215 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.825 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -128.32 142.56 43.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.035 . . . . 0.0 111.763 -178.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t0 -88.23 69.97 9.18 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 176.071 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.574 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.3 OUTLIER -34.44 -31.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.808 -177.423 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 52' ' ' ASP . 3.0 mt-10 -63.81 -56.18 17.43 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.82 -1.175 . . . . 0.0 108.953 178.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.491 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.5 OUTLIER -72.26 -36.1 68.95 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.27 -0.894 . . . . 0.0 109.112 178.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.755 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.86 -20.19 66.14 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.428 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 1.3 ttt180 -86.95 -22.33 25.68 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 121.246 -0.909 . . . . 0.0 109.795 178.305 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.871 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.9 OUTLIER -62.17 -46.62 88.16 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 123.276 1.513 . . . . 0.0 107.523 178.753 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.014 ' CD1' HG21 ' A' ' 36' ' ' ILE . 86.2 m95 -65.64 -58.35 5.94 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 113.762 -1.563 . . . . 0.0 109.863 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 48.5 mt -53.78 -22.55 9.67 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.488 177.366 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 1.1 m -79.2 -20.49 48.21 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 121.475 -0.766 . . . . 0.0 110.014 178.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.4 m -98.81 32.75 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.967 -1.083 . . . . 0.0 109.061 179.467 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.31 23.79 71.83 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -61.33 136.77 58.16 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.17 -1.194 . . . . 0.0 109.759 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.98 108.62 55.2 Favored Pre-proline 0 C--N 1.301 -1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 110.163 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 55.2 Cg_endo -83.62 123.69 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.51 1.268 . . . . 0.0 109.745 179.555 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.9 t -50.17 168.58 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.094 -1.004 . . . . 0.0 110.411 -179.735 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -73.1 56.26 0.44 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.098 -1.001 . . . . 0.0 110.42 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 19.2 m -166.49 -60.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.779 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -64.23 -24.86 67.82 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.47 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.408 ' HA ' HD12 ' A' ' 74' ' ' LEU . 9.3 ttt-85 -67.06 -44.42 80.17 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.132 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.506 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.3 OUTLIER -69.25 -11.86 61.17 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.137 179.163 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.779 HD12 ' HA ' ' A' ' 70' ' ' ALA . 11.6 mt -101.19 -27.32 13.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.437 ' O ' HG23 ' A' ' 79' ' ' VAL . 13.4 mt -72.8 -29.32 63.18 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 177.355 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.51 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.4 -30.93 48.03 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.942 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.0 OUTLIER -78.2 -31.73 49.61 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.846 0.831 . . . . 0.0 109.344 178.97 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.653 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -66.58 -10.57 46.78 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.876 178.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 100.81 20.36 14.72 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.058 -1.068 . . . . 0.0 110.646 179.5 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.574 ' HA ' HG23 ' A' ' 53' ' ' VAL . 21.2 t -86.06 -69.17 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.9 -1.353 . . . . 0.0 110.645 -179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.51 ' CE1' ' HB3' ' A' ' 75' ' ' ARG . 48.5 p90 -132.75 165.62 24.11 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.238 -0.914 . . . . 0.0 110.119 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.46 55.85 0.56 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.236 -0.915 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -77.13 136.36 38.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.271 -0.893 . . . . 0.0 109.674 179.531 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.24 -17.77 20.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.182 -0.949 . . . . 0.0 110.746 -179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -168.14 100.6 0.44 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.082 -1.011 . . . . 0.0 110.473 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -176.48 -37.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 0.0 110.103 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -65.59 90.17 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.442 -179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 118.19 136.02 5.41 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.139 -1.212 . . . . 0.0 110.209 -179.938 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.234 0.54 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 22.5 t -102.39 122.34 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.203 -0.935 . . . . 0.0 109.671 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -140.26 133.33 29.46 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.11 -0.994 . . . . 0.0 110.526 -179.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.988 HD11 ' CB ' ' A' ' 59' ' ' TRP . 79.0 mt -99.81 137.76 26.3 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.067 -1.021 . . . . 0.0 109.251 178.905 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.506 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.5 ptm180 -150.82 178.4 9.17 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.124 -0.985 . . . . 0.0 110.014 -179.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.79 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.4 pp -89.5 130.92 35.76 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.068 -1.053 . . . . 0.0 109.592 179.329 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.37 171.97 7.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.507 -0.746 . . . . 0.0 109.199 -179.164 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' CG ' ' CE1' ' A' ' 17' ' ' TYR . 1.7 tmt_? -133.8 116.88 16.22 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.935 -1.103 . . . . 0.0 112.065 -179.262 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.646 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -132.1 -150.65 0.43 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.507 -0.745 . . . . 0.0 109.487 178.737 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.42 55.24 1.27 Allowed Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.296 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 15.2 p -55.28 -61.69 2.16 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.16 -1.2 . . . . 0.0 109.906 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.469 ' N ' ' OG ' ' A' ' 11' ' ' SER . 23.2 mttm -145.99 50.57 1.17 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.316 -0.865 . . . . 0.0 109.11 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -138.9 -56.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.314 -0.866 . . . . 0.0 109.479 -178.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -173.3 142.29 0.98 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.655 -0.653 . . . . 0.0 109.485 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HB2' ' HG3' ' A' ' 42' ' ' ARG . 48.7 Cg_endo -72.98 108.32 2.57 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 O-C-N 123.532 1.28 . . . . 0.0 110.357 -179.893 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 24.9 p80 -147.98 147.39 29.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.025 . . . . 0.0 110.539 179.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.61 ' CD2' HD13 ' A' ' 6' ' ' LEU 0.255 12.1 m-30 -112.58 170.67 8.02 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.935 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 43.2 mtt180 -134.83 153.07 52.19 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.7 -1.2 . . . . 0.0 109.279 177.558 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -96.83 82.65 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 103.415 -2.809 . . . . 0.0 103.415 178.174 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.28 0.4 OUTLIER -97.95 158.34 3.37 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 CA-C-N 113.946 -1.479 . . . . 0.0 111.162 -174.224 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.951 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -106.19 111.92 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.584 -0.698 . . . . 0.0 111.096 -177.524 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.7 t -136.88 -167.68 2.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.193 -0.942 . . . . 0.0 110.139 179.468 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.9 p30 -108.42 -163.05 0.85 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.31 -0.868 . . . . 0.0 110.002 179.75 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -61.13 85.3 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.212 -0.93 . . . . 0.0 110.205 179.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.4 OUTLIER -58.43 123.21 15.4 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.236 -0.915 . . . . 0.0 110.65 -179.751 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.38 -169.85 1.98 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.744 179.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -95.14 28.6 2.75 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.04 -1.037 . . . . 0.0 110.228 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.82 -44.34 1.49 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.296 -0.877 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -126.36 -168.72 1.9 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 110.09 179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.68 97.57 0.11 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.15 132.85 27.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.201 -1.176 . . . . 0.0 109.936 179.751 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' HB3' HG13 ' A' ' 20' ' ' VAL . 26.9 p90 -101.91 163.82 12.05 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.278 -0.889 . . . . 0.0 110.637 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.611 HG21 ' HH2' ' A' ' 59' ' ' TRP . 7.2 mt -72.38 -53.32 19.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.625 -0.672 . . . . 0.0 110.262 179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -151.87 158.58 43.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 110.119 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' CG ' ' A' ' 35' ' ' LYS . 6.2 pttm -92.47 112.56 24.55 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -179.872 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.914 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.0 pt -104.75 -37.28 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.038 -1.039 . . . . 0.0 110.989 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.849 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -116.24 166.34 12.33 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 119.02 -1.562 . . . . 0.0 112.232 -178.642 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 73.3 t80 -140.95 117.19 10.65 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.88 ' HB2' HD11 ' A' ' 19' ' ' ILE . 14.3 t80 -109.12 147.14 32.92 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.58 -1.325 . . . . 0.0 110.472 -179.302 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 7.0 t70 -139.99 84.93 14.59 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.164 -0.96 . . . . 0.0 109.06 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HD3' ' CD2' ' A' ' 39' ' ' TYR . 43.0 Cg_endo -68.21 -23.9 38.64 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 O-C-N 123.6 1.316 . . . . 0.0 112.002 -178.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.44 ' HG3' ' HB2' ' A' ' 15' ' ' PRO . 18.6 mmt180 -93.04 16.85 11.84 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.87 -1.143 . . . . 0.0 111.053 -178.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -78.81 137.12 37.56 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.933 -1.104 . . . . 0.0 109.773 179.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.1 p -91.61 45.23 1.22 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.23 -0.919 . . . . 0.0 110.533 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -149.85 162.89 26.77 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.297 -0.877 . . . . 0.0 110.002 179.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.34 -12.95 30.38 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.673 1.354 . . . . 0.0 110.614 179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -108.82 89.23 2.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.225 -0.922 . . . . 0.0 109.942 179.704 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 9.2 p-90 -116.44 6.19 13.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.142 -0.973 . . . . 0.0 111.154 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.747 HD23 ' N ' ' A' ' 50' ' ' LYS . 1.5 tt -112.82 129.04 56.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.819 -1.176 . . . . 0.0 111.007 -179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.747 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -132.26 86.91 2.37 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.649 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.849 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -115.11 136.78 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 111.206 -178.963 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.4 t0 -81.23 69.05 7.77 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.729 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -36.53 -29.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 O-C-N 122.226 -0.296 . . . . 0.0 111.268 -177.423 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 15.5 tt0 -61.2 -50.5 72.86 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 120.714 -1.241 . . . . 0.0 108.416 177.862 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 22.6 mmm180 -76.23 -37.17 58.05 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.297 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.889 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.83 -19.3 65.83 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 178.207 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 53' ' ' VAL . 1.6 ttm-85 -89.56 -22.47 22.36 Favored 'General case' 0 N--CA 1.481 1.082 0 O-C-N 121.289 -0.882 . . . . 0.0 109.552 178.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.847 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.6 OUTLIER -62.7 -48.33 79.72 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.251 1.5 . . . . 0.0 107.182 178.366 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.988 ' CB ' HD11 ' A' ' 4' ' ' ILE . 84.3 m95 -65.07 -56.31 13.75 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-N 113.632 -1.622 . . . . 0.0 109.793 -179.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.59 HD12 HG11 ' A' ' 79' ' ' VAL . 20.5 mt -53.86 -22.07 9.05 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.141 -0.975 . . . . 0.0 108.434 177.107 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.9 OUTLIER -82.55 -19.48 38.47 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 121.351 -0.843 . . . . 0.0 110.391 179.129 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -98.91 32.91 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 O-C-N 120.87 -1.144 . . . . 0.0 109.403 179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.75 25.56 74.73 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.79 122.31 21.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.001 -1.293 . . . . 0.0 110.274 -179.807 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -92.55 116.05 65.83 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.223 -179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.6 Cg_endo -80.01 153.88 22.34 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 O-C-N 123.425 1.224 . . . . 0.0 110.188 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.591 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -76.57 167.06 22.52 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.078 -1.014 . . . . 0.0 109.96 179.608 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -58.05 -28.8 64.85 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.174 -0.954 . . . . 0.0 110.953 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 53.0 m -96.25 -44.98 7.02 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.098 -1.001 . . . . 0.0 110.527 -179.647 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.733 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.48 -28.46 69.22 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 67' ' ' THR . 1.7 ttm-85 -68.22 -40.35 82.13 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 178.115 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -66.64 -15.14 63.26 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.003 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.733 HD12 ' HA ' ' A' ' 70' ' ' ALA . 18.2 mt -99.31 -29.46 12.78 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.242 -0.911 . . . . 0.0 108.943 178.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.479 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 33.4 mt -72.82 -27.74 62.14 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 177.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.535 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.96 -29.61 44.05 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.268 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -79.2 -35.83 41.13 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 122.129 0.966 . . . . 0.0 109.24 179.201 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -57.51 -17.8 15.63 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.627 178.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 106.97 16.85 12.64 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.59 HG11 HD12 ' A' ' 60' ' ' LEU . 21.7 t -81.9 -63.6 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.911 -1.347 . . . . 0.0 110.495 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.535 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 45.9 p90 -137.54 125.11 22.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.107 -0.996 . . . . 0.0 110.893 -179.864 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.87 -9.63 7.76 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 110.461 179.455 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.97 168.1 28.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.08 . . . . 0.0 110.191 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -72.95 105.96 4.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.171 -0.956 . . . . 0.0 110.451 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -67.28 110.98 3.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.292 -0.88 . . . . 0.0 109.971 179.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -52.14 -62.01 1.91 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.225 -0.922 . . . . 0.0 110.471 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.72 -178.99 5.09 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 110.451 -179.806 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 174.05 126.69 0.94 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.31 -1.112 . . . . 0.0 110.255 -179.923 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.231 0.539 . . . . 0.0 110.412 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.479 ' CG1' HG12 ' A' ' 21' ' ' VAL . 97.4 t -80.3 148.13 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.121 179.772 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -140.62 128.51 21.89 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.146 -0.971 . . . . 0.0 111.072 -179.669 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.906 HD11 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -100.04 131.55 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.177 -0.952 . . . . 0.0 109.198 178.94 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 9.5 ptm180 -151.78 -165.24 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.975 -1.078 . . . . 0.0 110.654 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.514 HD22 ' HD2' ' A' ' 39' ' ' TYR . 79.4 mt -89.04 128.43 35.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.577 179.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.79 103.29 14.91 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.699 -0.626 . . . . 0.0 109.588 179.827 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.453 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 49.4 ttt-85 -71.91 122.63 21.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.27 -0.894 . . . . 0.0 112.405 -178.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.651 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 8.0 m-85 -120.67 -149.84 0.44 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.384 -0.823 . . . . 0.0 109.036 177.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 51.51 97.22 0.01 OUTLIER Glycine 0 N--CA 1.484 1.879 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.1 p -49.95 -36.02 26.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -1.196 . . . . 0.0 109.557 179.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 9.8 ptpt 179.81 65.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.682 -0.636 . . . . 0.0 109.843 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.489 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 15.1 m-70 -141.38 -63.21 0.46 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.133 -0.979 . . . . 0.0 109.847 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -128.25 129.84 23.6 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.498 -0.751 . . . . 0.0 110.037 -179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -78.39 97.14 1.12 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.431 1.227 . . . . 0.0 110.703 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.462 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 33.3 p80 -149.65 131.45 15.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 110.586 179.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 7.3 m-85 -115.9 150.33 37.26 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 1.6 ttt180 -99.33 159.87 14.69 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 176.427 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.944 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.22 83.11 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.176 0 N-CA-C 103.483 -2.784 . . . . 0.0 103.483 178.711 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -98.07 169.93 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 114.649 -1.16 . . . . 0.0 111.977 -173.908 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.893 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -114.82 114.13 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 CA-C-O 121.271 0.558 . . . . 0.0 110.285 -177.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.4 t -140.17 -164.14 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.304 -0.872 . . . . 0.0 110.025 179.811 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 9.1 m-20 -121.0 165.28 15.48 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.211 -0.931 . . . . 0.0 110.109 179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.77 -28.72 33.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.143 -0.973 . . . . 0.0 110.065 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 ttt-85 -63.13 134.78 56.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.0 110.262 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.82 62.67 1.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.287 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.98 -53.13 5.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.265 -0.897 . . . . 0.0 110.249 179.986 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -151.09 21.69 0.76 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.178 -0.951 . . . . 0.0 110.245 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -113.72 -71.55 0.74 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.213 -0.929 . . . . 0.0 110.227 -179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.35 21.25 56.74 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -128.14 -176.63 3.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -1.175 . . . . 0.0 110.045 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 20.6 p90 -114.55 177.86 4.49 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.125 -0.984 . . . . 0.0 110.715 -179.847 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.3 mt -89.0 -43.15 14.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.633 -0.667 . . . . 0.0 109.603 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.416 ' OE1' ' CD ' ' A' ' 55' ' ' ARG . 5.4 tt0 -160.98 169.33 22.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 0.0 109.956 179.742 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.1 mtmt -103.7 111.76 24.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 110.315 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.949 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.2 pt -101.67 -34.69 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.313 -0.867 . . . . 0.0 110.974 179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.796 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.97 165.83 20.02 Favored Glycine 0 C--N 1.294 -1.774 0 C-N-CA 118.868 -1.634 . . . . 0.0 111.547 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 34.4 t80 -134.51 142.3 46.99 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 177.127 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.514 ' HD2' HD22 ' A' ' 6' ' ' LEU . 11.3 t80 -140.42 134.13 30.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.812 -1.18 . . . . 0.0 109.974 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 20.9 t0 -140.2 84.74 14.37 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.771 -1.206 . . . . 0.0 110.512 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 41.2 Cg_endo -68.77 67.44 1.21 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.536 1.282 . . . . 0.0 110.65 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.02 163.09 15.05 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.237 -0.914 . . . . 0.0 110.391 -179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -95.2 30.56 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.197 -0.94 . . . . 0.0 110.173 179.886 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.5 p -102.01 -75.5 0.6 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.232 -179.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -128.74 160.66 61.91 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 0.0 110.123 179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.19 -9.99 23.86 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.697 1.367 . . . . 0.0 110.849 -179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -82.17 73.98 9.18 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.041 -1.037 . . . . 0.0 110.309 179.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.542 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -122.36 -4.77 8.85 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.211 -0.93 . . . . 0.0 111.027 179.835 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.567 HD23 ' C ' ' A' ' 49' ' ' LEU . 9.2 tt -91.49 121.52 33.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.895 -1.128 . . . . 0.0 111.03 -179.159 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' O ' ' HB3' ' A' ' 38' ' ' TYR . 2.0 ttpm? -136.1 87.32 2.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 0.0 109.318 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.944 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -112.53 157.82 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 122.374 1.083 . . . . 0.0 111.567 -179.054 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -106.02 64.91 0.68 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 176.064 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.728 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.9 -33.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.411 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.771 -177.365 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.1 mt-10 -60.77 -52.49 64.88 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.837 -1.164 . . . . 0.0 108.923 178.408 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -75.48 -35.56 60.81 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.201 -0.937 . . . . 0.0 108.957 178.665 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.909 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -66.05 -21.45 66.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 177.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -86.59 -22.2 26.38 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 121.336 -0.852 . . . . 0.0 109.836 178.507 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.589 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -61.31 -48.6 80.62 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.223 1.487 . . . . 0.0 107.2 178.521 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.949 ' CD1' HG21 ' A' ' 36' ' ' ILE . 90.5 m95 -63.54 -53.47 51.31 Favored 'General case' 0 C--N 1.284 -2.247 0 CA-C-N 113.82 -1.536 . . . . 0.0 109.527 -179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.594 HD11 HD13 ' A' ' 74' ' ' LEU . 5.8 mt -52.86 -23.59 7.36 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 176.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.0 -22.78 45.02 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.694 -0.629 . . . . 0.0 110.25 179.173 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 59' ' ' TRP . 3.8 m -98.81 32.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 120.841 -1.162 . . . . 0.0 109.666 179.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.46 27.11 73.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -66.37 135.11 53.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.076 -1.249 . . . . 0.0 110.119 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -106.23 111.01 64.39 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.186 -0.947 . . . . 0.0 110.5 -179.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 52.5 Cg_endo -79.99 127.0 6.69 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.452 1.238 . . . . 0.0 109.894 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.1 t -58.6 -177.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.04 -1.038 . . . . 0.0 110.15 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -76.6 52.05 0.78 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.264 -0.898 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -165.78 -57.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.959 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.852 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.75 -23.46 66.74 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 178.676 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 8.8 ttt-85 -68.73 -40.75 79.74 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -40.87 88.96 Favored 'General case' 0 C--N 1.308 -1.232 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.639 178.833 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.6 mt -65.52 -31.18 72.1 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.583 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.758 HD23 HG21 ' A' ' 79' ' ' VAL . 13.8 mt -72.38 -25.38 61.49 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.73 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.526 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.2 OUTLIER -83.5 -28.82 28.43 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.439 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.479 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 4.9 tp-100 -86.52 -37.28 18.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.674 0.75 . . . . 0.0 110.543 -179.375 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.14 -10.54 42.05 Favored 'General case' 0 C--N 1.29 -1.997 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.762 178.462 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 82.01 54.75 3.3 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.758 HG21 HD23 ' A' ' 74' ' ' LEU . 49.4 t -103.54 -61.02 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.172 -1.193 . . . . 0.0 111.678 -179.3 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 36.6 m-85 -49.54 171.86 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.999 -1.063 . . . . 0.0 110.465 -179.209 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.11 114.86 4.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 110.208 -179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -86.0 102.23 13.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.247 -0.908 . . . . 0.0 110.301 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.7 53.99 2.54 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 110.151 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -102.72 151.26 22.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 110.285 -179.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -95.78 -69.96 0.73 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.197 -0.939 . . . . 0.0 110.104 179.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -70.67 -172.36 0.62 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.147 -0.971 . . . . 0.0 110.392 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.46 -94.6 0.09 OUTLIER Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.319 -1.106 . . . . 0.0 110.13 179.974 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.255 0.55 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 58.2 t -65.33 107.45 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.353 -0.842 . . . . 0.0 110.205 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.1 mtpt -140.32 139.17 35.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.28 -0.887 . . . . 0.0 110.379 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.936 ' CG1' HG13 ' A' ' 21' ' ' VAL . 46.6 mt -100.04 139.06 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.007 -1.058 . . . . 0.0 109.427 179.297 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -150.85 -168.38 3.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.839 -1.163 . . . . 0.0 110.873 -179.101 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.7 HD12 ' HB2' ' A' ' 70' ' ' ALA . 6.6 mp -89.15 129.21 35.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.269 -0.895 . . . . 0.0 110.668 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -101.31 102.86 13.8 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.235 -0.916 . . . . 0.0 110.704 -179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -71.32 119.29 15.24 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 111.575 -179.54 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 15.7 m-85 -114.12 -61.31 1.76 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.102 -0.999 . . . . 0.0 110.121 178.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -46.19 107.07 0.16 Allowed Glycine 0 N--CA 1.486 2.02 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 -178.361 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 45.1 p -75.13 -56.37 4.8 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.326 -1.102 . . . . 0.0 109.347 179.126 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 11' ' ' SER . 4.2 mtmm -144.83 48.14 1.32 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -136.15 -65.73 0.57 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.375 -0.828 . . . . 0.0 109.848 -178.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -138.12 133.84 17.56 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.335 -0.853 . . . . 0.0 109.856 179.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.79 100.64 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.586 1.308 . . . . 0.0 110.845 -179.67 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 35.3 p80 -153.58 129.8 10.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.246 -0.909 . . . . 0.0 110.552 179.412 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.546 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 8.6 m-85 -119.28 151.03 39.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 178.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.523 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.98 163.55 12.39 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 118.083 -1.447 . . . . 0.0 108.085 177.229 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.936 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -98.4 81.25 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.186 0 N-CA-C 103.047 -2.945 . . . . 0.0 103.047 177.359 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.4 OUTLIER -97.71 165.61 2.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 121.787 0.803 . . . . 0.0 111.984 -173.96 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.936 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.07 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-O 121.251 0.548 . . . . 0.0 110.782 -177.462 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t -137.31 -174.29 3.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 0.0 109.973 179.246 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.92 -178.75 3.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.848 . . . . 0.0 110.144 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -89.21 -57.2 2.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.314 -0.866 . . . . 0.0 109.847 179.757 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.91 96.96 0.45 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.381 -0.824 . . . . 0.0 110.232 179.892 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.84 166.15 27.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.125 -0.984 . . . . 0.0 110.338 -179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -64.15 -175.26 0.15 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.862 . . . . 0.0 110.165 179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.162 -0.961 . . . . 0.0 110.069 179.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -79.63 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.155 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.38 77.17 0.36 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.54 146.11 27.5 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.191 -1.182 . . . . 0.0 110.459 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 10.7 p90 -118.26 -172.01 2.18 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.418 -0.801 . . . . 0.0 110.417 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.472 HG21 ' HH2' ' A' ' 59' ' ' TRP . 22.3 mt -99.01 -27.25 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.925 179.84 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -174.54 165.16 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.398 -0.814 . . . . 0.0 109.864 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 6.1 pttt -102.94 111.89 24.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.185 -0.947 . . . . 0.0 110.294 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.948 HG21 ' CD1' ' A' ' 59' ' ' TRP . 36.7 pt -106.06 -30.58 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 120.976 -1.077 . . . . 0.0 110.883 -179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.83 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.9 167.38 19.36 Favored Glycine 0 C--N 1.297 -1.619 0 C-N-CA 119.07 -1.538 . . . . 0.0 112.304 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG12 ' A' ' 19' ' ' ILE . 5.7 t80 -141.24 124.72 16.69 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.021 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.936 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.7 t80 -124.97 131.6 53.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.671 -1.268 . . . . 0.0 109.533 179.364 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 45.7 t0 -140.32 93.34 9.01 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 120.881 -1.137 . . . . 0.0 110.58 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -71.59 85.36 0.92 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.56 1.295 . . . . 0.0 110.579 179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.4 tpp85 -89.71 -148.95 0.19 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.308 -0.87 . . . . 0.0 109.969 179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -151.11 25.88 0.71 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 110.173 -179.871 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.41 HG23 HG22 ' A' ' 45' ' ' THR . 4.1 t -125.12 -32.6 2.97 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.18 -0.95 . . . . 0.0 110.648 -179.909 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.41 HG22 HG23 ' A' ' 44' ' ' THR . 5.5 t -132.92 149.59 73.31 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.061 -1.024 . . . . 0.0 110.681 179.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -81.55 -17.01 8.95 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.789 1.415 . . . . 0.0 110.617 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -93.52 88.29 5.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.128 -0.983 . . . . 0.0 110.721 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.531 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.9 p-90 -121.62 -8.69 9.01 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.256 -0.902 . . . . 0.0 110.691 179.59 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.669 HD21 ' HB2' ' A' ' 77' ' ' ALA . 5.8 tt -85.17 114.08 22.02 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.969 -1.082 . . . . 0.0 110.489 -179.884 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.8 tptm -126.9 92.3 3.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.06 179.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.83 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.51 137.41 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.053 -1.029 . . . . 0.0 111.118 -178.906 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.7 t0 -78.43 69.56 4.64 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 176.294 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -35.2 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.308 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.601 -177.773 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.3 mt-10 -65.08 -49.42 70.12 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.96 -1.088 . . . . 0.0 109.276 178.66 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.527 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -77.74 -32.73 52.92 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.369 -0.832 . . . . 0.0 109.077 178.75 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -70.04 -23.38 63.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 178.151 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -85.0 -21.52 29.44 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.376 -0.828 . . . . 0.0 109.417 178.093 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.659 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -60.77 -48.53 81.38 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 123.158 1.456 . . . . 0.0 107.147 178.464 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.948 ' CD1' HG21 ' A' ' 36' ' ' ILE . 87.3 m95 -62.88 -55.44 26.09 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 113.881 -1.509 . . . . 0.0 109.627 -179.481 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.8 mt -54.24 -21.81 10.03 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 119.234 -0.986 . . . . 0.0 108.467 177.052 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.49 -20.47 43.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.405 -0.81 . . . . 0.0 110.589 179.345 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 59' ' ' TRP . 4.7 m -98.92 32.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 O-C-N 120.865 -1.147 . . . . 0.0 109.502 179.798 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.98 26.36 74.43 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -77.89 141.18 39.24 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.122 -1.222 . . . . 0.0 110.035 -179.972 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.28 123.79 29.1 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.253 -0.904 . . . . 0.0 110.217 -179.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 53.6 Cg_endo -85.12 145.45 9.78 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.454 1.239 . . . . 0.0 109.938 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -64.65 -178.8 0.43 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.078 -1.014 . . . . 0.0 110.577 -179.751 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.04 52.47 1.78 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.11 -0.994 . . . . 0.0 110.481 179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 99.2 m -165.97 -61.39 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.887 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -64.73 -26.41 68.35 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.445 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 2.8 ttt180 -66.39 -44.75 82.19 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 107.086 -1.45 . . . . 0.0 107.086 178.174 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.482 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . 0.0 OUTLIER -67.34 -12.58 60.52 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.666 -0.813 . . . . 0.0 110.106 179.234 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.887 HD12 ' HA ' ' A' ' 70' ' ' ALA . 10.7 mt -99.89 -29.86 12.35 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 26.5 mt -71.62 -28.46 63.81 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 177.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HB3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -79.28 -29.87 42.7 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.477 ' HB3' HD13 ' A' ' 49' ' ' LEU . 2.4 tp-100 -78.36 -31.35 48.47 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.955 0.883 . . . . 0.0 109.363 178.878 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.669 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -64.64 -12.44 45.89 Favored 'General case' 0 C--N 1.292 -1.925 0 C-N-CA 120.183 -0.607 . . . . 0.0 109.978 178.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.0 16.59 20.95 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 179.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 53' ' ' VAL . 17.1 t -81.25 -59.02 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.884 -1.362 . . . . 0.0 110.152 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CE2' ' HB3' ' A' ' 75' ' ' ARG . 28.8 p90 -143.03 133.6 25.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.03 -1.044 . . . . 0.0 110.423 179.497 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.405 ' NH1' ' HG3' ' A' ' 81' ' ' ARG . 0.4 OUTLIER -71.76 -168.2 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 110.412 -179.934 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -97.68 167.76 10.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.294 -0.879 . . . . 0.0 110.189 179.841 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -150.46 75.6 1.23 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.225 -0.922 . . . . 0.0 110.198 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -82.22 93.99 7.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.361 -0.837 . . . . 0.0 110.065 179.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -81.58 -30.61 32.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.927 . . . . 0.0 110.22 -179.865 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -61.69 -61.32 2.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.15 -0.969 . . . . 0.0 110.306 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 171.89 -158.8 29.8 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.318 -1.107 . . . . 0.0 110.259 179.95 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.152 0.501 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.518 HG11 ' CE3' ' A' ' 59' ' ' TRP . 47.7 t -88.23 144.05 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.139 -0.976 . . . . 0.0 110.195 179.978 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.21 130.94 25.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 0.0 110.539 179.908 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.993 HD11 ' CB ' ' A' ' 59' ' ' TRP . 82.9 mt -102.47 135.42 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 121.126 -0.984 . . . . 0.0 109.783 179.367 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -151.49 177.87 9.87 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.036 -1.04 . . . . 0.0 109.941 179.94 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.712 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.3 pp -89.13 130.52 35.55 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.035 178.664 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.728 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -98.78 165.82 11.6 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.392 -0.817 . . . . 0.0 109.188 -178.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -128.36 117.19 20.98 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.967 -1.083 . . . . 0.0 111.673 -178.929 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.728 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -128.22 -154.18 0.62 Allowed 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.587 -0.696 . . . . 0.0 109.478 179.222 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.27 90.01 0.95 Allowed Glycine 0 N--CA 1.485 1.96 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -55.72 -48.28 75.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.143 -1.21 . . . . 0.0 109.102 179.162 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.35 35.42 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.548 0.69 . . . . 0.0 109.224 179.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -111.18 -44.51 3.56 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.593 -0.692 . . . . 0.0 109.563 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -165.58 132.29 2.17 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.502 -0.749 . . . . 0.0 109.744 179.742 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -73.72 106.04 2.12 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.458 1.241 . . . . 0.0 110.398 -179.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.46 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 28.4 p80 -143.49 140.65 30.43 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 110.429 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 6' ' ' LEU . 17.6 m-30 -114.64 167.82 10.41 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.582 ' HB2' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.81 149.09 50.42 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 120.962 -1.086 . . . . 0.0 108.76 177.899 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.979 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -96.94 81.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 103.244 -2.873 . . . . 0.0 103.244 178.112 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.291 0.4 OUTLIER -98.3 161.66 2.93 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.783 -173.526 . . . . . . . . 4 4 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.925 HG13 HG12 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -108.12 106.94 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.524 -0.735 . . . . 0.0 110.569 -178.102 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.42 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.8 t -133.31 -169.91 2.37 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.411 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 2.0 m-20 -99.63 174.47 6.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.264 -0.898 . . . . 0.0 110.357 -179.721 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.88 -53.97 7.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.398 -0.814 . . . . 0.0 110.271 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.99 118.99 0.33 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.301 -0.874 . . . . 0.0 110.493 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.422 ' HB3' ' HD3' ' A' ' 27' ' ' LYS . 6.8 mtt180 -106.32 -76.49 0.61 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.331 -0.856 . . . . 0.0 109.983 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD3' ' HB3' ' A' ' 26' ' ' ARG . 2.4 mptp? -123.97 -74.08 0.62 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.226 -0.921 . . . . 0.0 109.716 179.732 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 ptt85 -164.09 32.02 0.08 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.388 -0.82 . . . . 0.0 109.737 179.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -89.58 -157.16 0.44 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.343 -0.848 . . . . 0.0 110.23 -179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.3 88.25 0.08 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -168.87 173.62 6.97 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.154 -1.203 . . . . 0.0 110.595 -179.51 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.517 ' HB3' HG13 ' A' ' 20' ' ' VAL . 22.8 p90 -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.463 -0.773 . . . . 0.0 110.339 179.942 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.414 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.3 mt -78.36 -37.2 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.412 -0.805 . . . . 0.0 109.919 179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -165.45 168.07 16.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.28 -0.887 . . . . 0.0 110.057 179.765 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -103.7 113.47 27.02 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.307 -0.87 . . . . 0.0 110.5 -179.829 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.98 HG21 ' CD1' ' A' ' 59' ' ' TRP . 35.3 pt -104.76 -34.37 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.077 -1.014 . . . . 0.0 110.795 179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.797 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.9 166.92 15.21 Favored Glycine 0 C--N 1.295 -1.698 0 C-N-CA 118.881 -1.628 . . . . 0.0 111.895 -178.006 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.433 ' N ' HG12 ' A' ' 19' ' ' ILE . 16.3 t80 -140.6 122.34 15.34 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 177.61 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.979 ' HB2' HD11 ' A' ' 19' ' ' ILE . 7.1 t80 -114.46 141.01 48.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.733 -1.229 . . . . 0.0 109.671 -179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 1.9 t70 -139.21 87.21 13.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.044 -1.035 . . . . 0.0 109.813 179.476 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 40.7 Cg_endo -67.38 79.22 0.45 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.48 1.253 . . . . 0.0 110.6 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -98.77 178.02 5.11 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.454 -0.779 . . . . 0.0 110.311 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.35 19.61 6.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.106 179.754 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.2 p -121.37 -15.62 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 110.745 -179.806 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.3 p -134.6 139.67 33.24 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.063 -1.023 . . . . 0.0 110.333 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.89 -35.11 2.7 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.579 1.305 . . . . 0.0 110.102 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -93.06 99.92 12.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 110.166 179.876 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.555 ' HZ3' HD12 ' A' ' 49' ' ' LEU . 5.6 p-90 -124.21 -5.62 7.8 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.251 -0.906 . . . . 0.0 111.004 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 77' ' ' ALA . 3.8 tt -86.62 127.58 34.93 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.045 -1.035 . . . . 0.0 110.876 -179.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -133.04 88.07 2.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 0.0 108.95 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.797 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -114.11 139.55 39.3 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.115 -0.991 . . . . 0.0 111.09 -179.067 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.44 ' O ' ' N ' ' A' ' 54' ' ' GLU . 5.3 t0 -84.65 70.2 10.74 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 176.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.681 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.63 -32.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 O-C-N 122.268 -0.27 . . . . 0.0 111.461 -177.467 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.1 tm-20 -61.54 -54.64 40.41 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 120.863 -1.148 . . . . 0.0 108.728 178.341 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -69.33 -39.93 77.89 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.717 0.77 . . . . 0.0 109.065 178.685 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.804 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.57 -21.18 66.57 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.475 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -87.14 -20.5 26.95 Favored 'General case' 0 N--CA 1.482 1.171 0 O-C-N 121.217 -0.927 . . . . 0.0 110.01 178.642 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.586 ' O ' HG13 ' A' ' 62' ' ' VAL . 1.1 t80 -61.37 -48.94 78.96 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 123.362 1.553 . . . . 0.0 107.142 178.365 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.993 ' CB ' HD11 ' A' ' 4' ' ' ILE . 81.9 m95 -63.18 -54.27 40.19 Favored 'General case' 0 C--N 1.283 -2.29 0 CA-C-N 113.394 -1.73 . . . . 0.0 109.768 -178.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD21 ' HG3' ' A' ' 66' ' ' PRO . 10.7 mt -53.86 -21.99 8.86 Favored 'General case' 0 C--N 1.294 -1.816 0 C-N-CA 119.162 -1.015 . . . . 0.0 108.28 177.141 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.22 -22.78 38.56 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.471 -0.768 . . . . 0.0 110.679 179.298 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 59' ' ' TRP . 5.2 m -99.24 31.65 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.832 -1.168 . . . . 0.0 109.908 -179.904 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.82 26.22 71.87 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.994 -1.243 . . . . 0.0 109.994 179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -67.86 142.81 56.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.873 -1.369 . . . . 0.0 110.324 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 105.99 57.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.181 -0.949 . . . . 0.0 110.236 179.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 60' ' ' LEU . 52.2 Cg_endo -83.2 124.99 3.89 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.582 1.306 . . . . 0.0 110.763 179.958 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.757 HG23 ' H ' ' A' ' 70' ' ' ALA . 6.3 t -58.73 156.3 11.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.067 -1.02 . . . . 0.0 109.06 179.231 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -49.45 -48.66 47.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.054 -1.029 . . . . 0.0 111.556 -179.052 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.5 m -62.22 -56.42 18.78 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.1 -1.0 . . . . 0.0 111.825 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.953 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.45 -25.68 65.12 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.097 -1.002 . . . . 0.0 109.093 -179.383 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 67' ' ' THR . 25.7 ttt180 -69.8 -38.39 76.62 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.491 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtp180 -61.53 -30.41 70.62 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.291 -0.964 . . . . 0.0 108.419 178.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.953 HD12 ' HA ' ' A' ' 70' ' ' ALA . 24.7 mt -78.31 -37.6 44.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 68.6 mt -62.42 -30.66 71.38 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.788 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.424 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.73 -28.48 44.97 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.061 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.765 ' HB3' HD13 ' A' ' 49' ' ' LEU . 9.7 tp-100 -75.49 -35.76 60.74 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.069 0.938 . . . . 0.0 109.037 179.494 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.82 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -70.2 -8.0 46.45 Favored 'General case' 0 C--N 1.288 -2.087 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.057 178.495 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.93 53.02 3.45 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.681 HG22 ' CB ' ' A' ' 53' ' ' VAL . 61.9 t -109.44 -4.45 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.206 -1.173 . . . . 0.0 111.46 -179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' CD1' ' N ' ' A' ' 80' ' ' PHE . 13.2 m-85 -112.41 39.93 2.35 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.891 -1.131 . . . . 0.0 110.064 -179.4 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.89 164.02 1.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 110.263 -179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -141.22 145.87 36.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.265 -0.897 . . . . 0.0 110.056 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -50.97 150.58 2.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.212 -0.93 . . . . 0.0 110.443 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -146.47 -69.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 110.172 -179.882 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -69.21 -28.11 66.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.322 -0.861 . . . . 0.0 110.311 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -57.2 147.37 25.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.23 -0.919 . . . . 0.0 110.462 -179.778 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.41 47.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.304 -1.115 . . . . 0.0 110.156 179.969 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.334 0.587 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.71 HG11 ' CE3' ' A' ' 59' ' ' TRP . 95.2 t -80.89 132.41 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.387 -0.82 . . . . 0.0 110.021 179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 16.3 mtpt -140.02 139.25 35.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.256 -0.903 . . . . 0.0 110.248 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.867 ' CG1' HG13 ' A' ' 21' ' ' VAL . 41.4 mt -103.51 130.33 54.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.142 -0.974 . . . . 0.0 109.264 179.035 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -150.52 -165.28 2.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.288 -0.883 . . . . 0.0 110.331 -179.118 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.578 HD13 ' HD2' ' A' ' 17' ' ' TYR . 44.7 mt -89.09 133.81 34.23 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.99 -1.069 . . . . 0.0 110.695 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.659 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -104.95 105.84 16.06 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.518 -0.738 . . . . 0.0 110.996 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.477 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 15.6 ttp180 -74.43 120.15 19.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.269 -0.894 . . . . 0.0 111.1 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 18.0 m-85 -108.03 -64.99 1.15 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.326 -0.859 . . . . 0.0 110.739 -179.958 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.65 127.85 27.77 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.495 -1.042 . . . . 0.0 110.495 -178.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 p -62.59 -45.66 91.88 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -1.09 . . . . 0.0 109.505 179.394 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.58 34.47 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.677 0.751 . . . . 0.0 109.296 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -101.93 -51.52 3.39 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.802 0.81 . . . . 0.0 108.901 -179.405 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -141.46 129.7 12.14 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 179.079 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.13 113.6 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.345 1.182 . . . . 0.0 111.343 -178.821 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.1 p80 -167.65 124.63 1.15 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.182 -0.949 . . . . 0.0 111.115 178.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.578 ' HD2' HD13 ' A' ' 6' ' ' LEU . 5.2 m-30 -118.57 156.34 29.33 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.037 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.612 ' HD2' HG23 ' A' ' 20' ' ' VAL . 1.1 ptp180 -105.59 165.73 10.95 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.556 -1.658 . . . . 0.0 107.325 176.081 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.855 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.3 OUTLIER -98.11 85.32 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.923 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 179.219 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.644 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.261 0.3 OUTLIER -98.05 166.63 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 114.905 -1.043 . . . . 0.0 111.152 -175.031 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.877 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.42 107.41 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.494 -0.754 . . . . 0.0 110.159 -178.459 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.2 t -139.94 -170.31 2.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.345 -0.847 . . . . 0.0 110.382 -179.851 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.425 ' N ' ' OG1' ' A' ' 22' ' ' THR . 6.7 t0 -104.1 166.21 10.55 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.374 -0.829 . . . . 0.0 109.98 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.66 29.04 4.29 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.0 110.331 -179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -52.45 -53.73 41.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -0.928 . . . . 0.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -156.16 162.36 40.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 110.121 179.759 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.0 41.08 1.11 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.186 -0.946 . . . . 0.0 110.194 179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.23 32.18 1.1 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.255 -0.903 . . . . 0.0 110.048 179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -119.77 -44.06 2.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.347 -0.845 . . . . 0.0 110.299 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.77 26.09 62.27 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.984 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tttt -109.83 130.11 55.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 110.194 179.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.644 ' CD2' HG21 ' A' ' 20' ' ' VAL . 15.8 p90 -126.09 -176.44 3.64 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.338 -0.851 . . . . 0.0 110.796 -179.596 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.435 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.0 mp -98.11 -25.22 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.608 -0.683 . . . . 0.0 109.632 179.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -171.26 162.85 6.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 0.0 109.865 179.882 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 4.0 ptpt -105.07 115.55 30.46 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.991 . . . . 0.0 110.114 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.786 HG21 ' CD1' ' A' ' 59' ' ' TRP . 42.3 pt -105.09 -31.91 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.114 -0.991 . . . . 0.0 110.836 -179.475 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.793 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -136.29 177.88 19.24 Favored Glycine 0 C--N 1.295 -1.705 0 C-N-CA 118.215 -1.945 . . . . 0.0 112.583 -178.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 71.8 t80 -139.96 147.89 41.14 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.919 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.449 ' CE2' ' HD3' ' A' ' 41' ' ' PRO . 26.1 t80 -143.01 131.17 21.91 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.562 -1.337 . . . . 0.0 110.076 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 42.2 t0 -140.37 84.84 13.95 Favored Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 120.652 -1.28 . . . . 0.0 110.505 179.695 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.449 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 41.4 Cg_endo -68.86 73.3 0.98 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.511 1.269 . . . . 0.0 110.498 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -100.13 137.69 38.22 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.354 -0.841 . . . . 0.0 110.484 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.84 60.01 2.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.276 -0.89 . . . . 0.0 110.062 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.9 p -143.95 -60.07 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.154 -0.966 . . . . 0.0 110.692 -179.773 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.0 p -123.31 146.52 49.63 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.685 -179.546 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.16 -8.94 20.32 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 O-C-N 123.747 1.393 . . . . 0.0 110.726 179.722 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -90.69 75.18 6.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.081 -1.012 . . . . 0.0 110.543 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.705 ' HZ3' HD22 ' A' ' 73' ' ' LEU . 13.8 p-90 -116.72 -13.91 10.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.221 -0.924 . . . . 0.0 110.613 179.549 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.559 HD23 ' C ' ' A' ' 49' ' ' LEU . 4.7 tt -86.17 115.55 23.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.89 -179.303 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.453 ' N ' HD23 ' A' ' 49' ' ' LEU . 0.0 OUTLIER -127.26 86.98 2.57 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 108.971 178.828 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.855 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.0 OUTLIER -116.48 149.69 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.472 1.13 . . . . 0.0 112.294 -178.528 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.9 t70 -99.16 64.91 1.4 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 175.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.696 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.97 -32.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.539 -177.289 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 tp10 -61.07 -53.24 59.55 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.816 -1.177 . . . . 0.0 108.756 178.231 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.51 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -76.37 -34.03 58.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.434 -0.791 . . . . 0.0 108.869 178.636 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.712 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -67.52 -21.22 65.49 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.068 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.447 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 50.1 ttp85 -87.98 -21.21 24.97 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.231 -0.918 . . . . 0.0 109.721 178.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.51 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -60.75 -49.51 77.21 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 178.225 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.877 ' CD2' HG11 ' A' ' 21' ' ' VAL . 88.6 m95 -61.72 -53.18 59.57 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-N 113.76 -1.564 . . . . 0.0 109.315 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.778 HD12 HG11 ' A' ' 79' ' ' VAL . 25.2 mt -53.94 -22.26 9.82 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 176.762 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.5 -22.89 40.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.561 -0.712 . . . . 0.0 110.973 179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.5 m -98.99 32.95 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.758 -1.214 . . . . 0.0 109.606 179.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.43 29.81 71.53 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -69.37 128.47 36.69 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.043 -1.269 . . . . 0.0 110.015 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.491 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 0.4 OUTLIER -97.17 109.52 49.92 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.31 -0.869 . . . . 0.0 110.174 -179.905 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.585 ' HB3' HD12 ' A' ' 74' ' ' LEU . 52.0 Cg_endo -81.41 136.91 10.15 Favored 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 123.519 1.273 . . . . 0.0 110.29 179.849 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.444 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -62.02 179.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.152 -0.968 . . . . 0.0 109.525 179.476 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.419 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 19.4 p-10 -69.98 -18.98 63.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.075 -1.015 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.93 -50.37 5.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.256 -0.902 . . . . 0.0 110.503 -179.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -69.01 -25.06 64.31 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.351 -0.843 . . . . 0.0 108.913 -179.918 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 67' ' ' THR . 7.9 ttt-85 -68.53 -38.31 80.75 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.302 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.05 -39.36 90.08 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.511 -0.875 . . . . 0.0 108.76 178.716 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.705 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 40.7 mt -73.93 -26.26 60.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.575 -0.703 . . . . 0.0 109.261 179.22 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.598 HD13 HD11 ' A' ' 60' ' ' LEU . 16.4 mt -72.74 -25.94 61.39 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 177.581 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.544 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -81.89 -32.0 31.19 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.181 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.503 ' HB3' HD11 ' A' ' 49' ' ' LEU . 7.9 tp-100 -80.1 -37.21 34.17 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.998 0.904 . . . . 0.0 109.964 -179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.526 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -62.47 -12.48 22.31 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.887 178.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.78 38.18 8.91 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 179.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.778 HG11 HD12 ' A' ' 60' ' ' LEU . 39.4 t -91.39 -54.15 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.196 -1.179 . . . . 0.0 111.351 -179.377 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.5 m-30 -54.32 -177.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.151 -0.968 . . . . 0.0 110.339 -179.193 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -126.78 150.38 49.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.383 -0.823 . . . . 0.0 110.175 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -169.97 67.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.18 -0.95 . . . . 0.0 110.184 179.901 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.51 130.87 2.97 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.147 -0.97 . . . . 0.0 110.447 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.98 141.75 28.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.239 -0.913 . . . . 0.0 110.091 179.855 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.6 75.07 10.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.255 -0.903 . . . . 0.0 110.007 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -176.32 63.57 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 110.174 179.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.12 -77.37 0.03 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.256 -1.144 . . . . 0.0 110.164 -179.996 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.319 0.581 . . . . 0.0 110.201 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t -85.52 133.64 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.208 -0.933 . . . . 0.0 110.293 179.964 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.451 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 14.6 mtpt -140.73 143.02 34.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.178 -0.951 . . . . 0.0 110.637 -179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.91 HD11 ' CB ' ' A' ' 59' ' ' TRP . 46.7 mt -101.27 135.42 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.104 -0.997 . . . . 0.0 108.941 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.26 -177.76 6.24 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.928 -1.107 . . . . 0.0 110.956 -179.04 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.764 HD12 ' HB2' ' A' ' 70' ' ' ALA . 3.6 mp -88.96 125.12 34.83 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.39 -0.819 . . . . 0.0 109.887 179.835 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.715 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.14 111.62 23.96 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.461 -0.775 . . . . 0.0 110.901 -179.034 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.7 OUTLIER -78.16 119.43 21.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.963 . . . . 0.0 111.628 -179.382 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.715 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 8.0 m-85 -112.77 -63.88 1.38 Allowed 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.522 -0.736 . . . . 0.0 110.376 179.482 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.53 134.06 20.35 Favored Glycine 0 N--CA 1.485 1.908 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.513 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.522 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.9 OUTLIER -77.24 -154.48 0.06 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.386 -1.067 . . . . 0.0 109.456 179.548 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.495 ' N ' ' OG ' ' A' ' 11' ' ' SER . 0.7 OUTLIER -45.54 -31.54 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.634 0.731 . . . . 0.0 110.305 178.538 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.522 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 3.8 m-70 -53.99 -68.35 0.19 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.596 -0.69 . . . . 0.0 109.98 -178.239 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -127.2 103.02 23.33 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.175 -0.953 . . . . 0.0 109.917 179.975 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -76.35 122.85 6.77 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.597 1.314 . . . . 0.0 111.3 -179.416 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.501 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.5 p80 -172.7 125.55 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.391 -0.818 . . . . 0.0 109.926 178.84 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HA ' ' O ' ' A' ' 7' ' ' ALA . 7.0 m-30 -114.28 155.16 26.69 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.953 -1.092 . . . . 0.0 109.408 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -104.65 152.99 21.81 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.551 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.072 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.3 mm -98.42 80.1 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 103.17 -2.9 . . . . 0.0 103.17 178.299 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.449 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.28 0.4 OUTLIER -97.36 164.01 2.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 113.749 -1.568 . . . . 0.0 110.937 -173.759 . . . . . . . . 4 4 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.941 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -109.94 113.6 44.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.599 -0.688 . . . . 0.0 110.594 -176.92 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.2 t -139.96 -166.35 2.07 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.287 -0.883 . . . . 0.0 110.413 179.781 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.3 m-20 -128.2 -165.24 1.47 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.007 179.817 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.91 25.76 3.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.158 -0.963 . . . . 0.0 110.347 179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.72 -39.13 87.89 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.25 -0.906 . . . . 0.0 110.229 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -128.38 126.34 40.46 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.267 -0.896 . . . . 0.0 110.101 179.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.1 mttt -90.91 -7.81 51.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.1 -1.0 . . . . 0.0 110.679 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.3 ttt180 -75.35 -69.11 0.5 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.099 -1.001 . . . . 0.0 110.339 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.21 160.17 16.34 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -0.926 . . . . 0.0 110.411 -179.81 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -128.75 125.28 4.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.24 78.75 1.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -1.23 . . . . 0.0 110.634 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.442 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 8.5 p90 -54.62 159.53 2.13 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.066 -1.021 . . . . 0.0 110.681 179.907 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.728 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.7 mp -72.97 -59.5 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.504 -0.748 . . . . 0.0 109.604 179.519 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.725 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -144.98 149.78 35.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.348 -0.845 . . . . 0.0 109.945 179.869 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HG2' ' NE ' ' A' ' 18' ' ' ARG . 0.8 OUTLIER -89.82 126.6 35.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.272 -0.893 . . . . 0.0 109.94 179.962 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.003 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -122.86 -24.78 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.448 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.911 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -128.37 161.44 22.14 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.662 -1.732 . . . . 0.0 110.649 -179.786 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.498 ' N ' HG12 ' A' ' 19' ' ' ILE . 88.0 t80 -138.41 144.6 40.27 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.894 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.072 ' HB2' HD11 ' A' ' 19' ' ' ILE . 16.0 t80 -137.47 133.26 34.44 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.686 -1.206 . . . . 0.0 109.45 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 34.1 t0 -140.55 106.43 6.49 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.809 -1.182 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 48.0 Cg_endo -76.36 1.19 8.63 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.48 1.253 . . . . 0.0 110.848 179.844 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.2 -30.17 18.74 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.016 -1.052 . . . . 0.0 109.421 179.56 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -51.53 116.5 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.029 179.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.8 p -89.34 49.83 1.82 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.249 -178.392 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.21 159.23 35.56 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.692 -0.63 . . . . 0.0 109.613 179.413 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.32 60.19 3.24 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.611 1.322 . . . . 0.0 110.586 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -169.25 30.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.305 -0.872 . . . . 0.0 109.981 179.858 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.579 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 32.5 p-90 -68.0 -8.65 39.19 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.423 -0.798 . . . . 0.0 111.34 -179.623 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 3.3 tt -98.81 130.12 45.23 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.951 -1.093 . . . . 0.0 110.264 179.867 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -139.63 88.91 2.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.376 -0.828 . . . . 0.0 109.095 179.325 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.911 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -118.16 129.78 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.051 -1.031 . . . . 0.0 111.369 -178.833 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t70 -75.09 72.15 2.19 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 106.155 -1.795 . . . . 0.0 106.155 175.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.618 HG23 HG22 ' A' ' 79' ' ' VAL . 0.3 OUTLIER -33.7 -32.49 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.424 0 CA-C-N 116.693 -0.23 . . . . 0.0 111.549 -177.509 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.448 ' N ' ' O ' ' A' ' 52' ' ' ASP . 16.5 tt0 -61.56 -53.15 60.1 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.855 -1.153 . . . . 0.0 108.857 178.045 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.753 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -70.89 -37.47 73.0 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.698 0.761 . . . . 0.0 109.276 178.933 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.969 ' O ' HD12 ' A' ' 60' ' ' LEU . . . -68.82 -20.77 64.32 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 178.319 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.437 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 29.2 ttt-85 -85.11 -25.16 27.69 Favored 'General case' 0 N--CA 1.483 1.22 0 O-C-N 121.446 -0.784 . . . . 0.0 109.189 178.672 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 11.1 t80 -60.2 -43.96 95.51 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 123.211 1.482 . . . . 0.0 107.564 178.307 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.003 ' CD1' HG21 ' A' ' 36' ' ' ILE . 68.9 m95 -68.72 -57.01 6.26 Favored 'General case' 0 C--N 1.286 -2.18 0 CA-C-N 113.964 -1.471 . . . . 0.0 109.934 -179.07 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.969 HD12 ' O ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -55.11 -21.01 11.38 Favored 'General case' 0 C--N 1.294 -1.829 0 C-N-CA 119.333 -0.947 . . . . 0.0 108.873 177.497 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 38.2 t -81.43 -23.44 37.52 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.279 -0.888 . . . . 0.0 110.76 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.666 HG22 ' O ' ' A' ' 59' ' ' TRP . 36.0 m -99.09 32.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 120.944 -1.098 . . . . 0.0 109.404 179.571 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.04 30.54 74.08 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 179.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.453 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -76.32 120.77 22.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.967 -1.314 . . . . 0.0 109.769 179.736 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.451 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -92.07 115.83 65.37 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.181 -0.95 . . . . 0.0 110.458 -179.69 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.519 ' HB3' HD12 ' A' ' 74' ' ' LEU . 52.5 Cg_endo -82.87 133.25 6.7 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.435 1.229 . . . . 0.0 109.687 179.499 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.419 HG23 ' H ' ' A' ' 70' ' ' ALA . 9.4 t -53.0 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.008 -1.058 . . . . 0.0 110.594 -179.53 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -78.96 52.65 1.28 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.3 -0.875 . . . . 0.0 110.47 179.809 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.1 m -167.26 -59.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.825 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.92 -22.96 66.53 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.538 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 5.4 ttt180 -66.99 -42.67 84.63 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.407 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.43 -30.65 71.47 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.464 179.247 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.825 HD12 ' HA ' ' A' ' 70' ' ' ALA . 23.6 mt -77.59 -31.53 53.09 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.797 HD13 HD11 ' A' ' 60' ' ' LEU . 47.4 mt -67.42 -30.12 69.79 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.162 -1.422 . . . . 0.0 107.162 177.575 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -79.45 -30.56 42.24 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.368 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.431 ' HB3' HD13 ' A' ' 49' ' ' LEU . 7.4 tp-100 -77.46 -33.21 54.76 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.996 0.903 . . . . 0.0 109.56 179.473 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.461 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.53 -12.8 35.23 Favored 'General case' 0 C--N 1.29 -1.999 0 C-N-CA 120.252 -0.579 . . . . 0.0 110.06 178.608 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 95.38 27.92 10.25 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.921 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 HG23 ' A' ' 53' ' ' VAL . 30.5 t -87.72 -62.29 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.11 -1.23 . . . . 0.0 110.495 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.489 ' CE1' ' HG3' ' A' ' 75' ' ' ARG . 18.1 p90 -135.67 -177.05 4.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 0.0 110.347 -179.848 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 16.8 mtt85 -135.41 -50.58 0.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.323 -0.861 . . . . 0.0 109.88 179.828 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -154.51 170.63 20.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.411 -0.806 . . . . 0.0 109.892 179.85 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 41.21 3.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.139 -0.976 . . . . 0.0 110.308 -179.726 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -152.48 104.28 2.9 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -0.955 . . . . 0.0 110.254 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -60.16 -31.16 69.84 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -0.908 . . . . 0.0 109.866 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.66 100.17 3.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.368 -0.832 . . . . 0.0 110.111 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -106.99 120.66 6.28 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.898 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.268 -1.137 . . . . 0.0 110.245 179.956 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mmt . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.257 0.551 . . . . 0.0 110.266 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 70.9 t -68.03 127.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 110.09 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtpt -140.82 137.12 33.07 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.027 -1.046 . . . . 0.0 110.84 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.927 ' CG1' HG13 ' A' ' 21' ' ' VAL . 41.4 mt -100.68 134.04 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.125 -0.984 . . . . 0.0 108.494 178.474 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 53.9 ptt85 -150.8 -172.44 4.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.835 -1.165 . . . . 0.0 111.159 -178.768 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.8 mp -88.58 127.43 35.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.316 -0.865 . . . . 0.0 110.239 -179.756 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.695 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -101.22 108.98 20.78 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.466 -0.771 . . . . 0.0 111.455 -178.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.516 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 10.8 ttt-85 -74.78 121.15 21.32 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.145 -0.972 . . . . 0.0 111.2 179.832 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.695 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 15.1 m-85 -110.26 -63.16 1.42 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 0.0 110.891 -179.865 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -45.78 147.48 2.27 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -178.395 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.539 ' HG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -60.2 -73.08 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.645 -0.914 . . . . 0.0 109.632 178.991 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.493 ' HG2' ' CE1' ' A' ' 13' ' ' HIS . 0.7 OUTLIER -165.88 52.22 0.1 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.567 -0.708 . . . . 0.0 109.809 -179.815 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.539 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 17.2 m-70 -130.44 -52.43 1.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.446 -0.784 . . . . 0.0 109.072 -179.43 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.26 109.68 42.07 Favored Pre-proline 0 N--CA 1.491 1.575 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.142 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.61 91.35 0.6 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.527 1.277 . . . . 0.0 111.64 -178.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 33.7 p80 -135.25 118.56 16.69 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.288 178.723 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 5.7 m-30 -115.67 154.68 29.06 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.623 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . 3.2 ptm180 -104.0 161.74 13.73 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.522 -1.671 . . . . 0.0 107.755 177.142 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.829 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.09 85.37 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 N-CA-C 103.861 -2.644 . . . . 0.0 103.861 179.397 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' HD3' ' A' ' 18' ' ' ARG 0.27 0.3 OUTLIER -97.62 170.97 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.105 -174.324 . . . . . . . . 4 4 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.927 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -116.69 103.43 15.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.355 -0.84 . . . . 0.0 110.658 -177.292 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.8 t -128.53 -168.54 1.93 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.35 -0.844 . . . . 0.0 109.715 179.424 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' OD1' HD11 ' A' ' 33' ' ' ILE . 1.1 m-20 -121.57 160.09 25.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.217 -0.927 . . . . 0.0 110.213 -179.917 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -112.85 -69.68 0.85 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.0 110.258 -179.987 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.6 ttp85 -60.26 88.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.248 -0.908 . . . . 0.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' HD2' ' HB3' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -166.84 -65.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.933 . . . . 0.0 110.222 -179.987 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.71 -166.79 1.55 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.165 -0.959 . . . . 0.0 110.371 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -90.86 7.24 40.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.353 -0.842 . . . . 0.0 110.751 -179.924 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -62.49 -178.59 0.2 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 0.0 110.259 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -149.48 26.04 1.22 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.92 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 148.17 22.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.322 -1.105 . . . . 0.0 110.117 179.993 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 14.7 p90 -110.29 170.16 8.26 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.339 -0.851 . . . . 0.0 110.54 179.905 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.489 HG21 ' HH2' ' A' ' 59' ' ' TRP . 3.5 mt -80.25 -29.04 12.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.528 -0.733 . . . . 0.0 109.7 179.727 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 21' ' ' VAL . 1.6 tm-20 -174.37 169.75 3.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.441 -0.787 . . . . 0.0 109.918 179.891 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -110.14 121.99 46.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 109.782 179.816 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.057 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.5 pp -119.35 -30.36 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.145 -0.972 . . . . 0.0 111.179 -179.533 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.913 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.69 164.28 14.88 Favored Glycine 0 C--N 1.298 -1.549 0 C-N-CA 118.883 -1.627 . . . . 0.0 111.078 -179.838 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 75.2 t80 -137.64 140.43 40.87 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 176.981 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CE2' ' HD3' ' A' ' 41' ' ' PRO . 54.7 t80 -139.42 113.17 8.54 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.569 -1.332 . . . . 0.0 109.957 -179.023 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.458 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.5 t0 -126.24 83.62 63.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 120.613 -1.304 . . . . 0.0 110.709 -179.729 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.495 ' HD3' ' CE2' ' A' ' 39' ' ' TYR . 40.8 Cg_endo -66.72 78.04 0.37 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.708 1.373 . . . . 0.0 111.1 -179.681 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.88 124.42 40.85 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.275 -0.891 . . . . 0.0 109.939 179.504 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' O ' HG23 ' A' ' 44' ' ' THR . 0.2 OUTLIER -69.56 74.88 0.4 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.176 -0.952 . . . . 0.0 110.431 -179.753 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 43' ' ' LYS . 4.9 p -150.03 -55.16 0.17 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.205 -0.934 . . . . 0.0 110.406 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 18.4 p -140.32 150.99 63.15 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.227 -0.921 . . . . 0.0 110.384 -179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -74.89 59.31 5.06 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.713 1.375 . . . . 0.0 110.642 179.92 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -153.39 75.29 1.05 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.281 -0.887 . . . . 0.0 109.738 179.808 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.578 ' CZ3' HD22 ' A' ' 73' ' ' LEU . 12.7 p-90 -124.2 -15.13 6.85 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.272 -0.893 . . . . 0.0 111.321 -179.104 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.723 HD23 ' N ' ' A' ' 50' ' ' LYS . 3.7 tt -79.42 127.59 32.3 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.941 -1.099 . . . . 0.0 111.027 -178.877 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.723 ' N ' HD23 ' A' ' 49' ' ' LEU . 11.2 mtpt -140.45 94.5 2.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.457 -0.777 . . . . 0.0 109.222 178.833 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.913 HG22 ' CA ' ' A' ' 37' ' ' GLY . 2.2 t -129.94 134.9 62.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.923 -1.111 . . . . 0.0 112.069 -179.025 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 54' ' ' GLU . 14.8 t0 -82.96 71.01 10.08 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 175.26 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.599 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -33.43 -31.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 N-CA-C 111.852 0.316 . . . . 0.0 111.852 -177.04 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 52' ' ' ASP . 31.8 mt-10 -60.87 -49.57 76.94 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 118.721 -1.192 . . . . 0.0 108.956 178.224 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.567 ' HB3' HG22 ' A' ' 36' ' ' ILE . 26.6 mmm180 -75.01 -39.73 61.02 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.248 -0.908 . . . . 0.0 109.084 178.51 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.967 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -64.1 -22.87 67.11 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.356 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.43 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 7.5 ttt180 -86.35 -23.57 26.15 Favored 'General case' 0 N--CA 1.48 1.066 0 O-C-N 121.41 -0.806 . . . . 0.0 109.62 178.637 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.499 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.0 OUTLIER -63.52 -49.01 75.2 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 123.205 1.478 . . . . 0.0 107.484 178.477 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.057 ' CD1' HG21 ' A' ' 36' ' ' ILE . 71.8 m95 -61.76 -52.57 63.68 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.772 -1.558 . . . . 0.0 109.275 -179.321 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.504 HD11 ' HE2' ' A' ' 80' ' ' PHE . 7.4 mt -57.01 -21.2 28.91 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 176.899 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.2 OUTLIER -76.46 -26.17 55.12 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.333 -0.854 . . . . 0.0 110.311 179.502 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.687 HG22 ' O ' ' A' ' 59' ' ' TRP . 34.4 m -99.08 32.18 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 121.048 -1.032 . . . . 0.0 109.581 179.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.15 23.4 76.2 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 179.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -64.69 96.74 0.18 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.901 -1.353 . . . . 0.0 109.689 179.728 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -71.03 114.7 29.39 Favored Pre-proline 0 C--N 1.301 -1.539 0 O-C-N 121.278 -0.889 . . . . 0.0 110.615 -179.491 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.4 Cg_endo -85.67 130.44 3.75 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.528 1.278 . . . . 0.0 109.641 179.391 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.2 t -53.18 178.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.085 -1.009 . . . . 0.0 110.651 -179.456 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -80.22 54.28 1.94 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.32 -0.862 . . . . 0.0 110.073 179.703 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 m -164.72 -60.29 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -179.891 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 6' ' ' LEU . . . -67.58 -26.34 66.24 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.93 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 33.6 ttp180 -65.41 -43.15 91.49 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 178.098 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -63.03 -42.66 99.82 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.862 178.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.578 HD22 ' CZ3' ' A' ' 48' ' ' TRP . 27.6 mt -70.08 -28.87 65.78 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.561 -0.712 . . . . 0.0 109.431 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.509 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 28.7 mt -69.26 -29.14 66.98 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.841 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG2' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.53 -34.23 35.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.157 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.498 ' HB3' HD11 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -78.06 -26.02 48.04 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.866 0.841 . . . . 0.0 109.659 179.165 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.545 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -68.79 -9.82 53.19 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.211 0.529 . . . . 0.0 110.078 179.01 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.26 21.0 23.79 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.925 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 53' ' ' VAL . 14.0 t -85.8 -68.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.017 -1.284 . . . . 0.0 110.538 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CD1' ' HG2' ' A' ' 75' ' ' ARG . 21.1 p90 -129.02 -167.61 1.81 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.967 . . . . 0.0 110.082 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.411 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . 0.1 OUTLIER -163.35 178.06 8.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 110.293 -179.825 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -146.87 46.11 1.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.269 -0.894 . . . . 0.0 110.12 179.715 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -143.49 106.9 4.57 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.311 -0.868 . . . . 0.0 110.061 179.858 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -147.64 39.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.085 -1.009 . . . . 0.0 110.417 -179.745 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.08 -8.44 53.44 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 0.0 110.761 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -57.37 -65.57 0.6 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.034 -1.041 . . . . 0.0 110.358 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -163.25 168.47 37.99 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.246 -1.15 . . . . 0.0 110.282 -179.93 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.2 mmm . . . . . 0 N--CA 1.492 1.675 0 CA-C-O 121.207 0.527 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.507 HG11 HG23 ' A' ' 62' ' ' VAL . 59.6 t -55.28 119.34 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.211 179.985 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HG2' ' CB ' ' A' ' 65' ' ' GLN . 6.5 mttt -140.64 124.67 17.36 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 110.701 -179.725 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.884 HD11 ' CB ' ' A' ' 59' ' ' TRP . 49.7 mt -99.88 129.55 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 120.991 -1.068 . . . . 0.0 109.211 178.843 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.521 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.1 OUTLIER -151.07 -167.89 2.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.928 . . . . 0.0 110.64 -179.187 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.461 HD22 ' HD2' ' A' ' 39' ' ' TYR . 55.4 mt -88.59 127.96 35.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.16 -0.962 . . . . 0.0 110.706 -179.827 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.635 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.88 100.52 11.45 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.54 -0.725 . . . . 0.0 110.382 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 41.1 ttt180 -69.07 122.62 19.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.225 -0.922 . . . . 0.0 111.299 -179.505 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.635 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 15.5 m-85 -114.46 -63.49 1.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.22 -0.925 . . . . 0.0 110.168 179.164 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.63 115.04 2.29 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.32 -1.112 . . . . 0.0 110.32 -178.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.452 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 24.6 p -63.69 -59.5 4.51 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -1.161 . . . . 0.0 109.839 179.625 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.452 ' N ' ' OG ' ' A' ' 11' ' ' SER . 7.8 mttp -147.68 59.8 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.462 -0.773 . . . . 0.0 109.386 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.41 ' ND1' ' O ' ' A' ' 12' ' ' LYS . 4.4 m-70 -143.5 -65.96 0.37 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.146 -0.971 . . . . 0.0 109.965 -178.774 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -125.76 118.41 24.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.536 -0.728 . . . . 0.0 109.385 179.722 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.7 79.56 1.88 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.432 1.227 . . . . 0.0 111.103 -179.14 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 35.5 p80 -129.78 128.02 41.54 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.142 -0.973 . . . . 0.0 110.543 179.391 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 7.6 m-85 -117.21 150.87 38.03 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 178.215 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.603 ' HD2' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -99.81 160.29 14.41 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 117.231 -1.788 . . . . 0.0 106.751 176.535 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.915 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -97.62 85.44 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 103.487 -2.782 . . . . 0.0 103.487 179.125 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 18' ' ' ARG 0.271 0.3 OUTLIER -97.44 169.28 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.945 -174.159 . . . . . . . . 4 4 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.881 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -112.91 110.15 31.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.434 -0.792 . . . . 0.0 110.634 -177.405 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.0 t -139.84 -167.47 2.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.255 -0.903 . . . . 0.0 110.307 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.419 ' N ' ' OG1' ' A' ' 22' ' ' THR . 7.6 p-10 -113.98 -169.78 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.849 . . . . 0.0 109.769 179.496 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -136.48 37.17 2.69 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.998 -1.064 . . . . 0.0 110.361 179.999 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -51.0 65.31 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.083 -1.011 . . . . 0.0 110.418 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 -135.93 177.51 7.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.2 -0.938 . . . . 0.0 110.22 -179.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.7 pttm -122.54 67.76 0.95 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.307 -0.871 . . . . 0.0 110.219 179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.53 -53.7 0.61 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.307 -0.87 . . . . 0.0 110.073 179.841 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -122.4 98.0 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.978 179.811 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -64.63 85.32 0.07 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.687 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -94.76 101.32 13.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -1.145 . . . . 0.0 109.919 179.581 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 21.4 p90 -87.86 165.61 15.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.114 -0.991 . . . . 0.0 111.09 -179.529 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.519 HG21 ' HH2' ' A' ' 59' ' ' TRP . 6.2 mt -81.66 -32.55 11.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.407 0.623 . . . . 0.0 109.78 179.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.79 176.75 3.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.819 . . . . 0.0 109.754 179.941 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -113.32 123.86 51.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.128 -0.983 . . . . 0.0 110.354 -179.822 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.058 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.8 -26.9 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.862 179.738 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.85 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -125.85 166.05 18.76 Favored Glycine 0 C--N 1.299 -1.485 0 C-N-CA 118.765 -1.684 . . . . 0.0 111.325 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 40.5 t80 -138.33 140.76 39.64 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 177.103 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' HD2' HD22 ' A' ' 6' ' ' LEU . 15.1 t80 -138.17 127.84 25.11 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.794 -1.191 . . . . 0.0 109.909 -179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' A' ' 48' ' ' TRP . 32.1 t0 -137.63 83.62 24.55 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 120.619 -1.3 . . . . 0.0 110.499 -179.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HB3' ' OH ' ' A' ' 39' ' ' TYR . 41.1 Cg_endo -68.48 80.38 0.59 Allowed 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.517 1.272 . . . . 0.0 111.106 -179.534 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -98.49 158.64 15.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.247 -0.908 . . . . 0.0 109.849 179.392 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.62 37.67 1.19 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.101 -1.0 . . . . 0.0 110.397 -179.761 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 65.5 p -126.83 -56.57 1.36 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.201 -0.937 . . . . 0.0 110.062 179.867 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.6 p -131.74 140.22 37.59 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.242 -0.911 . . . . 0.0 110.083 179.877 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.404 ' O ' ' N ' ' A' ' 48' ' ' TRP . 47.8 Cg_endo -73.88 -15.57 23.66 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.529 1.278 . . . . 0.0 110.348 179.835 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -69.85 64.11 0.21 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.116 -0.99 . . . . 0.0 110.299 -179.907 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 5.4 p-90 -116.59 -13.16 10.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.16 -0.962 . . . . 0.0 110.86 179.854 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 76' ' ' GLN . 5.7 tt -79.28 121.62 25.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.005 -1.06 . . . . 0.0 110.43 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.406 ' CB ' ' HB3' ' A' ' 38' ' ' TYR . 6.7 ttpt -136.97 95.84 3.19 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.268 -0.895 . . . . 0.0 109.826 179.721 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.915 ' CG2' HD12 ' A' ' 19' ' ' ILE . 2.2 t -127.75 128.8 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.89 -1.124 . . . . 0.0 111.975 -179.48 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 54' ' ' GLU . 12.6 t0 -79.1 70.36 5.44 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 175.645 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.59 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -31.53 -34.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.158 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.465 ' N ' ' O ' ' A' ' 52' ' ' ASP . 14.7 mm-40 -60.63 -51.15 70.62 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.859 -1.136 . . . . 0.0 108.809 178.478 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.693 ' HB3' HG22 ' A' ' 36' ' ' ILE . 2.6 mmm180 -71.85 -41.85 67.61 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.386 -0.821 . . . . 0.0 108.836 178.398 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.971 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.94 -16.95 62.71 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.017 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -88.53 -29.03 20.39 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 121.313 -0.867 . . . . 0.0 109.198 178.394 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CE2' ' CZ2' ' A' ' 59' ' ' TRP 0.251 1.7 t80 -57.66 -43.47 84.99 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 123.331 1.539 . . . . 0.0 107.338 178.399 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.058 ' CD1' HG21 ' A' ' 36' ' ' ILE . 69.7 m95 -69.03 -52.99 22.93 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 113.53 -1.668 . . . . 0.0 109.282 -179.285 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.555 HD12 HG11 ' A' ' 79' ' ' VAL . 11.2 mt -57.65 -20.37 33.02 Favored 'General case' 0 C--N 1.291 -1.973 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.83 177.148 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 27.4 t -83.22 -22.77 33.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.307 -0.87 . . . . 0.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 59' ' ' TRP . 35.4 m -99.07 32.51 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 120.979 -1.075 . . . . 0.0 109.5 179.602 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 69.14 29.9 72.05 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -67.76 128.37 36.21 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.849 -1.383 . . . . 0.0 109.838 179.621 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.437 ' CB ' ' HG2' ' A' ' 3' ' ' LYS . 2.4 mm-40 -92.75 109.99 42.53 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.135 179.972 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.436 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 50.9 Cg_endo -81.17 150.86 17.85 Favored 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.468 1.246 . . . . 0.0 110.316 179.958 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.8 p -81.82 170.01 16.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.684 179.564 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.14 -17.88 30.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 179.979 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 m -99.54 -47.97 4.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.14 -0.975 . . . . 0.0 110.322 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.94 -25.75 64.72 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.871 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.73 -38.32 83.38 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.981 -1.489 . . . . 0.0 106.981 178.186 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.84 -39.82 94.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.651 -0.819 . . . . 0.0 108.958 178.821 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -70.43 -29.5 66.1 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.479 -0.763 . . . . 0.0 109.49 179.554 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.51 HD13 HD11 ' A' ' 60' ' ' LEU . 32.1 mt -72.25 -25.91 61.8 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.638 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.55 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -84.79 -27.0 27.16 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.385 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.568 ' HB3' HD11 ' A' ' 49' ' ' LEU . 5.9 tp-100 -85.21 -36.83 20.73 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.736 0.779 . . . . 0.0 110.212 -179.775 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.13 -10.61 32.3 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.685 -0.634 . . . . 0.0 109.812 178.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 85.44 44.83 6.04 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.931 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.555 HG11 HD12 ' A' ' 60' ' ' LEU . 25.5 t -97.73 -51.88 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.113 -1.228 . . . . 0.0 111.179 -179.51 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.4 m-30 -59.26 99.59 0.06 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.131 -0.981 . . . . 0.0 110.468 -178.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.412 ' NE ' ' O ' ' A' ' 81' ' ' ARG . 0.0 OUTLIER -103.32 29.47 5.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.181 -0.949 . . . . 0.0 109.936 179.516 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -111.03 -175.68 2.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -0.883 . . . . 0.0 110.354 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -68.12 135.54 52.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.251 -0.905 . . . . 0.0 110.149 -179.984 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -89.73 -72.98 0.53 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 0.0 110.266 179.918 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.2 ptt180 -157.29 -139.94 0.08 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.38 -0.825 . . . . 0.0 109.888 -179.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.24 -72.97 0.1 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.878 -1.139 . . . . 0.0 110.449 -179.706 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 124.15 46.72 0.25 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.207 -1.172 . . . . 0.0 110.237 179.825 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.235 0.54 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.561 HG11 ' CE3' ' A' ' 59' ' ' TRP . 38.5 t -69.06 134.36 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.294 -0.878 . . . . 0.0 110.031 179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.416 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.32 136.45 33.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.165 -0.959 . . . . 0.0 110.304 -179.923 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.997 ' CG1' HG13 ' A' ' 21' ' ' VAL . 60.8 mt -99.94 138.48 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.166 -0.959 . . . . 0.0 109.293 179.332 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 2.6 ptt180 -150.6 -170.88 3.77 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.992 -1.068 . . . . 0.0 110.745 -179.175 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.515 HD12 ' N ' ' A' ' 6' ' ' LEU . 6.5 mp -89.41 128.78 35.97 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.341 -0.85 . . . . 0.0 110.991 -179.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.71 157.26 16.6 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.657 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 3.9 ttp85 -126.35 109.35 12.15 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.869 -1.145 . . . . 0.0 111.752 -178.744 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -118.85 -151.0 0.47 Allowed 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.251 -0.906 . . . . 0.0 109.566 179.008 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.38 100.28 0.78 Allowed Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.22 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -65.27 -55.22 19.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.288 -1.125 . . . . 0.0 109.918 -179.937 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 5.1 ptpt -169.65 43.26 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.469 -0.769 . . . . 0.0 110.004 -179.707 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -123.81 -57.14 1.64 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.205 -0.935 . . . . 0.0 109.186 -179.486 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -152.62 126.23 4.3 Favored Pre-proline 0 C--N 1.304 -1.409 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' O ' ' HD2' ' A' ' 41' ' ' PRO . 47.2 Cg_endo -72.89 114.49 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.309 1.163 . . . . 0.0 111.122 -179.127 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.516 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 25.3 p80 -141.72 144.77 34.21 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.317 -0.864 . . . . 0.0 110.003 179.193 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.458 ' CB ' ' O ' ' A' ' 7' ' ' ALA 0.258 17.8 m-30 -115.32 178.06 4.43 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.678 179.262 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HA ' ' HA ' ' A' ' 38' ' ' TYR . 31.0 mtt180 -137.1 156.84 47.87 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 176.069 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -98.01 83.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 102.896 -3.002 . . . . 0.0 102.896 177.736 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.489 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.266 0.4 OUTLIER -97.8 165.77 2.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.582 -173.76 . . . . . . . . 4 4 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.997 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -109.13 104.62 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.718 -0.614 . . . . 0.0 110.716 -177.33 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.443 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 2.1 t -131.11 -165.76 1.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 109.643 179.139 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' OG1' ' A' ' 22' ' ' THR . 4.2 m-20 -124.42 158.96 31.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.027 -1.046 . . . . 0.0 110.618 -179.637 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -81.77 -51.77 7.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.233 -0.917 . . . . 0.0 109.868 179.664 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.42 124.0 19.78 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.886 . . . . 0.0 110.117 179.862 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -174.26 123.08 0.3 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 110.218 -179.817 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -68.75 0.78 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.274 -0.891 . . . . 0.0 110.125 179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.22 -51.69 3.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.324 -0.86 . . . . 0.0 110.173 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.16 144.74 54.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.287 -0.883 . . . . 0.0 110.364 -179.928 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.93 81.62 0.17 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.49 140.41 23.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.137 -1.213 . . . . 0.0 110.347 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.3 p90 -71.48 163.45 27.69 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.213 -0.929 . . . . 0.0 110.479 -179.959 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.576 HG21 ' HH2' ' A' ' 59' ' ' TRP . 5.0 mt -75.92 -39.3 37.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.649 -0.657 . . . . 0.0 110.339 -179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.65 170.28 21.14 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.321 -0.862 . . . . 0.0 110.353 -179.671 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.7 mtmt -107.29 112.69 25.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.344 -0.848 . . . . 0.0 110.024 179.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.95 HG21 ' CD1' ' A' ' 59' ' ' TRP . 22.6 pt -107.27 -36.35 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.19 -0.944 . . . . 0.0 111.338 -179.509 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.847 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -119.72 168.2 13.57 Favored Glycine 0 C--N 1.295 -1.741 0 C-N-CA 119.087 -1.53 . . . . 0.0 112.245 -177.842 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 49.8 t80 -141.36 125.5 17.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 177.351 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' ILE . 9.9 t80 -115.72 146.89 41.49 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.596 -1.315 . . . . 0.0 109.533 179.112 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.548 ' N ' ' CD1' ' A' ' 39' ' ' TYR . 33.6 t70 -136.68 102.18 9.54 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 120.977 -1.077 . . . . 0.0 109.715 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 15' ' ' PRO . 49.8 Cg_endo -88.43 28.01 0.51 Allowed 'Trans proline' 0 C--N 1.314 -1.267 0 O-C-N 123.686 1.361 . . . . 0.0 111.32 -179.346 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.411 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.0 OUTLIER -89.66 -156.64 0.42 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.838 -1.164 . . . . 0.0 110.326 -179.682 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.503 ' C ' HG23 ' A' ' 44' ' ' THR . 7.7 ttpt -68.66 70.62 0.19 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.216 -0.928 . . . . 0.0 109.805 179.804 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.503 HG23 ' C ' ' A' ' 43' ' ' LYS . 61.3 p -150.54 97.48 2.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.538 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 39.1 m -88.89 -40.54 0.45 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 121.28 -0.888 . . . . 0.0 111.78 -178.787 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' A' ' 45' ' ' THR . 53.3 Cg_endo -87.22 -45.56 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 122.745 0.866 . . . . 0.0 111.239 -179.909 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' O ' ' HB ' ' A' ' 44' ' ' THR . 2.5 m-20 -111.04 92.48 4.06 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.216 -0.927 . . . . 0.0 110.512 -179.406 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.564 ' CZ3' HD13 ' A' ' 49' ' ' LEU . 55.2 p-90 -140.75 11.16 2.25 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.291 -0.88 . . . . 0.0 110.852 -179.795 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.564 HD13 ' CZ3' ' A' ' 48' ' ' TRP . 14.6 tp -135.23 121.05 19.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 0.0 110.987 -179.697 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -133.15 102.51 5.61 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.765 . . . . 0.0 109.256 179.409 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.847 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.47 140.14 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 120.898 -1.126 . . . . 0.0 111.044 -179.234 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -82.33 69.23 9.03 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 175.948 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.892 HG23 HG22 ' A' ' 79' ' ' VAL . 1.4 p -34.25 -31.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.858 -177.773 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 52' ' ' ASP . 18.1 tp10 -62.95 -53.06 59.86 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.854 -1.154 . . . . 0.0 109.01 178.315 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.503 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 2.7 mtm-85 -73.27 -37.36 66.31 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.416 -0.803 . . . . 0.0 108.981 178.734 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.925 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.99 -18.98 65.75 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.754 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -88.95 -23.31 22.71 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.347 -0.846 . . . . 0.0 109.736 178.446 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.904 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -60.15 -45.83 91.73 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 123.247 1.499 . . . . 0.0 107.094 178.439 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.95 ' CD1' HG21 ' A' ' 36' ' ' ILE . 85.0 m95 -66.98 -58.48 4.87 Favored 'General case' 0 C--N 1.282 -2.331 0 CA-C-N 113.653 -1.612 . . . . 0.0 109.791 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.766 HD11 HD13 ' A' ' 74' ' ' LEU . 4.1 mt -52.89 -23.19 6.57 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.226 -0.99 . . . . 0.0 108.622 177.46 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.7 t -81.13 -20.03 42.24 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.58 -0.7 . . . . 0.0 110.49 179.405 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.9 m -98.74 31.71 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.767 -1.208 . . . . 0.0 109.382 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.05 75.64 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.788 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.429 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -72.01 143.55 49.13 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.105 -1.232 . . . . 0.0 110.235 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.416 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 18.0 mt-30 -117.34 118.19 35.81 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.552 ' HB3' HD12 ' A' ' 74' ' ' LEU . 55.2 Cg_endo -81.29 146.73 15.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.499 1.263 . . . . 0.0 109.881 179.603 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 10.2 t -70.27 -171.7 0.49 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.053 . . . . 0.0 109.94 179.675 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.71 50.88 1.76 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.146 -0.971 . . . . 0.0 110.101 179.553 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.457 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 28.4 m -165.3 -60.22 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -179.832 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.676 ' HB1' HG22 ' A' ' 19' ' ' ILE . . . -65.44 -23.83 67.03 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.113 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.45 ' CG ' ' HG2' ' A' ' 66' ' ' PRO . 6.8 ttt-85 -68.76 -46.22 69.37 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.465 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.455 ' O ' ' HG3' ' A' ' 75' ' ' ARG . 1.0 OUTLIER -71.71 -8.02 51.64 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.417 179.378 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.467 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 25.8 mt -102.7 -26.2 13.27 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.148 -0.97 . . . . 0.0 108.604 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.766 HD13 HD11 ' A' ' 60' ' ' LEU . 41.7 mt -72.01 -30.02 64.79 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 176.781 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.547 ' HB3' ' CE1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -77.15 -28.57 54.25 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 177.966 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -76.93 -33.23 57.73 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 122.108 0.956 . . . . 0.0 109.379 179.153 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.458 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -67.4 -9.38 40.99 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.912 178.885 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.69 17.78 32.16 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.954 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.892 HG22 HG23 ' A' ' 53' ' ' VAL . 22.8 t -78.5 -67.0 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.897 -1.355 . . . . 0.0 110.107 -179.992 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.547 ' CE1' ' HB3' ' A' ' 75' ' ' ARG . 40.1 p90 -135.59 -169.94 2.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.042 179.837 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -176.22 140.49 0.4 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.335 -0.853 . . . . 0.0 110.203 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.69 135.29 29.23 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.272 -0.893 . . . . 0.0 110.372 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -106.26 58.01 0.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 110.13 -179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -131.51 176.28 8.44 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 110.146 179.993 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -53.13 -26.46 16.85 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.204 -0.935 . . . . 0.0 110.229 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -54.68 151.99 7.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.309 -0.869 . . . . 0.0 110.286 -179.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 132.75 -157.63 22.69 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.175 -1.191 . . . . 0.0 110.26 -179.954 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.493 1.718 0 CA-C-O 121.241 0.543 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 57.9 t -73.93 125.88 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.217 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.591 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER -140.76 137.23 33.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.462 179.832 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.984 HD11 ' CB ' ' A' ' 59' ' ' TRP . 57.0 mt -99.56 140.16 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.098 -1.001 . . . . 0.0 109.081 179.07 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.491 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 2.2 ptt180 -150.64 171.22 17.48 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.965 -1.084 . . . . 0.0 110.266 -179.619 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 1.9 pp -89.62 128.35 36.04 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.568 179.484 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.02 175.99 5.73 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.536 -0.728 . . . . 0.0 109.07 -179.529 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 17' ' ' TYR . 4.5 ttt-85 -140.76 116.48 10.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.927 -1.108 . . . . 0.0 111.357 -179.368 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 0.0 OUTLIER -134.2 -153.54 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.384 -0.823 . . . . 0.0 109.806 179.302 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.62 120.27 4.74 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.494 ' OG ' ' CD2' ' A' ' 13' ' ' HIS . 0.1 OUTLIER -65.88 -87.38 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.227 -1.161 . . . . 0.0 110.289 179.951 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -148.83 30.01 0.81 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.127 -0.983 . . . . 0.0 109.092 -179.695 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.494 ' CD2' ' OG ' ' A' ' 11' ' ' SER . 4.2 m-70 -120.24 -38.71 2.88 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.475 -0.766 . . . . 0.0 109.482 -178.5 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -163.68 104.29 0.94 Allowed Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.596 -0.69 . . . . 0.0 109.67 -179.988 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.54 114.26 3.61 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.542 1.285 . . . . 0.0 110.464 -179.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 24.9 p80 -122.54 159.93 26.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.22 -0.925 . . . . 0.0 110.237 179.847 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' A' ' 7' ' ' ALA 0.267 9.2 m-85 -120.26 169.26 10.43 Favored 'General case' 0 C--N 1.295 -1.769 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.685 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -136.71 147.08 46.56 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 120.825 -1.172 . . . . 0.0 109.257 177.592 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -96.2 82.56 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 177.259 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.284 0.4 OUTLIER -97.8 161.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 113.548 -1.66 . . . . 0.0 111.204 -173.389 . . . . . . . . 4 4 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.938 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -108.46 111.9 38.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.61 -0.682 . . . . 0.0 110.599 -177.43 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.403 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 3.4 t -140.02 -164.45 1.7 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.336 -0.852 . . . . 0.0 109.94 179.639 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' N ' ' OG1' ' A' ' 22' ' ' THR . 28.2 t70 -104.91 138.31 41.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 110.142 179.915 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.591 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . . . -80.1 -33.4 38.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 110.065 179.946 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -26.75 68.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 110.188 -179.94 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.69 64.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -0.934 . . . . 0.0 110.252 -179.965 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.9 72.75 10.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -0.884 . . . . 0.0 110.134 179.875 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.11 -60.97 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.173 -0.955 . . . . 0.0 110.269 -179.911 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.05 -48.73 64.44 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.321 -0.862 . . . . 0.0 110.436 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.18 47.35 5.26 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.56 124.4 42.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -1.067 . . . . 0.0 110.073 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB3' HG13 ' A' ' 20' ' ' VAL . 12.6 p90 -108.33 141.75 39.68 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.557 HG21 ' HH2' ' A' ' 59' ' ' TRP . 15.2 mt -50.24 -31.09 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.441 -0.787 . . . . 0.0 110.327 179.874 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -176.81 171.31 2.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 110.095 179.952 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.12 119.48 39.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.202 -0.936 . . . . 0.0 110.101 179.813 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.013 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -113.1 -30.25 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.424 -0.798 . . . . 0.0 110.286 179.765 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.925 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -116.28 163.01 12.45 Favored Glycine 0 C--N 1.293 -1.816 0 C-N-CA 119.225 -1.464 . . . . 0.0 111.267 -179.718 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.469 ' CE2' ' HB2' ' A' ' 40' ' ' ASP . 85.3 t80 -140.81 117.16 10.71 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.701 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.838 ' HB2' HD11 ' A' ' 19' ' ' ILE . 1.7 t80 -107.44 122.57 46.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.797 -1.189 . . . . 0.0 109.537 179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.469 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 21.8 t0 -140.29 91.2 9.97 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.724 -1.235 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.28 79.03 0.81 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.78 1.41 . . . . 0.0 110.934 -179.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' O ' ' N ' ' A' ' 44' ' ' THR . 0.4 OUTLIER -89.92 120.58 31.26 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 110.12 179.754 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.14 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.222 -0.924 . . . . 0.0 110.257 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 42' ' ' ARG . 41.0 p -146.79 -63.71 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.218 -0.926 . . . . 0.0 110.209 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -150.0 170.45 7.68 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.226 -0.921 . . . . 0.0 109.747 -179.973 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 45' ' ' THR . 43.6 Cg_endo -69.5 62.76 1.63 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.536 1.282 . . . . 0.0 110.457 179.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -161.88 83.38 0.59 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.438 -0.788 . . . . 0.0 109.634 179.865 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.713 ' HZ3' HD23 ' A' ' 49' ' ' LEU . 17.4 p-90 -124.8 -11.85 7.15 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.237 -0.914 . . . . 0.0 111.139 -179.262 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.713 HD23 ' HZ3' ' A' ' 48' ' ' TRP . 1.3 tm? -94.48 119.79 33.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.945 -1.097 . . . . 0.0 110.702 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 49' ' ' LEU . 4.5 ttpt -125.87 94.55 4.14 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.694 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.925 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.2 t -116.38 132.52 65.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.034 -1.041 . . . . 0.0 111.202 -178.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.2 t0 -74.2 70.8 1.64 Allowed 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.678 HG23 HG22 ' A' ' 79' ' ' VAL . 1.1 p -35.61 -30.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.274 0 O-C-N 122.269 -0.269 . . . . 0.0 111.654 -177.377 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.8 OUTLIER -60.63 -54.14 48.93 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.776 -1.202 . . . . 0.0 108.435 177.949 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.654 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.5 mmp_? -69.65 -41.77 75.13 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.333 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.943 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -63.92 -17.29 63.08 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.341 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.44 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 15.1 tpt180 -88.35 -26.01 22.43 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 121.29 -0.881 . . . . 0.0 109.423 178.594 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.817 ' O ' HG13 ' A' ' 62' ' ' VAL . 3.0 t80 -59.49 -43.31 93.35 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 123.378 1.561 . . . . 0.0 107.302 178.241 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.013 ' CD1' HG21 ' A' ' 36' ' ' ILE . 75.8 m95 -69.23 -57.18 5.69 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 113.434 -1.712 . . . . 0.0 109.987 -178.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.749 HD11 HD13 ' A' ' 74' ' ' LEU . 33.1 mt -54.71 -22.08 12.82 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.076 -1.015 . . . . 0.0 108.532 177.338 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.9 t -80.93 -22.61 39.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.455 -0.778 . . . . 0.0 110.763 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.817 HG13 ' O ' ' A' ' 58' ' ' TYR . 6.0 m -98.88 32.63 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 120.828 -1.17 . . . . 0.0 109.585 179.871 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.6 26.49 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.656 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -75.11 124.44 27.02 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.98 -1.306 . . . . 0.0 110.431 -179.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.419 ' O ' ' CG ' ' A' ' 65' ' ' GLN . 7.0 pt20 -98.84 121.01 57.39 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.188 -0.945 . . . . 0.0 110.119 179.785 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.652 ' HB3' HD12 ' A' ' 74' ' ' LEU . 50.8 Cg_endo -80.8 168.05 17.94 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.401 1.211 . . . . 0.0 110.561 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.665 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -88.8 167.92 12.88 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.76 179.504 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -53.78 -29.53 40.53 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.994 -1.066 . . . . 0.0 111.28 -179.247 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.468 ' HB ' ' CD2' ' A' ' 6' ' ' LEU . 24.2 m -97.51 -44.74 6.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.085 -1.009 . . . . 0.0 110.855 -179.332 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.665 ' HB3' ' OG1' ' A' ' 67' ' ' THR . . . -69.97 -24.61 63.35 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.405 -0.809 . . . . 0.0 109.038 -179.609 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.458 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 25.1 ttt-85 -70.24 -36.54 74.57 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.577 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.99 -30.59 71.17 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.176 -1.01 . . . . 0.0 109.002 179.133 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.541 HD12 ' HA ' ' A' ' 70' ' ' ALA . 75.1 mt -75.45 -32.04 60.51 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.433 -0.792 . . . . 0.0 109.565 179.454 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 60' ' ' LEU . 24.6 mt -66.56 -30.0 70.2 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' CG ' ' CE1' ' A' ' 80' ' ' PHE . 4.7 tmm_? -79.81 -30.67 40.58 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.176 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -27.91 51.26 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.895 0.855 . . . . 0.0 109.703 179.191 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.456 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -73.16 -6.34 45.13 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.068 178.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.81 20.35 40.32 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 180.0 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.718 HG11 ' CD1' ' A' ' 60' ' ' LEU . 21.6 t -78.52 -63.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.933 -1.333 . . . . 0.0 110.289 179.979 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' CE1' ' CG ' ' A' ' 75' ' ' ARG . 14.3 p90 -133.72 -166.24 1.75 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.194 -0.942 . . . . 0.0 110.632 179.932 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.425 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . 8.9 mmt180 -121.19 -77.75 0.59 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.345 -0.847 . . . . 0.0 110.249 -179.858 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -169.51 150.44 4.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.251 -0.905 . . . . 0.0 110.114 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.73 165.41 14.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 110.163 -179.975 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -72.92 146.49 46.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.159 -0.963 . . . . 0.0 110.221 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.46 111.52 2.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.374 -0.829 . . . . 0.0 110.337 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 4.4 pt-20 -60.19 -19.3 53.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.286 -0.884 . . . . 0.0 110.393 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.426 ' N ' ' HG3' ' A' ' 86' ' ' GLU . . . -53.5 -78.91 0.1 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 -179.852 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.262 -1.14 . . . . 0.0 110.133 -179.886 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.308 0.575 . . . . 0.0 110.234 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 99.1 t -53.94 111.48 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.321 -0.862 . . . . 0.0 110.49 -179.868 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -140.19 138.12 34.89 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.0 110.068 179.568 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.979 HD11 ' CB ' ' A' ' 59' ' ' TRP . 86.0 mt -104.58 133.47 48.6 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.112 -0.992 . . . . 0.0 109.92 -179.996 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.483 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -150.77 -170.65 3.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 110.532 -179.238 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.825 HD21 ' CD1' ' A' ' 73' ' ' LEU . 16.8 mt -88.6 126.64 35.38 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.989 -1.069 . . . . 0.0 110.188 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.462 ' N ' ' HB3' ' A' ' 17' ' ' TYR . . . -99.91 103.09 14.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 0.0 110.93 -179.748 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 21.1 ttt180 -72.38 113.47 9.44 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.405 -0.809 . . . . 0.0 110.586 -179.921 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.507 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 66.1 m-85 -91.79 -63.91 1.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.363 -0.835 . . . . 0.0 109.995 179.442 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.59 134.59 42.57 Favored Glycine 0 N--CA 1.482 1.744 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 -178.828 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.42 ' OG ' ' HG2' ' A' ' 12' ' ' LYS . 1.6 p -62.23 -50.45 71.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.194 -1.18 . . . . 0.0 109.65 179.588 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HG2' ' OG ' ' A' ' 11' ' ' SER . 9.5 ptpp? -171.21 41.02 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.473 -0.767 . . . . 0.0 109.768 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -119.4 -63.5 1.38 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 109.509 -179.311 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -107.74 120.95 45.63 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.485 -0.759 . . . . 0.0 109.592 179.577 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -76.78 112.81 3.52 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.421 1.221 . . . . 0.0 111.297 -179.197 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.474 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.6 p80 -175.57 125.62 0.23 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 0.0 110.581 178.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 1.9 m-85 -121.23 165.17 15.82 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 177.884 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.507 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -107.98 160.51 15.72 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 118.7 -1.2 . . . . 0.0 108.002 176.971 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.039 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -97.91 79.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 N-CA-C 102.604 -3.11 . . . . 0.0 102.604 177.503 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.251 0.3 OUTLIER -97.44 163.49 2.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.299 -173.843 . . . . . . . . 4 4 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.939 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -110.46 114.04 45.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 121.359 0.599 . . . . 0.0 110.84 -176.921 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.403 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 1.3 t -137.43 -177.76 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 179.602 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -88.58 -174.55 4.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.378 -0.826 . . . . 0.0 110.086 179.865 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.74 65.91 5.05 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.358 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -53.33 -179.44 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.294 -0.879 . . . . 0.0 110.169 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.09 -83.8 0.56 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.154 -0.966 . . . . 0.0 110.482 -179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -168.52 33.77 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.11 -0.994 . . . . 0.0 110.247 -179.861 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -138.79 -53.49 0.59 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.12 -167.14 1.7 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.007 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.97 111.98 0.34 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -154.07 136.04 14.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -1.155 . . . . 0.0 109.788 179.733 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 21' ' ' VAL . 2.1 p90 -116.0 163.0 16.55 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.236 -0.915 . . . . 0.0 110.79 -179.642 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.56 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.2 mt -77.74 -30.26 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.408 -0.807 . . . . 0.0 109.787 179.878 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -172.32 177.24 3.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 110.108 179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -115.84 123.12 47.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.0 110.273 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.031 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -119.49 -27.02 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.154 -0.966 . . . . 0.0 110.98 179.815 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.866 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -127.87 165.85 20.74 Favored Glycine 0 N--CA 1.481 1.68 0 C-N-CA 118.925 -1.607 . . . . 0.0 112.305 -178.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' N ' HG12 ' A' ' 19' ' ' ILE . 25.3 t80 -140.71 138.28 34.11 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.865 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.039 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.5 t80 -133.32 135.18 44.66 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.547 -1.345 . . . . 0.0 110.304 179.75 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 26.7 t0 -140.93 95.0 7.77 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.974 -1.079 . . . . 0.0 110.337 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 46.4 Cg_endo -73.34 67.68 4.35 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 O-C-N 123.568 1.299 . . . . 0.0 110.596 -179.821 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.94 -174.14 4.14 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.192 -0.943 . . . . 0.0 110.298 179.871 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.14 57.08 1.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.273 -0.892 . . . . 0.0 110.452 -179.851 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 70.3 p -125.01 -43.52 1.97 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 110.194 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.5 p -145.05 163.73 31.07 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.919 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.6 -17.82 33.49 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.604 1.318 . . . . 0.0 110.47 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.29 105.74 18.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.195 -0.94 . . . . 0.0 110.143 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.709 ' HZ3' HD12 ' A' ' 49' ' ' LEU . 4.8 p-90 -133.6 11.64 4.07 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.261 -0.899 . . . . 0.0 110.856 -179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.807 HD13 ' HB3' ' A' ' 76' ' ' GLN . 3.0 tt -112.66 134.59 54.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 0.0 110.617 -179.436 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.405 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 2.8 ttpt -137.43 85.67 2.14 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.485 -0.759 . . . . 0.0 109.07 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.866 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -117.5 134.72 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.172 -0.955 . . . . 0.0 111.227 -178.974 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 54' ' ' GLU . 0.9 OUTLIER -80.81 71.32 7.73 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.376 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.564 HG23 ' HA ' ' A' ' 79' ' ' VAL . 0.1 OUTLIER -31.6 -35.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.483 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -177.505 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' N ' ' O ' ' A' ' 52' ' ' ASP . 2.6 mm-40 -59.73 -53.88 52.85 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.621 -1.299 . . . . 0.0 108.967 178.69 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.726 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.5 mmp_? -69.45 -41.42 76.28 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.445 -0.785 . . . . 0.0 109.212 178.737 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.936 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -65.39 -20.69 66.49 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.044 -1.035 . . . . 0.0 108.406 178.936 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -87.74 -23.48 24.11 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 121.284 -0.885 . . . . 0.0 109.451 178.703 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.7 t80 -60.0 -45.13 93.74 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 123.253 1.502 . . . . 0.0 107.085 178.148 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.031 ' CD1' HG21 ' A' ' 36' ' ' ILE . 78.4 m95 -65.23 -53.76 39.62 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-N 113.54 -1.663 . . . . 0.0 109.441 -179.103 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD11 HD13 ' A' ' 74' ' ' LEU . 11.4 mt -56.76 -20.93 24.78 Favored 'General case' 0 C--N 1.293 -1.873 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.566 176.844 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.62 -23.73 39.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 110.858 -179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 59' ' ' TRP . 34.1 m -99.27 33.05 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 120.882 -1.136 . . . . 0.0 109.565 179.838 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.32 30.62 73.55 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -68.62 146.28 53.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.03 -1.277 . . . . 0.0 110.079 179.74 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -108.46 106.35 58.51 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.36 -0.837 . . . . 0.0 110.282 -179.939 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -78.66 129.76 9.38 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.487 1.256 . . . . 0.0 110.238 179.888 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -54.15 174.66 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.077 -1.014 . . . . 0.0 109.9 179.646 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -66.59 -15.63 63.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.189 -0.944 . . . . 0.0 110.494 -179.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.546 ' CG2' HD11 ' A' ' 6' ' ' LEU . 81.1 m -106.12 -45.36 4.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 110.265 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.907 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -63.14 -24.76 68.04 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.247 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -70.0 -40.34 75.32 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.087 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.29 -40.81 94.31 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 119.57 -0.852 . . . . 0.0 108.931 178.697 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.907 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.8 mt -65.99 -33.03 74.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 178.742 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.699 HD13 HD11 ' A' ' 60' ' ' LEU . 31.9 mt -68.49 -26.68 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.336 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.499 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.33 -28.73 47.35 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 177.907 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.807 ' HB3' HD13 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -80.74 -37.41 30.52 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.955 0.883 . . . . 0.0 109.897 179.938 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -68.64 -7.84 36.7 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 120.08 -0.648 . . . . 0.0 110.071 178.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 77.01 47.68 9.09 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 -179.762 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.564 ' HA ' HG23 ' A' ' 53' ' ' VAL . 75.4 t -92.97 -57.01 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.305 -1.115 . . . . 0.0 111.698 -179.092 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.499 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 44.7 m-85 -53.02 -177.51 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.107 -0.996 . . . . 0.0 110.486 -179.275 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -73.7 175.46 7.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.851 . . . . 0.0 110.353 179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.82 163.04 38.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.396 -0.815 . . . . 0.0 110.094 179.926 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -103.01 91.01 3.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.229 -0.92 . . . . 0.0 110.043 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -167.35 -173.55 2.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.89 . . . . 0.0 110.114 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.11 64.28 1.28 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.166 -0.959 . . . . 0.0 110.366 -179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -54.29 147.57 13.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.051 -1.031 . . . . 0.0 109.985 179.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.9 24.86 22.4 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.936 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.231 -1.158 . . . . 0.0 110.136 179.935 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.2 mtt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.269 0.557 . . . . 0.0 110.297 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.481 HG11 ' CE3' ' A' ' 59' ' ' TRP . 33.6 t -86.11 140.94 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.311 -0.868 . . . . 0.0 109.922 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.436 ' HE2' ' HB3' ' A' ' 65' ' ' GLN . 10.8 mttt -140.75 137.85 33.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.99 -1.069 . . . . 0.0 110.758 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.918 HD11 ' CB ' ' A' ' 59' ' ' TRP . 44.5 mt -103.41 132.7 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.126 -0.984 . . . . 0.0 108.964 178.754 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.466 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 10.4 ptt180 -150.85 -169.89 3.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.102 -0.999 . . . . 0.0 110.391 -179.285 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.584 HD22 ' HD2' ' A' ' 39' ' ' TYR . 52.0 mt -89.7 130.39 35.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.135 -0.978 . . . . 0.0 111.452 -179.469 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.629 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.74 104.99 16.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.705 -0.622 . . . . 0.0 110.23 179.373 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -75.74 120.48 21.18 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.012 -1.055 . . . . 0.0 111.253 -179.618 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.629 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 15.8 m-85 -110.24 -64.8 1.22 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.506 -0.746 . . . . 0.0 110.797 179.888 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.11 134.14 27.97 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 -178.431 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 66.9 p -89.12 -59.17 2.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -1.034 . . . . 0.0 109.291 179.191 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 11' ' ' SER . 11.4 mtpt -141.82 61.28 1.46 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.631 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.408 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 5.0 m-70 -142.14 -64.66 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.403 -0.81 . . . . 0.0 109.467 -178.597 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -143.71 130.15 10.27 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.506 -0.746 . . . . 0.0 109.374 179.655 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.62 102.24 1.54 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.427 1.225 . . . . 0.0 111.097 -179.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.485 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 34.7 p80 -149.41 125.41 10.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.047 -1.033 . . . . 0.0 110.697 179.086 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 7.9 m-30 -117.92 154.18 32.33 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.047 -1.033 . . . . 0.0 108.554 178.408 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.562 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 9.5 mtt180 -99.19 160.03 14.56 Favored 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 117.844 -1.542 . . . . 0.0 107.131 176.017 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.912 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -99.21 81.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 N-CA-C 102.442 -3.17 . . . . 0.0 102.442 176.969 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.257 0.3 OUTLIER -97.26 165.49 2.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.397 -173.511 . . . . . . . . 4 4 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.928 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -110.02 119.9 60.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.735 -0.603 . . . . 0.0 110.724 -176.941 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.0 OUTLIER -140.21 -176.34 4.57 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.035 -1.041 . . . . 0.0 110.25 179.112 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 22' ' ' THR . 5.7 m-20 -102.23 158.33 16.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 110.513 -179.554 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -86.55 -60.1 2.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.883 . . . . 0.0 109.939 179.742 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -52.1 132.63 33.26 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.203 -0.935 . . . . 0.0 110.087 179.78 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.7 ttm180 -155.03 140.68 17.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.089 -1.007 . . . . 0.0 110.598 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -121.62 -34.91 3.32 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.314 -0.867 . . . . 0.0 109.948 179.687 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.72 -42.0 0.09 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.815 . . . . 0.0 109.971 179.725 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -72.0 -159.03 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -0.863 . . . . 0.0 110.012 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.07 77.33 0.02 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.18 113.11 11.03 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.227 -1.16 . . . . 0.0 110.145 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 4.4 p90 -50.36 172.58 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.223 -0.923 . . . . 0.0 110.539 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.841 HG21 ' HH2' ' A' ' 59' ' ' TRP . 19.7 mm -83.99 -61.66 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.415 -0.803 . . . . 0.0 109.266 179.771 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -151.16 160.48 43.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.751 -0.593 . . . . 0.0 109.593 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -89.83 110.72 21.63 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 -179.985 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.041 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.7 pp -104.75 -32.41 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.082 -1.011 . . . . 0.0 111.104 -179.79 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.923 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.04 162.54 15.78 Favored Glycine 0 C--N 1.295 -1.745 0 C-N-CA 118.837 -1.649 . . . . 0.0 110.956 -179.783 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.449 ' N ' HG13 ' A' ' 19' ' ' ILE . 45.9 t80 -134.35 141.49 46.91 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 177.217 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.584 ' HD2' HD22 ' A' ' 6' ' ' LEU . 4.6 t80 -142.27 130.9 22.61 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 118.087 -1.445 . . . . 0.0 111.365 -179.1 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 46.3 t0 -131.64 94.97 24.32 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.565 179.25 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 41.7 Cg_endo -68.32 78.46 0.63 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.569 1.3 . . . . 0.0 110.972 -179.357 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.13 165.77 12.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.371 -0.831 . . . . 0.0 110.068 179.733 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -117.15 54.43 0.87 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 110.276 -179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 45' ' ' THR . 4.3 t -139.21 -41.75 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.311 -0.868 . . . . 0.0 110.06 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.518 ' N ' HG23 ' A' ' 44' ' ' THR . 72.1 p -133.18 146.36 60.69 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.287 -0.883 . . . . 0.0 109.993 179.816 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.45 -14.25 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.675 1.355 . . . . 0.0 110.78 -179.77 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 47' ' ' ASP . 0.9 OUTLIER -97.37 103.42 15.35 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.138 -0.976 . . . . 0.0 109.996 179.926 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.753 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 0.9 OUTLIER -142.31 13.79 2.0 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.214 -0.929 . . . . 0.0 111.072 -179.823 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.753 HD13 ' HZ3' ' A' ' 48' ' ' TRP . 12.0 tp -111.14 132.58 54.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.917 -1.114 . . . . 0.0 111.34 -178.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -133.41 94.96 3.41 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.923 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.6 t -118.41 139.45 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.009 -1.057 . . . . 0.0 111.34 -179.037 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.2 t70 -85.01 72.99 10.75 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 175.776 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.699 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.53 -30.27 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -177.06 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -62.46 -48.4 79.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.589 -1.319 . . . . 0.0 108.771 178.257 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.712 ' HB3' HG22 ' A' ' 36' ' ' ILE . 1.1 mmp_? -76.22 -36.55 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.476 -0.765 . . . . 0.0 109.111 178.673 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.868 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -69.54 -20.39 63.68 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 178.598 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.439 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 2.2 ttp180 -86.78 -23.19 25.5 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 121.296 -0.877 . . . . 0.0 109.112 178.52 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.632 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.7 t80 -61.93 -45.37 94.0 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 123.099 1.428 . . . . 0.0 107.502 178.427 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.041 ' CD1' HG21 ' A' ' 36' ' ' ILE . 67.8 m95 -68.07 -57.44 6.1 Favored 'General case' 0 C--N 1.288 -2.09 0 CA-C-N 114.016 -1.447 . . . . 0.0 109.943 -179.166 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.728 HD21 ' HG3' ' A' ' 66' ' ' PRO . 10.9 mt -56.05 -20.82 18.45 Favored 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.329 -0.949 . . . . 0.0 108.707 177.335 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 t -79.98 -23.18 41.77 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.363 -0.836 . . . . 0.0 110.623 179.674 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 59' ' ' TRP . 18.8 m -98.89 31.93 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 O-C-N 120.964 -1.085 . . . . 0.0 109.627 179.857 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 25.77 75.17 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -66.56 134.88 53.28 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.951 -1.323 . . . . 0.0 110.164 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.436 ' HB3' ' HE2' ' A' ' 3' ' ' LYS . 2.9 mt-30 -99.88 107.83 48.49 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.937 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.728 ' HG3' HD21 ' A' ' 60' ' ' LEU . 53.7 Cg_endo -82.4 134.55 7.81 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.46 1.242 . . . . 0.0 110.229 179.968 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.49 163.19 0.93 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 0.0 110.032 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -59.07 -16.91 21.43 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.245 -0.909 . . . . 0.0 110.717 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 62.7 m -99.61 -47.8 4.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.311 -0.868 . . . . 0.0 110.53 -179.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.827 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -69.55 -28.8 66.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -179.856 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 41.1 ttp85 -66.27 -38.6 88.19 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.318 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.16 -26.74 68.3 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.287 178.939 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.827 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.1 mt -88.11 -29.03 20.91 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.641 HD12 ' HB3' ' A' ' 66' ' ' PRO . 34.0 mt -68.74 -28.24 66.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.733 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.52 -28.86 30.8 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.558 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -72.96 -33.76 66.07 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 122.142 0.972 . . . . 0.0 108.918 179.218 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.474 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -69.34 -9.59 54.03 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.919 178.523 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.409 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 84.91 52.9 3.32 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 -179.721 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.699 HG22 ' CB ' ' A' ' 53' ' ' VAL . 43.0 t -114.91 -6.82 12.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 121.12 -1.223 . . . . 0.0 111.716 -179.272 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 10.3 m-85 -104.08 -27.2 12.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.908 -1.12 . . . . 0.0 110.663 -178.733 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -130.52 98.44 4.67 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.09 -1.006 . . . . 0.0 110.387 -179.91 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -58.96 123.07 15.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 110.08 179.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -99.92 -167.24 1.43 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.289 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -135.29 -161.38 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.222 -0.924 . . . . 0.0 110.195 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.16 102.82 11.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 110.21 179.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -176.67 -58.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.279 -0.888 . . . . 0.0 110.113 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -55.9 -40.68 82.19 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.193 -1.181 . . . . 0.0 110.158 -179.972 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.0 mtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.197 0.522 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 41.6 t -60.12 121.52 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.294 -0.879 . . . . 0.0 110.087 179.968 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -140.52 134.9 31.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.28 -0.888 . . . . 0.0 110.603 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.974 ' CG1' HG13 ' A' ' 21' ' ' VAL . 73.4 mt -102.27 134.79 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.059 -1.026 . . . . 0.0 109.226 179.066 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.5 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 13.2 ptm180 -150.91 -167.86 2.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.961 -1.087 . . . . 0.0 111.009 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.48 HD12 ' HB2' ' A' ' 70' ' ' ALA . 4.8 mp -89.18 131.62 35.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.453 -0.779 . . . . 0.0 110.518 -179.866 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -107.27 111.23 23.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 110.169 179.937 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 17' ' ' TYR . 19.6 ttt-85 -86.17 115.01 23.46 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.259 -0.901 . . . . 0.0 112.313 -178.767 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.1 m-85 -114.07 -149.69 0.45 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.489 -0.757 . . . . 0.0 109.196 178.117 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.2 102.45 0.01 OUTLIER Glycine 0 N--CA 1.484 1.846 0 N-CA-C 110.137 -1.185 . . . . 0.0 110.137 178.552 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.99 -50.42 66.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 0.0 109.698 179.575 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.505 ' HG3' ' CE1' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -176.77 55.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.749 -179.886 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CE1' ' HG3' ' A' ' 12' ' ' LYS . 13.7 m-70 -133.76 -64.71 0.7 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.305 -0.872 . . . . 0.0 109.189 -179.658 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -123.8 120.1 26.75 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.556 -0.715 . . . . 0.0 109.323 179.447 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -73.6 120.51 6.49 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.46 1.242 . . . . 0.0 111.296 -179.217 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.505 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 32.0 p80 -164.48 131.54 3.14 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.281 -0.887 . . . . 0.0 110.405 178.836 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD1' ' HA ' ' A' ' 8' ' ' ARG . 15.2 m-30 -114.43 175.12 5.62 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.353 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.555 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 0.6 OUTLIER -134.32 158.17 44.48 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 176.193 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.877 HD12 HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -97.51 86.27 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 N-CA-C 103.29 -2.856 . . . . 0.0 103.29 178.003 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.268 0.4 OUTLIER -97.94 164.02 2.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.583 -173.945 . . . . . . . . 4 4 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.974 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -106.87 108.2 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.738 -0.601 . . . . 0.0 110.188 -178.278 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.468 ' HA ' HD12 ' A' ' 33' ' ' ILE . 2.4 t -133.93 -172.71 3.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.164 -0.96 . . . . 0.0 110.715 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.428 ' OD1' HD11 ' A' ' 33' ' ' ILE . 1.1 m-20 -117.25 162.7 17.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.593 -0.692 . . . . 0.0 109.715 179.665 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.52 14.45 14.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.046 -1.034 . . . . 0.0 110.763 -179.778 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -58.13 -30.0 65.97 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.993 -1.067 . . . . 0.0 110.17 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.3 167.95 9.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -130.27 1.4 4.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.263 -0.898 . . . . 0.0 110.582 -179.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -95.99 -71.05 0.69 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.983 -1.073 . . . . 0.0 110.238 179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -87.09 145.3 26.51 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -0.857 . . . . 0.0 110.095 179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -120.2 108.8 1.5 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.86 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 12.5 mtpt -133.56 141.24 47.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.236 -1.155 . . . . 0.0 109.849 179.585 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.554 ' HB3' HG13 ' A' ' 20' ' ' VAL . 22.7 p90 -106.34 177.79 4.75 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.157 -0.965 . . . . 0.0 111.037 -179.765 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 22' ' ' THR . 3.3 mp -91.27 -44.21 14.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.649 -0.657 . . . . 0.0 109.994 179.965 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.17 176.52 11.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.292 -0.88 . . . . 0.0 110.305 -179.91 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -109.14 115.01 29.21 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 0.0 110.078 179.847 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.013 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.9 pt -113.06 -31.31 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.145 -0.972 . . . . 0.0 110.825 -179.732 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.838 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -121.42 167.08 14.24 Favored Glycine 0 C--N 1.295 -1.743 0 C-N-CA 119.055 -1.545 . . . . 0.0 111.785 -178.813 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 18' ' ' ARG . 11.5 t80 -140.61 133.03 28.44 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 177.061 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.729 ' HB2' HD11 ' A' ' 19' ' ' ILE . 17.5 t80 -126.07 144.66 50.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.881 -1.137 . . . . 0.0 109.883 -179.965 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.2 t0 -140.91 107.44 6.33 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.071 -1.018 . . . . 0.0 109.772 178.718 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 43.8 Cg_endo -73.57 69.77 4.25 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.163 1.086 . . . . 0.0 110.828 -179.389 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.19 125.74 43.36 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.059 -1.026 . . . . 0.0 110.206 179.808 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -93.62 27.48 2.65 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.184 -0.947 . . . . 0.0 110.318 -179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.84 HG23 HG23 ' A' ' 45' ' ' THR . 7.2 t -121.28 -14.28 8.34 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 0.0 110.68 -179.964 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.84 HG23 HG23 ' A' ' 44' ' ' THR . 71.4 p -136.83 149.83 68.01 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.022 -1.049 . . . . 0.0 110.515 -179.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.416 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 47.1 Cg_endo -73.73 -51.88 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.772 1.406 . . . . 0.0 110.62 179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -76.88 107.93 9.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.185 -0.947 . . . . 0.0 110.274 -179.814 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.599 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 19.0 p-90 -132.15 2.89 3.96 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.283 -0.886 . . . . 0.0 110.803 179.896 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 49' ' ' LEU . 3.4 tm? -109.26 129.0 55.51 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.972 -1.08 . . . . 0.0 110.935 -179.638 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' N ' HD13 ' A' ' 49' ' ' LEU . 38.0 tttt -134.49 93.29 3.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.545 -0.722 . . . . 0.0 109.102 178.951 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.838 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -113.48 135.86 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.032 -1.042 . . . . 0.0 111.04 -179.274 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.447 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.7 t70 -77.0 70.04 3.35 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 176.412 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.58 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.13 -30.47 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 122.265 -0.272 . . . . 0.0 111.42 -177.797 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.447 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -61.99 -55.6 27.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.898 -1.126 . . . . 0.0 109.009 178.577 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.664 ' HB3' HG22 ' A' ' 36' ' ' ILE . 28.8 mmm180 -71.56 -39.92 70.32 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.185 -0.947 . . . . 0.0 108.797 178.571 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -62.59 -18.66 62.6 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 178.279 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.453 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 25.0 ttm180 -88.58 -24.79 22.76 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 178.218 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.777 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -61.43 -47.2 86.84 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 123.268 1.509 . . . . 0.0 107.47 178.576 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.013 ' CD1' HG21 ' A' ' 36' ' ' ILE . 83.7 m95 -64.66 -56.61 12.68 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-N 113.646 -1.616 . . . . 0.0 109.766 -179.016 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.526 HD11 HD22 ' A' ' 74' ' ' LEU . 38.4 mt -53.35 -22.68 7.77 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.534 177.238 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -80.82 -21.13 41.1 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.47 -0.769 . . . . 0.0 110.456 179.177 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.3 m -99.04 32.59 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 120.85 -1.156 . . . . 0.0 109.426 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.18 25.12 76.2 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.882 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.434 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -69.44 128.51 36.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.016 -1.285 . . . . 0.0 109.792 179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.37 113.24 65.85 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.153 -0.967 . . . . 0.0 110.669 -179.565 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -79.68 132.08 9.63 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.526 1.277 . . . . 0.0 109.766 179.467 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 8.2 t -62.93 -178.62 0.22 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.113 -0.992 . . . . 0.0 110.415 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.53 52.43 1.4 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.18 -0.95 . . . . 0.0 110.239 179.735 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.43 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 6.3 m -166.05 -59.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.996 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.878 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.55 -23.47 66.22 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.249 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.578 ' HA ' HD12 ' A' ' 74' ' ' LEU . 26.7 ttp180 -64.79 -41.11 96.08 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.105 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.0 mtp180 -63.82 -37.66 88.22 Favored 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.284 179.199 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.878 HD12 ' HA ' ' A' ' 70' ' ' ALA . 40.3 mt -67.37 -35.79 80.06 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.25 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.578 HD12 ' HA ' ' A' ' 71' ' ' ARG . 55.0 mt -65.08 -26.85 68.4 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.587 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.549 ' HG3' ' CE2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.32 -28.09 38.24 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.027 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -35.97 42.95 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.958 0.885 . . . . 0.0 109.967 179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.749 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -74.62 -2.9 28.13 Favored 'General case' 0 C--N 1.288 -2.077 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.042 179.083 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 73.25 48.01 20.94 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.579 ' HA ' HG23 ' A' ' 53' ' ' VAL . 57.9 t -91.44 -60.17 2.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.142 -1.211 . . . . 0.0 111.479 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.549 ' CE2' ' HG3' ' A' ' 75' ' ' ARG . 46.9 m-85 -50.41 165.73 0.09 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.154 -0.966 . . . . 0.0 110.286 -179.249 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.62 113.25 1.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 179.855 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -109.11 150.29 28.07 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.916 . . . . 0.0 110.44 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 83' ' ' GLU . 1.2 pm0 -109.35 66.81 0.64 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 0.0 109.949 179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -75.4 153.21 37.83 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.212 -0.93 . . . . 0.0 110.525 -179.621 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.72 27.72 7.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.424 -0.798 . . . . 0.0 110.024 179.847 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -50.81 129.71 23.61 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.31 -0.869 . . . . 0.0 110.408 -179.759 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -130.35 60.27 0.68 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.909 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.282 -1.128 . . . . 0.0 110.228 -179.903 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.179 0.514 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 92.3 t -61.56 109.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.215 -0.928 . . . . 0.0 109.87 179.876 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 3' ' ' LYS . 17.6 ptmt -140.14 137.15 34.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.115 -0.99 . . . . 0.0 111.044 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.024 HD11 ' CB ' ' A' ' 59' ' ' TRP . 93.6 mt -99.93 133.38 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 121.183 -0.948 . . . . 0.0 109.013 178.993 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.529 ' HA ' ' CB ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -150.69 173.83 13.72 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.172 -0.955 . . . . 0.0 110.383 -179.2 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.713 ' O ' HD12 ' A' ' 6' ' ' LEU . 4.0 pp -87.73 124.68 33.84 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.359 -0.936 . . . . 0.0 109.096 179.354 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.711 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.4 111.93 24.2 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.532 -0.73 . . . . 0.0 112.462 -176.807 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.4 ttp180 -72.81 122.41 21.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.139 -0.976 . . . . 0.0 111.35 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.711 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 18.6 m-85 -114.03 -62.66 1.56 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.119 -0.988 . . . . 0.0 110.028 178.961 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.71 107.99 1.37 Allowed Glycine 0 N--CA 1.485 1.934 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -178.837 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 34.7 p -70.52 -53.42 16.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.165 -1.197 . . . . 0.0 109.764 179.452 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.419 ' N ' ' OG ' ' A' ' 11' ' ' SER . 28.2 mttp -148.07 51.78 1.03 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -141.1 -51.45 0.45 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.445 -0.784 . . . . 0.0 109.366 -178.442 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.475 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 0.1 OUTLIER -145.23 116.4 5.12 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.603 -0.686 . . . . 0.0 109.36 179.614 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.41 115.33 4.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.404 1.212 . . . . 0.0 111.033 -179.074 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.475 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 32.2 p80 -176.68 136.98 0.25 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.35 -0.844 . . . . 0.0 110.647 179.139 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.566 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.5 m-85 -122.33 154.5 37.56 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.727 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' HB2' ' CZ ' ' A' ' 9' ' ' PHE . 14.8 ttm180 -103.12 148.13 26.14 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 118.311 -1.356 . . . . 0.0 108.422 178.2 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.954 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -96.89 79.41 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 178.278 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.49 HG23 ' CB ' ' A' ' 35' ' ' LYS 0.282 0.4 OUTLIER -97.61 163.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-N 113.187 -1.824 . . . . 0.0 111.229 -173.569 . . . . . . . . 4 4 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.926 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -110.63 110.05 30.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.497 -0.752 . . . . 0.0 110.464 -177.529 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.6 t -139.94 -174.56 3.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.222 -0.924 . . . . 0.0 110.366 179.602 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.413 ' N ' ' OG1' ' A' ' 22' ' ' THR . 56.7 m-20 -111.46 160.19 17.35 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.451 -0.78 . . . . 0.0 110.106 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.94 25.95 6.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.292 -0.88 . . . . 0.0 110.216 -179.995 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.92 -60.36 2.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.243 -0.91 . . . . 0.0 110.531 -179.805 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -131.35 155.39 47.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.305 -0.872 . . . . 0.0 110.694 -179.504 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -125.19 34.52 4.94 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.457 -0.777 . . . . 0.0 109.966 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 -18.33 13.77 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.199 -0.938 . . . . 0.0 110.648 -179.755 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -108.69 -43.32 4.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.098 -1.001 . . . . 0.0 110.334 -179.873 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.87 90.99 0.12 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.43 128.7 9.79 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.35 -1.088 . . . . 0.0 110.178 -179.997 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 24.4 p90 -110.21 145.94 36.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.264 -0.898 . . . . 0.0 110.438 179.856 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG21 ' HH2' ' A' ' 59' ' ' TRP . 1.1 mt -58.91 -36.63 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.438 -0.789 . . . . 0.0 109.592 179.561 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.798 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.4 tt0 -170.57 138.71 1.51 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 110.074 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' CB ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -89.71 134.58 34.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.597 179.802 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.961 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -124.15 -22.75 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.054 -1.028 . . . . 0.0 111.35 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.915 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -124.86 162.96 19.0 Favored Glycine 0 C--N 1.3 -1.469 0 C-N-CA 118.766 -1.683 . . . . 0.0 110.959 179.987 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.446 ' N ' HG13 ' A' ' 19' ' ' ILE . 65.2 t80 -136.93 137.72 39.86 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.357 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 5.2 t80 -131.15 128.36 39.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.934 -1.103 . . . . 0.0 109.869 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 8.4 t0 -140.07 76.14 28.02 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 120.871 -1.143 . . . . 0.0 110.866 -179.675 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.46 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 42.3 Cg_endo -69.89 76.91 1.16 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.544 1.287 . . . . 0.0 110.957 -179.786 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -94.8 162.82 13.61 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.228 -0.92 . . . . 0.0 110.101 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -89.79 69.75 7.63 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.209 -0.932 . . . . 0.0 110.008 179.87 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 p -137.94 -67.32 0.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.926 . . . . 0.0 110.348 -179.899 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.0 p -146.37 158.31 47.53 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.308 -0.87 . . . . 0.0 110.342 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.56 62.37 6.29 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 O-C-N 123.736 1.388 . . . . 0.0 110.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -156.98 68.43 0.56 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.229 -0.92 . . . . 0.0 109.876 179.726 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.576 ' CZ3' ' CE1' ' A' ' 39' ' ' TYR . 5.7 p-90 -122.54 -14.72 7.73 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.322 -0.861 . . . . 0.0 111.092 -179.415 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.544 ' N ' ' CE3' ' A' ' 48' ' ' TRP . 5.5 tt -74.13 115.1 13.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.968 -1.082 . . . . 0.0 110.321 -179.295 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -130.9 90.36 2.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.25 -0.906 . . . . 0.0 109.881 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.954 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.5 t -115.76 139.95 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.033 -1.042 . . . . 0.0 111.025 -179.656 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 54' ' ' GLU . 10.5 t70 -85.25 71.79 10.81 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 175.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.623 ' CB ' HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -34.93 -31.34 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.415 0 O-C-N 122.312 -0.242 . . . . 0.0 111.526 -177.31 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' A' ' 52' ' ' ASP . 5.5 tt0 -62.74 -49.81 73.55 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.788 -1.195 . . . . 0.0 108.928 178.145 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.69 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.2 OUTLIER -75.42 -36.17 60.84 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.383 -0.823 . . . . 0.0 108.877 178.63 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.936 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -69.3 -20.35 63.89 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.393 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.455 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 14.2 tpt180 -85.6 -25.0 26.93 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 121.239 -0.913 . . . . 0.0 109.216 178.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 62' ' ' VAL . 4.8 t80 -60.12 -44.72 94.69 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 123.169 1.461 . . . . 0.0 107.503 178.563 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.024 ' CB ' HD11 ' A' ' 4' ' ' ILE . 69.2 m95 -68.32 -53.64 22.83 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 114.022 -1.444 . . . . 0.0 110.254 -179.089 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.565 HD12 HG11 ' A' ' 79' ' ' VAL . 23.4 mt -58.28 -19.44 34.54 Favored 'General case' 0 C--N 1.293 -1.884 0 C-N-CA 119.339 -0.944 . . . . 0.0 108.493 177.437 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 3.7 m -82.78 -22.75 34.17 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.334 -0.854 . . . . 0.0 110.724 179.798 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 59' ' ' TRP . 28.0 m -98.92 33.23 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.835 -1.165 . . . . 0.0 109.376 179.407 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.88 35.04 91.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 179.865 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -70.37 140.82 52.21 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.078 -1.248 . . . . 0.0 110.156 179.883 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -99.59 106.57 40.73 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.341 -0.849 . . . . 0.0 110.31 179.965 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.5 Cg_endo -81.67 142.66 12.97 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.404 1.213 . . . . 0.0 110.031 179.858 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.542 ' OG1' ' HB3' ' A' ' 70' ' ' ALA . 0.1 OUTLIER -64.15 -176.44 0.21 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.033 -1.042 . . . . 0.0 110.36 -179.762 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.53 -21.57 48.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.491 -179.623 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.1 m -101.76 -44.44 5.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.265 -0.897 . . . . 0.0 110.285 -179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.688 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.39 -29.03 69.1 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 67' ' ' THR . 46.5 ttt180 -64.41 -38.32 90.63 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.365 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -62.35 -29.86 70.76 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.24 -0.984 . . . . 0.0 108.675 178.776 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.688 HD12 ' HA ' ' A' ' 70' ' ' ALA . 49.7 mt -81.86 -33.57 30.53 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.857 -0.527 . . . . 0.0 110.0 179.609 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 97.0 mt -67.04 -27.47 67.42 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.001 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.521 ' HG3' ' CG ' ' A' ' 80' ' ' PHE . 7.3 mtp180 -82.19 -30.93 30.63 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.621 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 3.1 tp-100 -78.3 -33.44 49.35 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.898 0.856 . . . . 0.0 109.458 179.949 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -64.32 -12.83 45.87 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.93 178.414 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 90.74 43.5 4.8 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.989 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.623 HG22 ' CB ' ' A' ' 53' ' ' VAL . 29.3 t -107.61 -16.58 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.112 -1.228 . . . . 0.0 111.321 -179.548 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.521 ' CG ' ' HG3' ' A' ' 75' ' ' ARG . 6.9 m-85 -96.95 81.6 3.12 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.099 . . . . 0.0 110.261 -178.733 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -93.22 21.81 5.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 110.025 179.688 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -139.19 109.97 6.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 0.0 109.851 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -50.69 128.58 20.95 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.176 -0.953 . . . . 0.0 110.537 -179.764 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -119.67 164.03 16.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.337 -0.852 . . . . 0.0 110.076 179.849 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -140.76 -48.9 0.43 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.153 -0.967 . . . . 0.0 110.269 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -55.88 120.21 7.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.174 -0.954 . . . . 0.0 110.194 179.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 159.27 65.1 0.01 OUTLIER Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.299 -1.118 . . . . 0.0 110.163 179.935 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.288 0.566 . . . . 0.0 110.229 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.649 ' CG1' HG12 ' A' ' 21' ' ' VAL . 63.9 t -81.13 148.17 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.316 -0.865 . . . . 0.0 110.233 179.982 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' CD ' ' HB3' ' A' ' 65' ' ' GLN . 5.3 mmmm -140.48 130.62 24.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -0.958 . . . . 0.0 110.382 -179.646 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.873 ' CG1' HG13 ' A' ' 21' ' ' VAL . 31.6 mt -99.81 129.45 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.899 -1.126 . . . . 0.0 109.102 178.941 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.456 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 15.7 ptt180 -150.94 -174.96 4.95 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.125 -0.984 . . . . 0.0 110.812 -178.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.609 HD23 ' HB2' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -88.98 125.36 34.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.0 110.969 -179.715 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.676 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.53 111.23 23.61 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.511 -0.743 . . . . 0.0 110.104 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -80.04 120.33 24.06 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.972 -1.08 . . . . 0.0 112.044 -178.807 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.676 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 1.8 m-85 -118.68 -155.01 0.59 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 178.345 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.68 113.84 0.01 OUTLIER Glycine 0 N--CA 1.486 1.99 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 178.281 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 p -56.7 -47.73 79.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.082 -1.246 . . . . 0.0 109.321 179.203 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.04 48.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.688 -0.632 . . . . 0.0 109.513 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 23.9 m-70 -116.75 -60.72 1.81 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.388 -0.82 . . . . 0.0 109.689 -179.198 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -133.13 130.19 21.23 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.513 -0.742 . . . . 0.0 109.769 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.09 114.45 4.02 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.467 1.246 . . . . 0.0 111.077 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 34.4 p80 -160.35 126.81 4.21 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.261 -0.899 . . . . 0.0 110.245 178.98 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.609 ' HB2' HD23 ' A' ' 6' ' ' LEU . 8.7 m-85 -114.06 161.44 17.71 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.089 -1.007 . . . . 0.0 108.534 178.931 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.534 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 14.2 ttm180 -114.08 151.53 32.39 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 177.351 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.906 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -97.94 80.79 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 102.513 -3.144 . . . . 0.0 102.513 178.171 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.488 HG13 ' HB3' ' A' ' 32' ' ' TYR 0.27 0.4 OUTLIER -97.57 166.32 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.41 -173.459 . . . . . . . . 4 4 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.873 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -111.49 113.42 44.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.595 -0.691 . . . . 0.0 110.627 -177.251 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.407 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.3 t -136.03 -176.23 4.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 0.0 110.259 179.683 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.407 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.2 OUTLIER -91.58 -165.76 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.316 -0.865 . . . . 0.0 110.02 179.814 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -134.16 28.52 3.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.298 -0.876 . . . . 0.0 110.119 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.09 -79.73 0.38 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.329 -0.857 . . . . 0.0 110.833 -179.539 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.52 123.43 18.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -0.843 . . . . 0.0 110.625 -179.521 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.94 45.21 0.98 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.036 179.817 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.3 tpp180 -136.97 -50.52 0.65 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 110.296 -179.792 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -93.53 173.95 7.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.236 -0.915 . . . . 0.0 110.308 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -121.5 40.91 1.99 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 179.96 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.47 121.52 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.278 -1.131 . . . . 0.0 110.594 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.488 ' HB3' HG13 ' A' ' 20' ' ' VAL . 7.5 p90 -120.35 143.69 48.26 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.276 -0.89 . . . . 0.0 110.499 179.896 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.679 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.3 mp -55.08 -33.3 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.818 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.12 175.11 2.79 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.908 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.49 126.05 54.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.222 -0.924 . . . . 0.0 110.034 179.895 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.047 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.6 pp -120.3 -31.15 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.158 -0.964 . . . . 0.0 111.15 -179.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.933 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -118.43 156.35 15.69 Favored Glycine 0 C--N 1.298 -1.543 0 C-N-CA 118.901 -1.618 . . . . 0.0 111.014 -179.999 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -126.72 143.5 51.22 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 177.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.607 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 33.9 t80 -138.6 136.86 36.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.671 -1.268 . . . . 0.0 110.752 -179.602 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.6 t0 -140.39 102.83 6.61 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.064 -1.022 . . . . 0.0 110.047 179.336 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.444 ' HD3' ' CD1' ' A' ' 39' ' ' TYR . 48.0 Cg_endo -78.9 82.09 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.073 1.038 . . . . 0.0 110.574 -179.253 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.8 mtt180 -91.7 170.3 10.02 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.044 -1.035 . . . . 0.0 110.451 -179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.05 46.62 1.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.29 -0.882 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.3 p -143.81 -63.33 0.39 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.205 -0.934 . . . . 0.0 110.219 179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.1 p -126.01 144.12 47.72 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.303 -0.873 . . . . 0.0 110.213 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.491 ' HA ' ' CD1' ' A' ' 48' ' ' TRP . 46.4 Cg_endo -73.51 -8.72 22.06 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.67 1.353 . . . . 0.0 110.806 179.892 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.11 61.97 0.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.983 -1.073 . . . . 0.0 110.384 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.607 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 13.9 p-90 -121.88 -13.31 8.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.191 -0.943 . . . . 0.0 110.802 179.88 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.656 HD12 HD22 ' A' ' 73' ' ' LEU . 3.1 tt -81.01 117.91 22.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.883 -1.136 . . . . 0.0 110.293 -179.905 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -131.96 98.31 4.41 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.32 179.269 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.5 t -122.81 138.1 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 111.324 -179.039 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' A' ' 54' ' ' GLU . 7.5 t70 -83.35 72.12 10.23 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 175.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.721 HG23 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -35.15 -31.48 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 CA-C-O 120.631 0.253 . . . . 0.0 111.348 -177.409 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.445 ' N ' ' O ' ' A' ' 52' ' ' ASP . 17.4 mt-10 -60.5 -52.76 63.84 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.878 -1.138 . . . . 0.0 108.626 178.148 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.58 ' HB3' HG22 ' A' ' 36' ' ' ILE . 53.5 mmm-85 -72.82 -41.05 65.29 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 178.357 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.941 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -62.25 -18.36 60.98 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.088 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 6.3 ttp180 -88.85 -27.99 20.68 Favored 'General case' 0 N--CA 1.479 1.023 0 O-C-N 121.259 -0.901 . . . . 0.0 109.368 178.566 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.733 ' O ' HG13 ' A' ' 62' ' ' VAL . 2.5 t80 -59.82 -44.33 94.09 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 123.294 1.521 . . . . 0.0 107.545 178.598 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.047 ' CD1' HG21 ' A' ' 36' ' ' ILE . 74.7 m95 -68.4 -56.68 7.66 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.711 -1.586 . . . . 0.0 109.889 -178.91 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.052 HD11 HD13 ' A' ' 74' ' ' LEU . 35.0 mt -54.61 -21.67 11.14 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.006 -1.059 . . . . 0.0 108.647 177.429 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 24.4 t -80.92 -23.42 38.93 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.399 -0.813 . . . . 0.0 110.619 179.678 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 58' ' ' TYR . 6.0 m -98.95 32.19 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 O-C-N 120.805 -1.184 . . . . 0.0 109.568 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 73.0 24.47 75.89 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 179.68 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.475 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -72.02 101.47 2.73 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.918 -1.343 . . . . 0.0 109.83 179.805 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.439 ' HB3' ' CD ' ' A' ' 3' ' ' LYS . 1.7 tt0 -69.84 114.78 27.47 Favored Pre-proline 0 C--N 1.297 -1.701 0 C-N-CA 120.082 -0.647 . . . . 0.0 109.355 179.904 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.639 ' HB3' HD12 ' A' ' 74' ' ' LEU . 53.2 Cg_endo -82.2 124.94 4.45 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.599 1.315 . . . . 0.0 109.982 179.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.63 164.98 0.19 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.15 -0.969 . . . . 0.0 110.212 -179.921 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -59.1 -18.04 31.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 0.0 110.479 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.433 ' O ' ' HG ' ' A' ' 73' ' ' LEU . 1.4 m -95.89 -50.14 5.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.23 -0.919 . . . . 0.0 110.564 -179.826 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.68 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -68.06 -28.5 67.42 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.389 -0.819 . . . . 0.0 109.206 -179.555 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.41 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 8.2 ttp180 -66.86 -38.08 85.66 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.735 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.77 -23.94 65.28 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.069 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 70' ' ' ALA . 17.9 mt -90.96 -26.39 19.28 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.459 -0.776 . . . . 0.0 109.621 179.881 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.052 HD13 HD11 ' A' ' 60' ' ' LEU . 25.6 mt -69.76 -30.12 67.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.85 -29.16 44.41 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.141 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.42 ' HG2' HD13 ' A' ' 49' ' ' LEU . 5.8 tp-100 -73.34 -34.2 65.51 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 122.139 0.971 . . . . 0.0 108.516 178.902 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.502 ' HB2' ' HB ' ' A' ' 51' ' ' VAL . . . -72.12 -7.33 48.42 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.692 177.994 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 53' ' ' VAL . . . 83.65 50.07 4.6 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.589 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.721 HG22 HG23 ' A' ' 53' ' ' VAL . 40.6 t -112.45 10.67 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.197 -1.178 . . . . 0.0 111.442 -179.27 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 75' ' ' ARG . 12.1 m-85 -121.67 15.28 11.05 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.908 -1.12 . . . . 0.0 110.441 -179.785 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.29 -80.16 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.044 -1.035 . . . . 0.0 110.78 -179.526 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -96.93 158.5 15.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -0.99 . . . . 0.0 110.51 -179.434 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -148.48 178.55 8.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 0.0 110.159 -179.996 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.17 54.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.285 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -131.24 -43.55 1.05 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.248 -0.908 . . . . 0.0 110.138 -179.964 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.57 49.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.984 179.844 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -133.96 49.49 0.91 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.986 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.195 -1.179 . . . . 0.0 110.181 179.993 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.204 0.526 . . . . 0.0 110.139 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.662 HG11 ' CE3' ' A' ' 59' ' ' TRP . 61.4 t -89.75 140.6 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.324 -0.86 . . . . 0.0 110.089 179.939 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.793 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 28.7 mtpt -140.24 130.62 25.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 0.0 110.511 -179.904 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.964 ' CG1' HG13 ' A' ' 21' ' ' VAL . 77.9 mt -102.37 133.11 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.135 -0.978 . . . . 0.0 109.925 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 3.2 ptt85 -150.8 -165.48 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 110.394 -179.63 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 50.5 mt -89.26 132.65 34.8 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.008 -1.058 . . . . 0.0 110.931 -179.577 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -104.26 100.88 10.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.766 . . . . 0.0 110.564 179.708 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.521 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -71.32 119.61 15.7 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.321 -0.862 . . . . 0.0 111.169 -179.645 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.532 ' CZ ' ' HG3' ' A' ' 18' ' ' ARG . 33.6 m-85 -105.26 -63.94 1.18 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.24 -0.913 . . . . 0.0 110.487 179.217 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -50.26 130.3 28.95 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 -178.547 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' NH1' ' A' ' 8' ' ' ARG . 1.5 p -68.87 -42.78 76.57 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.39 -1.065 . . . . 0.0 109.504 179.389 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -175.62 36.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.662 0.744 . . . . 0.0 109.353 -179.732 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 10.8 m-70 -115.46 -59.68 1.97 Allowed 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.35 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.468 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 10.9 t-20 -123.81 113.82 28.47 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.061 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.09 109.28 2.79 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 O-C-N 123.387 1.204 . . . . 0.0 111.255 -179.006 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.471 ' ND1' ' O ' ' A' ' 16' ' ' HIS . 33.5 p80 -164.88 131.8 3.0 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.345 -0.847 . . . . 0.0 110.351 179.164 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.565 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.8 m-85 -122.55 155.01 37.13 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.549 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.532 ' HG3' ' CZ ' ' A' ' 9' ' ' PHE . 1.8 mmt180 -99.81 165.25 11.67 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.147 -1.421 . . . . 0.0 107.999 176.736 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.885 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -98.48 81.43 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.067 0 N-CA-C 102.821 -3.029 . . . . 0.0 102.821 177.244 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 4' ' ' ILE . 0.3 OUTLIER -97.4 166.75 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.681 -173.947 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.964 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.1 OUTLIER -111.84 108.65 26.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.748 -0.595 . . . . 0.0 110.947 -176.951 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t -138.93 -164.99 1.75 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.004 179.452 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.417 ' N ' ' OG1' ' A' ' 22' ' ' THR . 5.0 t70 -96.63 177.1 5.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.141 -0.975 . . . . 0.0 110.206 -179.942 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.793 ' HB2' ' HD3' ' A' ' 3' ' ' LYS . . . -117.07 -51.53 2.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -0.952 . . . . 0.0 110.165 179.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.51 -34.8 37.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.204 -0.935 . . . . 0.0 110.293 179.965 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? -89.96 98.16 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.274 -0.892 . . . . 0.0 110.038 179.818 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.68 -13.86 19.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 110.713 -179.737 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -83.69 -21.79 32.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.078 -1.014 . . . . 0.0 110.364 -179.836 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.68 -76.83 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.92 179.884 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.04 16.59 40.64 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 179.695 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -112.36 144.99 40.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.061 -1.258 . . . . 0.0 110.277 179.987 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 25.6 p90 -113.61 178.32 4.32 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.199 -0.938 . . . . 0.0 110.495 179.951 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.78 HD12 ' O ' ' A' ' 21' ' ' VAL . 3.0 mt -82.88 -45.2 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.745 . . . . 0.0 109.667 179.76 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -159.22 165.91 32.55 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.447 -0.783 . . . . 0.0 110.01 179.787 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' HD3' ' NE ' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -99.0 108.47 21.16 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.194 -0.941 . . . . 0.0 110.004 179.861 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.001 HG21 ' CD1' ' A' ' 59' ' ' TRP . 30.9 pt -101.51 -36.22 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.095 -1.003 . . . . 0.0 111.581 -179.566 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.809 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -125.95 172.04 17.78 Favored Glycine 0 C--N 1.296 -1.645 0 C-N-CA 118.758 -1.687 . . . . 0.0 112.868 -177.934 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 18' ' ' ARG . 77.9 t80 -141.11 133.26 27.93 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.237 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.885 ' HB2' HD11 ' A' ' 19' ' ' ILE . 6.1 t80 -132.12 133.46 44.32 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.567 -1.333 . . . . 0.0 110.394 178.853 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 5.9 t0 -140.26 100.96 6.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.948 . . . . 0.0 109.724 179.138 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.69 82.78 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.569 1.3 . . . . 0.0 111.026 -179.315 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.843 ' NH2' HG21 ' A' ' 45' ' ' THR . 19.5 mtp180 -89.94 155.24 19.25 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.381 -0.824 . . . . 0.0 109.851 179.509 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.5 49.35 0.86 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.332 -179.987 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.516 HG23 ' N ' ' A' ' 45' ' ' THR . 6.9 t -149.86 -41.6 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.028 -1.045 . . . . 0.0 110.795 -179.881 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.843 HG21 ' NH2' ' A' ' 42' ' ' ARG . 3.9 t -110.25 152.74 43.38 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.028 -1.045 . . . . 0.0 110.686 -179.571 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.96 -49.03 0.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 O-C-N 123.751 1.395 . . . . 0.0 110.19 179.701 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.89 105.29 8.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 -179.98 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.734 ' HZ3' HD13 ' A' ' 49' ' ' LEU . 1.6 p-90 -126.58 17.11 7.55 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.314 -0.867 . . . . 0.0 110.597 -179.954 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.734 HD13 ' HZ3' ' A' ' 48' ' ' TRP . 10.9 tp -120.78 130.71 54.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.932 -1.105 . . . . 0.0 111.028 -179.607 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 21.0 tttp -128.4 92.64 3.47 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.134 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.809 HG22 ' HA3' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -115.84 149.07 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.026 -1.046 . . . . 0.0 111.29 -179.025 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' O ' ' N ' ' A' ' 54' ' ' GLU . 3.9 t0 -93.31 67.04 4.06 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 175.765 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -32.05 -33.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.484 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.667 -177.334 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -60.34 -53.33 58.91 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.995 178.537 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 25.7 mmm180 -71.7 -41.87 68.08 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.308 -0.87 . . . . 0.0 108.66 178.525 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -61.99 -18.68 61.26 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.222 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.452 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 9.2 ttt-85 -88.27 -27.2 21.89 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.326 -0.859 . . . . 0.0 109.508 178.167 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.808 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -59.49 -45.4 91.81 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 123.234 1.493 . . . . 0.0 107.564 178.637 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.001 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.5 m95 -66.38 -54.82 19.96 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 113.77 -1.559 . . . . 0.0 109.511 -178.923 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.665 HD11 HD13 ' A' ' 74' ' ' LEU . 9.1 mt -55.6 -21.49 17.73 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 119.255 -0.978 . . . . 0.0 108.533 177.081 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 10.8 t -82.57 -20.74 35.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.423 -0.798 . . . . 0.0 110.622 179.687 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.808 HG13 ' O ' ' A' ' 58' ' ' TYR . 4.5 m -99.12 32.2 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 O-C-N 120.929 -1.107 . . . . 0.0 109.48 179.825 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.44 27.36 72.77 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' A' ' 59' ' ' TRP . . . -68.07 142.52 55.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.036 -1.273 . . . . 0.0 109.755 179.755 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -110.62 109.4 57.97 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 110.645 -179.699 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.46 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 52.6 Cg_endo -80.21 125.41 5.81 Favored 'Trans proline' 0 C--N 1.313 -1.316 0 O-C-N 123.586 1.308 . . . . 0.0 109.815 179.339 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.8 t -56.91 178.87 0.05 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.007 -1.058 . . . . 0.0 110.539 -179.819 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.74 54.22 1.48 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.124 -0.985 . . . . 0.0 109.781 179.172 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.3 m -165.64 -58.3 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -179.761 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.642 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -66.48 -23.7 66.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.026 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.4 ttm180 -69.17 -41.79 76.75 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.157 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.2 mtt180 -65.78 -41.47 91.97 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.652 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.66 ' HB3' HD21 ' A' ' 49' ' ' LEU . 13.9 mt -69.97 -28.16 65.32 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 178.493 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.665 HD13 HD11 ' A' ' 60' ' ' LEU . 12.8 mt -68.82 -29.05 67.31 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 177.514 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.532 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -80.12 -30.77 39.11 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.421 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.95 -31.34 34.93 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.847 0.832 . . . . 0.0 109.877 -179.868 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.511 ' HB1' ' HB ' ' A' ' 51' ' ' VAL . . . -70.52 -6.83 39.1 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.051 178.863 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 80.45 48.6 6.24 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.791 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 53' ' ' VAL . 48.4 t -100.64 -62.18 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 121.206 -1.173 . . . . 0.0 111.461 -179.385 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.532 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 5.6 m-30 -52.74 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.077 -1.015 . . . . 0.0 110.225 -179.234 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' A' ' 79' ' ' VAL . 58.6 mtt180 -153.78 -165.56 2.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.0 110.16 -179.998 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -126.22 64.26 1.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.148 -0.97 . . . . 0.0 110.217 -179.913 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -100.44 73.44 1.65 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.252 -179.97 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -120.63 -159.84 0.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.0 110.438 -179.937 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.57 -14.29 49.26 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.346 -0.846 . . . . 0.0 110.469 -179.84 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.64 -54.07 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.046 -1.034 . . . . 0.0 110.208 179.957 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -131.84 -92.69 0.56 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.943 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.155 -1.203 . . . . 0.0 110.183 -179.97 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.308 0.575 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.617 HG11 ' CE3' ' A' ' 59' ' ' TRP . 70.3 t -58.67 132.51 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.283 -0.886 . . . . 0.0 110.146 -179.965 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.465 ' HG3' ' CB ' ' A' ' 65' ' ' GLN . 0.0 OUTLIER -140.19 135.33 32.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.2 -0.938 . . . . 0.0 110.352 -179.835 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.005 ' CG1' HG13 ' A' ' 21' ' ' VAL . 86.2 mt -102.86 135.34 40.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.038 -1.039 . . . . 0.0 109.737 179.433 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 8.7 ptm180 -151.38 -168.78 3.19 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.334 -0.854 . . . . 0.0 110.622 -179.373 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.703 HD12 ' HB2' ' A' ' 70' ' ' ALA . 7.0 mp -89.45 127.25 35.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.3 -0.875 . . . . 0.0 110.455 179.916 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -102.21 108.92 20.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.573 -0.705 . . . . 0.0 110.479 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.488 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 2.8 ttt180 -82.02 113.57 20.0 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.052 -1.03 . . . . 0.0 111.688 -179.468 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.498 ' HB2' ' CE1' ' A' ' 16' ' ' HIS . 11.3 m-85 -100.38 -62.96 1.17 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.067 -1.021 . . . . 0.0 109.821 178.43 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.66 124.93 33.33 Favored Glycine 0 N--CA 1.481 1.683 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -178.495 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.8 p -52.31 -40.23 61.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.167 -1.196 . . . . 0.0 109.851 179.405 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.64 -35.48 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.191 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -44.37 -64.61 0.65 Allowed 'General case' 0 N--CA 1.51 2.533 0 CA-C-O 121.601 0.715 . . . . 0.0 109.489 -179.634 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -106.68 96.0 13.34 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.586 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.05 96.17 0.45 Allowed 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.788 1.415 . . . . 0.0 111.271 -178.636 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 29.9 p80 -150.75 134.87 16.86 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.397 -0.814 . . . . 0.0 110.284 178.994 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.0 m-85 -121.32 -179.27 4.01 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.247 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' HB2' ' HZ ' ' A' ' 9' ' ' PHE . 70.7 mtt180 -131.99 157.15 44.83 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 176.686 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.77 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -98.07 81.86 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.07 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 177.622 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 32' ' ' TYR 0.254 0.4 OUTLIER -97.72 168.25 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 114.948 -1.024 . . . . 0.0 111.639 -173.785 . . . . . . . . 4 4 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.005 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -113.37 108.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.69 -0.631 . . . . 0.0 110.658 -177.087 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 3.1 t -140.19 -165.85 1.99 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 179.387 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' N ' ' OG1' ' A' ' 22' ' ' THR . 25.4 t0 -109.05 117.91 35.41 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 110.041 179.84 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.57 -47.37 82.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.239 -0.913 . . . . 0.0 110.353 -179.882 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.83 -29.92 21.36 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.138 -0.976 . . . . 0.0 110.494 -179.811 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.26 85.25 6.57 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 0.0 110.044 179.805 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -104.9 78.27 1.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 0.0 110.422 -179.825 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -169.9 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 110.249 179.8 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -60.98 -23.79 65.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.3 -0.875 . . . . 0.0 110.099 179.906 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.02 47.99 76.53 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 179.887 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -123.14 137.05 55.01 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.21 -1.171 . . . . 0.0 110.179 179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.476 ' CD2' HG21 ' A' ' 20' ' ' VAL . 5.3 p90 -110.17 -173.82 2.34 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.203 -0.936 . . . . 0.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.647 HG21 ' HH2' ' A' ' 59' ' ' TRP . 56.3 mt -93.58 -36.31 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.503 -0.748 . . . . 0.0 110.002 -179.876 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.12 167.82 15.98 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.904 -179.958 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' CG ' ' O ' ' A' ' 35' ' ' LYS . 4.2 pttp -102.05 111.7 24.08 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.284 -0.885 . . . . 0.0 110.267 179.902 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.965 HG21 ' CD1' ' A' ' 59' ' ' TRP . 32.2 pt -107.41 -35.21 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.912 -1.117 . . . . 0.0 111.244 -179.648 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.815 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.78 168.05 15.1 Favored Glycine 0 C--N 1.296 -1.648 0 C-N-CA 118.959 -1.591 . . . . 0.0 112.254 -177.887 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.448 ' N ' HG12 ' A' ' 19' ' ' ILE . 90.8 t80 -141.36 125.9 17.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 177.571 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.77 ' HB2' HD11 ' A' ' 19' ' ' ILE . 10.9 t80 -120.66 130.12 53.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.813 -1.179 . . . . 0.0 109.43 179.6 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 14.8 t0 -140.68 82.14 16.12 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 120.293 -1.504 . . . . 0.0 111.633 179.851 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 44.1 Cg_endo -71.24 76.65 1.71 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.343 1.181 . . . . 0.0 110.647 179.439 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.92 -178.91 4.96 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.2 -0.938 . . . . 0.0 110.307 -179.968 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -111.73 50.77 0.82 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.203 -0.936 . . . . 0.0 110.036 -179.972 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 22.5 p -134.81 -49.79 0.76 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.496 -179.743 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.7 t -144.98 152.4 51.49 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 110.124 -179.911 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.83 -11.32 21.8 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.75 1.395 . . . . 0.0 110.694 -179.885 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -80.43 74.89 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.817 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.512 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 10.9 p-90 -117.69 -21.17 8.61 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.18 -0.95 . . . . 0.0 110.509 179.841 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.512 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.3 tt -75.01 112.62 11.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.285 -0.885 . . . . 0.0 110.438 -179.852 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -133.93 95.66 3.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.288 -0.882 . . . . 0.0 109.5 179.393 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.815 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -117.57 143.53 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.176 -0.953 . . . . 0.0 111.411 -179.102 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.2 t70 -87.95 70.16 9.44 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 176.389 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.588 ' HB ' HG22 ' A' ' 79' ' ' VAL . 0.1 OUTLIER -34.11 -32.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -177.486 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -61.47 -57.18 13.22 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.7 -1.25 . . . . 0.0 108.818 178.526 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.651 ' HD3' HG22 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -67.64 -41.3 84.1 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.443 -0.785 . . . . 0.0 108.998 178.538 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.836 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.5 -19.35 65.53 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.615 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.9 ttt180 -89.17 -22.26 22.89 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 121.222 -0.924 . . . . 0.0 109.806 178.501 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.939 ' O ' HG13 ' A' ' 62' ' ' VAL . 5.3 t80 -59.95 -44.64 94.27 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 123.25 1.5 . . . . 0.0 107.14 178.282 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.965 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.0 m95 -68.43 -58.22 4.67 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 113.605 -1.634 . . . . 0.0 109.909 -179.185 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.744 HD11 HD13 ' A' ' 74' ' ' LEU . 30.6 mt -53.13 -23.57 8.44 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 119.363 -0.935 . . . . 0.0 108.586 177.474 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 19.5 m -80.87 -21.33 40.77 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.484 -0.76 . . . . 0.0 110.348 179.287 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.939 HG13 ' O ' ' A' ' 58' ' ' TYR . 3.5 m -99.12 31.88 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.872 -1.143 . . . . 0.0 109.47 179.684 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.91 24.9 75.94 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.972 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -68.15 138.59 55.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.916 -1.343 . . . . 0.0 110.264 -179.983 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.465 ' CB ' ' HG3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -105.47 107.87 60.16 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.228 -0.92 . . . . 0.0 110.152 179.912 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.468 ' HB3' HD12 ' A' ' 74' ' ' LEU . 56.2 Cg_endo -82.38 132.01 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.474 1.25 . . . . 0.0 110.484 179.982 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 71' ' ' ARG . 1.1 p -58.97 166.27 2.07 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.101 -1.0 . . . . 0.0 109.692 179.417 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -59.17 -26.31 64.67 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.985 -1.072 . . . . 0.0 110.913 -179.67 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 8.4 m -84.87 -51.8 6.48 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.159 -0.963 . . . . 0.0 110.482 -179.879 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.809 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -70.15 -25.42 63.45 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.441 -0.787 . . . . 0.0 108.942 179.981 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 67' ' ' THR . 8.1 ttm180 -69.39 -36.09 76.44 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.131 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -40.98 92.49 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.557 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.809 HD12 ' HA ' ' A' ' 70' ' ' ALA . 16.2 mt -69.29 -28.08 65.98 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.267 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.744 HD13 HD11 ' A' ' 60' ' ' LEU . 25.0 mt -73.18 -27.03 61.4 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 177.468 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.523 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.6 -29.93 29.84 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.117 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -84.37 -31.07 24.94 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 121.859 0.837 . . . . 0.0 110.045 179.93 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.455 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -70.6 -7.9 47.62 Favored 'General case' 0 C--N 1.29 -1.989 0 O-C-N 121.772 -0.58 . . . . 0.0 109.829 178.667 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.09 50.3 4.64 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.691 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.588 HG22 ' HB ' ' A' ' 53' ' ' VAL . 21.8 t -102.74 -59.87 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.119 -1.224 . . . . 0.0 111.206 -179.696 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 2.9 m-30 -56.41 -33.27 65.63 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.019 -1.05 . . . . 0.0 109.603 -179.6 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -80.21 -168.65 1.74 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.387 -0.821 . . . . 0.0 110.216 -179.602 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -111.94 -174.18 2.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.305 -0.872 . . . . 0.0 110.016 179.892 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -51.82 147.72 6.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.239 -0.913 . . . . 0.0 110.157 179.836 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -144.74 111.29 5.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.267 -0.896 . . . . 0.0 110.268 -179.951 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.96 42.45 0.78 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.28 -0.887 . . . . 0.0 110.322 -179.93 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -102.87 77.57 1.59 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.236 -0.915 . . . . 0.0 110.277 179.987 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -116.89 -168.79 14.91 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.829 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.202 -1.176 . . . . 0.0 110.227 -179.905 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.304 0.573 . . . . 0.0 110.116 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' ALA . 46.8 t -62.43 116.31 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.232 -0.918 . . . . 0.0 110.177 179.944 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -140.81 141.19 34.77 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.108 -0.995 . . . . 0.0 110.521 -179.775 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.909 HD11 ' CB ' ' A' ' 59' ' ' TRP . 91.0 mt -108.57 131.11 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.055 -1.028 . . . . 0.0 109.462 178.97 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -151.2 -175.68 5.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.177 -0.952 . . . . 0.0 110.69 -179.138 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.533 HD11 HD12 ' A' ' 73' ' ' LEU . 3.9 mp -88.72 122.41 32.11 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.06 -179.944 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 17' ' ' TYR . . . -99.95 107.15 19.05 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.35 -0.844 . . . . 0.0 112.055 -178.561 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -57.21 127.79 33.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.653 179.036 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.582 ' HB2' ' CE1' ' A' ' 16' ' ' HIS . 27.6 m-85 -101.65 -79.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.451 -0.781 . . . . 0.0 111.834 -178.588 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -52.04 168.14 0.73 Allowed Glycine 0 N--CA 1.482 1.756 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -177.901 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.2 p -85.56 -42.7 14.15 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.559 -0.965 . . . . 0.0 109.755 179.682 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.07 47.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.619 -0.676 . . . . 0.0 109.981 -179.562 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -125.83 -64.36 1.06 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.435 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 20.0 m-20 -118.3 106.56 44.71 Favored Pre-proline 0 C--N 1.304 -1.398 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.606 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' O ' ' CD ' ' A' ' 41' ' ' PRO . 43.8 Cg_endo -70.15 66.45 2.0 Allowed 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.503 1.265 . . . . 0.0 112.667 -177.893 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 23.3 p80 -109.95 134.83 51.68 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.93 -1.106 . . . . 0.0 109.441 177.987 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 10.2 m-85 -117.82 157.84 25.87 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.272 -0.893 . . . . 0.0 109.069 179.74 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.554 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.5 153.52 18.96 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.777 -1.169 . . . . 0.0 108.645 177.303 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.031 HD11 ' HB2' ' A' ' 39' ' ' TYR . 1.2 mm -97.67 73.21 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 101.56 -3.496 . . . . 0.0 101.56 176.336 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.258 0.4 OUTLIER -97.59 162.1 2.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 113.914 -1.493 . . . . 0.0 112.093 -173.053 . . . . . . . . 4 4 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.821 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.15 114.32 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.439 0.638 . . . . 0.0 111.441 -176.883 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.418 ' OG1' ' N ' ' A' ' 23' ' ' ASP . 1.2 t -140.03 -173.03 3.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.432 -0.793 . . . . 0.0 109.603 178.888 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.418 ' N ' ' OG1' ' A' ' 22' ' ' THR . 15.6 p30 -104.66 176.25 5.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.178 -0.951 . . . . 0.0 110.323 -179.841 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.16 22.51 15.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.202 -0.936 . . . . 0.0 110.528 -179.621 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -77.88 0.06 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.179 -0.951 . . . . 0.0 110.248 179.943 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.61 130.94 54.28 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.258 -0.901 . . . . 0.0 110.169 179.966 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.5 mttt -101.45 44.84 0.99 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.171 -0.956 . . . . 0.0 110.329 -179.979 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.34 -60.4 1.89 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 110.106 179.885 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -71.68 -71.5 0.27 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.895 . . . . 0.0 110.211 179.936 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.74 28.87 3.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.976 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.66 136.54 54.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -1.138 . . . . 0.0 110.33 -179.885 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' CE2' ' HG3' ' A' ' 35' ' ' LYS . 11.9 p90 -122.5 177.66 5.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.367 -0.833 . . . . 0.0 110.549 -179.851 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.648 HG21 ' HH2' ' A' ' 59' ' ' TRP . 14.8 mt -88.45 -31.75 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.514 -0.741 . . . . 0.0 109.878 179.858 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -175.48 157.14 2.07 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.487 -0.758 . . . . 0.0 109.877 -179.88 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' HA ' HG23 ' A' ' 20' ' ' VAL . 36.3 mtmt -93.85 109.85 21.53 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.148 -0.97 . . . . 0.0 110.361 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.911 HG21 ' CD1' ' A' ' 59' ' ' TRP . 29.0 pt -100.0 -35.62 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.201 -0.937 . . . . 0.0 110.859 179.861 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.858 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -126.13 166.38 18.92 Favored Glycine 0 C--N 1.296 -1.666 0 C-N-CA 119.121 -1.514 . . . . 0.0 112.017 -178.453 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.473 ' N ' HG12 ' A' ' 19' ' ' ILE . 84.8 t80 -141.01 137.07 32.71 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 177.808 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.031 ' HB2' HD11 ' A' ' 19' ' ' ILE . 16.3 t80 -127.08 131.02 50.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.632 -1.292 . . . . 0.0 109.296 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 17.8 t0 -140.67 107.13 6.45 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.741 -1.224 . . . . 0.0 111.31 179.917 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' CD ' ' O ' ' A' ' 15' ' ' PRO . 54.4 Cg_endo -86.75 39.15 0.6 Allowed 'Trans proline' 0 C--N 1.315 -1.225 0 O-C-N 123.521 1.274 . . . . 0.0 110.69 179.089 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.7 ttt180 -89.69 -135.92 0.11 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.026 -1.046 . . . . 0.0 109.77 -179.798 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.481 ' C ' HG23 ' A' ' 44' ' ' THR . 5.6 mttt -70.99 62.04 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.736 -1.227 . . . . 0.0 109.246 179.378 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.481 HG23 ' C ' ' A' ' 43' ' ' LYS . 56.5 p -150.94 96.4 2.33 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.431 -0.793 . . . . 0.0 109.387 -179.602 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' A' ' 46' ' ' PRO . 8.9 m -88.67 -43.23 0.46 Allowed Pre-proline 0 C--N 1.295 -1.776 0 O-C-N 121.191 -0.943 . . . . 0.0 110.544 -179.824 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' A' ' 45' ' ' THR . 51.3 Cg_endo -91.45 -55.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.046 1.024 . . . . 0.0 110.654 179.603 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' A' ' 44' ' ' THR . 7.9 m-20 -101.62 90.47 4.06 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.355 -0.841 . . . . 0.0 110.352 -179.429 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.781 ' HZ3' HD23 ' A' ' 49' ' ' LEU . 27.3 p-90 -129.3 5.54 5.26 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.434 -0.792 . . . . 0.0 110.831 -179.793 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.781 HD23 ' HZ3' ' A' ' 48' ' ' TRP . 1.6 tm? -118.23 123.47 45.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.89 -1.131 . . . . 0.0 110.508 179.998 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.618 ' N ' HD13 ' A' ' 49' ' ' LEU . 11.6 tttm -125.7 97.6 5.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.571 -0.706 . . . . 0.0 109.111 179.175 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.858 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.1 t -124.06 144.22 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.031 -1.043 . . . . 0.0 111.396 -178.953 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 54' ' ' GLU . 8.3 t0 -87.66 70.27 9.7 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 105.925 -1.88 . . . . 0.0 105.925 175.794 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.615 HG23 HG22 ' A' ' 79' ' ' VAL . 0.7 OUTLIER -35.33 -30.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.471 -177.655 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' N ' ' O ' ' A' ' 52' ' ' ASP . 10.6 mt-10 -62.18 -54.74 36.7 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.909 -1.119 . . . . 0.0 108.967 178.092 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.502 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 3.4 mtm-85 -74.15 -33.57 63.57 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.337 -0.852 . . . . 0.0 109.186 178.951 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.901 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -68.24 -24.69 64.94 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.212 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.441 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -84.35 -22.94 30.38 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 121.351 -0.843 . . . . 0.0 109.764 178.285 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.502 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 0.1 OUTLIER -61.65 -51.76 67.13 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.192 1.472 . . . . 0.0 107.722 178.909 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.911 ' CD1' HG21 ' A' ' 36' ' ' ILE . 82.9 m95 -59.81 -53.75 54.33 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 113.925 -1.489 . . . . 0.0 109.899 -179.183 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.962 HD11 HD13 ' A' ' 74' ' ' LEU . 9.8 mt -55.2 -20.06 9.66 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.559 177.094 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 1.1 t -81.56 -21.29 38.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.289 -0.882 . . . . 0.0 110.682 179.279 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.693 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.2 m -98.88 32.98 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 O-C-N 120.816 -1.177 . . . . 0.0 109.813 179.968 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.18 28.04 72.06 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.965 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -73.39 122.62 22.36 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.183 -1.187 . . . . 0.0 110.109 179.974 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.54 112.49 48.79 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.283 -0.886 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.731 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.8 Cg_endo -82.12 127.31 5.28 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.518 1.273 . . . . 0.0 110.066 179.868 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.59 167.39 0.14 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.082 -1.011 . . . . 0.0 109.789 179.677 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -59.33 -17.35 28.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.15 -0.969 . . . . 0.0 110.735 -179.626 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.442 ' HB ' HD13 ' A' ' 6' ' ' LEU . 1.0 OUTLIER -99.06 -49.57 4.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.268 -0.895 . . . . 0.0 110.346 -179.868 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.587 ' HB2' ' HA ' ' A' ' 5' ' ' ARG . . . -66.7 -23.08 66.07 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.335 -0.853 . . . . 0.0 109.026 -179.961 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.459 ' CA ' ' HB2' ' A' ' 66' ' ' PRO . 7.5 tmm_? -71.75 -41.35 68.55 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -38.28 83.6 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.291 -0.963 . . . . 0.0 108.962 178.847 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.568 HD22 ' HZ3' ' A' ' 48' ' ' TRP . 28.5 mt -72.62 -27.05 61.91 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.513 -0.742 . . . . 0.0 109.15 179.192 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.962 HD13 HD11 ' A' ' 60' ' ' LEU . 15.0 mt -72.37 -29.57 63.9 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 177.763 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.452 ' HG3' ' CE1' ' A' ' 80' ' ' PHE . 1.4 tmm_? -79.59 -31.88 41.85 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 177.548 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.31 -26.81 47.07 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 122.016 0.913 . . . . 0.0 109.218 178.69 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.705 ' HB1' ' CG1' ' A' ' 51' ' ' VAL . . . -70.67 -7.74 46.73 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.117 178.983 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 93.78 16.51 45.0 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.99 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.615 HG22 HG23 ' A' ' 53' ' ' VAL . 22.2 t -77.12 -66.27 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.977 -1.308 . . . . 0.0 109.826 179.728 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.452 ' CE1' ' HG3' ' A' ' 75' ' ' ARG . 15.9 p90 -129.37 60.74 1.56 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.349 -0.844 . . . . 0.0 110.431 179.331 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -60.67 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.22 -0.925 . . . . 0.0 109.879 179.507 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -149.39 122.85 9.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.021 -1.049 . . . . 0.0 110.429 179.979 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -129.74 104.42 7.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.0 109.974 179.784 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -94.16 157.41 16.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.298 -179.851 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -177.43 70.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.255 -0.903 . . . . 0.0 110.292 179.941 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -178.63 60.75 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 179.959 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -82.13 69.48 3.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.867 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.339 -1.095 . . . . 0.0 110.315 179.896 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 mtt . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.249 0.547 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.465 HG11 ' CE3' ' A' ' 59' ' ' TRP . 92.8 t -80.0 131.56 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.24 -179.959 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -140.77 142.49 34.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.217 -0.927 . . . . 0.0 110.282 179.924 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.909 HD11 ' CB ' ' A' ' 59' ' ' TRP . 73.8 mt -109.92 134.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.035 -1.041 . . . . 0.0 109.825 179.382 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.27 -171.21 3.87 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.948 -1.095 . . . . 0.0 110.766 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 70' ' ' ALA . 7.1 mp -89.01 126.4 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.317 -0.864 . . . . 0.0 110.519 -179.816 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.679 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.92 106.31 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.392 -0.818 . . . . 0.0 110.767 -179.634 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.525 ' CG ' ' CE2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -75.77 119.0 19.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.822 -1.174 . . . . 0.0 111.43 -179.714 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.679 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 9.0 m-85 -113.68 -63.5 1.44 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.139 -0.975 . . . . 0.0 110.463 178.935 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -48.2 115.25 2.29 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.449 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.464 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 36.2 p -81.18 -60.86 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -1.148 . . . . 0.0 109.665 179.488 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.464 ' N ' ' OG ' ' A' ' 11' ' ' SER . 12.9 mtmt -141.91 41.26 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.508 -0.745 . . . . 0.0 109.035 -179.876 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.45 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.6 m-70 -128.23 -44.68 1.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.796 0.808 . . . . 0.0 109.137 -178.672 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -162.88 117.29 1.15 Allowed Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.718 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.49 107.39 2.28 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.304 1.16 . . . . 0.0 111.359 -178.93 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 33.6 p80 -153.14 131.39 11.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.415 -0.803 . . . . 0.0 110.124 178.945 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.533 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.4 m-85 -117.54 155.49 29.7 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.864 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.528 ' C ' HD13 ' A' ' 19' ' ' ILE . 16.7 mtt-85 -108.75 160.47 15.94 Favored 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 118.256 -1.378 . . . . 0.0 107.988 176.678 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.994 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -98.62 81.53 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.033 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 177.643 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 35' ' ' LYS . 0.4 OUTLIER -97.32 164.38 2.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.611 -173.856 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.92 HG21 ' CD1' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -110.09 109.98 30.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.76 -0.587 . . . . 0.0 110.181 -177.483 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 5.7 t -140.06 -158.69 0.88 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.234 -0.916 . . . . 0.0 110.184 179.818 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.404 ' N ' ' OG1' ' A' ' 22' ' ' THR . 0.3 OUTLIER -96.72 162.9 13.23 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 0.0 109.939 179.658 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.64 -48.49 74.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.211 -0.93 . . . . 0.0 110.547 -179.706 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -164.14 123.54 1.98 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.223 -0.923 . . . . 0.0 110.317 -179.916 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -129.13 156.18 44.29 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.24 -0.912 . . . . 0.0 109.968 179.869 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.82 -1.04 33.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.218 -0.926 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -97.54 -43.5 7.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.953 -1.092 . . . . 0.0 110.362 -179.839 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -172.77 167.61 5.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.294 -0.879 . . . . 0.0 110.147 -179.971 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -124.0 58.92 0.63 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.954 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 105.18 16.27 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -1.165 . . . . 0.0 110.157 179.925 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HB3' ' HB ' ' A' ' 22' ' ' THR . 6.3 p90 -51.86 172.55 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.271 -0.893 . . . . 0.0 110.699 -179.867 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.724 HG21 ' HH2' ' A' ' 59' ' ' TRP . 2.6 mp -83.7 -33.06 9.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.616 -0.678 . . . . 0.0 109.367 179.383 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.21 156.06 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.559 -0.713 . . . . 0.0 109.688 179.472 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.475 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -91.87 111.34 22.84 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.388 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.033 HG21 ' CD1' ' A' ' 59' ' ' TRP . 2.8 pp -102.42 -26.93 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.203 -0.935 . . . . 0.0 110.59 179.482 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.886 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -123.39 165.96 15.97 Favored Glycine 0 C--N 1.297 -1.637 0 C-N-CA 119.173 -1.489 . . . . 0.0 111.925 -179.468 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.479 ' N ' HG12 ' A' ' 19' ' ' ILE . 6.5 t80 -140.86 132.9 27.82 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.901 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.994 ' HB2' HD11 ' A' ' 19' ' ' ILE . 15.0 t80 -130.7 140.61 50.37 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.754 -1.216 . . . . 0.0 109.877 179.913 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 29.8 t0 -140.34 93.24 9.01 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 120.869 -1.145 . . . . 0.0 109.863 179.051 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 40.9 Cg_endo -67.17 82.27 0.36 Allowed 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.285 1.15 . . . . 0.0 111.014 -179.184 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -104.54 156.6 17.82 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.338 -0.851 . . . . 0.0 110.246 179.73 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -106.94 60.71 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.208 -0.933 . . . . 0.0 110.394 179.939 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 37.5 p -140.16 -81.01 0.27 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.127 -0.983 . . . . 0.0 110.141 179.932 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.3 p -118.14 149.37 45.51 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.872 . . . . 0.0 110.025 179.899 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.44 61.26 3.46 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.675 1.355 . . . . 0.0 110.445 -179.964 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -142.1 60.49 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.239 -0.913 . . . . 0.0 110.19 -180.0 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 7.7 p-90 -123.39 -11.37 7.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.152 -0.968 . . . . 0.0 110.971 -179.949 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.472 ' HB2' ' CZ3' ' A' ' 48' ' ' TRP . 6.3 tt -84.58 116.25 23.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.939 -1.101 . . . . 0.0 110.229 179.903 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.46 88.99 2.46 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.289 -0.882 . . . . 0.0 109.867 179.908 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.886 HG22 ' CA ' ' A' ' 37' ' ' GLY . 1.4 t -115.53 130.41 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.004 -1.06 . . . . 0.0 111.197 -179.484 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 2.1 t70 -75.32 71.42 2.3 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 176.016 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.569 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -34.18 -31.75 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.681 -177.45 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 39.9 tt0 -62.12 -51.94 65.85 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.667 -1.271 . . . . 0.0 108.851 178.136 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.667 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -71.41 -39.18 71.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.827 . . . . 0.0 109.016 178.701 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.906 ' CB ' HD13 ' A' ' 36' ' ' ILE . . . -66.99 -19.53 65.73 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.335 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.456 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.1 ttp85 -87.18 -25.73 23.91 Favored 'General case' 0 N--CA 1.481 1.109 0 O-C-N 121.402 -0.811 . . . . 0.0 109.377 178.755 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.673 ' O ' HG13 ' A' ' 62' ' ' VAL . 7.9 t80 -59.32 -45.9 90.07 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 123.231 1.491 . . . . 0.0 107.519 178.539 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.033 ' CD1' HG21 ' A' ' 36' ' ' ILE . 70.9 m95 -66.89 -56.95 8.04 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 113.824 -1.535 . . . . 0.0 109.415 -179.452 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 79' ' ' VAL . 12.7 mt -53.67 -22.83 9.71 Favored 'General case' 0 C--N 1.293 -1.85 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.572 177.327 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.59 -23.28 49.95 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.465 -0.772 . . . . 0.0 110.234 179.28 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.717 HG22 ' O ' ' A' ' 59' ' ' TRP . 5.4 m -98.88 32.54 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 O-C-N 120.898 -1.126 . . . . 0.0 109.509 179.873 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.43 22.33 77.69 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.901 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -63.53 134.59 55.82 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.979 -1.306 . . . . 0.0 110.156 -179.979 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -105.83 110.0 63.71 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.243 -0.91 . . . . 0.0 110.401 -179.797 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.54 ' HG3' HD21 ' A' ' 60' ' ' LEU . 54.1 Cg_endo -83.62 130.71 5.25 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.455 1.24 . . . . 0.0 109.814 179.516 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.595 HG23 ' H ' ' A' ' 70' ' ' ALA . 4.8 t -54.76 -177.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.192 -0.942 . . . . 0.0 110.091 -179.853 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -75.68 0.67 16.89 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.969 -1.082 . . . . 0.0 111.707 -179.163 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.502 ' H ' HG23 ' A' ' 67' ' ' THR . 2.6 m -110.86 -50.9 2.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.862 -1.149 . . . . 0.0 110.035 179.794 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.868 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -72.04 -26.82 62.34 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.635 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.443 ' CB ' ' O ' ' A' ' 67' ' ' THR . 5.6 ttt180 -67.26 -38.12 84.6 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.383 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -66.63 -36.95 83.8 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 118.718 -1.193 . . . . 0.0 108.724 179.061 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 70' ' ' ALA . 12.2 mt -72.79 -28.32 62.52 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.878 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.518 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 30.9 mt -71.55 -28.69 64.03 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 177.443 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -78.71 -30.62 46.07 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.327 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.2 tp-100 -84.07 -32.2 24.93 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.881 0.848 . . . . 0.0 110.265 -179.843 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 51' ' ' VAL . . . -63.88 -13.36 44.52 Favored 'General case' 0 C--N 1.289 -2.037 0 O-C-N 121.766 -0.583 . . . . 0.0 109.999 178.963 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 98.26 25.03 10.58 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.878 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 60' ' ' LEU . 30.1 t -85.43 -68.94 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.801 -1.411 . . . . 0.0 110.348 179.982 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.422 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 17.8 p90 -126.83 149.91 49.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.303 -0.873 . . . . 0.0 110.153 -179.98 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' CG ' ' O ' ' A' ' 80' ' ' PHE . 4.0 mtt180 -158.48 -79.23 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.411 -0.806 . . . . 0.0 109.904 179.932 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -164.72 1.96 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 110.044 179.727 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -96.39 76.84 2.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.862 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.77 123.62 26.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.205 -0.935 . . . . 0.0 109.693 179.693 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 4.1 mtm-85 -107.68 132.87 52.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.65 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -62.44 -48.75 78.31 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.375 -0.828 . . . . 0.0 110.059 179.78 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -54.74 -90.72 0.01 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.959 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.264 -1.139 . . . . 0.0 110.323 179.972 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.8 mtt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.229 0.538 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.612 HG21 HG23 ' A' ' 62' ' ' VAL . 14.1 m -119.0 116.49 51.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.333 -0.854 . . . . 0.0 110.596 -179.692 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.419 ' CG ' ' HB2' ' A' ' 65' ' ' GLN . 0.4 OUTLIER -140.25 132.26 27.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.288 -0.883 . . . . 0.0 110.184 179.667 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.861 ' CG1' HG13 ' A' ' 21' ' ' VAL . 76.3 mt -103.08 132.09 50.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.095 -1.003 . . . . 0.0 109.551 179.351 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 0.0 OUTLIER -151.35 -169.07 3.28 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.265 -0.897 . . . . 0.0 110.149 -179.2 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 6' ' ' LEU . 36.4 mt -88.81 129.41 35.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.193 -0.942 . . . . 0.0 110.3 179.752 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.488 ' O ' ' CE2' ' A' ' 9' ' ' PHE . . . -99.39 101.11 12.28 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.488 -0.758 . . . . 0.0 110.155 -179.914 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.45 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 1.2 tmm_? -71.18 115.14 9.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.722 -0.611 . . . . 0.0 111.538 -179.252 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.524 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 27.6 m-85 -102.77 -62.33 1.29 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.177 -0.952 . . . . 0.0 109.845 178.698 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -54.86 140.15 38.84 Favored Glycine 0 N--CA 1.482 1.71 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -178.679 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.421 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 55.2 p -92.75 -56.64 2.93 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -1.069 . . . . 0.0 109.595 179.403 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.421 ' N ' ' OG ' ' A' ' 11' ' ' SER . 1.1 mtmt -144.49 55.95 1.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 179.936 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -140.46 -64.28 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.325 -0.86 . . . . 0.0 109.396 -178.615 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -135.38 116.69 12.07 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.629 -0.67 . . . . 0.0 109.33 179.481 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.97 83.6 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.362 1.191 . . . . 0.0 111.1 -179.18 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 34.6 p80 -131.69 129.81 41.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 110.285 179.128 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.54 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 6.1 m-85 -121.4 162.17 20.87 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.224 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 2.1 mtt180 -106.6 159.56 16.1 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.043 -1.465 . . . . 0.0 107.043 176.13 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.886 HD12 ' CG2' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -98.09 78.6 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 177.628 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.511 HG13 ' HB3' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -97.65 167.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 CA-C-N 114.243 -1.344 . . . . 0.0 111.543 -173.845 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.935 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -108.99 105.58 19.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.285 0.564 . . . . 0.0 110.354 -177.662 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 32' ' ' TYR . 6.5 t -138.77 -165.85 1.9 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.307 -0.87 . . . . 0.0 110.294 179.79 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 25' ' ' ARG . 7.9 p-10 -140.57 -159.82 1.0 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.448 -0.783 . . . . 0.0 109.955 179.936 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.68 85.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.34 -0.85 . . . . 0.0 109.663 179.584 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -48.64 147.31 2.61 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.888 . . . . 0.0 110.49 -179.515 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.14 -63.16 1.33 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.305 -0.872 . . . . 0.0 110.595 -179.475 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 29.3 mttm -101.85 -162.52 0.94 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.139 -0.976 . . . . 0.0 110.421 -179.761 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -80.52 79.77 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.408 -0.807 . . . . 0.0 110.183 179.991 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.84 135.45 13.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.301 -0.874 . . . . 0.0 109.957 -179.948 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.74 64.06 3.75 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -179.831 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' O ' ' HB ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -73.93 -171.51 1.11 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.169 -1.195 . . . . 0.0 109.852 179.776 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.511 ' HB3' HG13 ' A' ' 20' ' ' VAL . 6.1 p90 179.45 178.98 0.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.254 -0.904 . . . . 0.0 110.777 -179.941 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.3 mt -97.59 -27.96 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.645 -0.66 . . . . 0.0 109.33 179.751 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.34 166.26 14.66 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.418 -0.801 . . . . 0.0 109.798 179.817 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.06 117.63 34.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.074 -1.016 . . . . 0.0 110.27 -179.886 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.932 HG21 ' CD1' ' A' ' 59' ' ' TRP . 41.4 pt -112.24 -33.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.091 -1.005 . . . . 0.0 111.153 -179.811 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.776 ' HA3' HG22 ' A' ' 51' ' ' VAL . . . -130.07 170.38 20.78 Favored Glycine 0 C--N 1.297 -1.614 0 C-N-CA 119.021 -1.561 . . . . 0.0 111.924 -178.362 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.511 ' N ' HG13 ' A' ' 19' ' ' ILE . 68.2 t80 -139.17 143.66 38.24 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.651 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.479 ' CE1' ' CZ3' ' A' ' 48' ' ' TRP . 11.8 t80 -140.04 123.72 17.3 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.857 -1.152 . . . . 0.0 109.995 -179.85 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.498 ' HB2' ' CE2' ' A' ' 38' ' ' TYR . 19.7 t0 -140.3 79.82 20.59 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 120.613 -1.304 . . . . 0.0 110.915 -179.865 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HG3' ' CZ ' ' A' ' 39' ' ' TYR . 48.1 Cg_endo -72.7 65.41 3.9 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.55 1.289 . . . . 0.0 110.654 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -89.65 -164.6 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.205 -0.934 . . . . 0.0 110.339 -179.828 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 3.3 pttm -121.51 38.42 4.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.884 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.454 HG23 ' OG1' ' A' ' 45' ' ' THR . 14.8 t -117.37 -32.32 4.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.21 -0.931 . . . . 0.0 110.141 179.99 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.454 ' OG1' HG23 ' A' ' 44' ' ' THR . 1.3 p -145.79 146.17 28.03 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 110.011 179.846 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.81 -29.57 15.34 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.651 1.343 . . . . 0.0 110.445 179.771 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -89.13 101.3 13.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 110.108 179.97 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.504 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 6.2 p-90 -121.81 -11.2 8.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.331 -0.856 . . . . 0.0 110.823 -179.904 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.541 HD12 HD23 ' A' ' 73' ' ' LEU . 7.1 tt -79.75 127.83 32.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.05 -1.031 . . . . 0.0 110.743 -179.481 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -139.46 100.2 3.92 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.889 . . . . 0.0 109.177 179.23 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.886 ' CG2' HD12 ' A' ' 19' ' ' ILE . 1.3 t -129.68 140.7 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 118.885 -1.126 . . . . 0.0 112.047 -179.054 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t0 -90.06 70.23 7.36 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.08 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.512 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -32.07 -33.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.474 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.741 -177.458 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 52' ' ' ASP . 1.6 mm-40 -60.43 -55.87 28.34 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.75 -1.219 . . . . 0.0 109.095 178.432 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.62 ' HB3' HG22 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -68.94 -40.81 78.74 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.481 -0.762 . . . . 0.0 109.135 178.836 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.722 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -64.81 -20.62 66.49 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.705 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.445 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 3.7 tpt180 -87.32 -22.52 25.07 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.2 -0.937 . . . . 0.0 110.079 178.511 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.486 ' HB3' ' O ' ' A' ' 55' ' ' ARG . 1.2 t80 -60.08 -49.21 78.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 123.317 1.532 . . . . 0.0 107.096 178.553 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.935 ' CD2' HG11 ' A' ' 21' ' ' VAL . 87.7 m95 -61.69 -51.22 69.31 Favored 'General case' 0 C--N 1.285 -2.232 0 CA-C-N 113.578 -1.646 . . . . 0.0 109.292 -179.569 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.46 HD12 HG11 ' A' ' 79' ' ' VAL . 18.5 mt -54.33 -22.35 11.85 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 176.669 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -79.25 -25.09 42.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.494 -0.754 . . . . 0.0 110.777 179.529 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.612 HG23 HG21 ' A' ' 2' ' ' VAL . 7.6 m -99.13 33.47 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.907 -1.121 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.5 31.32 78.41 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.918 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.572 ' HA ' HG23 ' A' ' 2' ' ' VAL . . . -63.16 138.5 58.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -1.22 . . . . 0.0 110.172 179.985 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.419 ' HB2' ' CG ' ' A' ' 3' ' ' LYS . 2.7 mp0 -104.06 103.39 37.67 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.893 . . . . 0.0 110.134 179.94 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.485 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 55.6 Cg_endo -82.2 130.06 6.23 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.499 1.263 . . . . 0.0 110.196 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 70' ' ' ALA . 3.8 t -64.65 168.44 6.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.983 -1.073 . . . . 0.0 109.739 179.757 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.62 -26.96 24.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.292 -0.88 . . . . 0.0 111.582 -178.914 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -87.26 -50.25 6.72 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.044 -1.035 . . . . 0.0 110.894 -179.472 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.765 ' H ' HG23 ' A' ' 67' ' ' THR . . . -66.61 -24.91 66.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.858 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 67' ' ' THR . 3.6 ttp180 -70.75 -39.81 73.05 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 178.429 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -65.93 -40.66 91.61 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 119.352 -0.939 . . . . 0.0 108.603 178.539 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 70' ' ' ALA . 14.7 mt -69.7 -29.07 66.4 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.576 -0.703 . . . . 0.0 109.125 179.017 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.485 ' CD1' ' HB3' ' A' ' 66' ' ' PRO . 20.8 mt -71.98 -27.58 62.85 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.565 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.545 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.22 -26.77 32.98 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.455 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.468 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 2.1 tp-100 -85.39 -37.68 19.57 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.642 0.734 . . . . 0.0 110.406 -179.58 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.468 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -65.43 -10.98 38.41 Favored 'General case' 0 C--N 1.289 -2.05 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.681 178.638 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 86.4 50.26 3.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.938 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.506 HG22 ' HB ' ' A' ' 53' ' ' VAL . 43.6 t -101.96 -56.81 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.087 -1.243 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.545 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.2 m-30 -54.66 -175.48 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.063 -1.023 . . . . 0.0 109.948 -179.379 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.46 42.83 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.224 -0.923 . . . . 0.0 110.46 -179.757 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -88.71 48.24 1.61 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 179.837 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -97.11 76.21 2.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.319 -179.792 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.98 177.84 0.73 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.171 179.935 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.58 0.98 16.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.172 -0.955 . . . . 0.0 110.703 -179.928 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -52.27 152.86 3.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 0.0 110.334 -179.958 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -138.14 89.87 0.2 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.953 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.325 -1.103 . . . . 0.0 110.155 -179.956 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' C ' HG23 ' A' ' 2' ' ' VAL . 2.5 mmm . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.112 0.482 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.496 HG23 ' C ' ' A' ' 1' ' ' MET . 57.9 t -149.71 134.66 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.0 110.557 -179.933 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' CE ' ' HB3' ' A' ' 65' ' ' GLN . 30.0 mtpt -140.37 134.6 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.235 -0.916 . . . . 0.0 110.073 179.759 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.936 ' CG1' HG13 ' A' ' 21' ' ' VAL . 74.3 mt -99.99 133.82 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.0 -1.063 . . . . 0.0 109.656 179.452 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.601 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -151.4 -172.27 4.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 110.646 -178.968 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 2.8 mp -89.1 125.86 35.21 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.286 -0.884 . . . . 0.0 110.904 -179.788 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -99.81 102.62 14.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.487 -0.758 . . . . 0.0 111.313 -179.5 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.506 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 4.9 ttm180 -68.97 119.12 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.404 -0.81 . . . . 0.0 111.577 179.917 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.525 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 25.7 m-85 -109.93 -62.86 1.45 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.156 -0.965 . . . . 0.0 110.13 178.569 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -49.97 138.35 20.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -178.679 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.47 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 36.9 p -84.66 -60.64 2.0 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.329 -1.1 . . . . 0.0 109.84 179.714 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.47 ' N ' ' OG ' ' A' ' 11' ' ' SER . 6.2 mttt -144.19 25.94 1.52 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.439 -0.788 . . . . 0.0 109.271 -179.79 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -109.97 -48.46 3.2 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.749 0.785 . . . . 0.0 109.21 -178.863 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' O ' ' CD2' ' A' ' 16' ' ' HIS . 10.5 m120 -150.64 103.51 3.06 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.475 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' O ' ' CG ' ' A' ' 41' ' ' PRO . 43.3 Cg_endo -69.22 64.84 1.49 Allowed 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.595 1.313 . . . . 0.0 111.183 -179.003 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 14' ' ' ASN . 31.4 p80 -104.63 136.12 44.77 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.172 -0.955 . . . . 0.0 109.513 178.895 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.0 m-85 -119.3 154.94 32.73 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.144 -0.972 . . . . 0.0 108.465 178.861 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.525 ' HG3' ' CE2' ' A' ' 9' ' ' PHE . 3.4 mmt180 -100.14 157.07 16.84 Favored 'General case' 0 C--N 1.294 -1.838 0 C-N-CA 118.128 -1.429 . . . . 0.0 107.669 176.614 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.956 HD12 ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -98.19 77.85 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.24 0 N-CA-C 102.469 -3.159 . . . . 0.0 102.469 176.824 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 35' ' ' LYS 0.258 0.4 OUTLIER -97.46 171.71 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.51 -173.715 . . . . . . . . 4 4 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.936 HG13 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -115.98 112.81 41.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.769 -0.582 . . . . 0.0 110.633 -177.184 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 32' ' ' TYR . 1.9 t -136.81 -177.18 4.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.072 -1.017 . . . . 0.0 110.492 179.591 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -134.49 -170.63 2.58 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.518 -0.739 . . . . 0.0 110.189 -179.839 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -127.59 25.34 6.07 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.145 -0.972 . . . . 0.0 110.292 -179.948 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.6 mtt-85 -62.64 -67.5 0.41 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 110.224 -179.907 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 ttm180 -73.91 -171.73 1.16 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.258 -0.901 . . . . 0.0 110.217 179.968 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -65.37 150.7 47.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.216 -0.927 . . . . 0.0 110.328 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.1 ttt-85 -71.82 110.1 6.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.244 -0.91 . . . . 0.0 110.158 179.891 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -123.17 -51.8 1.87 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 110.199 179.96 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.97 83.04 0.11 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.942 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.417 ' O ' ' HB ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -156.86 -163.3 1.39 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.224 -1.162 . . . . 0.0 110.222 -179.878 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CB ' HG13 ' A' ' 20' ' ' VAL . 23.5 p90 179.74 176.57 0.67 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.356 -0.84 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.625 HG21 ' HH2' ' A' ' 59' ' ' TRP . 4.4 mt -82.48 -50.3 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.576 -0.703 . . . . 0.0 109.869 179.658 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' O ' HG23 ' A' ' 21' ' ' VAL . 10.5 mt-10 -156.13 158.98 38.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.85 179.784 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.577 ' HA ' HG23 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -93.37 110.22 21.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.127 -0.983 . . . . 0.0 110.384 -179.864 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.984 HG21 ' CD1' ' A' ' 59' ' ' TRP . 26.4 pt -99.75 -36.71 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.22 -0.925 . . . . 0.0 110.717 -179.924 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.818 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -123.23 168.14 15.45 Favored Glycine 0 C--N 1.294 -1.783 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.361 -178.403 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.465 ' N ' HG13 ' A' ' 19' ' ' ILE . 93.0 t80 -140.13 135.78 32.85 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.745 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.604 ' CE2' ' CZ3' ' A' ' 48' ' ' TRP . 12.7 t80 -128.03 133.01 49.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.986 -1.071 . . . . 0.0 109.378 -179.973 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 31.1 t0 -140.31 105.62 6.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.901 -1.125 . . . . 0.0 110.327 179.768 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' CG ' ' O ' ' A' ' 15' ' ' PRO . 49.1 Cg_endo -77.42 1.81 8.38 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.571 1.301 . . . . 0.0 111.083 -179.818 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -89.45 -21.06 23.18 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.922 -1.111 . . . . 0.0 110.091 -179.956 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 48' ' ' TRP . 0.0 OUTLIER -50.47 129.81 22.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.848 179.647 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 71.4 p -90.7 22.42 3.54 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 110.576 -179.503 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.91 171.64 7.14 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.287 -0.883 . . . . 0.0 109.602 179.445 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.75 -14.07 26.96 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.587 1.309 . . . . 0.0 110.764 -179.945 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -106.79 90.32 3.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.105 -0.997 . . . . 0.0 110.157 179.933 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.604 ' CZ3' ' CE2' ' A' ' 39' ' ' TYR . 13.1 p-90 -113.64 3.5 15.67 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.249 -0.907 . . . . 0.0 110.716 179.966 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.727 HD13 ' HB3' ' A' ' 76' ' ' GLN . 7.9 tt -104.4 120.06 40.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.978 -1.076 . . . . 0.0 110.195 -179.859 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt -121.99 97.22 5.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.099 179.175 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.956 ' CG2' HD12 ' A' ' 19' ' ' ILE . 0.9 OUTLIER -120.3 159.73 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.334 1.064 . . . . 0.0 111.654 -178.854 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.451 ' O ' ' N ' ' A' ' 54' ' ' GLU . 6.9 t0 -107.21 65.84 0.66 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 175.98 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.798 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -35.0 -30.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.539 -177.542 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -59.93 -54.17 49.3 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.747 -1.221 . . . . 0.0 108.495 178.149 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.504 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 0.3 OUTLIER -75.74 -35.26 60.26 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.413 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.914 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -65.02 -21.02 66.78 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 177.969 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 53' ' ' VAL . 51.1 ttt-85 -86.61 -25.41 24.95 Favored 'General case' 0 N--CA 1.481 1.1 0 O-C-N 121.363 -0.836 . . . . 0.0 109.854 178.566 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.622 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.4 OUTLIER -58.04 -46.29 85.58 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 123.179 1.466 . . . . 0.0 107.547 178.773 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.984 ' CD1' HG21 ' A' ' 36' ' ' ILE . 81.9 m95 -66.14 -52.31 49.62 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.736 -1.574 . . . . 0.0 109.621 -179.259 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.752 HD11 HD22 ' A' ' 74' ' ' LEU . 6.4 mt -55.04 -22.19 14.87 Favored 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.441 177.119 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 57' ' ' ARG . 0.9 OUTLIER -80.96 -23.54 38.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.482 -0.761 . . . . 0.0 110.612 179.604 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 58' ' ' TYR . 5.1 m -98.9 32.92 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 O-C-N 120.925 -1.109 . . . . 0.0 109.549 -179.899 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.3 29.44 73.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.789 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 2' ' ' VAL . . . -70.48 126.1 28.67 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.043 -1.269 . . . . 0.0 109.975 179.816 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . 0.454 ' HB3' ' CE ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -93.68 111.19 51.53 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.207 -0.933 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.51 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 54.9 Cg_endo -82.29 130.71 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.492 1.259 . . . . 0.0 110.418 179.911 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.36 168.31 1.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.227 -0.92 . . . . 0.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -53.75 -30.35 43.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.122 -0.986 . . . . 0.0 110.243 -179.914 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.434 ' HB ' ' CD1' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -84.54 -50.4 7.74 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.433 -0.792 . . . . 0.0 110.384 -179.959 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.645 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.27 -22.88 66.91 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.227 -0.92 . . . . 0.0 108.781 179.972 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.35 -40.26 67.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 178.51 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.84 -38.86 83.73 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.691 -0.804 . . . . 0.0 108.921 178.802 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 70' ' ' ALA . 19.4 mt -69.05 -28.15 66.29 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.654 -0.654 . . . . 0.0 109.357 179.404 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.778 HD23 HG21 ' A' ' 79' ' ' VAL . 13.3 mt -73.07 -26.19 61.17 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.465 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.538 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -82.79 -28.68 30.11 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.271 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.727 ' HB3' HD13 ' A' ' 49' ' ' LEU . 4.8 tp-100 -83.01 -39.81 20.78 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 121.764 0.792 . . . . 0.0 110.152 179.96 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.503 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -65.04 -11.28 37.49 Favored 'General case' 0 C--N 1.29 -2.012 0 C-N-CA 120.035 -0.666 . . . . 0.0 109.872 178.433 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 83.79 51.64 3.96 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.855 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.778 HG21 HD23 ' A' ' 74' ' ' LEU . 53.6 t -102.48 -55.84 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.076 -1.25 . . . . 0.0 111.221 -179.686 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.538 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.3 m-30 -52.94 -25.15 10.96 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.136 -0.978 . . . . 0.0 110.423 -179.267 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.81 -39.66 39.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.148 -0.97 . . . . 0.0 110.364 -179.874 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -90.13 115.07 27.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.0 110.011 179.845 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -116.02 179.8 3.88 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.126 -0.984 . . . . 0.0 110.494 -179.806 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -155.43 -79.04 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.0 110.208 179.968 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -135.59 -69.85 0.49 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.246 -0.909 . . . . 0.0 110.477 -179.917 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -169.66 -175.13 2.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.138 -0.976 . . . . 0.0 110.208 -179.961 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -162.31 -141.53 3.15 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.965 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.382 -1.069 . . . . 0.0 110.227 179.898 . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.3 ttm . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.244 0.545 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.547 HG11 ' CE3' ' A' ' 59' ' ' TRP . 73.8 t -110.57 141.19 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.262 -0.899 . . . . 0.0 110.016 179.937 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.4 mmmm -137.8 131.01 30.54 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.18 -0.95 . . . . 0.0 110.355 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.018 HD11 ' CB ' ' A' ' 59' ' ' TRP . 93.3 mt -102.69 129.46 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.089 -1.007 . . . . 0.0 109.534 179.251 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 19' ' ' ILE . 28.1 ptt180 -151.67 -166.63 2.56 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.116 -0.99 . . . . 0.0 111.232 -179.37 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.683 HD12 ' N ' ' A' ' 6' ' ' LEU . 7.0 mp -89.05 127.41 35.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.365 -0.834 . . . . 0.0 111.214 -179.212 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 9' ' ' PHE . . . -100.26 105.52 17.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.789 . . . . 0.0 110.655 179.855 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HG3' ' CE2' ' A' ' 17' ' ' TYR . 14.9 ttt180 -75.08 121.93 22.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.023 -1.048 . . . . 0.0 111.302 -179.711 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.623 ' CZ ' ' HB3' ' A' ' 7' ' ' ALA . 16.5 m-85 -114.09 -61.61 1.72 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.29 -0.881 . . . . 0.0 110.6 179.313 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.78 134.44 5.78 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.269 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.457 ' OG ' ' N ' ' A' ' 12' ' ' LYS . 24.1 p -96.4 -56.43 2.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.444 -1.033 . . . . 0.0 109.752 179.552 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.457 ' N ' ' OG ' ' A' ' 11' ' ' SER . 39.2 mttt -145.3 49.17 1.26 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.719 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.405 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 3.0 m-70 -138.33 -58.74 0.64 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.287 -0.883 . . . . 0.0 109.824 -177.963 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -148.29 127.06 6.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.428 -0.795 . . . . 0.0 109.806 179.823 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -77.19 90.67 1.23 Allowed 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.471 1.248 . . . . 0.0 111.361 -179.423 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . 0.501 ' CE1' ' HB2' ' A' ' 9' ' ' PHE . 35.3 p80 -132.31 129.22 39.23 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.222 -0.924 . . . . 0.0 110.053 178.847 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.529 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 5.0 m-85 -119.25 149.29 42.01 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.406 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.539 ' C ' HD13 ' A' ' 19' ' ' ILE . 13.5 mtt-85 -101.12 161.99 13.21 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.064 -1.455 . . . . 0.0 108.457 177.178 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.073 HD11 ' HB2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -99.1 80.28 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 177.649 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 4' ' ' ILE 0.252 0.4 OUTLIER -97.61 165.25 2.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.155 -173.75 . . . . . . . . 4 4 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -108.94 115.34 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.896 -0.503 . . . . 0.0 110.596 -177.659 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 32' ' ' TYR . 1.1 t -140.66 -177.64 5.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.08 -1.013 . . . . 0.0 110.7 179.116 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -94.6 164.41 12.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.828 . . . . 0.0 110.526 -179.696 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -121.02 31.26 6.46 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.376 -0.827 . . . . 0.0 110.047 179.913 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -50.93 -59.96 3.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 110.589 -179.878 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -152.35 136.95 16.89 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 110.292 -179.709 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -64.26 94.79 0.12 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.302 -0.874 . . . . 0.0 110.04 179.619 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.23 -38.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.114 -179.862 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -101.9 177.06 5.01 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 110.063 179.783 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -144.86 55.09 0.55 Allowed Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.846 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.59 122.62 44.19 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.366 -1.079 . . . . 0.0 110.383 -179.698 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' THR . 5.9 p90 -111.74 179.63 3.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.185 -0.947 . . . . 0.0 110.336 179.395 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.797 HG21 ' HH2' ' A' ' 59' ' ' TRP . 10.0 mm -96.53 -41.35 11.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.361 -0.837 . . . . 0.0 109.576 -179.796 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.15 167.07 10.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.468 -0.77 . . . . 0.0 109.913 179.946 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -96.24 107.65 20.02 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.12 -0.988 . . . . 0.0 110.307 -179.89 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.916 HG21 ' CD1' ' A' ' 59' ' ' TRP . 28.1 pt -99.91 -36.51 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.157 -0.965 . . . . 0.0 110.571 179.936 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.785 ' CA ' HG22 ' A' ' 51' ' ' VAL . . . -122.78 165.89 15.35 Favored Glycine 0 C--N 1.295 -1.716 0 C-N-CA 119.027 -1.559 . . . . 0.0 111.989 -178.521 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.45 ' N ' HG12 ' A' ' 19' ' ' ILE . 9.3 t80 -140.49 130.53 24.77 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.066 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 1.073 ' HB2' HD11 ' A' ' 19' ' ' ILE . 4.9 t80 -131.58 133.14 44.69 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.636 -1.29 . . . . 0.0 110.378 -179.738 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 48' ' ' TRP . 4.2 t0 -133.01 89.21 34.67 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.918 -1.113 . . . . 0.0 109.997 179.495 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' HD2' ' HA ' ' A' ' 16' ' ' HIS . 41.7 Cg_endo -68.98 74.37 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.54 1.284 . . . . 0.0 110.921 -179.686 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.28 177.25 6.01 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.3 -0.875 . . . . 0.0 109.976 179.683 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 4.1 mmtm -119.56 45.86 2.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.165 -0.959 . . . . 0.0 110.281 -179.958 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.406 ' OG1' ' N ' ' A' ' 45' ' ' THR . 64.4 p -131.48 -69.52 0.62 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.321 -0.862 . . . . 0.0 110.036 179.888 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.406 ' N ' ' OG1' ' A' ' 44' ' ' THR . 45.8 p -112.56 144.82 31.68 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.319 -0.863 . . . . 0.0 110.118 179.848 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.01 -20.84 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.654 1.344 . . . . 0.0 110.683 -179.888 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.66 77.3 2.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.19 -0.944 . . . . 0.0 110.221 -179.894 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 49' ' ' LEU . 8.2 p-90 -123.25 4.28 9.17 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.326 -0.859 . . . . 0.0 110.927 -179.954 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.505 ' CD1' ' HB3' ' A' ' 76' ' ' GLN . 10.2 tt -100.51 123.61 44.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.809 -1.182 . . . . 0.0 111.071 -179.033 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.93 93.83 3.16 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.46 -0.775 . . . . 0.0 109.474 179.328 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.785 HG22 ' CA ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -122.03 135.45 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.086 -1.046 . . . . 0.0 111.607 -179.071 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.437 ' O ' ' N ' ' A' ' 54' ' ' GLU . 1.3 t70 -84.3 69.83 10.52 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 175.838 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.714 ' HA ' ' HB3' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -36.6 -29.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 O-C-N 122.135 -0.353 . . . . 0.0 111.496 -177.405 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 52' ' ' ASP . 0.9 OUTLIER -59.64 -51.69 68.74 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.7 -1.25 . . . . 0.0 108.745 178.605 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.489 ' O ' ' HB3' ' A' ' 58' ' ' TYR . 26.7 mmm180 -75.9 -38.35 57.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.509 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 36' ' ' ILE . . . -63.44 -21.23 66.18 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.282 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.446 ' N ' ' O ' ' A' ' 53' ' ' VAL . 15.2 ttt180 -88.31 -21.86 24.18 Favored 'General case' 0 N--CA 1.482 1.158 0 O-C-N 121.315 -0.865 . . . . 0.0 109.732 178.447 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.51 ' O ' HG13 ' A' ' 62' ' ' VAL . 0.3 OUTLIER -65.34 -48.26 73.61 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 123.194 1.474 . . . . 0.0 107.668 178.704 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 1.018 ' CB ' HD11 ' A' ' 4' ' ' ILE . 81.4 m95 -63.82 -54.03 41.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.834 -179.04 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.501 HD11 HD13 ' A' ' 74' ' ' LEU . 83.4 mt -55.33 -21.04 13.4 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 118.984 -1.086 . . . . 0.0 108.33 177.256 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.416 ' HB2' ' O ' ' A' ' 58' ' ' TYR . 0.6 OUTLIER -80.43 -23.91 39.98 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.4 -0.812 . . . . 0.0 110.773 179.504 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 59' ' ' TRP . 10.1 m -99.16 34.02 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 O-C-N 120.849 -1.157 . . . . 0.0 109.574 179.817 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.32 26.06 74.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.588 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.448 ' HB3' ' C ' ' A' ' 59' ' ' TRP . . . -73.67 112.07 9.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.983 -1.304 . . . . 0.0 109.718 179.69 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.88 116.52 64.54 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 0.0 110.664 -179.521 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 51.2 Cg_endo -83.61 124.47 3.57 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.471 1.248 . . . . 0.0 109.567 179.13 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 5.2 t -55.08 175.26 0.06 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 110.468 -179.47 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -76.52 56.61 1.13 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.218 -0.926 . . . . 0.0 110.474 179.993 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 m -165.9 -60.97 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.745 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.884 ' HA ' HD12 ' A' ' 73' ' ' LEU . . . -65.85 -25.2 67.09 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.819 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 66' ' ' PRO . 4.8 ttp180 -65.76 -41.56 91.94 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.065 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.03 -41.51 98.18 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.682 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.884 HD12 ' HA ' ' A' ' 70' ' ' ALA . 13.3 mt -70.03 -32.81 71.13 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.983 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' CD2' ' HB1' ' A' ' 56' ' ' ALA . 46.9 mt -68.58 -26.83 65.59 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.805 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.534 ' CG ' ' CD2' ' A' ' 80' ' ' PHE . 0.8 OUTLIER -82.13 -28.78 32.01 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.395 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.505 ' HB3' ' CD1' ' A' ' 49' ' ' LEU . 0.8 OUTLIER -82.52 -36.86 25.98 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.706 0.765 . . . . 0.0 110.43 -179.677 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.426 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -67.37 -8.96 36.8 Favored 'General case' 0 C--N 1.289 -2.024 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.986 178.663 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 84.22 50.75 4.19 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.574 HG22 ' HB ' ' A' ' 53' ' ' VAL . 39.8 t -101.11 -55.5 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.032 -1.275 . . . . 0.0 111.36 -179.552 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.534 ' CD2' ' CG ' ' A' ' 75' ' ' ARG . 6.0 m-30 -54.56 140.14 35.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.145 -0.972 . . . . 0.0 110.149 -179.44 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -68.69 161.37 28.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 0.0 110.211 -179.943 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -68.45 158.01 34.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.324 -0.86 . . . . 0.0 110.682 -179.624 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -95.74 113.53 25.17 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.274 -0.891 . . . . 0.0 109.868 179.584 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.84 -26.41 44.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 110.362 -179.764 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -54.99 -63.37 1.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 0.0 110.253 -179.888 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -61.01 -64.16 1.05 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.538 -179.906 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -81.76 113.95 3.74 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.861 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.313 -1.11 . . . . 0.0 110.194 -179.886 . . . . . . . . 0 0 . 1 stop_ save_